<?xml version="1.0" encoding="UTF-8"?>
<rows>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911286</term_id>
  <id>15170</id>
  <title>Photodynamic Therapy for Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Photodynamic Therapy for Cancer</field_short_title>
  <field_page_description>A fact sheet that explains photodynamic therapy, how it is administered, and indications and side effects of treatment.</field_page_description>
  <field_date_posted>2011-09-06</field_date_posted>
  <field_date_reviewed>2011-09-06</field_date_reviewed>
  <field_pretty_url>photodynamic-fact-sheet</field_pretty_url>
  <para_id>15170</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>914830</term_id>
  <id>915263</id>
  <title>Research Performance Progress Report (RPPR)</title>
  <langcode>en</langcode>
  <field_short_title>Research Performance Progress Report (RPPR)</field_short_title>
  <field_date_posted>2015-04-02</field_date_posted>
  <field_date_reviewed>2015-03-12</field_date_reviewed>
  <para_id>915263</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>911142</term_id>
  <id>915358</id>
  <title>Hormones </title>
  <langcode>en</langcode>
  <field_short_title>Hormones</field_short_title>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915358</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915624</term_id>
  <id>915663</id>
  <title>Public Health Research and Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Public Health Research and Cancer</field_short_title>
  <field_page_description>Population-based cancer research can provide important information that influences practices, policies, and programs that directly affect and could improve public health.</field_page_description>
  <field_date_posted>2015-05-07</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915663</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>898585</term_id>
  <id>916661</id>
  <title>Progress in Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Progress</field_short_title>
  <field_page_description>Through its Annual Report to the Nation and other reports and publications, the National Cancer Institute – leader of the National Cancer Program – marks the progress that’s been made by the cancer research community. </field_page_description>
  <field_date_posted>2015-03-16</field_date_posted>
  <field_date_reviewed>2015-03-16</field_date_reviewed>
  <para_id>916661</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>916828</term_id>
  <id>916829</id>
  <title>Grants Management Contacts</title>
  <langcode>en</langcode>
  <field_short_title>Grants Management Contacts</field_short_title>
  <field_page_description>Contact a grants management specialist assigned to your institution. </field_page_description>
  <field_date_posted>2019-02-01</field_date_posted>
  <field_date_reviewed>2019-02-01</field_date_reviewed>
  <para_id>916829</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>917415</id>
  <title>Grantee Spotlight: Joseph Kofi Agyin, PhD, MBA - Exploring Bone-Targeted Proteasome Inhibitors to Cure Multiple Myeloma</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Joseph Kofi Agyin, PhD, MBA </field_short_title>
  <field_date_posted>2014-07-14</field_date_posted>
  <field_date_reviewed>2014-07-14</field_date_reviewed>
  <field_pretty_url>agyin-spotlight-blog</field_pretty_url>
  <para_id>917415</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>917486</id>
  <title>Grantee Spotlight: Dana-Lynn Koomoa-Lange, Ph.D.- Exploring Chemical Pathways to Hinder Development of Neuroblastoma</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Dana-Lynn Koomoa-Lange, Ph.D.</field_short_title>
  <field_date_posted>2014-09-23</field_date_posted>
  <field_date_reviewed>2014-09-23</field_date_reviewed>
  <para_id>917486</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917277</term_id>
  <id>917733</id>
  <title>NCI Community Oncology Research Program (NCORP) - Cancer Control Steering Committees</title>
  <langcode>en</langcode>
  <field_short_title>NCORP - Cancer Control Steering Committees</field_short_title>
  <field_page_description>Information about Cancer Care Delivery Research (CCDR) and Symptom Management and Health-Related Quality of Life (SxQOL) Steering Committees, including membership, clinical trial planning meetings, publications and approved trials conducted through NCORP.</field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2015-03-20</field_date_reviewed>
  <para_id>917733</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>916951</term_id>
  <id>918912</id>
  <title>NCI Advisory Boards, Committees, and Review Groups</title>
  <langcode>en</langcode>
  <field_short_title>Advisory Boards </field_short_title>
  <field_date_posted>2015-03-23</field_date_posted>
  <field_date_reviewed>2015-03-23</field_date_reviewed>
  <para_id>918912</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911286</term_id>
  <id>15469</id>
  <title>Cryosurgery in Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Cryosurgery in Cancer Treatment</field_short_title>
  <field_page_description>A fact sheet that describes cryosurgery, the technique of using extreme cold to treat tumors. Lists the indications, risks, benefits, and side effects of cryotherapy.</field_page_description>
  <field_date_posted>2005-09-09</field_date_posted>
  <field_date_reviewed>2003-09-10</field_date_reviewed>
  <field_pretty_url>cryosurgery-fact-sheet</field_pretty_url>
  <para_id>15469</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>882493</term_id>
  <id>15541</id>
  <title>Formaldehyde and Cancer Risk</title>
  <langcode>en</langcode>
  <field_short_title>Formaldehyde and Cancer Risk</field_short_title>
  <field_page_description>A fact sheet that discusses formaldehyde and its possible association with cancer. Includes resources for more information.</field_page_description>
  <field_date_posted>2011-06-10</field_date_posted>
  <field_date_reviewed>2011-06-10</field_date_reviewed>
  <field_pretty_url>formaldehyde-fact-sheet</field_pretty_url>
  <para_id>15541</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>11738</term_id>
  <id>16393</id>
  <title>NCI Cancer Genetics Services Directory: Search Results</title>
  <langcode>en</langcode>
  <field_short_title>NCI Cancer Genetics Services Directory: Search Results</field_short_title>
  <field_date_posted>2011-02-02</field_date_posted>
  <field_date_reviewed>2011-02-02</field_date_reviewed>
  <field_pretty_url>results</field_pretty_url>
  <para_id>16393</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>63846</term_id>
  <id>63856</id>
  <title>Paying for Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>Paying for Clinical Trials</field_short_title>
  <field_page_description>Learn about the different types of costs related to taking part in a clinical trial, who is expected to pay for which costs, and tips for working with insurance companies.</field_page_description>
  <field_date_posted>2011-02-24</field_date_posted>
  <field_date_reviewed>2011-02-24</field_date_reviewed>
  <para_id>63856</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>333718</id>
  <title>Study shows colon and rectal tumors constitute a single type of cancer; &lt;span style="font-weight:normal"&gt;&lt;i&gt;The Cancer Genome Atlas generates genomic data for colon and rectal cancers that point to potential targets for treatment&lt;/i&gt;&lt;/span&gt;</title>
  <langcode>en</langcode>
  <field_short_title>Study shows colon and rectal tumors constitute a single type of cancer</field_short_title>
  <field_page_description>The pattern of genomic alterations in colon and rectal tissues is the same regardless of anatomic location or origin within the colon or the rectum, leading researchers to conclude that these two cancer types can be grouped as one, according to The Cancer</field_page_description>
  <field_date_posted>2012-07-18</field_date_posted>
  <field_date_reviewed>2012-07-17</field_date_reviewed>
  <field_pretty_url>TCGAcolorectal</field_pretty_url>
  <para_id>333718</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919516</term_id>
  <id>807051</id>
  <title>OGA Staff</title>
  <langcode>en</langcode>
  <field_short_title>OGA Staff</field_short_title>
  <field_date_posted>2019-02-07</field_date_posted>
  <field_date_reviewed>2019-02-07</field_date_reviewed>
  <para_id>807051</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>809153</id>
  <title>Reducing the Burden of Cancer in East Africa</title>
  <langcode>en</langcode>
  <field_short_title>Reducing the Burden of Cancer in East Africa</field_short_title>
  <field_date_posted>2014-07-29</field_date_posted>
  <field_date_reviewed>2014-07-29</field_date_reviewed>
  <field_pretty_url>east-africa</field_pretty_url>
  <para_id>809153</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>809187</id>
  <title>NCI Statement on the U.S. Surgeon General's "Call to Action to Prevent Skin Cancer"</title>
  <langcode>en</langcode>
  <field_short_title>NCI Statement on the U.S. Surgeon General's "Call to Action to Prevent Skin Cancer"</field_short_title>
  <field_date_posted>2014-07-29</field_date_posted>
  <field_date_reviewed>2014-07-29</field_date_reviewed>
  <field_pretty_url>CallToActionToPreventSkinCancer</field_pretty_url>
  <para_id>809187</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>810259</term_id>
  <id>810260</id>
  <title>Office of Communications and Public Liaison</title>
  <langcode>en</langcode>
  <field_short_title>Office of Communications and Public Liaison</field_short_title>
  <field_date_posted>2014-08-04</field_date_posted>
  <field_date_reviewed>2014-08-04</field_date_reviewed>
  <para_id>810260</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>937897</term_id>
  <id>821976</id>
  <title>Training Providers and Patients to Talk about End-of-Life Care</title>
  <langcode>en</langcode>
  <field_short_title>Training Providers and Patients to Talk about End-of-Life Care</field_short_title>
  <field_date_posted>2010-03-23</field_date_posted>
  <field_date_reviewed>2014-09-03</field_date_reviewed>
  <field_pretty_url>training-talk-end-of-life-care</field_pretty_url>
  <para_id>821976</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938227</term_id>
  <id>824933</id>
  <title>Matters of the Heart: Why Are Cardiac Tumors So Rare?</title>
  <langcode>en</langcode>
  <field_short_title>Matters of the Heart: Why Are Cardiac Tumors So Rare?</field_short_title>
  <field_date_posted>2009-02-10</field_date_posted>
  <field_date_reviewed>2014-09-05</field_date_reviewed>
  <field_pretty_url>cardiac-tumors</field_pretty_url>
  <para_id>824933</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>608323</term_id>
  <id>827181</id>
  <title>HER2’s Genetic Link to Breast Cancer Spurs Development of New Treatments </title>
  <langcode>en</langcode>
  <field_short_title>HER2's Genetic Link to Breast Cancer</field_short_title>
  <field_page_description>When researchers discovered the HER2 gene's importance to breast cancer growth, this led to the development of trastuzumab and other treatments that have improved survival for women with HER2-positive breast cancer.</field_page_description>
  <field_date_posted>2014-09-15</field_date_posted>
  <field_date_reviewed>2014-09-15</field_date_reviewed>
  <field_pretty_url>HER2</field_pretty_url>
  <para_id>827181</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>904178</term_id>
  <id>828659</id>
  <title>Examples of Cancer Health Disparities</title>
  <langcode>en</langcode>
  <field_short_title>Examples of Cancer Health Disparities</field_short_title>
  <field_date_posted>2014-09-17</field_date_posted>
  <field_date_reviewed>2014-09-17</field_date_reviewed>
  <para_id>828659</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>904180</term_id>
  <id>828660</id>
  <title>Health Disparities Resources</title>
  <langcode>en</langcode>
  <field_short_title>Health Disparities Resources</field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-09-17</field_date_reviewed>
  <para_id>828660</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>904068</term_id>
  <id>828713</id>
  <title>About The Center to Reduce Cancer Health Disparities</title>
  <langcode>en</langcode>
  <field_short_title>About CRCHD</field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-09-18</field_date_reviewed>
  <para_id>828713</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>941579</term_id>
  <id>829631</id>
  <title>NCI-MATCH Trial (Molecular Analysis for Therapy Choice)</title>
  <langcode>en</langcode>
  <field_short_title>NCI-MATCH Trial (Molecular Analysis for Therapy Choice)</field_short_title>
  <field_page_description>Information about the NCI-MATCH precision medicine trial, in which patients with advanced solid tumors and lymphomas are assigned to treatment arms based on the molecular profiles of their disease.</field_page_description>
  <field_date_posted>2015-06-01</field_date_posted>
  <field_date_reviewed>2014-09-19</field_date_reviewed>
  <field_pretty_url>nci-match</field_pretty_url>
  <para_id>829631</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>833181</term_id>
  <id>833187</id>
  <title>Special Populations Networks (SPN) </title>
  <langcode>en</langcode>
  <field_short_title>SPN </field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-09-24</field_date_reviewed>
  <para_id>833187</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>833196</term_id>
  <id>833198</id>
  <title>National Outreach Network (NON)</title>
  <langcode>en</langcode>
  <field_short_title>NON</field_short_title>
  <field_date_posted>2014-09-24</field_date_posted>
  <field_date_reviewed>2014-09-24</field_date_reviewed>
  <para_id>833198</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>136764</id>
  <title>Long-Term Data from 20 Trials Confirm Tamoxifen’s Long-Lasting Benefit</title>
  <langcode>en</langcode>
  <field_short_title>Long-Term Data from 20 Trials Confirm Tamoxifen's Long-Lasting Benefit</field_short_title>
  <field_page_description>Women with estrogen receptor-positive breast cancer who received about 5 years of adjuvant tamoxifen had a lower risk of recurrence in the 15 years after treatment than women who did not receive tamoxifen.</field_page_description>
  <field_date_posted>2011-11-23</field_date_posted>
  <field_date_reviewed>2011-11-23</field_date_reviewed>
  <field_pretty_url>tamoxifen-long-lasting-benefit</field_pretty_url>
  <para_id>136764</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>139068</id>
  <title>Radiation Therapy after Breast-Conserving Surgery Improves Survival</title>
  <langcode>en</langcode>
  <field_short_title>Radiation Therapy after Breast-Conserving Surgery Improves Survival</field_short_title>
  <field_page_description>Radiation therapy after breast-conserving surgery substantially reduces the risk of cancer recurring in the breast and moderately reduces the risk of death from the disease.</field_page_description>
  <field_date_posted>2011-12-02</field_date_posted>
  <field_date_reviewed>2011-12-02</field_date_reviewed>
  <field_pretty_url>radiation-improves-survival</field_pretty_url>
  <para_id>139068</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>150014</id>
  <title>Two Drugs that Hit One Target Improve Survival in Women with Metastatic Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Targeted Drug Combination Improves Survival in Women with Metastatic Breast Cancer</field_short_title>
  <field_page_description>Combining two drugs that target the HER2 protein, trastuzumab (Herceptin®) and pertuzumab, with chemotherapy may be a new treatment option for women with HER2-positive metastatic breast cancer.</field_page_description>
  <field_date_posted>2011-12-21</field_date_posted>
  <field_date_reviewed>2011-12-21</field_date_reviewed>
  <field_pretty_url>two-drugs-one-target</field_pretty_url>
  <para_id>150014</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>912559</term_id>
  <id>895058</id>
  <title>CCG News and Events </title>
  <langcode>en</langcode>
  <field_short_title>CCG News &amp; Events </field_short_title>
  <field_page_description>NCI's Center for Cancer Genomics (CCG) has been widely recognized for its research efforts to facilitiate advances in cancer genomic research and improve patient outcomes. Find the latest news about and events featuring CCG.</field_page_description>
  <field_date_posted>2015-04-13</field_date_posted>
  <field_date_reviewed>2015-01-14</field_date_reviewed>
  <para_id>895058</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>898466</term_id>
  <id>898468</id>
  <title>Anemia and Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Anemia</field_short_title>
  <field_page_description>Anemia is a side effect of cancer treatments, including chemotherapy and radiation therapy. It can make women and men feel fatigued, dizzy, and short of breath. Learn how to manage fatigue caused by anemia during cancer treatment.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2018-02-13</field_date_reviewed>
  <para_id>898468</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>899180</id>
  <title>Grantee Spotlight: Bill Nelson, M.D., Ph.D. - Steering a Partnership to Improve Cancer Outcomes for African Americans in Maryland and DC</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Bill Nelson, M.D., Ph.D.</field_short_title>
  <field_date_posted>2015-01-19</field_date_posted>
  <field_date_reviewed>2015-01-20</field_date_reviewed>
  <field_pretty_url>nelson-spotlight</field_pretty_url>
  <para_id>899180</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>899353</id>
  <title>Program Spotlight: Arizona's Partnership for Native American Cancer Prevention - Fostering the Next Generation of Native American Cancer Researchers</title>
  <langcode>en</langcode>
  <field_short_title>Program Spotlight: Arizona's Partnership for Native American Cancer Prevention</field_short_title>
  <field_date_posted>2014-12-11</field_date_posted>
  <field_date_reviewed>2014-12-11</field_date_reviewed>
  <field_pretty_url>nacp-spotlight</field_pretty_url>
  <para_id>899353</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>899429</id>
  <title>Grantee Spotlight: Daniel Petereit, M.D. - A "Frontier" Oncologist Studying Smoking Cessation in American Indians </title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Daniel Petereit, M.D. - A "Frontier" Oncologist Studying Smoking Cessation </field_short_title>
  <field_date_posted>2014-05-05</field_date_posted>
  <field_date_reviewed>2014-05-05</field_date_reviewed>
  <field_pretty_url>petereit-spotlight</field_pretty_url>
  <para_id>899429</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>901913</id>
  <title>Precision Medicine Initiative&amp;reg; and Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Precision Medicine Initiative&amp;reg; and Cancer Research</field_short_title>
  <field_page_description>Under the Precision Medicine Initiative, NCI is working to accelerate the pace of research that will help identify which treatments work best for which patients.</field_page_description>
  <field_date_posted>2015-01-30</field_date_posted>
  <field_date_reviewed>2015-01-30</field_date_reviewed>
  <field_pretty_url>precision-medicine-initiative-2016</field_pretty_url>
  <para_id>901913</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>899926</term_id>
  <id>902108</id>
  <title>Nausea and Vomiting in People with Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Nausea and Vomiting</field_short_title>
  <field_page_description>Types of nausea and vomiting caused by cancer treatment include: anticipatory, acute, and delayed. Controlling these side effects will help to prevent serious problems such as malnutrition and dehydration in people with cancer.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-01-30</field_date_reviewed>
  <para_id>902108</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>903672</id>
  <title>Genome Study Yields Clues to Head and Neck Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Genome Study Yields Clues to Head and Neck Cancers</field_short_title>
  <field_date_posted>2015-02-03</field_date_posted>
  <field_date_reviewed>2015-02-03</field_date_reviewed>
  <field_pretty_url>tcga-head-and-neck-hpv</field_pretty_url>
  <para_id>903672</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>899932</term_id>
  <id>903722</id>
  <title>Diarrhea and Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Diarrhea</field_short_title>
  <field_page_description>Diarrhea, a side effect of cancer treatment, may cause symptoms such as loose, watery stools. Diarrhea can lead to dehydration and malnutrition in cancer patients. Learn about ways to treat and manage diarrhea during cancer treatment.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2017-12-04</field_date_reviewed>
  <para_id>903722</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>861460</term_id>
  <id>12891</id>
  <title>Cell Phones and Cancer Risk</title>
  <langcode>en</langcode>
  <field_short_title>Cell Phones and Cancer Risk</field_short_title>
  <field_page_description>A fact sheet that outlines the available evidence regarding use of cellular/mobile telephones and cancer risk.</field_page_description>
  <field_date_posted>2019-01-14</field_date_posted>
  <field_date_reviewed>2018-11-01</field_date_reviewed>
  <field_pretty_url>cell-phones-fact-sheet</field_pretty_url>
  <para_id>12891</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915370</term_id>
  <id>13089</id>
  <title>Home Care Nursing Improves Cancer Symptom Management</title>
  <langcode>en</langcode>
  <field_short_title>Home Care Nursing Improves Cancer Symptom Management</field_short_title>
  <field_page_description>Home care nursing (HCN) improves the management of symptoms in breast and colorectal cancer patients who take the oral chemotherapy drug capecitabine, according to a study published online November 16 in the &lt;i&gt;Journal of Clinical Oncology&lt;/i&gt;.</field_page_description>
  <field_date_posted>2009-12-16</field_date_posted>
  <field_date_reviewed>2009-12-16</field_date_reviewed>
  <field_pretty_url>home-care-symptom-management</field_pretty_url>
  <para_id>13089</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>858168</term_id>
  <id>859575</id>
  <title>Cancer Support Groups</title>
  <langcode>en</langcode>
  <field_short_title>Support Groups</field_short_title>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-17</field_date_reviewed>
  <para_id>859575</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>857993</term_id>
  <id>859583</id>
  <title>Day-to-Day Life</title>
  <langcode>en</langcode>
  <field_short_title>Day-to-Day Life</field_short_title>
  <field_page_description>Enjoy life and stay active during and after cancer treatment. Get tips for keeping up with your daily routine, going back to work, and finding spiritual well-being.</field_page_description>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-17</field_date_reviewed>
  <para_id>859583</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>858187</term_id>
  <id>859801</id>
  <title>Support for Caregivers of Cancer Patients</title>
  <langcode>en</langcode>
  <field_short_title>Support for Caregivers</field_short_title>
  <field_page_description>Being a caregiver of cancer patients can be stressful. Find out what to expect and how to deal with caring for a loved one with cancer.</field_page_description>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-17</field_date_reviewed>
  <para_id>859801</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>860262</term_id>
  <id>860263</id>
  <title>Human Papillomavirus (HPV) Vaccines: An Interview with Douglas R. Lowy, M.D.</title>
  <langcode>en</langcode>
  <field_short_title>Human Papillomavirus (HPV) Vaccines: An Interview with Douglas R. Lowy, M.D.</field_short_title>
  <field_page_description>NCI’s Dr. Doug Lowy discusses HPV vaccines, including their efficacy, safety, and the development of next-generation vaccines.</field_page_description>
  <field_date_posted>2014-11-20</field_date_posted>
  <field_date_reviewed>2014-11-20</field_date_reviewed>
  <field_pretty_url>hpv-vaccines-lowy</field_pretty_url>
  <para_id>860263</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>762611</term_id>
  <id>861865</id>
  <title>CGH Staff Present at the World Cancer Congress 2014</title>
  <langcode>en</langcode>
  <field_short_title>CGH at World Cancer Congress 2014</field_short_title>
  <field_date_posted>2014-11-24</field_date_posted>
  <field_date_reviewed>2014-11-24</field_date_reviewed>
  <field_pretty_url>wcc-2014</field_pretty_url>
  <para_id>861865</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>903959</term_id>
  <id>866520</id>
  <title>About The Center for Cancer Genomics (CCG)</title>
  <langcode>en</langcode>
  <field_short_title>About CCG</field_short_title>
  <field_page_description>The Center for Cancer Genomics applies next-generation sequencing and genomic analysis to identify genetic drivers of cancer and produce data for researchers.</field_page_description>
  <field_date_posted>2015-04-13</field_date_posted>
  <field_date_reviewed>2014-12-03</field_date_reviewed>
  <para_id>866520</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>783955</term_id>
  <id>867853</id>
  <title>Office of Budget and Finance (OBF)</title>
  <langcode>en</langcode>
  <field_short_title>Office of Budget and Finance (OBF)</field_short_title>
  <field_date_posted>2014-12-05</field_date_posted>
  <field_date_reviewed>2014-12-05</field_date_reviewed>
  <para_id>867853</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>869606</term_id>
  <id>869607</id>
  <title>CRCHD Funding for Research and Training</title>
  <langcode>en</langcode>
  <field_short_title>Funding for Research &amp; Training </field_short_title>
  <field_page_description>CRCHD provides extramural research grants to researchers and institutions and training and career development funding opportunities to increase workforce diversity.</field_page_description>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-12-08</field_date_reviewed>
  <para_id>869607</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>869838</id>
  <title>Premenopausal women who received ovarian suppression treatment along with tamoxifen had a lower risk of breast cancer recurrence</title>
  <langcode>en</langcode>
  <field_short_title>Ovarian suppression treatment lowers risk of breast cancer recurrence</field_short_title>
  <field_page_description>A clinical trial sponsored and supported by NCI showed that suppressing ovarian function reduced breast cancer recurrence in premenopausal women receiving the drug tamoxifen after surgery for early-stage breast cancer.</field_page_description>
  <field_date_posted>2014-12-11</field_date_posted>
  <field_date_reviewed>2014-12-09</field_date_reviewed>
  <field_pretty_url>SOFTtrialResult</field_pretty_url>
  <para_id>869838</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>869765</term_id>
  <id>869871</id>
  <title>Aflatoxins</title>
  <langcode>en</langcode>
  <field_short_title>Aflatoxins</field_short_title>
  <field_page_description>Learn about aflatoxins, a family of toxins associated with an increased risk of liver cancer. Aflatoxins are produced by certain fungi found on agricultural crops such as maize (corn), peanuts, cottonseed, and tree nuts. </field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2018-12-28</field_date_reviewed>
  <para_id>869871</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>870055</term_id>
  <id>870060</id>
  <title>What We Do &amp; Future Goals</title>
  <langcode>en</langcode>
  <field_short_title>What We Do &amp; Future Goals</field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-12-10</field_date_reviewed>
  <para_id>870060</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>860262</term_id>
  <id>870062</id>
  <title>Debate, Research on E-Cigarettes Continue</title>
  <langcode>en</langcode>
  <field_short_title>Debate, Research on E-Cigarettes Continue</field_short_title>
  <field_page_description>Since they first began to be sold in North America in the mid-2000s, electronic cigarettes have been the subject of intense debate. NCI's Dr. Michele Bloch recently presented an update on some of the issues surrounding e-cigarettes.</field_page_description>
  <field_date_posted>2014-12-11</field_date_posted>
  <field_date_reviewed>2014-12-10</field_date_reviewed>
  <field_pretty_url>e-cigarettes</field_pretty_url>
  <para_id>870062</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>882364</term_id>
  <id>882350</id>
  <title>Thorium </title>
  <langcode>en</langcode>
  <field_short_title>Thorium </field_short_title>
  <field_page_description>Learn about thorium, which can raise the  risk of liver, lung, and pancreatic cancers. The primary ways people are exposed are inhalation, intravenous injection, ingestion, and absorption through the skin.</field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2014-12-15</field_date_reviewed>
  <para_id>882350</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>882432</term_id>
  <id>882433</id>
  <title>Radon</title>
  <langcode>en</langcode>
  <field_short_title>Radon</field_short_title>
  <field_page_description>Learn about radon, which can raise your risk of lung cancer. Radon gas usually exists at very low levels outdoors, but the gas can accumulate in areas without adequate ventilation, such as underground mines or residential basements.  </field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2014-12-15</field_date_reviewed>
  <para_id>882433</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>11886</term_id>
  <id>13128</id>
  <title>Inflammatory Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Inflammatory Breast Cancer</field_short_title>
  <field_page_description>A fact sheet about the diagnosis and treatment of inflammatory breast cancer (IBC), an uncommon type of cancer in which the breast becomes red, swollen, and warm. </field_page_description>
  <field_date_posted>2016-01-15</field_date_posted>
  <field_date_reviewed>2016-01-06</field_date_reviewed>
  <field_pretty_url>ibc-fact-sheet</field_pretty_url>
  <para_id>13128</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>936684</term_id>
  <id>170976</id>
  <title>Questions to Ask Your Doctor When You Have Finished Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Questions to Ask Your Doctor When You Have Finished Treatment</field_short_title>
  <field_date_posted>2012-02-14</field_date_posted>
  <field_date_reviewed>2012-01-23</field_date_reviewed>
  <para_id>170976</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>916488</term_id>
  <id>905791</id>
  <title>NCI’s Role in Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>NCI’s Role in Cancer Research</field_short_title>
  <field_date_posted>2015-03-19</field_date_posted>
  <field_date_reviewed>2015-02-09</field_date_reviewed>
  <para_id>905791</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>906471</id>
  <title>FDA Grants Palbociclib Accelerated Approval for Advanced Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Grants Palbociclib Accelerated Approval for Advanced Breast Cancer</field_short_title>
  <field_date_posted>2015-02-11</field_date_posted>
  <field_date_reviewed>2015-02-11</field_date_reviewed>
  <field_pretty_url>palbociclib-breast-cancer</field_pretty_url>
  <para_id>906471</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>910207</id>
  <title>New from NCI: Resources, Tools, and News</title>
  <langcode>en</langcode>
  <field_short_title>New from NCI: Resources, Tools, and News</field_short_title>
  <field_page_description>NCI is constantly publishing new information on its websites, so periodically we provide updates on new content of interest to the cancer community.</field_page_description>
  <field_date_posted>2015-02-20</field_date_posted>
  <field_date_reviewed>2015-02-20</field_date_reviewed>
  <field_pretty_url>resources</field_pretty_url>
  <para_id>910207</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>911695</id>
  <title>Global Health Diplomacy Begins at Home</title>
  <langcode>en</langcode>
  <field_short_title>Global Health Diplomacy Begins at Home</field_short_title>
  <field_date_posted>2015-02-27</field_date_posted>
  <field_date_reviewed>2015-02-27</field_date_reviewed>
  <field_pretty_url>globalhealthdiplomacy</field_pretty_url>
  <para_id>911695</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>916947</term_id>
  <id>912885</id>
  <title>Radiation Therapy to Treat Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Radiation Therapy </field_short_title>
  <field_page_description>Radiation therapy is a type of cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors. Learn about the types of radiation, why side effects happen, which ones you might have, and more.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2018-05-01</field_date_reviewed>
  <para_id>912885</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>914799</term_id>
  <id>914801</id>
  <title>Apply for a Grant</title>
  <langcode>en</langcode>
  <field_short_title>Apply for a Grant</field_short_title>
  <field_page_description>The NCI Grants Process provides an overview of the end-to-end lifecycle of grant funding. Learn about the types of funding available and the basics for application, review, award, and on-going administration within the NCI.</field_page_description>
  <field_date_posted>2015-03-11</field_date_posted>
  <field_date_reviewed>2015-03-11</field_date_reviewed>
  <para_id>914801</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938137</term_id>
  <id>915039</id>
  <title>Treating High-grade Lesions to Prevent Anal Cancer in HIV-infected People</title>
  <langcode>en</langcode>
  <field_short_title>Treating High-grade Lesions to Prevent Anal Cancer in HIV-infected People</field_short_title>
  <field_page_description>This study, called the ANCHOR trial, will investigate whether screening and prevention methods similar to those used to prevent cervical cancer can help prevent anal cancer in HIV-infected men and women. </field_page_description>
  <field_date_posted>2015-03-11</field_date_posted>
  <field_date_reviewed>2015-03-11</field_date_reviewed>
  <field_pretty_url>anchor-trial</field_pretty_url>
  <para_id>915039</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>915248</id>
  <title>Treatment Helps Preserve Fertility for Some Women with Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Treatment Helps Preserve Fertility for Some Women with Breast Cancer</field_short_title>
  <field_page_description>In a large clinical trial, giving a hormone-suppressing drug helped some younger women with breast cancer get pregnant after completing cancer treatment.</field_page_description>
  <field_date_posted>2015-03-12</field_date_posted>
  <field_date_reviewed>2015-03-12</field_date_reviewed>
  <field_pretty_url>fertility-breast-cancer</field_pretty_url>
  <para_id>915248</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>914832</term_id>
  <id>915264</id>
  <title>Grant Closeout</title>
  <langcode>en</langcode>
  <field_short_title>Grant Closeout</field_short_title>
  <field_page_description>Requirements and reports to comply with grant closeout, including Final Federal Financial Report (FFR, SF425); Final Research Performance Progress Report (FRPPR); Interim Research Performance Progress Report (IRPPR); Final Invention Statement (FIS, HHS</field_page_description>
  <field_date_posted>2015-04-02</field_date_posted>
  <field_date_reviewed>2015-03-12</field_date_reviewed>
  <para_id>915264</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915801</term_id>
  <id>916017</id>
  <title>Talking about Your Advanced Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Talking about Your Advanced Cancer</field_short_title>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>916017</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915813</term_id>
  <id>916031</id>
  <title>Advanced Cancer and Caregivers</title>
  <langcode>en</langcode>
  <field_short_title>Advanced Cancer and Caregivers</field_short_title>
  <field_page_description>Learn tips for taking care of yourself, coping with your feelings and grief, asking for help, ,communicating with your loved one about their wishes for care, talking to children about death</field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>916031</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>916474</term_id>
  <id>882657</id>
  <title>Coke Oven Emissions</title>
  <langcode>en</langcode>
  <field_short_title>Coke Oven Emissions</field_short_title>
  <field_page_description>Learn about coke oven emissions, which can raise your risk of lung cancer. Workers at coking plants and coal-tar production plants may be exposed to coke oven emissions. </field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2019-02-01</field_date_reviewed>
  <para_id>882657</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>887320</id>
  <title>The United States - Latin America Cancer Research Network: A multidisciplinary and collaborative approach to conducting clinical cancer research in Latin America </title>
  <langcode>en</langcode>
  <field_short_title>US-LA CRN Clinical Cancer Research in Latin America</field_short_title>
  <field_date_posted>2014-12-29</field_date_posted>
  <field_date_reviewed>2014-12-29</field_date_reviewed>
  <field_pretty_url>uslacrn-clinical-cancer-research</field_pretty_url>
  <para_id>887320</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>895218</id>
  <title>Grantee Spotlight: Beatriz M. Carreno, Ph.D. - Seeking a Vaccine to Cure Melanoma </title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Beatriz M. Carreno, Ph.D. - Seeking a Vaccine to Cure Melanoma </field_short_title>
  <field_date_posted>2014-06-05</field_date_posted>
  <field_date_reviewed>2014-06-05</field_date_reviewed>
  <field_pretty_url>carreno-spotlight</field_pretty_url>
  <para_id>895218</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>899198</id>
  <title>Grantee Spotlight: Dr. Meena Jaggi - Investigating Curcumin (Turmeric) as HPV Repressor for Native American Women</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Dr. Meena Jaggi - Investigating Curcumin (Turmeric) as HPV Repressor for Native A</field_short_title>
  <field_date_posted>2015-01-20</field_date_posted>
  <field_date_reviewed>2015-01-20</field_date_reviewed>
  <field_pretty_url>jaggi-spotlight</field_pretty_url>
  <para_id>899198</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>899525</id>
  <title>A Good Year: FDA Approved Nine New Cancer Drugs in 2014</title>
  <langcode>en</langcode>
  <field_short_title>A Good Year: FDA Approved Nine New Cancer Drugs in 2014</field_short_title>
  <field_date_posted>2015-01-23</field_date_posted>
  <field_date_reviewed>2015-01-23</field_date_reviewed>
  <field_pretty_url>fda-nine-new-cancer-drugs</field_pretty_url>
  <para_id>899525</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919329</term_id>
  <id>903598</id>
  <title>Finding Health Care Services</title>
  <langcode>en</langcode>
  <field_short_title>Finding Health Care Services</field_short_title>
  <field_page_description>If you have been diagnosed with cancer, finding a doctor and treatment hospital for your cancer care is an important step to getting the best treatment possible. Learn tips for choosing a doctor and treatment facility to manage your cancer care.</field_page_description>
  <field_date_posted>2015-03-10</field_date_posted>
  <field_date_reviewed>2015-02-02</field_date_reviewed>
  <para_id>903598</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>903592</term_id>
  <id>903604</id>
  <title>Using Trusted Resources</title>
  <langcode>en</langcode>
  <field_short_title>Using Trusted Resources</field_short_title>
  <field_page_description>Information to help people evaluate the source and credibility of health information that they find in print or online.</field_page_description>
  <field_date_posted>2015-03-10</field_date_posted>
  <field_date_reviewed>2015-02-02</field_date_reviewed>
  <para_id>903604</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>899930</term_id>
  <id>903717</id>
  <title>Skin and Nail Changes during Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Skin and Nail Changes</field_short_title>
  <field_page_description>Cancer treatments can cause skin to become dry, itchy, red, or peel. Nails may become dark, yellow, or cracked. Learn about signs of skin problems that may need urgent medical care. Get a helpful list of questions to ask your doctor.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-02-04</field_date_reviewed>
  <para_id>903717</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>903759</term_id>
  <id>903748</id>
  <title>Lymphedema and Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Lymphedema</field_short_title>
  <field_page_description>Lymphedema is a side effect of some cancer treatments. Symptoms of lymphedema are presented. Ways to treat or manage swelling in the arm or leg are covered for cancer patients and cancer survivors.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-02-04</field_date_reviewed>
  <para_id>903748</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>11914</term_id>
  <id>12879</id>
  <title>Head and Neck Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Head and Neck Cancers</field_short_title>
  <field_page_description>A fact sheet about the risk factors, symptoms, diagnosis, treatment, follow-up, and rehabilitation for cancers of the head and neck. </field_page_description>
  <field_date_posted>2013-02-11</field_date_posted>
  <field_date_reviewed>2017-03-29</field_date_reviewed>
  <field_pretty_url>head-neck-fact-sheet</field_pretty_url>
  <para_id>12879</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>212928</id>
  <title>New platform developed to link clinical data with electronic health records</title>
  <langcode>en</langcode>
  <field_short_title>Platform links clinical data with electronic health records</field_short_title>
  <field_page_description>To make data gathered from patients in clinical trials available for use in standard care, NCI has created a new computer tool to support interoperability between clinical research and electronic health record systems. This new software represents an inno</field_page_description>
  <field_date_posted>2012-02-21</field_date_posted>
  <field_date_reviewed>2012-02-21</field_date_reviewed>
  <field_pretty_url>HL7TRANSCEND</field_pretty_url>
  <para_id>212928</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>216653</id>
  <title>Additional Surgery after Breast-Conserving Surgery Varies Widely</title>
  <langcode>en</langcode>
  <field_short_title>Additional Surgery after Breast-Conserving Surgery Varies Widely</field_short_title>
  <field_date_posted>2012-02-28</field_date_posted>
  <field_date_reviewed>2012-02-28</field_date_reviewed>
  <field_pretty_url>additional-surgery-variation</field_pretty_url>
  <para_id>216653</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911172</term_id>
  <id>12972</id>
  <title>HPV and Cancer</title>
  <langcode>en</langcode>
  <field_short_title>HPV and Cancer</field_short_title>
  <field_page_description>Human papillomaviruses (HPVs) are a group of more than 200 related viruses that can cause several cancers including cervical cancer, anal cancer, and oropharyngeal cancer. Learn more about how HPV is transmitted, the different types of HPV, HPV vaccines, and HPV treatment.</field_page_description>
  <field_date_posted>2015-05-15</field_date_posted>
  <field_date_reviewed>2015-02-19</field_date_reviewed>
  <field_pretty_url>hpv-fact-sheet</field_pretty_url>
  <para_id>12972</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911291</term_id>
  <id>13001</id>
  <title>"Light" Cigarettes and Cancer Risk</title>
  <langcode>en</langcode>
  <field_short_title>"Light" Cigarettes and Cancer Risk</field_short_title>
  <field_page_description>This fact sheet answers questions about the health effects of smoking "low-tar," "mild," or "light" cigarettes.</field_page_description>
  <field_date_posted>2005-08-18</field_date_posted>
  <field_date_reviewed>2010-10-28</field_date_reviewed>
  <field_pretty_url>light-cigarettes-fact-sheet</field_pretty_url>
  <para_id>13001</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>167985</id>
  <title>Genetic abnormality predicts benefit from treatment for a rare brain tumor:</title>
  <langcode>en</langcode>
  <field_short_title>Genetic abnormality predicts benefit for a rare brain tumor</field_short_title>
  <field_page_description>A clinical trial has shown that addition of chemotherapy to radiation therapy leads to a near doubling of median survival time in patients with a form of brain tumor (oligodendroglioma) that carries a chromosomal abnormality called the 1p19q co-deletion. </field_page_description>
  <field_date_posted>2012-01-19</field_date_posted>
  <field_date_reviewed>2012-01-18</field_date_reviewed>
  <field_pretty_url>OligodendrogliomaRTOG</field_pretty_url>
  <para_id>167985</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>172406</id>
  <title>Study finds racial and ethnic disparities in U.S. cancer screening rates:</title>
  <langcode>en</langcode>
  <field_short_title>Racial and ethnic disparities in U.S. cancer screening rates</field_short_title>
  <field_page_description>The percentage of U.S. citizens screened for cancer remains below national targets, with significant disparities among racial and ethnic populations, according to the first federal study to identify cancer screening disparities among Asian and Hispanic gr</field_page_description>
  <field_date_posted>2012-01-27</field_date_posted>
  <field_date_reviewed>2012-01-27</field_date_reviewed>
  <field_pretty_url>DisparitiesInCancerScreeningRates</field_pretty_url>
  <para_id>172406</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>908136</id>
  <title>Exposure to Secondhand Smoke Plummets, but Disparities Persist</title>
  <langcode>en</langcode>
  <field_short_title>Exposure to Secondhand Smoke Plummets, but Disparities Persist</field_short_title>
  <field_page_description>Second-hand smoke exposure has fallen by 50 percent since 1999, a new study finds, but millions are still routinely exposed to secondhand smoke.</field_page_description>
  <field_date_posted>2015-02-13</field_date_posted>
  <field_date_reviewed>2015-02-13</field_date_reviewed>
  <field_pretty_url>secondhand-smoke-exposure-plummets</field_pretty_url>
  <para_id>908136</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>909432</term_id>
  <id>909433</id>
  <title>Health Communications Publications</title>
  <langcode>en</langcode>
  <field_short_title>Health Communications Publications</field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2015-02-17</field_date_reviewed>
  <para_id>909433</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>911481</id>
  <title>Genetic Studies Yield Clues to Treatment-Related Side Effects in Children with Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Genetic Studies Yield Clues to Treatment-Related Side Effects in Children with Cancer</field_short_title>
  <field_page_description>Researchers have identified genetic variations in children with brain cancer that increased their risk of rapid hearing loss after treatment.</field_page_description>
  <field_date_posted>2015-02-26</field_date_posted>
  <field_date_reviewed>2015-02-26</field_date_reviewed>
  <field_pretty_url>genetic-studies</field_pretty_url>
  <para_id>911481</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>912681</id>
  <title>Special Spotlight: Widely Acclaimed Cancer Disparities Researcher, Claudia R. Baquet, MD, MPH, Retires from University of Maryland Baltimore School of Medicine</title>
  <langcode>en</langcode>
  <field_short_title>Special Spotlight: Widely Acclaimed Cancer Disparities Researcher, Claudia R. Baquet, Retires</field_short_title>
  <field_date_posted>2015-03-03</field_date_posted>
  <field_date_reviewed>2015-03-03</field_date_reviewed>
  <field_pretty_url>baquet-spotlight</field_pretty_url>
  <para_id>912681</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>915112</term_id>
  <id>915130</id>
  <title>Divide and Conquer: The Molecular Diagnosis of Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Divide and Conquer: The Molecular Diagnosis of Cancer</field_short_title>
  <field_date_posted>2015-04-13</field_date_posted>
  <field_date_reviewed>2015-03-12</field_date_reviewed>
  <field_pretty_url>april-leadership-update</field_pretty_url>
  <para_id>915130</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>915112</term_id>
  <id>915144</id>
  <title>American Society of Clinical Oncology (ASCO) Recognizes TCGA’s Importance in the Past Decade and in Tumor Biology</title>
  <langcode>en</langcode>
  <field_short_title>ASCO Recognizes TCGA’s Importance in the Past Decade and in Tumor Biology</field_short_title>
  <field_date_posted>2015-04-13</field_date_posted>
  <field_date_reviewed>2015-03-12</field_date_reviewed>
  <field_pretty_url>asco-how-far-weve-come</field_pretty_url>
  <para_id>915144</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>911116</term_id>
  <id>915357</id>
  <title>Diet</title>
  <langcode>en</langcode>
  <field_short_title>Diet</field_short_title>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915357</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915273</term_id>
  <id>915364</id>
  <title>Legal Requirements</title>
  <langcode>en</langcode>
  <field_short_title>Legal Requirements</field_short_title>
  <field_date_posted>2015-04-02</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915364</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>217876</id>
  <title>Diesel Exhaust in Miners Study: Questions &amp; Answers</title>
  <langcode>en</langcode>
  <field_short_title>Diesel Exhaust in Miners Study: Q&amp;A</field_short_title>
  <field_page_description>The Diesel Exhaust in Miners Study was designed to evaluate the risk of death associated with diesel exhaust exposure, particularly as it may relate to lung cancer. The researchers observed increased risk for lung cancer death with increasing levels of ex</field_page_description>
  <field_date_posted>2012-03-02</field_date_posted>
  <field_date_reviewed>2012-03-02</field_date_reviewed>
  <field_pretty_url>DieselMinersQandA</field_pretty_url>
  <para_id>217876</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>903865</term_id>
  <id>903866</id>
  <title>Symptoms of Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Symptoms </field_short_title>
  <field_page_description>Cancer can cause different symptoms, such as abnormal bumps, night sweats, or unknown weight gain or loss. Only a doctor can tell if symptoms are caused by cancer or some other problem.</field_page_description>
  <field_date_posted>2015-03-05</field_date_posted>
  <field_date_reviewed>2018-03-29</field_date_reviewed>
  <para_id>903866</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>907072</id>
  <title>Twitter Chat on Non-Communicable Diseases and Global Health</title>
  <langcode>en</langcode>
  <field_short_title>Twitter Chat on Non-Communicable Diseases and Global Health</field_short_title>
  <field_date_posted>2015-02-12</field_date_posted>
  <field_date_reviewed>2015-02-12</field_date_reviewed>
  <field_pretty_url>twitter-chat</field_pretty_url>
  <para_id>907072</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>903750</term_id>
  <id>911134</id>
  <title>Diagnosis and Staging</title>
  <langcode>en</langcode>
  <field_short_title>Diagnosis and Staging</field_short_title>
  <field_date_posted>2015-02-24</field_date_posted>
  <field_date_reviewed>2015-02-24</field_date_reviewed>
  <para_id>911134</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938026</term_id>
  <id>911742</id>
  <title>Gardasil 9 Vaccine Protects against Additional HPV Types</title>
  <langcode>en</langcode>
  <field_short_title>Gardasil 9 Protects against Additional HPV Types</field_short_title>
  <field_page_description>A summary of results from a large randomized clinical trial that shows a new human papillomavirus (HPV) vaccine effectively prevented infection and disease caused by seven HPV types that cause cancer and two HPV types that cause genital warts.</field_page_description>
  <field_date_posted>2015-03-02</field_date_posted>
  <field_date_reviewed>2015-03-02</field_date_reviewed>
  <field_pretty_url>gardasil9-prevents-more-HPV-types</field_pretty_url>
  <para_id>911742</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>914810</term_id>
  <id>914834</id>
  <title>Step 1: Application Development &amp; Submission</title>
  <langcode>en</langcode>
  <field_short_title>Step 1: Application Development &amp; Submission</field_short_title>
  <field_page_description>There are nine research grant application types, each with specific procedures. Learn more about developing, submitting, and tracking a cancer research grant application.</field_page_description>
  <field_date_posted>2015-04-02</field_date_posted>
  <field_date_reviewed>2015-03-11</field_date_reviewed>
  <para_id>914834</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>914812</term_id>
  <id>914835</id>
  <title>Step 2: Application Receipt &amp; Assignment</title>
  <langcode>en</langcode>
  <field_short_title>Step 2: Application Receipt &amp; Assignment</field_short_title>
  <field_page_description>Information on the assignment numbers the Center for Scientific Review (CSR) creates once an application is submitted and other submission policies.</field_page_description>
  <field_date_posted>2015-04-02</field_date_posted>
  <field_date_reviewed>2015-03-11</field_date_reviewed>
  <para_id>914835</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>914943</term_id>
  <id>914948</id>
  <title>Fatigue and Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Fatigue</field_short_title>
  <field_page_description>Fatigue is a common side effect of many cancer treatments such as chemotherapy, radiation therapy, immunotherapy, and surgery. Anemia and pain can also cause fatigue. Learn about symptoms and way to manage fatigue.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2018-09-14</field_date_reviewed>
  <para_id>914948</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>915079</term_id>
  <id>915081</id>
  <title>Center for Cancer Genomics Videos</title>
  <langcode>en</langcode>
  <field_short_title>CCG Videos</field_short_title>
  <field_page_description>Find video presentations, meeting addresses, and discussions about work by the NCI Center for Cancer Genomics (CCG).</field_page_description>
  <field_date_posted>2015-04-13</field_date_posted>
  <field_date_reviewed>2015-03-12</field_date_reviewed>
  <para_id>915081</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogSeries</CONTENTTYPENAME>
  <term_id>919423</term_id>
  <id>915110</id>
  <title>Insights &amp;amp; Innovations Blog</title>
  <langcode>en</langcode>
  <field_short_title>Insights &amp;amp; Innovations Blog</field_short_title>
  <field_page_description>Read interviews with investigators, updates from CCG's Director and others, CCG's latest news and announcements, and overviews of new influential papers in cancer genomics.</field_page_description>
  <field_date_posted>2015-03-12</field_date_posted>
  <field_date_reviewed>2015-03-12</field_date_reviewed>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915362</term_id>
  <id>915363</id>
  <title>Sunlight</title>
  <langcode>en</langcode>
  <field_short_title>Sunlight</field_short_title>
  <field_page_description>Exposure to UV radiation from the sun, sunlamps, and tanning booths causes early aging and skin damage that can lead to skin cancer. Find information, including tips, on how to protect your skin.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915363</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>911291</term_id>
  <id>915365</id>
  <title>Tobacco </title>
  <langcode>en</langcode>
  <field_short_title>Tobacco </field_short_title>
  <field_page_description>Tobacco use is a leading cause of cancer and of death from cancer. Find resources on the harms of tobacco use and how to get help quitting.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915365</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915611</term_id>
  <id>915651</id>
  <title>Cancer Genomics Research</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Genomics Research</field_short_title>
  <field_page_description>Investigating the genetic foundations of cancer has improved our understanding of cancer biology and led to better prevention, diagnosis and treatment methods.</field_page_description>
  <field_date_posted>2015-03-13</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915651</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>915278</term_id>
  <id>915368</id>
  <title>Grant Resources</title>
  <langcode>en</langcode>
  <field_short_title>Grant Resources</field_short_title>
  <field_page_description>Resources to help with the NCI and NIH grants and funding process.</field_page_description>
  <field_date_posted>2015-04-02</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915368</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>914486</term_id>
  <id>915591</id>
  <title>Research Areas</title>
  <langcode>en</langcode>
  <field_short_title>Research Areas</field_short_title>
  <field_page_description>Making sustained progress against cancer requires advances across the research continuum. Learn about the breadth of NCI's work and the programs the institute supports to advance cancer research.</field_page_description>
  <field_date_posted>2015-03-13</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915591</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915603</term_id>
  <id>915637</id>
  <title>Cancer Biology Research</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Biology Research</field_short_title>
  <field_date_posted>2015-05-07</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915637</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915607</term_id>
  <id>915643</id>
  <title>Cancer Diagnosis Research </title>
  <langcode>en</langcode>
  <field_short_title>Cancer Diagnosis Research </field_short_title>
  <field_date_posted>2015-03-13</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915643</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915605</term_id>
  <id>915676</id>
  <title>Cancer Screening and Early Detection Research</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Screening and Early Detection Research</field_short_title>
  <field_page_description>Information about cancer screening and early detection research, including a summary of NCI programs dedicated to advancing screening and early detection.</field_page_description>
  <field_date_posted>2015-05-07</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915676</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>911160</term_id>
  <id>916009</id>
  <title>Choices for Care When Treatment May Not Be an Option</title>
  <langcode>en</langcode>
  <field_short_title>Choices for Care</field_short_title>
  <field_page_description>Know your choices for cancer care when coping with advanced cancer. Learn about palliative care, hospice care, and trying a clinical trial. </field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>916009</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915803</term_id>
  <id>916020</id>
  <title>Coping with Your Feelings During Advanced Cancer </title>
  <langcode>en</langcode>
  <field_short_title>Coping with Your Feelings During Advanced Cancer</field_short_title>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>916020</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>911152</term_id>
  <id>916035</id>
  <title>Alcohol</title>
  <langcode>en</langcode>
  <field_short_title>Alcohol</field_short_title>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>916035</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915816</term_id>
  <id>916037</id>
  <title>Questions to Ask Your Doctor about Advanced Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Questions to Ask about Advanced Cancer</field_short_title>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>916037</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>916689</term_id>
  <id>916690</id>
  <title>Frederick National Laboratory for Cancer Research </title>
  <langcode>en</langcode>
  <field_short_title>Frederick National Laboratory for Cancer Research </field_short_title>
  <field_date_posted>2015-03-16</field_date_posted>
  <field_date_reviewed>2015-03-16</field_date_reviewed>
  <para_id>916690</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>917284</term_id>
  <id>917286</id>
  <title>Resources for You</title>
  <langcode>en</langcode>
  <field_short_title>Resources for You</field_short_title>
  <field_page_description>Let us help you find information and resources that fit your needs as a patient, health professional, researcher, or other visitor.</field_page_description>
  <field_date_posted>2015-03-18</field_date_posted>
  <field_date_reviewed>2015-03-18</field_date_reviewed>
  <para_id>917286</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>917297</term_id>
  <id>917517</id>
  <title>Resources for Advocates and Policymakers</title>
  <langcode>en</langcode>
  <field_short_title>Resources for Advocates &amp; Policymakers</field_short_title>
  <field_date_posted>2015-03-19</field_date_posted>
  <field_date_reviewed>2015-03-19</field_date_reviewed>
  <para_id>917517</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938032</term_id>
  <id>15347</id>
  <title>Video Eases End-of-Life Care Discussions</title>
  <langcode>en</langcode>
  <field_short_title>End-of-Life Care Video</field_short_title>
  <field_page_description>Patients with advanced cancer who watched a video that depicts options for end-of-life care were more certain of their end-of-life decision making than patients who only listened to a verbal narrative. </field_page_description>
  <field_date_posted>2010-01-12</field_date_posted>
  <field_date_reviewed>2013-01-03</field_date_reviewed>
  <field_pretty_url>video-helps-end-of-life-discussions</field_pretty_url>
  <para_id>15347</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>915875</term_id>
  <id>15422</id>
  <title>Cancer Clusters</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Clusters</field_short_title>
  <field_page_description>A fact sheet that describes what constitutes a cancer cluster and the process for reporting and investigating suspected clusters.</field_page_description>
  <field_date_posted>2018-09-05</field_date_posted>
  <field_date_reviewed>2018-08-29</field_date_reviewed>
  <field_pretty_url>cancer-clusters-fact-sheet</field_pretty_url>
  <para_id>15422</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>11954</term_id>
  <id>15458</id>
  <title>Prostate-Specific Antigen (PSA) Test</title>
  <langcode>en</langcode>
  <field_short_title>Prostate-Specific Antigen (PSA) Test</field_short_title>
  <field_page_description>A fact sheet that describes the PSA screening test for prostate cancer and explains the benefits and limitations of the test.</field_page_description>
  <field_date_posted>2017-06-09</field_date_posted>
  <field_date_reviewed>2017-10-04</field_date_reviewed>
  <field_pretty_url>psa-fact-sheet</field_pretty_url>
  <para_id>15458</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>45782</term_id>
  <id>16358</id>
  <title>Contact the Center for Cancer Training</title>
  <langcode>en</langcode>
  <field_short_title>Program Contacts</field_short_title>
  <field_page_description>Contact staff at the Center for Cancer Training and read staff bios. </field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2016-01-15</field_date_reviewed>
  <para_id>16358</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>916844</term_id>
  <id>16360</id>
  <title>Training</title>
  <langcode>en</langcode>
  <field_short_title>Training</field_short_title>
  <field_date_posted>2014-12-31</field_date_posted>
  <field_date_reviewed>2008-11-14</field_date_reviewed>
  <para_id>16360</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>396047</term_id>
  <id>396060</id>
  <title>What Are Clinical Trials? </title>
  <langcode>en</langcode>
  <field_short_title>What Are Clinical Trials? </field_short_title>
  <field_page_description>Information about the basics of cancer clinical trials.</field_page_description>
  <field_date_posted>2012-08-10</field_date_posted>
  <field_date_reviewed>2012-08-10</field_date_reviewed>
  <para_id>396060</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>396049</term_id>
  <id>396061</id>
  <title>Types of Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>Types of Clinical Trials</field_short_title>
  <field_date_posted>2012-08-10</field_date_posted>
  <field_date_reviewed>2012-08-10</field_date_reviewed>
  <para_id>396061</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>966269</id>
  <title>TCGA study improves understanding of genetic drivers of cutaneous melanoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA study of genetic drivers of melanoma</field_short_title>
  <field_date_posted>2015-06-18</field_date_posted>
  <field_date_reviewed>2015-06-12</field_date_reviewed>
  <field_pretty_url>TCGA-cutaneous-melanoma-mutated-genes</field_pretty_url>
  <para_id>966269</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>969910</term_id>
  <id>969912</id>
  <title>Funding for Research Areas</title>
  <langcode>en</langcode>
  <field_short_title>Research Funding</field_short_title>
  <field_page_description>See how appropriated funds are spent for frequently requested areas of cancer research.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-06-24</field_date_reviewed>
  <para_id>969912</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>971521</id>
  <title>In Mice, New Drug Conjugate Suggests Promise for Hard-to-Treat Pediatric Cancers</title>
  <langcode>en</langcode>
  <field_short_title>New Drug Conjugate Suggests Promise against Sarcoma</field_short_title>
  <field_date_posted>2015-06-30</field_date_posted>
  <field_date_reviewed>2015-06-30</field_date_reviewed>
  <field_pretty_url>hsp90-conjugate-sarcoma</field_pretty_url>
  <para_id>971521</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>971636</id>
  <title>NCI Launches Competition to Spur Research on Breast Cancer Genomics, Disease Risk</title>
  <langcode>en</langcode>
  <field_short_title>Competition Spurs Research on Breast Cancer Genomics and Risk</field_short_title>
  <field_date_posted>2015-07-02</field_date_posted>
  <field_date_reviewed>2015-07-01</field_date_reviewed>
  <field_pretty_url>u4c-challenge</field_pretty_url>
  <para_id>971636</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>974312</id>
  <title>Cancer Currents Now Available in Spanish</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Currents Now Available in Spanish</field_short_title>
  <field_date_posted>2015-07-08</field_date_posted>
  <field_date_reviewed>2015-07-07</field_date_reviewed>
  <field_pretty_url>spanish-blog</field_pretty_url>
  <para_id>974312</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>974631</term_id>
  <id>974632</id>
  <title>Comparison of Dollars, Positions, and Space</title>
  <langcode>en</langcode>
  <field_short_title>Comparison of Dollars, Positions &amp; Space</field_short_title>
  <field_page_description>Find information about obligations against the annual NCI appropriation for full-time equivalent (FTE) positions and occupied space since 2009.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-07-08</field_date_reviewed>
  <para_id>974632</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>930502</term_id>
  <id>978804</id>
  <title>Pembrolizumab Improves Progression-Free Survival in Patients with Ipilimumab-Resistant Melanoma</title>
  <langcode>en</langcode>
  <field_short_title>Pembrolizumab for Ipilimumab-Resistant Melanoma</field_short_title>
  <field_page_description>KEYNOTE-002 was designed to test the safety and efficacy of two doses of pembrolizumab compared with chemotherapy in patients with ipilimumab-resistant melanoma; interim results show that pembrolizumab improves progression-free survival for these patients</field_page_description>
  <field_date_posted>2015-07-20</field_date_posted>
  <field_date_reviewed>2015-07-20</field_date_reviewed>
  <field_pretty_url>pembrolizumab-ipilimumab-resistance</field_pretty_url>
  <para_id>978804</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922403</term_id>
  <id>989277</id>
  <title>Adding Chemotherapy to Hormone Therapy Extends Overall Survival in Metastatic Prostate Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Hormone Therapy Plus Chemotherapy for Metastatic Prostate Cancer</field_short_title>
  <field_page_description>A trial of androgen deprivation therapy (ADT) plus six cycles of docetaxel versus ADT alone found that after a median follow-up of nearly 29 months, median overall survival was 13.6 months longer with the combination therapy than with ADT alone.</field_page_description>
  <field_date_posted>2015-08-31</field_date_posted>
  <field_date_reviewed>2015-08-31</field_date_reviewed>
  <field_pretty_url>chemohormonal-treatment-extends-survival</field_pretty_url>
  <para_id>989277</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>993432</id>
  <title>NCI Initiative to Speed Development of Childhood Cancer Therapies </title>
  <langcode>en</langcode>
  <field_short_title>NCI Pediatric Preclinical Testing Consortium</field_short_title>
  <field_date_posted>2015-09-08</field_date_posted>
  <field_date_reviewed>2015-09-03</field_date_reviewed>
  <field_pretty_url>PPTC-awards</field_pretty_url>
  <para_id>993432</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>1001033</id>
  <title>Children with Cancer: A Guide for Parents</title>
  <langcode>en</langcode>
  <field_short_title>Children with Cancer: A Guide for Parents</field_short_title>
  <field_date_posted>2015-09-09</field_date_posted>
  <field_date_reviewed>2015-09-09</field_date_reviewed>
  <field_pretty_url>guide-for-parents</field_pretty_url>
  <para_id>1001033</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>1001053</id>
  <title>Meta-Analysis Finds Benefits of Adjuvant Bisphosphonates for Postmenopausal Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Meta-Analysis Finds Benefits of Adjuvant Bisphosphonates for Postmenopausal Breast Cancer</field_short_title>
  <field_page_description>A summary of a meta-analysis of randomized trials of bisphosphonates as adjuvant therapy for women with early-stage breast cancer that shows the drugs can reduce the rate of disease recurrence in bone.</field_page_description>
  <field_date_posted>2015-09-09</field_date_posted>
  <field_date_reviewed>2015-09-09</field_date_reviewed>
  <field_pretty_url>adjuvant-bisphosphonates-meta-analysis</field_pretty_url>
  <para_id>1001053</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>608323</term_id>
  <id>1001476</id>
  <title>Improved Strategies for Cancer Prevention and Early Detection</title>
  <langcode>en</langcode>
  <field_short_title>Improved Strategies for Cancer Prevention and Early Detection</field_short_title>
  <field_date_posted>2015-09-11</field_date_posted>
  <field_date_reviewed>2015-09-11</field_date_reviewed>
  <field_pretty_url>strategies-prevention-early-detection</field_pretty_url>
  <para_id>1001476</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1004569</term_id>
  <id>1004570</id>
  <title>Genomic Data Access</title>
  <langcode>en</langcode>
  <field_short_title>Data Access</field_short_title>
  <field_date_posted>2015-12-10</field_date_posted>
  <field_date_reviewed>2015-09-23</field_date_reviewed>
  <para_id>1004570</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1004580</term_id>
  <id>1004581</id>
  <title>Advisory Board Meetings</title>
  <langcode>en</langcode>
  <field_short_title>Advisory Board Meetings</field_short_title>
  <field_page_description>Upcoming meetings and recent meeting proceedings for NCAB and BSA.</field_page_description>
  <field_date_posted>2015-09-23</field_date_posted>
  <field_date_reviewed>2015-09-23</field_date_reviewed>
  <para_id>1004581</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938030</term_id>
  <id>708410</id>
  <title>Combination of Obinutuzumab Plus Chlorambucil Improves Survival in Patients with Chronic Lymphocytic Leukemia and Other Health Conditions</title>
  <langcode>en</langcode>
  <field_short_title>Obinutuzumab Plus Chlorambucil for Chronic Lymphocytic Leukemia</field_short_title>
  <field_page_description>A summary of results from an international phase III trial that compared the combination of obinutuzumab (Gazyva™) and chlorambucil (Leukeran®) versus chlorambucil alone, as well as obinutuzumab plus chlorambucil versus  rituximab (Rituxan®) plus chloramb</field_page_description>
  <field_date_posted>2014-02-21</field_date_posted>
  <field_date_reviewed>2014-02-21</field_date_reviewed>
  <field_pretty_url>obinutuzumab-chlorambucil-cll</field_pretty_url>
  <para_id>708410</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919351</term_id>
  <id>748303</id>
  <title>Funding for Global Research and Training</title>
  <langcode>en</langcode>
  <field_short_title>Funding for Global Research and Training</field_short_title>
  <field_page_description>Find research and training opportunities from NCI's Center for Global Health (CGH).</field_page_description>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-04-09</field_date_reviewed>
  <para_id>748303</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>746640</term_id>
  <id>748305</id>
  <title>Resources</title>
  <langcode>en</langcode>
  <field_short_title>Resources</field_short_title>
  <field_page_description>Find helpful education materials, documents and essays, and online tools.</field_page_description>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-04-09</field_date_reviewed>
  <para_id>748305</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919351</term_id>
  <id>748891</id>
  <title>Cancer Clinical Trial Leadership and Management Program</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Clinical Trial Leadership and Management Program</field_short_title>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-04-10</field_date_reviewed>
  <field_pretty_url>clinical-trial-leadership-management</field_pretty_url>
  <para_id>748891</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922399</term_id>
  <id>761484</id>
  <title>Refining Preoperative Therapy for Locally Advanced Rectal Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Refining Preoperative Therapy for Locally Advanced Rectal Cancer</field_short_title>
  <field_page_description>In the PROSPECT trial, patients with locally advanced, resectable rectal cancer will be randomly assigned to receive either standard neoadjuvant chemoradiation therapy or neoadjuvant FOLFOX chemotherapy, with chemoradiation reserved for nonresponders.</field_page_description>
  <field_date_posted>2014-04-25</field_date_posted>
  <field_date_reviewed>2014-04-25</field_date_reviewed>
  <field_pretty_url>preop-treatment</field_pretty_url>
  <para_id>761484</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>765087</term_id>
  <id>762709</id>
  <title>Center for Global Health Staff</title>
  <langcode>en</langcode>
  <field_short_title>CGH Staff</field_short_title>
  <field_page_description>Contact information for NCI's Center for Global Health leadership and staff. CGH is a collaborative team of over 40 cancer researchers, scientists, and communication experts. </field_page_description>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-04-30</field_date_reviewed>
  <para_id>762709</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>770425</term_id>
  <id>770423</id>
  <title>Brain Malignancies Steering Committee Roster</title>
  <langcode>en</langcode>
  <field_short_title>Brain Malignancies Steering Committee Roster</field_short_title>
  <field_date_posted>2014-05-21</field_date_posted>
  <field_date_reviewed>2014-05-21</field_date_reviewed>
  <field_pretty_url>roster</field_pretty_url>
  <para_id>770423</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1072619</id>
  <title>NCTN/NCORP Data Archive: Expanding Access to Clinical Trial Data</title>
  <langcode>en</langcode>
  <field_short_title>NCTN/NCORP Data Archive: Expanding Access to Clinical Trial Data</field_short_title>
  <field_date_posted>2017-02-06</field_date_posted>
  <field_date_reviewed>2017-02-06</field_date_reviewed>
  <field_pretty_url>nctn-ncorp-data-archive</field_pretty_url>
  <para_id>1072619</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1072867</id>
  <title>Three-Drug Combination Extends Survival for Patients with Multiple Myeloma</title>
  <langcode>en</langcode>
  <field_short_title>Three-Drug Combination for Multiple Myeloma</field_short_title>
  <field_page_description>A Cancer Currents blog on a clinical trial showing that the combination of bortezomib, lenalidomide, and dexamethasone improves survival in multiple myeloma.</field_page_description>
  <field_date_posted>2017-02-10</field_date_posted>
  <field_date_reviewed>2017-02-10</field_date_reviewed>
  <field_pretty_url>three-drug-combination-myeloma</field_pretty_url>
  <para_id>1072867</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1073211</id>
  <title>Combination Therapy Improves Survival for Some Men with Recurrent Prostate Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Androgen Deprivation Therapy for Recurrent Prostate Cancer</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post on clinical trial results showing that adding androgen deprivation therapy to radiation therapy can improve survival for some men with recurrent prostate cancer.</field_page_description>
  <field_date_posted>2017-02-13</field_date_posted>
  <field_date_reviewed>2017-02-13</field_date_reviewed>
  <field_pretty_url>androgen-deprivation-therapy-prostate</field_pretty_url>
  <para_id>1073211</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1073379</id>
  <title>Potential New Cancer Therapy Could Target Tumors Two Ways</title>
  <langcode>en</langcode>
  <field_short_title>Therapy Could Target Tumors Two Ways</field_short_title>
  <field_page_description>An &lt;i&gt;NCI Cancer Currents&lt;/i&gt; blog post on a potential new therapy that may work by both killing cancer cells and immune cells that can suppress the anti-cancer immune response.</field_page_description>
  <field_date_posted>2017-02-15</field_date_posted>
  <field_date_reviewed>2017-02-15</field_date_reviewed>
  <field_pretty_url>tnfr2-target-tumors</field_pretty_url>
  <para_id>1073379</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1099300</term_id>
  <id>1073408</id>
  <title>Selected Presentations by Dr. Doug Lowy</title>
  <langcode>en</langcode>
  <field_short_title>Selected Presentations by Doug Lowy</field_short_title>
  <field_page_description>In these selected presentations, Douglas R. Lowy, M.D., Deputy Director of the National Cancer Institute (NCI), discusses strategic and scientific initiatives that are advancing  cancer research. </field_page_description>
  <field_date_posted>2017-02-28</field_date_posted>
  <field_date_reviewed>2017-02-15</field_date_reviewed>
  <para_id>1073408</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1077678</id>
  <title>Colorectal Cancer Incidence Rising in Young Adults: An Interview with Drs. Philip Rosenberg and William Anderson</title>
  <langcode>en</langcode>
  <field_short_title>Colorectal Cancer Incidence Rising in Young Adults </field_short_title>
  <field_page_description>An interview with NCI’s Drs. Philip Rosenberg and William Anderson on NCI’s Cancer Currents blog about a new study showing rising colorectal cancer incidence rates in adults under age 50. </field_page_description>
  <field_date_posted>2017-03-23</field_date_posted>
  <field_date_reviewed>2017-03-23</field_date_reviewed>
  <field_pretty_url>young-adult-colorectal-incidence-increasing</field_pretty_url>
  <para_id>1077678</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1078441</term_id>
  <id>1078449</id>
  <title>2014 Social Media Events</title>
  <langcode>en</langcode>
  <field_short_title>2014 Social Media Events</field_short_title>
  <field_page_description>Find past social media events involving NCI and its partners from 2014.</field_page_description>
  <field_date_posted>2017-03-28</field_date_posted>
  <field_date_reviewed>2017-03-28</field_date_reviewed>
  <para_id>1078449</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894084</term_id>
  <id>1078454</id>
  <title>Screen to Save Community Spotlight: UT Health San Antonio </title>
  <langcode>en</langcode>
  <field_short_title>Screen to Save Spotlight: UT Health San Antonio </field_short_title>
  <field_date_posted>2017-03-28</field_date_posted>
  <field_date_reviewed>2017-03-28</field_date_reviewed>
  <field_pretty_url>s2s-uthsa</field_pretty_url>
  <para_id>1078454</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1082594</term_id>
  <id>1080219</id>
  <title>AIDS and Cancer Specimen Resource</title>
  <langcode>en</langcode>
  <field_short_title>AIDS and Cancer Specimen Resource</field_short_title>
  <field_page_description>The AIDS Cancer Specimen Resource (ACSR) is a biorepository for HIV-infected human biospecimens. Learn how ACSR encourages pivotal understanding of the epidemic and its impact on cancer incidence.</field_page_description>
  <field_date_posted>2017-07-10</field_date_posted>
  <field_date_reviewed>2017-04-04</field_date_reviewed>
  <para_id>1080219</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1080236</term_id>
  <id>1080252</id>
  <title>OHAM Staff and Contact Information</title>
  <langcode>en</langcode>
  <field_short_title>OHAM Staff and Contact Information</field_short_title>
  <field_page_description>Contact the NCI Office of HIV and AIDS Malignancy and learn more about leadership and staff. </field_page_description>
  <field_date_posted>2017-07-10</field_date_posted>
  <field_date_reviewed>2017-04-04</field_date_reviewed>
  <para_id>1080252</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1080375</id>
  <title>Advancing the Potential and Promise of Total-Body PET Imaging</title>
  <langcode>en</langcode>
  <field_short_title>Advancing the Promise of Total-Body PET Imaging</field_short_title>
  <field_page_description>A Cancer Currents blog on how NCI is supporting a total-body PET scanner and the institute’s role in advancing new research and cancer care-related technologies.</field_page_description>
  <field_date_posted>2017-04-07</field_date_posted>
  <field_date_reviewed>2017-04-06</field_date_reviewed>
  <field_pretty_url>total-body-pet</field_pretty_url>
  <para_id>1080375</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894084</term_id>
  <id>1080475</id>
  <title>April Spotlight: National Minority Health Month</title>
  <langcode>en</langcode>
  <field_short_title>April Spotlight: National Minority Health Month</field_short_title>
  <field_date_posted>2017-04-07</field_date_posted>
  <field_date_reviewed>2017-04-06</field_date_reviewed>
  <field_pretty_url>nmhm17</field_pretty_url>
  <para_id>1080475</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>505615</term_id>
  <id>505753</id>
  <title>Accessibility Policy</title>
  <langcode>en</langcode>
  <field_short_title>Accessibility</field_short_title>
  <field_page_description>Learn about the accessibility policy for the NCI website, including information about Section 508 of the Rehabilitation Act. </field_page_description>
  <field_date_posted>2013-02-05</field_date_posted>
  <field_date_reviewed>2013-02-05</field_date_reviewed>
  <para_id>505753</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>564059</id>
  <title>Endometrial and acute myeloid leukemia cancer genomes characterized</title>
  <langcode>en</langcode>
  <field_short_title>Endometrial and acute myeloid leukemia cancer genomes characterized</field_short_title>
  <field_page_description>Two studies from The Cancer Genome Atlas (TCGA) program reveal details about the genomic landscapes of acute myeloid leukemia (AML) and endometrial cancer. Both provide new insights into the molecular underpinnings of these cancers.</field_page_description>
  <field_date_posted>2013-05-01</field_date_posted>
  <field_date_reviewed>2013-04-29</field_date_reviewed>
  <field_pretty_url>endometrialAMLcombo1May2013</field_pretty_url>
  <para_id>564059</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>565077</id>
  <title>Experimental drug beneficial in NIH trial to treat a rare sarcoma</title>
  <langcode>en</langcode>
  <field_short_title>Experimental drug beneficial in NIH trial to treat a rare sarcoma</field_short_title>
  <field_page_description>Patients with advanced alveolar soft part sarcoma (ASPS), a rare cancer, achieved some control of their disease using an experimental anti-cancer drug called cediranib. </field_page_description>
  <field_date_posted>2013-05-02</field_date_posted>
  <field_date_reviewed>2013-05-01</field_date_reviewed>
  <field_pretty_url>ASPScediranib</field_pretty_url>
  <para_id>565077</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>937976</term_id>
  <id>571449</id>
  <title>More Research Is Needed on What Patients Being Treated for Cancer Should Eat</title>
  <langcode>en</langcode>
  <field_short_title>Diet Recommendations for Cancer Patients</field_short_title>
  <field_page_description>An article about the need for new research on the optimal nutrition for patients being treated for cancer.</field_page_description>
  <field_date_posted>2013-05-14</field_date_posted>
  <field_date_reviewed>2013-05-14</field_date_reviewed>
  <field_pretty_url>nutrition-during-after-treatment</field_pretty_url>
  <para_id>571449</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>963034</id>
  <title>Genomic underpinnings of brain tumors expanded</title>
  <langcode>en</langcode>
  <field_short_title>Genomic underpinnings of brain tumors</field_short_title>
  <field_date_posted>2015-06-10</field_date_posted>
  <field_date_reviewed>2015-06-04</field_date_reviewed>
  <field_pretty_url>tcga-lowergradegliomas</field_pretty_url>
  <para_id>963034</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>967894</id>
  <title>Using Gene Expression to Diagnose Lung Cancer More Accurately</title>
  <langcode>en</langcode>
  <field_short_title>Gene Classifier May Help to Diagnose Lung Cancer</field_short_title>
  <field_date_posted>2015-06-19</field_date_posted>
  <field_date_reviewed>2015-06-19</field_date_reviewed>
  <field_pretty_url>lung-genomic-classifier</field_pretty_url>
  <para_id>967894</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>969678</id>
  <title>International Collaboration Enhances Cancer Screening Efforts</title>
  <langcode>en</langcode>
  <field_short_title>International Collaboration Enhances Cancer Screening Efforts</field_short_title>
  <field_date_posted>2015-06-23</field_date_posted>
  <field_date_reviewed>2015-06-23</field_date_reviewed>
  <field_pretty_url>international-collaboration</field_pretty_url>
  <para_id>969678</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>969698</term_id>
  <id>969699</id>
  <title>NCI Budget Fact Book</title>
  <langcode>en</langcode>
  <field_short_title>NCI Budget Fact Book</field_short_title>
  <field_page_description>The NCI Budget Fact Book summarizes the recent NCI fiscal year budget, including research funding and overall spending. Review the highlights of NCI's 2018 Fiscal Year Budget.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-06-24</field_date_reviewed>
  <para_id>969699</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069530</term_id>
  <id>974490</id>
  <title>Mutations in Human Cancers Through the Lens of KRAS</title>
  <langcode>en</langcode>
  <field_short_title>Mutations in Human Cancers Related to KRAS</field_short_title>
  <field_date_posted>2015-07-07</field_date_posted>
  <field_date_reviewed>2015-07-07</field_date_reviewed>
  <field_pretty_url>kras-cancer-co-mutation</field_pretty_url>
  <para_id>974490</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>974535</term_id>
  <id>974536</id>
  <title>Grant and Contract Awards</title>
  <langcode>en</langcode>
  <field_short_title>Grant and Contract Awards</field_short_title>
  <field_page_description>Find information about grant and contract awards by state, by country, and by institutions that received more than $15 million in support from NCI.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-07-07</field_date_reviewed>
  <para_id>974536</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>974634</term_id>
  <id>974635</id>
  <title>NCI Personnel</title>
  <langcode>en</langcode>
  <field_short_title>Personnel and Staffing Levels</field_short_title>
  <field_page_description>See NCI-staffing levels by type of appointment since 2009, including full-time, permanent appointments; appointments other than full-time, permanent; and training fellows.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-07-08</field_date_reviewed>
  <para_id>974635</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>975112</term_id>
  <id>975114</id>
  <title>NCI Budget Fact Book Archive</title>
  <langcode>en</langcode>
  <field_short_title>NCI Budget Fact Book Archive</field_short_title>
  <field_page_description>History of NCI Budget Fact Books from 2017 to 1971. View and download NCI’s archived Budget Fact Books.</field_page_description>
  <field_date_posted>2016-12-16</field_date_posted>
  <field_date_reviewed>2015-07-10</field_date_reviewed>
  <para_id>975114</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>975213</id>
  <title>Healthy Border 2020 Embassy Launch</title>
  <langcode>en</langcode>
  <field_short_title>Healthy Border 2020 Embassy Launch</field_short_title>
  <field_date_posted>2015-07-10</field_date_posted>
  <field_date_reviewed>2015-07-10</field_date_reviewed>
  <field_pretty_url>healthyborder</field_pretty_url>
  <para_id>975213</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>975284</id>
  <title>Fostering Cooperation in Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Fostering Cooperation in Cancer Research</field_short_title>
  <field_date_posted>2015-07-10</field_date_posted>
  <field_date_reviewed>2015-07-10</field_date_reviewed>
  <field_pretty_url>indiamou</field_pretty_url>
  <para_id>975284</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>974492</term_id>
  <id>976613</id>
  <title>Dr. Ruth L. Kirschstein National Research Service Awards (NRSA)</title>
  <langcode>en</langcode>
  <field_short_title>Dr. Ruth L. Kirschstein National Research Service Awards</field_short_title>
  <field_page_description>The NCI Ruth L. Kirschstein National Research Service Award (NRSA) program helps ensure that a diverse pool of highly trained scientists is available to meet the Nation’s research needs. Learn more about the NRSA program and the types of predoc and postdoc trainees awarded.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-07-14</field_date_reviewed>
  <para_id>976613</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1074837</term_id>
  <id>1081666</id>
  <title>Clinical Trial Sequencing Project</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trial Sequencing</field_short_title>
  <field_page_description>The Clinical Trial Sequencing Project performs genomic characterization of samples from NCI-sponsored trials with the goal of improving the understanding and treatment of various cancers.</field_page_description>
  <field_date_posted>2017-08-04</field_date_posted>
  <field_date_reviewed>2017-04-17</field_date_reviewed>
  <field_pretty_url>clinical-trial-sequencing</field_pretty_url>
  <para_id>1081666</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1083491</term_id>
  <id>1083492</id>
  <title>Tumor Metastasis Research</title>
  <langcode>en</langcode>
  <field_short_title>Tumor Metastasis Research</field_short_title>
  <field_page_description>Tumor metastasis research examines the mechanisms that allow cancer cells to leave the primary tumor and spread to another part of the body. Learn about recent tumor metastasis research studies supported by the Division of Cancer Biology.</field_page_description>
  <field_date_posted>2017-06-01</field_date_posted>
  <field_date_reviewed>2017-05-05</field_date_reviewed>
  <para_id>1083492</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1083493</id>
  <title>Nanoparticles Create Effective CAR T Cells in Living Mice</title>
  <langcode>en</langcode>
  <field_short_title>Nanoparticles Create Effective CAR T Cells in Mice</field_short_title>
  <field_page_description>A Cancer Currents blog on the development of a method to genetically engineer cancer-fighting immune cells, known as CAR T cells, in living animals using nanoparticles that carry DNA. </field_page_description>
  <field_date_posted>2017-05-05</field_date_posted>
  <field_date_reviewed>2017-05-05</field_date_reviewed>
  <field_pretty_url>nanoparticles-engineer-immune-cells</field_pretty_url>
  <para_id>1083493</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>860258</term_id>
  <id>1084754</id>
  <title>Cancer Risk - Cancer Currents Blog</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Risk</field_short_title>
  <field_page_description>Blog posts on research related to cancer risk—including inherited, behavioral, and environmental risks and studies about decreasing risk—from NCI Cancer Currents.</field_page_description>
  <field_date_posted>2017-05-12</field_date_posted>
  <field_date_reviewed>2017-05-12</field_date_reviewed>
  <field_pretty_url>cancer-risk</field_pretty_url>
  <para_id>1084754</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>860258</term_id>
  <id>1084762</id>
  <title>FDA Approvals - Cancer Currents Blog</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approvals</field_short_title>
  <field_page_description>Blog posts on cancer drugs and devices approved by the Food and Drug Administration—including summaries of the evidence to support the approvals and what they mean for patients—from NCI Cancer Currents.</field_page_description>
  <field_date_posted>2017-05-12</field_date_posted>
  <field_date_reviewed>2017-05-12</field_date_reviewed>
  <field_pretty_url>fda-approvals</field_pretty_url>
  <para_id>1084762</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>860258</term_id>
  <id>1084784</id>
  <title>Treatment - Cancer Currents Blog</title>
  <langcode>en</langcode>
  <field_short_title>Treatment</field_short_title>
  <field_page_description>Blog posts on cancer treatment research—including new treatments for cancer and their effects, clinical trial results, and overcoming treatment resistance—from NCI Cancer Currents. </field_page_description>
  <field_date_posted>2017-05-12</field_date_posted>
  <field_date_reviewed>2017-05-12</field_date_reviewed>
  <field_pretty_url>treatment</field_pretty_url>
  <para_id>1084784</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1086244</id>
  <title>New on NCI’s Websites for May 2017</title>
  <langcode>en</langcode>
  <field_short_title>New on NCI’s Websites for May 2017</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post that provides an update on new content of interest to the cancer community recently added to NCI’s websites.</field_page_description>
  <field_date_posted>2017-05-30</field_date_posted>
  <field_date_reviewed>2017-05-26</field_date_reviewed>
  <field_pretty_url>new-online-may-2017</field_pretty_url>
  <para_id>1086244</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1087617</term_id>
  <id>1087619</id>
  <title>2015 Outstanding Investigator Award Recipients</title>
  <langcode>en</langcode>
  <field_short_title>2015 Recipients of NCI Outstanding Investigator Awards</field_short_title>
  <field_page_description>Learn how these investigators' projects aim to break new ground in biomedical, behavioral, and clinical cancer research.</field_page_description>
  <field_date_posted>2015-10-14</field_date_posted>
  <field_date_reviewed>2015-10-14</field_date_reviewed>
  <para_id>1087619</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894084</term_id>
  <id>1087994</id>
  <title>Celebrating 21 Years of the CURE Program</title>
  <langcode>en</langcode>
  <field_short_title>Celebrating 21 Years of the CURE Program</field_short_title>
  <field_page_description>In honor of the 21st anniversary of the Continuing Umbrella of Research Experiences (CURE) program, CRCHD will host “Celebrating 21 Years of the CURE Program” on June 27, 2017.</field_page_description>
  <field_date_posted>2017-06-21</field_date_posted>
  <field_date_reviewed>2017-06-21</field_date_reviewed>
  <field_pretty_url>celebrating-cure</field_pretty_url>
  <para_id>1087994</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1088562</term_id>
  <id>1088563</id>
  <title>Engineered Invasive Human Breast Tumors with Integrated Capillaries and Lymphatics</title>
  <langcode>en</langcode>
  <field_short_title>Engineered Invasive Human Breast Tumors </field_short_title>
  <field_page_description>This collaborative study seeks to develop and apply new methods of engineering human breast tumors that allow for modular control over key aspects of a tumor and its microenvironment.</field_page_description>
  <field_date_posted>2017-09-21</field_date_posted>
  <field_date_reviewed>2017-06-28</field_date_reviewed>
  <para_id>1088563</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1089021</id>
  <title>Improving Cancer Control in Rural Communities: Next Steps</title>
  <langcode>en</langcode>
  <field_short_title>Improving Cancer Control in Rural Communities</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post from NCI’s Dr. Robert Croyle on how the institute is working to address disparities in cancer outcomes in US rural communities.</field_page_description>
  <field_date_posted>2017-07-07</field_date_posted>
  <field_date_reviewed>2017-07-06</field_date_reviewed>
  <field_pretty_url>rural-cancer-disparities-next-steps</field_pretty_url>
  <para_id>1089021</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>941787</term_id>
  <id>916034</id>
  <title>Planning for the Caregiver</title>
  <langcode>en</langcode>
  <field_short_title>Planning for the Caregiver</field_short_title>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>916034</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917000</term_id>
  <id>917205</id>
  <title>Accrual Reporting </title>
  <langcode>en</langcode>
  <field_short_title>Accrual Reporting </field_short_title>
  <field_page_description>An overview of accrual reporting requirements of clinical trials into the Clinical Trial Reporting Program.</field_page_description>
  <field_date_posted>2015-03-17</field_date_posted>
  <field_date_reviewed>2015-03-17</field_date_reviewed>
  <para_id>917205</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917503</term_id>
  <id>917507</id>
  <title>Complementary and Alternative Medicine for Patients</title>
  <langcode>en</langcode>
  <field_short_title>CAM for Patients</field_short_title>
  <field_date_posted>2015-04-10</field_date_posted>
  <field_date_reviewed>2015-03-18</field_date_reviewed>
  <para_id>917507</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>917513</id>
  <title>DNA "Minicircles" Could Improve Cancer Detection, Study Suggests</title>
  <langcode>en</langcode>
  <field_short_title>DNA "Minicircles" Could Improve Cancer Detection, Study Suggests</field_short_title>
  <field_date_posted>2015-03-19</field_date_posted>
  <field_date_reviewed>2015-03-19</field_date_reviewed>
  <field_pretty_url>dna-minicircles</field_pretty_url>
  <para_id>917513</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918914</term_id>
  <id>918915</id>
  <title>Previous NCI Directors</title>
  <langcode>en</langcode>
  <field_short_title>Previous NCI Directors</field_short_title>
  <field_page_description>Find a listing of the previous directors of NCI.</field_page_description>
  <field_date_posted>2015-04-13</field_date_posted>
  <field_date_reviewed>2015-03-23</field_date_reviewed>
  <para_id>918915</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>919126</id>
  <title>The Exceptional Responders Initiative: Welcoming More Cases</title>
  <langcode>en</langcode>
  <field_short_title>The Exceptional Responders Initiative: Welcoming More Cases</field_short_title>
  <field_date_posted>2015-03-24</field_date_posted>
  <field_date_reviewed>2015-03-24</field_date_reviewed>
  <field_pretty_url>exceptional-responders-initiative</field_pretty_url>
  <para_id>919126</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>916821</term_id>
  <id>15247</id>
  <title>Research Program Contacts</title>
  <langcode>en</langcode>
  <field_short_title>Research Program Contacts</field_short_title>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>15247</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11972</term_id>
  <id>15562</id>
  <title>Thyroid Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Thyroid Cancer</field_short_title>
  <field_page_description>Thyroid cancer can be of four main types. Anaplastic thyroid cancer is hard to cure with current treatments, whereas papillary (the most common), follicular, and medullary thyroid cancer can usually be cured. Start here to find information on thyroid cancer treatment, screening, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>15562</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>952660</term_id>
  <id>15611</id>
  <title>PDQ&amp;reg; Cancer Information Summaries: Prevention</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Prevention</field_short_title>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>15611</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>1052958</term_id>
  <id>16380</id>
  <title>Find NCI-Supported Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>Find NCI-Supported Clinical Trials</field_short_title>
  <field_date_posted>2011-02-02</field_date_posted>
  <field_date_reviewed>2011-02-02</field_date_reviewed>
  <para_id>16380</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127294</term_id>
  <id>57472</id>
  <title>FDA Terminology</title>
  <langcode>en</langcode>
  <field_short_title>FDA Terminology</field_short_title>
  <field_page_description>FDA works with NCI EVS to develop regulatory and other controlled terminology standards.</field_page_description>
  <field_date_posted>2011-02-07</field_date_posted>
  <field_date_reviewed>2017-03-31</field_date_reviewed>
  <para_id>57472</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127296</term_id>
  <id>57474</id>
  <title>NCPDP Terminology</title>
  <langcode>en</langcode>
  <field_short_title>NCPDP Terminology</field_short_title>
  <field_page_description>NCPDP Terminology developed with NCI EVS for prescription drugs.</field_page_description>
  <field_date_posted>2011-02-07</field_date_posted>
  <field_date_reviewed>2017-03-31</field_date_reviewed>
  <para_id>57474</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>404280</id>
  <title>Breast cancer patients with high density mammograms do not have increased risk of death</title>
  <langcode>en</langcode>
  <field_short_title>Breast cancer patients with dense breasts do not have increased death risk</field_short_title>
  <field_page_description>High mammographic breast density, which is a marker of increased risk of developing breast cancer, does not seem to increase the risk of death among breast cancer patients, according to a study led by Gretchen L. Gierach, Ph.D., NCI. Image shows physician</field_page_description>
  <field_date_posted>2012-08-20</field_date_posted>
  <field_date_reviewed>2012-08-16</field_date_reviewed>
  <field_pretty_url>breastdensitymammogram</field_pretty_url>
  <para_id>404280</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>430531</id>
  <title>Study reveals genomic similarities between breast and ovarian cancers</title>
  <langcode>en</langcode>
  <field_short_title>Genomic similarities between breast and ovarian cancers</field_short_title>
  <field_page_description>One subtype of breast cancer shares many genetic features with high-grade serous ovarian cancer, a cancer that is very difficult to treat, according to researchers supported by the National Institutes of Health. The findings suggest that the two cancers a</field_page_description>
  <field_date_posted>2012-09-24</field_date_posted>
  <field_date_reviewed>2012-09-21</field_date_reviewed>
  <field_pretty_url>TCGAbreast</field_pretty_url>
  <para_id>430531</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>441136</id>
  <title>HIV infection connected to rising anal cancer rates in men in the U.S.</title>
  <langcode>en</langcode>
  <field_short_title>HIV infection connected to rising anal cancer rates in men in the U.S.</field_short_title>
  <field_page_description>Human immunodeficiency virus (HIV) infection contributes substantially to the epidemic of anal cancer in men, but not women in the United States, according to new research from NCI. Chart shows overall incidence rates of anal cancers in general population</field_page_description>
  <field_date_posted>2012-10-05</field_date_posted>
  <field_date_reviewed>2012-10-04</field_date_reviewed>
  <field_pretty_url>HIVwithAnalCancer</field_pretty_url>
  <para_id>441136</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1090265</term_id>
  <id>1090266</id>
  <title>Cancer Prevention Steering Committee</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Prevention SC</field_short_title>
  <field_page_description>The Cancer Prevention Steering Committee reviews innovative cancer prevention, screening, and surveillance concepts.</field_page_description>
  <field_date_posted>2017-09-28</field_date_posted>
  <field_date_reviewed>2017-07-21</field_date_reviewed>
  <para_id>1090266</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1091095</id>
  <title>In Melanoma, Personalized Treatment Vaccines Show Promise</title>
  <langcode>en</langcode>
  <field_short_title>Personalized Treatment Vaccines for Melanoma</field_short_title>
  <field_page_description>In patients with melanoma, a personalized treatment vaccine generated a robust immune response and may have helped prevent a recurrence, the Cancer Currents blog reports.</field_page_description>
  <field_date_posted>2017-08-04</field_date_posted>
  <field_date_reviewed>2017-08-03</field_date_reviewed>
  <field_pretty_url>melanoma-personalized-vaccine</field_pretty_url>
  <para_id>1091095</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1091122</id>
  <title>“First in Human” Documentary Highlights NCI Immunotherapy Research</title>
  <langcode>en</langcode>
  <field_short_title>“First in Human” Highlights NCI Immunotherapy Research</field_short_title>
  <field_page_description>The Discovery Channel documentary, First in Human, will feature some of the groundbreaking work on cancer immunotherapy being done at the NIH Clinical Center.</field_page_description>
  <field_date_posted>2017-08-07</field_date_posted>
  <field_date_reviewed>2017-08-04</field_date_reviewed>
  <field_pretty_url>first-in-human-nci-immunotherapy</field_pretty_url>
  <para_id>1091122</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1091773</id>
  <title>Ibrutinib Becomes First FDA-Approved Drug for Chronic Graft-Versus-Host Disease</title>
  <langcode>en</langcode>
  <field_short_title>Ibrutinib Approved for Graft-Versus-Host Disease</field_short_title>
  <field_page_description>The FDA has approved ibrutinib for chronic graft-versus-host disease, a common side effect of cancer-related stem cell transplants, NCI’s Cancer Currents blog reports.</field_page_description>
  <field_date_posted>2017-08-11</field_date_posted>
  <field_date_reviewed>2017-08-11</field_date_reviewed>
  <field_pretty_url>ibrutinib-fda-gvhd</field_pretty_url>
  <para_id>1091773</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1092594</id>
  <title>NCI Program Supports Small Businesses to Advance Cancer Research Innovation – A Q&amp;A with Michael Weingarten</title>
  <langcode>en</langcode>
  <field_short_title>Supporting Small Business to Drive Cancer Research Innovation</field_short_title>
  <field_page_description>NCI’s SBIR program is offering funding to help small businesses develop innovative cancer-related therapies and technologies, including those prioritized by the Cancer Moonshot.</field_page_description>
  <field_date_posted>2017-08-21</field_date_posted>
  <field_date_reviewed>2017-08-17</field_date_reviewed>
  <field_pretty_url>sbir-contract-solicitations-cancer-moonshot</field_pretty_url>
  <para_id>1092594</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1093752</term_id>
  <id>1093757</id>
  <title>Sexual Health Issues in Men with Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Sexual Health Issues in Men</field_short_title>
  <field_page_description>Cancer treatments such as chemotherapy, radiation therapy and prostate surgery may affect a man’s sexual function, lower libido, and make it difficult to get an erection. Learn how to manage and treat these sexual problems, during cancer treatment.</field_page_description>
  <field_date_posted>2017-09-22</field_date_posted>
  <field_date_reviewed>2017-08-28</field_date_reviewed>
  <para_id>1093757</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1093820</id>
  <title>Modified Stem Cells Deliver Chemotherapy to Metastatic Tumors</title>
  <langcode>en</langcode>
  <field_short_title>Stem Cells Deliver Chemo to Metastatic Breast Cancer</field_short_title>
  <field_page_description>Using modified stem cells, researchers delivered a cancer drug selectively to metastatic breast cancer tumors in mice, as this NCI Cancer Currents post explains.</field_page_description>
  <field_date_posted>2017-08-30</field_date_posted>
  <field_date_reviewed>2017-08-30</field_date_reviewed>
  <field_pretty_url>breast-metastases-targeting-stem-cells</field_pretty_url>
  <para_id>1093820</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894084</term_id>
  <id>1096343</id>
  <title>Dr. John M. Carethers to Deliver Second NCI CURE Distinguished Scholars Seminar</title>
  <langcode>en</langcode>
  <field_short_title>Dr. John M. Carethers to Deliver CURE Distinguished Scholars Seminar</field_short_title>
  <field_page_description>Dr. John M. Carethers will deliver the second CURE Distinguished Scholars Seminar on Oct. 5, 2017. </field_page_description>
  <field_date_posted>2017-09-19</field_date_posted>
  <field_date_reviewed>2017-09-19</field_date_reviewed>
  <field_pretty_url>carethers-seminar</field_pretty_url>
  <para_id>1096343</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1096585</id>
  <title>FDA Expands Approval of Fulvestrant for Advanced Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Expands Approval of Fulvestrant for Breast Cancer</field_short_title>
  <field_page_description>Fulvestrant (Faslodex®) has been approved by FDA for some women with advanced breast cancer, this Cancer Currents post reports.</field_page_description>
  <field_date_posted>2017-09-22</field_date_posted>
  <field_date_reviewed>2017-09-21</field_date_reviewed>
  <field_pretty_url>fda-fulvestrant-breast-cancer</field_pretty_url>
  <para_id>1096585</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1096930</id>
  <title>Low-Tech Outreach Methods Improve Colorectal Cancer Screening</title>
  <langcode>en</langcode>
  <field_short_title>Outreach Improves Colorectal Cancer Screening</field_short_title>
  <field_page_description>Colorectal cancer screening, completion of the appropriate follow-up was increased by mailed invitations, free test kits, this Cancer Currents post reports.</field_page_description>
  <field_date_posted>2017-09-26</field_date_posted>
  <field_date_reviewed>2017-09-25</field_date_reviewed>
  <field_pretty_url>colorectal-cancer-screening-outreach</field_pretty_url>
  <para_id>1096930</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>464421</id>
  <title>Understanding Breast Changes: A Health Guide for Women</title>
  <langcode>en</langcode>
  <field_short_title>Understanding Breast Changes: A Health Guide for Women</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2012-11-23</field_date_reviewed>
  <field_pretty_url>understanding-breast-changes</field_pretty_url>
  <para_id>464421</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>921723</id>
  <title>Making Sense of Key Cancer Reports</title>
  <langcode>en</langcode>
  <field_short_title>Making Sense of Key Cancer Reports</field_short_title>
  <field_date_posted>2015-03-30</field_date_posted>
  <field_date_reviewed>2015-03-30</field_date_reviewed>
  <field_pretty_url>cancer-reports</field_pretty_url>
  <para_id>921723</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922403</term_id>
  <id>922405</id>
  <title>Prostate Cancer Prevention Trial (PCPT): Questions and Answers</title>
  <langcode>en</langcode>
  <field_short_title>Prostate Cancer Prevention Trial (PCPT): Questions and Answers</field_short_title>
  <field_page_description>Learn the results of the Prostate Cancer Prevention Trial, which was a study designed to see whether the drug finasteride (trade name Proscar) could prevent prostate cancer in men ages 55 and older.</field_page_description>
  <field_date_posted>2015-04-01</field_date_posted>
  <field_date_reviewed>2015-04-01</field_date_reviewed>
  <field_pretty_url>prostate-cancer-prevention-trial-qa</field_pretty_url>
  <para_id>922405</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922594</term_id>
  <id>922595</id>
  <title>Chronic Inflammation</title>
  <langcode>en</langcode>
  <field_short_title>Chronic Inflammation</field_short_title>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-04-02</field_date_reviewed>
  <para_id>922595</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>930057</id>
  <title>Global Cancer Humanitarian Award Honors Pat Garcia-Gonzalez of the Max Foundation</title>
  <langcode>en</langcode>
  <field_short_title>Global Cancer Humanitarian Award </field_short_title>
  <field_date_posted>2015-04-08</field_date_posted>
  <field_date_reviewed>2015-04-08</field_date_reviewed>
  <field_pretty_url>humanitarian-award</field_pretty_url>
  <para_id>930057</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>930167</term_id>
  <id>930168</id>
  <title>NCI Dictionaries</title>
  <langcode>en</langcode>
  <field_short_title>NCI Dictionaries</field_short_title>
  <field_page_description>Links to NCI's three main dictionaries; the NCI Dictionary of Cancer Terms, the NCI Dictionary of Genetics Terms, and the NCI Drug Dictionary.</field_page_description>
  <field_date_posted>2015-05-15</field_date_posted>
  <field_date_reviewed>2015-04-08</field_date_reviewed>
  <para_id>930168</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>936428</id>
  <title>Grantee Spotlight: Kurt Richard Weiss, M.D. - From Osteosarcoma Survivor to Osteosarcoma Researcher</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Kurt Richard Weiss, M.D. - From Osteosarcoma Survivor to Osteosarcoma Researcher</field_short_title>
  <field_date_posted>2014-06-27</field_date_posted>
  <field_date_reviewed>2014-06-27</field_date_reviewed>
  <field_pretty_url>weiss-spotlight-blog</field_pretty_url>
  <para_id>936428</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>937959</id>
  <title>HPV Vaccine Effective Against Infection at Multiple Sites, Provides Partial Protection in Women with Previous Infections</title>
  <langcode>en</langcode>
  <field_short_title>HPV Vaccine Effective at Multiple Anatomic Sites</field_short_title>
  <field_page_description>A new study from NCI researchers finds that the HPV vaccine protects young women from infection with high-risk HPV types at the three primary anatomic sites where persistent HPV infections can cause cancer. The multi-site protection also was observed at l</field_page_description>
  <field_date_posted>2015-04-22</field_date_posted>
  <field_date_reviewed>2015-04-22</field_date_reviewed>
  <field_pretty_url>hpvvaccine-multisite</field_pretty_url>
  <para_id>937959</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>938866</id>
  <title>Multi-center anal pre-cancer treatment and cancer prevention study launched in HIV-infected persons</title>
  <langcode>en</langcode>
  <field_short_title>Anal pre-cancer treatment and cancer prevention study launched</field_short_title>
  <field_page_description>NCI has launched a multicenter phase III clinical trial called the ANCHOR Study -- Anal Cancer HSIL (High-grade Squamous Intraepithelial Lesion) Outcomes Research Study -- to determine if treatment of HSIL in HIV-infected individuals can prevent anal canc</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-04-24</field_date_reviewed>
  <field_pretty_url>anchor-trial-launch</field_pretty_url>
  <para_id>938866</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>939885</term_id>
  <id>939892</id>
  <title>Bone Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Bone Cancer</field_short_title>
  <field_page_description>There are several types of bone cancer. Osteosarcoma usually starts in osteoblasts, a type of bone cell that becomes new bone tissue. Ewing sarcoma arises from a primordial bone marrow–derived mesenchymal stem cell. Find evidence-based information on bone cancer including treatment, research, genetics, and statistics.</field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-04-30</field_date_reviewed>
  <para_id>939892</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>939958</term_id>
  <id>939963</id>
  <title>Breast Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Breast Cancer</field_short_title>
  <field_page_description>The most common type of breast cancer is ductal carcinoma, which begins in the cells of the ducts. Breast cancer can also begin in the cells of a lobule and in other tissues of the breast. Find evidence-based information on breast cancer treatment, causes and prevention, genetics, screening, research, and statistics.</field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-04-30</field_date_reviewed>
  <para_id>939963</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940109</term_id>
  <id>940116</id>
  <title>Esophageal Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Esophageal Cancer</field_short_title>
  <field_page_description>The incidence of esophageal cancer has risen in recent decades, coinciding with a shift in histologic type and primary tumor location. Find evidence-based information on esophageal cancer treatment, causes and prevention, screening, research, and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940116</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940470</term_id>
  <id>940477</id>
  <title>Liver and Bile Duct Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Liver and Bile Duct Cancer</field_short_title>
  <field_page_description>Liver cancer includes two major types: hepatocellular carcinoma (HCC) and intrahepatic bile duct cancer, also known as cholangiocarcinoma. Find evidence-based information on liver and bile duct cancer treatment, causes and prevention, screening, research, genomics and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940477</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938229</term_id>
  <id>940618</id>
  <title>Plasma Cell Neoplasms (Including Multiple Myeloma) Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on plasma cell neoplasms (including multiple myeloma), which may include news stories, clinical trials, blog posts, and descriptions of active studies. </field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940618</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940704</term_id>
  <id>940711</id>
  <title>Ovarian, Fallopian Tube, and Primary Peritoneal Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Ovarian, Fallopian Tube, and Primary Peritoneal Cancer</field_short_title>
  <field_page_description>Ovarian epithelial, fallopian tube, and peritoneal cancers are diseases in which malignant cells form in the tissue covering the ovary, lining the fallopian tube, or peritoneum. Find evidence-based information on ovarian cancer treatment, causes and prevention, screening, research, genetics and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940711</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938042</term_id>
  <id>940712</id>
  <title>Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on ovarian, fallopian tube, and primary peritoneal cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940712</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940801</term_id>
  <id>940806</id>
  <title>Penile Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Penile Cancer </field_short_title>
  <field_page_description>Penile cancer is most commonly squamous cell carcinoma. When diagnosed early, penile cancer is highly curable. Some studies suggest an association between human papillomavirus (HPV) infection and penile cancer. Find evidence-based information on penile cancer treatment.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940806</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>941081</term_id>
  <id>941086</id>
  <title>Thymoma and Thymic Carcinoma—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Thymoma and Thymic Carcinoma </field_short_title>
  <field_page_description>Thymomas and thymic carcinomas are epithelial tumors of the thymus. A thymic epithelial tumor that exhibits cytologic atypia and histologic features no longer specific to the thymus is known as a thymic carcinoma. Find evidence-based information on thymoma and thymic carcinoma treatment.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941086</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>941168</term_id>
  <id>941176</id>
  <title>Uterine Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on uterine cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941176</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>922517</term_id>
  <id>941434</id>
  <title>NCI Senior Leadership</title>
  <langcode>en</langcode>
  <field_short_title>NCI Senior Leadership</field_short_title>
  <field_page_description>Information about NCI Director and other senior NCI leaders.</field_page_description>
  <field_date_posted>2015-05-15</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941434</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911142</term_id>
  <id>14362</id>
  <title>Diethylstilbestrol (DES) and Cancer </title>
  <langcode>en</langcode>
  <field_short_title>Diethylstilbestrol (DES) and Cancer </field_short_title>
  <field_page_description>A fact sheet about DES (a synthetic form of estrogen) and the health problems of children who were exposed to DES while in the womb.</field_page_description>
  <field_date_posted>2011-10-05</field_date_posted>
  <field_date_reviewed>2011-10-05</field_date_reviewed>
  <field_pretty_url>des-fact-sheet</field_pretty_url>
  <para_id>14362</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>63848</term_id>
  <id>63858</id>
  <title>Patient Safety in Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>Patient Safety in Clinical Trials</field_short_title>
  <field_page_description>Information about how the rights and safety of people who take part in clinical trials are protected. </field_page_description>
  <field_date_posted>2011-02-24</field_date_posted>
  <field_date_reviewed>2016-06-22</field_date_reviewed>
  <para_id>63858</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>65326</id>
  <title>Drugs Approved for Prostate Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Prostate Cancer</field_short_title>
  <field_date_posted>2011-05-04</field_date_posted>
  <field_date_reviewed>2011-03-11</field_date_reviewed>
  <field_pretty_url>prostate</field_pretty_url>
  <para_id>65326</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>68317</term_id>
  <id>68483</id>
  <title>The Pathway to Independence Award (K99/R00)</title>
  <langcode>en</langcode>
  <field_short_title>NCI K99 Award</field_short_title>
  <field_date_posted>2011-03-22</field_date_posted>
  <field_date_reviewed>2016-01-11</field_date_reviewed>
  <para_id>68483</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938223</term_id>
  <id>68632</id>
  <title>Novel Combination Chemotherapy for Localized Ewing Sarcoma</title>
  <langcode>en</langcode>
  <field_short_title>Novel Combination Chemotherapy for Localized Ewing Sarcoma</field_short_title>
  <field_page_description>In this clinical trial, researchers will test whether the addition of the drug combination vincristine, topotecan, and cyclophosphamide to a standard chemotherapy regimen improves overall survival in patients with extracranial Ewing</field_page_description>
  <field_date_posted>2011-03-22</field_date_posted>
  <field_date_reviewed>2011-03-24</field_date_reviewed>
  <field_pretty_url>novel-chemo-combo</field_pretty_url>
  <para_id>68632</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>78747</id>
  <title>Starting Hormone Therapy at Menopause Increases Breast Cancer Risk</title>
  <langcode>en</langcode>
  <field_short_title>Starting Hormone Therapy at Menopause Increases Breast Cancer Risk</field_short_title>
  <field_date_posted>2011-05-11</field_date_posted>
  <field_date_reviewed>2011-05-11</field_date_reviewed>
  <field_pretty_url>menopausal-ht-risk</field_pretty_url>
  <para_id>78747</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>79693</id>
  <title>Drugs Approved for Anal Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Anal Cancer</field_short_title>
  <field_date_posted>2011-08-26</field_date_posted>
  <field_date_reviewed>2011-05-20</field_date_reviewed>
  <field_pretty_url>anal</field_pretty_url>
  <para_id>79693</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>79721</id>
  <title>Menopausal Estrogen Therapy Benefits and Risks Vary by Age, WHI Analysis Suggests</title>
  <langcode>en</langcode>
  <field_short_title>Menopausal Estrogen Therapy Benefits and Risks Vary by Age, WHI Analysis Suggests</field_short_title>
  <field_page_description>Long-term follow-up data from the Women’s Health Initiative (WHI) provide new information about the potential risks and benefits of hormone therapy to treat symptoms related to menopause, including its effect on breast cancer risk,</field_page_description>
  <field_date_posted>2011-05-20</field_date_posted>
  <field_date_reviewed>2011-05-20</field_date_reviewed>
  <field_pretty_url>ert-benefits-risks-age</field_pretty_url>
  <para_id>79721</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>84042</id>
  <title>Five Years of Tamoxifen Continues to Benefit Women 15 Years after Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Five Years of Tamoxifen Continues to Benefit Women 15 Years after Treatment</field_short_title>
  <field_page_description>In a large randomized clinical trial, women with early-stage breast cancer who received 5 years of adjuvant treatment with tamoxifen had better outcomes up to 15 years after the start of treatment than those who received 2 years of tamoxifen therapy. </field_page_description>
  <field_date_posted>2011-06-03</field_date_posted>
  <field_date_reviewed>2011-06-03</field_date_reviewed>
  <field_pretty_url>tamoxifen-15-year-benefits</field_pretty_url>
  <para_id>84042</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>707517</id>
  <title>NIH study confirms risk factors for male breast cancer</title>
  <langcode>en</langcode>
  <field_short_title>NIH study confirms risk factors for male breast cancer</field_short_title>
  <field_page_description>Pooled data from studies of about 2,400 men with breast cancer and 52,000 men without breast cancer confirmed that risk factors for male breast cancer include obesity, a rare genetic condition called Klinefelter syndrome, and gynecomastia.</field_page_description>
  <field_date_posted>2014-02-19</field_date_posted>
  <field_date_reviewed>2014-02-18</field_date_reviewed>
  <field_pretty_url>BreastCancerMalePoolingStudy</field_pretty_url>
  <para_id>707517</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919486</term_id>
  <id>722578</id>
  <title>Contact the Office of Advocacy Relations</title>
  <langcode>en</langcode>
  <field_short_title>Contact OAR</field_short_title>
  <field_page_description>Contact information for the Office of Advocacy Relations, including staff directory.</field_page_description>
  <field_date_posted>2014-03-11</field_date_posted>
  <field_date_reviewed>2014-03-11</field_date_reviewed>
  <para_id>722578</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>725920</id>
  <title>Implementation of the NCI’s National Clinical Trials Network</title>
  <langcode>en</langcode>
  <field_short_title>Implementation of the NCI’s National Clinical Trials Network</field_short_title>
  <field_page_description>NCI is launching a new clinical trials research network intended to improve treatment for the more than 1.6 million Americans diagnosed with cancer each year.  The new system, NCI’s National Clinical Trials Network (NCTN), will facilitate the rapid initia</field_page_description>
  <field_date_posted>2014-03-20</field_date_posted>
  <field_date_reviewed>2014-03-19</field_date_reviewed>
  <field_pretty_url>NCTNlaunch</field_pretty_url>
  <para_id>725920</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>746613</term_id>
  <id>747150</id>
  <title>NCI Center for Global Health (CGH)</title>
  <langcode>en</langcode>
  <field_short_title>NCI Center for Global Health (CGH)</field_short_title>
  <field_page_description>NCI’s Center for Global Health coordinates research and works with national and international partners to understand and address the burden of cancer worldwide.</field_page_description>
  <field_date_posted>2014-04-08</field_date_posted>
  <field_date_reviewed>2014-04-08</field_date_reviewed>
  <para_id>747150</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>919353</term_id>
  <id>747173</id>
  <title>Research Programs and Initiatives</title>
  <langcode>en</langcode>
  <field_short_title>Research Programs and Initiatives</field_short_title>
  <field_page_description>CGH develops international initiatives and collaborates with other NCI divisions, NCI-designated Cancer Centers, and other countries to support cancer control planning, encourage capacity building, and support cancer research and research networks.</field_page_description>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-04-08</field_date_reviewed>
  <para_id>747173</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>608323</term_id>
  <id>748346</id>
  <title>The "Accidental" Cure—Platinum-based Treatment for Cancer: The Discovery of Cisplatin</title>
  <langcode>en</langcode>
  <field_short_title>Use of Cisplatin for Cancer Treatment</field_short_title>
  <field_date_posted>2014-05-30</field_date_posted>
  <field_date_reviewed>2014-04-09</field_date_reviewed>
  <field_pretty_url>cisplatin</field_pretty_url>
  <para_id>748346</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>748347</id>
  <title>Study in mice shows that an aggressive type of breast cancer is linked to an inflammatory protein</title>
  <langcode>en</langcode>
  <field_short_title>Study in mice shows that an aggressive type of breast cancer is linked to an inflammatory protein</field_short_title>
  <field_page_description>Aberrant expression of an inflammatory protein, nitric oxide synthase 2 (NOS2), may enhance the progression and metastasis of an aggressive and less common form of breast cancer, known as the estrogen receptor-negative type of disease.</field_page_description>
  <field_date_posted>2014-04-14</field_date_posted>
  <field_date_reviewed>2014-04-09</field_date_reviewed>
  <field_pretty_url>NOS2breastcancer</field_pretty_url>
  <para_id>748347</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919351</term_id>
  <id>748498</id>
  <title>Cancer Detection, Diagnosis, and Treatment Technologies for Global Health </title>
  <langcode>en</langcode>
  <field_short_title>Cancer Detection, Diagnosis, and Treatment Technologies for Global Health</field_short_title>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-04-09</field_date_reviewed>
  <field_pretty_url>technologies</field_pretty_url>
  <para_id>748498</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>750237</id>
  <title>An Open Letter to the Cancer Community Regarding Community Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>An Open Letter to the Cancer Community Regarding Community Clinical Trials</field_short_title>
  <field_page_description>The National Cancer Institute (NCI) is in the process of combining its two community-based research networks to create a single network that builds on the strengths of the Community Clinical Oncology Program/Minority-Based Community Clinical Oncology Prog</field_page_description>
  <field_date_posted>2014-04-11</field_date_posted>
  <field_date_reviewed>2014-04-11</field_date_reviewed>
  <field_pretty_url>VarmusOpenLetter</field_pretty_url>
  <para_id>750237</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919353</term_id>
  <id>762664</id>
  <title>United States-Latin America Cancer Research Network (US-LA CRN)</title>
  <langcode>en</langcode>
  <field_short_title>United States-Latin America Cancer Research Network (US-LA CRN)</field_short_title>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-04-30</field_date_reviewed>
  <field_pretty_url>us-la-crn</field_pretty_url>
  <para_id>762664</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>792865</term_id>
  <id>768977</id>
  <title>The Global Cancer Research Story</title>
  <langcode>en</langcode>
  <field_short_title>Global Cancer Research Story</field_short_title>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-05-16</field_date_reviewed>
  <para_id>768977</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>770427</term_id>
  <id>770429</id>
  <title>Breast Cancer Steering Committee Roster</title>
  <langcode>en</langcode>
  <field_short_title>Breast Cancer Steering Committee Roster</field_short_title>
  <field_date_posted>2014-05-21</field_date_posted>
  <field_date_reviewed>2014-05-21</field_date_reviewed>
  <field_pretty_url>roster</field_pretty_url>
  <para_id>770429</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>772002</term_id>
  <id>772119</id>
  <title>Thoracic Malignancy Steering Committee Roster</title>
  <langcode>en</langcode>
  <field_short_title>Thoracic Malignancy Steering Committee Roster</field_short_title>
  <field_date_posted>2014-05-23</field_date_posted>
  <field_date_reviewed>2014-05-23</field_date_reviewed>
  <field_pretty_url>roster</field_pretty_url>
  <para_id>772119</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894082</term_id>
  <id>1062763</id>
  <title>Program Spotlight: Twenty Years of Professional Development and Mock Review Workshops </title>
  <langcode>en</langcode>
  <field_short_title>Twenty Years of Professional Development and Mock Review Workshops </field_short_title>
  <field_page_description>Twenty Years of Professional Development and Mock Review Workshops, 2016 </field_page_description>
  <field_date_posted>2016-09-26</field_date_posted>
  <field_date_reviewed>2016-09-26</field_date_reviewed>
  <field_pretty_url>PDW-2016</field_pretty_url>
  <para_id>1062763</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1065398</id>
  <title>New on NCI Websites for October 2016</title>
  <langcode>en</langcode>
  <field_short_title>New on NCI’s Websites for October 2016</field_short_title>
  <field_page_description>NCI periodically provides updates on new websites and other online content of interest to the cancer community.</field_page_description>
  <field_date_posted>2016-10-19</field_date_posted>
  <field_date_reviewed>2016-10-19</field_date_reviewed>
  <field_pretty_url>new-online-october-2016</field_pretty_url>
  <para_id>1065398</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1066189</id>
  <title>Scientists Identify Potential Marker of Resistance to PARP Inhibitors</title>
  <langcode>en</langcode>
  <field_short_title>Study Identifies Potential Marker of PARP Inhibitor Resistance</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post about a new study from NCI researchers that could help predict whether a tumor will respond to a new class of promising cancer drugs.</field_page_description>
  <field_date_posted>2016-10-31</field_date_posted>
  <field_date_reviewed>2016-10-31</field_date_reviewed>
  <field_pretty_url>parp-inhibitor-resistance</field_pretty_url>
  <para_id>1066189</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1066246</id>
  <title>Olaratumab Approved to Treat Advanced Soft Tissue Sarcoma </title>
  <langcode>en</langcode>
  <field_short_title>New Treatment Approved for Soft Tissue Sarcoma </field_short_title>
  <field_page_description>An NCI Cancer Currents blog post about the FDA’s granting accelerated approval to olaratumab (Lartruvo®) for the treatment of some patients with soft tissue sarcoma. </field_page_description>
  <field_date_posted>2016-11-02</field_date_posted>
  <field_date_reviewed>2016-11-02</field_date_reviewed>
  <field_pretty_url>fda-olaratumab-sarcoma</field_pretty_url>
  <para_id>1066246</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>770431</term_id>
  <id>770433</id>
  <title>Gastrointestinal Steering Committee Roster</title>
  <langcode>en</langcode>
  <field_short_title>Gastrointestinal Steering Committee Roster</field_short_title>
  <field_date_posted>2014-05-21</field_date_posted>
  <field_date_reviewed>2014-05-21</field_date_reviewed>
  <field_pretty_url>roster</field_pretty_url>
  <para_id>770433</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>771999</term_id>
  <id>772117</id>
  <title>Pediatric Leukemia and Lymphoma Steering Committee Roster</title>
  <langcode>en</langcode>
  <field_short_title>Pediatric Leukemia and Lymphoma Steering Committee Roster</field_short_title>
  <field_date_posted>2014-05-23</field_date_posted>
  <field_date_reviewed>2014-05-23</field_date_reviewed>
  <field_pretty_url>roster</field_pretty_url>
  <para_id>772117</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1062940</id>
  <title>Studies Highlight Potential of Targeting HIF-2 in Kidney Cancer</title>
  <langcode>en</langcode>
  <field_short_title>New Drugs Show Potential Against Kidney Cancer</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post about two studies that suggest a new class of drugs can effectively target a molecular driver of the most common type of kidney cancer.</field_page_description>
  <field_date_posted>2016-09-29</field_date_posted>
  <field_date_reviewed>2016-09-29</field_date_reviewed>
  <field_pretty_url>hif2-kidney-cancer</field_pretty_url>
  <para_id>1062940</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1066679</id>
  <title>More Immunotherapy Options Approved for Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>More Immunotherapy Options Approved for Lung Cancer</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post about the FDA approval of the checkpoint inhibitors atezolizumab and pembrolizumab for patients with the most common form of lung cancer.</field_page_description>
  <field_date_posted>2016-11-17</field_date_posted>
  <field_date_reviewed>2016-11-14</field_date_reviewed>
  <field_pretty_url>fda-atezolizumab-pembrolizumab-lung</field_pretty_url>
  <para_id>1066679</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1066696</id>
  <title>Connected Health: An Important Tool for Making Progress against Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Connected Health and Progress against Cancer</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post about a new report from President’s Cancer Panel outlining how connective technologies can promote cancer prevention, enhance patients’ treatment experience, and accelerate progress in cancer research.</field_page_description>
  <field_date_posted>2016-11-16</field_date_posted>
  <field_date_reviewed>2016-11-15</field_date_reviewed>
  <field_pretty_url>pcp-connected-health</field_pretty_url>
  <para_id>1066696</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1032046</term_id>
  <id>1067313</id>
  <title>Cancer Metabolism: A Conversation with Jason Locasale</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Metabolism: A Conversation with Jason Locasale</field_short_title>
  <field_page_description>Cancers driven by oncogenes such as RAS have altered metabolic pathways. Scientists hope such differences make cancers vulnerable to new drugs.</field_page_description>
  <field_date_posted>2016-11-28</field_date_posted>
  <field_date_reviewed>2016-11-28</field_date_reviewed>
  <field_pretty_url>cancer-metabolism-locasale</field_pretty_url>
  <para_id>1067313</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1067400</id>
  <title>Prescription Subsidies Reduce Breast Cancer Treatment Disparities</title>
  <langcode>en</langcode>
  <field_short_title>Prescription Subsidies Reduce Breast Cancer Treatment Disparities</field_short_title>
  <field_page_description> An NCI Cancer Currents blog about a new study showing that subsidies for prescription drugs can help to reduce racial/ethnic disparities in the use of a proven breast cancer treatment.</field_page_description>
  <field_date_posted>2016-11-30</field_date_posted>
  <field_date_reviewed>2016-11-30</field_date_reviewed>
  <field_pretty_url>subsidies-breast-disparities</field_pretty_url>
  <para_id>1067400</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1087419</term_id>
  <id>1087420</id>
  <title>Cancer Tissue Engineering Collaborative </title>
  <langcode>en</langcode>
  <field_short_title>Cancer Tissue Engineering Collaborative</field_short_title>
  <field_page_description>The NCI's Cancer Tissue Engineering Collaborative (TEC) supports the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research.</field_page_description>
  <field_date_posted>2018-10-31</field_date_posted>
  <field_date_reviewed>2017-06-14</field_date_reviewed>
  <para_id>1087420</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1087503</id>
  <title>Abiraterone Improves Survival for Some Men with Hormone-Sensitive Prostate Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Abiraterone Improves Survival for Men with Hormone-Sensitive Prostate Cancer</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post on results from two clinical trials that showed adding abiraterone to androgen-deprivation therapy improved survival for men with metastatic hormone-sensitive prostate cancer.</field_page_description>
  <field_date_posted>2017-06-19</field_date_posted>
  <field_date_reviewed>2017-06-16</field_date_reviewed>
  <field_pretty_url>abiraterone-hormone-sensitive-prostate</field_pretty_url>
  <para_id>1087503</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1089455</id>
  <title>New Rituximab Formulation Approved for Some Lymphomas, Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Subcutaneous Rituximab for Some Blood Cancers</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on FDA’s approval of a new formulation of rituximab, Rituxan Hycela, for some patients with lymphoma and leukemia.</field_page_description>
  <field_date_posted>2017-07-14</field_date_posted>
  <field_date_reviewed>2017-07-13</field_date_reviewed>
  <field_pretty_url>fda-rituxan-hycela</field_pretty_url>
  <para_id>1089455</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1089582</term_id>
  <id>1089583</id>
  <title>Cancer Moonshot&amp;#8480; Funding Opportunities Resources</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Moonshot&amp;#8480; FOAs Resources</field_short_title>
  <field_page_description>Funding opportunities that address the goals of the Blue Ribbon Panel are available. Learn more about these FOAs and pre-application webinars.</field_page_description>
  <field_date_posted>2017-07-18</field_date_posted>
  <field_date_reviewed>2017-07-14</field_date_reviewed>
  <para_id>1089583</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1094068</id>
  <title>New on NCI’s Websites for September 2017</title>
  <langcode>en</langcode>
  <field_short_title>New on NCI’s Websites for September 2017</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post that provides an update on new content of interest to the cancer community recently added to NCI’s websites.</field_page_description>
  <field_date_posted>2017-09-01</field_date_posted>
  <field_date_reviewed>2017-09-01</field_date_reviewed>
  <field_pretty_url>new-online-september-2017</field_pretty_url>
  <para_id>1094068</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1096310</id>
  <title>Long-Term Nerve Damage Possible after Chemotherapy for Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Nerve Damage after Chemotherapy for Breast Cancer</field_short_title>
  <field_page_description>Peripheral neuropathy can persist for 2 years or more in women with breast cancer treated with taxane chemotherapy drugs, as this Cancer Currents post reports.</field_page_description>
  <field_date_posted>2017-09-19</field_date_posted>
  <field_date_reviewed>2017-09-18</field_date_reviewed>
  <field_pretty_url>peripheral-neuropathy-chemotherapy-breast-cancer</field_pretty_url>
  <para_id>1096310</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1096610</term_id>
  <id>1096590</id>
  <title>NCI Deputy Director</title>
  <langcode>en</langcode>
  <field_short_title>NCI Deputy Director</field_short_title>
  <field_page_description>Learn about Douglas R. Lowy, M.D., Deputy Director of the National Cancer Institute. His research interests include the biology of papillomaviruses and the regulation of normal and neoplastic cell growth.</field_page_description>
  <field_date_posted>2017-10-17</field_date_posted>
  <field_date_reviewed>2017-09-22</field_date_reviewed>
  <para_id>1096590</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1097513</id>
  <title>Timing and Sequence Critical for Immunotherapy Combination</title>
  <langcode>en</langcode>
  <field_short_title>Timing and Sequence Critical for Immunotherapy Combination</field_short_title>
  <field_page_description>Combining two immune checkpoint inhibitors, an OX40 agonist and a PD-1 inhibitor, may require a specific sequence, as this Cancer Currents post on a new study in mice explains.</field_page_description>
  <field_date_posted>2017-10-03</field_date_posted>
  <field_date_reviewed>2017-10-03</field_date_reviewed>
  <field_pretty_url>combining-checkpoint-inhibitors</field_pretty_url>
  <para_id>1097513</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938032</term_id>
  <id>1097676</id>
  <title>Adding Immune-based Treatments to Standard Glioblastoma Therapy</title>
  <langcode>en</langcode>
  <field_short_title>Adding Immunotherapy and Vaccine to Standard Glioblastoma Therapy</field_short_title>
  <field_page_description>This clinical trial is testing standard therapy (surgery, radiation and temozolomide) plus immunotherapy with pembrolizumab with or without a cancer treatment vaccine for patients with newly diagnosed glioblastoma, a common and deadly type of brain tumor.</field_page_description>
  <field_date_posted>2017-10-11</field_date_posted>
  <field_date_reviewed>2017-10-05</field_date_reviewed>
  <field_pretty_url>immunotherapy-with-standard-glioblastoma-treatment</field_pretty_url>
  <para_id>1097676</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1098692</id>
  <title>Nivolumab Receives Accelerated Approval from FDA for Advanced Liver Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Nivolumab Approved by FDA for Advanced Liver Cancer</field_short_title>
  <field_page_description>The immunotherapy nivolumab (Opdivo®) has been approved by FDA for patients with advanced liver cancer who have previously been treated with sorafenib (Nexavar®).</field_page_description>
  <field_date_posted>2017-10-20</field_date_posted>
  <field_date_reviewed>2017-10-20</field_date_reviewed>
  <field_pretty_url>opdivo-fda-liver</field_pretty_url>
  <para_id>1098692</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894084</term_id>
  <id>1081765</id>
  <title>Mentor Spotlight: Elva M. Arredondo, PhD</title>
  <langcode>en</langcode>
  <field_short_title>Mentor Spotlight: Elva M. Arredondo, PhD</field_short_title>
  <field_page_description>Lilian G. Perez shares how her mentor, Dr. Elva M. Arredondo, has supported her career development.</field_page_description>
  <field_date_posted>2017-04-18</field_date_posted>
  <field_date_reviewed>2017-04-18</field_date_reviewed>
  <field_pretty_url>mentor-spotlight-arredondo</field_pretty_url>
  <para_id>1081765</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>860258</term_id>
  <id>1084766</id>
  <title>Leadership and Expert Views - Cancer Currents Blog</title>
  <langcode>en</langcode>
  <field_short_title>Leadership &amp; Expert Views</field_short_title>
  <field_page_description>Blog posts featuring the views of NCI leaders and other scientific experts—including first-person commentaries and Q&amp;As about research trends and new research programs—from NCI Cancer Currents.</field_page_description>
  <field_date_posted>2017-05-12</field_date_posted>
  <field_date_reviewed>2017-05-12</field_date_reviewed>
  <field_pretty_url>leadership-expert-views</field_pretty_url>
  <para_id>1084766</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070074</term_id>
  <id>1086589</id>
  <title>TRACERx: Trailblazing Longitudinal Cancer Genomics</title>
  <langcode>en</langcode>
  <field_short_title>TRACERx Longitudinal Cancer Genomics Study</field_short_title>
  <field_page_description>The Center for Cancer Genomics is supporting TRACERx, a longitudinal lung cancer genomics study.</field_page_description>
  <field_date_posted>2017-06-01</field_date_posted>
  <field_date_reviewed>2017-05-30</field_date_reviewed>
  <field_pretty_url>tracerx-longitudinal-lung-study</field_pretty_url>
  <para_id>1086589</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1086813</id>
  <title>FDA Expands Approval of Pembrolizumab for First-Line Treatment of Non-Small Cell Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Expands Approval of Pembrolizumab for Lung Cancer</field_short_title>
  <field_page_description>A Cancer Currents blog post on FDA’s approval of pembrolizumab (Keytruda®) to be used with chemotherapy as a first-line treatment for non-small cell lung cancer.</field_page_description>
  <field_date_posted>2017-06-06</field_date_posted>
  <field_date_reviewed>2017-06-05</field_date_reviewed>
  <field_pretty_url>fda-pembrolizumab-lung-expanded</field_pretty_url>
  <para_id>1086813</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1086816</term_id>
  <id>1086817</id>
  <title>NCI Cancer Moonshot&amp;#8480; Public Access and Data Sharing Policy</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Moonshot&amp;#8480; Public Access and Data Sharing Policy</field_short_title>
  <field_page_description>NCI has established a data sharing policy that supports open, public access to all research and data for projects funded as part of the Cancer Moonshot. Find details on the policy.</field_page_description>
  <field_date_posted>2017-06-07</field_date_posted>
  <field_date_reviewed>2017-06-05</field_date_reviewed>
  <para_id>1086817</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1070068</term_id>
  <id>1087263</id>
  <title>TCGA study of liver cancer reveals potential targets for therapy</title>
  <langcode>en</langcode>
  <field_short_title>TCGA Liver Cancer Study Finds Potential Therapeutic Targets</field_short_title>
  <field_page_description>An NCI News Note about a new TCGA study in Cell that reveals several potential therapeutic targets for liver cancer. </field_page_description>
  <field_date_posted>2017-06-15</field_date_posted>
  <field_date_reviewed>2017-06-12</field_date_reviewed>
  <field_pretty_url>tcga-liver-study</field_pretty_url>
  <para_id>1087263</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1082596</term_id>
  <id>1087413</id>
  <title>Archived International Conference on HIV/AIDS Meeting Materials</title>
  <langcode>en</langcode>
  <field_short_title>Archived International Conference on HIV/AIDS Meeting Materials</field_short_title>
  <field_date_posted>2017-06-14</field_date_posted>
  <field_date_reviewed>2017-06-14</field_date_reviewed>
  <field_pretty_url>icmh-archives</field_pretty_url>
  <para_id>1087413</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1080236</term_id>
  <id>1088803</id>
  <title>Denise Jenkins, M.B.A.</title>
  <langcode>en</langcode>
  <field_short_title>Denise Jenkins, M.B.A.</field_short_title>
  <field_page_description>Learn more about Denise Jenkins, M.B.A., program specialist in the NCI Office of HIV and AIDS Malignancy. </field_page_description>
  <field_date_posted>2017-06-30</field_date_posted>
  <field_date_reviewed>2017-06-30</field_date_reviewed>
  <field_pretty_url>denise-jenkins</field_pretty_url>
  <para_id>1088803</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1089297</id>
  <title>Large Study Verifies Cancer Risk for Women Carrying BRCA1 or BRCA2 Mutations</title>
  <langcode>en</langcode>
  <field_short_title>Study Affirms Cancer Risk for Women with BRCA Mutations</field_short_title>
  <field_page_description>A Cancer Currents blog post on a large, prospective study of breast, ovarian, and contralateral breast cancer risks associated with BRCA1 and BRCA2 gene mutations.</field_page_description>
  <field_date_posted>2017-07-12</field_date_posted>
  <field_date_reviewed>2017-07-12</field_date_reviewed>
  <field_pretty_url>brca-mutation-cancer-risk</field_pretty_url>
  <para_id>1089297</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1089578</id>
  <title>NCI’s Technology Transfer Center—Moving Inventions and Ideas from the Lab to Patients: An Interview with Dr. Michael Salgaller</title>
  <langcode>en</langcode>
  <field_short_title>Technology Transfer: From the Lab to Patients</field_short_title>
  <field_page_description>A Cancer Currents blog post featuring an interview with Dr. Michael Salgaller about how NCI’s Technology Transfer Center helps to move NCI-developed technologies from the lab to the bedside.</field_page_description>
  <field_date_posted>2017-07-17</field_date_posted>
  <field_date_reviewed>2017-07-14</field_date_reviewed>
  <field_pretty_url>tech-transfer-salgaller</field_pretty_url>
  <para_id>1089578</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1090183</id>
  <title>FDA Clears Wider Use of Cooling Cap to Reduce Hair Loss during Chemotherapy</title>
  <langcode>en</langcode>
  <field_short_title>FDA Clears Wider Use of Cooling Cap </field_short_title>
  <field_page_description>An NCI Cancer Currents blog post about FDA’s clearance of the DigniCap Scalp Cooling System for use in reducing hair loss during chemotherapy by patients with any type of solid tumor. </field_page_description>
  <field_date_posted>2017-07-21</field_date_posted>
  <field_date_reviewed>2017-07-19</field_date_reviewed>
  <field_pretty_url>fda-cooling-cap-chemotherapy</field_pretty_url>
  <para_id>1090183</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1088949</term_id>
  <id>1088954</id>
  <title>3D Models of Immunotherapy</title>
  <langcode>en</langcode>
  <field_short_title>3D Immunotherapy Models</field_short_title>
  <field_page_description>This collaborative grant is developing 3D models of both mouse and human biology to investigate aspects of therapeutic vaccination in order to answer key questions relevant to human cancer immunotherapy.</field_page_description>
  <field_date_posted>2017-09-21</field_date_posted>
  <field_date_reviewed>2017-07-03</field_date_reviewed>
  <para_id>1088954</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1070068</term_id>
  <id>1088988</id>
  <title>NCI-COG Pediatric MATCH trial to test targeted drugs in childhood cancers</title>
  <langcode>en</langcode>
  <field_short_title>NCI-COG Pediatric MATCH Trial to Test Targeted Therapies</field_short_title>
  <field_page_description>An NCI-COG press release about the launch of a nationwide clinical trial that aims to match targeted treatments to pediatric cancers with specific genetic mutations.</field_page_description>
  <field_date_posted>2017-07-24</field_date_posted>
  <field_date_reviewed>2017-07-06</field_date_reviewed>
  <field_pretty_url>nci-pediatric-match-trial-opens</field_pretty_url>
  <para_id>1088988</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1089222</id>
  <title>NCI's CURE Program—21 Years of Increasing Diversity in the Biomedical Workforce</title>
  <langcode>en</langcode>
  <field_short_title>Increasing Diversity in the Biomedical Workforce</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post from Dr. Sanya Springfield on NCI’s CURE program, which helps to improve the diversity of people involved in cancer research and care.</field_page_description>
  <field_date_posted>2017-07-10</field_date_posted>
  <field_date_reviewed>2017-07-10</field_date_reviewed>
  <field_pretty_url>cure-workforce-diversity</field_pretty_url>
  <para_id>1089222</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1090424</id>
  <title>FDA Grants Full Approval to Blinatumomab for Acute Lymphoblastic Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Blinatumomab Gets Full FDA Approval for ALL</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post about the FDA changing its accelerated approval of blinatumomab (Blincyto) for some patients with acute lymphoblastic leukemia to a full approval.</field_page_description>
  <field_date_posted>2017-07-25</field_date_posted>
  <field_date_reviewed>2017-07-25</field_date_reviewed>
  <field_pretty_url>blinatumomab-all-fda-full-approval</field_pretty_url>
  <para_id>1090424</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070072</term_id>
  <id>1092415</id>
  <title>Ras–dependent Paracrine Cascades</title>
  <langcode>en</langcode>
  <field_short_title>Ras–dependent Paracrine Cascades</field_short_title>
  <field_page_description>Interrupting paracrine cascades in the tumor microenvironment of pancreatic cancers may improve treatment.</field_page_description>
  <field_date_posted>2017-08-17</field_date_posted>
  <field_date_reviewed>2017-08-17</field_date_reviewed>
  <field_pretty_url>paracrine-cascades</field_pretty_url>
  <para_id>1092415</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1093264</term_id>
  <id>1093265</id>
  <title>Fertility Issues in Girls and Women with Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Female Fertility Issues</field_short_title>
  <field_page_description>Fertility issues are common in women getting cancer treatment. Fertility preservation options include egg freezing, embryo freezing, ovarian tissue freezing, ovarian shielding and ovarian transposition. Resources, support, and clinical trials are listed.</field_page_description>
  <field_date_posted>2017-09-22</field_date_posted>
  <field_date_reviewed>2017-08-23</field_date_reviewed>
  <para_id>1093265</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1093276</term_id>
  <id>1093277</id>
  <title>Fertility Issues in Boys and Men with Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Male Fertility Issues</field_short_title>
  <field_page_description>Fertility issues are common in boys and men getting cancer treatment. Fertility preservation options include sperm banking, testicular shielding, testicular sperm extraction (TESE), and testicular tissue freezing. Support and clinical trials are listed.</field_page_description>
  <field_date_posted>2017-09-22</field_date_posted>
  <field_date_reviewed>2017-08-23</field_date_reviewed>
  <para_id>1093277</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1066360</term_id>
  <id>1096125</id>
  <title>Working with India to Advance Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Working with India to Advance Cancer Research </field_short_title>
  <field_date_posted>2017-09-15</field_date_posted>
  <field_date_reviewed>2017-09-15</field_date_reviewed>
  <field_pretty_url>India-collaboration</field_pretty_url>
  <para_id>1096125</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1099118</term_id>
  <id>1099174</id>
  <title>Supporting Cancer Research Through Priority initiatives at NCI</title>
  <langcode>en</langcode>
  <field_short_title>Supporting Cancer Research Priority Initiatives</field_short_title>
  <field_page_description>CRS leads priority initiatives to support cancer research to advance scientific knowledge and help people live longer, healthier lives. Learn more about the Resources for Cancer Researchers portal, Team Science, and Idea Generation with NCI staff.</field_page_description>
  <field_date_posted>2018-04-13</field_date_posted>
  <field_date_reviewed>2017-10-26</field_date_reviewed>
  <para_id>1099174</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1099213</id>
  <title>TMIST Trial Aims to Provide Clarity on Breast Cancer Screening Approaches</title>
  <langcode>en</langcode>
  <field_short_title>TMIST Trial Comparing Breast Cancer Screening Approaches</field_short_title>
  <field_page_description>TMIST, a breast cancer screening clinical trial, is comparing tomosynthesis, or 3D mammography, and 2D digital mammography, as this Cancer Currents article explains.</field_page_description>
  <field_date_posted>2017-10-30</field_date_posted>
  <field_date_reviewed>2017-10-26</field_date_reviewed>
  <field_pretty_url>tmist-breast-cancer-screening</field_pretty_url>
  <para_id>1099213</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1035160</term_id>
  <id>1060803</id>
  <title>TCGA Data Leveraged for Developing FDA-Designated Breakthrough Therapy</title>
  <langcode>en</langcode>
  <field_short_title>TCGA Data Inform LOXO-101 Drug Development</field_short_title>
  <field_page_description>Pharmaceutical company Loxo Oncology used TCGA data in research that led them to develop FDA-designated breakthrough therapy LOXO-101, a targeted therapy. </field_page_description>
  <field_date_posted>2016-09-06</field_date_posted>
  <field_date_reviewed>2016-08-24</field_date_reviewed>
  <field_pretty_url>tcga-loxo-101-targeted-therapy-development</field_pretty_url>
  <para_id>1060803</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1061588</id>
  <title>Blue Ribbon Panel Report: The Power of the Cancer Community Coming Together</title>
  <langcode>en</langcode>
  <field_short_title>Blue Ribbon Panel Report: The Power of Coming Together</field_short_title>
  <field_page_description>An NCI Cancer Currents blog by the NCI acting director thanking the cancer community for contributing to the Cancer Moonshot Blue Ribbon Panel report, which was presented to the National Cancer Advisory Board on September 7.</field_page_description>
  <field_date_posted>2016-09-09</field_date_posted>
  <field_date_reviewed>2016-09-09</field_date_reviewed>
  <field_pretty_url>brp-report-ncab</field_pretty_url>
  <para_id>1061588</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1061698</id>
  <title>The Impact and Future of the Childhood Cancer Survivor Study: An Interview with Greg Armstrong, M.D.</title>
  <langcode>en</langcode>
  <field_short_title>Impact and Future of the Childhood Cancer Survivor Study</field_short_title>
  <field_date_posted>2016-09-14</field_date_posted>
  <field_date_reviewed>2016-09-13</field_date_reviewed>
  <field_pretty_url>childhood-survivor-study</field_pretty_url>
  <para_id>1061698</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1061725</term_id>
  <id>1061727</id>
  <title>RAS Screens and Assays at FNLCR</title>
  <langcode>en</langcode>
  <field_short_title>RAS Screens &amp; Assays</field_short_title>
  <field_page_description>A primary goal of the RAS Initiative is to develop assays for RAS activity, localization, and signaling and adapt those assays so they can be used for finding new drug candidates. Explore the work leading to highly validated screening protocols.</field_page_description>
  <field_date_posted>2016-09-14</field_date_posted>
  <field_date_reviewed>2016-09-14</field_date_reviewed>
  <para_id>1061727</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>13377</id>
  <title>Trastuzumab Benefits Women with Locally Advanced or Inflammatory Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Trastuzumab Benefits Women with Locally Advanced or Inflammatory</field_short_title>
  <field_page_description>Women treated with trastuzumab (Herceptin) and chemotherapy before surgery and trastuzumab again after surgery had a reduced risk of the disease recurring or progressing compared with women who received pre-surgical chemotherapy but no trastuzumab, accord</field_page_description>
  <field_date_posted>2010-03-15</field_date_posted>
  <field_date_reviewed>2010-03-09</field_date_reviewed>
  <field_pretty_url>trastuzumab-locally-advanced-inflammatory</field_pretty_url>
  <para_id>13377</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>12608</term_id>
  <id>13430</id>
  <title>Syndication Services</title>
  <langcode>en</langcode>
  <field_short_title>Syndication Services</field_short_title>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2010-05-14</field_date_reviewed>
  <para_id>13430</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>952689</term_id>
  <id>13491</id>
  <title>PDQ&amp;reg; Cancer Integrative, Alternative, and Complementary Therapies Editorial Board</title>
  <langcode>en</langcode>
  <field_short_title>Integrative Therapies Editorial Board</field_short_title>
  <field_date_posted>2002-05-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13491</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>11886</term_id>
  <id>13803</id>
  <title>Breast Cancer Risk in American Women</title>
  <langcode>en</langcode>
  <field_short_title>Breast Cancer Risk in American Women</field_short_title>
  <field_page_description>A fact sheet that provides statistics about a woman’s risk of developing breast cancer and information about breast cancer risk factors.</field_page_description>
  <field_date_posted>2012-09-28</field_date_posted>
  <field_date_reviewed>2012-09-24</field_date_reviewed>
  <field_pretty_url>risk-fact-sheet</field_pretty_url>
  <para_id>13803</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11984</term_id>
  <id>14016</id>
  <title>Vulvar Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Vulvar Cancer</field_short_title>
  <field_page_description>Vulvar cancer usually forms slowly, most often on the vaginal lips or the sides of the vaginal opening. Having vulvar intraepithelial neoplasia or human papillomavirus (HPV) infection can increase the risk of developing vulvar cancer. Start here to find information on vulvar cancer treatment, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14016</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11912</term_id>
  <id>14091</id>
  <title>Gestational Trophoblastic Disease—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Gestational Trophoblastic Disease</field_short_title>
  <field_page_description>Gestational trophoblastic disease (GTD) is a general term for rare tumors that form from the tissues surrounding fertilized egg. GTD is often found early and usually cured. Start here to find information on gestational trophoblastic disease treatment.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14091</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>258564</id>
  <title>Investigational targeted drug induces responses in aggressive lymphomas</title>
  <langcode>en</langcode>
  <field_short_title>Targeted drug induces responses in aggressive lymphomas</field_short_title>
  <field_page_description>Preliminary results from clinical trials in a subtype of lymphoma show that for a number of patients whose disease was not cured by other treatments, the drug ibrutinib can provide significant anti-cancer responses with modest side effects.  </field_page_description>
  <field_date_posted>2012-03-31</field_date_posted>
  <field_date_reviewed>2012-03-30</field_date_reviewed>
  <field_pretty_url>IbrutinibAACR</field_pretty_url>
  <para_id>258564</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1067637</id>
  <title>FDA Approves Nivolumab for Head and Neck Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Nivolumab for Head and Neck Cancer</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post about the FDA approval of nivolumab for recurrent or progressive squamous cell carcinoma of the head and neck.</field_page_description>
  <field_date_posted>2016-12-01</field_date_posted>
  <field_date_reviewed>2016-12-01</field_date_reviewed>
  <field_pretty_url>fda-nivolumab-scchn</field_pretty_url>
  <para_id>1067637</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1068131</term_id>
  <id>1068213</id>
  <title>Track 1: Oncology Product Research and Review for M.D. Oncology Fellows</title>
  <langcode>en</langcode>
  <field_short_title>IOTF: Oncology Product Review for Oncology Fellows</field_short_title>
  <field_page_description>NCI and FDA collaborate to train physicians in clinical trials methodology and medical product development. Learn more about this cancer training program.</field_page_description>
  <field_date_posted>2016-12-08</field_date_posted>
  <field_date_reviewed>2016-12-08</field_date_reviewed>
  <para_id>1068213</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1070068</term_id>
  <id>1070653</id>
  <title>New Drug Formulary Will Help Expedite Use of Agents in Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>New Drug Formulary Will Help Expedite Use of Agents in Clinical Trials</field_short_title>
  <field_page_description>NCI launched the “NCI Formulary” that will enable investigators at NCI-designated Cancer Centers to have quicker access to approved and investigational agents for use in preclinical studies and cancer clinical trials.</field_page_description>
  <field_date_posted>2017-01-11</field_date_posted>
  <field_date_reviewed>2017-01-04</field_date_reviewed>
  <field_pretty_url>nci-formulary-launch</field_pretty_url>
  <para_id>1070653</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070072</term_id>
  <id>1071552</id>
  <title>Kras and Cancer Metabolism: A Conversation with Carla Martins</title>
  <langcode>en</langcode>
  <field_short_title>Kras and Cancer Metabolism: A Conversation with Carla Martins</field_short_title>
  <field_page_description>Cancers in which both KRAS genes are mutated are more agressive and have different metabolism compared to cells with one mutated KRAS gene.</field_page_description>
  <field_date_posted>2017-01-23</field_date_posted>
  <field_date_reviewed>2017-01-23</field_date_reviewed>
  <field_pretty_url>mutant-kras-copy-number-martins</field_pretty_url>
  <para_id>1071552</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1071600</id>
  <title>Genome Study Points to New Subtypes of Esophageal Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Study Points to Genetic Subtypes of Esophageal Cancer</field_short_title>
  <field_page_description>A Cancer Currents blog post about a study by The Cancer Genome Atlas Research Network that identified distinct genetic and molecular changes in esophageal cancers that could improve their classification and identify potential new treatments.</field_page_description>
  <field_date_posted>2017-01-25</field_date_posted>
  <field_date_reviewed>2017-01-25</field_date_reviewed>
  <field_pretty_url>esophageal-genomic-subtypes</field_pretty_url>
  <para_id>1071600</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1071837</id>
  <title>Less-Frequent Zoledronic Acid Treatment Effective at Preventing Bone Metastasis Complications</title>
  <langcode>en</langcode>
  <field_short_title>Less-Frequent Zoledronic Acid in Patients with Bone Metastases</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post on a clinical trial showing that less frequent zoledronic acid treatment is effective in patients with cancer-related bone metastases.</field_page_description>
  <field_date_posted>2017-01-30</field_date_posted>
  <field_date_reviewed>2017-01-27</field_date_reviewed>
  <field_pretty_url>zoledronic-acid-bone-metastasis</field_pretty_url>
  <para_id>1071837</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1072223</id>
  <title>New Therapy Benefits Patients with Neuroendocrine Tumors</title>
  <langcode>en</langcode>
  <field_short_title>Therapy Benefits Patients with Neuroendocrine Tumors</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post on clinical trial results that suggest the new drug &lt;sup&gt;177&lt;/sup&gt;Lu-Dotatate may soon be a treatment option for advanced neuroendocrine tumors.</field_page_description>
  <field_date_posted>2017-02-02</field_date_posted>
  <field_date_reviewed>2017-02-01</field_date_reviewed>
  <field_pretty_url>new-treatment-neuroendocrine-tumors</field_pretty_url>
  <para_id>1072223</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1073678</term_id>
  <id>1073679</id>
  <title>Connect with Screen to Save</title>
  <langcode>en</langcode>
  <field_short_title>Connect with Screen to Save</field_short_title>
  <field_page_description>Join NCI community health educators and partners in helping to increase colorectal cancer screenings among men and women age 50–75 from racially and ethnically diverse communities and in rural areas.</field_page_description>
  <field_date_posted>2017-02-21</field_date_posted>
  <field_date_reviewed>2017-02-21</field_date_reviewed>
  <para_id>1073679</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1073806</id>
  <title>Lung Cancer Screening Pilot Reveals Challenges, Growing Pains</title>
  <langcode>en</langcode>
  <field_short_title>U.S. Lung Cancer Screening Experience</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post the complexities and challenges associated with the expansion of lung cancer screening in the United States.</field_page_description>
  <field_date_posted>2017-02-27</field_date_posted>
  <field_date_reviewed>2017-02-24</field_date_reviewed>
  <field_pretty_url>lung-cancer-screening-challenges</field_pretty_url>
  <para_id>1073806</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1074540</id>
  <title>Study Shows Platelets Can Deliver Immunotherapy, Reduce Tumor Regrowth</title>
  <langcode>en</langcode>
  <field_short_title>Platelets Deliver Immunotherapy, Slow Tumor Growth</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on an experimental adjuvant therapy using blood platelets engineered to deliver an immune checkpoint inhibitor.</field_page_description>
  <field_date_posted>2017-03-03</field_date_posted>
  <field_date_reviewed>2017-03-02</field_date_reviewed>
  <field_pretty_url>platelet-immunotherapy</field_pretty_url>
  <para_id>1074540</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1092400</id>
  <title>FDA Approves Nivolumab for Some Metastatic Colorectal Cancers</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Nivolumab for Colorectal Cancer</field_short_title>
  <field_page_description>FDA has approved nivolumab (Opdivo®) for metastatic colorectal cancer with tumors that have alterations that affect DNA repair, as this Cancer Currents post explains.</field_page_description>
  <field_date_posted>2017-08-17</field_date_posted>
  <field_date_reviewed>2017-08-17</field_date_reviewed>
  <field_pretty_url>nivolumab-fda-colorectal</field_pretty_url>
  <para_id>1092400</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1092459</term_id>
  <id>1092471</id>
  <title>Prior Approval Requests</title>
  <langcode>en</langcode>
  <field_short_title>Prior Approval Requests</field_short_title>
  <field_page_description>Approval from NIH may be required before a cancer research grant recipient makes budget modifications or undertakes particular activities. Learn how to request approval.</field_page_description>
  <field_date_posted>2017-08-17</field_date_posted>
  <field_date_reviewed>2017-08-17</field_date_reviewed>
  <para_id>1092471</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1092473</term_id>
  <id>1092474</id>
  <title>Monitoring Research Grant Awards</title>
  <langcode>en</langcode>
  <field_short_title>Monitoring Research Grant Awards</field_short_title>
  <field_page_description>NCI grants management staff regularly monitor individual grants within each budget period and within the overall project period.</field_page_description>
  <field_date_posted>2017-08-17</field_date_posted>
  <field_date_reviewed>2017-08-17</field_date_reviewed>
  <para_id>1092474</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1093241</id>
  <title>Neratinib Approved by FDA for HER2-Positive Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Neratinib for HER2-Positive Breast Cancer</field_short_title>
  <field_page_description>Neratinib (Nerlynx) has been approved by FDA for patients with early-stage HER2-positive breast cancer who have finished at least 1 year of adjuvant therapy with trastuzumab (Herceptin).</field_page_description>
  <field_date_posted>2017-08-23</field_date_posted>
  <field_date_reviewed>2017-08-23</field_date_reviewed>
  <field_pretty_url>neratinib-breast-cancer-fda</field_pretty_url>
  <para_id>1093241</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1094195</id>
  <title>Crizotinib Shows Promise for Childhood Cancers </title>
  <langcode>en</langcode>
  <field_short_title>Crizotinib Shows Promise for Childhood Cancers </field_short_title>
  <field_page_description>Crizotinib (Xalkori®) shrank tumors in children with anaplastic large cell lymphoma (ALCL) and inflammatory myofibroblastic tumors (IMT).</field_page_description>
  <field_date_posted>2017-09-05</field_date_posted>
  <field_date_reviewed>2017-09-05</field_date_reviewed>
  <field_pretty_url>crizotinib-childhood-cancers</field_pretty_url>
  <para_id>1094195</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1095911</id>
  <title>FDA Approves Inotuzumab for Adults with B-Cell Acute Lymphoblastic Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Inotuzumab Approved for Adults with B-Cell ALL</field_short_title>
  <field_page_description>Inotuzumab (Besponsa®) has been approved by FDA for some adults with B-cell acute lymphoblastic leukemia (ALL) that has returned or doesn’t respond to chemotherapy.</field_page_description>
  <field_date_posted>2017-09-18</field_date_posted>
  <field_date_reviewed>2017-09-13</field_date_reviewed>
  <field_pretty_url>fda-inotuzumab-leukemia</field_pretty_url>
  <para_id>1095911</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1070068</term_id>
  <id>1096624</id>
  <title>NCI-funded TMIST study compares 2-D and 3-D mammography for finding breast cancers</title>
  <langcode>en</langcode>
  <field_short_title>TMIST trial compares 2-D and 3-D mammography</field_short_title>
  <field_page_description>The TMIST study is enrolling 165,000 women to compare 2-D and 3-D mammography for finding breast cancers. This NCI and ECOG-ACRIN press release describes the trial.</field_page_description>
  <field_date_posted>2017-09-26</field_date_posted>
  <field_date_reviewed>2017-09-22</field_date_reviewed>
  <field_pretty_url>tmist-mammography-trial</field_pretty_url>
  <para_id>1096624</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1097890</id>
  <title>Extensive Lymph Node Removal Doesn't Improve Survival in Some Women with Early-Stage Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Trial Provides Insights on Lymph Node Removal in Breast Cancer</field_short_title>
  <field_page_description>For some women with early-stage breast cancer who have a lumpectomy, a sentinel node biopsy is sufficient, as this Cancer Currents article explains.</field_page_description>
  <field_date_posted>2017-10-10</field_date_posted>
  <field_date_reviewed>2017-10-10</field_date_reviewed>
  <field_pretty_url>breast-cancer-lymph-node-removal</field_pretty_url>
  <para_id>1097890</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1098083</id>
  <title>Copanlisib Approved for Follicular Lymphoma</title>
  <langcode>en</langcode>
  <field_short_title>Copanlisib Approved for Follicular Lymphoma</field_short_title>
  <field_page_description>Copanlisib (Aliqopa®), a type of PI3K inhibitor, has been approved by the FDA for the treatment of patients with advanced follicular lymphoma.</field_page_description>
  <field_date_posted>2017-10-16</field_date_posted>
  <field_date_reviewed>2017-10-13</field_date_reviewed>
  <field_pretty_url>aliqopa-fda-follicular-lymphoma</field_pretty_url>
  <para_id>1098083</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1098890</id>
  <title>Study Uses Open Data to Analyze “Normal” Tissue Near Tumors</title>
  <langcode>en</langcode>
  <field_short_title>Tissue adjacent to tumors may not be “normal,” study finds</field_short_title>
  <field_page_description>The tissue immediately surrounding a tumor may not be normal, even if it appears normal under the microscope, as this Cancer Currents article explains.</field_page_description>
  <field_date_posted>2017-10-23</field_date_posted>
  <field_date_reviewed>2017-10-23</field_date_reviewed>
  <field_pretty_url>tumor-adjacent-tissue</field_pretty_url>
  <para_id>1098890</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>699543</id>
  <title>Adding chemotherapy following radiation treatment improves survival for adults with a slow-growing type of brain tumor</title>
  <langcode>en</langcode>
  <field_short_title>Adding chemo after radiation treatment improves survival for adults with a type of brain tumor</field_short_title>
  <field_page_description>Adults with low-grade gliomas, a form of brain tumor, who received chemotherapy following completion of radiation therapy lived longer than patients who received radiation therapy alone, according to long-term follow-up results from a NIH-supported random</field_page_description>
  <field_date_posted>2014-02-03</field_date_posted>
  <field_date_reviewed>2014-01-31</field_date_reviewed>
  <field_pretty_url>RTOG9802</field_pretty_url>
  <para_id>699543</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>702831</id>
  <title>NIH study finds regular aspirin use may reduce ovarian cancer risk</title>
  <langcode>en</langcode>
  <field_short_title>NIH study finds regular aspirin use may reduce ovarian cancer risk</field_short_title>
  <field_page_description>Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health. However, further research is needed before clinical r</field_page_description>
  <field_date_posted>2014-02-06</field_date_posted>
  <field_date_reviewed>2014-02-05</field_date_reviewed>
  <field_pretty_url>AspirinReducedOvarianCancer</field_pretty_url>
  <para_id>702831</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1026867</id>
  <title>How Genomics Is Shaping Precision Medicine in Oncology</title>
  <langcode>en</langcode>
  <field_short_title>How Genomics Is Shaping Precision Medicine in Oncology</field_short_title>
  <field_date_posted>2015-11-19</field_date_posted>
  <field_date_reviewed>2015-11-19</field_date_reviewed>
  <field_pretty_url>understanding-precision-medicine</field_pretty_url>
  <para_id>1026867</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1026061</term_id>
  <id>1026882</id>
  <title>Contact OGCR</title>
  <langcode>en</langcode>
  <field_short_title>Contact OGCR</field_short_title>
  <field_page_description>Contact the Office of Government and Congressional Relations (OGCR) if you have any questions or need more information on federal legislation and congressional activity affecting cancer research.</field_page_description>
  <field_date_posted>2017-08-08</field_date_posted>
  <field_date_reviewed>2015-11-19</field_date_reviewed>
  <para_id>1026882</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1026800</term_id>
  <id>1026918</id>
  <title>Federal Health Legislation</title>
  <langcode>en</langcode>
  <field_short_title>Federal Health Legislation</field_short_title>
  <field_page_description>Legislation from the current Congress dealing with federal health related to NCI.</field_page_description>
  <field_date_posted>2016-02-16</field_date_posted>
  <field_date_reviewed>2015-11-19</field_date_reviewed>
  <para_id>1026918</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1028596</term_id>
  <id>1028597</id>
  <title>National Cancer Act of 1971</title>
  <langcode>en</langcode>
  <field_short_title>National Cancer Act of 1971</field_short_title>
  <field_page_description>The National Cancer Act of 1971, signed into law by President Richard Nixon, established the National Cancer Institute in its current form.</field_page_description>
  <field_date_posted>2016-02-16</field_date_posted>
  <field_date_reviewed>2015-12-04</field_date_reviewed>
  <para_id>1028597</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1031697</id>
  <title>FDA Approves Cobimetinib as Part of Drug Combination for Advanced Melanoma</title>
  <langcode>en</langcode>
  <field_short_title>Cobimetinib Approved for Advanced Melanoma</field_short_title>
  <field_date_posted>2015-12-15</field_date_posted>
  <field_date_reviewed>2015-12-15</field_date_reviewed>
  <field_pretty_url>cobimetinib-melanoma</field_pretty_url>
  <para_id>1031697</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>1031743</id>
  <title>Returning to Vietnam – Building on Collaborations in Cancer Control and Research</title>
  <langcode>en</langcode>
  <field_short_title>Returning to Vietnam – Building on Collaborations in Cancer Control and Research</field_short_title>
  <field_date_posted>2015-12-15</field_date_posted>
  <field_date_reviewed>2015-12-15</field_date_reviewed>
  <field_pretty_url>vietnam_jcm</field_pretty_url>
  <para_id>1031743</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938231</term_id>
  <id>1032050</id>
  <title>Overcoming Global Cultural and Financial Disparities to Treat Children with Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Overcoming Global Cultural and Financial Disparities to Treat Children with Cancer</field_short_title>
  <field_date_posted>2015-12-18</field_date_posted>
  <field_date_reviewed>2015-12-18</field_date_reviewed>
  <field_pretty_url>overcoming-global-health-disparities</field_pretty_url>
  <para_id>1032050</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1033636</id>
  <title>Driving New Approaches to Cancer Prevention and Early Detection</title>
  <langcode>en</langcode>
  <field_short_title>Driving New Approaches to Cancer Prevention and Early Detection</field_short_title>
  <field_page_description>Researchers are pioneering new approaches to preventing and screening for cancer, and the management of very early-stage disease.</field_page_description>
  <field_date_posted>2016-01-13</field_date_posted>
  <field_date_reviewed>2016-01-08</field_date_reviewed>
  <field_pretty_url>new-approaches-prevention</field_pretty_url>
  <para_id>1033636</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1033900</id>
  <title>Two Drugs Show Efficacy against Common Form of Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Two Drugs Show Efficacy against Common Form of Leukemia</field_short_title>
  <field_page_description>Reports from early-stage trials of two new oral drugs provide hope for patients with high-risk chronic lymphocytic leukemia.</field_page_description>
  <field_date_posted>2016-01-15</field_date_posted>
  <field_date_reviewed>2016-01-14</field_date_reviewed>
  <field_pretty_url>cll-new-drugs</field_pretty_url>
  <para_id>1033900</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1034329</id>
  <title>Novel Treatment Approach Shrinks Ovarian Tumors in Mice</title>
  <langcode>en</langcode>
  <field_short_title>Novel Treatment Shrinks Ovarian Tumors in Mice</field_short_title>
  <field_page_description>Researchers have developed a new approach for treating tumors that express mutant versions of the p53 protein, which are present in more than half of all cancers, including an aggressive and common subtype of ovarian cancer.</field_page_description>
  <field_date_posted>2016-01-25</field_date_posted>
  <field_date_reviewed>2016-01-22</field_date_reviewed>
  <field_pretty_url>p53-aggregation-blocker</field_pretty_url>
  <para_id>1034329</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1074835</term_id>
  <id>1074840</id>
  <title>Functional Genomics Research</title>
  <langcode>en</langcode>
  <field_short_title>Functional Genomics Research</field_short_title>
  <field_page_description>NCI's Center for Cancer Genomics uses functional genomics to understand the impact of cancer genes and pathways, and how to target them effectively.</field_page_description>
  <field_date_posted>2017-08-04</field_date_posted>
  <field_date_reviewed>2017-03-06</field_date_reviewed>
  <para_id>1074840</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>420501</term_id>
  <id>1074857</id>
  <title>Cancer Clinical Trials at the National Institutes of Health Clinical Center</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Clinical Trials at the NIH Clinical Center </field_short_title>
  <field_page_description>Information about cancer clinical trials at the NIH Clinical Center in Bethesda, Maryland.</field_page_description>
  <field_date_posted>2017-03-08</field_date_posted>
  <field_date_reviewed>2017-05-25</field_date_reviewed>
  <field_pretty_url>clinical-center</field_pretty_url>
  <para_id>1074857</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1078474</id>
  <title>Blinatumomab Extends Survival for Patients with Advanced ALL</title>
  <langcode>en</langcode>
  <field_short_title>Blinatumomab Improves Survival in Advanced ALL</field_short_title>
  <field_page_description>A Cancer Currents blog post on a large clinical trial showing that blinatumomab improves survival and causes fewer side effects than standard chemotherapy.</field_page_description>
  <field_date_posted>2017-03-30</field_date_posted>
  <field_date_reviewed>2017-03-29</field_date_reviewed>
  <field_pretty_url>blinatumomab-leukemia</field_pretty_url>
  <para_id>1078474</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1078426</term_id>
  <id>1078672</id>
  <title>NCI Funding for HIV and AIDS Malignancies Research</title>
  <langcode>en</langcode>
  <field_short_title>NCI Funding for HIV/AIDS Malignancies Research</field_short_title>
  <field_page_description>OHAM supports funding to advance the study of HIV/AIDS-related cancers. Find funding to investigate HIV/AIDS infection, transmission, and treatment. </field_page_description>
  <field_date_posted>2017-07-10</field_date_posted>
  <field_date_reviewed>2017-03-31</field_date_reviewed>
  <para_id>1078672</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1080196</term_id>
  <id>1080199</id>
  <title>Cancer Moonshot&amp;#8480; Research Initiatives</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Moonshot&amp;#8480; Research Initiatives</field_short_title>
  <field_date_posted>2017-04-26</field_date_posted>
  <field_date_reviewed>2017-04-03</field_date_reviewed>
  <para_id>1080199</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1080223</term_id>
  <id>1080234</id>
  <title>NCI HIV and AIDS Research Coordinated by OHAM</title>
  <langcode>en</langcode>
  <field_short_title>NCI HIV/AIDS Research Coordinated by OHAM</field_short_title>
  <field_page_description>NCI scientists have made a number of critical contributions to HIV/AIDS research since the beginning of the AIDS epidemic. Learn more about intramural and extramural research supported by NCI. </field_page_description>
  <field_date_posted>2017-07-10</field_date_posted>
  <field_date_reviewed>2017-04-04</field_date_reviewed>
  <para_id>1080234</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1080925</id>
  <title>FDA Approves Ribociclib, Expands Palbociclib Approval for Metastatic Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Ribociclib, Palbociclib for Metastatic Breast Cancer</field_short_title>
  <field_page_description>A Cancer Currents blog on the FDA’s approval of two targeted therapies, ribociclib and palbociclib, for women with metastatic breast cancer.</field_page_description>
  <field_date_posted>2017-04-10</field_date_posted>
  <field_date_reviewed>2017-04-10</field_date_reviewed>
  <field_pretty_url>fda-ribociclib-palbociclib-breast-cancer</field_pretty_url>
  <para_id>1080925</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1083418</id>
  <title>Collection of Patient-Reported Outcomes Feasible in Cancer Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>Collecting Patient-Reported Outcomes in Cancer Clinical Trials</field_short_title>
  <field_page_description>A &lt;i&gt;Cancer Currents&lt;/i&gt; blog post on a study showing that patient-reported outcomes, or PROs, can be successfully collected during cancer clinical trials</field_page_description>
  <field_date_posted>2017-05-10</field_date_posted>
  <field_date_reviewed>2017-05-03</field_date_reviewed>
  <field_pretty_url>patient-reported-outcomes-clinical-trials</field_pretty_url>
  <para_id>1083418</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1084559</id>
  <title>NCI ALMANAC: A New Tool for Research on Cancer Drug Combinations</title>
  <langcode>en</langcode>
  <field_short_title>NCI ALMANAC Tool for Research on Cancer Drug Combinations</field_short_title>
  <field_page_description>A Cancer Currents blog post on the NCI ALMANAC, a new resource that provides data showing how well pairs of FDA-approved cancer drugs performed in killing tumor cells from NCI-60 Human Tumor Cell Lines.</field_page_description>
  <field_date_posted>2017-05-12</field_date_posted>
  <field_date_reviewed>2017-05-12</field_date_reviewed>
  <field_pretty_url>nci-almanac-drug-combinations</field_pretty_url>
  <para_id>1084559</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>860258</term_id>
  <id>1084768</id>
  <title>Prevention - Cancer Currents Blog</title>
  <langcode>en</langcode>
  <field_short_title>Prevention</field_short_title>
  <field_page_description>Blog posts on cancer prevention research—including behavioral interventions and other ways to prevent cancer and prevention-related research programs—from NCI Cancer Currents.</field_page_description>
  <field_date_posted>2017-05-12</field_date_posted>
  <field_date_reviewed>2017-05-12</field_date_reviewed>
  <field_pretty_url>prevention</field_pretty_url>
  <para_id>1084768</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>860258</term_id>
  <id>1084770</id>
  <title>Prognosis - Cancer Currents Blog</title>
  <langcode>en</langcode>
  <field_short_title>Prognosis</field_short_title>
  <field_page_description>Blog posts on cancer prognosis research—including factors that influence prognosis, prognostic biomarkers, and doctor–patient communication about prognosis—from NCI Cancer Currents.</field_page_description>
  <field_date_posted>2017-05-12</field_date_posted>
  <field_date_reviewed>2017-05-12</field_date_reviewed>
  <field_pretty_url>prognosis</field_pretty_url>
  <para_id>1084770</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>89610</id>
  <title>Drugs Approved for Myeloproliferative Neoplasms</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Myeloproliferative Neoplasms</field_short_title>
  <field_date_posted>2011-07-26</field_date_posted>
  <field_date_reviewed>2011-07-12</field_date_reviewed>
  <field_pretty_url>myeloproliferative-neoplasms</field_pretty_url>
  <para_id>89610</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>93439</id>
  <title>Drugs Approved for Skin Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Skin Cancer</field_short_title>
  <field_date_posted>2011-08-25</field_date_posted>
  <field_date_reviewed>2011-07-19</field_date_reviewed>
  <field_pretty_url>skin</field_pretty_url>
  <para_id>93439</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>595560</id>
  <title>HPV vaccine shown to also protect against oral HPV infection</title>
  <langcode>en</langcode>
  <field_short_title>HPV vaccine shown to also protect against oral HPV infection</field_short_title>
  <field_page_description>Costa Rican women who received a vaccine targeting two types of the HPV that cause 70 percent of cervical cancers had the added benefit of protection against oral HPV infection. </field_page_description>
  <field_date_posted>2013-07-17</field_date_posted>
  <field_date_reviewed>2013-07-16</field_date_reviewed>
  <field_pretty_url>VaccineProtectsAgainstOralHPV</field_pretty_url>
  <para_id>595560</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>617567</id>
  <title>Long-term survival of participants in prostate cancer prevention trial detailed</title>
  <langcode>en</langcode>
  <field_short_title>Survival in prostate cancer prevention trial detailed</field_short_title>
  <field_page_description>In the NCI-sponsored Prostate Cancer Prevention Trial, initial findings from a decade ago showed that the drug finasteride significantly reduced the risk of prostate cancer, but among those who did develop prostate cancer, paradoxically, the drug was asso</field_page_description>
  <field_date_posted>2013-08-14</field_date_posted>
  <field_date_reviewed>2013-08-12</field_date_reviewed>
  <field_pretty_url>PCPTFollowupAugNEJM</field_pretty_url>
  <para_id>617567</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>621732</id>
  <title>NIH study links Hodgkin lymphoma treatment to possible risk of stomach cancer</title>
  <langcode>en</langcode>
  <field_short_title>NIH study links Hodgkin lymphoma treatment to possible risk of stomach cancer</field_short_title>
  <field_page_description>Hodgkin lymphoma survivors who received certain radiation and chemotherapy regimens have been found to be at increased risk of subsequently developing stomach cancer.</field_page_description>
  <field_date_posted>2013-08-26</field_date_posted>
  <field_date_reviewed>2013-08-21</field_date_reviewed>
  <field_pretty_url>HodgkinTreatmentStomachCancer</field_pretty_url>
  <para_id>621732</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922403</term_id>
  <id>623825</id>
  <title>Finasteride Reduces the Risk of Low-Grade Prostate Cancer in Men 55 and Older</title>
  <langcode>en</langcode>
  <field_short_title>Finasteride for Prostate Cancer Prevention</field_short_title>
  <field_page_description>A summary of results from a phase III trial that tested whether the drug finasteride could help prevent prostate cancer in men age 55 and older.</field_page_description>
  <field_date_posted>2013-08-28</field_date_posted>
  <field_date_reviewed>2013-08-28</field_date_reviewed>
  <field_pretty_url>finasteride-reduces-low-grade</field_pretty_url>
  <para_id>623825</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>633382</id>
  <title>NCI clinician-scientists at the forefront of new prostate cancer diagnostics and treatment</title>
  <langcode>en</langcode>
  <field_short_title>NCI scientists at forefront of new prostate cancer diagnostics </field_short_title>
  <field_page_description>Introduction of the UroNav was the result of nearly a decade’s research and development, principally conducted at NCI. Resembling a stylized computer workstation on wheels, the system electronically fuses together pictures from magnetic resonance imaging </field_page_description>
  <field_date_posted>2013-09-05</field_date_posted>
  <field_date_reviewed>2013-09-04</field_date_reviewed>
  <field_pretty_url>UroNav</field_pretty_url>
  <para_id>633382</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>637656</id>
  <title>Avon Foundation for Women, NIH, and The Center for Advancing Innovation launch start-up challenge to advance breast cancer biomedical inventions; student and entrepreneur mentor teams to develop strategic business plan and launch biotech start-up</title>
  <langcode>en</langcode>
  <field_short_title>Avon Foundation, NIH, and CAI launch start-up challenge </field_short_title>
  <field_page_description>A world-wide competition to bring emerging breast cancer technologies to market is being launched by the Avon Foundation for Women, in partnership with NCI and the Center for Advancing Innovation.  </field_page_description>
  <field_date_posted>2013-09-19</field_date_posted>
  <field_date_reviewed>2013-09-18</field_date_reviewed>
  <field_pretty_url>StartUpChallenge</field_pretty_url>
  <para_id>637656</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>674711</id>
  <title>New studies demonstrate that modified T cells are effective in treating blood-borne cancers</title>
  <langcode>en</langcode>
  <field_short_title>Studies demonstrate modified T cells effective in treating blood-borne cancers</field_short_title>
  <field_page_description>At the 2013 American Society of Hematology meeting in Dec. 2013, James Kochenderfer, M.D., NCI, presented findings from two clinical trials evaluating the use of genetically modified immune system T cells as cancer therapy.  These reports represent import</field_page_description>
  <field_date_posted>2013-12-09</field_date_posted>
  <field_date_reviewed>2013-12-03</field_date_reviewed>
  <field_pretty_url>ASH2013</field_pretty_url>
  <para_id>674711</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1034916</id>
  <title>January is Cervical Cancer Awareness Month</title>
  <langcode>en</langcode>
  <field_short_title>January is Cervical Cancer Awareness Month</field_short_title>
  <field_date_posted>2016-01-28</field_date_posted>
  <field_date_reviewed>2016-01-28</field_date_reviewed>
  <field_pretty_url>cervical-cancer</field_pretty_url>
  <para_id>1034916</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1103853</term_id>
  <id>1104012</id>
  <title>Treatment of Head and Neck Cancer in Adults—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Head and Neck Cancer Treatment in Adults</field_short_title>
  <field_page_description>Find information about prognosis, staging, and treatment for adult head and neck cancer sites: hypopharynx, larynx, lip and oral cavity, neck cancer with occult primary, nasopharynx, oropharynx, paranasal sinus and nasal cavity, and salivary gland cancer.</field_page_description>
  <field_date_posted>2018-01-15</field_date_posted>
  <field_date_reviewed>2018-01-15</field_date_reviewed>
  <para_id>1104012</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1104019</term_id>
  <id>1104024</id>
  <title>Cancer Moonshot℠ - Recent Fiscal Year Funding</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Moonshot Funding for FY 2018</field_short_title>
  <field_page_description>The 21st Century Cures Act authorized $1.8 billion to fund the Cancer Moonshot over a 7-year period. See appropriated funding by fiscal year for the Cancer Moonshot.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2018-01-15</field_date_reviewed>
  <para_id>1104024</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894086</term_id>
  <id>1104880</id>
  <title>NCI Launches the Intramural Continuing Umbrella of Research Experiences (iCURE) Program!</title>
  <langcode>en</langcode>
  <field_short_title>NCI Launches iCURE!</field_short_title>
  <field_page_description>The new iCURE program supports students’ and scientists’ mentored research experiences in the NCI research community and encourages participation by underrepresented individuals.</field_page_description>
  <field_date_posted>2018-03-16</field_date_posted>
  <field_date_reviewed>2018-01-23</field_date_reviewed>
  <field_pretty_url>icure-launch</field_pretty_url>
  <para_id>1104880</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>941577</term_id>
  <id>1107095</id>
  <title>Clinical Trials for Transitional Cell Cancer of the Renal Pelvis and Ureter</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trials for Transitional Cell Cancer of the Renal Pelvis and Ureter</field_short_title>
  <field_date_posted>2018-02-14</field_date_posted>
  <field_date_reviewed>2018-02-14</field_date_reviewed>
  <field_pretty_url>transitional-cell-cancer-renal-pelvis-ureter</field_pretty_url>
  <para_id>1107095</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>941577</term_id>
  <id>1107101</id>
  <title>Clinical Trials to Treat Adult Metastatic Brain Tumors</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trials to Treat Adult Metastatic Brain Tumors</field_short_title>
  <field_date_posted>2018-02-14</field_date_posted>
  <field_date_reviewed>2018-02-14</field_date_reviewed>
  <field_pretty_url>adult-metastatic-brain-tumors</field_pretty_url>
  <para_id>1107101</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>941577</term_id>
  <id>1107102</id>
  <title>Clinical Trials to Treat Childhood Astrocytoma</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trials to Treat Childhood Astrocytoma</field_short_title>
  <field_date_posted>2018-02-14</field_date_posted>
  <field_date_reviewed>2018-02-14</field_date_reviewed>
  <field_pretty_url>childhood-astrocytoma</field_pretty_url>
  <para_id>1107102</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1107151</id>
  <title>Abiraterone Approved for Earlier Use in Men with Metastatic Prostate Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Abiraterone Approval Expanded for Prostate Cancer</field_short_title>
  <field_page_description>The FDA has expanded the approval of abiraterone (Zytiga) to treat men with metastatic prostate cancer. The agency approved abiraterone, in combination with prednisone, for men whose cancer that is responsive to hormone-blocking treatments (also known as castration-sensitive) and is at high risk of progressing.</field_page_description>
  <field_date_posted>2018-02-15</field_date_posted>
  <field_date_reviewed>2018-02-15</field_date_reviewed>
  <field_pretty_url>abiraterone-fda-prostate-hormone-sensitive</field_pretty_url>
  <para_id>1107151</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1108288</id>
  <title>Cabozantinib Approval Expands Initial Treatment Options for Advanced Kidney Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Cabozantinib for Initial Treatment of Kidney Cancer</field_short_title>
  <field_page_description>FDA has approved cabozantinib (Cabometyx®) as an initial treatment for patients with advanced renal cell carcinoma. The approval adds another tyrosine kinase inhibitor to the available options for patients with advanced kidney cancer.</field_page_description>
  <field_date_posted>2018-02-27</field_date_posted>
  <field_date_reviewed>2018-02-26</field_date_reviewed>
  <field_pretty_url>cabozantinib-fda-first-line-kidney</field_pretty_url>
  <para_id>1108288</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1111028</id>
  <title>Forging Military Partnerships to Empower the Cancer Research Enterprise</title>
  <langcode>en</langcode>
  <field_short_title>NCI Partners with VA, DoD for Cancer Research</field_short_title>
  <field_page_description>Partnerships and collaborations are an important component of NCI’s success. In this Cancer Currents blog post, NCI Director Dr. Norman Sharpless describes three efforts made possible by a memorandum of agreement with three US military institutions: the APOLLO network, NAVIGATE, and BD-STEP.</field_page_description>
  <field_date_posted>2018-03-27</field_date_posted>
  <field_date_reviewed>2018-03-26</field_date_reviewed>
  <field_pretty_url>sharpless-va-dod-collaborations</field_pretty_url>
  <para_id>1111028</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1102622</term_id>
  <id>1111089</id>
  <title>NIH-funded study shows sorafenib improves progression-free survival for patients with rare sarcomas</title>
  <langcode>en</langcode>
  <field_short_title>Sorafenib Improved Progression-free Survival in Desmoid Tumor Study</field_short_title>
  <field_page_description>In an NCI-funded trial for patients with desmoid tumors or aggressive fibromatosis (DT/DF), rare sarcomas with limited treatment options, the drug sorafenib tosylate (Nexavar) extended progression-free survival compared with a placebo.</field_page_description>
  <field_date_posted>2018-03-28</field_date_posted>
  <field_date_reviewed>2018-03-27</field_date_reviewed>
  <field_pretty_url>sorafenib-desmoid-trial</field_pretty_url>
  <para_id>1111089</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>662098</id>
  <title>Worldwide trends show oropharyngeal cancer rates increasing</title>
  <langcode>en</langcode>
  <field_short_title>Worldwide trends show oropharyngeal cancer rates increasing</field_short_title>
  <field_page_description>NCI scientists report that the incidence of oropharyngeal cancer significantly increased during the period 1983-2002 among people in countries that are economically developed. Oropharyngeal cancer occurs primarily in the middle part of the throat behind t</field_page_description>
  <field_date_posted>2013-11-20</field_date_posted>
  <field_date_reviewed>2013-11-20</field_date_reviewed>
  <field_pretty_url>HPVOropharynxWorldwideTrend</field_pretty_url>
  <para_id>662098</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>608323</term_id>
  <id>679249</id>
  <title>Targeted Treatments for a Type of Pancreatic Cancer: Rapamycin and Other mTOR Inhibitors</title>
  <langcode>en</langcode>
  <field_short_title>Targeted Treatments for a Type of Pancreatic Cancer</field_short_title>
  <field_date_posted>2014-03-07</field_date_posted>
  <field_date_reviewed>2013-12-12</field_date_reviewed>
  <field_pretty_url>mtor-inhibitors</field_pretty_url>
  <para_id>679249</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>694946</id>
  <title>NIH scientists map genetic changes that drive tumors in a common pediatric soft-tissue cancer</title>
  <langcode>en</langcode>
  <field_short_title>NIH scientists map gene changes driving tumors in common pediatric soft-tissue cancer</field_short_title>
  <field_page_description>Scientists have mapped the genetic changes that drive tumors in rhabdomyosarcoma, a pediatric soft-tissue cancer, and found that the disease is characterized by two distinct genotypes. The genetic alterations identified in this malignancy could be useful </field_page_description>
  <field_date_posted>2014-01-23</field_date_posted>
  <field_date_reviewed>2014-01-22</field_date_reviewed>
  <field_pretty_url>RhabdomyosarcomaGeneMap</field_pretty_url>
  <para_id>694946</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1026032</term_id>
  <id>1026781</id>
  <title>Legislative Activities </title>
  <langcode>en</langcode>
  <field_short_title>Legislative Activities </field_short_title>
  <field_page_description>Find information on current and past legislation along with resources to learn more on congressional activities impacting NCI.</field_page_description>
  <field_date_posted>2016-02-16</field_date_posted>
  <field_date_reviewed>2015-11-16</field_date_reviewed>
  <para_id>1026781</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1026059</term_id>
  <id>1026898</id>
  <title>Legislative Resources</title>
  <langcode>en</langcode>
  <field_short_title>Legislative Resources</field_short_title>
  <field_page_description>Find external resources as well as a glossary of commons legislative terms.</field_page_description>
  <field_date_posted>2016-02-16</field_date_posted>
  <field_date_reviewed>2015-11-19</field_date_reviewed>
  <para_id>1026898</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1026796</term_id>
  <id>1026914</id>
  <title>Cancer Research Legislation</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Research Legislation</field_short_title>
  <field_page_description>Legislation from the current Congress dealing with cancer research related to NCI.</field_page_description>
  <field_date_posted>2016-02-16</field_date_posted>
  <field_date_reviewed>2015-11-19</field_date_reviewed>
  <para_id>1026914</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1026802</term_id>
  <id>1026926</id>
  <title>Congressional Resolutions</title>
  <langcode>en</langcode>
  <field_short_title>Congressional Resolutions</field_short_title>
  <field_page_description>Congressional resolutions from the current Congress related to NCI's mission.</field_page_description>
  <field_date_posted>2016-02-16</field_date_posted>
  <field_date_reviewed>2015-11-19</field_date_reviewed>
  <para_id>1026926</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1026932</term_id>
  <id>1026934</id>
  <title>Legislative History Timeline</title>
  <langcode>en</langcode>
  <field_short_title>Legislative History Timeline</field_short_title>
  <field_page_description>A timeline of important legislation related to cancer research, public health or NCI.</field_page_description>
  <field_date_posted>2016-02-16</field_date_posted>
  <field_date_reviewed>2015-11-19</field_date_reviewed>
  <para_id>1026934</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1027658</id>
  <title>FDA Approves Irinotecan Liposome to Treat Pancreatic Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Irinotecan Liposome to Treat Pancreatic Cancer</field_short_title>
  <field_date_posted>2015-11-24</field_date_posted>
  <field_date_reviewed>2015-11-23</field_date_reviewed>
  <field_pretty_url>irinotecan-liposome-pancreatic</field_pretty_url>
  <para_id>1027658</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>915112</term_id>
  <id>1028125</id>
  <title>The Cancer Genome Atlas: More Than a Large Collection of Data</title>
  <langcode>en</langcode>
  <field_short_title>TCGA: More Than a Large Collection of Data</field_short_title>
  <field_page_description>Though TCGA will wrap up in 2016 with a concluding symposium, cancer genomics projects built upon the success of TCGA will continue to play a major part in the NCI’s mission to better understand and treat cancer in the years to come.</field_page_description>
  <field_date_posted>2015-12-07</field_date_posted>
  <field_date_reviewed>2015-12-01</field_date_reviewed>
  <field_pretty_url>zenklusen-leadership-update</field_pretty_url>
  <para_id>1028125</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1028539</id>
  <title>FDA Approves Trabectedin to Treat Two Types of Soft Tissue Sarcoma</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Trabectedin for Sarcoma</field_short_title>
  <field_date_posted>2015-12-04</field_date_posted>
  <field_date_reviewed>2015-12-03</field_date_reviewed>
  <field_pretty_url>fda-trabectedin-sarcoma</field_pretty_url>
  <para_id>1028539</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1030201</id>
  <title>Study Sheds Light on Role of Inherited Mutations in Childhood Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Study Sheds Light on Role of Inherited Mutations in Childhood Cancer</field_short_title>
  <field_date_posted>2015-12-08</field_date_posted>
  <field_date_reviewed>2015-12-07</field_date_reviewed>
  <field_pretty_url>pediatric-germline</field_pretty_url>
  <para_id>1030201</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1031900</id>
  <title>New Drug for Pediatric Neuroblastoma Shows Promise in Preclinical Studies</title>
  <langcode>en</langcode>
  <field_short_title>Drug Shows Promise for Pediatric Neuroblastoma</field_short_title>
  <field_date_posted>2015-12-17</field_date_posted>
  <field_date_reviewed>2015-12-16</field_date_reviewed>
  <field_pretty_url>fact-target-neuroblastoma</field_pretty_url>
  <para_id>1031900</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911116</term_id>
  <id>312922</id>
  <title>Cruciferous Vegetables and Cancer Prevention</title>
  <langcode>en</langcode>
  <field_short_title>Cruciferous Vegetables and Cancer Prevention</field_short_title>
  <field_page_description>A fact sheet that summarizes the results of studies about cruciferous vegetables and cancer. Includes a list of cruciferous vegetables and dietary recommendations.</field_page_description>
  <field_date_posted>2012-06-15</field_date_posted>
  <field_date_reviewed>2012-06-07</field_date_reviewed>
  <field_pretty_url>cruciferous-vegetables-fact-sheet</field_pretty_url>
  <para_id>312922</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>314962</id>
  <title>NIH study finds childhood CT scans linked to leukemia and brain cancer later in life  </title>
  <langcode>en</langcode>
  <field_short_title>Childhood CT scans linked to leukemia and brain cancer later in life</field_short_title>
  <field_page_description>Children and young adults scanned multiple times by computed tomography (CT), a commonly used diagnostic tool, have a small increased risk of leukemia and brain tumors in the decade following their first scan. </field_page_description>
  <field_date_posted>2012-06-07</field_date_posted>
  <field_date_reviewed>2012-06-05</field_date_reviewed>
  <field_pretty_url>CTpediatricLancet</field_pretty_url>
  <para_id>314962</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>315053</term_id>
  <id>315056</id>
  <title>NCI Dictionary of Cancer Terms Widget </title>
  <langcode>en</langcode>
  <field_short_title>NCI Dictionary Widget</field_short_title>
  <field_date_posted>2012-06-05</field_date_posted>
  <field_date_reviewed>2012-06-05</field_date_reviewed>
  <para_id>315056</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>930502</term_id>
  <id>318034</id>
  <title>For Some Skin Cancers, Targeted Drug Hits the Mark</title>
  <langcode>en</langcode>
  <field_short_title>For Some Skin Cancers, Targeted Drug Hits the Mark</field_short_title>
  <field_page_description>Two studies reported June 7, 2012, in NEJM indicate that the drug vismodegib can elicit responses in people with advanced or metastatic basal cell carcinoma and help shrink or prevent tumors in those with basal cell nevus syndrome.</field_page_description>
  <field_date_posted>2012-06-15</field_date_posted>
  <field_date_reviewed>2012-06-15</field_date_reviewed>
  <field_pretty_url>vismodegib-basal-cell</field_pretty_url>
  <para_id>318034</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>417536</term_id>
  <id>321607</id>
  <title>Coordinating Center for Clinical Trials (CCCT)</title>
  <langcode>en</langcode>
  <field_short_title>Coordinating Center for Clinical Trials (CCCT)</field_short_title>
  <field_page_description>The Coordinating Center for Clinical Trials (CCCT) plays a key role in supporting NCI’s clinical and translational research programs to advance science and patient care.</field_page_description>
  <field_date_posted>2012-06-21</field_date_posted>
  <field_date_reviewed>2012-06-21</field_date_reviewed>
  <para_id>321607</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1100833</id>
  <title>Dasatinib Approved by FDA for Some Children with Chronic Myelogenous Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Dasatinib Approved for Some Children with Chronic Myelogenous Leukemia</field_short_title>
  <field_page_description>FDA has approved dasatinib (Sprycel®) for children with chronic myelogenous leukemia (CML) that expresses the Philadelphia chromosome and whose disease is in the chronic phase.</field_page_description>
  <field_date_posted>2017-11-30</field_date_posted>
  <field_date_reviewed>2017-11-29</field_date_reviewed>
  <field_pretty_url>dasatinib-fda-cml-children</field_pretty_url>
  <para_id>1100833</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070074</term_id>
  <id>1102387</id>
  <title>How to Navigate the CTD&lt;sup&gt;2&lt;/sup&gt; Dashboard: Access to Translational Data</title>
  <langcode>en</langcode>
  <field_short_title>Navigating the CTD&lt;sup&gt;2&lt;/sup&gt; Dashboard</field_short_title>
  <field_page_description>How the NCI’s CTD&lt;sup&gt;2&lt;/sup&gt;Dashboard makes it easy to access and utilize genomic research data for developing cancer treatments.</field_page_description>
  <field_date_posted>2017-12-18</field_date_posted>
  <field_date_reviewed>2017-12-18</field_date_reviewed>
  <field_pretty_url>ctd2-dashboard</field_pretty_url>
  <para_id>1102387</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1102842</id>
  <title>Drug Combination Improves Outlook for Some Patients with Chronic Lymphocytic Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>New Drug Combination Shows Promise for CLL</field_short_title>
  <field_page_description>Venetoclax (Venclexta) and rituximab (Rituxan) substantially improved progression-free survival in chronic lymphocytic leukemia (CLL) compared with chemotherapy, MURANO trial shows.</field_page_description>
  <field_date_posted>2018-01-05</field_date_posted>
  <field_date_reviewed>2018-01-04</field_date_reviewed>
  <field_pretty_url>venetoclax-rituximab-cll</field_pretty_url>
  <para_id>1102842</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1104028</term_id>
  <id>1104029</id>
  <title>Intramural Continuing Umbrella of Research Experiences (iCURE)</title>
  <langcode>en</langcode>
  <field_short_title>iCURE</field_short_title>
  <field_page_description>iCURE supports mentored research experiences for students and scientists in the NCI research community. iCURE encourages the participation of underrepresented individuals.</field_page_description>
  <field_date_posted>2018-02-06</field_date_posted>
  <field_date_reviewed>2018-01-16</field_date_reviewed>
  <para_id>1104029</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1104882</id>
  <title>The Challenging Landscape of Cancer and Aging: Charting a Way Forward</title>
  <langcode>en</langcode>
  <field_short_title>The Challenging Landscape of Cancer and Aging</field_short_title>
  <field_page_description>NCI Director Dr. Norman Sharpless discusses research to bettter understand the biology of aging and its relationship to cancer, as well as participation in cancer clinical trials by older patients.</field_page_description>
  <field_date_posted>2018-01-24</field_date_posted>
  <field_date_reviewed>2018-01-24</field_date_reviewed>
  <field_pretty_url>sharpless-aging-cancer-research</field_pretty_url>
  <para_id>1104882</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938142</term_id>
  <id>315480</id>
  <title>Low-Dose Radioactive Iodine Destroys Thyroid Tissue Left after Surgery</title>
  <langcode>en</langcode>
  <field_short_title>Low-Dose Radioactive Iodine Destroys Thyroid Tissue Left after Surgery</field_short_title>
  <field_page_description>A low dose of radioactive iodine given after surgery for thyroid cancer destroyed (ablated) residual thyroid tissue as effectively as a higher dose, with fewer side effects and less exposure to radiation, according to two randomized controlled trials.</field_page_description>
  <field_date_posted>2012-06-07</field_date_posted>
  <field_date_reviewed>2012-06-07</field_date_reviewed>
  <field_pretty_url>low-dose-radiation</field_pretty_url>
  <para_id>315480</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922410</term_id>
  <id>318053</id>
  <title>Expanding the Playing Field: Immune-Based Therapy Shows Potential for Lung, Other Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Expanding the Playing Field: Immune-Based Therapy Shows Potential for Lung, Other Cancers</field_short_title>
  <field_page_description>Results from two early-phase clinical trials presented at the 2012 American Society of Clinical Oncology annual meeting provide further evidence that priming the immune system to attack tumors has potential as a treatment for certain cancers. </field_page_description>
  <field_date_posted>2012-06-15</field_date_posted>
  <field_date_reviewed>2012-06-15</field_date_reviewed>
  <field_pretty_url>pd-1-immunotherapy</field_pretty_url>
  <para_id>318053</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917232</term_id>
  <id>321611</id>
  <title>Clinical Trials and Translational Research Advisory Committee </title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trials and Translational Research Advisory Committee </field_short_title>
  <field_page_description>Clinical Trials and Translational Research Advisory Committee, CTAC, is an external oversight committee that advises NCI leadership on its clinical and translational research enterprises.</field_page_description>
  <field_date_posted>2012-06-21</field_date_posted>
  <field_date_reviewed>2012-06-21</field_date_reviewed>
  <para_id>321611</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1066360</term_id>
  <id>1101546</id>
  <title>New Lancet Oncology publication - Defining a research and policy agenda for betel quid and areca nut</title>
  <langcode>en</langcode>
  <field_short_title>New Lancet Oncology publication - Defining a research and policy agenda for betel quid and areca nut</field_short_title>
  <field_date_posted>2017-12-08</field_date_posted>
  <field_date_reviewed>2017-12-07</field_date_reviewed>
  <field_pretty_url>betel-quid</field_pretty_url>
  <para_id>1101546</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1102079</term_id>
  <id>1102107</id>
  <title>Selected Presentations by the NCI Director</title>
  <langcode>en</langcode>
  <field_short_title>Selected Presentations by the NCI Director</field_short_title>
  <field_page_description>This page lists some of the presentations given by Dr. Norman "Ned" Sharpless during his time as NCI director.</field_page_description>
  <field_date_posted>2017-12-15</field_date_posted>
  <field_date_reviewed>2017-12-14</field_date_reviewed>
  <para_id>1102107</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1102112</id>
  <title>Brentuximab Vedotin Approved for Two Rare Lymphomas</title>
  <langcode>en</langcode>
  <field_short_title>Brentuximab Approved for Two Rare Lymphomas</field_short_title>
  <field_page_description>Brentuximab vedotin (Adcetris®) has been approved for the treatment of adults who have been treated previously for either primary cutaneous anaplastic large cell lymphoma or CD30-expressing mycosis fungoides.</field_page_description>
  <field_date_posted>2017-12-18</field_date_posted>
  <field_date_reviewed>2017-12-15</field_date_reviewed>
  <field_pretty_url>brentuximab-fda-rare-lymphomas</field_pretty_url>
  <para_id>1102112</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1102804</id>
  <title>Unique Trial Aims to Decrease Early Deaths in Patients with Rare Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Decreasing Early Deaths in Patients with Rare Leukemia</field_short_title>
  <field_page_description>Acute promyelocytic leukemia (APL) is a highly curable cancer. A new NCI-funded clinical trial is aimed at preventing early deaths in patients with APL.</field_page_description>
  <field_date_posted>2018-01-03</field_date_posted>
  <field_date_reviewed>2018-01-02</field_date_reviewed>
  <field_pretty_url>apl-trial-preventing-early-death</field_pretty_url>
  <para_id>1102804</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1102848</id>
  <title>Acupuncture May Reduce Treatment-Related Joint Pain for Breast Cancer Patients</title>
  <langcode>en</langcode>
  <field_short_title>Acupuncture May Reduce Joint Pain Caused by Breast Cancer Therapy</field_short_title>
  <field_page_description>Acupuncture may reduce joint pain caused by aromatase inhibitors in postmenopausal women with breast cancer, according to results of a rigorous clinical trial.</field_page_description>
  <field_date_posted>2018-01-08</field_date_posted>
  <field_date_reviewed>2018-01-04</field_date_reviewed>
  <field_pretty_url>acupuncture-aromatase-inhibitor-joint-pain</field_pretty_url>
  <para_id>1102848</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1104030</id>
  <title>Incidence of Cancers of the Lower Stomach Increasing among Younger Americans</title>
  <langcode>en</langcode>
  <field_short_title>Incidence of Lower Stomach Cancer in US Changing</field_short_title>
  <field_page_description>The incidence of cancer that occurs in the lower stomach has been increasing among Americans under age 50, particularly in non-Hispanic white women.</field_page_description>
  <field_date_posted>2018-01-18</field_date_posted>
  <field_date_reviewed>2018-01-16</field_date_reviewed>
  <field_pretty_url>lower-stomach-cancer-incidence-changing</field_pretty_url>
  <para_id>1104030</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1061644</term_id>
  <id>1061645</id>
  <title>RAS Community Outreach</title>
  <langcode>en</langcode>
  <field_short_title>RAS Community Outreach</field_short_title>
  <field_page_description>Through community and technical collaborations, workshops and symposia, and the distribution of reference reagents, the RAS Initiative seeks to increase the sharing of knowledge and resources essential to defeating cancers caused by mutant RAS genes.</field_page_description>
  <field_date_posted>2016-09-12</field_date_posted>
  <field_date_reviewed>2016-09-28</field_date_reviewed>
  <para_id>1061645</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciLandingPage</CONTENTTYPENAME>
  <term_id>829</term_id>
  <id>13367</id>
  <title>About Cancer</title>
  <langcode>en</langcode>
  <field_short_title>About Cancer</field_short_title>
  <field_page_description>Information from the National Cancer Institute about cancer treatment, prevention, screening, genetics, causes, and how to cope with cancer.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13367</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>952658</term_id>
  <id>13866</id>
  <title>PDQ&amp;reg; Cancer Information Summaries: Screening/Detection (Testing for Cancer)</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Screening</field_short_title>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13866</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>952664</term_id>
  <id>13879</id>
  <title>PDQ&amp;reg; Cancer Information Summaries: Integrative, Alternative, and Complementary Therapies</title>
  <langcode>en</langcode>
  <field_short_title>Integrative Therapies</field_short_title>
  <field_page_description>Information about complementary and alternative forms of medicine, or CAM, for cancer patients. </field_page_description>
  <field_date_posted>2018-01-01</field_date_posted>
  <field_date_reviewed>2016-04-12</field_date_reviewed>
  <para_id>13879</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>930690</term_id>
  <id>13917</id>
  <title>Visitor Information</title>
  <langcode>en</langcode>
  <field_short_title>Visitor Information</field_short_title>
  <field_page_description>Visitor information including directions by car and public transportation to NCI in Rockville, MD, and contact details for NCI campuses and the National Institutes of Health in Bethesda, MD.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2010-02-22</field_date_reviewed>
  <para_id>13917</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>14222</id>
  <title>A to Z List of Cancer Drugs</title>
  <langcode>en</langcode>
  <field_short_title>A to Z List of Cancer Drugs</field_short_title>
  <field_page_description>List of cancer drug information summaries providing details about cancer drugs and cancer drug combinations.</field_page_description>
  <field_date_posted>2012-01-30</field_date_posted>
  <field_date_reviewed>2006-09-28</field_date_reviewed>
  <para_id>14222</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>228639</id>
  <title>NCI and the Chinese Academy of Medical Sciences Sign Statement of Intent</title>
  <langcode>en</langcode>
  <field_short_title>NCI and the Chinese Academy of Medical Sciences Sign Statement of Intent</field_short_title>
  <field_page_description>Today the National Cancer Institute (NCI) and the Cancer Institute/Hospital of the Chinese Academy of Medical Sciences (CICAMS) signed a statement of intent to share an interest in fostering collaborative biomedical research in oncology and a common goal </field_page_description>
  <field_date_posted>2012-03-14</field_date_posted>
  <field_date_reviewed>2012-03-14</field_date_reviewed>
  <field_pretty_url>ChineseNCISOINewsNote</field_pretty_url>
  <para_id>228639</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>267257</term_id>
  <id>267267</id>
  <title>Find a Cancer Center</title>
  <langcode>en</langcode>
  <field_short_title>Find an NCI-Designated Cancer Center</field_short_title>
  <field_date_posted>2012-08-13</field_date_posted>
  <field_date_reviewed>2012-04-05</field_date_reviewed>
  <para_id>267267</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1100730</id>
  <title>An Important Moment in Tobacco Control </title>
  <langcode>en</langcode>
  <field_short_title>An Important Moment in Tobacco Control</field_short_title>
  <field_page_description>The major tobacco companies have begun publishing corrective statements explaining the harms of smoking, addressing common misconceptions about cigarettes.</field_page_description>
  <field_date_posted>2017-11-28</field_date_posted>
  <field_date_reviewed>2017-11-27</field_date_reviewed>
  <field_pretty_url>tobacco-corrective-statements</field_pretty_url>
  <para_id>1100730</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1102376</term_id>
  <id>1102381</id>
  <title>Selected Publications by the NCI Director</title>
  <langcode>en</langcode>
  <field_short_title>Selected Publications by the NCI Director</field_short_title>
  <field_page_description>Dr. Norman Sharpless's written work on cancer research appears in many leading scientific journals, as well as a variety of other publications. This page lists some of the articles published by Dr. Sharpless since becoming NCI director.</field_page_description>
  <field_date_posted>2017-12-19</field_date_posted>
  <field_date_reviewed>2017-12-18</field_date_reviewed>
  <para_id>1102381</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102628</term_id>
  <id>1102878</id>
  <title>Genetic Ablation of KRAS in Pancreas Cancer: When an Essential Oncogene Isn’t</title>
  <langcode>en</langcode>
  <field_short_title>Genetic Ablation of KRAS in Pancreas Cancer: When an Essential Oncogene Isn’t</field_short_title>
  <field_page_description>How pancreatic cancer cell lines adapt to loss of their mutant KRAS genes suggest how new treatments for pancreatic cancers should be used.</field_page_description>
  <field_date_posted>2018-01-05</field_date_posted>
  <field_date_reviewed>2018-01-04</field_date_reviewed>
  <field_pretty_url>kras-dependence</field_pretty_url>
  <para_id>1102878</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1102949</term_id>
  <id>1102953</id>
  <title>Partnerships</title>
  <langcode>en</langcode>
  <field_short_title>Partnerships</field_short_title>
  <field_page_description>NCI fellows and trainees assist with science needs, workshops, and career guidance for middle school and high school students. Partner with us to enhance science education in your classroom.   </field_page_description>
  <field_date_posted>2018-01-05</field_date_posted>
  <field_date_reviewed>2018-01-05</field_date_reviewed>
  <para_id>1102953</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102630</term_id>
  <id>1112035</id>
  <title>Office of Cancer Genomics: Integration of Structural, Functional, and Computational Genomic Data Advances Precision Oncology</title>
  <langcode>en</langcode>
  <field_short_title>Collaborative Genomics Study Advances Precision Oncology</field_short_title>
  <field_date_posted>2018-04-05</field_date_posted>
  <field_date_reviewed>2018-04-02</field_date_reviewed>
  <field_pretty_url>ocg-collaborative-study</field_pretty_url>
  <para_id>1112035</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1112214</id>
  <title>Interactive App Improves Colorectal Cancer Screening Rates</title>
  <langcode>en</langcode>
  <field_short_title>App Improves Colorectal Cancer Screening Rates</field_short_title>
  <field_page_description>Colorectal cancer screening reduces deaths from the disease, yet about one-third of Americans aren’t up to date with screening. In this Cancer Currents blog post, learn what happened when people waiting for routine checkups could order their own screening test using a computer app.</field_page_description>
  <field_date_posted>2018-04-09</field_date_posted>
  <field_date_reviewed>2018-04-05</field_date_reviewed>
  <field_pretty_url>colorectal-cancer-screening-app-improves-rates</field_pretty_url>
  <para_id>1112214</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1102622</term_id>
  <id>1112791</id>
  <title>NCI study revises molecular classification for most common type of lymphoma</title>
  <langcode>en</langcode>
  <field_short_title>NCI Study Offers Genetic Insights into Common Lymphoma</field_short_title>
  <field_page_description>An NCI study identifies genetic subtypes of diffuse large B-cell lymphoma (DLBCL), helping explain why only some patients with this most common lymphoma respond to treatment, and offering a path toward targeted therapies.</field_page_description>
  <field_date_posted>2018-04-11</field_date_posted>
  <field_date_reviewed>2018-04-09</field_date_reviewed>
  <field_pretty_url>lymphoma-genetic-subtypes</field_pretty_url>
  <para_id>1112791</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894086</term_id>
  <id>1113671</id>
  <title>PACHE Trainee Spotlight: Roslyn Curry Featured on Thesis Thursday Radio Show</title>
  <langcode>en</langcode>
  <field_short_title>PACHE Trainee Spotlight: Roslyn Curry Featured on Thesis Thursday Radio Show</field_short_title>
  <field_page_description>Roslyn Curry, a student at the University of Arizona (UA), was featured on a local radio program, Thesis Thursday, where she discussed her participation in the U54 PACHE Partnership for Native American Cancer Prevention (NACP) as a research trainee in Dr. William Montfort’s Lab at the University of Arizona Cancer Cente</field_page_description>
  <field_date_posted>2018-04-24</field_date_posted>
  <field_date_reviewed>2018-04-24</field_date_reviewed>
  <field_pretty_url>pache-spotlight-curry</field_pretty_url>
  <para_id>1113671</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1115690</id>
  <title>Some Children with Wilms Tumor Can Receive Less Therapy, Study Suggests</title>
  <langcode>en</langcode>
  <field_short_title>Less Therapy Okay for Some Children with Wilms Tumor?</field_short_title>
  <field_page_description>Some children with advanced Wilms tumor, a form of kidney cancer, may be able to skip radiation therapy, findings from an NCI-funded clinical trial show. It’s unclear if the finding will change clinical practice, as this Cancer Currents post reports.</field_page_description>
  <field_date_posted>2018-05-23</field_date_posted>
  <field_date_reviewed>2018-05-16</field_date_reviewed>
  <field_pretty_url>wilms-tumor-skip-radiation-therapy</field_pretty_url>
  <para_id>1115690</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>922517</term_id>
  <id>1117061</id>
  <title>Patrick McGarey</title>
  <langcode>en</langcode>
  <field_short_title>Patrick McGarey</field_short_title>
  <field_page_description>Patrick McGarey, Associate Director for Finance and Legislation, oversees NCI budget, legislation, grants financing and administration, and technology transfer. </field_page_description>
  <field_date_posted>2018-06-05</field_date_posted>
  <field_date_reviewed>2018-06-05</field_date_reviewed>
  <field_pretty_url>patrick-mcgarey-bio</field_pretty_url>
  <para_id>1117061</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1118165</id>
  <title>New on NCI Websites for June 2018</title>
  <langcode>en</langcode>
  <field_short_title>New on NCI Websites for June 2018</field_short_title>
  <field_page_description>NCI’s online collection of cancer information products is constantly growing. See selected content of interest to the cancer community that has been added as of June 2018 in this Cancer Currents blog post.</field_page_description>
  <field_date_posted>2018-06-25</field_date_posted>
  <field_date_reviewed>2018-06-21</field_date_reviewed>
  <field_pretty_url>new-online-june-2018</field_pretty_url>
  <para_id>1118165</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1119343</id>
  <title>Cancer Prevention Message Is Key for HPV Vaccination Discussions with Parents</title>
  <langcode>en</langcode>
  <field_short_title>HPV Vaccination and Parents: What Message Works Best?</field_short_title>
  <field_page_description>When it comes to the HPV vaccine, doctors should emphasize cancer prevention while discussing vaccination with the parents of preteens, results from a new study show. As this Cancer Currents post explains, parents thought this was the best message by far.</field_page_description>
  <field_date_posted>2018-07-10</field_date_posted>
  <field_date_reviewed>2018-07-05</field_date_reviewed>
  <field_pretty_url>hpv-vaccine-parents-prevention-best-message</field_pretty_url>
  <para_id>1119343</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1074837</term_id>
  <id>1119620</id>
  <title>Requests for TCGA Materials</title>
  <langcode>en</langcode>
  <field_short_title>Requests for TCGA Materials</field_short_title>
  <field_date_posted>2018-07-09</field_date_posted>
  <field_date_reviewed>2018-07-09</field_date_reviewed>
  <field_pretty_url>material-requests</field_pretty_url>
  <para_id>1119620</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1033214</id>
  <title>Approval of Osimertinib and Necitumumab Increases Lung Cancer Treatment Options</title>
  <langcode>en</langcode>
  <field_short_title>Approvals Increase Lung Cancer Treatment Options</field_short_title>
  <field_page_description>The FDA has approved two targeted therapies, osimertinib (Tagrisso™) and necitumumab (Portrazza™), for the treatment of some patients with advanced lung cancer.</field_page_description>
  <field_date_posted>2015-12-28</field_date_posted>
  <field_date_reviewed>2015-12-23</field_date_reviewed>
  <field_pretty_url>fda-osimertinib-necitumumab</field_pretty_url>
  <para_id>1033214</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1034898</id>
  <title>Video Intervention Helps Prepare Patients to Participate in Cancer Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>Video Helps Prepare Patients to Participate in Cancer Clinical Trials</field_short_title>
  <field_page_description>Patients who took part in a tailored, video-based educational program had a better understanding of and fewer concerns about participating in clinical trials than patients who received text-based educational.</field_page_description>
  <field_date_posted>2016-01-28</field_date_posted>
  <field_date_reviewed>2016-01-28</field_date_reviewed>
  <field_pretty_url>trial-participation-video</field_pretty_url>
  <para_id>1034898</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1035636</id>
  <title>Tackling the Global Cancer Burden: A Conversation with NCI’s Dr. Ted Trimble</title>
  <langcode>en</langcode>
  <field_short_title>Tackling the Global Cancer Burden: A Conversation with NCI’s Dr. Ted Trimble</field_short_title>
  <field_page_description>In honor of World Cancer Day, the director of NCI’s Center for Global Health discusses key opportunities in global cancer research.</field_page_description>
  <field_date_posted>2016-02-04</field_date_posted>
  <field_date_reviewed>2016-02-03</field_date_reviewed>
  <field_pretty_url>trimble-global-cancer</field_pretty_url>
  <para_id>1035636</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1036897</id>
  <title>Prospective Study Links HPV Detection in the Mouth to Head and Neck Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Study Confirms Oral HPV Infection Precedes Head and Neck Cancer </field_short_title>
  <field_page_description>A new study confirms that infection with HPV 16 precedes the development of head and neck cancer.</field_page_description>
  <field_date_posted>2016-02-12</field_date_posted>
  <field_date_reviewed>2016-02-11</field_date_reviewed>
  <field_pretty_url>hpv-head-and-neck-cancer</field_pretty_url>
  <para_id>1036897</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1037158</id>
  <title>NCI-DOE Collaboration Paving Way for Large-Scale Computational Cancer Science</title>
  <langcode>en</langcode>
  <field_short_title>Paving the Way for Large-Scale Computational Cancer Science</field_short_title>
  <field_page_description>NCI and the Department of Energy have entered into a collaboration to develop a plan to use large-scale computing to influence cancer science and, ultimately, clinical treatment.</field_page_description>
  <field_date_posted>2016-02-17</field_date_posted>
  <field_date_reviewed>2016-02-12</field_date_reviewed>
  <field_pretty_url>nci-doe-computing</field_pretty_url>
  <para_id>1037158</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1037619</id>
  <title>What’s New on NCI’s Websites?</title>
  <langcode>en</langcode>
  <field_short_title>What’s New on NCI’s Websites?</field_short_title>
  <field_page_description>NCI periodically provides updates on new websites and other online content of interest to the cancer community.</field_page_description>
  <field_date_posted>2016-02-19</field_date_posted>
  <field_date_reviewed>2016-02-19</field_date_reviewed>
  <field_pretty_url>new-online-february-2016</field_pretty_url>
  <para_id>1037619</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1038587</id>
  <title>Study of Cancer’s Origins Reveals Genetic Reprogramming of Single Cells</title>
  <langcode>en</langcode>
  <field_short_title>Zebrafish Model of Cancer Reveals Genetic Reprogramming of Single Cells</field_short_title>
  <field_page_description>Researchers have used a new zebrafish model of cancer to characterize the early genetic changes associated with the initiation of tumors.</field_page_description>
  <field_date_posted>2016-02-24</field_date_posted>
  <field_date_reviewed>2016-02-24</field_date_reviewed>
  <field_pretty_url>zebrafish-model-cancer-origins</field_pretty_url>
  <para_id>1038587</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1041541</id>
  <title>High-Magnification Microscopy Visualizes Tumor Blood Vessels in Real Time</title>
  <langcode>en</langcode>
  <field_short_title>Researchers visualize tumor blood vessels during surgery</field_short_title>
  <field_page_description>High powered intravital microscopy reveals that 50 percent of blood vessels in melanoma tumors do not have any blood flow, according to a new study. </field_page_description>
  <field_date_posted>2016-03-17</field_date_posted>
  <field_date_reviewed>2016-03-16</field_date_reviewed>
  <field_pretty_url>intravital-microscopy</field_pretty_url>
  <para_id>1041541</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1042455</id>
  <title>Blocking Calcium Transfer May Selectively Kill Cancer Cells</title>
  <langcode>en</langcode>
  <field_short_title>Blocking Calcium Transfer May Selectively Kill Cancer Cells</field_short_title>
  <field_page_description>A new study shows that blocking the transfer of calcium ions into mitochondria is toxic to cancer cells and impairs growth of tumors in mice, while sparing normal cells.</field_page_description>
  <field_date_posted>2016-03-31</field_date_posted>
  <field_date_reviewed>2016-03-31</field_date_reviewed>
  <field_pretty_url>blocking-calcium</field_pretty_url>
  <para_id>1042455</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1047449</id>
  <title>The Cancer Community's Next Steps for the Moonshot Initiative</title>
  <langcode>en</langcode>
  <field_short_title>Next Steps for the Moonshot Initiative</field_short_title>
  <field_page_description>The National Cancer Moonshot Initiative’s Blue Ribbon Panel is moving quickly to develop recommendations on how to accelerate progress against cancer.</field_page_description>
  <field_date_posted>2016-04-29</field_date_posted>
  <field_date_reviewed>2016-04-28</field_date_reviewed>
  <field_pretty_url>moonshot-blue-ribbon-panel</field_pretty_url>
  <para_id>1047449</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1129047</term_id>
  <id>1120005</id>
  <title>TCGA Data Types Collected</title>
  <langcode>en</langcode>
  <field_short_title>TCGA Data Types</field_short_title>
  <field_page_description>Learn about the molecular and clinical data generated for TCGA samples.</field_page_description>
  <field_date_posted>2018-10-30</field_date_posted>
  <field_date_reviewed>2018-07-17</field_date_reviewed>
  <para_id>1120005</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1120550</id>
  <title>FDA Alters Approved Use of Two Checkpoint Inhibitors for Bladder Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Checkpoint Inhibitor Use Changed for Bladder Cancer</field_short_title>
  <field_page_description>FDA has altered the approved uses of pembrolizumab (Keytruda) and atezolizumab (Tecentriq) to treat the most common form of bladder cancer. The change is based on whether patients’ tumors have a specific biomarker.</field_page_description>
  <field_date_posted>2018-07-26</field_date_posted>
  <field_date_reviewed>2018-07-24</field_date_reviewed>
  <field_pretty_url>bladder-cancer-checkpoint-inhibitor-change</field_pretty_url>
  <para_id>1120550</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1120605</id>
  <title>Developing Biomarkers for Immunotherapy: A Conversation with Drs. Magdalena Thurin and Helen Chen</title>
  <langcode>en</langcode>
  <field_short_title>Developing Biomarkers for Immunotherapy</field_short_title>
  <field_page_description>Identifying biomarkers for cancer immunotherapy is the goal of a new NCI-supported research network. Such markers can help to identify patients most likely to benefit from immune-based treatments. </field_page_description>
  <field_date_posted>2018-07-27</field_date_posted>
  <field_date_reviewed>2018-07-25</field_date_reviewed>
  <field_pretty_url>immunotherapy-biomarkers-research-network</field_pretty_url>
  <para_id>1120605</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1121222</term_id>
  <id>1121223</id>
  <title>Develop Ways to Overcome Cancer’s Resistance to Therapy</title>
  <langcode>en</langcode>
  <field_short_title>Overcoming Drug Resistance</field_short_title>
  <field_page_description>Cancer cells can develop resistance to drugs that were previously effective. This Cancer Moonshot initiative aims to increase understanding of how this resistance develops, and to use biomarkers to predict who will develop it, and ways to counteract it to improve patient care and survival.</field_page_description>
  <field_date_posted>2018-10-22</field_date_posted>
  <field_date_reviewed>2018-08-01</field_date_reviewed>
  <para_id>1121223</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1121491</id>
  <title>TCGA's Study of Endometrial Carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Endometrial Carcinoma</field_short_title>
  <field_page_description>TCGA's Study of Endometrial Carcinoma</field_page_description>
  <field_date_posted>2018-08-06</field_date_posted>
  <field_date_reviewed>2018-08-06</field_date_reviewed>
  <field_pretty_url>endometrial</field_pretty_url>
  <para_id>1121491</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1121494</term_id>
  <id>1121495</id>
  <title>Establish a Network for Direct Patient Engagement</title>
  <langcode>en</langcode>
  <field_short_title>Direct Patient Engagement Network</field_short_title>
  <field_page_description>This Cancer Moonshot initiative will engage patients to contribute their tumor profile data to expand knowledge about what therapies work, in whom, and in which types of cancer. A patient’s genomic data may guide treatment decisions.</field_page_description>
  <field_date_posted>2018-10-22</field_date_posted>
  <field_date_reviewed>2018-08-06</field_date_reviewed>
  <para_id>1121495</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1121591</id>
  <title>TCGA's Study of Urothelial Bladder Carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Urothelial Bladder Carcinoma</field_short_title>
  <field_page_description>TCGA's Study of Urothelial Bladder Carcinoma</field_page_description>
  <field_date_posted>2018-08-07</field_date_posted>
  <field_date_reviewed>2018-08-07</field_date_reviewed>
  <field_pretty_url>bladder</field_pretty_url>
  <para_id>1121591</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1121684</term_id>
  <id>1121685</id>
  <title>Generation of Human Tumor Atlases</title>
  <langcode>en</langcode>
  <field_short_title>Generation of Human Tumor Atlases</field_short_title>
  <field_page_description>Human tumor atlases act as maps that describe the multidimensional cellular, structural, and molecular characteristics of human cancers over time. This information will improve understanding of how cancers develop and respond to treatment, ultimately improving care.</field_page_description>
  <field_date_posted>2018-10-22</field_date_posted>
  <field_date_reviewed>2018-08-09</field_date_reviewed>
  <para_id>1121685</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1102622</term_id>
  <id>1122245</id>
  <title>Rosenberg, NCI-supported researchers to receive 2018 Albany Prize</title>
  <langcode>en</langcode>
  <field_short_title>Rosenberg named co-recipient of 2018 Albany Prize</field_short_title>
  <field_page_description>NCI’s Steven A. Rosenberg, M.D., Ph.D., has been named a recipient of the 2018 Albany Medical Center Prize in Medicine and Biomedical Research for his pioneering immunotherapy research. He will share the prize with two NCI-supported immunotherapy researchers.</field_page_description>
  <field_date_posted>2018-08-15</field_date_posted>
  <field_date_reviewed>2018-08-14</field_date_reviewed>
  <field_pretty_url>rosenberg-albany-prize</field_pretty_url>
  <para_id>1122245</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1123624</term_id>
  <id>1123625</id>
  <title>NCI Community Oncology Research Program (NCORP)</title>
  <langcode>en</langcode>
  <field_short_title>NCI Community Oncology Research Program (NCORP)</field_short_title>
  <field_page_description>The NCI Community Oncology Research Program (NCORP) is a community-based program that brings cancer clinical trials and cancer care delivery research to individuals in their own communities.</field_page_description>
  <field_date_posted>2018-08-27</field_date_posted>
  <field_date_reviewed>2018-08-27</field_date_reviewed>
  <para_id>1123625</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1105290</id>
  <title>Olaparib Approved for Treating Some Breast Cancers with BRCA Gene Mutations</title>
  <langcode>en</langcode>
  <field_short_title>Olaparib Approved for Breast Cancers with BRCA Gene Mutations</field_short_title>
  <field_page_description>The Food and Drug Administration has approved olaparib (Lynparza®) to treat metastatic breast cancers that have inherited mutations in the BRCA1 or BRCA2 genes as well as a companion diagnostic test for selecting candidates for the therapy.</field_page_description>
  <field_date_posted>2018-01-29</field_date_posted>
  <field_date_reviewed>2018-01-29</field_date_reviewed>
  <field_pretty_url>fda-olaparib-breast-brca-mutations</field_pretty_url>
  <para_id>1105290</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1107079</id>
  <title>For Rare Melanoma, Checkpoint Inhibitors May Hold Substantial Promise</title>
  <langcode>en</langcode>
  <field_short_title>Checkpoint Inhibitors Hold Promise for Rare Melanoma</field_short_title>
  <field_page_description>Patients with a rare form of melanoma, called desmoplastic melanoma, may be particularly likely to benefit from immune checkpoint inhibitors, a new study shows. As this Cancer Currents post explains, an NCI-sponsored clinical trial is already testing one such drug, pembrolizumab (Keytruda) in patients with this cancer.</field_page_description>
  <field_date_posted>2018-02-14</field_date_posted>
  <field_date_reviewed>2018-02-14</field_date_reviewed>
  <field_pretty_url>desmoplastic-melanoma-checkpoint-inhibitors</field_pretty_url>
  <para_id>1107079</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>941577</term_id>
  <id>1107109</id>
  <title>Clinical Trials for Childhood Brain Stem Glioma</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trials for Childhood Brain Stem Glioma</field_short_title>
  <field_date_posted>2018-02-14</field_date_posted>
  <field_date_reviewed>2018-02-14</field_date_reviewed>
  <field_pretty_url>childhood-brainstem-glioma</field_pretty_url>
  <para_id>1107109</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1109800</id>
  <title>Drug May Help Prevent Resistance to Toxin-Based Leukemia Therapy</title>
  <langcode>en</langcode>
  <field_short_title>Drug May Help Prevent Resistance to Toxin-Based Leukemia Therapy</field_short_title>
  <field_page_description>Adding the drug 5-AZA to moxetumomab pasudotox, a toxin-based cancer drug, may improve its efficacy in acute lymphoblastic leukemia (ALL). As this Cancer Currents blog post explains, in mice, both drugs were more effective than moxetumomab alone.</field_page_description>
  <field_date_posted>2018-03-12</field_date_posted>
  <field_date_reviewed>2018-03-09</field_date_reviewed>
  <field_pretty_url>moxetumomab-leukemia-overcoming-resistance</field_pretty_url>
  <para_id>1109800</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1114558</term_id>
  <id>1114560</id>
  <title>Brachytherapy to Treat Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Brachytherapy</field_short_title>
  <field_page_description>When getting brachytherapy, a solid source of radiation is put inside your body. It can be used treat different kinds of cancer, head and neck, breast, cervix, prostate, and eye. Learn more about how what to expect when getting internal radiation therapy. </field_page_description>
  <field_date_posted>2018-05-01</field_date_posted>
  <field_date_reviewed>2018-05-01</field_date_reviewed>
  <para_id>1114560</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102626</term_id>
  <id>1114660</id>
  <title>Assessing the International Landscape of Cancer Research through Successful Partnership</title>
  <langcode>en</langcode>
  <field_short_title>Assessing the International Landscape</field_short_title>
  <field_date_posted>2018-05-04</field_date_posted>
  <field_date_reviewed>2018-05-04</field_date_reviewed>
  <field_pretty_url>icrp-2018</field_pretty_url>
  <para_id>1114660</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1114844</term_id>
  <id>1114850</id>
  <title>Get Involved: Community Groups for Trainees and Fellows</title>
  <langcode>en</langcode>
  <field_short_title>Get Involved: Community Groups</field_short_title>
  <field_page_description>Cancer research fellows and trainees will find information about special interest groups at NCI and NIH. Learn more about how to get involved. </field_page_description>
  <field_date_posted>2018-05-25</field_date_posted>
  <field_date_reviewed>2018-05-04</field_date_reviewed>
  <para_id>1114850</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1114842</term_id>
  <id>1115079</id>
  <title>New to NCI: Information for New Trainees and Fellows</title>
  <langcode>en</langcode>
  <field_short_title>New to NCI: Information for New Trainees</field_short_title>
  <field_page_description>Fellows and cancer research trainees will find information to support their onboarding at NCI, including stipend and tax information and NIH rules and regulations. Learn more about orientation for NCI trainees. </field_page_description>
  <field_date_posted>2018-05-25</field_date_posted>
  <field_date_reviewed>2018-05-09</field_date_reviewed>
  <para_id>1115079</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102628</term_id>
  <id>1116064</id>
  <title>Conversation with Elizabeth Jaffee: An Immuno-Oncology Update</title>
  <langcode>en</langcode>
  <field_short_title>Conversation with Elizabeth Jaffee: An Immuno-Oncology Update</field_short_title>
  <field_page_description>Immunotherapy has dramatically improved the outlook for some cancer patients. Researchers are striving to increase the proportion of patients that respond.</field_page_description>
  <field_date_posted>2018-05-21</field_date_posted>
  <field_date_reviewed>2018-05-21</field_date_reviewed>
  <field_pretty_url>jaffee-immunotherapy</field_pretty_url>
  <para_id>1116064</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1102622</term_id>
  <id>1116310</id>
  <title>New approach to immunotherapy leads to complete response in breast cancer patient unresponsive to other treatments</title>
  <langcode>en</langcode>
  <field_short_title>Immunotherapy targets metastatic breast cancer–cell mutations</field_short_title>
  <field_page_description>A novel approach to immunotherapy developed by NCI researchers led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments. The findings were published in Nature Medicine.</field_page_description>
  <field_date_posted>2018-06-04</field_date_posted>
  <field_date_reviewed>2018-05-24</field_date_reviewed>
  <field_pretty_url>immunotherapy-targets-breast-cancer-case-report</field_pretty_url>
  <para_id>1116310</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1047603</term_id>
  <id>1047622</id>
  <title>Midcareer Investigator Award in Patient-Oriented Research (K24)</title>
  <langcode>en</langcode>
  <field_short_title>NCI K24 Award</field_short_title>
  <field_date_posted>2011-03-22</field_date_posted>
  <field_date_reviewed>2011-03-22</field_date_reviewed>
  <para_id>1047622</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1047990</id>
  <title>After Rising for Decades, Thyroid Cancer Incidence Stabilizes</title>
  <langcode>en</langcode>
  <field_short_title>U.S. Thyroid Cancer Incidence Stabilizes</field_short_title>
  <field_page_description>After rising steadily since the 1990s, the incidence of thyroid cancer in the United States may be leveling off, according to an analysis of data from NCI’s SEER program. </field_page_description>
  <field_date_posted>2016-05-06</field_date_posted>
  <field_date_reviewed>2016-05-06</field_date_reviewed>
  <field_pretty_url>thyroid-incidence-trend</field_pretty_url>
  <para_id>1047990</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1048214</id>
  <title>Calling on Data Enthusiasts to Help Advance Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Data Sharing and the Cancer Moonshot </field_short_title>
  <field_page_description>Health data enthusiasts of all stripes were in Washington, D.C., today for Health Datapalooza. NCI's Dr. Warren Kibbe explains that this annual event explores a topic that is central to NCI’s efforts against cancer: creating knowledge from data.</field_page_description>
  <field_date_posted>2016-05-09</field_date_posted>
  <field_date_reviewed>2016-05-09</field_date_reviewed>
  <field_pretty_url>datapalooza-moonshot</field_pretty_url>
  <para_id>1048214</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1051289</id>
  <title>Survival Disparities Identified in Young African Americans with Colorectal Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Survival Disparities Identified in Young African Americans with Colorectal Cancer</field_short_title>
  <field_page_description>A blog post on a new study that found African Americans younger than age 50 who are diagnosed with colorectal cancer have significantly worse survival rates than whites of the same age.</field_page_description>
  <field_date_posted>2016-05-25</field_date_posted>
  <field_date_reviewed>2016-05-25</field_date_reviewed>
  <field_pretty_url>colorectal-survival-disparities</field_pretty_url>
  <para_id>1051289</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1051954</id>
  <title>Newly launched Genomic Data Commons to facilitate data and clinical information sharing</title>
  <langcode>en</langcode>
  <field_short_title>Newly launched Genomic Data Commons to facilitate data and clinical information sharing</field_short_title>
  <field_page_description>The Genomic Data Commons (GDC), a unified data system that promotes sharing of genomic and clinical data between researchers, launched today with a visit from Vice President Joe Biden to the operations center at the University of Chicago.</field_page_description>
  <field_date_posted>2016-06-06</field_date_posted>
  <field_date_reviewed>2016-06-02</field_date_reviewed>
  <field_pretty_url>genomic-data-commons-launch</field_pretty_url>
  <para_id>1051954</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069530</term_id>
  <id>963824</id>
  <title>Nanotechnology for Treating Cancer: Pitfalls and Bridges on the Path to Nanomedicines</title>
  <langcode>en</langcode>
  <field_short_title>Nanotechnology for Treating Cancer: Pitfalls and Bridges on the Path to Nanomedicines</field_short_title>
  <field_date_posted>2015-06-08</field_date_posted>
  <field_date_reviewed>2015-06-08</field_date_reviewed>
  <field_pretty_url>nanomedicines</field_pretty_url>
  <para_id>963824</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922399</term_id>
  <id>966540</id>
  <title>TAS-102 Improves Overall Survival in Patients with Metastatic Colorectal Cancer</title>
  <langcode>en</langcode>
  <field_short_title>TAS-102 for Metastatic Colorectal Cancer</field_short_title>
  <field_page_description>A summary of results from an international phase III trial that compared TAS-102 with placebo in patients with metastatic colorectal cancer whose disease progressed following prior treatment.</field_page_description>
  <field_date_posted>2015-06-12</field_date_posted>
  <field_date_reviewed>2015-06-12</field_date_reviewed>
  <field_pretty_url>TAS-102-overall-survival</field_pretty_url>
  <para_id>966540</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>768744</term_id>
  <id>966689</id>
  <title>Webinar Summary: A Conversation with NCI Acting Director, Dr. Douglas R Lowy</title>
  <langcode>en</langcode>
  <field_short_title>A Conversation with NCI Acting Director, Dr. Douglas R. Lowy</field_short_title>
  <field_date_posted>2015-06-15</field_date_posted>
  <field_date_reviewed>2015-06-15</field_date_reviewed>
  <field_pretty_url>lowy-precision-medicine-webinar</field_pretty_url>
  <para_id>966689</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>969898</term_id>
  <id>969899</id>
  <title>Extramural Funding</title>
  <langcode>en</langcode>
  <field_short_title>Extramural Funding</field_short_title>
  <field_page_description>Find details about obligations  for the NCI extramural research program, including grants and contracts.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-06-24</field_date_reviewed>
  <para_id>969899</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>971569</id>
  <title>Changing patterns in survival for U.S. women with invasive breast cancer</title>
  <langcode>en</langcode>
  <field_short_title>Changing Patterns in Breast Cancer Survival</field_short_title>
  <field_date_posted>2015-07-20</field_date_posted>
  <field_date_reviewed>2015-06-30</field_date_reviewed>
  <field_pretty_url>changing-survival-patterns-breast</field_pretty_url>
  <para_id>971569</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938231</term_id>
  <id>971650</id>
  <title>Childhood Cancer Genomics Gaps and Opportunities: Identification of Research Priorities Workshop Summary</title>
  <langcode>en</langcode>
  <field_short_title>Childhood Cancer Genomics Gaps and Opportunities - Workshop Summary</field_short_title>
  <field_date_posted>2015-07-17</field_date_posted>
  <field_date_reviewed>2015-07-01</field_date_reviewed>
  <field_pretty_url>childhood-genomics-workshop-summary</field_pretty_url>
  <para_id>971650</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>974318</term_id>
  <id>974319</id>
  <title>NCI Historical Trends</title>
  <langcode>en</langcode>
  <field_short_title>Historical Trends</field_short_title>
  <field_page_description>Find information about the history of NCI appropriations and the Professional Judgment (Bypass) Budget, as well as data on funding trends and staffing levels.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-07-07</field_date_reviewed>
  <para_id>974319</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>974559</term_id>
  <id>974560</id>
  <title>Extramural vs Intramural and RMS Funding</title>
  <langcode>en</langcode>
  <field_short_title>Extramural vs Intramural &amp; RMS Funding</field_short_title>
  <field_page_description>See a comparison of extramural funding and intramural and research management funding by mechanism since 2014.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-07-08</field_date_reviewed>
  <para_id>974560</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>975113</id>
  <title>Test May Identify Poor Prognosis for Some Patients with Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Test May Identify Poor Prognosis for Some Patients with Lung Cancer</field_short_title>
  <field_date_posted>2015-07-13</field_date_posted>
  <field_date_reviewed>2015-07-10</field_date_reviewed>
  <field_pretty_url>lung-prognostic</field_pretty_url>
  <para_id>975113</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069530</term_id>
  <id>987801</id>
  <title>Targeted Therapies, Tooth Extraction, and Metastasis</title>
  <langcode>en</langcode>
  <field_short_title>Targeted Therapies, Tooth Extraction, and Metastasis</field_short_title>
  <field_date_posted>2015-08-24</field_date_posted>
  <field_date_reviewed>2015-08-21</field_date_reviewed>
  <field_pretty_url>obenauf-rosen-massague</field_pretty_url>
  <para_id>987801</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>988237</id>
  <title>FDA Approves Expanded Indication for Carfilzomib in Patients with Multiple Myeloma</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves New Indication for Carfilzomib</field_short_title>
  <field_date_posted>2015-08-24</field_date_posted>
  <field_date_reviewed>2015-08-24</field_date_reviewed>
  <field_pretty_url>carfilzomib-myeloma</field_pretty_url>
  <para_id>988237</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>988479</id>
  <title>Risk of Breast Cancer Death is Low After a Diagnosis of Ductal Carcinoma in Situ</title>
  <langcode>en</langcode>
  <field_short_title>Risk of Breast Cancer Death is Low After DCIS Diagnosis  </field_short_title>
  <field_date_posted>2015-08-26</field_date_posted>
  <field_date_reviewed>2015-08-26</field_date_reviewed>
  <field_pretty_url>dcis-low-risk</field_pretty_url>
  <para_id>988479</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>989310</id>
  <title>Skillful News Reporting Drives Progress in Research</title>
  <langcode>en</langcode>
  <field_short_title>Skillful News Reporting Drives Progress in Research</field_short_title>
  <field_date_posted>2015-08-31</field_date_posted>
  <field_date_reviewed>2015-08-31</field_date_reviewed>
  <field_pretty_url>crim</field_pretty_url>
  <para_id>989310</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>915112</term_id>
  <id>1000675</id>
  <title>Researcher Interview: Tom Hudson</title>
  <langcode>en</langcode>
  <field_short_title>Researcher Interview: Tom Hudson</field_short_title>
  <field_date_posted>2015-09-09</field_date_posted>
  <field_date_reviewed>2015-09-08</field_date_reviewed>
  <field_pretty_url>tom-hudson-interview</field_pretty_url>
  <para_id>1000675</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>10960</term_id>
  <id>1004879</id>
  <title>Join the Conversation about the Annual Plan and Budget</title>
  <langcode>en</langcode>
  <field_short_title>Join the Conversation</field_short_title>
  <field_date_posted>2015-09-25</field_date_posted>
  <field_date_reviewed>2015-09-25</field_date_reviewed>
  <field_pretty_url>plan-conversation</field_pretty_url>
  <para_id>1004879</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1007881</term_id>
  <id>1007882</id>
  <title>Information on DCB Funding Mechanisms</title>
  <langcode>en</langcode>
  <field_short_title>Information on DCB Funding Mechanisms</field_short_title>
  <field_page_description>The Division of Cancer Biology funds investigator-initiated cancer research using a variety of grant mechanisms such as FOA, PA, RFA &amp; NOT.  </field_page_description>
  <field_date_posted>2016-08-08</field_date_posted>
  <field_date_reviewed>2015-10-01</field_date_reviewed>
  <para_id>1007882</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1012245</id>
  <title>TCGA Wins 2015 Sammies People’s Choice Award</title>
  <langcode>en</langcode>
  <field_short_title>TCGA Wins 2015 Sammies People’s Choice Award</field_short_title>
  <field_page_description>The Partnership for Public Service presented the 2015 People’s Choice Award to the government staff and researchers who have worked on The Cancer Genome Atlas.</field_page_description>
  <field_date_posted>2015-10-08</field_date_posted>
  <field_date_reviewed>2015-10-08</field_date_reviewed>
  <field_pretty_url>tcga-sammie</field_pretty_url>
  <para_id>1012245</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1022102</id>
  <title>A Holistic Approach to Cancer Health Disparities</title>
  <langcode>en</langcode>
  <field_short_title>A Holistic Approach to Cancer Health Disparities</field_short_title>
  <field_date_posted>2015-11-05</field_date_posted>
  <field_date_reviewed>2015-11-05</field_date_reviewed>
  <field_pretty_url>annual-plan-disparities</field_pretty_url>
  <para_id>1022102</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>65980</term_id>
  <id>65990</id>
  <title>Mentored Clinical Scientist Research Career Development Award (K08)</title>
  <langcode>en</langcode>
  <field_short_title>NCI K08 Award</field_short_title>
  <field_date_posted>2011-03-18</field_date_posted>
  <field_date_reviewed>2017-12-11</field_date_reviewed>
  <para_id>65990</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>81826</id>
  <title>Drugs Approved for Bone Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Bone Cancer</field_short_title>
  <field_date_posted>2011-06-09</field_date_posted>
  <field_date_reviewed>2011-05-23</field_date_reviewed>
  <field_pretty_url>bone</field_pretty_url>
  <para_id>81826</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>84773</id>
  <title>Tool Weighs Benefits, Risks of Raloxifene or Tamoxifen to Prevent Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Tool Weighs Benefits, Risks of Raloxifene or Tamoxifen to Prevent Breast Cancer</field_short_title>
  <field_page_description>Researchers have developed a benefit-risk index to help guide decisions on whether postmenopausal women at increased risk of developing breast cancer should take raloxifene or tamoxifen to reduce that risk. </field_page_description>
  <field_date_posted>2011-06-14</field_date_posted>
  <field_date_reviewed>2011-06-14</field_date_reviewed>
  <field_pretty_url>benefit-risk-tool</field_pretty_url>
  <para_id>84773</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>84829</id>
  <title>Drugs Approved for Malignant Mesothelioma</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Malignant Mesothelioma</field_short_title>
  <field_date_posted>2011-06-17</field_date_posted>
  <field_date_reviewed>2011-06-17</field_date_reviewed>
  <field_pretty_url>mesothelioma</field_pretty_url>
  <para_id>84829</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>88731</id>
  <title>Drugs Approved for Multiple Myeloma and Other Plasma Cell Neoplasms</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Multiple Myeloma </field_short_title>
  <field_date_posted>2011-07-26</field_date_posted>
  <field_date_reviewed>2011-07-07</field_date_reviewed>
  <field_pretty_url>multiple-myeloma</field_pretty_url>
  <para_id>88731</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938030</term_id>
  <id>723108</id>
  <title>Combination of Idelalisib and Rituximab Improves Survival in Patients with Relapsed Chronic Lymphocytic Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Idelalisib Plus Rituximab for Relapsed Chronic Lymphocytic Leukemia</field_short_title>
  <field_page_description>A summary of results from an international double-blind phase III trial that compared the combination of idelalisib plus rituximab (Rituxan®) versus placebo plus rituximab. </field_page_description>
  <field_date_posted>2014-03-12</field_date_posted>
  <field_date_reviewed>2014-03-12</field_date_reviewed>
  <field_pretty_url>idelalisib-rituximab-cll</field_pretty_url>
  <para_id>723108</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>727551</id>
  <title>NCI-supported facility to conduct cancer trials breaks ground in Puerto Rico</title>
  <langcode>en</langcode>
  <field_short_title>NCI-supported facility to conduct cancer trials breaks ground in Puerto Rico</field_short_title>
  <field_page_description>The Puerto Rican government has allocated $196 million dollars to build a 287,000 sq. ft., 96-bed, cancer hospital in San Juan. The new hospital, which will provide cancer treatment and conduct clinical trials, is the first of its kind in the Caribbean.</field_page_description>
  <field_date_posted>2014-03-25</field_date_posted>
  <field_date_reviewed>2014-03-25</field_date_reviewed>
  <field_pretty_url>CancerCenterPuertoRico</field_pretty_url>
  <para_id>727551</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>762611</term_id>
  <id>748304</id>
  <title>Global Health Events</title>
  <langcode>en</langcode>
  <field_short_title>Global Health Events</field_short_title>
  <field_page_description>CGH sponsors a number of global health events for both national and international audiences, focused on the open exchange of scientific knowledge.</field_page_description>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-04-09</field_date_reviewed>
  <para_id>748304</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919349</term_id>
  <id>748306</id>
  <title>About NCI Center for Global Health</title>
  <langcode>en</langcode>
  <field_short_title>About NCI Center for Global Health</field_short_title>
  <field_page_description>Provides assistance and guidance to nations as they develop and implement cancer control plans, trains international investigators, and strengthens U.S. national, regional, multilateral, and bilateral collaboration.</field_page_description>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-04-09</field_date_reviewed>
  <para_id>748306</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>608323</term_id>
  <id>754654</id>
  <title>TARGET Initiative Leading the Way to New and Exciting Discoveries in Childhood Cancers</title>
  <langcode>en</langcode>
  <field_short_title>New Discoveries in Childhood Cancers</field_short_title>
  <field_date_posted>2014-08-28</field_date_posted>
  <field_date_reviewed>2014-04-16</field_date_reviewed>
  <field_pretty_url>target-initiative</field_pretty_url>
  <para_id>754654</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919353</term_id>
  <id>762665</id>
  <title>International Bilateral Programs for Collaborative Scientific Research</title>
  <langcode>en</langcode>
  <field_short_title>International Bilateral Programs for Collaborative Scientific Research</field_short_title>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-04-30</field_date_reviewed>
  <field_pretty_url>international-bilateral-programs</field_pretty_url>
  <para_id>762665</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>770431</term_id>
  <id>770432</id>
  <title>Gastrointestinal Steering Committee</title>
  <langcode>en</langcode>
  <field_short_title>Gastrointestinal Steering Committee</field_short_title>
  <field_page_description>The Gastrointestinal Steering Committee addresses the design, prioritization, and evaluation of concepts for phase 2 and phase 3 clinical trials in adult gastrointestinal cancers. </field_page_description>
  <field_date_posted>2014-05-21</field_date_posted>
  <field_date_reviewed>2014-05-21</field_date_reviewed>
  <para_id>770432</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>771993</term_id>
  <id>772093</id>
  <title>Lymphoma Steering Committee</title>
  <langcode>en</langcode>
  <field_short_title>Lymphoma Steering Committee</field_short_title>
  <field_page_description>The Lymphoma Steering Committee addresses the design, prioritization and evaluation of concepts for phase II and phase III clinical trials in adult lymphoma.  </field_page_description>
  <field_date_posted>2014-05-23</field_date_posted>
  <field_date_reviewed>2014-05-23</field_date_reviewed>
  <para_id>772093</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>771993</term_id>
  <id>772094</id>
  <title>Lymphoma Steering Committee Roster</title>
  <langcode>en</langcode>
  <field_short_title>Lymphoma Steering Committee Roster</field_short_title>
  <field_date_posted>2014-05-23</field_date_posted>
  <field_date_reviewed>2014-05-23</field_date_reviewed>
  <field_pretty_url>roster</field_pretty_url>
  <para_id>772094</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>771997</term_id>
  <id>772113</id>
  <title>Pediatric and Adolescent Solid Tumor Steering Committee Roster</title>
  <langcode>en</langcode>
  <field_short_title>Pediatric and Adolescent Solid Tumor Steering Committee Roster</field_short_title>
  <field_date_posted>2014-05-23</field_date_posted>
  <field_date_reviewed>2014-05-23</field_date_reviewed>
  <field_pretty_url>roster</field_pretty_url>
  <para_id>772113</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>772006</term_id>
  <id>772123</id>
  <title>Symptom Management and Health-Related Quality of Life Steering Committee</title>
  <langcode>en</langcode>
  <field_short_title>Symptom Management and Health-Related QoL SC</field_short_title>
  <field_page_description>The Symptom Management and Health-Related Quality of Life Steering Committee (SxQoLSC) evaluates and prioritizes clinical trial concepts to manage cancer symptoms and cancer treatment side effects.</field_page_description>
  <field_date_posted>2014-05-23</field_date_posted>
  <field_date_reviewed>2014-05-23</field_date_reviewed>
  <para_id>772123</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>772006</term_id>
  <id>772124</id>
  <title>Symptom Management and Health-Related Quality of Life Steering Committee Roster</title>
  <langcode>en</langcode>
  <field_short_title>Symptom Management and Health-Related Quality of Life Steering Committee Roster</field_short_title>
  <field_date_posted>2014-05-23</field_date_posted>
  <field_date_reviewed>2014-05-23</field_date_reviewed>
  <field_pretty_url>roster</field_pretty_url>
  <para_id>772124</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>772008</term_id>
  <id>772125</id>
  <title>Clinical Imaging Steering Committee</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Imaging Steering Committee</field_short_title>
  <field_page_description>The Clinical Imaging Steering Committee serves as a forum for the extramural imaging and oncology communities to provide strategic input to the NCI regarding its significant investment in imaging activities in clinical trials.</field_page_description>
  <field_date_posted>2014-05-23</field_date_posted>
  <field_date_reviewed>2014-05-23</field_date_reviewed>
  <para_id>772125</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>772128</term_id>
  <id>772130</id>
  <title>Patient Advocate Steering Committee Roster</title>
  <langcode>en</langcode>
  <field_short_title>Patient Advocate Steering Committee Roster</field_short_title>
  <field_date_posted>2014-05-23</field_date_posted>
  <field_date_reviewed>2014-05-23</field_date_reviewed>
  <field_pretty_url>roster</field_pretty_url>
  <para_id>772130</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1062817</id>
  <title>NCI collaborates with Multiple Myeloma Research Foundation</title>
  <langcode>en</langcode>
  <field_short_title>NCI collaborates with Multiple Myeloma Research Foundation</field_short_title>
  <field_page_description>The National Cancer Institute (NCI) announced a collaboration with the Multiple Myeloma Research Foundation (MMRF) to incorporate MMRF's wealth of genomic and clinical data on the disease into the NCI Genomic Data Commons (GDC), a publicly available datab</field_page_description>
  <field_date_posted>2016-09-28</field_date_posted>
  <field_date_reviewed>2016-09-27</field_date_reviewed>
  <field_pretty_url>gdc-data-expansion-mmrf</field_pretty_url>
  <para_id>1062817</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1063033</id>
  <title>TARGET Initiative Fueling Progress Against Childhood Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Initiative Fueling Progress Against Childhood Leukemia</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post about how TARGET, an NCI-funded initiative, has led to the launch of clinical trials of targeted therapies for childhood leukemia.</field_page_description>
  <field_date_posted>2016-09-30</field_date_posted>
  <field_date_reviewed>2016-09-30</field_date_reviewed>
  <field_pretty_url>target-leukemia</field_pretty_url>
  <para_id>1063033</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1063058</id>
  <title>Educating Patients about Genetic Test Results: An Interview with Carol Weil about the COMET Study</title>
  <langcode>en</langcode>
  <field_short_title>Educating Patients about Genetic Test Results</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post about the COMET study, which will examine the impact of counseling patients about the results of their tumor profiling results.</field_page_description>
  <field_date_posted>2016-10-14</field_date_posted>
  <field_date_reviewed>2016-09-30</field_date_reviewed>
  <field_pretty_url>comet-study</field_pretty_url>
  <para_id>1063058</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1063059</id>
  <title>Supporting the development of affordable technologies for cancer detection, diagnosis, and treatment in LMICs</title>
  <langcode>en</langcode>
  <field_short_title>Supporting the development of affordable technologies for cancer detection</field_short_title>
  <field_page_description>Supporting the development of affordable technologies for cancer detection</field_page_description>
  <field_date_posted>2016-09-30</field_date_posted>
  <field_date_reviewed>2016-09-30</field_date_reviewed>
  <para_id>1063059</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1063214</id>
  <title>Avelumab Induces Sustained Tumor Responses in Some Patients with Rare Skin Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Avelumab Shrinks Merkel Cell Tumors</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post about results from a phase II clinical trial showing durable tumor responses to the immunotherapy drug avelumab in patients with metastatic Merkel cell carcinoma.</field_page_description>
  <field_date_posted>2016-10-06</field_date_posted>
  <field_date_reviewed>2016-10-05</field_date_reviewed>
  <field_pretty_url>avelumab-merkel-cell</field_pretty_url>
  <para_id>1063214</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1066798</id>
  <title>NCI’s Office of Cancer Survivorship: Celebrating 20 Years, Planning for Continued Progress</title>
  <langcode>en</langcode>
  <field_short_title>NCI’s Office of Cancer Survivorship: Celebrating 20 Years</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post from Dr. Julia Rowland, director of NCI’s Office of Cancer Survivorship, on efforts to ensure continued progress in survivorship research</field_page_description>
  <field_date_posted>2016-11-17</field_date_posted>
  <field_date_reviewed>2016-11-16</field_date_reviewed>
  <field_pretty_url>ocs-20th-anniversary</field_pretty_url>
  <para_id>1066798</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1035160</term_id>
  <id>1066996</id>
  <title>Developer Interview: Vincent Ferretti</title>
  <langcode>en</langcode>
  <field_short_title>Question &amp; Answer with Vincent Ferretti</field_short_title>
  <field_page_description>In this Q&amp;A, GDC web interface developer Vincent Ferretti, Ph.D., explains his team's design process and describes search and visualization expansions.</field_page_description>
  <field_date_posted>2016-11-21</field_date_posted>
  <field_date_reviewed>2016-11-18</field_date_reviewed>
  <field_pretty_url>vincent-ferretti-interview</field_pretty_url>
  <para_id>1066996</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1067965</id>
  <title>Immune-Cell Traps May Aid Cancer Metastasis</title>
  <langcode>en</langcode>
  <field_short_title>Immune-Cell Traps May Aid Cancer Metastasis</field_short_title>
  <field_page_description>A Cancer Currents blog post on a new study that suggests cancer cells may exploit a normal function of neutrophils, a type of immune cell, to help form metastatic tumors.</field_page_description>
  <field_date_posted>2016-12-06</field_date_posted>
  <field_date_reviewed>2016-12-02</field_date_reviewed>
  <field_pretty_url>nets-metastasis</field_pretty_url>
  <para_id>1067965</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1069431</id>
  <title>Early-phase trial demonstrates shrinkage in pediatric neural tumors</title>
  <langcode>en</langcode>
  <field_short_title>Drug Shrinks Pediatric Neural Tumor</field_short_title>
  <field_page_description>The drug selumetinib shrunk neural tumors in children with plexiform neurofibromas.</field_page_description>
  <field_date_posted>2016-12-28</field_date_posted>
  <field_date_reviewed>2016-12-20</field_date_reviewed>
  <field_pretty_url>selumetinib-shrinks-pediatric-tumors</field_pretty_url>
  <para_id>1069431</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1071049</term_id>
  <id>1071047</id>
  <title>Screen to Save: NCI Colorectal Cancer Outreach and Screening Initiative</title>
  <langcode>en</langcode>
  <field_short_title>Screen to Save</field_short_title>
  <field_date_posted>2017-01-17</field_date_posted>
  <field_date_reviewed>2017-01-17</field_date_reviewed>
  <para_id>1071047</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1070068</term_id>
  <id>1071092</id>
  <title>TCGA study identifies genomic features of cervical cancer</title>
  <langcode>en</langcode>
  <field_short_title>Genomic features of cervical cancer</field_short_title>
  <field_page_description>Investigators have identified novel genomic and molecular characteristics of cervical cancer.</field_page_description>
  <field_date_posted>2017-01-23</field_date_posted>
  <field_date_reviewed>2017-01-19</field_date_reviewed>
  <field_pretty_url>tcga-cervical-cancer</field_pretty_url>
  <para_id>1071092</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922410</term_id>
  <id>1071558</id>
  <title>Pembrolizumab Improves Survival for Some Patients with Advanced Non-Small Cell Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Pembrolizumab for Non-Small Cell Lung Cancer Improves Survival</field_short_title>
  <field_page_description>A summary of clinical trial results showing that pembrolizumab improved progression-free and overall survival for patients with advanced non-small cell lung cancer.</field_page_description>
  <field_date_posted>2017-01-24</field_date_posted>
  <field_date_reviewed>2017-01-23</field_date_reviewed>
  <field_pretty_url>pembrolizumab-nsclc-keynote-024</field_pretty_url>
  <para_id>1071558</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1066360</term_id>
  <id>1072644</id>
  <title>First Cohort of Affordable Technologies for Cancer Detection, Diagnosis, and Treatment in LMICs Enters their Second Phase </title>
  <langcode>en</langcode>
  <field_short_title>First Cohort of ACTs Enters Second Phase</field_short_title>
  <field_date_posted>2017-02-06</field_date_posted>
  <field_date_reviewed>2017-02-06</field_date_reviewed>
  <field_pretty_url>acts-transition</field_pretty_url>
  <para_id>1072644</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1066360</term_id>
  <id>1072646</id>
  <title>Third Cohort joins NCI’s Affordable Cancer Technologies Program: supporting the development of affordable technologies for cancer detection, diagnosis, and treatment in LMICs</title>
  <langcode>en</langcode>
  <field_short_title>Third Cohort joins NCI’s Affordable Cancer Technologies Program: supporting the development of affor</field_short_title>
  <field_date_posted>2017-02-06</field_date_posted>
  <field_date_reviewed>2017-02-06</field_date_reviewed>
  <field_pretty_url>acts-cohort3</field_pretty_url>
  <para_id>1072646</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1066360</term_id>
  <id>1073550</id>
  <title>A new focus for the International Cancer Screening Network</title>
  <langcode>en</langcode>
  <field_short_title>A new focus for the International Cancer Screening Network</field_short_title>
  <field_date_posted>2017-02-17</field_date_posted>
  <field_date_reviewed>2017-02-17</field_date_reviewed>
  <field_pretty_url>icsn</field_pretty_url>
  <para_id>1073550</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1073557</id>
  <title>Cancer Moonshot Moves Forward, Bringing Funding Opportunities for Researchers</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Moonshot Funding Opportunities</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post from NCI Acting Director Dr. Doug Lowy describing a series of funding opportunity announcements related to the Beau Biden Cancer Moonshot&amp;#8480;.</field_page_description>
  <field_date_posted>2017-02-17</field_date_posted>
  <field_date_reviewed>2017-02-17</field_date_reviewed>
  <field_pretty_url>moonshot-funding-opportunities</field_pretty_url>
  <para_id>1073557</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894084</term_id>
  <id>1073680</id>
  <title>Screen to Save: Message from the Branch Chief</title>
  <langcode>en</langcode>
  <field_short_title>Screen to Save: Message from the Branch Chief</field_short_title>
  <field_page_description>Screen to Save, S2S, colorectal cancer,  screening, education and outreach </field_page_description>
  <field_date_posted>2017-02-22</field_date_posted>
  <field_date_reviewed>2017-02-21</field_date_reviewed>
  <field_pretty_url>screen-to-save-bailey-message</field_pretty_url>
  <para_id>1073680</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1074760</id>
  <title>New on NCI Websites for March 2017</title>
  <langcode>en</langcode>
  <field_short_title>New on NCI Websites for March 2017</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post that provides an update on new content of interest to the cancer community recently added to NCI’s websites.</field_page_description>
  <field_date_posted>2017-03-06</field_date_posted>
  <field_date_reviewed>2017-03-06</field_date_reviewed>
  <field_pretty_url>new-online-march-2017</field_pretty_url>
  <para_id>1074760</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1075365</id>
  <title>Putting the Cancer Patient Front and Center: An Interview with NCI’s Dr. Paul Jacobsen</title>
  <langcode>en</langcode>
  <field_short_title>Putting the Cancer Patient Front and Center</field_short_title>
  <field_page_description>A Cancer Currents blog featuring NCI’s Dr. Paul Jacobsen discussing NCI’s Healthcare Delivery Research Program and improving the delivery of cancer care.</field_page_description>
  <field_date_posted>2017-03-14</field_date_posted>
  <field_date_reviewed>2017-03-13</field_date_reviewed>
  <field_pretty_url>cancer-care-delivery-jacobsen</field_pretty_url>
  <para_id>1075365</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1066360</term_id>
  <id>1075683</id>
  <title>New Report: Guiding Principles for Quality Cancer Treatment Services</title>
  <langcode>en</langcode>
  <field_short_title>New Report: Guiding Principles for Quality Cancer Treatment Services</field_short_title>
  <field_date_posted>2017-03-17</field_date_posted>
  <field_date_reviewed>2017-03-17</field_date_reviewed>
  <field_pretty_url>ccan-2025</field_pretty_url>
  <para_id>1075683</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1078443</term_id>
  <id>1078448</id>
  <title>2015 Social Media Events</title>
  <langcode>en</langcode>
  <field_short_title>2015 Social Media Events</field_short_title>
  <field_page_description>Find past social media events involving NCI and its partners from 2015.</field_page_description>
  <field_date_posted>2017-03-28</field_date_posted>
  <field_date_reviewed>2017-03-28</field_date_reviewed>
  <para_id>1078448</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1078428</term_id>
  <id>1078673</id>
  <title>NCI HIV and AIDS Research</title>
  <langcode>en</langcode>
  <field_short_title>NCI HIV and AIDS Research</field_short_title>
  <field_page_description>OHAM is driving important advances in prevention, diagnosis, and treatment of HIV-associated malignancies. Learn about major programs and initiatives. </field_page_description>
  <field_date_posted>2017-07-10</field_date_posted>
  <field_date_reviewed>2017-03-31</field_date_reviewed>
  <para_id>1078673</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1078430</term_id>
  <id>1078698</id>
  <title>HIV and AIDS Research Resources</title>
  <langcode>en</langcode>
  <field_short_title>HIV and AIDS Research Resources</field_short_title>
  <field_page_description>NCI offers resources to investigators researching HIV/AIDS and HIV-malignancies. Find resources that are specific to this area and links to other selected resources.</field_page_description>
  <field_date_posted>2017-07-10</field_date_posted>
  <field_date_reviewed>2017-03-31</field_date_reviewed>
  <para_id>1078698</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1082603</term_id>
  <id>1080220</id>
  <title>Strengthening Capacity for Research for HIV-Associated Malignancies in Africa and Other Low- and Middle-Income Countries (LMICs)</title>
  <langcode>en</langcode>
  <field_short_title>OHAM: Strengthening Research in Africa and Other Low- and Middle-Income Countries (LMICs)</field_short_title>
  <field_date_posted>2017-07-10</field_date_posted>
  <field_date_reviewed>2017-04-04</field_date_reviewed>
  <para_id>1080220</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1082596</term_id>
  <id>1080221</id>
  <title>International Conference on Malignancies in HIV/AIDS (ICMH)</title>
  <langcode>en</langcode>
  <field_short_title>International Conference on Malignancies in HIV/AIDS (ICMH)</field_short_title>
  <field_page_description>This biannual conference focuses on presentation of basic, epidemiologic, and clinical aspects of research on malignancies in HIV-infected and other immunosuppressed individuals. </field_page_description>
  <field_date_posted>2017-07-10</field_date_posted>
  <field_date_reviewed>2017-04-04</field_date_reviewed>
  <para_id>1080221</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070074</term_id>
  <id>1080376</id>
  <title>Researchers Design a Precise Library for CRISPR-Mediated Genetic Screens</title>
  <langcode>en</langcode>
  <field_short_title>Optimized CRISPR Library</field_short_title>
  <field_page_description>Researchers used machine learning method to optimize CRISPR libraries for genomic studies.</field_page_description>
  <field_date_posted>2017-04-06</field_date_posted>
  <field_date_reviewed>2017-04-06</field_date_reviewed>
  <field_pretty_url>crispr-genomics-library</field_pretty_url>
  <para_id>1080376</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1081663</id>
  <title>FDA Approves Pembrolizumab for Hodgkin Lymphoma</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Pembrolizumab for Hodgkin Lymphoma</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on the FDA’s approval of pembrolizumab for the treatment of some adult and pediatric patients with classical Hodgkin lymphoma.</field_page_description>
  <field_date_posted>2017-04-17</field_date_posted>
  <field_date_reviewed>2017-04-17</field_date_reviewed>
  <field_pretty_url>fda-pembrolizumab-hodgkin-lymphoma</field_pretty_url>
  <para_id>1081663</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1081704</term_id>
  <id>1081705</id>
  <title>NCI's Genome Characterization Pipeline</title>
  <langcode>en</langcode>
  <field_short_title>NCI's Genome Characterization Pipeline</field_short_title>
  <field_page_description>The Genome Characterization Pipeline, run by NCI’s Center for Cancer Genomics, transforms cancer tissue samples into rich genomic datasets that are shared with the research community. </field_page_description>
  <field_date_posted>2017-08-04</field_date_posted>
  <field_date_reviewed>2017-04-17</field_date_reviewed>
  <para_id>1081705</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1082561</id>
  <title>Patients Who Choose No Intervention for Small Thyroid Cancers Report Lack of Support</title>
  <langcode>en</langcode>
  <field_short_title>Choosing No Intervention for Thyroid Cancer Can Be Difficult</field_short_title>
  <field_page_description>An NCI &lt;i&gt;Cancer Currents&lt;/i&gt; blog on a study showing that patients with early stage thyroid cancers who don’t pursue immediate intervention experience a lack of support from doctors, loved ones.</field_page_description>
  <field_date_posted>2017-04-27</field_date_posted>
  <field_date_reviewed>2017-04-26</field_date_reviewed>
  <field_pretty_url>thyroid-cancer-surveillance-support</field_pretty_url>
  <para_id>1082561</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1080236</term_id>
  <id>1082574</id>
  <title>Robert Yarchoan, M.D.</title>
  <langcode>en</langcode>
  <field_short_title>Robert Yarchoan, M.D.</field_short_title>
  <field_page_description>Learn more about Robert Yarchoan, M.D., director of NCI Office of HIV and AIDS Malignancy. </field_page_description>
  <field_date_posted>2017-04-27</field_date_posted>
  <field_date_reviewed>2017-04-27</field_date_reviewed>
  <field_pretty_url>yarchoan-bio</field_pretty_url>
  <para_id>1082574</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070072</term_id>
  <id>1083953</id>
  <title>The Mutational Spectra of Cancer Genes in TCGA Data</title>
  <langcode>en</langcode>
  <field_short_title>The Mutational Spectra of Cancer Genes in TCGA Data</field_short_title>
  <field_page_description>The Cancer Genome Atlas has catalogued mutations in more than 30 cancer types. Bar graphs show data for KRAS, HRAS, NRAS, BRAF, TP53, EGFR, PIK3CA, and PTEN.</field_page_description>
  <field_date_posted>2017-05-10</field_date_posted>
  <field_date_reviewed>2017-05-10</field_date_reviewed>
  <field_pretty_url>cancer-mutation-spectra</field_pretty_url>
  <para_id>1083953</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915376</term_id>
  <id>1085524</id>
  <title>Aiming to Prevent Hereditary Cancers, Researchers Focus on Lynch Syndrome</title>
  <langcode>en</langcode>
  <field_short_title>NCI Lynch Syndrome Workshop Focuses on Preventing Hereditary Cancers</field_short_title>
  <field_page_description>An NCI research update article about a workshop to discuss new strategies for preventing hereditary cancers by using Lynch syndrome as a model.</field_page_description>
  <field_date_posted>2017-05-22</field_date_posted>
  <field_date_reviewed>2017-05-19</field_date_reviewed>
  <field_pretty_url>lynch-syndrome-hereditary-cancers</field_pretty_url>
  <para_id>1085524</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1086024</id>
  <title>Regorafenib Becomes First FDA-Approved Drug for Liver Cancer in Nearly a Decade</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Regorafenib for Liver Cancer</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on FDA’s approval of regorafenib (Stivarga®), the first drug approved for liver cancer in nearly a decade.</field_page_description>
  <field_date_posted>2017-05-24</field_date_posted>
  <field_date_reviewed>2017-05-24</field_date_reviewed>
  <field_pretty_url>fda-regorafenib-liver</field_pretty_url>
  <para_id>1086024</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1086779</id>
  <title>HPV Vaccination Linked to Decreased Oral HPV Infections</title>
  <langcode>en</langcode>
  <field_short_title>HPV Vaccine May Prevent Oral HPV Infection</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on a study showing that the HPV vaccine Gardasil may sharply reduce oral HPV infections linked to oropharyngeal cancer.</field_page_description>
  <field_date_posted>2017-06-05</field_date_posted>
  <field_date_reviewed>2017-06-04</field_date_reviewed>
  <field_pretty_url>hpv-vaccine-oral-infection</field_pretty_url>
  <para_id>1086779</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1087279</id>
  <title>Genomic Study Seeks Clues to Help Explain Breast Cancer Disparities</title>
  <langcode>en</langcode>
  <field_short_title>Genome Study of Breast Cancer in African Americans</field_short_title>
  <field_page_description>A Cancer Currents blog on a genomic study that assessed the extent to which molecular characteristics of breast tumors may help to explain some breast cancer disparities.</field_page_description>
  <field_date_posted>2017-06-13</field_date_posted>
  <field_date_reviewed>2017-06-12</field_date_reviewed>
  <field_pretty_url>genome-breast-cancer-disparities</field_pretty_url>
  <para_id>1087279</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894084</term_id>
  <id>1087896</id>
  <title>CRCHD Announces New CURE Distinguished Scholars Seminar Series</title>
  <langcode>en</langcode>
  <field_short_title>CURE Distinguished Scholars Seminar Series</field_short_title>
  <field_page_description>In celebration of 21 years of the CURE program, CRCHD is pleased to announce a new scientific seminar series the CURE Distinguished Scholars Seminar Series. </field_page_description>
  <field_date_posted>2017-06-21</field_date_posted>
  <field_date_reviewed>2017-06-19</field_date_reviewed>
  <field_pretty_url>inaugural-cure-seminar</field_pretty_url>
  <para_id>1087896</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1070068</term_id>
  <id>1090579</id>
  <title>NCI study identifies essential genes for cancer immunotherapy</title>
  <langcode>en</langcode>
  <field_short_title>Study identifies essential genes for immunotherapy</field_short_title>
  <field_page_description>An NCI press release about a study in Nature that identifies genes in cancer cells that could play a role in immunotherapy response and may help explain why some patients don’t respond.</field_page_description>
  <field_date_posted>2017-08-07</field_date_posted>
  <field_date_reviewed>2017-07-27</field_date_reviewed>
  <field_pretty_url>immunotherapy-genes-study</field_pretty_url>
  <para_id>1090579</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1090873</id>
  <title>Survivors of Breast Cancer Differ on Who Should Manage Follow-Up Care</title>
  <langcode>en</langcode>
  <field_short_title>Breast Cancer Survivors’ Preferences on Follow-Up Care</field_short_title>
  <field_page_description>Some survivors of early-stage breast cancer prefer that their oncologist handle aspects of their routine follow-up care, according to a new study discussed in this Cancer Currents blog post.</field_page_description>
  <field_date_posted>2017-08-02</field_date_posted>
  <field_date_reviewed>2017-08-01</field_date_reviewed>
  <field_pretty_url>survivorship-care-preferences</field_pretty_url>
  <para_id>1090873</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1092165</id>
  <title>Study Uncovers Previously Unrecognized Effect of Chemotherapy</title>
  <langcode>en</langcode>
  <field_short_title>Unrecognized Effect of Chemotherapy Uncovered</field_short_title>
  <field_page_description>A study conducted primarily in mice suggests that pre-surgical chemotherapy in breast cancer can cause changes in cells in and around the tumor that aid metastasis.</field_page_description>
  <field_date_posted>2017-08-15</field_date_posted>
  <field_date_reviewed>2017-08-14</field_date_reviewed>
  <field_pretty_url>chemotherapy-effect-metastasis</field_pretty_url>
  <para_id>1092165</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>16374</term_id>
  <id>1092402</id>
  <title>We've Updated Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>We've Updated Clinical Trials</field_short_title>
  <field_date_posted>2017-08-17</field_date_posted>
  <field_date_reviewed>2017-08-17</field_date_reviewed>
  <field_pretty_url>options</field_pretty_url>
  <para_id>1092402</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1092428</term_id>
  <id>1092431</id>
  <title>Manage Your Award</title>
  <langcode>en</langcode>
  <field_short_title>Manage Your Award</field_short_title>
  <field_date_posted>2017-08-17</field_date_posted>
  <field_date_reviewed>2017-08-17</field_date_reviewed>
  <para_id>1092431</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1093388</id>
  <title>Heart Attack, Stroke Risk May Be Elevated Following Cancer Diagnosis</title>
  <langcode>en</langcode>
  <field_short_title>Heart Attack, Stroke Risk Elevated Following Cancer Diagnosis</field_short_title>
  <field_page_description>A cancer diagnosis can come with an increased risk of a heart attack or stroke in the months after beginning treatment, a new study suggests.</field_page_description>
  <field_date_posted>2017-08-25</field_date_posted>
  <field_date_reviewed>2017-08-25</field_date_reviewed>
  <field_pretty_url>heart-attack-stroke-risk-cancer</field_pretty_url>
  <para_id>1093388</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1093791</term_id>
  <id>1093801</id>
  <title>Engineering Personalized Micro-Tumor Ecosystems</title>
  <langcode>en</langcode>
  <field_short_title>Engineering Micro-Tumor Ecosystems</field_short_title>
  <field_page_description>This study seeks to develop a micronized tumor ecosystem which can be used to choose the most effective cancer therapy for a patient before initiation of treatment.</field_page_description>
  <field_date_posted>2017-09-27</field_date_posted>
  <field_date_reviewed>2017-09-27</field_date_reviewed>
  <para_id>1093801</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1096918</term_id>
  <id>1096919</id>
  <title>TMIST (Tomosynthesis Mammographic Imaging Screening Trial)</title>
  <langcode>en</langcode>
  <field_short_title>TMIST (Tomosynthesis Mammographic Imaging Screening Trial)</field_short_title>
  <field_page_description>TMIST is a randomized breast screening trial that compares two Food and Drug Administration (FDA)-approved types of digital mammography, standard digital mammography (2-D) with a newer technology called tomosynthesis mammography (3-D).</field_page_description>
  <field_date_posted>2017-09-26</field_date_posted>
  <field_date_reviewed>2017-09-25</field_date_reviewed>
  <para_id>1096919</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1066360</term_id>
  <id>1097711</id>
  <title>Addressing the Global Burden of Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Addressing the Global Burden of Breast Cancer</field_short_title>
  <field_date_posted>2017-10-06</field_date_posted>
  <field_date_reviewed>2017-10-06</field_date_reviewed>
  <field_pretty_url>breast-cancer</field_pretty_url>
  <para_id>1097711</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>45782</term_id>
  <id>1097899</id>
  <title>Ofelia Olivero, Ph.D.</title>
  <langcode>en</langcode>
  <field_short_title>Ofelia Olivero, Ph.D.</field_short_title>
  <field_page_description>Read more about Intramural Diversity Workforce Branch Chief Ofelia Olivero, Ph.D.</field_page_description>
  <field_date_posted>2017-10-10</field_date_posted>
  <field_date_reviewed>2017-10-10</field_date_reviewed>
  <field_pretty_url>ofelia-olivero</field_pretty_url>
  <para_id>1097899</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1098454</term_id>
  <id>1098455</id>
  <title>2016 Outstanding Investigator Award Recipients</title>
  <langcode>en</langcode>
  <field_short_title>NCI Outstanding Investigator Award Recipients</field_short_title>
  <field_page_description>Learn how these investigators' projects aim to break new ground in biomedical, behavioral, and clinical cancer research.</field_page_description>
  <field_date_posted>2015-10-14</field_date_posted>
  <field_date_reviewed>2015-10-14</field_date_reviewed>
  <para_id>1098455</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1099364</term_id>
  <id>1099383</id>
  <title>Create an Adult Immunotherapy Network</title>
  <langcode>en</langcode>
  <field_short_title>Adult Immunotherapy Network</field_short_title>
  <field_page_description>This Cancer Moonshot initiative aims to establish an adult cancer immunotherapy network to develop immune-based approaches for the treatment and prevention of cancer in adult patients and discover why immunotherapy is effective in some patients but not in others. </field_page_description>
  <field_date_posted>2018-10-22</field_date_posted>
  <field_date_reviewed>2017-10-30</field_date_reviewed>
  <para_id>1099383</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1099367</term_id>
  <id>1099385</id>
  <title>Minimize Cancer Treatment’s Debilitating Side Effects</title>
  <langcode>en</langcode>
  <field_short_title>Symptom Management</field_short_title>
  <field_page_description>Cancer Moonshot initiative to develop a better system for monitoring and managing patient-reported side effects, in an effort to minimize debilitating side effects and reduce cancer costs related to poorly controlled symptoms.</field_page_description>
  <field_date_posted>2018-10-22</field_date_posted>
  <field_date_reviewed>2017-10-30</field_date_reviewed>
  <para_id>1099385</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1066360</term_id>
  <id>1100197</id>
  <title>Engaging Brazilian Partners in Collaborative Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Engaging Brazilian Partners in Collaborative Cancer Research</field_short_title>
  <field_date_posted>2017-11-14</field_date_posted>
  <field_date_reviewed>2017-11-14</field_date_reviewed>
  <field_pretty_url>brazil-visit</field_pretty_url>
  <para_id>1100197</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070074</term_id>
  <id>1100551</id>
  <title>Hope for a Rare Disease Through TCGA: My Perspective as a Caregiver, Patient Advocate, and Physician </title>
  <langcode>en</langcode>
  <field_short_title>Hope for a Rare Disease Through TCGA</field_short_title>
  <field_page_description>Faced with a rare disease, a caregiver founds a patient advocacy group and joins a collaborative genomic research effort.</field_page_description>
  <field_date_posted>2017-11-20</field_date_posted>
  <field_date_reviewed>2017-11-20</field_date_reviewed>
  <field_pretty_url>cure-om</field_pretty_url>
  <para_id>1100551</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>93513</id>
  <title>Drugs Approved for Testicular Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Testicular Cancer</field_short_title>
  <field_date_posted>2011-08-25</field_date_posted>
  <field_date_reviewed>2011-07-19</field_date_reviewed>
  <field_pretty_url>testicular</field_pretty_url>
  <para_id>93513</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>576429</id>
  <title>NIH scientists find link between allergic and autoimmune diseases in mouse study </title>
  <langcode>en</langcode>
  <field_short_title>Scientists find link between allergic and autoimmune diseases in mouse study </field_short_title>
  <field_page_description>Scientists at the National Institutes of Health, and their colleagues, have discovered that a gene called BACH2 may play a central role in the development of diverse allergic and autoimmune diseases, such as multiple sclerosis, asthma, Crohn's disease, ce</field_page_description>
  <field_date_posted>2013-06-02</field_date_posted>
  <field_date_reviewed>2013-05-24</field_date_reviewed>
  <field_pretty_url>BACH2</field_pretty_url>
  <para_id>576429</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>587450</id>
  <title>Reforms speed initiation of NCI-sponsored clinical trials</title>
  <langcode>en</langcode>
  <field_short_title>Reforms speed initiation of NCI-sponsored clinical trials</field_short_title>
  <field_page_description>The process of opening a cancer clinical trial for patient accrual often takes years, and research has shown that trials which are slow to register patients often fail to finish. Following a thorough review, NCI’s Operational Efficiency Working Group prod</field_page_description>
  <field_date_posted>2013-06-17</field_date_posted>
  <field_date_reviewed>2013-06-17</field_date_reviewed>
  <field_pretty_url>ReformNCItrials</field_pretty_url>
  <para_id>587450</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>637154</id>
  <title>Study in mice finds decreased glucose metabolism increases immune potential</title>
  <langcode>en</langcode>
  <field_short_title>Study in mice finds decreased glucose metabolism increases immune potential</field_short_title>
  <field_page_description>Regulating glucose metabolism in immune cells may extend and enhance their ability to fight cancer and infection.</field_page_description>
  <field_date_posted>2013-09-16</field_date_posted>
  <field_date_reviewed>2013-09-13</field_date_reviewed>
  <field_pretty_url>GlucoseMetabolismTCells</field_pretty_url>
  <para_id>637154</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>608323</term_id>
  <id>637652</id>
  <title>Harnessing the Power of Our Immune Systems to Treat Neuroblastoma: Discovery of Ch14.18 Immunotherapy </title>
  <langcode>en</langcode>
  <field_short_title>Ch14.18 Immunotherapy to Treat Neuroblastoma</field_short_title>
  <field_date_posted>2014-03-07</field_date_posted>
  <field_date_reviewed>2013-09-17</field_date_reviewed>
  <field_pretty_url>neuroblastoma</field_pretty_url>
  <para_id>637652</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938229</term_id>
  <id>637658</id>
  <title>Pomalidomide plus Low-Dose Dexamethasone Improves Survival for Patients with Multiple Myeloma </title>
  <langcode>en</langcode>
  <field_short_title>Pomalidomide for Multiple Myeloma</field_short_title>
  <field_page_description>A summary of results from a phase III trial that compared the combination of pomalidomide (Pomalyst®) and low-dose dexamethasone versus high-dose dexamethasone alone in patients with multiple myeloma that has progressed despite other treatments. </field_page_description>
  <field_date_posted>2013-09-19</field_date_posted>
  <field_date_reviewed>2013-09-19</field_date_reviewed>
  <field_pretty_url>pomalidomide-dexamethasone</field_pretty_url>
  <para_id>637658</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>676217</id>
  <title>Drugs Approved for Endometrial Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Endometrial Cancer</field_short_title>
  <field_date_posted>2013-12-06</field_date_posted>
  <field_date_reviewed>2013-12-06</field_date_reviewed>
  <field_pretty_url>endometrial</field_pretty_url>
  <para_id>676217</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>698539</id>
  <title>NCI launches trial to assess the utility of genetic sequencing to improve patient outcomes</title>
  <langcode>en</langcode>
  <field_short_title>Trial to assess the utility of genetic sequencing to improve patient outcomes</field_short_title>
  <field_page_description>A pilot trial to assess whether assigning treatment based on specific gene mutations can provide benefit to patients with metastatic solid tumors is being launched this month by the NCI.  The Molecular Profiling based Assignment of Cancer Therapeutics, or</field_page_description>
  <field_date_posted>2014-01-30</field_date_posted>
  <field_date_reviewed>2014-01-30</field_date_reviewed>
  <field_pretty_url>MPACTlaunch</field_pretty_url>
  <para_id>698539</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1026034</term_id>
  <id>1026786</id>
  <title>Hearings and Testimonies </title>
  <langcode>en</langcode>
  <field_short_title>Hearings &amp; Testimonies </field_short_title>
  <field_page_description>Written testimony from NCI experts from appropriations hearings and other hearings focused on cancer research and related topics.</field_page_description>
  <field_date_posted>2016-02-16</field_date_posted>
  <field_date_reviewed>2015-11-16</field_date_reviewed>
  <para_id>1026786</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1028126</id>
  <title>Patient with Brain Tumor Responds Dramatically to Targeted Therapy</title>
  <langcode>en</langcode>
  <field_short_title>Patient with Brain Tumor Responds Dramatically to Targeted Therapy</field_short_title>
  <field_date_posted>2015-12-03</field_date_posted>
  <field_date_reviewed>2015-12-01</field_date_reviewed>
  <field_pretty_url>brain-tumor-targeted-therapy</field_pretty_url>
  <para_id>1028126</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1026055</term_id>
  <id>1028164</id>
  <title>Legislative History</title>
  <langcode>en</langcode>
  <field_short_title>Legislative History</field_short_title>
  <field_date_posted>2016-02-16</field_date_posted>
  <field_date_reviewed>2015-12-02</field_date_reviewed>
  <para_id>1028164</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>937976</term_id>
  <id>1030185</id>
  <title>Treating Cancer without Harming the Heart</title>
  <langcode>en</langcode>
  <field_short_title>Treating Cancer without Harming the Heart</field_short_title>
  <field_page_description>Researchers from the fields of oncology and cardiology are working to find ways to prevent, manage, and possibly even reverse the cardiovascular side effects of certain cancer therapies.</field_page_description>
  <field_date_posted>2015-12-07</field_date_posted>
  <field_date_reviewed>2015-12-07</field_date_reviewed>
  <field_pretty_url>cardiotoxicity</field_pretty_url>
  <para_id>1030185</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1030601</id>
  <title>Precision Medicine Trials for Cancer: A New Era</title>
  <langcode>en</langcode>
  <field_short_title>Trials offer flexibility, efficiency, and potential for rapid advances.</field_short_title>
  <field_page_description>Advances in genomics, imaging, bioinformatics, and related disciplines, allow us to design smaller, quicker, and smarter trials that incorporate the principal tenets of precision medicine.</field_page_description>
  <field_date_posted>2015-12-10</field_date_posted>
  <field_date_reviewed>2015-12-10</field_date_reviewed>
  <field_pretty_url>precision-medicine-trials</field_pretty_url>
  <para_id>1030601</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1011700</term_id>
  <id>1033572</id>
  <title>Cancer Cell Biology Research</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Cell Biology Research</field_short_title>
  <field_page_description>Part of NCI's Division of Cancer Biology research portfolio, this research defines the biological basis for the differences between normal cells and cancer cells.</field_page_description>
  <field_date_posted>2016-08-08</field_date_posted>
  <field_date_reviewed>2016-01-06</field_date_reviewed>
  <para_id>1033572</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1034233</id>
  <title>Supporting Vice President Biden's Cancer Initiative</title>
  <langcode>en</langcode>
  <field_short_title>Supporting Vice President Biden’s Cancer Initiative</field_short_title>
  <field_page_description>A message from NCI Acting Director Doug Lowy on the Institute's readiness to work with partners on Vice President Biden's cancer research initiative.</field_page_description>
  <field_date_posted>2016-01-21</field_date_posted>
  <field_date_reviewed>2016-01-21</field_date_reviewed>
  <field_pretty_url>biden-cancer-initiative</field_pretty_url>
  <para_id>1034233</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1034471</id>
  <title>2016 Press Releases</title>
  <langcode>en</langcode>
  <field_short_title>2016 Press Releases</field_short_title>
  <field_page_description>Press releases from the National Cancer Institute for the year 2016.</field_page_description>
  <field_date_posted>2015-04-15</field_date_posted>
  <field_date_reviewed>2015-04-15</field_date_reviewed>
  <para_id>1034471</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1038935</term_id>
  <id>1038936</id>
  <title>Center for Research Strategy Contact and Staff</title>
  <langcode>en</langcode>
  <field_short_title>CRS Contact and Staff</field_short_title>
  <field_page_description>Staff and contact information for the Center for Research Strategy.</field_page_description>
  <field_date_posted>2016-03-29</field_date_posted>
  <field_date_reviewed>2016-03-02</field_date_reviewed>
  <para_id>1038936</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1041318</id>
  <title>Keeping Pace: How New Data Can Affect Ongoing Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>How New Data Can Affect Ongoing Clinical Trials</field_short_title>
  <field_page_description>Research results sometimes outrace the design of an ongoing clinical trial and the trial has to be recalibrated to include newer treatments, according to NCI’s Dr. Jo Anne Zujewski.</field_page_description>
  <field_date_posted>2016-03-16</field_date_posted>
  <field_date_reviewed>2016-03-14</field_date_reviewed>
  <field_pretty_url>recalibrating-clinical-trials</field_pretty_url>
  <para_id>1041318</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938223</term_id>
  <id>1041767</id>
  <title>Vaccine Therapy for Unresectable Chordoma</title>
  <langcode>en</langcode>
  <field_short_title>Vaccine Therapy for Unresectable Chordoma</field_short_title>
  <field_page_description>In this phase II clinical trial, adult patients with inoperable chordoma who are scheduled to undergo radiation therapy will be randomly assigned to receive a yeast-based vaccine that targets a protein called brachyury or a placebo injection.</field_page_description>
  <field_date_posted>2016-03-23</field_date_posted>
  <field_date_reviewed>2016-03-17</field_date_reviewed>
  <field_pretty_url>chordoma-vaccine-trial</field_pretty_url>
  <para_id>1041767</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1042135</term_id>
  <id>1042136</id>
  <title>Special Research Programs</title>
  <langcode>en</langcode>
  <field_short_title>DCB's Special Research Programs</field_short_title>
  <field_page_description>Research Programs from NCI's Division of Cancer Biology - PS-ON, CSBC, TMEN, OMF, BETRNet, KRAS, MCL, TEC</field_page_description>
  <field_date_posted>2016-08-08</field_date_posted>
  <field_date_reviewed>2016-03-25</field_date_reviewed>
  <para_id>1042136</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1045410</id>
  <title>Pembrolizumab Shows Promise in Patients with Rare Form of Skin Cancer </title>
  <langcode>en</langcode>
  <field_short_title>Immunotherapy Shows Promise against Rare Skin Cancer</field_short_title>
  <field_page_description>In a small clinical trial, more than half of the patients with an aggressive form of skin cancer called Merkel cell carcinoma responded to the immunotherapy drug pembrolizumab.</field_page_description>
  <field_date_posted>2016-04-19</field_date_posted>
  <field_date_reviewed>2016-04-18</field_date_reviewed>
  <field_pretty_url>pembrolizumab-merkel-cell</field_pretty_url>
  <para_id>1045410</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1047416</term_id>
  <id>1047417</id>
  <title>Diversity Career Development Program</title>
  <langcode>en</langcode>
  <field_short_title>Diversity Career Development Program</field_short_title>
  <field_date_posted>2016-05-19</field_date_posted>
  <field_date_reviewed>2016-04-27</field_date_reviewed>
  <para_id>1047417</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1048207</id>
  <title>Bringing global cancer leaders together at the 4th Annual Symposium on Global Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Bringing global cancer leaders together at the 4th Annual Symposium on Global Cancer Research</field_short_title>
  <field_date_posted>2016-05-09</field_date_posted>
  <field_date_reviewed>2016-05-09</field_date_reviewed>
  <field_pretty_url>symposium</field_pretty_url>
  <para_id>1048207</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1048482</id>
  <title>New Treatment Target Identified for Diffuse Large B-Cell Lymphoma</title>
  <langcode>en</langcode>
  <field_short_title>Study Identifies Potential Lymphoma Treatment Target</field_short_title>
  <field_page_description>NCI researchers have identified new therapeutic targets for diffuse large B-cell lymphoma. Drugs that hit these targets are under clinical development and the researchers hope to begin testing them in clinical trials of patients with DLBCL.</field_page_description>
  <field_date_posted>2016-05-13</field_date_posted>
  <field_date_reviewed>2016-05-13</field_date_reviewed>
  <field_pretty_url>dlbcl-smac-mimetics</field_pretty_url>
  <para_id>1048482</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1049998</id>
  <title>Improving Cancer Control in Rural Communities: An Interview with Dr. Robert Croyle</title>
  <langcode>en</langcode>
  <field_short_title>Improving Cancer Control in Rural Communities</field_short_title>
  <field_page_description>NCI’s Dr. Robert Croyle discusses some of the issues related to cancer control faced by rural communities and how NCI is approaching this important problem.</field_page_description>
  <field_date_posted>2016-05-18</field_date_posted>
  <field_date_reviewed>2016-05-18</field_date_reviewed>
  <field_pretty_url>cancer-control-rural</field_pretty_url>
  <para_id>1049998</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1050940</id>
  <title>Charting a Course toward Precision Cancer Prevention</title>
  <langcode>en</langcode>
  <field_short_title>Charting a Course toward Precision Cancer Prevention</field_short_title>
  <field_page_description>Cancer researchers are increasingly exploring how cancer risk is influenced by genetic predisposition to cancer and the effects of environmental exposures, and what this means for cancer prevention.</field_page_description>
  <field_date_posted>2016-05-26</field_date_posted>
  <field_date_reviewed>2016-05-23</field_date_reviewed>
  <field_pretty_url>precision-prevention-chanock</field_pretty_url>
  <para_id>1050940</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1051834</id>
  <title>FDA Approves First Immunotherapy for Lymphoma</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves First Immunotherapy for Lymphoma</field_short_title>
  <field_page_description>The FDA has approved nivolumab (Opdivo®) for the treatment of patients with classical Hodgkin lymphoma whose disease has relapsed or worsened after receiving an autologous hematopoietic stem cell transplantation followed by brentuximab vedotin (Adcetris®)</field_page_description>
  <field_date_posted>2016-05-31</field_date_posted>
  <field_date_reviewed>2016-05-31</field_date_reviewed>
  <field_pretty_url>fda-nivolumab-lymphoma</field_pretty_url>
  <para_id>1051834</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1052076</id>
  <title>FDA Approves New Immunotherapy Drug for Bladder Cancer </title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Atezolizumab for Bladder Cancer</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on the FDA approval of atezolizumab (Tecentriq®) for the treatment of patients with the most common type of bladder cancer.</field_page_description>
  <field_date_posted>2016-06-07</field_date_posted>
  <field_date_reviewed>2016-06-06</field_date_reviewed>
  <field_pretty_url>fda-atezolizumab-bladder</field_pretty_url>
  <para_id>1052076</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1052101</id>
  <title>Trials Produce Practice-Changing Results for Brain Cancer </title>
  <langcode>en</langcode>
  <field_short_title>Trials Produce Practice-Changing Results for Brain Cancer</field_short_title>
  <field_page_description>An NCI Cancer Currents blog about two clinical trials that showed treatment with temozolomide plus radiation increased overall and progression-free survival.</field_page_description>
  <field_date_posted>2016-06-09</field_date_posted>
  <field_date_reviewed>2016-06-07</field_date_reviewed>
  <field_pretty_url>asco-temozolomide-brain</field_pretty_url>
  <para_id>1052101</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>988383</term_id>
  <id>1052650</id>
  <title>Division of Cancer Biology Research Portfolio</title>
  <langcode>en</langcode>
  <field_short_title>DCB Research Portfolio</field_short_title>
  <field_page_description>Explore the broad range of investigator-initiated research and programs funded by the Division of Cancer Biology (DCB) to advance existing and emerging research areas in cancer biology.</field_page_description>
  <field_date_posted>2016-08-08</field_date_posted>
  <field_date_reviewed>2016-06-16</field_date_reviewed>
  <para_id>1052650</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>105038</id>
  <title>Drugs Approved for Vaginal Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Vaginal Cancer</field_short_title>
  <field_date_posted>2011-10-25</field_date_posted>
  <field_date_reviewed>2011-08-16</field_date_reviewed>
  <field_pretty_url>vaginal</field_pretty_url>
  <para_id>105038</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>777640</term_id>
  <id>777641</id>
  <title>NCI Summer Curriculum in Cancer Prevention - Additional Lectures for International Participants</title>
  <langcode>en</langcode>
  <field_short_title>NCI Summer Curriculum in Cancer Prevention - Additional Lectures for International Participants</field_short_title>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2013-07-22</field_date_reviewed>
  <para_id>777641</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>792795</term_id>
  <id>791265</id>
  <title>NCI Congressional Justification</title>
  <langcode>en</langcode>
  <field_short_title>NCI Congressional Justification</field_short_title>
  <field_page_description>The NCI budget Congressional Justification is prepared to justify the President's annual budget request to Congress. View and download the 2018 Congressional Justification.</field_page_description>
  <field_date_posted>2014-12-21</field_date_posted>
  <field_date_reviewed>2014-06-13</field_date_reviewed>
  <para_id>791265</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>799307</term_id>
  <id>799373</id>
  <title>RAS Target Identification at FNLCR</title>
  <langcode>en</langcode>
  <field_short_title>RAS Target Identification</field_short_title>
  <field_page_description>Discover the cutting edge technologies being used to better define target vulnerabilities in RAS proteins and pathways essential to cancer cells.</field_page_description>
  <field_date_posted>2014-09-22</field_date_posted>
  <field_date_reviewed>2014-06-30</field_date_reviewed>
  <para_id>799373</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogSeries</CONTENTTYPENAME>
  <term_id>799459</term_id>
  <id>799464</id>
  <title>RAS Dialogue</title>
  <langcode>en</langcode>
  <field_short_title>RAS Dialogue</field_short_title>
  <field_date_posted>2014-06-30</field_date_posted>
  <field_date_reviewed>2014-06-30</field_date_reviewed>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>917268</term_id>
  <id>800098</id>
  <title>The NCI Outstanding Investigator Award (R35)</title>
  <langcode>en</langcode>
  <field_short_title>Outstanding Investigator Award</field_short_title>
  <field_date_posted>2014-07-02</field_date_posted>
  <field_date_reviewed>2014-07-02</field_date_reviewed>
  <para_id>800098</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>804905</id>
  <title>Researchers report first large-scale integrated proteomic and genomic analysis of a human cancer: &lt;span style="font-weight:normal"&gt;&lt;i&gt;Identification of new molecular features of colorectal cancer&lt;/i&gt;&lt;/span&gt;</title>
  <langcode>en</langcode>
  <field_short_title>Integrated proteomic and genomic analysis of colorectal cancer</field_short_title>
  <field_page_description>Investigators who analyzed 95 human colorectal tumor samples have determined how gene alterations identified in previous analyses of the same samples are expressed at the protein level. The integration of proteomic and genomic data, or proteogenomics, pro</field_page_description>
  <field_date_posted>2014-07-21</field_date_posted>
  <field_date_reviewed>2014-07-16</field_date_reviewed>
  <field_pretty_url>ProteogenomicAnalysis</field_pretty_url>
  <para_id>804905</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>763331</term_id>
  <id>814107</id>
  <title>Understanding Cervical Changes: Next Steps After an Abnormal Screening Test</title>
  <langcode>en</langcode>
  <field_short_title>Understanding Cervical Changes</field_short_title>
  <field_page_description>Explains abnormal Pap test, HPV test, and Pap/HPV cotest results. Treatment and follow-up care for abnormal cervical cancer screening results including ASC-US, AGC, LSIL, ASC-H, HSIL, AIS. Learn about colposcopy, types of biopsies, CIN, and HPV vaccine.</field_page_description>
  <field_date_posted>2014-01-16</field_date_posted>
  <field_date_reviewed>2014-01-16</field_date_reviewed>
  <para_id>814107</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>911288</term_id>
  <id>814466</id>
  <title>Targeted Therapy to Treat Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Targeted Therapy</field_short_title>
  <field_page_description>Targeted therapy is a type of cancer treatment that targets the changes in cancer cells that help them grow, divide, and spread. Learn how targeted therapy works against cancer and about side effects that may occur.</field_page_description>
  <field_date_posted>2014-08-15</field_date_posted>
  <field_date_reviewed>2014-08-14</field_date_reviewed>
  <para_id>814466</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>814538</id>
  <title>NIH announces the launch of 3 integrated precision medicine trials; &lt;span style="font-weight:normal"&gt;&lt;i&gt;ALCHEMIST is for patients with certain types of early-stage lung cancer&lt;/i&gt;&lt;/span&gt;</title>
  <langcode>en</langcode>
  <field_short_title>NIH announces the launch of 3 integrated precision medicine trials: ALCHEMIST </field_short_title>
  <field_page_description>The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials, or ALCHEMIST, will identify early-stage lung cancer patients with tumors that harbor certain uncommon genetic changes and evaluate whether drug treatments targeted against </field_page_description>
  <field_date_posted>2014-08-18</field_date_posted>
  <field_date_reviewed>2014-08-14</field_date_reviewed>
  <field_pretty_url>ALCHEMISTlaunch</field_pretty_url>
  <para_id>814538</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938350</term_id>
  <id>826428</id>
  <title>Monoclonal Antibody Therapy for Relapsed or Treatment-Resistant Neuroblastoma</title>
  <langcode>en</langcode>
  <field_short_title>Monoclonal Antibody Therapy for Relapsed or Treatment-Resistant Neuroblastoma</field_short_title>
  <field_page_description>NCI is sponsoring two clinical trials of a monoclonal antibody called ch14.18, in combination with other drugs, to see if the antibody may be helpful for children or young adults (up to age 21) with relapsed or refractory neuroblastoma.</field_page_description>
  <field_date_posted>2014-09-09</field_date_posted>
  <field_date_reviewed>2014-09-08</field_date_reviewed>
  <field_pretty_url>2-studies-mab</field_pretty_url>
  <para_id>826428</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>793147</id>
  <title>Study finds stronger nicotine dependency associated with higher risk of lung cancer</title>
  <langcode>en</langcode>
  <field_short_title>Study finds stronger nicotine dependency associated with higher risk of lung cancer </field_short_title>
  <field_page_description>NCI headed study finds people who are highly addicted to nicotine -- those who smoke their first cigarette within five minutes after awakening -- are at higher risk of developing lung cancer than those who wait for an hour or more to smoke.</field_page_description>
  <field_date_posted>2014-06-19</field_date_posted>
  <field_date_reviewed>2014-06-18</field_date_reviewed>
  <field_pretty_url>SmokingLungCancer</field_pretty_url>
  <para_id>793147</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069528</term_id>
  <id>799467</id>
  <title>A Message from Dr. Frank McCormick</title>
  <langcode>en</langcode>
  <field_short_title>A Message from Dr. Frank McCormick</field_short_title>
  <field_date_posted>2014-09-22</field_date_posted>
  <field_date_reviewed>2014-06-30</field_date_reviewed>
  <field_pretty_url>mccormick-message</field_pretty_url>
  <para_id>799467</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919531</term_id>
  <id>799547</id>
  <title>RAS Meetings and Videos</title>
  <langcode>en</langcode>
  <field_short_title>Meetings &amp; Videos</field_short_title>
  <field_page_description>Find upcoming RAS-related workshops, seminars, and conferences and previously recorded webcasts of such events.</field_page_description>
  <field_date_posted>2015-02-06</field_date_posted>
  <field_date_reviewed>2014-06-30</field_date_reviewed>
  <para_id>799547</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>917270</term_id>
  <id>804860</id>
  <title>NCI Outstanding Investigator Award (R35) Frequently Asked Questions</title>
  <langcode>en</langcode>
  <field_short_title>FAQs</field_short_title>
  <field_date_posted>2014-07-15</field_date_posted>
  <field_date_reviewed>2014-07-15</field_date_reviewed>
  <para_id>804860</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919505</term_id>
  <id>805068</id>
  <title>Contact the Office of Budget and Finance</title>
  <langcode>en</langcode>
  <field_short_title>Contact OBF</field_short_title>
  <field_page_description>Address and phone number for NCI's Office of Budget and Finance.</field_page_description>
  <field_date_posted>2014-12-21</field_date_posted>
  <field_date_reviewed>2014-07-17</field_date_reviewed>
  <para_id>805068</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>816960</term_id>
  <id>817099</id>
  <title>RAS Structural Biology</title>
  <langcode>en</langcode>
  <field_short_title>RAS Structural Biology</field_short_title>
  <field_page_description>The RAS Structural Biology group determines the structures of RAS proteins, alone and in complex with important effectors.</field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2014-08-20</field_date_reviewed>
  <para_id>817099</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>937976</term_id>
  <id>822283</id>
  <title>Preserving Fertility while Battling Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Preserving Fertility while Battling Cancer</field_short_title>
  <field_date_posted>2011-01-11</field_date_posted>
  <field_date_reviewed>2014-09-04</field_date_reviewed>
  <field_pretty_url>fertility-preservation</field_pretty_url>
  <para_id>822283</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>828581</term_id>
  <id>828647</id>
  <title>Meetings &amp; Events</title>
  <langcode>en</langcode>
  <field_short_title>Meetings &amp; Events</field_short_title>
  <field_page_description>Upcoming meetings and events NCI CRCHD may attend as well as select resources from recent past meetings and events.</field_page_description>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-09-17</field_date_reviewed>
  <para_id>828647</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>904113</term_id>
  <id>828648</id>
  <title>CRCHD Programs &amp; Initiatives</title>
  <langcode>en</langcode>
  <field_short_title>Programs &amp; Initiatives</field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-09-17</field_date_reviewed>
  <para_id>828648</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>828700</id>
  <title>Grantee Spotlight: Harold "Bo" Netwon Lovvorn, III, M.D. - Molecular Analysis of Ethnic Variations in Wilms tumor</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Dr. Harold "Bow" Netwon Lovvorn</field_short_title>
  <field_date_posted>2014-09-18</field_date_posted>
  <field_date_reviewed>2014-09-18</field_date_reviewed>
  <field_pretty_url>lovvorn-spotlight</field_pretty_url>
  <para_id>828700</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>833177</term_id>
  <id>833185</id>
  <title>Community Networks Program Centers (CNPC)</title>
  <langcode>en</langcode>
  <field_short_title>Community Networks Program Centers (CNPC)</field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-09-24</field_date_reviewed>
  <para_id>833185</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938103</term_id>
  <id>836262</id>
  <title>Rituximab Retreatment after Disease Progression Is Comparable to Rituximab Maintenance Therapy in Patients with Low-Tumor Burden Follicular Lymphoma </title>
  <langcode>en</langcode>
  <field_short_title>Rituximab Retreatment for Low-Tumor Burden Follicular Lymphoma</field_short_title>
  <field_page_description>A summary of results from a randomized clinical trial of patients with low–tumor burden follicular lymphoma that compared maintenance therapy with rituximab versus retreatment with rituximab only when there was evidence of disease progression.</field_page_description>
  <field_date_posted>2014-10-02</field_date_posted>
  <field_date_reviewed>2014-10-02</field_date_reviewed>
  <field_pretty_url>rituximab-retreatment-follicular</field_pretty_url>
  <para_id>836262</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>836324</id>
  <title>Caring for the Caregiver</title>
  <langcode>en</langcode>
  <field_short_title>Caring for the Caregiver</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2014-10-02</field_date_reviewed>
  <field_pretty_url>caring-for-the-caregiver</field_pretty_url>
  <para_id>836324</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>837579</id>
  <title>NCI scientists awarded National Medal of Technology and Innovation by President Obama</title>
  <langcode>en</langcode>
  <field_short_title>NCI scientists awarded National Medal of Technology and Innovation </field_short_title>
  <field_page_description>President Obama announced that two NCI scientists would be recipients of the National Medal of Technology and Innovation -- the nation's highest honor for technological achievement. The honorees, John Schiller, Ph.D., Laboratory of Cellular Oncology (LCO)</field_page_description>
  <field_date_posted>2014-10-07</field_date_posted>
  <field_date_reviewed>2014-10-07</field_date_reviewed>
  <field_pretty_url>NationalMedalTechnologyLowySchiller</field_pretty_url>
  <para_id>837579</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>842607</id>
  <title>TCGA study improves understanding of genetic drivers of thyroid cancer</title>
  <langcode>en</langcode>
  <field_short_title>TCGA study improves understanding of genetic drivers of thyroid cancer</field_short_title>
  <field_page_description>A comprehensive analysis of the genomes of nearly 500 papillary thyroid carcinomas (PTC) – the most common form of thyroid cancer – has provided new insights into the roles of frequently mutated cancer genes and other genomic alterations that drive diseas</field_page_description>
  <field_date_posted>2014-10-23</field_date_posted>
  <field_date_reviewed>2014-10-21</field_date_reviewed>
  <field_pretty_url>TCGAthyroidNewsNote</field_pretty_url>
  <para_id>842607</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>848686</id>
  <title>The Mexican President, NCI’s Dr. Varmus, and Cancer Control in Mexico</title>
  <langcode>en</langcode>
  <field_short_title>The Mexican President, NCI’s Dr. Varmus, and Cancer Control in Mexico</field_short_title>
  <field_date_posted>2014-10-29</field_date_posted>
  <field_date_reviewed>2014-10-29</field_date_reviewed>
  <field_pretty_url>mexican-president</field_pretty_url>
  <para_id>848686</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>849032</term_id>
  <id>849033</id>
  <title>Basic and Translational Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Basic and Translational Cancer Research</field_short_title>
  <field_page_description>CRCHD supports basic and translational research funding opportunities to increase our scientific knowledge and ultimately reduce cancer health disparities. </field_page_description>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-10-30</field_date_reviewed>
  <para_id>849033</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>12362</term_id>
  <id>857613</id>
  <title>Help Finding NCI-Supported Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>Help Finding NCI-Supported Clinical Trials</field_short_title>
  <field_date_posted>2014-11-13</field_date_posted>
  <field_date_reviewed>2014-11-13</field_date_reviewed>
  <para_id>857613</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>858183</term_id>
  <id>859781</id>
  <title>Family Issues after Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Family Issues</field_short_title>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-17</field_date_reviewed>
  <para_id>859781</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>858193</term_id>
  <id>859988</id>
  <title>Caregiving after Treatment Ends</title>
  <langcode>en</langcode>
  <field_short_title>Caregiving After Treatment Ends</field_short_title>
  <field_page_description>Even when treatment ends, both cancer survivors and caregivers are still dealing with a lot. Find information to help you understand and cope with the transition after cancer treatment. </field_page_description>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-18</field_date_reviewed>
  <para_id>859988</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>860631</term_id>
  <id>860657</id>
  <title>Support for Teens When a Family Member has Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Support for Teens When a Family Member has Cancer</field_short_title>
  <field_page_description>When a parent, brother, or sister has been diagnosed with cancer, family members need extra support. Information to help teens learn how to cope, talk with family members, manage stress, and get support from counselors when a loved one has been diagnosed with, or is being treated for, cancer.</field_page_description>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2017-10-20</field_date_reviewed>
  <para_id>860657</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>861405</id>
  <title>Multiple biopsies are superior to a single biopsy in detecting cervical cancer precursors</title>
  <langcode>en</langcode>
  <field_short_title>Multiple biopsies superior to single biopsy in detecting cervical cancer precursors</field_short_title>
  <field_page_description>Performing multiple biopsies during a procedure known as colposcopy—visual inspection of the cervix—is more effective than performing only a single biopsy of the worst-appearing area for detecting cervical cancer precursors. This multiple biopsy approach </field_page_description>
  <field_date_posted>2014-11-24</field_date_posted>
  <field_date_reviewed>2014-11-24</field_date_reviewed>
  <field_pretty_url>MultipleColposcopyJCO</field_pretty_url>
  <para_id>861405</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>881600</id>
  <title>Promoting Cancer Control in Indonesia</title>
  <langcode>en</langcode>
  <field_short_title>Promoting Cancer Control in Indonesia</field_short_title>
  <field_date_posted>2014-12-15</field_date_posted>
  <field_date_reviewed>2014-12-15</field_date_reviewed>
  <field_pretty_url>promoting-cancer-control-in-indonesia</field_pretty_url>
  <para_id>881600</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>916480</term_id>
  <id>882436</id>
  <title>Nickel Compounds</title>
  <langcode>en</langcode>
  <field_short_title>Nickel Compounds</field_short_title>
  <field_page_description>Learn about nickel compounds, which can raise your risk of lung cancer and nasal cancer. Workers in mining, smelting, welding, and other industrial occupations are most commonly exposed to nickel.  </field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2019-02-15</field_date_reviewed>
  <para_id>882436</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>916476</term_id>
  <id>882439</id>
  <title>Indoor Emissions from the Household Combustion of Coal</title>
  <langcode>en</langcode>
  <field_short_title>Indoor Emissions from the Household Combustion of Coal</field_short_title>
  <field_page_description>Learn about the lung cancer risk associated with burning coal inside your home. Indoor emissions from the household combustion of coal contain harmful chemicals such as benzene, carbon monoxide, and formaldehyde. </field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2019-02-15</field_date_reviewed>
  <para_id>882439</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>882633</term_id>
  <id>882634</id>
  <title>Cadmium</title>
  <langcode>en</langcode>
  <field_short_title>Cadmium</field_short_title>
  <field_page_description>Learn about cadmium, which may raise your risk of lung cancer. Cadmium is a natural element: all soils and rocks contain some cadmium. Exposure occurs mostly where cadmium products (such as batteries, pigments, metal coatings, and plastics) are made or recycled. Tobacco smoke also contains cadmium.  </field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2019-02-01</field_date_reviewed>
  <para_id>882634</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>861456</term_id>
  <id>883849</id>
  <title>Causes and Prevention</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Causes and Prevention</field_short_title>
  <field_page_description>Covers known cancer risk factors, how certain cancers can be prevented, and ongoing research into causes and prevention.</field_page_description>
  <field_date_posted>2014-12-17</field_date_posted>
  <field_date_reviewed>2014-12-17</field_date_reviewed>
  <para_id>883849</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>826715</id>
  <title>New genetic risk variants identified in multiethnic analysis of prostate cancer</title>
  <langcode>en</langcode>
  <field_short_title>New genetic variants associated with prostate cancer </field_short_title>
  <field_page_description>Researchers have newly identified 23 common genetic variants -- one-letter changes in DNA known as single-nucleotide polymorphisms or SNPs -- that are associated with risk of prostate cancer. These results come from an analysis of more than 10 million SNP</field_page_description>
  <field_date_posted>2014-09-14</field_date_posted>
  <field_date_reviewed>2014-09-12</field_date_reviewed>
  <field_pretty_url>GeneticRiskProstate</field_pretty_url>
  <para_id>826715</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogSeries</CONTENTTYPENAME>
  <term_id>919767</term_id>
  <id>828591</id>
  <title>CRCHD Dialogue on Disparities</title>
  <langcode>en</langcode>
  <field_short_title>Dialogue on Disparities</field_short_title>
  <field_page_description>Blog from CRCHD. Stay up-to-date with cancer health disparities issues and read CRCHD spotlights on promising research findings and program updates.</field_page_description>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-09-17</field_date_reviewed>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>828650</term_id>
  <id>828697</id>
  <title>About Cancer Health Disparities</title>
  <langcode>en</langcode>
  <field_short_title>About Cancer Health Disparities</field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-09-18</field_date_reviewed>
  <para_id>828697</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>833172</term_id>
  <id>833173</id>
  <title>Disparities Research</title>
  <langcode>en</langcode>
  <field_short_title>Disparities Research</field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-09-24</field_date_reviewed>
  <para_id>833173</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>836316</id>
  <title>Providing Your Tissue for Research: What You Need To Know</title>
  <langcode>en</langcode>
  <field_short_title>Providing Your Tissue for Research: What You Need To Know</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2014-10-02</field_date_reviewed>
  <field_pretty_url>providing-tissue</field_pretty_url>
  <para_id>836316</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>836754</id>
  <title>Understanding Prostate Changes: A Health Guide for Men</title>
  <langcode>en</langcode>
  <field_short_title>Understanding Prostate Changes: A Health Guide for Men</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2014-10-03</field_date_reviewed>
  <field_pretty_url>understanding-prostate-changes</field_pretty_url>
  <para_id>836754</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>126781</id>
  <title>Chemotherapy Less Toxic to the Heart May Be Option for Some Women with HER2-Positive Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Chemotherapy Less Toxic to the Heart May Be Option for Some Women with HER2-Positive Breast Cancer</field_short_title>
  <field_page_description>A nonanthracycline-containing chemotherapy regimen combined with the targeted therapy trastuzumab may be an option for some women with HER2-positive breast cancer, according to results from the BCIRG-006 trial.</field_page_description>
  <field_date_posted>2011-11-03</field_date_posted>
  <field_date_reviewed>2011-11-03</field_date_reviewed>
  <field_pretty_url>less-heart-toxic-regimen</field_pretty_url>
  <para_id>126781</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>849741</id>
  <title>CURE Scholar Spotlight - Dr. Donita Colette Brady</title>
  <langcode>en</langcode>
  <field_short_title>CURE Scholar Spotlight - Dr. Brady</field_short_title>
  <field_date_posted>2014-08-21</field_date_posted>
  <field_date_reviewed>2014-10-30</field_date_reviewed>
  <field_pretty_url>brady-spotlight</field_pretty_url>
  <para_id>849741</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915609</term_id>
  <id>850495</id>
  <title>Tackling Cancer Health Disparities: Small Steps, Big Hopes</title>
  <langcode>en</langcode>
  <field_short_title>Tackling Cancer Health Disparities</field_short_title>
  <field_page_description>An article about steps for developing and testing ways to reduce—or eliminate—cancer-related health disparities.</field_page_description>
  <field_date_posted>2014-11-03</field_date_posted>
  <field_date_reviewed>2014-10-31</field_date_reviewed>
  <field_pretty_url>health-disparity-studies</field_pretty_url>
  <para_id>850495</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>857168</id>
  <title>National Cancer Institute’s New NCD Coordinator</title>
  <langcode>en</langcode>
  <field_short_title>National Cancer Institute’s New NCD Coordinator</field_short_title>
  <field_date_posted>2014-11-12</field_date_posted>
  <field_date_reviewed>2014-11-12</field_date_reviewed>
  <field_pretty_url>ncd-new-coordinator</field_pretty_url>
  <para_id>857168</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>858166</term_id>
  <id>859567</id>
  <title>Talking to Children about Your Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Talking to Children</field_short_title>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-17</field_date_reviewed>
  <para_id>859567</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>858181</term_id>
  <id>859665</id>
  <title>Follow-Up Medical Care</title>
  <langcode>en</langcode>
  <field_short_title>Follow-Up Medical Care</field_short_title>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-17</field_date_reviewed>
  <para_id>859665</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>858185</term_id>
  <id>859757</id>
  <title>Late Side Effects of Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Late Side Effects</field_short_title>
  <field_page_description>Cancer treatment can cause late side effects that may not show up for months or years after treatment. These late effects may include heart and lung problems, bone loss, eye and hearing changes,  lymphedema, and other problems</field_page_description>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-17</field_date_reviewed>
  <para_id>859757</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>10962</term_id>
  <id>860046</id>
  <title>The Cancer Information Service (CIS)</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Information Service (CIS)</field_short_title>
  <field_date_posted>2014-11-18</field_date_posted>
  <field_date_reviewed>2014-11-18</field_date_reviewed>
  <para_id>860046</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>903754</term_id>
  <id>860491</id>
  <title>Understanding Cancer Prognosis</title>
  <langcode>en</langcode>
  <field_short_title>Prognosis</field_short_title>
  <field_date_posted>2014-11-24</field_date_posted>
  <field_date_reviewed>2018-08-29</field_date_reviewed>
  <para_id>860491</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>861460</term_id>
  <id>867268</id>
  <title>State and County Exposure Levels to I-131</title>
  <langcode>en</langcode>
  <field_short_title>State and County Exposure Levels to I-131</field_short_title>
  <field_page_description>Estimated average exposures to I-131 (iodine-131) for individuals living in the contiguous United States at the time of the Cold War, listed by state and county.</field_page_description>
  <field_date_posted>2003-08-01</field_date_posted>
  <field_date_reviewed>2014-12-04</field_date_reviewed>
  <field_pretty_url>stateandcountyexposure</field_pretty_url>
  <para_id>867268</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>882283</term_id>
  <id>882315</id>
  <title>Wood Dust </title>
  <langcode>en</langcode>
  <field_short_title>Wood Dust </field_short_title>
  <field_page_description>Learn about wood dust, which can raise the risk of cancers of the paranasal sinuses and nasal cavity. High amounts of wood dust are produced in sawmills, and in the furniture-making, cabinet-making, and carpentry industries.</field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2018-12-28</field_date_reviewed>
  <para_id>882315</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>917510</term_id>
  <id>882379</id>
  <title>Soot</title>
  <langcode>en</langcode>
  <field_short_title>Soot</field_short_title>
  <field_page_description>Learn about soot, which can raise the risk of scrotal and other skin cancers, as well as lung, esophageal, and bladder cancers. Soot is a byproduct of the burning of carbon-containing materials, such as wood, fuel oil, plastics, and household refuse. Chimney sweeps face the highest risk.</field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2014-12-15</field_date_reviewed>
  <para_id>882379</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>882543</term_id>
  <id>882591</id>
  <title>Erionite</title>
  <langcode>en</langcode>
  <field_short_title>Erionite</field_short_title>
  <field_page_description>Learn about erionite, which can raise your risk of lung cancer and mesothelioma. Erionite is a a naturally occurring fibrous mineral. Erionite-related disease has been reported most often among road construction and maintenance workers.</field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2019-02-13</field_date_reviewed>
  <para_id>882591</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>904458</term_id>
  <id>882610</id>
  <title>Benzidine</title>
  <langcode>en</langcode>
  <field_short_title>Benzidine</field_short_title>
  <field_page_description>Learn about benzidine, exposure to which raises your risk of bladder cancer. Benzidine is a manufactured chemical. In the past, benzidine was used to produce dyes or products used in clinical laboratories. However, benzidine has not been sold in the United States since the mid-1970s.</field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2019-01-31</field_date_reviewed>
  <para_id>882610</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>892292</id>
  <title>Report Offers Comprehensive Look at Global Smokeless Tobacco Use</title>
  <langcode>en</langcode>
  <field_short_title>Comprehensive Look at Global Smokeless Tobacco Use Report</field_short_title>
  <field_page_description>The first report of its kind finds that more than 300 million people worldwide use smokeless tobacco products and that they are linked to a number of cancers.</field_page_description>
  <field_date_posted>2015-01-07</field_date_posted>
  <field_date_reviewed>2015-01-07</field_date_reviewed>
  <field_pretty_url>smokeless-tobacco-report</field_pretty_url>
  <para_id>892292</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938229</term_id>
  <id>892451</id>
  <title>Three-Drug Combination Benefits Some Patients with Relapsed Multiple Myeloma </title>
  <langcode>en</langcode>
  <field_short_title>Three-Drug Combination for Relapsed Multiple Myeloma</field_short_title>
  <field_page_description>A summary of Interim results from an international, randomized phase III trial that suggest that adding carfilzomib (Kyprolis®) to a standard treatment improves outcomes for patients with multiple myeloma whose cancer has relapsed.</field_page_description>
  <field_date_posted>2015-01-09</field_date_posted>
  <field_date_reviewed>2015-01-09</field_date_reviewed>
  <field_pretty_url>carfilzomib-lenalidomide-dexamethasone</field_pretty_url>
  <para_id>892451</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>894092</id>
  <title>Implementation Research Workshop in Argentina: Moving Research into Practice</title>
  <langcode>en</langcode>
  <field_short_title>Implementation Research Workshop in Argentina: Moving Research into Practice</field_short_title>
  <field_date_posted>2015-01-12</field_date_posted>
  <field_date_reviewed>2015-01-12</field_date_reviewed>
  <field_pretty_url>implementation-research-workshop</field_pretty_url>
  <para_id>894092</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>899477</id>
  <title>Program Spotlight: University of Puerto Rico and MD Anderson Partnership Welcomes Its First Graduates, Dedicated to Researching Cancer Health Disparities</title>
  <langcode>en</langcode>
  <field_short_title>Program Spotlight: UPR and MD Anderson Partnership Welcomes Its First Graduates</field_short_title>
  <field_date_posted>2014-10-01</field_date_posted>
  <field_date_reviewed>2014-10-01</field_date_reviewed>
  <field_pretty_url>uprmda-spotlight</field_pretty_url>
  <para_id>899477</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>899478</id>
  <title>Strengthening National Cancer Planning Efforts and Building on 20 Years of US-Vietnam Relations</title>
  <langcode>en</langcode>
  <field_short_title>Strengthening National Cancer Planning Efforts and Building on 20 Years of US-Vietnam Relations</field_short_title>
  <field_date_posted>2015-01-23</field_date_posted>
  <field_date_reviewed>2015-01-23</field_date_reviewed>
  <field_pretty_url>strengthening-us-vietnan-relations</field_pretty_url>
  <para_id>899478</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919353</term_id>
  <id>901342</id>
  <title>Head and Neck Cancer International Group (HNCIG)</title>
  <langcode>en</langcode>
  <field_short_title>Head and Neck International Group (HNIG)</field_short_title>
  <field_date_posted>2015-01-28</field_date_posted>
  <field_date_reviewed>2015-01-28</field_date_reviewed>
  <field_pretty_url>hncig</field_pretty_url>
  <para_id>901342</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>899934</term_id>
  <id>901824</id>
  <title>Mouth and Throat Problems during Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Mouth and Throat Problems</field_short_title>
  <field_page_description>Cancer treatments may cause dental, mouth, and throat side effects such as changes in taste (dysgeusia), dry mouth (xerostomia), infections, mouth sores, pain or swelling in your mouth (oral mucositis), sensitivity to foods, and swallowing problems.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2018-05-03</field_date_reviewed>
  <para_id>901824</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>860262</term_id>
  <id>883852</id>
  <title>Which Patients Will Benefit from Immunotherapy for Cancer? Some Hints Emerge</title>
  <langcode>en</langcode>
  <field_short_title>Who Will Benefit from Cancer Immunotherapy?</field_short_title>
  <field_page_description>Researchers have identified a “genetic signature” in the tumors of patients with advanced melanoma who responded to a form of immunotherapy called checkpoint blockade. The results could be the basis for a test that identifies likely responders.</field_page_description>
  <field_date_posted>2014-12-17</field_date_posted>
  <field_date_reviewed>2014-12-17</field_date_reviewed>
  <field_pretty_url>who-responds-immunotherapy</field_pretty_url>
  <para_id>883852</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>11828</term_id>
  <id>884327</id>
  <title>Understanding Prostate Changes: A Health Guide for Men</title>
  <langcode>en</langcode>
  <field_short_title>Understanding Prostate Changes</field_short_title>
  <field_page_description>Prostate changes and symptoms that are not cancer. Learn about symptoms, risk factors, and treatment for prostatitis, enlarged prostate (BPH), prostate cancer. Talk with doctor about prostate cancer screening tests (DRE, PSA), biopsy, and Gleason score.</field_page_description>
  <field_date_posted>2014-12-18</field_date_posted>
  <field_date_reviewed>2014-12-18</field_date_reviewed>
  <para_id>884327</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>890966</id>
  <title>New on Cancer.gov: Resources on Melanoma Therapies</title>
  <langcode>en</langcode>
  <field_short_title>New Resources on Melanoma Therapies</field_short_title>
  <field_page_description>A blog post about several new Cancer.gov resources that provide details about the changing treatment landscape for advanced melanoma.</field_page_description>
  <field_date_posted>2015-01-06</field_date_posted>
  <field_date_reviewed>2015-01-06</field_date_reviewed>
  <field_pretty_url>melanoma-resources</field_pretty_url>
  <para_id>890966</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>915875</term_id>
  <id>894866</id>
  <title>Environmental Carcinogens and Cancer Risk</title>
  <langcode>en</langcode>
  <field_short_title>Environmental Carcinogens and Cancer Risk</field_short_title>
  <field_page_description>Factors are discussed that may influence whether a person exposed to a cancer-causing substance (carcinogen) will develop cancer.</field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2017-12-12</field_date_reviewed>
  <field_pretty_url>carcinogens</field_pretty_url>
  <para_id>894866</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>895701</id>
  <title>Program Spotlight: PACHE Partners Discuss Better Ways to Advance Cancer Health Equity</title>
  <langcode>en</langcode>
  <field_short_title>Program Spotlight: PACHE Partners Discuss Better Ways to Advance Cancer Health Equity</field_short_title>
  <field_date_posted>2014-10-23</field_date_posted>
  <field_date_reviewed>2014-10-23</field_date_reviewed>
  <field_pretty_url>pache-spotlight</field_pretty_url>
  <para_id>895701</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>898730</id>
  <title>November Spotlight: Native American Heritage Month and Cancer Awareness Highlights</title>
  <langcode>en</langcode>
  <field_short_title>November Spotlight: Native American Heritage Month and Cancer Awareness Highlights</field_short_title>
  <field_date_posted>2014-11-01</field_date_posted>
  <field_date_reviewed>2014-11-18</field_date_reviewed>
  <field_pretty_url>november-spotlight</field_pretty_url>
  <para_id>898730</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>898735</id>
  <title>Special Spotlight: Hispanic Heritage Month</title>
  <langcode>en</langcode>
  <field_short_title>Special Spotlight: Hispanic Heritage Month</field_short_title>
  <field_date_posted>2014-11-19</field_date_posted>
  <field_date_reviewed>2014-09-15</field_date_reviewed>
  <field_pretty_url>2014hispanicmonth-spotlight-blog</field_pretty_url>
  <para_id>898735</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>899253</id>
  <title>Grantee Spotlight: Isabel Scarinci, Ph.D., M.P.H. - Ensuring Latina Immigrants Have Equal Breast and Cervical Cancer Care</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Isabel Scarinci, Ph.D., M.P.H. - Ensuring Latina Immigrants Have Equal Breast and</field_short_title>
  <field_date_posted>2014-10-29</field_date_posted>
  <field_date_reviewed>2014-10-29</field_date_reviewed>
  <field_pretty_url>scarinci-spotlight</field_pretty_url>
  <para_id>899253</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>899272</id>
  <title>Grantee Spotlight: Marvella Ford, Ph.D. - Reducing Barriers to Surgical Cancer Care among African Americans with Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Marvella Ford, Ph.D. - Reducing Barriers to Surgical Cancer Care among African Am</field_short_title>
  <field_date_posted>2014-01-10</field_date_posted>
  <field_date_reviewed>2014-01-10</field_date_reviewed>
  <field_pretty_url>ford-spotlight</field_pretty_url>
  <para_id>899272</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>901950</term_id>
  <id>901860</id>
  <title>Bleeding and Bruising (Thrombocytopenia) and Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Bleeding and Bruising (Thrombocytopenia)</field_short_title>
  <field_page_description>Cancer treatments, such as chemotherapy and targeted therapy, can increase patients’ risk of bleeding and bruising, also called thrombocytopenia. Learn about steps to take if you are at increased risk of a low platelet count.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2018-09-14</field_date_reviewed>
  <para_id>901860</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>11796</term_id>
  <id>12954</id>
  <title>Cancer Screening</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Screening</field_short_title>
  <field_page_description>Cancer screening is checking for cancer in people who don't have symptoms. Screening tests can help doctors find and treat several types of cancer early, but cancer screening can have harms as well as benefits. </field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2010-09-14</field_date_reviewed>
  <para_id>12954</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>171058</id>
  <title>Women with BRCA1 and BRCA2 mutations survive ovarian cancer at higher rates than those without mutations</title>
  <langcode>en</langcode>
  <field_short_title>Women with BRCA1 and BRCA2 mutations survive ovarian cancer at higher rates </field_short_title>
  <field_page_description>Results from a National Cancer Institute (NCI) sponsored multicenter study published in the Journal of the American Medical Association on January 25, 2012, provides strong evidence that BRCA1 and BRCA2 gene mutation carriers with ovarian cancer were more</field_page_description>
  <field_date_posted>2012-01-24</field_date_posted>
  <field_date_reviewed>2012-01-24</field_date_reviewed>
  <field_pretty_url>BRCAmutationsOvarianNewsNote</field_pretty_url>
  <para_id>171058</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>762611</term_id>
  <id>902260</id>
  <title>CGH Celebrates World Cancer Day 2015</title>
  <langcode>en</langcode>
  <field_short_title>CGH Celebrates World Cancer Day 2015</field_short_title>
  <field_date_posted>2015-01-30</field_date_posted>
  <field_date_reviewed>2015-01-30</field_date_reviewed>
  <field_pretty_url>wcd-2015</field_pretty_url>
  <para_id>902260</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>903596</term_id>
  <id>903600</id>
  <title>Support Services</title>
  <langcode>en</langcode>
  <field_short_title>Support Services</field_short_title>
  <field_page_description>Various services to help you cope during and after your cancer treatment.</field_page_description>
  <field_date_posted>2015-03-10</field_date_posted>
  <field_date_reviewed>2015-02-02</field_date_reviewed>
  <para_id>903600</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>903677</id>
  <title>Donor telomere length and survival after hematopoietic cell transplantation in patients with severe aplastic anemia</title>
  <langcode>en</langcode>
  <field_short_title>Donor telomere length and survival in severe aplastic anemia</field_short_title>
  <field_page_description>A new NCI study has found that, among patients with severe aplastic anemia who received a hematopoietic cell transplant from an unrelated donor, those whose donor white blood cells had longer telomeres had higher survival rates five-years after transplant</field_page_description>
  <field_date_posted>2015-02-10</field_date_posted>
  <field_date_reviewed>2015-02-03</field_date_reviewed>
  <field_pretty_url>donor-telomere-length-saa</field_pretty_url>
  <para_id>903677</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>903757</term_id>
  <id>903755</id>
  <title>Memory or Concentration Problems and Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Memory or Concentration Problems</field_short_title>
  <field_page_description>Cancer treatments, such as chemo, may cause difficulty thinking, concentrating, or other cognitive problems. Learn about steps people with cancer can take to manage these side effects. See a list of helpful questions for families to ask the doctor.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-02-04</field_date_reviewed>
  <para_id>903755</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940345</term_id>
  <id>12915</id>
  <title>Intraocular (Eye) Melanoma—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Intraocular (Eye) Melanoma</field_short_title>
  <field_page_description>Intraocular (uveal) melanoma is a rare cancer that forms in the eye. It usually has no early signs or symptoms. As with melanoma of the skin, risk factors include having fair skin and light-colored eyes. Start here to find information on intraocular melanoma treatment.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>12915</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>936689</term_id>
  <id>172407</id>
  <title>Questions to Ask Your Doctor about Your Diagnosis</title>
  <langcode>en</langcode>
  <field_short_title>Questions to Ask about Your Diagnosis</field_short_title>
  <field_page_description>Suggested questions for patients to ask their doctors when they learn they have cancer and want to know what to expect next. </field_page_description>
  <field_date_posted>2015-04-02</field_date_posted>
  <field_date_reviewed>2018-08-09</field_date_reviewed>
  <para_id>172407</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>936649</term_id>
  <id>176775</id>
  <title>Questions to Ask Your Doctor about Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Questions to Ask Your Doctor about Cancer</field_short_title>
  <field_page_description>Sets of questions, organized by topic, that cancer patients may want to ask their doctors or other members of their health care team to learn more about their cancer and what to expect.</field_page_description>
  <field_date_posted>2012-02-01</field_date_posted>
  <field_date_reviewed>2012-01-30</field_date_reviewed>
  <para_id>176775</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>904556</id>
  <title>Medicare to Cover Annual Lung Cancer Screening for Some Beneficiaries</title>
  <langcode>en</langcode>
  <field_short_title>Medicare to Cover Annual Lung Cancer Screening for Some Beneficiaries</field_short_title>
  <field_date_posted>2015-02-06</field_date_posted>
  <field_date_reviewed>2015-02-06</field_date_reviewed>
  <field_pretty_url>medicare-lung-cancer-screening</field_pretty_url>
  <para_id>904556</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>886985</term_id>
  <id>905020</id>
  <title>Screening Tests</title>
  <langcode>en</langcode>
  <field_short_title>Screening Tests</field_short_title>
  <field_page_description>Information about tests such as mammography and colonoscopy that may be used to screen for cancer in people without symptoms of disease.  </field_page_description>
  <field_date_posted>2015-03-24</field_date_posted>
  <field_date_reviewed>2015-02-06</field_date_reviewed>
  <para_id>905020</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>905761</id>
  <title>Study Shows Elevated Number of Cancers in US HIV Positive Population</title>
  <langcode>en</langcode>
  <field_short_title>Study Shows Elevated Number of Cancers in US HIV Positive Population</field_short_title>
  <field_page_description>In 2010, an estimated 7,760 new cancers were diagnosed among the nearly 900,000 Americans known to be living with HIV infection. According to the first comprehensive study in the United States, approximately half of these cancers were in excess of what wo</field_page_description>
  <field_date_posted>2015-02-09</field_date_posted>
  <field_date_reviewed>2015-02-08</field_date_reviewed>
  <field_pretty_url>hiv-excess-cancers-jnci</field_pretty_url>
  <para_id>905761</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>906093</term_id>
  <id>906094</id>
  <title>Cancer Staging</title>
  <langcode>en</langcode>
  <field_short_title>Staging</field_short_title>
  <field_page_description>Staging is the process of determining how much cancer is within the body (tumor size) and if it has spread. Learn about the TNM Staging system and other ways that stage is described.</field_page_description>
  <field_date_posted>2015-03-09</field_date_posted>
  <field_date_reviewed>2015-03-09</field_date_reviewed>
  <para_id>906094</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>936692</term_id>
  <id>171104</id>
  <title>Questions to Ask Your Doctor about Your Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Questions to Ask about Your Treatment</field_short_title>
  <field_page_description>Suggested questions for cancer patients to ask their doctors about treatment choices and the possible side effects of cancer treatment.</field_page_description>
  <field_date_posted>2012-02-14</field_date_posted>
  <field_date_reviewed>2018-08-09</field_date_reviewed>
  <para_id>171104</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>904676</id>
  <title>Special Spotlight: World Cancer Day - Ending Cancer Health Disparities is Not Beyond Us</title>
  <langcode>en</langcode>
  <field_short_title>Special Spotlight: World Cancer Day - Ending Cancer Health Disparities is Not Beyond Us</field_short_title>
  <field_date_posted>2015-02-04</field_date_posted>
  <field_date_reviewed>2015-02-04</field_date_reviewed>
  <field_pretty_url>worldcancerday2015-spotlight-blog</field_pretty_url>
  <para_id>904676</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919353</term_id>
  <id>907253</id>
  <title>e-ASIA Joint Research Program</title>
  <langcode>en</langcode>
  <field_short_title>e-ASIA Joint Research Program</field_short_title>
  <field_date_posted>2015-02-12</field_date_posted>
  <field_date_reviewed>2015-02-12</field_date_reviewed>
  <field_pretty_url>e-asia-jrp</field_pretty_url>
  <para_id>907253</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>861460</term_id>
  <id>915360</id>
  <title>Radiation</title>
  <langcode>en</langcode>
  <field_short_title>Radiation </field_short_title>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915360</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915538</term_id>
  <id>915540</id>
  <title>Stem Cell Transplants in Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Stem Cell Transplant </field_short_title>
  <field_page_description>Stem cell transplants are procedures that restore blood-forming stem cells in cancer patients who have had theirs destroyed by very high doses of chemotherapy or radiation therapy. Learn about the types of transplants and side effects that may occur.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915540</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915609</term_id>
  <id>915644</id>
  <title>Cancer Health Disparities Research</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Health Disparities Research</field_short_title>
  <field_page_description>NCI is addressing cancer health disparities through its efforts in basic research, community-level programs, and more. </field_page_description>
  <field_date_posted>2015-05-12</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915644</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915615</term_id>
  <id>915654</id>
  <title>Global Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Global Cancer Research</field_short_title>
  <field_page_description>NCI is confronting the global burden of cancer through many programs and international partnerships.</field_page_description>
  <field_date_posted>2015-05-12</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915654</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>916697</term_id>
  <id>916695</id>
  <title>Spotlight on Scientists</title>
  <langcode>en</langcode>
  <field_short_title>Spotlight on Scientists</field_short_title>
  <field_page_description>Written profiles highlighting the work of NCI and NCI-funded researchers, clinicians, and others who contribute to cancer research.</field_page_description>
  <field_date_posted>2015-03-16</field_date_posted>
  <field_date_reviewed>2015-03-16</field_date_reviewed>
  <para_id>916695</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>916793</term_id>
  <id>916804</id>
  <title>Funding Strategy</title>
  <langcode>en</langcode>
  <field_short_title>Funding Strategy</field_short_title>
  <field_page_description>NCI formulates funding guidelines based on expected allocations, program requirements, and funding history. Learn how NCI funding decisions are made.</field_page_description>
  <field_date_posted>2015-03-17</field_date_posted>
  <field_date_reviewed>2015-03-16</field_date_reviewed>
  <para_id>916804</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>916848</term_id>
  <id>916849</id>
  <title>Contracts and Small Business</title>
  <langcode>en</langcode>
  <field_short_title>Contracts and Small Business</field_short_title>
  <field_date_posted>2015-03-16</field_date_posted>
  <field_date_reviewed>2015-03-16</field_date_reviewed>
  <para_id>916849</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>917216</term_id>
  <id>917217</id>
  <title>Childhood Cancers Research</title>
  <langcode>en</langcode>
  <field_short_title>Childhood Cancers Research</field_short_title>
  <field_page_description>Learn about NCI-supported research efforts to address pediatric cancers, from basic science to clinical research on new treatments.</field_page_description>
  <field_date_posted>2015-03-18</field_date_posted>
  <field_date_reviewed>2015-03-18</field_date_reviewed>
  <para_id>917217</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>917482</id>
  <title>Indicators related to lung cancer recurrence, metastases and survival can inform treatment of patients</title>
  <langcode>en</langcode>
  <field_short_title>Lung cancer prognostic factors can inform treatment </field_short_title>
  <field_page_description>This study describes prognostic factors for lung cancer spread and recurrence, as well as subsequent risk of death from the disease. The investigators observed that regardless of cancer stage, grade, or type of lung cancer, patients in the study were more</field_page_description>
  <field_date_posted>2015-03-23</field_date_posted>
  <field_date_reviewed>2015-03-18</field_date_reviewed>
  <field_pretty_url>lung-cancer-indicators-recurrence</field_pretty_url>
  <para_id>917482</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>917518</id>
  <title>FDA Approves Panobinostat for Some Patients with Multiple Myeloma</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Panobinostat for Some Patients with Multiple Myeloma</field_short_title>
  <field_date_posted>2015-03-19</field_date_posted>
  <field_date_reviewed>2015-03-19</field_date_reviewed>
  <field_pretty_url>fda-approves-panobinostat</field_pretty_url>
  <para_id>917518</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917273</term_id>
  <id>917734</id>
  <title>National Clinical Trials Network (NCTN) Steering Committees</title>
  <langcode>en</langcode>
  <field_short_title>NCTN Steering Committees</field_short_title>
  <field_page_description>The National Clinical Trials Network (NCTN) Steering Committees review concepts, or proposals, for large phase 2 or phase 3 treatment or imaging trials conducted in the NCTN.</field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2015-03-20</field_date_reviewed>
  <para_id>917734</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>860150</term_id>
  <id>907517</id>
  <title>Spotlight on Scientists Videos</title>
  <langcode>en</langcode>
  <field_short_title>Video Stories</field_short_title>
  <field_page_description>Researchers, fellows, principal investigators, and medical doctors provide inspiration and advice to students interested in medical research.</field_page_description>
  <field_date_posted>2015-02-13</field_date_posted>
  <field_date_reviewed>2015-02-13</field_date_reviewed>
  <para_id>907517</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>903584</term_id>
  <id>911505</id>
  <title>Managing Cancer Care</title>
  <langcode>en</langcode>
  <field_short_title>Managing Cancer Care</field_short_title>
  <field_page_description>Information on choosing a doctor or treatment facility, home care, financial help, insurance coverage, end-of-life planning, and resources to help you avoid scams.</field_page_description>
  <field_date_posted>2015-02-26</field_date_posted>
  <field_date_reviewed>2015-02-26</field_date_reviewed>
  <para_id>911505</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>912900</term_id>
  <id>912902</id>
  <title>Hormone Therapy to Treat Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Hormone Therapy </field_short_title>
  <field_page_description>Hormone therapy is a treatment that slows or stops the growth of breast and prostate cancers that use hormones to grow. Learn about the types of hormone therapy and side effects that may happen.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-03-17</field_date_reviewed>
  <para_id>912902</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>914814</term_id>
  <id>915046</id>
  <title>Step 3: Peer Review and Funding Outcomes</title>
  <langcode>en</langcode>
  <field_short_title>Step 3: Peer Review and Funding Outcomes</field_short_title>
  <field_page_description>The NCI review process seeks to achieve a balanced grant portfolio, that addresses scientific priorities. Learn about NCI’s peer review for grant applications. </field_page_description>
  <field_date_posted>2015-04-02</field_date_posted>
  <field_date_reviewed>2015-03-12</field_date_reviewed>
  <para_id>915046</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>915259</id>
  <title>Special Spotlight: 2014 AACR Conference: The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved</title>
  <langcode>en</langcode>
  <field_short_title>Special Spotlight: 2014 AACR Conference</field_short_title>
  <field_date_posted>2014-12-01</field_date_posted>
  <field_date_reviewed>2014-12-01</field_date_reviewed>
  <field_pretty_url>2014aacr-spotlight-blog</field_pretty_url>
  <para_id>915259</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915528</term_id>
  <id>915530</id>
  <title>Immunotherapy to Treat Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Immunotherapy</field_short_title>
  <field_page_description>Immunotherapy is treatment that helps your immune system fight cancer. Get information about the different types of immunotherapy and what you can expect during treatment.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2017-05-04</field_date_reviewed>
  <para_id>915530</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915632</term_id>
  <id>915642</id>
  <title>Research on Causes of Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Research on Causes of Cancer</field_short_title>
  <field_date_posted>2015-05-12</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915642</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>916029</term_id>
  <id>916030</id>
  <title>Planning for Advanced Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Planning for Advanced Cancer</field_short_title>
  <field_page_description>Find out what issues need to be addressed when dealing with an advanced or metastatic cancer diagnosis. Completing advance directives, looking at health insurance, organizing records and documents, and looking at the meanings in your life are some of the things to think about. </field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>916030</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>916482</id>
  <title>Smoking’s Disease Burden: Worse than Previously Thought?</title>
  <langcode>en</langcode>
  <field_short_title>Smoking’s Disease Burden: Worse than Previously Thought?</field_short_title>
  <field_page_description>According to a new study, smoking may be responsible for far more deaths each year than previously thought.</field_page_description>
  <field_date_posted>2015-03-16</field_date_posted>
  <field_date_reviewed>2015-03-16</field_date_reviewed>
  <field_pretty_url>smoking-burden</field_pretty_url>
  <para_id>916482</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>916837</term_id>
  <id>916787</id>
  <title>Annual Report to the Nation on the Status of Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Annual Report to the Nation</field_short_title>
  <field_page_description>The Annual Report to the Nation on the Status of Cancer is an update of rates for new cases, deaths, and trends for the most common cancers in the United States. </field_page_description>
  <field_date_posted>2015-03-30</field_date_posted>
  <field_date_reviewed>2015-03-30</field_date_reviewed>
  <para_id>916787</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917229</term_id>
  <id>917230</id>
  <title>Resources</title>
  <langcode>en</langcode>
  <field_short_title>Resources</field_short_title>
  <field_date_posted>2015-03-18</field_date_posted>
  <field_date_reviewed>2015-03-18</field_date_reviewed>
  <para_id>917230</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917279</term_id>
  <id>917306</id>
  <title>Cancer Care Delivery Research Steering Committee </title>
  <langcode>en</langcode>
  <field_short_title>CCDR Steering Committee</field_short_title>
  <field_page_description>The Cancer Care Delivery Research (CCDR) Steering Committee evaluates and prioritizes cancer care delivery research study concepts for trials conducted through NCORP.</field_page_description>
  <field_date_posted>2015-03-18</field_date_posted>
  <field_date_reviewed>2015-03-18</field_date_reviewed>
  <para_id>917306</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>919139</id>
  <title>FDA Approves First Immunotherapy Treatment for Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves First Immunotherapy Treatment for Lung Cancer</field_short_title>
  <field_date_posted>2015-03-24</field_date_posted>
  <field_date_reviewed>2015-03-24</field_date_reviewed>
  <field_pretty_url>fda-opdivo</field_pretty_url>
  <para_id>919139</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919143</term_id>
  <id>919144</id>
  <title>Sleep Problems (Insomnia) and Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Sleep Problems</field_short_title>
  <field_page_description>Sleep problems are a common side effect during cancer treatment. Learn how a polysomnogram can assess sleep problems. Learn about the benefits of managing sleep disorders in men and women with cancer. </field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2018-04-11</field_date_reviewed>
  <para_id>919144</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911116</term_id>
  <id>15312</id>
  <title>Artificial Sweeteners and Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Artificial Sweeteners and Cancer</field_short_title>
  <field_page_description>A fact sheet that reviews research studies on the possible connection between artificial sweeteners and cancer.</field_page_description>
  <field_date_posted>2005-08-18</field_date_posted>
  <field_date_reviewed>2016-08-10</field_date_reviewed>
  <field_pretty_url>artificial-sweeteners-fact-sheet</field_pretty_url>
  <para_id>15312</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11910</term_id>
  <id>15315</id>
  <title>Gastrointestinal Carcinoid Tumors—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Gastrointestinal Carcinoid Tumors</field_short_title>
  <field_page_description>Gastrointestinal (GI) carcinoid tumors are slow-growing tumors that form in the neuroendocrine cells in the GI tract. The GI tract includes the stomach, small intestine, colon, rectum, appendix, and other organs. Start here to find treatment information and research on gastrointestinal carcinoid tumors.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>15315</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>857987</term_id>
  <id>15333</id>
  <title>Psychological Stress and Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Psychological Stress and Cancer</field_short_title>
  <field_page_description>A fact sheet that describes the effects of stress on the body, the results of research on the relationship between stress and cancer, and information about coping with stress.</field_page_description>
  <field_date_posted>2012-12-17</field_date_posted>
  <field_date_reviewed>2012-12-10</field_date_reviewed>
  <field_pretty_url>stress-fact-sheet</field_pretty_url>
  <para_id>15333</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911291</term_id>
  <id>15500</id>
  <title>Where To Get Help When You Decide To Quit Smoking</title>
  <langcode>en</langcode>
  <field_short_title>Where To Get Help When You Decide To Quit Smoking</field_short_title>
  <field_page_description>This fact sheet provides information about helpful resources for people who have decided to quit smoking.</field_page_description>
  <field_date_posted>2010-10-28</field_date_posted>
  <field_date_reviewed>2010-10-28</field_date_reviewed>
  <field_pretty_url>help-quitting-fact-sheet</field_pretty_url>
  <para_id>15500</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11884</term_id>
  <id>15597</id>
  <title>Brain Tumors—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Brain Tumors </field_short_title>
  <field_page_description>Brain tumors are growths of malignant cells in tissues of the brain. Tumors that start in the brain are called primary brain tumors. Tumors that spread to the brain are called metastatic brain tumors. Start here to find information on brain cancer treatment, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>15597</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>937903</term_id>
  <id>16365</id>
  <title>Adolescents and Young Adults with Cancer</title>
  <langcode>en</langcode>
  <field_short_title>AYA</field_short_title>
  <field_page_description>Information about cancer in adolescents and young adults (AYAs), including treatment, follow-up care, coping, and related research.</field_page_description>
  <field_date_posted>2015-05-15</field_date_posted>
  <field_date_reviewed>2018-01-31</field_date_reviewed>
  <para_id>16365</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938227</term_id>
  <id>394026</id>
  <title>Genetically Engineered Immunotherapy for Advanced Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Genetically Engineered Immunotherapy for Advanced Cancer</field_short_title>
  <field_page_description>In this trial, doctors will collect T lymphocytes from patients with advanced mesothelin-expressing cancer and genetically engineer them to recognize mesothelin. The gene-engineered cells will be multiplied and infused into the patient to fight the cancer</field_page_description>
  <field_date_posted>2012-08-07</field_date_posted>
  <field_date_reviewed>2012-08-08</field_date_reviewed>
  <field_pretty_url>immunotherapy-target-mesothelin</field_pretty_url>
  <para_id>394026</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>420504</term_id>
  <id>420505</id>
  <title>Questions to Ask Your Doctor about Treatment Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>Questions to Ask about Treatment Clinical Trials</field_short_title>
  <field_page_description>Suggested questions to ask your doctor, if you are thinking about taking part in a clinical trial.</field_page_description>
  <field_date_posted>2012-09-11</field_date_posted>
  <field_date_reviewed>2016-06-22</field_date_reviewed>
  <para_id>420505</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>916765</term_id>
  <id>916766</id>
  <title>Research Grants</title>
  <langcode>en</langcode>
  <field_short_title>Research Grants</field_short_title>
  <field_page_description>NCI funds a range of cancer research activities through various mechanisms and pay lines. Find cancer research funding opportunities.  </field_page_description>
  <field_date_posted>2015-03-16</field_date_posted>
  <field_date_reviewed>2015-03-16</field_date_reviewed>
  <para_id>916766</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917505</term_id>
  <id>917508</id>
  <title>Complementary and Alternative Medicine for Health Professionals</title>
  <langcode>en</langcode>
  <field_short_title>CAM for Health Professionals</field_short_title>
  <field_date_posted>2015-04-10</field_date_posted>
  <field_date_reviewed>2015-03-18</field_date_reviewed>
  <para_id>917508</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>917548</id>
  <title>Grantee Spotlight: Sunday O. Akintoye, B.D.S., D.D.S., M.S.- Studying the Biology of Bone Cells to Reduce Head and Neck Cancer Treatment Complications </title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Sunday O. Akintoye, B.D.S., D.D.S., M.S.- Studying the Biology of Bone Cells </field_short_title>
  <field_date_posted>2014-08-20</field_date_posted>
  <field_date_reviewed>2014-08-20</field_date_reviewed>
  <field_pretty_url>akintoye-blog</field_pretty_url>
  <para_id>917548</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>918999</term_id>
  <id>919000</id>
  <title>Resources for News Media</title>
  <langcode>en</langcode>
  <field_short_title>Resources for News Media</field_short_title>
  <field_page_description>Resources to help the news media provide accurate, timely information and disseminate cancer research news. </field_page_description>
  <field_date_posted>2015-03-23</field_date_posted>
  <field_date_reviewed>2015-03-23</field_date_reviewed>
  <para_id>919000</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>919120</id>
  <title>Who Will Respond to PD-1 Inhibition? Study Provides Clues</title>
  <langcode>en</langcode>
  <field_short_title>Who Will Respond to PD-1 Inhibition? Study Provides Clues</field_short_title>
  <field_date_posted>2015-03-24</field_date_posted>
  <field_date_reviewed>2015-03-24</field_date_reviewed>
  <field_pretty_url>pd-1-inhibition</field_pretty_url>
  <para_id>919120</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>919347</id>
  <title>New analysis of breast cancer subtypes could lead to better risk stratification; Annual Report to the Nation shows that mortality and incidence for most cancers continue to decline</title>
  <langcode>en</langcode>
  <field_short_title>Annual Report to the Nation shows mortality and incidence for most cancers declining</field_short_title>
  <field_page_description>For the first time, researchers have used national data to determine the incidence of the four major molecular subtypes of breast cancer by age, race/ethnicity, poverty level, and several other factors.  The report showed continuing declines in cancer dea</field_page_description>
  <field_date_posted>2015-03-30</field_date_posted>
  <field_date_reviewed>2015-03-24</field_date_reviewed>
  <field_pretty_url>report-nation-march-2015-press-release</field_pretty_url>
  <para_id>919347</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>919564</id>
  <title>Mapping International Cancer Activities – Global Cancer Project Map Launch</title>
  <langcode>en</langcode>
  <field_short_title>Mapping International Cancer Activities – Global Cancer Project Map Launch</field_short_title>
  <field_date_posted>2015-03-25</field_date_posted>
  <field_date_reviewed>2015-03-25</field_date_reviewed>
  <field_pretty_url>gcpm</field_pretty_url>
  <para_id>919564</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919680</term_id>
  <id>919682</id>
  <title>Blogs and Newsletters</title>
  <langcode>en</langcode>
  <field_short_title>Blogs and Newsletters</field_short_title>
  <field_page_description>Blogs and newsletters featured on the Cancer.gov website.</field_page_description>
  <field_date_posted>2015-04-16</field_date_posted>
  <field_date_reviewed>2015-03-25</field_date_reviewed>
  <para_id>919682</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>952678</term_id>
  <id>15332</id>
  <title>PDQ&amp;reg; Supportive and Palliative Care Editorial Board</title>
  <langcode>en</langcode>
  <field_short_title>Supportive &amp;amp; Palliative Care Editorial Board</field_short_title>
  <field_date_posted>2002-05-01</field_date_posted>
  <field_date_reviewed>2005-04-12</field_date_reviewed>
  <para_id>15332</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911291</term_id>
  <id>15397</id>
  <title>How To Handle Withdrawal Symptoms and Triggers When You Decide To Quit Smoking</title>
  <langcode>en</langcode>
  <field_short_title>Handling Withdrawal Symptoms &amp; Triggers When You Decide to Quit</field_short_title>
  <field_page_description>This fact sheet provides helpful tips related to smoking cessation.</field_page_description>
  <field_date_posted>2010-10-29</field_date_posted>
  <field_date_reviewed>2010-10-29</field_date_reviewed>
  <field_pretty_url>withdrawal-fact-sheet</field_pretty_url>
  <para_id>15397</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911172</term_id>
  <id>15614</id>
  <title>Helicobacter pylori and Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Helicobacter pylori and Cancer</field_short_title>
  <field_page_description>A fact sheet about the relationship between H. pylori infection and gastric cancer, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, and other cancers.</field_page_description>
  <field_date_posted>2013-09-25</field_date_posted>
  <field_date_reviewed>2013-09-05</field_date_reviewed>
  <field_pretty_url>h-pylori-fact-sheet</field_pretty_url>
  <para_id>15614</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11946</term_id>
  <id>15830</id>
  <title>Parathyroid Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Parathyroid Cancer</field_short_title>
  <field_page_description>Parathyroid tumors are usually benign (not cancer) and are called adenomas. Parathyroid cancer is very rare. Having certain inherited disorders can increase the risk of parathyroid cancer. Start here to find information on parathyroid cancer treatment.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2007-03-09</field_date_reviewed>
  <para_id>15830</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>929499</term_id>
  <id>16226</id>
  <title>Cancer Training at NCI</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Training at NCI</field_short_title>
  <field_page_description>Training, fellowships, and other professional education opportunities for students and scientists on the NIH/NCI campus in Maryland (intramural).</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2008-11-14</field_date_reviewed>
  <para_id>16226</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>396057</term_id>
  <id>396117</id>
  <title>Deciding to Take Part in a Clinical Trial</title>
  <langcode>en</langcode>
  <field_short_title>Deciding to Take Part</field_short_title>
  <field_page_description>Information to help people think about whether taking part in a cancer clinical trial is right for them. Covers benefits and risks of taking part, as well as eligibility criteria.</field_page_description>
  <field_date_posted>2012-08-10</field_date_posted>
  <field_date_reviewed>2016-06-22</field_date_reviewed>
  <para_id>396117</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>419028</term_id>
  <id>419029</id>
  <title>Research Team Members</title>
  <langcode>en</langcode>
  <field_short_title>Research Team Members</field_short_title>
  <field_date_posted>2012-09-04</field_date_posted>
  <field_date_reviewed>2012-09-04</field_date_reviewed>
  <para_id>419029</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>430356</id>
  <title>Rare cancers yield potential source of tumor growth</title>
  <langcode>en</langcode>
  <field_short_title>Rare cancers yield potential source of tumor growth</field_short_title>
  <field_page_description>Researchers at the National Institutes of Health have discovered a genetic mutation that appears to increase production of red blood cells in tumors. </field_page_description>
  <field_date_posted>2012-09-17</field_date_posted>
  <field_date_reviewed>2012-09-20</field_date_reviewed>
  <field_pretty_url>RareCancersNICHD</field_pretty_url>
  <para_id>430356</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>463786</id>
  <title>Radiation Therapy and You: Support for People With Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Radiation Therapy and You</field_short_title>
  <field_page_description>This booklet explains the different types of radiation therapy, what people can expect during treatment, side effects that may happen and ways to manage them.</field_page_description>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2012-11-20</field_date_reviewed>
  <field_pretty_url>radiation-therapy-and-you</field_pretty_url>
  <para_id>463786</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917237</term_id>
  <id>478615</id>
  <title>BIQSFP FAQs</title>
  <langcode>en</langcode>
  <field_short_title>BIQSFP FAQs</field_short_title>
  <field_page_description>Find a list of frequently asked questions related to Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP).</field_page_description>
  <field_date_posted>2012-12-17</field_date_posted>
  <field_date_reviewed>2012-12-17</field_date_reviewed>
  <field_pretty_url>faq</field_pretty_url>
  <para_id>478615</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>922452</id>
  <title>Douglas Lowy named Acting Director of the National Cancer Institute</title>
  <langcode>en</langcode>
  <field_short_title>Douglas Lowy named Acting Director of NCI</field_short_title>
  <field_page_description>Douglas Lowy, M.D., today was officially named the National Cancer Institute’s Acting Director. Dr. Lowy, a cancer researcher for more than 40 years, received the National Medal of Technology and Innovation from President Obama in 2014 for his research th</field_page_description>
  <field_date_posted>2015-04-01</field_date_posted>
  <field_date_reviewed>2015-04-01</field_date_reviewed>
  <field_pretty_url>lowy-named-acting-nci-director-april-2015</field_pretty_url>
  <para_id>922452</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>929672</term_id>
  <id>929673</id>
  <title>Office of Management Policy and Compliance </title>
  <langcode>en</langcode>
  <field_short_title>Office of Management Policy and Compliance</field_short_title>
  <field_page_description>NCI’s Office of Management Policy and Compliance is responsible for NCI-wide evaluation and implementation of HHS, NIH and NCI policies, guidelines and regulations with oversight in the areas of Risk and Records Management, Organizational Change, PRA/OMB Clearance, Policy, and Delegated Authorities.</field_page_description>
  <field_date_posted>2015-04-06</field_date_posted>
  <field_date_reviewed>2015-04-06</field_date_reviewed>
  <para_id>929673</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>929695</term_id>
  <id>929700</id>
  <title>Multimedia from NCI</title>
  <langcode>en</langcode>
  <field_short_title>Multimedia from NCI</field_short_title>
  <field_page_description>The National Cancer Institute’s collection of multimedia includes photography, illustrations, videos, infographics, and apps.</field_page_description>
  <field_date_posted>2015-04-06</field_date_posted>
  <field_date_reviewed>2015-04-06</field_date_reviewed>
  <para_id>929700</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>931040</id>
  <title>Take Action to Decrease Your Cancer Risk - Obesity and Its Role in Cancer Health Disparities</title>
  <langcode>en</langcode>
  <field_short_title>Take Action to Decrease Your Cancer Risk - Obesity and Its Role in Cancer Health Disparities</field_short_title>
  <field_date_posted>2015-04-10</field_date_posted>
  <field_date_reviewed>2015-04-10</field_date_reviewed>
  <field_pretty_url>nmhm15-spotlight</field_pretty_url>
  <para_id>931040</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>937180</id>
  <title>Targeted Agents Active Against HER2-positive Breast Cancer: Questions and Answers</title>
  <langcode>en</langcode>
  <field_short_title>Targeted Agents Active Against Breast Cancer: Q&amp;A</field_short_title>
  <field_date_posted>2015-04-17</field_date_posted>
  <field_date_reviewed>2015-04-17</field_date_reviewed>
  <field_pretty_url>altto-qa</field_pretty_url>
  <para_id>937180</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>937783</id>
  <title>At NCI, A Continued Commitment to Supporting the Best Science</title>
  <langcode>en</langcode>
  <field_short_title>At NCI, Supporting the Best Science</field_short_title>
  <field_page_description>Yesterday, at the AACR annual meeting, Dr. Doug Lowy spoke directly to the research community about his goals as NCI Acting Director. Dr. Lowy said that he plans to continue many of the programs launched by his predecessor, Dr. Harold Varmus, and to sharp</field_page_description>
  <field_date_posted>2015-04-21</field_date_posted>
  <field_date_reviewed>2015-04-21</field_date_reviewed>
  <field_pretty_url>Lowy-AACR</field_pretty_url>
  <para_id>937783</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>937997</id>
  <title>Study Forecasts New Breast Cancer Cases by 2030</title>
  <langcode>en</langcode>
  <field_short_title>Study Forecasts New Breast Cancer Cases by 2030</field_short_title>
  <field_date_posted>2015-04-23</field_date_posted>
  <field_date_reviewed>2015-04-23</field_date_reviewed>
  <field_pretty_url>breast-forecast</field_pretty_url>
  <para_id>937997</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911184</term_id>
  <id>15241</id>
  <title>Fluoridated Water</title>
  <langcode>en</langcode>
  <field_short_title>Fluoridated Water</field_short_title>
  <field_page_description>A fact sheet that reviews research about the possibility of a connection between fluoridated water and cancer.</field_page_description>
  <field_date_posted>2012-02-21</field_date_posted>
  <field_date_reviewed>2017-05-15</field_date_reviewed>
  <field_pretty_url>fluoridated-water-fact-sheet</field_pretty_url>
  <para_id>15241</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>929549</term_id>
  <id>550781</id>
  <title>Genetic Testing for Hereditary Cancer Syndromes</title>
  <langcode>en</langcode>
  <field_short_title>Genetic Testing for Hereditary Cancer Syndromes</field_short_title>
  <field_page_description>A fact sheet about genetic testing for inherited cancer risk. Includes types of tests, who should consider testing, and how to understand test results.</field_page_description>
  <field_date_posted>2013-04-22</field_date_posted>
  <field_date_reviewed>2013-04-11</field_date_reviewed>
  <field_pretty_url>genetic-testing-fact-sheet</field_pretty_url>
  <para_id>550781</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>550989</id>
  <title>A drug target that stimulates development of healthy stem cells</title>
  <langcode>en</langcode>
  <field_short_title>A drug target that stimulates development of healthy stem cells</field_short_title>
  <field_page_description>Scientists have overcome a major impediment to the development of effective stem cell therapies by studying mice that lack CD47, a protein found on the surface of both healthy and cancer cells. They discovered that cells obtained from the lungs of CD47-de</field_page_description>
  <field_date_posted>2013-04-17</field_date_posted>
  <field_date_reviewed>2013-04-16</field_date_reviewed>
  <field_pretty_url>CD47stemcell</field_pretty_url>
  <para_id>550989</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>564061</id>
  <title>TCGA researchers identify potential drug targets, markers for leukemia risk; &lt;span style="font-weight:normal;"&gt;&lt;i&gt;New study reveals relatively few mutations in AML genomes&lt;/i&gt;&lt;/span&gt;</title>
  <langcode>en</langcode>
  <field_short_title>TCGA researchers identify potential drug targets, markers for leukemia risk</field_short_title>
  <field_page_description>Investigators for The Cancer Genome Atlas (TCGA) Research Network have detailed and broadly classified the genomic alterations that frequently underlie the development of acute myeloid leukemia (AML), a deadly cancer of the blood and bone marrow. Their wo</field_page_description>
  <field_date_posted>2013-05-01</field_date_posted>
  <field_date_reviewed>2013-04-29</field_date_reviewed>
  <field_pretty_url>tcga-aml</field_pretty_url>
  <para_id>564061</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>959427</id>
  <title>Screening Rates for Several Cancers Miss Their Targets</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Screening Rates Missing Targets</field_short_title>
  <field_date_posted>2015-05-26</field_date_posted>
  <field_date_reviewed>2015-05-26</field_date_reviewed>
  <field_pretty_url>screening-targets</field_pretty_url>
  <para_id>959427</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>959841</term_id>
  <id>959842</id>
  <title>NCI-COG Pediatric MATCH</title>
  <langcode>en</langcode>
  <field_short_title>NCI-COG Pediatric MATCH</field_short_title>
  <field_page_description>In this precision medicine clinical trial, children and adolescents with advanced cancers whose tumors have certain genetic mutations will be treated with drugs that are matched to those mutations.</field_page_description>
  <field_date_posted>2015-06-01</field_date_posted>
  <field_date_reviewed>2015-05-27</field_date_reviewed>
  <para_id>959842</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>962853</id>
  <title>Grantee Spotlight: Marta Torroella-Kouri, Ph.D. – Studying the Role of Obesity and Breast Fat Tissue Inflammation in African American Women with Breast Cancer </title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Marta Torroella-Kouri – Studying the Role of Obesity in African American Women</field_short_title>
  <field_date_posted>2015-06-02</field_date_posted>
  <field_date_reviewed>2015-06-02</field_date_reviewed>
  <field_pretty_url>torroella-kouri-spotlight</field_pretty_url>
  <para_id>962853</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>963035</id>
  <title>The Playing Field for Cancer Checkpoint Inhibitors Is Expanding</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Checkpoint Inhibitor Use Expanding</field_short_title>
  <field_date_posted>2015-06-04</field_date_posted>
  <field_date_reviewed>2015-06-04</field_date_reviewed>
  <field_pretty_url>pd1-trials</field_pretty_url>
  <para_id>963035</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>969901</term_id>
  <id>969902</id>
  <title>Obligations by Budget Mechanism and Division</title>
  <langcode>en</langcode>
  <field_short_title>NCI and Division Obligations</field_short_title>
  <field_page_description>See obligations for the 2018 fiscal year by budget mechanism and division, including grants, contracts, training fellowships, intramural research, and management and support. </field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-06-24</field_date_reviewed>
  <para_id>969902</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>969904</term_id>
  <id>969905</id>
  <title>NIH Management Fund, Service and Supply Fund (SSF), and GSA Rent</title>
  <langcode>en</langcode>
  <field_short_title>NIH Management Fund</field_short_title>
  <field_page_description>See the distribution of NCI's payment for common research and support activities required by NIH, including GSA rent and the Service and Supply Fund.  </field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-06-24</field_date_reviewed>
  <para_id>969905</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>974292</id>
  <title>Setting the Course: Genomics Workshop on Childhood Cancers Identifies Research Opportunities</title>
  <langcode>en</langcode>
  <field_short_title>Genomics Workshop on Childhood Cancers Identifies Research Opportunities</field_short_title>
  <field_date_posted>2015-07-17</field_date_posted>
  <field_date_reviewed>2015-07-06</field_date_reviewed>
  <field_pretty_url>childhood-genomic-workshop</field_pretty_url>
  <para_id>974292</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>16387</term_id>
  <id>16388</id>
  <title>NCI Drug Dictionary</title>
  <langcode>en</langcode>
  <field_short_title>NCI Drug Dictionary</field_short_title>
  <field_date_posted>2011-02-02</field_date_posted>
  <field_date_reviewed>2011-02-02</field_date_reviewed>
  <para_id>16388</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>11738</term_id>
  <id>16394</id>
  <title>Cancer Genetics Professionals</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Genetics Professionals</field_short_title>
  <field_date_posted>2011-02-02</field_date_posted>
  <field_date_reviewed>2011-02-02</field_date_reviewed>
  <field_pretty_url>view</field_pretty_url>
  <para_id>16394</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>16399</term_id>
  <id>16400</id>
  <title>NCI Search Results</title>
  <langcode>en</langcode>
  <field_short_title>NCI Search Results</field_short_title>
  <field_date_posted>2011-02-02</field_date_posted>
  <field_date_reviewed>2011-02-02</field_date_reviewed>
  <para_id>16400</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127290</term_id>
  <id>57473</id>
  <title>CDISC Terminology</title>
  <langcode>en</langcode>
  <field_short_title>CDISC Terminology</field_short_title>
  <field_date_posted>2011-02-07</field_date_posted>
  <field_date_reviewed>2017-03-31</field_date_reviewed>
  <para_id>57473</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938231</term_id>
  <id>327274</id>
  <title>Study Finds Small Increase in Cancer Risk after Childhood CT Scans</title>
  <langcode>en</langcode>
  <field_short_title>Study Finds Small Increase in Cancer Risk after Childhood CT Scans</field_short_title>
  <field_date_posted>2012-07-10</field_date_posted>
  <field_date_reviewed>2012-07-10</field_date_reviewed>
  <field_pretty_url>ct-scans-risk</field_pretty_url>
  <para_id>327274</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>336369</term_id>
  <id>336402</id>
  <title>NCI Dictionary of Genetics Terms</title>
  <langcode>en</langcode>
  <field_short_title>NCI Dictionary of Genetics Terms</field_short_title>
  <field_date_posted>2012-07-20</field_date_posted>
  <field_date_reviewed>2012-07-20</field_date_reviewed>
  <para_id>336402</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>394938</id>
  <title>NIH study shows Burkitt lymphoma is molecularly distinct from other lymphomas </title>
  <langcode>en</langcode>
  <field_short_title>Burkitt lymphoma is molecularly distinct from other lymphomas </field_short_title>
  <field_page_description>Scientists have uncovered a number of molecular signatures in Burkitt lymphoma, including unique genetic alterations that promote cell survival, that are not found in other lymphomas. These findings provide the first genetic evidence that Burkitt lymphoma</field_page_description>
  <field_date_posted>2012-08-13</field_date_posted>
  <field_date_reviewed>2012-08-09</field_date_reviewed>
  <field_pretty_url>BurkittReleaseStaudt</field_pretty_url>
  <para_id>394938</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>396051</term_id>
  <id>396064</id>
  <title>Phases of Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>Phases of Clinical Trials</field_short_title>
  <field_date_posted>2012-08-10</field_date_posted>
  <field_date_reviewed>2012-08-10</field_date_reviewed>
  <para_id>396064</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>419282</id>
  <title>TCGA discovers potential therapeutic targets for lung squamous cell carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>Potential targets for lung squamous cell carcinoma</field_short_title>
  <field_page_description>Researchers have identified potential therapeutic targets in lung squamous cell carcinoma, the second most common form of lung cancer. The Cancer Genome Atlas (TCGA) Research Network study comprehensively characterized the lung squamous cell carcinoma gen</field_page_description>
  <field_date_posted>2012-09-10</field_date_posted>
  <field_date_reviewed>2012-09-05</field_date_reviewed>
  <field_pretty_url>LungSquamousTCGA</field_pretty_url>
  <para_id>419282</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>804863</term_id>
  <id>420512</id>
  <title>Insurance Coverage and Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>Insurance Coverage and Clinical Trials</field_short_title>
  <field_page_description>Most health insurance plans are required to cover routine patient care costs in clinical trials under certain conditions. Learn about the conditions that insurance plans take into account and how to work with your insurance company.</field_page_description>
  <field_date_posted>2012-09-11</field_date_posted>
  <field_date_reviewed>2012-09-11</field_date_reviewed>
  <para_id>420512</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>464420</id>
  <title>Taking Time: Support for People With Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Taking Time: Support for People With Cancer</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2012-11-23</field_date_reviewed>
  <field_pretty_url>taking-time</field_pretty_url>
  <para_id>464420</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>481101</id>
  <title>Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in HPV-Associated Cancers and HPV Vaccination Coverage Levels: Questions and Answers</title>
  <langcode>en</langcode>
  <field_short_title>Annual Report to the Nation 1975–2009: Q&amp;A</field_short_title>
  <field_page_description>A January 7, 2013, press release from the National Cancer Institute about the Annual Report to the Nation on the Status of Cancer, 1975-2009.</field_page_description>
  <field_date_posted>2013-01-07</field_date_posted>
  <field_date_reviewed>2012-12-27</field_date_reviewed>
  <field_pretty_url>ReportNationQA</field_pretty_url>
  <para_id>481101</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>922131</id>
  <title>Circulating tumor DNA in blood can predict recurrence of the most common type of lymphoma</title>
  <langcode>en</langcode>
  <field_short_title>Circulating tumor DNA can predict recurrence of a lymphoma</field_short_title>
  <field_page_description>Measurement of circulating tumor DNA in blood can be used to detect disease recurrence in patients with a curable form of cancer known as diffuse large B-cell lymphoma (DLBCL). In most patients, measurement of ctDNA enabled detection of microscopic diseas</field_page_description>
  <field_date_posted>2015-04-01</field_date_posted>
  <field_date_reviewed>2015-03-31</field_date_reviewed>
  <field_pretty_url>ctdna-dlbcl-detection-lancet-oncology</field_pretty_url>
  <para_id>922131</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922410</term_id>
  <id>922411</id>
  <title>National Lung Screening Trial: Questions and Answers</title>
  <langcode>en</langcode>
  <field_short_title>National Lung Screening Trial: Questions and Answers</field_short_title>
  <field_page_description>Learn the results of the National Lung Screening Trial (NLST), which compared two ways of detecting lung cancer: low-dose helical (spiral) computed tomography  and standard chest X-ray, for their effects on lung cancer death rates in a high-risk population.</field_page_description>
  <field_date_posted>2002-09-18</field_date_posted>
  <field_date_reviewed>2015-04-01</field_date_reviewed>
  <field_pretty_url>nlst-qa</field_pretty_url>
  <para_id>922411</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>10978</term_id>
  <id>112133</id>
  <title>Emergency Resources for the Cancer Community</title>
  <langcode>en</langcode>
  <field_short_title>Emergency Resources for the Cancer Community</field_short_title>
  <field_page_description>Information to help prepare for an emergency. Includes resources to continue cancer care, to prepare and update NCI employees and contractors, and NCI contacts for grantees.</field_page_description>
  <field_date_posted>2011-10-03</field_date_posted>
  <field_date_reviewed>2011-10-03</field_date_reviewed>
  <para_id>112133</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>777590</term_id>
  <id>777638</id>
  <title>Center for Global Health Seminar Series</title>
  <langcode>en</langcode>
  <field_short_title>Center for Global Health Seminar Series</field_short_title>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2013-02-20</field_date_reviewed>
  <para_id>777638</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>801795</term_id>
  <id>801797</id>
  <title>RAS Tools and Resources</title>
  <langcode>en</langcode>
  <field_short_title>Tools and Resources</field_short_title>
  <field_page_description>Find RAS datasets, tools, and resources. You can also share your own tools with the community for further collaboration. </field_page_description>
  <field_date_posted>2014-09-22</field_date_posted>
  <field_date_reviewed>2014-07-07</field_date_reviewed>
  <para_id>801797</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>802441</term_id>
  <id>802442</id>
  <title>How to Work With Your Health Insurance Plan</title>
  <langcode>en</langcode>
  <field_short_title>How to Work With Your Health Insurance Plan</field_short_title>
  <field_page_description>Insurance plans may cover some costs of taking part in a clinical trial. Learn who to contact for help, questions to ask, and the types of information to collect.</field_page_description>
  <field_date_posted>2014-07-10</field_date_posted>
  <field_date_reviewed>2016-06-22</field_date_reviewed>
  <para_id>802442</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919511</term_id>
  <id>807050</id>
  <title>About the Office of Grants Administration</title>
  <langcode>en</langcode>
  <field_short_title>About the Office of Grants Administration</field_short_title>
  <field_page_description>OGA supports grants and cooperative agreements awarded to scientific institutions, small businesses, and individuals to help build, maintain, and enhance a cohesive and comprehensive cancer research agenda. Learn more about OGA and its program structure.</field_page_description>
  <field_date_posted>2014-07-22</field_date_posted>
  <field_date_reviewed>2014-07-22</field_date_reviewed>
  <para_id>807050</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>814411</term_id>
  <id>814412</id>
  <title>About the NCI Council of Research Advocates</title>
  <langcode>en</langcode>
  <field_short_title>About the NCI Council of Research Advocates</field_short_title>
  <field_page_description>The NCRA focuses on matters that facilitate research and often identifies and responds to challenges facing the Institute at the request of NCI leadership.</field_page_description>
  <field_date_posted>2014-01-30</field_date_posted>
  <field_date_reviewed>2014-01-30</field_date_reviewed>
  <para_id>814412</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>816949</term_id>
  <id>816965</id>
  <title>RAS Drug Discovery</title>
  <langcode>en</langcode>
  <field_short_title>RAS Drug Discovery</field_short_title>
  <field_page_description>The RAS Drug Discovery group aims to develop assays that will reveal aspects of RAS biology upon which cancer cells depend. Successful assay formats are made available for high-throughput screening programs to yield potentially effective drug compounds.</field_page_description>
  <field_date_posted>2015-02-20</field_date_posted>
  <field_date_reviewed>2014-08-19</field_date_reviewed>
  <para_id>816965</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>898587</term_id>
  <id>818142</id>
  <title>Milestones in Cancer Research and Discovery</title>
  <langcode>en</langcode>
  <field_short_title>Milestones in Cancer Research and Discovery</field_short_title>
  <field_page_description>During the past 250 years, we have witnessed many landmark discoveries in our efforts to make progress against cancer, an affliction known to humanity for thousands of years. This timeline shows a few key milestones in the history of cancer research.</field_page_description>
  <field_date_posted>2015-01-21</field_date_posted>
  <field_date_reviewed>2014-08-22</field_date_reviewed>
  <para_id>818142</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>827981</term_id>
  <id>828020</id>
  <title>NCI Center to Reduce Cancer Health Disparities (CRCHD)</title>
  <langcode>en</langcode>
  <field_short_title>CRCHD</field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2018-05-17</field_date_reviewed>
  <para_id>828020</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>828699</id>
  <title>September Spotlight: Childhood Cancer Awareness Month and other Cancer Awareness Highlights</title>
  <langcode>en</langcode>
  <field_short_title>September Spotlight: Childhood Cancer Awareness Month and other Cancer Awareness Highlights</field_short_title>
  <field_date_posted>2014-09-18</field_date_posted>
  <field_date_reviewed>2014-09-18</field_date_reviewed>
  <field_pretty_url>september-spotlight</field_pretty_url>
  <para_id>828699</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>832769</id>
  <title>NCI's Center for Global Health announces first major research grants to support portable technologies</title>
  <langcode>en</langcode>
  <field_short_title>Center for Global Health announces  grants to support portable technologies</field_short_title>
  <field_page_description>NCI's Center for Global Health announced grants that will support the development and validation of low-cost, portable technologies. These technologies have the potential to improve early detection, diagnosis, and non-invasive or minimally invasive treatm</field_page_description>
  <field_date_posted>2014-09-22</field_date_posted>
  <field_date_reviewed>2014-09-22</field_date_reviewed>
  <field_pretty_url>CGHPortabilityAwards</field_pretty_url>
  <para_id>832769</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>833179</term_id>
  <id>833184</id>
  <title>Community Networks Program (CNP)</title>
  <langcode>en</langcode>
  <field_short_title>CNP </field_short_title>
  <field_date_posted>2014-09-24</field_date_posted>
  <field_date_reviewed>2014-09-24</field_date_reviewed>
  <para_id>833184</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>416992</id>
  <title>Gene identified that sensitizes cancer cells to chemotherapy drugs</title>
  <langcode>en</langcode>
  <field_short_title>Gene sensitizes cancer cells to chemotherapy drugs</field_short_title>
  <field_page_description>NCI scientists have found that a gene, Schlafen-11 (SLFN11), sensitizes cells to substances known to cause irreparable damage to DNA.  As part of their study, the researchers used a repository of 60 cell types to identify predictors of cancer cell respons</field_page_description>
  <field_date_posted>2012-08-27</field_date_posted>
  <field_date_reviewed>2012-08-27</field_date_reviewed>
  <field_pretty_url>SchlafenPNASNewsNote</field_pretty_url>
  <para_id>416992</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>459325</id>
  <title>NIH study finds leisure-time physical activity extends life expectancy as much as 4.5 years</title>
  <langcode>en</langcode>
  <field_short_title>Physical activity extends life expectancy</field_short_title>
  <field_page_description>Leisure-time physical activity is associated with longer life expectancy, even at relatively low levels of activity and regardless of body weight, according to a study by a team of researchers led by the NCI. </field_page_description>
  <field_date_posted>2012-11-06</field_date_posted>
  <field_date_reviewed>2012-11-05</field_date_reviewed>
  <field_pretty_url>PhysicalActivityLifeExpectancy</field_pretty_url>
  <para_id>459325</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>463787</id>
  <title>Eating Hints: Before, during, and after Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Eating Hints: Before, during, and after Cancer Treatment</field_short_title>
  <field_page_description>Eating Hints covers eating problems that may be caused by cancer and its treatment. Learn about common eating problems and ways to manage them.</field_page_description>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2012-11-20</field_date_reviewed>
  <field_pretty_url>eating-hints</field_pretty_url>
  <para_id>463787</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938032</term_id>
  <id>468217</id>
  <title>Adding Chemotherapy to Radiation Improves Survival for Some Patients with Rare Brain Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Adding Chemotherapy to Radiation Improves Survival for Some Patients with Rare Brain Cancer</field_short_title>
  <field_page_description>Long-term results from two clinical trials confirm that certain patients with anaplastic oligodendrogliomas live substantially longer if they are treated with a combination of chemotherapy and radiation therapy rather than radiatiation alone.</field_page_description>
  <field_date_posted>2012-11-29</field_date_posted>
  <field_date_reviewed>2012-11-28</field_date_reviewed>
  <field_pretty_url>chemotherapy-improves-survival</field_pretty_url>
  <para_id>468217</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917237</term_id>
  <id>478616</id>
  <title>Concept Checklist  </title>
  <langcode>en</langcode>
  <field_short_title>Concept Checklist  </field_short_title>
  <field_date_posted>2012-12-17</field_date_posted>
  <field_date_reviewed>2012-12-17</field_date_reviewed>
  <field_pretty_url>concept-checklists</field_pretty_url>
  <para_id>478616</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917237</term_id>
  <id>478617</id>
  <title>Evaluator Resources</title>
  <langcode>en</langcode>
  <field_short_title>Evaluator Resources</field_short_title>
  <field_date_posted>2012-12-17</field_date_posted>
  <field_date_reviewed>2012-12-17</field_date_reviewed>
  <field_pretty_url>evaluator-resources</field_pretty_url>
  <para_id>478617</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069530</term_id>
  <id>920991</id>
  <title>The RAS Reference Reagents Program: Sharing Resources and Enabling RAS Research</title>
  <langcode>en</langcode>
  <field_short_title>The RAS Reference Reagents Program: Sharing Resources and Enabling RAS Research</field_short_title>
  <field_date_posted>2015-03-30</field_date_posted>
  <field_date_reviewed>2015-03-27</field_date_reviewed>
  <field_pretty_url>ras-reference-reagents-program</field_pretty_url>
  <para_id>920991</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>921717</id>
  <title>A Week of Excitement and Hope: Communicating the Story of Cancer </title>
  <langcode>en</langcode>
  <field_short_title>A Week of Excitement and Hope: Communicating the Story of Cancer </field_short_title>
  <field_date_posted>2015-03-30</field_date_posted>
  <field_date_reviewed>2015-03-30</field_date_reviewed>
  <field_pretty_url>garret-arn</field_pretty_url>
  <para_id>921717</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>921992</id>
  <title>Looking to the Future of Childhood Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Looking to the Future of Childhood Cancer Research</field_short_title>
  <field_page_description>NCI’s Dr. Malcolm Smith discusses future directions of childhood cancer research, including treatment directions and clinical trials.</field_page_description>
  <field_date_posted>2015-03-31</field_date_posted>
  <field_date_reviewed>2015-03-31</field_date_reviewed>
  <field_pretty_url>future-childhood-cancer-research</field_pretty_url>
  <para_id>921992</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>941428</term_id>
  <id>922213</id>
  <title>NCI Director Dr. Norman E. Sharpless</title>
  <langcode>en</langcode>
  <field_short_title>Director's Page</field_short_title>
  <field_page_description>Information about NCI Director Dr. Norman E. Sharpless</field_page_description>
  <field_date_posted>2017-10-17</field_date_posted>
  <field_date_reviewed>2015-03-31</field_date_reviewed>
  <para_id>922213</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>922511</term_id>
  <id>922514</id>
  <title>Reports, Research, and Literature</title>
  <langcode>en</langcode>
  <field_short_title>Reports, Research, and Literature</field_short_title>
  <field_date_posted>2015-04-01</field_date_posted>
  <field_date_reviewed>2015-04-01</field_date_reviewed>
  <para_id>922514</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>922522</id>
  <title>The Cancer Genome Atlas: Generating a "Parts List" for Cancer</title>
  <langcode>en</langcode>
  <field_short_title>The Cancer Genome Atlas: Generating a "Parts List" for Cancer</field_short_title>
  <field_date_posted>2015-04-02</field_date_posted>
  <field_date_reviewed>2015-04-02</field_date_reviewed>
  <field_pretty_url>tcga-parts-list</field_pretty_url>
  <para_id>922522</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>929888</term_id>
  <id>929890</id>
  <title>PDQ&amp;reg; Cancer Information Summaries</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Information Summaries</field_short_title>
  <field_page_description>Peer-reviewed, evidence-based summaries on topics including adult and pediatric cancer treatment, supportive and palliative care, screening, prevention, genetics, and complementary and alternative medicine. References to published literature are included.</field_page_description>
  <field_date_posted>2015-04-07</field_date_posted>
  <field_date_reviewed>2015-04-07</field_date_reviewed>
  <para_id>929890</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>923820</id>
  <title>India Models New Institute on NCI</title>
  <langcode>en</langcode>
  <field_short_title>India Models New Institute on NCI</field_short_title>
  <field_date_posted>2015-04-03</field_date_posted>
  <field_date_reviewed>2015-04-03</field_date_reviewed>
  <field_pretty_url>india-delegation</field_pretty_url>
  <para_id>923820</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>915878</term_id>
  <id>929550</id>
  <title>Risk Factors for Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Risk Factors</field_short_title>
  <field_page_description>Information about behaviors, exposures, and other factors that may influence the risk of cancer.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-04-06</field_date_reviewed>
  <para_id>929550</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>929876</term_id>
  <id>929880</id>
  <title>NCI Mobile Apps</title>
  <langcode>en</langcode>
  <field_short_title>Mobile Apps</field_short_title>
  <field_page_description>Download free mobile apps from the National Cancer Institute, including apps for smoking cessation support and the training of the next generation of cancer researchers.</field_page_description>
  <field_date_posted>2015-04-07</field_date_posted>
  <field_date_reviewed>2015-04-07</field_date_reviewed>
  <para_id>929880</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>930340</id>
  <title>The RAS Problem: Turning Off a Broken Switch </title>
  <langcode>en</langcode>
  <field_short_title>The RAS Problem: Turning Off a Broken Switch </field_short_title>
  <field_date_posted>2015-04-09</field_date_posted>
  <field_date_reviewed>2015-04-09</field_date_reviewed>
  <field_pretty_url>turning-off-broken-switch</field_pretty_url>
  <para_id>930340</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>936263</id>
  <title>2015 Press Releases</title>
  <langcode>en</langcode>
  <field_short_title>2015 Press Releases</field_short_title>
  <field_page_description>Press releases from the National Cancer Institute for the year 2015.</field_page_description>
  <field_date_posted>2015-04-15</field_date_posted>
  <field_date_reviewed>2015-04-15</field_date_reviewed>
  <para_id>936263</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>936344</id>
  <title>Microscopy Advances Open Up New Avenues of Cancer Discovery</title>
  <langcode>en</langcode>
  <field_short_title>Microscopy Opening Up New Cancer Discovery Avenues</field_short_title>
  <field_page_description>Today’s high-powered microscopes are allowing researchers to study the fine details of individual cells and to peer into cells, opening up new avenues of discovery about the inner workings of cells, including the events that can cause healthy cells to tra</field_page_description>
  <field_date_posted>2015-04-15</field_date_posted>
  <field_date_reviewed>2015-04-15</field_date_reviewed>
  <field_pretty_url>microscopy-advances</field_pretty_url>
  <para_id>936344</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>936439</id>
  <title>Grantee Spotlight: Shawna Hudson, Ph.D. - Helping Cancer Survivors EXCEL </title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Shawna Hudson, Ph.D. - Helping Cancer Survivors EXCEL </field_short_title>
  <field_date_posted>2014-06-05</field_date_posted>
  <field_date_reviewed>2014-06-05</field_date_reviewed>
  <field_pretty_url>hudson-spotlight-blog</field_pretty_url>
  <para_id>936439</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>937990</id>
  <title>Special Spotlight: In Memoriam Alessandra Margherita Bini, Ph.D. CRCHD Program Director </title>
  <langcode>en</langcode>
  <field_short_title>Special Spotlight: In Memoriam Alessandra Margherita Bini, Ph.D. CRCHD Program Director </field_short_title>
  <field_date_posted>2014-03-14</field_date_posted>
  <field_date_reviewed>2014-03-14</field_date_reviewed>
  <field_pretty_url>bini-spotlight</field_pretty_url>
  <para_id>937990</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>937992</id>
  <title>Special Spotlight: In Memoriam Patricia Susana Lorenzo, Ph.D. Cancer Researcher and Former CRCHD Grantee </title>
  <langcode>en</langcode>
  <field_short_title>Special Spotlight: In Memoriam Patricia Susana Lorenzo, Ph.D. </field_short_title>
  <field_date_posted>2014-03-14</field_date_posted>
  <field_date_reviewed>2014-03-14</field_date_reviewed>
  <field_pretty_url>lorenzo-spotlight</field_pretty_url>
  <para_id>937992</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069530</term_id>
  <id>939610</id>
  <title>Enzymology of GTP-competitive RAS inhibitors</title>
  <langcode>en</langcode>
  <field_short_title>Enzymology of GTP-competitive RAS inhibitors</field_short_title>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-04-29</field_date_reviewed>
  <field_pretty_url>Enzymology-of-GTP-competitive-RAS-inhibitors</field_pretty_url>
  <para_id>939610</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>939791</term_id>
  <id>939796</id>
  <title>Adrenocortical Carcinoma—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Adrenocortical Carcinoma</field_short_title>
  <field_page_description>Adrenocortical carcinoma is also called cancer of the adrenal cortex. A tumor of the adrenal cortex may be functioning or nonfunctioning. Most adrenocortical tumors are functioning. Find evidence-based information on adrenocortical carcinoma including treatment and research.</field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-04-30</field_date_reviewed>
  <para_id>939796</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938137</term_id>
  <id>939825</id>
  <title>Anal Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on anal cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-04-30</field_date_reviewed>
  <para_id>939825</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940149</term_id>
  <id>940154</id>
  <title>Extracranial Germ Cell Tumors—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Extracranial Germ Cell Tumors</field_short_title>
  <field_page_description>Extracranial germ cell tumors (GCTs) arise from primordial germ cells, which migrate during embryogenesis from the yolk sac to the gonads. Childhood extracranial GCTs can be divided into the following two types: gonadal, and extragonadal. Find evidence-based information on extracranial germ cell tumors treatment.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940154</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940261</term_id>
  <id>940266</id>
  <title>Gastrointestinal Carcinoid Tumors—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Gastrointestinal Carcinoid Tumors</field_short_title>
  <field_page_description>Gastrointestinal carcinoid tumors are rare, slow-growing tumors that originate in the neuroendocrine cells in the GI tract. Find evidence-based information on gastrointestinal carcinoid tumors treatment and research. </field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940266</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>836658</id>
  <title>Facing Forward: When Someone You Love Has Completed Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Facing Forward: When Someone You Love Has Completed Cancer Treatment</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2014-10-03</field_date_reviewed>
  <field_pretty_url>someone-you-love-completed-cancer-treatment</field_pretty_url>
  <para_id>836658</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922399</term_id>
  <id>139071</id>
  <title>Study Shows Aspirin Reduces Colorectal Cancer in Those at High Risk</title>
  <langcode>en</langcode>
  <field_short_title>Study Shows Aspirin Reduces Colorectal Cancer in Those at High Risk</field_short_title>
  <field_page_description>Findings from the first large clinical trial of its kind indicate that taking high doses of aspirin daily for at least 2 years substantially reduces the risk of colorectal cancer among people at increased risk of the disease.</field_page_description>
  <field_date_posted>2011-12-02</field_date_posted>
  <field_date_reviewed>2011-12-02</field_date_reviewed>
  <field_pretty_url>aspirin-reduces-risk</field_pretty_url>
  <para_id>139071</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069528</term_id>
  <id>842460</id>
  <title>What Do We Mean By "RAS Pathway"?</title>
  <langcode>en</langcode>
  <field_short_title>What Do We Mean By "RAS Pathway"?</field_short_title>
  <field_date_posted>2014-10-22</field_date_posted>
  <field_date_reviewed>2014-10-22</field_date_reviewed>
  <field_pretty_url>what-do-we-mean-ras-pathway</field_pretty_url>
  <para_id>842460</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>858164</term_id>
  <id>858342</id>
  <title>Facing Cancer with Your Spouse or Partner</title>
  <langcode>en</langcode>
  <field_short_title>Facing Cancer with Your Spouse or Partner</field_short_title>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-14</field_date_reviewed>
  <para_id>858342</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>912419</term_id>
  <id>859634</id>
  <title>Survivorship</title>
  <langcode>en</langcode>
  <field_short_title>Survivorship</field_short_title>
  <field_page_description>After cancer treatment, the transition to a new way of life can be hard. Find out how to plan for follow-up care and adjust to physical, emotional, and family changes.</field_page_description>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-17</field_date_reviewed>
  <para_id>859634</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>860592</id>
  <title>Approaching Pediatric Cancers through a Global Lens</title>
  <langcode>en</langcode>
  <field_short_title>Approaching Pediatric Cancers through a Global Lens</field_short_title>
  <field_date_posted>2014-11-21</field_date_posted>
  <field_date_reviewed>2014-11-21</field_date_reviewed>
  <field_pretty_url>pediatrics</field_pretty_url>
  <para_id>860592</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>903966</term_id>
  <id>867900</id>
  <title>CCG Contact and Staff</title>
  <langcode>en</langcode>
  <field_short_title>CCG Contact &amp; Staff</field_short_title>
  <field_page_description>Contact information and staff listing for the Center for Cancer Genomics Office of the Director, Office of Cancer Genomics, and the Cancer Genome Atlas Program Office.</field_page_description>
  <field_date_posted>2015-04-13</field_date_posted>
  <field_date_reviewed>2014-12-05</field_date_reviewed>
  <para_id>867900</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>882522</term_id>
  <id>882531</id>
  <title>Aristolochic Acids </title>
  <langcode>en</langcode>
  <field_short_title>Aristolochic Acids </field_short_title>
  <field_page_description>Learn about aristolochic acids, which may increase your risk of bladder cancer and cancers of the upper urinary tract (renal pelvis and ureter).  Aristolochic acids are found naturally in many types of plants, some of which are used in herbal products marketed as dietary supplements.</field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2019-01-14</field_date_reviewed>
  <para_id>882531</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>916470</term_id>
  <id>882631</id>
  <title>1,3-Butadiene</title>
  <langcode>en</langcode>
  <field_short_title>1,3-Butadiene</field_short_title>
  <field_page_description>Learn about 1,3-butadiene, exposure to which can raise your risk of leukemia. 1,3-Butadiene is a gas used to produce synthetic rubber products, such as tires, resins, and plastics. Other sources of exposure include car exhaust; tobacco smoke; and polluted air and water near industrial facilities.</field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2019-01-31</field_date_reviewed>
  <para_id>882631</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>883417</id>
  <title>More than 300 million people in at least 70 countries use smokeless tobacco </title>
  <langcode>en</langcode>
  <field_short_title>More than 300 million people in at least 70 countries use smokeless tobacco </field_short_title>
  <field_date_posted>2014-12-16</field_date_posted>
  <field_date_reviewed>2014-12-16</field_date_reviewed>
  <field_pretty_url>smokeless-tobacco</field_pretty_url>
  <para_id>883417</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>885683</id>
  <title>A key molecular defect in a childhood gastrointestinal tumor may have important diagnostic implications</title>
  <langcode>en</langcode>
  <field_short_title>Key molecular defect in a childhood gastrointestinal tumor found</field_short_title>
  <field_page_description>NCI scientists have identified a key molecular defect in a tumor in children known as gastrointestinal stromal tumor, or GIST, that may have important diagnostic implications.</field_page_description>
  <field_date_posted>2014-12-24</field_date_posted>
  <field_date_reviewed>2014-12-19</field_date_reviewed>
  <field_pretty_url>SDHCepimutantGIST</field_pretty_url>
  <para_id>885683</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>929838</term_id>
  <id>892302</id>
  <title>CCG Funding Opportunities</title>
  <langcode>en</langcode>
  <field_short_title>Funding Opportunities</field_short_title>
  <field_page_description>Center for Cancer Genomics (CCG) Funding Opportunities</field_page_description>
  <field_date_posted>2015-10-23</field_date_posted>
  <field_date_reviewed>2015-01-08</field_date_reviewed>
  <para_id>892302</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>892471</id>
  <title>January Monthly Spotlight: Cervical Health and Cervical Cancer Disparities</title>
  <langcode>en</langcode>
  <field_short_title>January Monthly Spotlight: Cervical Health and Cervical Cancer Disparities</field_short_title>
  <field_date_posted>2015-01-09</field_date_posted>
  <field_date_reviewed>2015-01-09</field_date_reviewed>
  <field_pretty_url>january-spotlight</field_pretty_url>
  <para_id>892471</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>938462</id>
  <title>Trial Yields Positive Data on Pembrolizumab for Lung Cancer, Potential Response Biomarker</title>
  <langcode>en</langcode>
  <field_short_title>Trial Yields Positive Data on Pembrolizumab for Lung Cancer</field_short_title>
  <field_page_description>Findings from an early phase clinical trial may point to a biomarker that identifies patients with advanced non-small cell lung cancer most likely to respond to the immunotherapy drug pembrolizumab (Keytruda®). </field_page_description>
  <field_date_posted>2015-04-27</field_date_posted>
  <field_date_reviewed>2015-04-24</field_date_reviewed>
  <field_pretty_url>pembrolizumab-biomarker</field_pretty_url>
  <para_id>938462</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>939555</id>
  <title>Mexico’s National Cancer Control Plan: From Development to Implementation</title>
  <langcode>en</langcode>
  <field_short_title>Mexico’s National Cancer Control Plan: From Development to Implementation</field_short_title>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-04-29</field_date_reviewed>
  <field_pretty_url>mexico-nccp</field_pretty_url>
  <para_id>939555</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>939623</id>
  <title>Empowering Women through Education and Advocacy in Breast and Cervical Cancer Prevention and Control</title>
  <langcode>en</langcode>
  <field_short_title>Empowering Women through Education and Advocacy in Breast and Cervical Cancer Prevention and Control</field_short_title>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-04-30</field_date_reviewed>
  <field_pretty_url>wcs-peru</field_pretty_url>
  <para_id>939623</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938161</term_id>
  <id>939859</id>
  <title>Bladder Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on bladder cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-04-30</field_date_reviewed>
  <para_id>939859</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>939964</id>
  <title>Breast Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on breast cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-04-30</field_date_reviewed>
  <para_id>939964</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940225</term_id>
  <id>940232</id>
  <title>Stomach (Gastric) Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Stomach (Gastric) Cancer</field_short_title>
  <field_page_description>Almost all gastric cancers are adenocarcinomas. Other types of gastric cancer are gastrointestinal carcinoid tumors, gastrointestinal stromal tumors, and lymphomas. Find evidence-based information on gastric cancer treatment, causes and prevention, screening, research, and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940232</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940313</term_id>
  <id>940322</id>
  <title>Head and Neck Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Head and Neck Cancer </field_short_title>
  <field_page_description>Head and neck cancers include hypopharyngeal, laryngeal, lip and oral cavity, metastatic squamous neck, nasopharyngeal, oropharyngeal, paranasal sinus, and salivary gland cancers. Find evidence-based information on head and neck cancer treatment, causes and prevention, research, screening, and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940322</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940644</term_id>
  <id>940649</id>
  <title>Myeloproliferative Neoplasms—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Myeloproliferative Neoplasms </field_short_title>
  <field_page_description>Myeloproliferative neoplasms and myelodysplastic syndromes are diseases of the blood cells. They include chronic myeloproliferative neoplasms, myelodysplastic syndromes, and myelodysplastic/myeloproliferative neoplasms. Find evidence-based information on myeloproliferative neoplasms treatment.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940649</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>922403</term_id>
  <id>940891</id>
  <title>Prostate Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on prostate cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940891</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940990</term_id>
  <id>940995</id>
  <title>Small Intestine Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Small Intestine Cancer</field_short_title>
  <field_page_description>Adenocarcinoma is the most common type of small intestine cancer. Other types of small intestine cancer are sarcomas, carcinoid tumors, gastrointestinal stromal tumors, and lymphomas. Find evidence-based information on small intestine cancer treatment, research, and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940995</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>941107</term_id>
  <id>941114</id>
  <title>Thyroid Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Thyroid Cancer </field_short_title>
  <field_page_description>There are four types of thyroid cancer. These are papillary, follicular, medullary, and anaplastic thyroid cancer. Papillary is the most common type of thyroid cancer. Find evidence-based information on thyroid cancer treatment, screening, research, genetics, and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941114</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>940829</term_id>
  <id>940837</id>
  <title>Pheochromocytoma and Paraganglioma Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on pheochromocytoma and paraganglioma, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940837</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940858</term_id>
  <id>940863</id>
  <title>Pituitary Tumors—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Pituitary Tumors</field_short_title>
  <field_page_description>Pituitary tumors represent from 10% to 25% of all intracranial neoplasms. Pituitary tumors can be classified into three groups: benign adenoma, invasive adenoma, and carcinoma. Find evidence-based information on pituitary tumors treatment.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940863</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938139</term_id>
  <id>941026</id>
  <title>Soft Tissue Sarcoma Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on soft tissue sarcoma, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941026</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>941166</term_id>
  <id>941175</id>
  <title>Uterine Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Uterine Cancer</field_short_title>
  <field_page_description>Most uterine cancers start in the endometrium, which is called endometrial cancer. Uterine sarcoma is a form of uterine cancer of the muscle and tissue that support the uterus. Find evidence-based information on uterine cancer treatment, causes and prevention, screening, research, genetics, and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941175</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>941229</term_id>
  <id>941234</id>
  <title>Vulvar Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Vulvar Cancer </field_short_title>
  <field_page_description>Vulvar cancer forms in a woman's external genitalia, and most often affects the outer vaginal lips. Having vulvar intraepithelial neoplasia or HPV infection can affect the risk of vulvar cancer. Find evidence-based information on vulvar cancer treatment, research, and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941234</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>917293</term_id>
  <id>941581</id>
  <title>Resources for Patients</title>
  <langcode>en</langcode>
  <field_short_title>Resources for Patients</field_short_title>
  <field_page_description>Authoritative information about your type of cancer, as well as information on a wide range of cancer topics and the latest cancer research. </field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941581</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>917291</term_id>
  <id>941598</id>
  <title>Information for the Cancer Research Community </title>
  <langcode>en</langcode>
  <field_short_title>Resources for the Cancer Research Community </field_short_title>
  <field_page_description>Find research and development tools, datasets, information about research training programs, and basics about applying for and managing grants.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941598</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>922822</term_id>
  <id>951125</id>
  <title>NCI Events</title>
  <langcode>en</langcode>
  <field_short_title>Events</field_short_title>
  <field_page_description>Find upcoming scientific conferences where NCI will be exhibiting, NCI-hosted lectures, scientific meetings, board meetings, and live social media Twitter chat events involving NCI and our partners.</field_page_description>
  <field_date_posted>2015-05-05</field_date_posted>
  <field_date_reviewed>2015-05-05</field_date_reviewed>
  <para_id>951125</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938227</term_id>
  <id>952011</id>
  <title>Metastatic Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Metastatic Cancer Research</field_short_title>
  <field_page_description>Find research articles about metastatic cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies. </field_page_description>
  <field_date_posted>2015-05-12</field_date_posted>
  <field_date_reviewed>2015-05-08</field_date_reviewed>
  <para_id>952011</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>952652</term_id>
  <id>14308</id>
  <title>PDQ&amp;reg; Cancer Information Summaries: Adult Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Adult Treatment</field_short_title>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14308</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1062505</id>
  <title>Chromosomal Instability Score May Predict Response to Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Novel Cancer Biomarker May Predict Prognosis, Treatment Response</field_short_title>
  <field_page_description>An NCI Cancer Currents blog about a study of a new type of cancer biomarker that measures the extent of chromosomal instability as a way to potentially predict patient prognosis and help guide cancer treatment choices.</field_page_description>
  <field_date_posted>2016-09-23</field_date_posted>
  <field_date_reviewed>2016-09-23</field_date_reviewed>
  <field_pretty_url>chromosomal-instability</field_pretty_url>
  <para_id>1062505</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>930502</term_id>
  <id>1066022</id>
  <title>New Therapies Are Changing the Outlook for Advanced Melanoma</title>
  <langcode>en</langcode>
  <field_short_title>New Therapies Available for Advanced Melanoma</field_short_title>
  <field_page_description>An article about a host of new treatment options that have been produced in the last several years for patients with the skin cancer melanoma.</field_page_description>
  <field_date_posted>2014-12-19</field_date_posted>
  <field_date_reviewed>2016-10-26</field_date_reviewed>
  <field_pretty_url>advanced-melanoma-therapies</field_pretty_url>
  <para_id>1066022</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>1066661</id>
  <title>Ribociclib Improves Progression-Free Survival for Some Women with Metastatic Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Ribociclib Improves Progression-Free Survival in Breast Cancer</field_short_title>
  <field_page_description>A summary of interim results from a phase III trial testing ribociclib plus letrozole (Femara®) as a first-line treatment for postmenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer.</field_page_description>
  <field_date_posted>2016-11-14</field_date_posted>
  <field_date_reviewed>2016-11-14</field_date_reviewed>
  <field_pretty_url>ribociclib-metastatic-breast</field_pretty_url>
  <para_id>1066661</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1067324</id>
  <title>No Safe Level of Smoking: Even low-intensity smokers are at increased risk of earlier death</title>
  <langcode>en</langcode>
  <field_short_title>No Safe Level of Smoking</field_short_title>
  <field_page_description>People who consistently smoked an average of less than one cigarette per day over their lifetimes had a 64 percent higher risk of earlier death than people who never smoked.</field_page_description>
  <field_date_posted>2016-12-05</field_date_posted>
  <field_date_reviewed>2016-11-29</field_date_reviewed>
  <field_pretty_url>low-intensity-smoking-risk</field_pretty_url>
  <para_id>1067324</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1068421</id>
  <title>FDA Approves New Use for Daratumumab in Multiple Myeloma</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves New Use for Daratumumab in Multiple Myeloma</field_short_title>
  <field_page_description>A Cancer Currents blog post on the FDA’s approval of daratumumab in patients with multiple myeloma whose disease has progressed after only a single prior treatment course.</field_page_description>
  <field_date_posted>2016-12-09</field_date_posted>
  <field_date_reviewed>2016-12-09</field_date_reviewed>
  <field_pretty_url>daratumumab-fda-myeloma-new</field_pretty_url>
  <para_id>1068421</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1069645</id>
  <title>New on NCI’s Websites for December 2016</title>
  <langcode>en</langcode>
  <field_short_title>New on NCI’s Websites for December 2016</field_short_title>
  <field_page_description>An update on new content of interest to the cancer community recently added to NCI’s websites.</field_page_description>
  <field_date_posted>2016-12-28</field_date_posted>
  <field_date_reviewed>2016-12-22</field_date_reviewed>
  <field_pretty_url>new-online-december-2016</field_pretty_url>
  <para_id>1069645</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1070753</id>
  <title>FDA Approves Rucaparib for BRCA-Positive Ovarian Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Rucaparib for BRCA-Positive Ovarian Cancer</field_short_title>
  <field_page_description>An NCI Cancer Currents blog about the FDA approval of rucaparib for women with BRCA-positive ovarian cancer who have received at least two chemotherapy regimens.</field_page_description>
  <field_date_posted>2017-01-09</field_date_posted>
  <field_date_reviewed>2017-01-09</field_date_reviewed>
  <field_pretty_url>fda-rucaparib-ovarian</field_pretty_url>
  <para_id>1070753</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1066360</term_id>
  <id>1072118</id>
  <title>Together, WE CAN Make a Difference</title>
  <langcode>en</langcode>
  <field_short_title>Together, WE CAN Make a Difference</field_short_title>
  <field_date_posted>2017-01-30</field_date_posted>
  <field_date_reviewed>2017-01-30</field_date_reviewed>
  <field_pretty_url>wcd-2017</field_pretty_url>
  <para_id>1072118</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070072</term_id>
  <id>1072628</id>
  <title>The K-Ras Anchor: Another Twist to the Tale</title>
  <langcode>en</langcode>
  <field_short_title>The K-Ras Anchor: Another Twist to the Tale</field_short_title>
  <field_page_description>The amino acid sequence of the C-terminus of K-Ras4B combines with its lipid modifications to strongly influence its interactions with the plasma membrane.</field_page_description>
  <field_date_posted>2017-02-06</field_date_posted>
  <field_date_reviewed>2017-02-06</field_date_reviewed>
  <field_pretty_url>kras4b-hvr-sequence-lipids-hancock</field_pretty_url>
  <para_id>1072628</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070072</term_id>
  <id>1073715</id>
  <title>RAS Pathway v3.0?</title>
  <langcode>en</langcode>
  <field_short_title>RAS Pathway v3.0?</field_short_title>
  <field_page_description>Defining the most important elements of RAS signaling is an important objective of the NCI RAS Initiative.  Advisor Frank McCormick invites community input on version 3 of the RAS Pathway.</field_page_description>
  <field_date_posted>2017-02-28</field_date_posted>
  <field_date_reviewed>2017-02-22</field_date_reviewed>
  <field_pretty_url>mccormick-ras-pathway-v3</field_pretty_url>
  <para_id>1073715</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070074</term_id>
  <id>1070682</id>
  <title>TCGA to Complete its Final Analysis: the PanCanAtlas</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's PanCanAtlas</field_short_title>
  <field_page_description>The PanCanAtlas, TCGA’s final project, will analyze the whole TCGA dataset.</field_page_description>
  <field_date_posted>2017-01-09</field_date_posted>
  <field_date_reviewed>2017-01-05</field_date_reviewed>
  <field_pretty_url>tcga-pancan-atlas</field_pretty_url>
  <para_id>1070682</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1070725</id>
  <title>Ibrutinib Relieves Chronic Graft-Versus-Host Disease Symptoms</title>
  <langcode>en</langcode>
  <field_short_title>Ibrutinib Effective against Graft-Versus-Host Disease</field_short_title>
  <field_page_description>A Cancer Currents blog post on results from a small clinical trial showing that ibrutinib can effectively treat graft-versus-host-disease, a common and serious complication of allogeneic stem cell transplants.</field_page_description>
  <field_date_posted>2017-01-11</field_date_posted>
  <field_date_reviewed>2017-01-06</field_date_reviewed>
  <field_pretty_url>ibrutinib-stem-cell-transplant-gvhd</field_pretty_url>
  <para_id>1070725</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070074</term_id>
  <id>1072254</id>
  <title>Functional Genomics Study Finds Druggable Target in &lt;em&gt;KRAS&lt;/em&gt;-mutant Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>New Lung Cancer Target</field_short_title>
  <field_page_description>A genomics study, published in &lt;em&gt;Nature&lt;/em&gt;, identified a vulnerability specific to &lt;em&gt;KRAS&lt;/em&gt;-mutant lung cancers that can be treated with available drugs.</field_page_description>
  <field_date_posted>2017-02-02</field_date_posted>
  <field_date_reviewed>2017-02-02</field_date_reviewed>
  <field_pretty_url>xpo1-kras-lung-target</field_pretty_url>
  <para_id>1072254</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1074837</term_id>
  <id>1074843</id>
  <title>Structural Genomics Research</title>
  <langcode>en</langcode>
  <field_short_title>Structural Genomics Research</field_short_title>
  <field_page_description>NCI's Center for Cancer Genomics uses structural cancer genomics to identify genomic alterations that contribute to cancer growth, metastasis, and recurrence.</field_page_description>
  <field_date_posted>2017-08-04</field_date_posted>
  <field_date_reviewed>2017-03-06</field_date_reviewed>
  <para_id>1074843</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1074839</term_id>
  <id>1075487</id>
  <title>Computational Genomics Research</title>
  <langcode>en</langcode>
  <field_short_title>Computational Genomics Research</field_short_title>
  <field_page_description>NCI’s Center for Cancer Genomics uses computational cancer genomics to derive insight about cancer genes and pathways using big data.</field_page_description>
  <field_date_posted>2017-08-04</field_date_posted>
  <field_date_reviewed>2017-03-14</field_date_reviewed>
  <para_id>1075487</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1075562</id>
  <title>FDA Approves New Use for Lenalidomide in Multiple Myeloma</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves New Use for Lenalidomide in Multiple Myeloma</field_short_title>
  <field_page_description>A Cancer Currents blog on the approval of lenalidomide as maintenance therapy for patients with multiple myeloma who have received an autologous stem cell transplant.</field_page_description>
  <field_date_posted>2017-03-16</field_date_posted>
  <field_date_reviewed>2017-03-16</field_date_reviewed>
  <field_pretty_url>fda-lenalidomide-myeloma-maintenance</field_pretty_url>
  <para_id>1075562</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1077659</id>
  <title>Stem-Cell Based Tool May Help Measure Heart Toxicity of Cancer Drugs</title>
  <langcode>en</langcode>
  <field_short_title>Stem Cell-Based Tool Ranks Heart Toxicity of Cancer Drugs</field_short_title>
  <field_page_description>A Cancer Currents blog post on a new research study that uses a type of adult stem cell to assess the heart toxicity of cancer drugs known as tyrosine kinase inhibitors.</field_page_description>
  <field_date_posted>2017-03-21</field_date_posted>
  <field_date_reviewed>2017-03-21</field_date_reviewed>
  <field_pretty_url>heart-toxicity-index</field_pretty_url>
  <para_id>1077659</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919353</term_id>
  <id>1078552</id>
  <title>Regional Centers of Research Excellence Program</title>
  <langcode>en</langcode>
  <field_short_title>Regional Centers of Research Excellence Program</field_short_title>
  <field_date_posted>2017-03-30</field_date_posted>
  <field_date_reviewed>2017-03-30</field_date_reviewed>
  <field_pretty_url>rcres-program</field_pretty_url>
  <para_id>1078552</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1078422</term_id>
  <id>1078650</id>
  <title>Office of HIV and AIDS Malignancy</title>
  <langcode>en</langcode>
  <field_short_title>Office of HIV and AIDS Malignancy</field_short_title>
  <field_page_description>OHAM conducts HIV and AIDS-associated research and coordinates related research activities across NCI. Learn more about key discoveries made by NCI scientists. </field_page_description>
  <field_date_posted>2017-03-31</field_date_posted>
  <field_date_reviewed>2017-03-31</field_date_reviewed>
  <para_id>1078650</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1082592</term_id>
  <id>1080218</id>
  <title>AIDS Malignancy Consortium</title>
  <langcode>en</langcode>
  <field_short_title>AIDS Malignancy Consortium</field_short_title>
  <field_page_description>AMC was founded in 1995 to support trial innovation. Learn more about AMC’s commitment to enhancing therapeutic options for patients with HIV-associated malignancies.</field_page_description>
  <field_date_posted>2017-07-10</field_date_posted>
  <field_date_reviewed>2017-04-04</field_date_reviewed>
  <para_id>1080218</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894084</term_id>
  <id>1082565</id>
  <title>Program Spotlight: Training Navigation</title>
  <langcode>en</langcode>
  <field_short_title>Program Spotlight: Training Navigation </field_short_title>
  <field_page_description>Dr. Hana Odeh talks about CRCHD’s new training navigation initiative and her role as training navigator.  </field_page_description>
  <field_date_posted>2017-04-26</field_date_posted>
  <field_date_reviewed>2017-04-26</field_date_reviewed>
  <field_pretty_url>training-navigation</field_pretty_url>
  <para_id>1082565</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915376</term_id>
  <id>1083954</id>
  <title>In an Era of Precision Medicine, Testing New Approaches to Breast Cancer Screening</title>
  <langcode>en</langcode>
  <field_short_title>Testing Precision Screening for Breast Cancer</field_short_title>
  <field_page_description>An NCI research article about individualized approaches that could help identify those at risk of breast cancer who need to be screened and testing screening intervals that are appropriate for each person’s level of risk.</field_page_description>
  <field_date_posted>2017-05-09</field_date_posted>
  <field_date_reviewed>2017-05-08</field_date_reviewed>
  <field_pretty_url>precision-screening-breast</field_pretty_url>
  <para_id>1083954</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1070068</term_id>
  <id>1084137</id>
  <title>Study estimates number of U.S. women living with metastatic breast cancer</title>
  <langcode>en</langcode>
  <field_short_title>Study estimates number of U.S. women living with metastatic breast cancer</field_short_title>
  <field_date_posted>2017-05-18</field_date_posted>
  <field_date_reviewed>2017-05-09</field_date_reviewed>
  <field_pretty_url>metastatic-breast-cancer-survival-rates</field_pretty_url>
  <para_id>1084137</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>860258</term_id>
  <id>1084734</id>
  <title>Biology of Cancer - Cancer Currents Blog</title>
  <langcode>en</langcode>
  <field_short_title>Biology of Cancer</field_short_title>
  <field_page_description>Blog posts on cancer biology research—including genomics, the tumor microenvironment, and potential new treatment targets—from NCI Cancer Currents.</field_page_description>
  <field_date_posted>2017-05-12</field_date_posted>
  <field_date_reviewed>2017-05-12</field_date_reviewed>
  <field_pretty_url>biology</field_pretty_url>
  <para_id>1084734</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>860258</term_id>
  <id>1084760</id>
  <title>Cancer Disparities - Cancer Currents Blog</title>
  <langcode>en</langcode>
  <field_short_title>Disparities</field_short_title>
  <field_page_description>Blog posts on cancer health disparities research—including factors that influence disparities, disparities-related research efforts, and diversity in the cancer research workforce—from NCI Cancer Currents.</field_page_description>
  <field_date_posted>2017-05-12</field_date_posted>
  <field_date_reviewed>2017-05-12</field_date_reviewed>
  <field_pretty_url>disparities</field_pretty_url>
  <para_id>1084760</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1086663</id>
  <title>Midostaurin Approved by FDA for Acute Myeloid Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Midostaurin for AML</field_short_title>
  <field_page_description>A Cancer Currents blog post on the FDA approval of midostaurin for patients with newly diagnosed acute myeloid leukemia (AML) and mutations in the FLT3 gene.</field_page_description>
  <field_date_posted>2017-06-01</field_date_posted>
  <field_date_reviewed>2017-06-01</field_date_reviewed>
  <field_pretty_url>fda-midostaurin-aml</field_pretty_url>
  <para_id>1086663</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1080236</term_id>
  <id>1087220</id>
  <title>Mostafa Nokta, M.D., Ph.D.</title>
  <langcode>en</langcode>
  <field_short_title>Mostafa Nokta, M.D., Ph.D.</field_short_title>
  <field_page_description>Learn more about Mostafa Nokta, M.D., Ph.D., director of the AIDS Cancer Clinical Program in the Office of HIV and AIDS Malignancy. </field_page_description>
  <field_date_posted>2017-06-09</field_date_posted>
  <field_date_reviewed>2017-06-09</field_date_reviewed>
  <field_pretty_url>mostafa-nokta</field_pretty_url>
  <para_id>1087220</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>941577</term_id>
  <id>1087307</id>
  <title>Intervention Dynamic Trial Listing Page</title>
  <langcode>en</langcode>
  <field_short_title>Intervention Dynamic Trial Listing Page</field_short_title>
  <field_date_posted>2017-06-13</field_date_posted>
  <field_date_reviewed>2017-06-13</field_date_reviewed>
  <field_pretty_url>intervention</field_pretty_url>
  <para_id>1087307</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1074358</term_id>
  <id>1088972</id>
  <title>Tumor Microenvironment Network</title>
  <langcode>en</langcode>
  <field_short_title>Tumor Microenvironment Network</field_short_title>
  <field_page_description>TMEN funded cancer research investigated mechanisms of a tumor’s interaction with its surrounding environment.</field_page_description>
  <field_date_posted>2017-07-21</field_date_posted>
  <field_date_reviewed>2017-02-28</field_date_reviewed>
  <para_id>1088972</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1070068</term_id>
  <id>1090440</id>
  <title>NCI study shows feasibility of cancer screening protocol for patients with Li-Fraumeni syndrome</title>
  <langcode>en</langcode>
  <field_short_title>Cancer screening protocol for patients with Li-Fraumeni syndrome</field_short_title>
  <field_page_description>An NCI press release about a study in JAMA Oncology that shows the feasibility of a screening protocol for patients with Li-Fraumeni syndrome, a rare disorder.</field_page_description>
  <field_date_posted>2017-08-03</field_date_posted>
  <field_date_reviewed>2017-07-25</field_date_reviewed>
  <field_pretty_url>li-fraumeni-syndrome-screening-study</field_pretty_url>
  <para_id>1090440</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1092536</term_id>
  <id>1092547</id>
  <title>Transfer of a Grant</title>
  <langcode>en</langcode>
  <field_short_title>Transfer of a Grant</field_short_title>
  <field_page_description>NIH prior approval is required for the transfer of a grant. Learn more about transferring a cancer research grant from one entity to another.</field_page_description>
  <field_date_posted>2017-08-17</field_date_posted>
  <field_date_reviewed>2017-08-17</field_date_reviewed>
  <para_id>1092547</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919353</term_id>
  <id>1093697</id>
  <title>U.S. - China Program for Biomedical Research Cooperation</title>
  <langcode>en</langcode>
  <field_short_title>U.Sl - China Program for Biomedical Research Cooperation</field_short_title>
  <field_date_posted>2017-08-28</field_date_posted>
  <field_date_reviewed>2017-08-28</field_date_reviewed>
  <field_pretty_url>international-bilateral-programs-china</field_pretty_url>
  <para_id>1093697</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1096317</id>
  <title>Overcoming the Challenges of Metastatic Cancer: An Interview with Dr. Rosandra Kaplan</title>
  <langcode>en</langcode>
  <field_short_title>Overcoming the Challenges of Metastatic Cancer</field_short_title>
  <field_page_description>NCI’s Dr. Rosandra Kaplan discusses metastatic cancer research and new ideas for treating and preventing metastatic cancer.</field_page_description>
  <field_date_posted>2017-09-20</field_date_posted>
  <field_date_reviewed>2017-09-18</field_date_reviewed>
  <field_pretty_url>metastatic-cancer-kaplan</field_pretty_url>
  <para_id>1096317</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1070068</term_id>
  <id>1096929</id>
  <title>Norman Sharpless sworn in as director of the National Cancer Institute</title>
  <langcode>en</langcode>
  <field_short_title>Sharpless sworn in as National Cancer Institute director</field_short_title>
  <field_page_description>Dr. Norman E. “Ned” Sharpless becomes the 15th director of the National Cancer Institute. This NCI press release reports on his swearing in and background.</field_page_description>
  <field_date_posted>2017-10-18</field_date_posted>
  <field_date_reviewed>2017-09-25</field_date_reviewed>
  <field_pretty_url>sharpless-nci-director</field_pretty_url>
  <para_id>1096929</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1097043</id>
  <title>Kids First Pediatric Research Program Moves Forward</title>
  <langcode>en</langcode>
  <field_short_title>Kids First Pediatric Research Program Moves Forward</field_short_title>
  <field_page_description>A new data resource center is being developed for the Gabriella Miller Kids First Research Program, so investigators can better collaborate on childhood cancers and birth defect research.</field_page_description>
  <field_date_posted>2017-09-29</field_date_posted>
  <field_date_reviewed>2017-09-28</field_date_reviewed>
  <field_pretty_url>kidsfirst-childhood-cancer-moving-forward</field_pretty_url>
  <para_id>1097043</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>979426</id>
  <title>Palbociclib Improves Survival in Women with Hormone Receptor-Positive Metastatic Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Palbociclib for Advanced Breast Cancer</field_short_title>
  <field_page_description>An interim analysis of the PALOMA3 trial shows that women with hormone receptor-positive metastatic breast cancer who received palbociclib plus fulvestrant had longer progression-free survival rates than women who received a placebo plus fulvestrant.</field_page_description>
  <field_date_posted>2015-07-24</field_date_posted>
  <field_date_reviewed>2015-07-23</field_date_reviewed>
  <field_pretty_url>palbociclib-hormone-receptor-positive</field_pretty_url>
  <para_id>979426</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>988329</id>
  <title>Cancer Risk in Childhood Cancer Survivors Continues for Decades</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Risk for Childhood Cancer Survivors </field_short_title>
  <field_date_posted>2015-08-31</field_date_posted>
  <field_date_reviewed>2015-08-31</field_date_reviewed>
  <field_pretty_url>childhood-longterm</field_pretty_url>
  <para_id>988329</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>988768</id>
  <title>Overdiagnosis of Cancer: Bringing an Important Problem into Focus </title>
  <langcode>en</langcode>
  <field_short_title>Overdiagnosis of Cancer Conference</field_short_title>
  <field_date_posted>2015-08-28</field_date_posted>
  <field_date_reviewed>2015-08-28</field_date_reviewed>
  <field_pretty_url>overdiagnosis-meeting</field_pretty_url>
  <para_id>988768</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>989418</id>
  <title>How You Can Help Medical Research: Donating Your Blood, Tissue, and Other Samples</title>
  <langcode>en</langcode>
  <field_short_title>How You Can Help Medical Research</field_short_title>
  <field_date_posted>2015-09-01</field_date_posted>
  <field_date_reviewed>2015-09-01</field_date_reviewed>
  <field_pretty_url>help-research-donate-tissue</field_pretty_url>
  <para_id>989418</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1002751</id>
  <title>CPTAC, the Complementary Sibling of TCGA: An Interview with Dr. Henry Rodriguez about NCI’s Proteomics Program </title>
  <langcode>en</langcode>
  <field_short_title>Shedding New Light on Cancer Biology</field_short_title>
  <field_date_posted>2015-09-18</field_date_posted>
  <field_date_reviewed>2015-09-17</field_date_reviewed>
  <field_pretty_url>cptac</field_pretty_url>
  <para_id>1002751</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1004321</term_id>
  <id>1004322</id>
  <title>Data Submission Under the Genomic Data Sharing (GDS) Policy</title>
  <langcode>en</langcode>
  <field_short_title>Data Submission</field_short_title>
  <field_page_description>Information for intramural, extramural, and non-NIH funded investigators looking to submit study data under the Genomic Data Sharing (GDS) Policy. </field_page_description>
  <field_date_posted>2015-10-22</field_date_posted>
  <field_date_reviewed>2015-09-21</field_date_reviewed>
  <para_id>1004322</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1004553</term_id>
  <id>1004557</id>
  <title>DCB Funding Opportunities</title>
  <langcode>en</langcode>
  <field_short_title>DCB Funding Opportunities</field_short_title>
  <field_page_description>Find current funding opportunities in basic cancer biology from the Division of Cancer Biology (DCB).</field_page_description>
  <field_date_posted>2016-08-08</field_date_posted>
  <field_date_reviewed>2015-09-22</field_date_reviewed>
  <para_id>1004557</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>1005118</id>
  <title>Thinking Out of the Box to Expand Research in LMICs </title>
  <langcode>en</langcode>
  <field_short_title>Thinking Out of the Box to Expand Research in LMICs </field_short_title>
  <field_date_posted>2015-09-25</field_date_posted>
  <field_date_reviewed>2015-09-25</field_date_reviewed>
  <field_pretty_url>naidoo</field_pretty_url>
  <para_id>1005118</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1007484</term_id>
  <id>1007485</id>
  <title>Genomic Data Sharing (GDS) Policy Contact Information</title>
  <langcode>en</langcode>
  <field_short_title>Contact</field_short_title>
  <field_date_posted>2015-10-22</field_date_posted>
  <field_date_reviewed>2015-09-30</field_date_reviewed>
  <para_id>1007485</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1002053</term_id>
  <id>1011470</id>
  <title>NCI Grant Policies</title>
  <langcode>en</langcode>
  <field_short_title>NCI Grant Policies</field_short_title>
  <field_page_description>Research grants are subject to a variety of policy requirements. Find highlights of policy announcements or changes specific to NCI.</field_page_description>
  <field_date_posted>2015-10-06</field_date_posted>
  <field_date_reviewed>2015-10-06</field_date_reviewed>
  <para_id>1011470</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1011547</id>
  <title>NCI’s Steven Rosenberg Wins Service to America Medal</title>
  <langcode>en</langcode>
  <field_short_title>NCI’s Steven Rosenberg Wins Service to America Medal</field_short_title>
  <field_date_posted>2015-10-07</field_date_posted>
  <field_date_reviewed>2015-10-06</field_date_reviewed>
  <field_pretty_url>rosenberg-sammie</field_pretty_url>
  <para_id>1011547</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1014272</id>
  <title>FDA Approves Combination Drug for Patients with Advanced Colorectal Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Combination Drug to Treat Patients with Advanced Colorectal Cancer</field_short_title>
  <field_date_posted>2015-10-14</field_date_posted>
  <field_date_reviewed>2015-10-13</field_date_reviewed>
  <field_pretty_url>lonsurf-colorectal</field_pretty_url>
  <para_id>1014272</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069530</term_id>
  <id>1025815</id>
  <title>No Magic Bullet for RAS</title>
  <langcode>en</langcode>
  <field_short_title>No Magic Bullet for RAS</field_short_title>
  <field_date_posted>2015-11-13</field_date_posted>
  <field_date_reviewed>2015-11-09</field_date_reviewed>
  <field_pretty_url>ras-no-magic-bullet</field_pretty_url>
  <para_id>1025815</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>919157</term_id>
  <id>63861</id>
  <title>NCI's Clinical Trials Programs and Initiatives</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trials</field_short_title>
  <field_page_description>Information about NCI programs and initiatives that sponsor, conduct, develop, or support clinical trials, including NCI’s Clinical Trial Network (NCTN) and NCI Community Oncology Research Program (NCORP) initiatives.</field_page_description>
  <field_date_posted>2011-02-24</field_date_posted>
  <field_date_reviewed>2011-02-24</field_date_reviewed>
  <para_id>63861</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>941577</term_id>
  <id>63867</id>
  <title>Clinical Trials Information for Patients and Caregivers</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trials Information for Patients and Caregivers</field_short_title>
  <field_page_description>Explains clinical trials, including what they are, why they are important, things to think about when deciding to take part, and questions to ask your doctor.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2011-02-24</field_date_reviewed>
  <para_id>63867</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1097042</id>
  <title>Gemtuzumab Receives New FDA Approval for Acute Myeloid Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Gemtuzumab Approved by FDA for Acute Myeloid Leukemia</field_short_title>
  <field_page_description>FDA approved gemtuzumab ozogamicin (Mylotarg™) for adults with newly diagnosed CD33-positive AML and some patients 2 years and older with CD33-positive AML.</field_page_description>
  <field_date_posted>2017-09-28</field_date_posted>
  <field_date_reviewed>2017-09-28</field_date_reviewed>
  <field_pretty_url>gemtuzumab-fda-leukemia</field_pretty_url>
  <para_id>1097042</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1097231</term_id>
  <id>1097232</id>
  <title>Tumor DNA Sequencing in Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Tumor DNA Sequencing</field_short_title>
  <field_page_description>Tumor DNA sequencing (also called genetic profiling or genetic testing) is a test to identify DNA changes in a patient’s cancer. In some cases, this information can help determine a treatment plan. </field_page_description>
  <field_date_posted>2017-10-05</field_date_posted>
  <field_date_reviewed>2017-09-29</field_date_reviewed>
  <para_id>1097232</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1097874</term_id>
  <id>1097875</id>
  <title>Access to the National Cryo-Electron Microscopy Facility</title>
  <langcode>en</langcode>
  <field_short_title>NCEF Access</field_short_title>
  <field_page_description>The National Cryo-EM Facility (NCEF) at NCI provides researchers access to the latest technology for high resolution imaging. Find information on how to request access to NCEF.</field_page_description>
  <field_date_posted>2017-10-13</field_date_posted>
  <field_date_reviewed>2017-10-09</field_date_reviewed>
  <para_id>1097875</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070074</term_id>
  <id>1098035</id>
  <title>CTD&lt;sup&gt;2&lt;/sup&gt;: Bridging Genomics to Therapeutics</title>
  <langcode>en</langcode>
  <field_short_title>CTD&lt;sup&gt;2&lt;/sup&gt;: Bridging Genomics to Therapeutics</field_short_title>
  <field_page_description>How the NCI’s CTD&lt;sup&gt;2&lt;/sup&gt; initiative is making strides in turning genomic research into effective cancer treatments.</field_page_description>
  <field_date_posted>2017-10-19</field_date_posted>
  <field_date_reviewed>2017-10-13</field_date_reviewed>
  <field_pretty_url>ctd2-therapeutics</field_pretty_url>
  <para_id>1098035</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1098602</id>
  <title>Studies Identify Therapies That May Delay Melanoma Recurrence after Surgery</title>
  <langcode>en</langcode>
  <field_short_title>Immune, Targeted Therapies May Delay Melanoma Recurrence</field_short_title>
  <field_page_description>In clinical trials, nivolumab (Opdivo®) and the combination of dabrafenib (Tafinlar®) and trametinib (Mekinist®) delayed cancer recurrence in patients with melanoma.</field_page_description>
  <field_date_posted>2017-10-19</field_date_posted>
  <field_date_reviewed>2017-10-19</field_date_reviewed>
  <field_pretty_url>melanoma-adjuvant-immunotherapy-targeted-therapy</field_pretty_url>
  <para_id>1098602</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1099737</id>
  <title>Levels of Immune Cells within Ovarian Tumors Linked to Survival for Some Patients</title>
  <langcode>en</langcode>
  <field_short_title>Immune Cells in Ovarian Tumors Tied to Survival</field_short_title>
  <field_page_description>In some women with ovarian cancer, levels of tumor-infiltrating lymphocytes (TILs) may be associated with survival, as this Cancer Currents blog post explains.</field_page_description>
  <field_date_posted>2017-11-06</field_date_posted>
  <field_date_reviewed>2017-11-03</field_date_reviewed>
  <field_pretty_url>ovarian-cancer-tils-survival</field_pretty_url>
  <para_id>1099737</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1100328</id>
  <title>Experimental Ovarian Cancer Vaccine Shows Promise in Mice</title>
  <langcode>en</langcode>
  <field_short_title>Experimental Ovarian Cancer Vaccine Shows Promise in Mice</field_short_title>
  <field_page_description>The vaccine targets a protein that is present at elevated levels in approximately 90% of the most common type of ovarian cancer, this Cancer Currents post explains.</field_page_description>
  <field_date_posted>2017-11-17</field_date_posted>
  <field_date_reviewed>2017-11-16</field_date_reviewed>
  <field_pretty_url>ovarian-cancer-vaccine</field_pretty_url>
  <para_id>1100328</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918922</term_id>
  <id>102551</id>
  <title>Drugs Approved for Different Types of Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Different Types of Cancer</field_short_title>
  <field_page_description>Find drugs approved by the FDA for specific types of cancer.</field_page_description>
  <field_date_posted>2011-11-02</field_date_posted>
  <field_date_reviewed>2011-08-04</field_date_reviewed>
  <para_id>102551</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>574508</id>
  <title>NIH researchers conduct first genomic survey of human skin fungal diversity; &lt;span style="font-weight:normal;"&gt;&lt;i&gt;Location on the body surface determines fungal composition with the greatest diversity on feet&lt;/i&gt;&lt;/span&gt;</title>
  <langcode>en</langcode>
  <field_short_title>First genomic survey of human skin fungal diversity</field_short_title>
  <field_page_description>Fungal infections of the skin affect 29 million people in the United States. In the first study of human fungal skin diversity, National Institutes of Health researchers sequenced the DNA of fungi that thrive at different skin sites of healthy adults to d</field_page_description>
  <field_date_posted>2013-05-22</field_date_posted>
  <field_date_reviewed>2013-05-20</field_date_reviewed>
  <field_pretty_url>SkinFungalNature</field_pretty_url>
  <para_id>574508</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>586656</id>
  <title>Coping with Advanced Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Coping with Advanced Cancer</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2013-06-11</field_date_reviewed>
  <field_pretty_url>advanced-cancer</field_pretty_url>
  <para_id>586656</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>586657</id>
  <title>When Someone You Love Is Being Treated for Cancer: Support for Caregivers</title>
  <langcode>en</langcode>
  <field_short_title>When Someone You Love Is Being Treated for Cancer</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2013-06-11</field_date_reviewed>
  <field_pretty_url>when-someone-you-love-is-being-treated</field_pretty_url>
  <para_id>586657</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1067780</term_id>
  <id>1067782</id>
  <title>Cancer Moonshot&amp;#8480; – Funding Opportunities</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Moonshot – Funding Opportunities</field_short_title>
  <field_page_description>NCI is accepting applications for research grants that support the Cancer Moonshot Blue Ribbon Panel recommendations to accelerate cancer research.</field_page_description>
  <field_date_posted>2016-12-12</field_date_posted>
  <field_date_reviewed>2017-09-27</field_date_reviewed>
  <para_id>1067782</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1035160</term_id>
  <id>1067855</id>
  <title>Diagnosed With Ovarian Cancer, a Researcher Mined TCGA Data to Study Her Own Disease</title>
  <langcode>en</langcode>
  <field_short_title>Researcher Studies Own Cancer</field_short_title>
  <field_page_description>Shirley Pepke, Ph.D., used her computational biology background to study her own ovarian cancer data in comparison to The Cancer Genome Atlas. </field_page_description>
  <field_date_posted>2016-12-06</field_date_posted>
  <field_date_reviewed>2016-12-02</field_date_reviewed>
  <field_pretty_url>personalized-cancer-treatment-TCGA-data</field_pretty_url>
  <para_id>1067855</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1069583</term_id>
  <id>1069584</id>
  <title>Track 2: Oncology Product Research and Review for Board Certified Oncologists</title>
  <langcode>en</langcode>
  <field_short_title>IOTF: Oncology Product Review for BC Oncologists</field_short_title>
  <field_page_description>NCI and FDA collaborate to train physicians in aspects of drug, biologic, or device development and standards for assessing medical product safety. Learn more about this cancer training program.</field_page_description>
  <field_date_posted>2016-12-21</field_date_posted>
  <field_date_reviewed>2016-12-21</field_date_reviewed>
  <para_id>1069584</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938229</term_id>
  <id>1070678</id>
  <title>Daratumumab Improves Progression-Free Survival for Patients with Multiple Myeloma</title>
  <langcode>en</langcode>
  <field_short_title>Daratumumab for Multiple Myeloma Improves Progression-Free Survival</field_short_title>
  <field_page_description>A summary of clinical trial results showing that daratumumab plus lenalidomide and dexamethasone improved progression-free survival for patients with relapsed or refractory disease.</field_page_description>
  <field_date_posted>2017-01-04</field_date_posted>
  <field_date_reviewed>2017-01-04</field_date_reviewed>
  <field_pretty_url>daratumumab-castor-pollux</field_pretty_url>
  <para_id>1070678</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1099303</term_id>
  <id>1073407</id>
  <title>Selected Interviews with Dr. Doug Lowy</title>
  <langcode>en</langcode>
  <field_short_title>Selected Interviews with Doug Lowy</field_short_title>
  <field_page_description>In these selected interviews, Douglas R. Lowy, M.D., Deputy Director of the National Cancer Institute (NCI), talks with media and scientific institutions about basic science, clinical research, and the work of NCI.</field_page_description>
  <field_date_posted>2017-02-28</field_date_posted>
  <field_date_reviewed>2017-02-15</field_date_reviewed>
  <para_id>1073407</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1073548</id>
  <title>U.S. Cancer Mortality Rates Falling, But Some Regions Left Behind, Study Finds</title>
  <langcode>en</langcode>
  <field_short_title>County-Level Disparities Found in Cancer Deaths</field_short_title>
  <field_page_description>A &lt;i&gt;Cancer Currents&lt;/i&gt; blog post on a study that showed the rate of cancer deaths in the U.S. is declining overall but increasing in some counties.</field_page_description>
  <field_date_posted>2017-02-21</field_date_posted>
  <field_date_reviewed>2017-02-17</field_date_reviewed>
  <field_pretty_url>cancer-death-disparities</field_pretty_url>
  <para_id>1073548</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1090419</term_id>
  <id>1074402</id>
  <title>TMEN Investigators</title>
  <langcode>en</langcode>
  <field_short_title>TMEN Investigators</field_short_title>
  <field_page_description>TMEN funded cancer research grants investigating the mechanisms of a tumor’s interaction with its surrounding environment.</field_page_description>
  <field_date_posted>2017-07-21</field_date_posted>
  <field_date_reviewed>2017-02-28</field_date_reviewed>
  <para_id>1074402</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1070068</term_id>
  <id>1078434</id>
  <title>Annual Report to the Nation: Cancer death rates continue to decline</title>
  <langcode>en</langcode>
  <field_short_title>Annual Report to the Nation: Cancer death rates continue to decline</field_short_title>
  <field_page_description>A press release from the American Cancer Society and NCI about the Annual Report to the Nation on the Status of Cancer, 1975-2014, reports that overall cancer death rates continue to decline, however, death rates for some cancers increased or stabilized.</field_page_description>
  <field_date_posted>2017-03-31</field_date_posted>
  <field_date_reviewed>2017-03-28</field_date_reviewed>
  <field_pretty_url>annual-report-to-nation-1975-2014</field_pretty_url>
  <para_id>1078434</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1078445</term_id>
  <id>1078446</id>
  <title>2016 Social Media Events</title>
  <langcode>en</langcode>
  <field_short_title>2016 Social Media Events</field_short_title>
  <field_page_description>Find past social media events involving NCI and its partners from 2016.</field_page_description>
  <field_date_posted>2017-03-28</field_date_posted>
  <field_date_reviewed>2017-03-28</field_date_reviewed>
  <para_id>1078446</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1078782</term_id>
  <id>1078794</id>
  <title>OHAM Research Activities</title>
  <langcode>en</langcode>
  <field_short_title>OHAM Research Activities</field_short_title>
  <field_page_description>OHAM manages HIV/AIDS research and shares oversight for activities across NCI and NIH. Learn how OHAM is addressing the diverse population of HIV/AIDS patients. </field_page_description>
  <field_date_posted>2017-07-10</field_date_posted>
  <field_date_reviewed>2017-03-31</field_date_reviewed>
  <para_id>1078794</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894084</term_id>
  <id>1080972</id>
  <title>Celebrating National Minority Health Month 2017</title>
  <langcode>en</langcode>
  <field_short_title>Celebrating National Minority Health Month 2017</field_short_title>
  <field_page_description>NCI and other organizations recognize National Minority Health Month in April 2017.</field_page_description>
  <field_date_posted>2017-04-12</field_date_posted>
  <field_date_reviewed>2017-04-12</field_date_reviewed>
  <field_pretty_url>nci-nmhm-2017</field_pretty_url>
  <para_id>1080972</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938030</term_id>
  <id>63868</id>
  <title>Treating Multiply Relapsed or Refractory Hairy Cell Leukemia </title>
  <langcode>en</langcode>
  <field_short_title>Treating Multiply Relapsed or Refractory Hairy Cell Leukemia </field_short_title>
  <field_page_description>In this trial, patients with hairy cell leukemia who have not responded or relapsed after initial chemotherapy will be randomly assigned to receive rituximab combined with either pentostatin or bendamustine. </field_page_description>
  <field_date_posted>2011-02-22</field_date_posted>
  <field_date_reviewed>2011-02-24</field_date_reviewed>
  <field_pretty_url>pentostatin-bendamustine-hairy-cell</field_pretty_url>
  <para_id>63868</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>65187</id>
  <title>Drugs Approved for Brain Tumors</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Brain Tumors</field_short_title>
  <field_date_posted>2012-03-02</field_date_posted>
  <field_date_reviewed>2011-03-09</field_date_reviewed>
  <field_pretty_url>brain</field_pretty_url>
  <para_id>65187</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1096587</term_id>
  <id>65192</id>
  <title>About the Annual Plan and Budget Proposal</title>
  <langcode>en</langcode>
  <field_short_title>About the Annual Plan &amp; Budget Proposal</field_short_title>
  <field_page_description>Learn about the annual budget plan and proposal NCI submits to the President and Congress each fiscal year, including an archive of plans from previous years.</field_page_description>
  <field_date_posted>2015-09-17</field_date_posted>
  <field_date_reviewed>2011-03-09</field_date_reviewed>
  <para_id>65192</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>861460</term_id>
  <id>74367</id>
  <title>Accidents at Nuclear Power Plants and Cancer Risk</title>
  <langcode>en</langcode>
  <field_short_title>Accidents at Nuclear Power Plants and Cancer Risk</field_short_title>
  <field_page_description>A fact sheet about cancer risks associated with accidents at nuclear power plants. </field_page_description>
  <field_date_posted>2011-04-19</field_date_posted>
  <field_date_reviewed>2011-04-19</field_date_reviewed>
  <field_pretty_url>nuclear-accidents-fact-sheet</field_pretty_url>
  <para_id>74367</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>82012</id>
  <title>Drugs Approved for Head and Neck Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Head and Neck Cancer</field_short_title>
  <field_date_posted>2011-07-12</field_date_posted>
  <field_date_reviewed>2011-05-27</field_date_reviewed>
  <field_pretty_url>head-neck</field_pretty_url>
  <para_id>82012</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>84176</id>
  <title>Eribulin Improves Survival of Women with Metastatic Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Eribulin Improves Survival of Women with Metastatic Breast Cancer</field_short_title>
  <field_page_description>Treatment with eribulin (Halaven™) improved overall survival in women with metastatic breast cancer whose disease progressed despite multiple rounds of prior chemotherapy, according to the results of a phase III clinical trial called EMBRACE. </field_page_description>
  <field_date_posted>2011-06-10</field_date_posted>
  <field_date_reviewed>2011-06-10</field_date_reviewed>
  <field_pretty_url>eribulin-improves-survival</field_pretty_url>
  <para_id>84176</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938042</term_id>
  <id>87570</id>
  <title>Combining Chemotherapy with Bevacizumab Improves Outcomes for Ovarian Cancer Patients</title>
  <langcode>en</langcode>
  <field_short_title>Combining Chemotherapy with Bevacizumab Improves Outcomes for Ovarian Cancer Patients</field_short_title>
  <field_page_description>Results from two phase III randomized clinical trials suggest that, at least for some patients with ovarian cancer, adding the antiangiogenesis agent bevacizumab to chemotherapy increases the time to disease progression and may improve survival. </field_page_description>
  <field_date_posted>2011-06-29</field_date_posted>
  <field_date_reviewed>2011-06-29</field_date_reviewed>
  <field_pretty_url>bevacizumab-combo-chemo</field_pretty_url>
  <para_id>87570</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>11502</term_id>
  <id>707545</id>
  <title>NCI and Medical Decision Making</title>
  <langcode>en</langcode>
  <field_short_title>NCI and Medical Decision Making</field_short_title>
  <field_page_description>NCI conducts and facilitates basic and translational research that can inform standard clinical practice and medical decision making.</field_page_description>
  <field_date_posted>2014-02-18</field_date_posted>
  <field_date_reviewed>2014-03-25</field_date_reviewed>
  <field_pretty_url>medical-decision-making</field_pretty_url>
  <para_id>707545</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>608323</term_id>
  <id>728762</id>
  <title>Treatment of Solid Tumor Cancers with the Chemotherapy Drug Methotrexate</title>
  <langcode>en</langcode>
  <field_short_title>Methotrexate: Chemotherapy Treatment for Cancer</field_short_title>
  <field_date_posted>2014-04-30</field_date_posted>
  <field_date_reviewed>2014-03-28</field_date_reviewed>
  <field_pretty_url>methotrexate</field_pretty_url>
  <para_id>728762</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915352</term_id>
  <id>759574</id>
  <title>Aspirin to Reduce Cancer Risk</title>
  <langcode>en</langcode>
  <field_short_title>Aspirin to Reduce Cancer Risk</field_short_title>
  <field_page_description>A federal advisory panel supports aspirin to reduce the risk of colorectal cancer, while researchers are investigating whether it may help reduce the risk of other cancers.</field_page_description>
  <field_date_posted>2014-04-21</field_date_posted>
  <field_date_reviewed>2014-04-21</field_date_reviewed>
  <field_pretty_url>aspirin-cancer-risk</field_pretty_url>
  <para_id>759574</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>608323</term_id>
  <id>762580</id>
  <title>Lung Cancer Screening Saves Lives: The National Lung Screening Trial</title>
  <langcode>en</langcode>
  <field_short_title>Lung Cancer Screening Saves Lives</field_short_title>
  <field_date_posted>2014-07-31</field_date_posted>
  <field_date_reviewed>2014-07-31</field_date_reviewed>
  <field_pretty_url>NLST</field_pretty_url>
  <para_id>762580</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>768744</term_id>
  <id>768770</id>
  <title>Advocacy Announcements and Resources</title>
  <langcode>en</langcode>
  <field_short_title>Announcements and Resources</field_short_title>
  <field_page_description>Get updates from the Office of Advocacy Relations (OAR) and find resources for cancer research advocates.</field_page_description>
  <field_date_posted>2014-05-15</field_date_posted>
  <field_date_reviewed>2014-05-15</field_date_reviewed>
  <para_id>768770</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>770112</term_id>
  <id>770110</id>
  <title>What We Do</title>
  <langcode>en</langcode>
  <field_short_title>What We Do</field_short_title>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-05-19</field_date_reviewed>
  <para_id>770110</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919351</term_id>
  <id>748499</id>
  <title>CGH Short Term Scientist Exchange Program (STSEP)</title>
  <langcode>en</langcode>
  <field_short_title>CGH Short Term Scientist Exchange Program (STSEP)</field_short_title>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-04-09</field_date_reviewed>
  <field_pretty_url>stsep</field_pretty_url>
  <para_id>748499</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919351</term_id>
  <id>748890</id>
  <title>Cancer Prevention Fellowship Program</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Prevention Fellowship Program</field_short_title>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-04-10</field_date_reviewed>
  <field_pretty_url>prevention-fellowship</field_pretty_url>
  <para_id>748890</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919356</term_id>
  <id>768980</id>
  <title>CGH Future Directions</title>
  <langcode>en</langcode>
  <field_short_title>CGH Future Directions</field_short_title>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-05-16</field_date_reviewed>
  <para_id>768980</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919362</term_id>
  <id>768983</id>
  <title>Contact The Center for Global Health</title>
  <langcode>en</langcode>
  <field_short_title>Contact CGH</field_short_title>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-05-16</field_date_reviewed>
  <para_id>768983</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>770435</term_id>
  <id>770437</id>
  <title>Genitourinary Cancers Steering Committee Roster</title>
  <langcode>en</langcode>
  <field_short_title>Genitourinary Cancers Steering Committee Roster</field_short_title>
  <field_date_posted>2014-05-21</field_date_posted>
  <field_date_reviewed>2014-05-21</field_date_reviewed>
  <field_pretty_url>roster</field_pretty_url>
  <para_id>770437</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>770469</term_id>
  <id>770497</id>
  <title>Head and Neck Steering Committee</title>
  <langcode>en</langcode>
  <field_short_title>Head and Neck Steering Committee</field_short_title>
  <field_page_description>The Head and Neck Steering Committee addresses the design, prioritization and evaluation of concepts for phase II and phase III clinical trials in adult head and neck cancers. </field_page_description>
  <field_date_posted>2014-05-21</field_date_posted>
  <field_date_reviewed>2014-05-21</field_date_reviewed>
  <para_id>770497</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919351</term_id>
  <id>771896</id>
  <title>NCI Summer Curriculum in Cancer Prevention Program</title>
  <langcode>en</langcode>
  <field_short_title>NCI Summer Curriculum in Cancer Prevention Program</field_short_title>
  <field_date_posted>2016-02-03</field_date_posted>
  <field_date_reviewed>2016-02-03</field_date_reviewed>
  <field_pretty_url>summer-curriculum-prevention</field_pretty_url>
  <para_id>771896</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938142</term_id>
  <id>772122</id>
  <title>Sorafenib Improves Progression-Free Survival in Some Patients with Metastatic Thyroid Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Sorafenib Improves Progression-Free Survival in Some Patients with Metastatic Thyroid Cancer</field_short_title>
  <field_page_description>A summary of results from an international phase III trial that compared sorafenib (Nexavar®) and a placebo for the treatment of locally advanced or metastatic differentiated thyroid cancer that is no longer responding to treatment with radioactive iodine</field_page_description>
  <field_date_posted>2014-05-27</field_date_posted>
  <field_date_reviewed>2014-05-23</field_date_reviewed>
  <field_pretty_url>sorafenib</field_pretty_url>
  <para_id>772122</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1062269</id>
  <title>CGH Announces Recipients of Regional Centers of Research Excellence (RCREs) P20 Grant Awards </title>
  <langcode>en</langcode>
  <field_short_title>Recipients of Regional Centers of Research Excellence (RCREs) P20 Grant Awards Announced</field_short_title>
  <field_date_posted>2016-09-21</field_date_posted>
  <field_date_reviewed>2016-09-26</field_date_reviewed>
  <field_pretty_url>RCREs</field_pretty_url>
  <para_id>1062269</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1035160</term_id>
  <id>1062779</id>
  <title>A Key Data Sharing Partnership: The Multiple Myeloma Research Foundation Donates Data to the GDC</title>
  <langcode>en</langcode>
  <field_short_title>The MMRF Contributes to GDC</field_short_title>
  <field_page_description>MMRF will share its genomic and clinical data on multiple myeloma patients through a first of its kind partnership with the NCI Genomic Data Commons (GDC).</field_page_description>
  <field_date_posted>2016-09-28</field_date_posted>
  <field_date_reviewed>2016-09-27</field_date_reviewed>
  <field_pretty_url>mmrf-shares-genomic-data-commons</field_pretty_url>
  <para_id>1062779</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1065468</id>
  <title>Modified Immunotherapy Approach Shows Promise for Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Modified Immunotherapy Approach Shows Promise for Leukemia</field_short_title>
  <field_page_description>A Cancer Currents blog post highlighting a new study of a modified immunotherapy approach that uses immune cells called natural killer cells.</field_page_description>
  <field_date_posted>2016-10-21</field_date_posted>
  <field_date_reviewed>2016-10-20</field_date_reviewed>
  <field_pretty_url>nk-immunotherapy-leukemia</field_pretty_url>
  <para_id>1065468</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1066282</id>
  <title>2nd Annual Intra-NCI Global Cancer Research Day: Highlighting Prevention and Screening </title>
  <langcode>en</langcode>
  <field_short_title>2nd Annual Intra-NCI Global Cancer Research Day</field_short_title>
  <field_page_description>2nd Annual Intra-NCI Global Cancer Research Day: Highlighting Prevention and Screening (GCR2016)</field_page_description>
  <field_date_posted>2016-11-02</field_date_posted>
  <field_date_reviewed>2016-11-02</field_date_reviewed>
  <field_pretty_url>intraNCI_global_cancer_research_day_2016</field_pretty_url>
  <para_id>1066282</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922403</term_id>
  <id>1067315</id>
  <title>Examining the Effects of Presurgical Treatment for Prostate Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Effects of Presurgical Treatment for Prostate Cancer</field_short_title>
  <field_page_description>In this study, men diagnosed with androgen-sensitive prostate cancer with intermediate- or high-risk features will be examined with mpMRI, undergo targeted biopsies, and be treated with neoadjuvant androgen deprivation therapy.</field_page_description>
  <field_date_posted>2016-11-28</field_date_posted>
  <field_date_reviewed>2016-11-28</field_date_reviewed>
  <field_pretty_url>mri-neoadjuvant-prostate</field_pretty_url>
  <para_id>1067315</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1068074</id>
  <title>Cellular Immunotherapy Targets a Common Human Cancer Mutation</title>
  <langcode>en</langcode>
  <field_short_title>Immunotherapy Targets Common Cancer Mutation</field_short_title>
  <field_date_posted>2016-12-07</field_date_posted>
  <field_date_reviewed>2016-12-05</field_date_reviewed>
  <field_pretty_url>immunotherapy-targets-kras</field_pretty_url>
  <para_id>1068074</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1097589</term_id>
  <id>1097590</id>
  <title>Identifying Strategic Scientific Opportunities at NCI</title>
  <langcode>en</langcode>
  <field_short_title>Identifying Strategic Scientific Opportunities</field_short_title>
  <field_page_description>As NCI's central scientific strategy office, CRS collaborates with the institute's divisions, offices, and centers to identify research opportunities to advance NCI's vision for the future of cancer research.</field_page_description>
  <field_date_posted>2018-04-13</field_date_posted>
  <field_date_reviewed>2017-10-04</field_date_reviewed>
  <para_id>1097590</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>45782</term_id>
  <id>1097904</id>
  <title>Susan Perkins, Ph.D.</title>
  <langcode>en</langcode>
  <field_short_title>Susan Perkins, Ph.D.</field_short_title>
  <field_page_description>Read more about Cancer Training Branch Deputy Chief Susan Perkins, Ph.D.</field_page_description>
  <field_date_posted>2017-10-10</field_date_posted>
  <field_date_reviewed>2017-10-10</field_date_reviewed>
  <field_pretty_url>susan-perkins</field_pretty_url>
  <para_id>1097904</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1099487</id>
  <title>New on NCI’s Websites for November 2017</title>
  <langcode>en</langcode>
  <field_short_title>New on NCI’s Websites for November 2017</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post that provides an update on new content of interest to the cancer community recently added to NCI’s websites.</field_page_description>
  <field_date_posted>2017-11-03</field_date_posted>
  <field_date_reviewed>2017-11-01</field_date_reviewed>
  <field_pretty_url>new-online-november-2017</field_pretty_url>
  <para_id>1099487</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1099568</id>
  <title>Assuming the Role of NCI Director: Working to Accelerate Progress</title>
  <langcode>en</langcode>
  <field_short_title>As NCI Director, Working to Accelerate Progress</field_short_title>
  <field_page_description>Norman Sharpless, M.D., discusses his appointment as the new National Cancer Institute director and continuing NCI’s tradition of commitment to improving people’s lives.</field_page_description>
  <field_date_posted>2017-11-02</field_date_posted>
  <field_date_reviewed>2017-11-02</field_date_reviewed>
  <field_pretty_url>norman-sharpless-nci-director-new</field_pretty_url>
  <para_id>1099568</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1099936</id>
  <title>Liquid Biopsy: Using DNA in Blood to Detect, Track, and Treat Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Liquid Biopsy: Using Tumor DNA in Blood to Aid Cancer Care</field_short_title>
  <field_page_description>Learn how tests that analyze circulating tumor DNA in blood, called liquid biopsies, have the potential to track cancer as it develops and changes in this in-depth Cancer Currents article.</field_page_description>
  <field_date_posted>2017-11-08</field_date_posted>
  <field_date_reviewed>2017-11-08</field_date_reviewed>
  <field_pretty_url>liquid-biopsy-detects-treats-cancer</field_pretty_url>
  <para_id>1099936</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1099974</id>
  <title>Study Identifies Potential Drug Combination for Ewing Sarcoma</title>
  <langcode>en</langcode>
  <field_short_title>Drug Combination May Target Ewing Sarcoma</field_short_title>
  <field_page_description>In Ewing sarcoma, combining YK-4-279, a drug that targets the fusion protein EWS-FLI1, with vincristine may be more effective than either drug alone.</field_page_description>
  <field_date_posted>2017-11-09</field_date_posted>
  <field_date_reviewed>2017-11-09</field_date_reviewed>
  <field_pretty_url>ewing-sarcoma-drug-combination</field_pretty_url>
  <para_id>1099974</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>89698</id>
  <title>Drugs Approved for Neuroblastoma</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Neuroblastoma</field_short_title>
  <field_date_posted>2011-07-26</field_date_posted>
  <field_date_reviewed>2011-07-14</field_date_reviewed>
  <field_pretty_url>neuroblastoma</field_pretty_url>
  <para_id>89698</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>99821</id>
  <title>Drugs Approved for Wilms Tumor and Other Childhood Kidney Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Wilms Tumor </field_short_title>
  <field_date_posted>2011-10-04</field_date_posted>
  <field_date_reviewed>2011-07-26</field_date_reviewed>
  <field_pretty_url>wilms-tumor</field_pretty_url>
  <para_id>99821</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922403</term_id>
  <id>99866</id>
  <title>Abiraterone Improves Survival in Metastatic Prostate Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Abiraterone Improves Survival in Metastatic Prostate Cancer</field_short_title>
  <field_page_description>A multinational phase III trial found that the drug abiraterone acetate prolonged the median survival of patients with metastatic castration-resistant prostate cancer by 4 months compared with patients who received a placebo. </field_page_description>
  <field_date_posted>2011-07-27</field_date_posted>
  <field_date_reviewed>2012-12-31</field_date_reviewed>
  <field_pretty_url>abiraterone</field_pretty_url>
  <para_id>99866</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>101531</id>
  <title>Breast Cancers Arising Between Mammograms Have Aggressive Features</title>
  <langcode>en</langcode>
  <field_short_title>Breast Cancers Between Mammograms Have Aggressive Features</field_short_title>
  <field_page_description>Breast cancers that are discovered in the period between regular screening mammograms—known as interval cancers—are more likely to have features associated with aggressive behavior and a poor prognosis than cancers found via screening mammograms. </field_page_description>
  <field_date_posted>2011-08-16</field_date_posted>
  <field_date_reviewed>2011-08-02</field_date_reviewed>
  <field_pretty_url>interval-breast-cancer</field_pretty_url>
  <para_id>101531</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>587570</id>
  <title>Kidney cancer progression linked to shifts in tumor metabolism; &lt;span style="font-weight:normal"&gt;&lt;i&gt;Scientists with The Cancer Genome Atlas identify genomic alterations tied to tumor aggressiveness&lt;/i&gt;&lt;/span&gt;</title>
  <langcode>en</langcode>
  <field_short_title>Kidney cancer progression linked to shifts in tumor metabolism</field_short_title>
  <field_page_description>Investigators in The Cancer Genome Atlas Research Network have uncovered a connection between how tumor cells use energy from metabolic processes and the aggressiveness of the most common form of kidney cancer, clear cell renal cell carcinoma.</field_page_description>
  <field_date_posted>2013-06-24</field_date_posted>
  <field_date_reviewed>2013-06-18</field_date_reviewed>
  <field_pretty_url>TCGArenalClearCell</field_pretty_url>
  <para_id>587570</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911286</term_id>
  <id>14411</id>
  <title>Lasers in Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Lasers in Cancer Treatment</field_short_title>
  <field_page_description>A fact sheet that describes use of high-intensity light in cancer treatment, its advantages and disadvantages, and types of procedures that use it.</field_page_description>
  <field_date_posted>2011-09-13</field_date_posted>
  <field_date_reviewed>2011-09-13</field_date_reviewed>
  <field_pretty_url>lasers-fact-sheet</field_pretty_url>
  <para_id>14411</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>915528</term_id>
  <id>14524</id>
  <title>Angiogenesis Inhibitors</title>
  <langcode>en</langcode>
  <field_short_title>Angiogenesis Inhibitors</field_short_title>
  <field_page_description>A fact sheet that describes cancer-fighting agents that block the growth of blood vessels that support tumor growth.</field_page_description>
  <field_date_posted>2018-05-01</field_date_posted>
  <field_date_reviewed>2018-04-02</field_date_reviewed>
  <field_pretty_url>angiogenesis-inhibitors-fact-sheet</field_pretty_url>
  <para_id>14524</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>11886</term_id>
  <id>14625</id>
  <title>Paget Disease of the Breast</title>
  <langcode>en</langcode>
  <field_short_title>Paget Disease of the Breast</field_short_title>
  <field_page_description>A fact sheet about Paget disease of the breast, a rare type of cancer that is sometimes called Paget disease of the nipple or mammary Paget disease.</field_page_description>
  <field_date_posted>2012-05-21</field_date_posted>
  <field_date_reviewed>2012-04-10</field_date_reviewed>
  <field_pretty_url>paget-breast-fact-sheet</field_pretty_url>
  <para_id>14625</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>952687</term_id>
  <id>14637</id>
  <title>PDQ&amp;reg; Cancer Genetics Editorial Board</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Genetics Editorial Board</field_short_title>
  <field_date_posted>2002-05-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14637</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11920</term_id>
  <id>14653</id>
  <title>Kidney (Renal Cell) Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Kidney Cancer</field_short_title>
  <field_page_description>Kidney cancer can develop in adults and children. The main types of kidney cancer are renal cell cancer, transitional cell cancer, and Wilms tumor. Certain inherited conditions increase the risk of kidney cancer. Start here to find information on kidney cancer treatment, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14653</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11890</term_id>
  <id>14756</id>
  <title>Cervical Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Cervical Cancer </field_short_title>
  <field_page_description>Cervical cancer is the fourth most common cancer in women worldwide. The primary risk factor for cervical cancer is human papillomavirus (HPV) infection. Start here to find evidence-based information on cervical cancer treatment, causes and prevention, screening, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14756</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911291</term_id>
  <id>14875</id>
  <title>Harms of Cigarette Smoking and Health Benefits of Quitting</title>
  <langcode>en</langcode>
  <field_short_title>Harms of Cigarette Smoking and Health Benefits of Quitting</field_short_title>
  <field_page_description>A fact sheet that lists some of the cancer-causing chemicals in tobacco smoke and describes the health problems caused by cigarette smoking and the benefits of quitting.</field_page_description>
  <field_date_posted>2017-12-21</field_date_posted>
  <field_date_reviewed>2017-12-19</field_date_reviewed>
  <field_pretty_url>cessation-fact-sheet</field_pretty_url>
  <para_id>14875</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911172</term_id>
  <id>15074</id>
  <title>HIV Infection and Cancer Risk</title>
  <langcode>en</langcode>
  <field_short_title>HIV Infection and Cancer Risk</field_short_title>
  <field_page_description>A fact sheet that describes the increased risk of certain types of cancer by people infected with HIV. </field_page_description>
  <field_date_posted>2017-10-05</field_date_posted>
  <field_date_reviewed>2017-09-14</field_date_reviewed>
  <field_pretty_url>hiv-fact-sheet</field_pretty_url>
  <para_id>15074</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938026</term_id>
  <id>15160</id>
  <title>Treatment Regimen Extends Survival for Women with Cervical Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Treatment Extends Survival for Women with Cervical Cancer</field_short_title>
  <field_date_posted>2009-06-29</field_date_posted>
  <field_date_reviewed>2011-10-20</field_date_reviewed>
  <field_pretty_url>gemcitabine-improves-survival</field_pretty_url>
  <para_id>15160</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>937922</term_id>
  <id>495557</id>
  <title>Cancer Education Webinars for Multicultural Media </title>
  <langcode>en</langcode>
  <field_short_title>Cancer Education Webinars for Multicultural Media </field_short_title>
  <field_date_posted>2013-01-25</field_date_posted>
  <field_date_reviewed>2013-01-21</field_date_reviewed>
  <para_id>495557</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1038738</id>
  <title>Missed Radiation Therapy Sessions Increase Risk of Cancer Recurrence</title>
  <langcode>en</langcode>
  <field_short_title>Missed Radiation Therapy Sessions Increase Risk of Cancer Recurrence</field_short_title>
  <field_page_description>Patients who miss radiation therapy sessions during cancer treatment have an increased risk of their disease returning, even if they eventually complete their course of radiation treatment, according to a new study.</field_page_description>
  <field_date_posted>2016-02-26</field_date_posted>
  <field_date_reviewed>2016-02-26</field_date_reviewed>
  <field_pretty_url>missed-radiation-therapy</field_pretty_url>
  <para_id>1038738</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1040845</id>
  <title>Fueling Basic Discovery: NCI’s Cooperative Human Tissue Network</title>
  <langcode>en</langcode>
  <field_short_title>Fueling Basic Discovery: NCI’s Cooperative Human Tissue Network</field_short_title>
  <field_page_description>Quality biospecimens are a foundational resource for cancer research. One of NCI’s longest running biospecimen programs is the Cooperative Human Tissue Network, a resource mainly for basic discovery and early translational research.</field_page_description>
  <field_date_posted>2016-03-07</field_date_posted>
  <field_date_reviewed>2016-03-07</field_date_reviewed>
  <field_pretty_url>chtn-biospecimens</field_pretty_url>
  <para_id>1040845</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1041539</term_id>
  <id>1041540</id>
  <title>Delirium and Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Diagnosing and Treating Delirium in Cancer Patients</field_short_title>
  <field_page_description>Delirium is a confused mental state. Symptoms may include changes in thinking and sleeping. In cancer patients, it may be caused by medicine, dehydration, or happen at the end of life. Delirium may be mistaken for depression or dementia.</field_page_description>
  <field_date_posted>2016-04-01</field_date_posted>
  <field_date_reviewed>2018-09-14</field_date_reviewed>
  <para_id>1041540</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1043841</id>
  <title>Sunitinib and Sorafenib Ineffective as Adjuvant Therapies for Kidney Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Adjuvant Anti-Angiogenesis Drugs Are No Benefit in Kidney Cancer</field_short_title>
  <field_page_description>Results from a recent clinical trial show that post-surgical therapy with two anti-angiogenesis drugs does not improve progression-free survival for patients with kidney cancer and may cause serious side effects.</field_page_description>
  <field_date_posted>2016-04-08</field_date_posted>
  <field_date_reviewed>2016-04-08</field_date_reviewed>
  <field_pretty_url>adjuvant-angiogenesis-kidney</field_pretty_url>
  <para_id>1043841</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1047361</term_id>
  <id>1047364</id>
  <title>Care for Childhood Cancer Survivors</title>
  <langcode>en</langcode>
  <field_short_title>Survivorship Care for Children</field_short_title>
  <field_page_description>Survivorship care for children who have been treated for cancer is important. Get your child's treatment summary, survivorship plan, and recommendations on follow-up care clinics. Learn about long-term and late effects.</field_page_description>
  <field_date_posted>2016-05-04</field_date_posted>
  <field_date_reviewed>2018-09-10</field_date_reviewed>
  <para_id>1047364</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894082</term_id>
  <id>1047453</id>
  <title>National Minority Health Month Spotlight: Career Development</title>
  <langcode>en</langcode>
  <field_short_title>National Minority Health Month: Career Development</field_short_title>
  <field_date_posted>2016-04-28</field_date_posted>
  <field_date_reviewed>2016-04-28</field_date_reviewed>
  <field_pretty_url>nmhm-2016</field_pretty_url>
  <para_id>1047453</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1047526</id>
  <title>New on NCI’s Websites for May 2016</title>
  <langcode>en</langcode>
  <field_short_title>New on NCI’s Websites for May 2016</field_short_title>
  <field_page_description>NCI periodically provides updates on new websites and other online content of interest to the cancer community.</field_page_description>
  <field_date_posted>2016-05-02</field_date_posted>
  <field_date_reviewed>2016-04-29</field_date_reviewed>
  <field_pretty_url>new-online-may-2016</field_pretty_url>
  <para_id>1047526</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1047564</term_id>
  <id>1047566</id>
  <title>Cancer Systems Biology Consortium</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Systems Biology Consortium</field_short_title>
  <field_page_description>The CSBC looks at the changing cancer ecosystem, allowing researchers to understand and predict how one alteration effects an entire tumor system.</field_page_description>
  <field_date_posted>2016-08-29</field_date_posted>
  <field_date_reviewed>2016-04-29</field_date_reviewed>
  <para_id>1047566</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1047770</id>
  <title>Analysis of rare endocrine cancer reveals novel genetic alterations</title>
  <langcode>en</langcode>
  <field_short_title>Rare endocrine cancers have novel genetic alterations</field_short_title>
  <field_date_posted>2016-05-09</field_date_posted>
  <field_date_reviewed>2016-05-04</field_date_reviewed>
  <field_pretty_url>TCGA-adrenocortical</field_pretty_url>
  <para_id>1047770</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1032046</term_id>
  <id>1047850</id>
  <title>A Conversation with Arul Chinnaiyan</title>
  <langcode>en</langcode>
  <field_short_title>A Conversation with Arul Chinnaiyan</field_short_title>
  <field_page_description>In a new blog in RAS Dialogue, Dr. Chinnaiyan discusses the biology behind his lab's discovery of the interaction of RAS with the RNA processing enzyme AGO2.</field_page_description>
  <field_date_posted>2016-05-10</field_date_posted>
  <field_date_reviewed>2016-05-05</field_date_reviewed>
  <field_pretty_url>arul-chinnaiyan-interview</field_pretty_url>
  <para_id>1047850</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>227641</term_id>
  <id>267255</id>
  <title>NCI-Designated Cancer Centers</title>
  <langcode>en</langcode>
  <field_short_title>NCI-Designated Cancer Centers</field_short_title>
  <field_date_posted>2012-04-05</field_date_posted>
  <field_date_reviewed>2012-04-05</field_date_reviewed>
  <para_id>267255</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>300956</id>
  <title>Drug used in NIH-supported trial shows benefit in children with previously treated cancers </title>
  <langcode>en</langcode>
  <field_short_title>NIH-supported trial drug shows benefit in children with previously treated cancers </field_short_title>
  <field_page_description>Young patients with some types of advanced cancer, for whom standard treatment had failed, had their tumors disappear during treatment with a drug that both targets and blocks a protein associated with their disease. These findings are from a Phase I, mul</field_page_description>
  <field_date_posted>2012-05-16</field_date_posted>
  <field_date_reviewed>2012-05-15</field_date_reviewed>
  <field_pretty_url>crizotinib</field_pretty_url>
  <para_id>300956</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938269</term_id>
  <id>316878</id>
  <title>Adjuvant Everolimus for Resected Kidney Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Adjuvant Everolimus for Resected Kidney Cancer</field_short_title>
  <field_page_description>In this clinical trial, patients with renal cell cancer who have undergone partial or complete nephrectomy will be randomly assigned to take everolimus tablets or matching placebo tablets daily for 54 weeks. </field_page_description>
  <field_date_posted>2012-06-12</field_date_posted>
  <field_date_reviewed>2012-06-12</field_date_reviewed>
  <field_pretty_url>adjuvant-everolimus</field_pretty_url>
  <para_id>316878</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>317012</id>
  <title>NIH Human Microbiome Project defines normal bacterial makeup of the body; Genome sequencing creates first reference data for microbes living with healthy adults</title>
  <langcode>en</langcode>
  <field_short_title>NIH Human Microbiome Project defines normal bacterial makeup of the body</field_short_title>
  <field_page_description>Microbes inhabit just about every part of the human body, living on the skin, in the gut, and up the nose. Sometimes they cause sickness, but most of the time, microorganisms live in harmony with their human hosts, providing vital functions essential for </field_page_description>
  <field_date_posted>2012-06-13</field_date_posted>
  <field_date_reviewed>2012-06-12</field_date_reviewed>
  <field_pretty_url>HMPnormalbodybacteria</field_pretty_url>
  <para_id>317012</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>320912</id>
  <title>NCI and the Republic of Peru Sign Statement of Intent</title>
  <langcode>en</langcode>
  <field_short_title>NCI and the Republic of Peru Sign Statement of Intent</field_short_title>
  <field_page_description>The U.S. National Cancer Institute and the Republic of Peru signed a statement of intent to share an interest in fostering collaborative biomedical research in oncology and a common goal in educating and training the next generation of cancer research sci</field_page_description>
  <field_date_posted>2012-06-21</field_date_posted>
  <field_date_reviewed>2012-06-19</field_date_reviewed>
  <field_pretty_url>PeruLOI</field_pretty_url>
  <para_id>320912</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1066360</term_id>
  <id>1101896</id>
  <title>Addressing a silent killer – WHO Western Pacific Region Sub-Regional Workshop on Betel (Areca) Nut and Tobacco Use</title>
  <langcode>en</langcode>
  <field_short_title>Addressing a silent killer – WHO Western Pacific Region Sub-Regional Workshop on Betel (Areca) Nut a</field_short_title>
  <field_date_posted>2017-12-11</field_date_posted>
  <field_date_reviewed>2017-12-11</field_date_reviewed>
  <field_pretty_url>betel-quid-workshop</field_pretty_url>
  <para_id>1101896</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1102179</id>
  <title>NCI: Taking Risks to Advance Science </title>
  <langcode>en</langcode>
  <field_short_title>NCI: Taking Risks to Advance Science</field_short_title>
  <field_page_description>Dr. Norman Sharpless discusses his experience thus far as NCI director and areas, like big data, where NCI can help advance cancer research.</field_page_description>
  <field_date_posted>2017-12-15</field_date_posted>
  <field_date_reviewed>2017-12-15</field_date_reviewed>
  <field_pretty_url>norman-sharpless-nci-advancing-science</field_pretty_url>
  <para_id>1102179</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1102620</id>
  <title>New on NCI’s Websites for December 2017</title>
  <langcode>en</langcode>
  <field_short_title>New on NCI’s Websites for December 2017</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post that provides an update on new content of interest to the cancer community recently added to NCI’s websites.</field_page_description>
  <field_date_posted>2017-12-27</field_date_posted>
  <field_date_reviewed>2017-12-27</field_date_reviewed>
  <field_pretty_url>new-online-December-2017</field_pretty_url>
  <para_id>1102620</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1102818</term_id>
  <id>1102830</id>
  <title>2017 Social Media Events</title>
  <langcode>en</langcode>
  <field_short_title>2017 Social Media Events</field_short_title>
  <field_page_description>Find past social media events involving NCI and its partners from 2017.</field_page_description>
  <field_date_posted>2018-01-03</field_date_posted>
  <field_date_reviewed>2017-03-28</field_date_reviewed>
  <para_id>1102830</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1104185</id>
  <title>Nilotinib Can Be Discontinued in Some Patients with Chronic Myelogenous Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Nilotinib Can Be Stopped in Some Patients with CML</field_short_title>
  <field_page_description>FDA now says nilotinib (Tasignia) can be safely stopped in some patients with CML whose cancer has been in remission for an extended period.</field_page_description>
  <field_date_posted>2018-01-19</field_date_posted>
  <field_date_reviewed>2018-01-19</field_date_reviewed>
  <field_pretty_url>nilotinib-cml-fda-discontinue</field_pretty_url>
  <para_id>1104185</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102630</term_id>
  <id>1105752</id>
  <title>Recommended Reads in Cancer Genomics</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Genomics Reading List</field_short_title>
  <field_page_description>CCG leadership recommends some leisure reading and academic resources in cancer genomics.</field_page_description>
  <field_date_posted>2018-02-20</field_date_posted>
  <field_date_reviewed>2018-02-12</field_date_reviewed>
  <field_pretty_url>winter-reading-list</field_pretty_url>
  <para_id>1105752</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>1107038</term_id>
  <id>1107039</id>
  <title>Gastrointestinal Carcinoid Tumors Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on gastrointestinal carcinoid tumors, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2018-02-12</field_date_posted>
  <field_date_reviewed>2018-02-12</field_date_reviewed>
  <para_id>1107039</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1107042</id>
  <title>New Cancer Treatment Approach Targets Circadian Clock</title>
  <langcode>en</langcode>
  <field_short_title>Targeting the Circadian Clock to Treat Cancer</field_short_title>
  <field_page_description>Two compounds that target components of the circadian clock killed several types of cancer cells in the lab and slowed the growth of brain cancer in mice without harming healthy cells, as this Cancer Currents post reports.</field_page_description>
  <field_date_posted>2018-02-13</field_date_posted>
  <field_date_reviewed>2018-02-12</field_date_reviewed>
  <field_pretty_url>targeting-circadian-clock-cancer</field_pretty_url>
  <para_id>1107042</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1107074</term_id>
  <id>1107075</id>
  <title>NCI’s Role in Immunotherapy Research</title>
  <langcode>en</langcode>
  <field_short_title>NCI’s Role in Immunotherapy Research</field_short_title>
  <field_page_description>Advances in cancer immunotherapy are the result of several decades of basic research, much of it supported by NCI, on how the immune system responds to cancer. Learn how NCI continues to support a wide range of research, from basic research to clinical trials, to advance the field of cancer immunotherapy.</field_page_description>
  <field_date_posted>2018-02-14</field_date_posted>
  <field_date_reviewed>2018-02-13</field_date_reviewed>
  <para_id>1107075</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>941577</term_id>
  <id>1107110</id>
  <title>Clinical Trials to Treat Pituitary Tumors</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trials to Treat Pituitary Tumors</field_short_title>
  <field_date_posted>2018-02-14</field_date_posted>
  <field_date_reviewed>2018-02-14</field_date_reviewed>
  <field_pretty_url>pituitary-tumors</field_pretty_url>
  <para_id>1107110</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1107678</id>
  <title>Can Oxygen “Microbubbles” Make Radiation Therapy More Effective?</title>
  <langcode>en</langcode>
  <field_short_title>Using Oxygen “Microbubbles” to Improve Radiation Therapy</field_short_title>
  <field_page_description>Oxygen-carrying “microbubbles” could potentially improve the effectiveness of radiation therapy in the treatment of breast cancer, findings from a study in mice suggest. Using the bubbles along with radiation slowed tumor growth more than radiation alone, as this NCI Cancer Currents post reports.</field_page_description>
  <field_date_posted>2018-02-20</field_date_posted>
  <field_date_reviewed>2018-02-20</field_date_reviewed>
  <field_pretty_url>microbubbles-radiation-breast-cancer</field_pretty_url>
  <para_id>1107678</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1109911</id>
  <title>Drug Combination Reduces Number of Colorectal Polyps in Patients with Hereditary Cancer Syndrome</title>
  <langcode>en</langcode>
  <field_short_title>Drug Combo Decreases Colorectal Polyps in People with FAP</field_short_title>
  <field_page_description>In people with familial adenomatous polyposis, or FAP, a combination treatment of erlotinib (Tarceva) and sulindac (Aflodac) decreased the number of precancerous colorectal polyps, according to recently published clinical trial results.</field_page_description>
  <field_date_posted>2018-03-14</field_date_posted>
  <field_date_reviewed>2018-03-13</field_date_reviewed>
  <field_pretty_url>fap-erlotinib-sulindac-colorectal-polyps</field_pretty_url>
  <para_id>1109911</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1110615</id>
  <title>Abemaciclib Approval Expands Initial Treatment Options for Advanced Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Abemaciclib Gets New Approval for Breast Cancer</field_short_title>
  <field_page_description>DA has approved the CDK4/6 inhibitor abemaciclib (Verzenio) as a first-line treatment in some women with advanced or metastatic breast cancer. Under the approval, it must be used in combination with an aromatase inhibitor, as this Cancer Currents blog post explains.</field_page_description>
  <field_date_posted>2018-03-20</field_date_posted>
  <field_date_reviewed>2018-03-20</field_date_reviewed>
  <field_pretty_url>abemaciclib-fda-breast-cancer-first-line</field_pretty_url>
  <para_id>1110615</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1111690</id>
  <title>NCI Launches New Resource for Specimens and Data from Cancer Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>NCTN Navigator Opens to Cancer Researchers </field_short_title>
  <field_page_description>NCI has launched Navigator, a new resource for blood and tissue specimens and clinical data from phase 3 cancer clinical trials. As this Cancer Currents post explains, the resource can help researchers answer important questions about patient care.</field_page_description>
  <field_date_posted>2018-04-02</field_date_posted>
  <field_date_reviewed>2018-03-30</field_date_reviewed>
  <field_pretty_url>nctn-navigator-cancer-clinical-trial-specimens</field_pretty_url>
  <para_id>1111690</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1098967</id>
  <title>With FDA Approval for Advanced Lymphoma, Second CAR T-Cell Therapy Moves to the Clinic</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Second CAR T-Cell Therapy</field_short_title>
  <field_page_description>FDA has approved the CAR T-cell therapy axicabtagene ciloleucel (Yescarta™) for patients with advanced non-Hodgkin lymphoma, as this Cancer Currents article explains.</field_page_description>
  <field_date_posted>2017-10-25</field_date_posted>
  <field_date_reviewed>2017-10-24</field_date_reviewed>
  <field_pretty_url>yescarta-fda-lymphoma</field_pretty_url>
  <para_id>1098967</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>93512</id>
  <title>Drugs Approved for Stomach (Gastric) Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Stomach (Gastric) Cancer</field_short_title>
  <field_date_posted>2011-08-25</field_date_posted>
  <field_date_reviewed>2011-07-19</field_date_reviewed>
  <field_pretty_url>stomach</field_pretty_url>
  <para_id>93512</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>99815</id>
  <title>Drugs Approved for Vulvar Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Vulvar Cancer</field_short_title>
  <field_date_posted>2011-10-25</field_date_posted>
  <field_date_reviewed>2011-07-26</field_date_reviewed>
  <field_pretty_url>vulvar</field_pretty_url>
  <para_id>99815</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>579785</id>
  <title>Cervical Cancer: paradigms at home and abroad</title>
  <langcode>en</langcode>
  <field_short_title>Cervical Cancer: paradigms at home and abroad</field_short_title>
  <field_page_description>NCI funded a clinical trial that will have an impact on the treatment of late-stage cervical cancer, and also supported a screening trial in India using a network of community outreach workers offering low tech-screening by direct visualization of the cer</field_page_description>
  <field_date_posted>2013-06-02</field_date_posted>
  <field_date_reviewed>2013-05-28</field_date_reviewed>
  <field_pretty_url>CervicalCancerASCO2013</field_pretty_url>
  <para_id>579785</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>593633</id>
  <title>Comprehensive list of gene variants developed for cancer cells from nine tissue types</title>
  <langcode>en</langcode>
  <field_short_title>List of gene variants developed for cancer cells from nine tissue types</field_short_title>
  <field_page_description>NCI scientists have developed a comprehensive list of genetic variants for each of the types of cells that comprise what is known as the NCI-60 cell line collection. This new list adds depth to the most frequently studied human tumor cell lines in cancer </field_page_description>
  <field_date_posted>2013-07-15</field_date_posted>
  <field_date_reviewed>2013-07-15</field_date_reviewed>
  <field_pretty_url>NCI-60CellLine</field_pretty_url>
  <para_id>593633</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>608323</term_id>
  <id>608324</id>
  <title>Stories of Discovery</title>
  <langcode>en</langcode>
  <field_short_title>Stories of Discovery</field_short_title>
  <field_page_description>Read these stories describing landmark developments in cancer prevention and treatment supported by NCI funding.</field_page_description>
  <field_date_posted>2013-07-31</field_date_posted>
  <field_date_reviewed>2013-07-31</field_date_reviewed>
  <para_id>608324</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922403</term_id>
  <id>609331</id>
  <title>Radium-223 Improves Survival in Patients with Advanced Prostate Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Radium-223 for Advanced Prostate Cancer</field_short_title>
  <field_page_description>A summary of results from a phase III trial that compared radium-223 dichloride plus the best standard of care versus a placebo plus the best standard of care in men with metastatic, castration-resistant prostate cancer.</field_page_description>
  <field_date_posted>2013-08-02</field_date_posted>
  <field_date_reviewed>2013-08-01</field_date_reviewed>
  <field_pretty_url>radium-223-improves-survival</field_pretty_url>
  <para_id>609331</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>610152</id>
  <title>NIH scientists visualize how cancer chromosome abnormalities form in living cells</title>
  <langcode>en</langcode>
  <field_short_title>Visualizing how cancer chromosome abnormalities form in living cells </field_short_title>
  <field_page_description>For the first time, scientists have directly observed events that lead to the formation of a chromosome abnormality that is often found in cancer cells. The abnormality, called a translocation, occurs when part of a chromosome breaks off and becomes attac</field_page_description>
  <field_date_posted>2013-08-08</field_date_posted>
  <field_date_reviewed>2013-08-05</field_date_reviewed>
  <field_pretty_url>ChromosomeLivingCellsMisteli</field_pretty_url>
  <para_id>610152</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>608323</term_id>
  <id>678040</id>
  <title>Preventing Stomach Cancer: The Link to H. pylori Bacteria</title>
  <langcode>en</langcode>
  <field_short_title>The Link to H. pylori Bacteria</field_short_title>
  <field_date_posted>2014-03-07</field_date_posted>
  <field_date_reviewed>2013-12-10</field_date_reviewed>
  <field_pretty_url>stomach-cancer</field_pretty_url>
  <para_id>678040</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919481</term_id>
  <id>698662</id>
  <title>About the Office of Advocacy Relations</title>
  <langcode>en</langcode>
  <field_short_title>About OAR</field_short_title>
  <field_page_description>OAR works with cancer research advocates and organizations to ensure the advocacy community's perspectives and ideas are integrated into NCI activities to advance research.</field_page_description>
  <field_date_posted>2014-01-30</field_date_posted>
  <field_date_reviewed>2014-01-30</field_date_reviewed>
  <para_id>698662</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>937976</term_id>
  <id>699643</id>
  <title>Blocking DNA Repair in Advanced BRCA-Mutated Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Blocking DNA Repair in Advanced BRCA-Mutated Cancer</field_short_title>
  <field_page_description>In this trial, patients with relapsed or refractory advanced cancer and confirmed BRCA mutations who have not previously been treated with a PARP inhibitor will be given BMN 673 by mouth once a day in 28-day cycles.</field_page_description>
  <field_date_posted>2014-01-31</field_date_posted>
  <field_date_reviewed>2018-02-28</field_date_reviewed>
  <field_pretty_url>advanced-brca-mutated-cancer</field_pretty_url>
  <para_id>699643</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070072</term_id>
  <id>1099372</id>
  <title>Glutamine, Cystine, and Cancer Susceptibilities</title>
  <langcode>en</langcode>
  <field_short_title>Glutamine, Cystine, and Cancer Susceptibilities</field_short_title>
  <field_page_description>Cancer cells generate increased amounts of toxic ROS. Recent papers show how understanding how cancers deal with ROS can lead to therapeutic opportunities.</field_page_description>
  <field_date_posted>2017-10-30</field_date_posted>
  <field_date_reviewed>2017-10-30</field_date_reviewed>
  <field_pretty_url>glutamine-cystine-ros</field_pretty_url>
  <para_id>1099372</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1066360</term_id>
  <id>1099540</id>
  <title>HIV and Cancer Interaction Highlights Need to Address Disease Stigma</title>
  <langcode>en</langcode>
  <field_short_title>HIV and Cancer Interaction Highlights Need to Address Disease Stigma</field_short_title>
  <field_date_posted>2017-11-02</field_date_posted>
  <field_date_reviewed>2017-11-02</field_date_reviewed>
  <field_pretty_url>stigma</field_pretty_url>
  <para_id>1099540</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1099823</id>
  <title>Study Tracks the Evolution of Treatment Resistance in Metastatic Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Tracking Treatment Resistance in Metastatic Breast Cancer</field_short_title>
  <field_page_description>In women with metastatic breast cancer that is resistant to available treatments, a new study suggests that their tumors may have common vulnerabilities.</field_page_description>
  <field_date_posted>2017-11-07</field_date_posted>
  <field_date_reviewed>2017-11-06</field_date_reviewed>
  <field_pretty_url>metastatic-breast-cancer-treatment-resistance-evolution</field_pretty_url>
  <para_id>1099823</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1100184</id>
  <title>Alternate Driver of Treatment-Resistant Prostate Cancer Identified</title>
  <langcode>en</langcode>
  <field_short_title>New Subtype of Treatment-Resistant Prostate Cancer Identified</field_short_title>
  <field_page_description>An emerging subtype of treatment-resistant metastatic prostate cancer can grow without help from androgen hormones, as this Cancer Currents post explains.</field_page_description>
  <field_date_posted>2017-11-14</field_date_posted>
  <field_date_reviewed>2017-11-14</field_date_reviewed>
  <field_pretty_url>prostate-cancer-resistant-new-subtype</field_pretty_url>
  <para_id>1100184</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1100206</id>
  <title>Many Ovarian Cancers May Start in Fallopian Tubes, Study Finds</title>
  <langcode>en</langcode>
  <field_short_title>Many Ovarian Cancers May Start in Fallopian Tubes</field_short_title>
  <field_page_description>The most common form of ovarian cancer may originate in the fallopian tubes, a study finding that has implications for prevention and detection of the disease.</field_page_description>
  <field_date_posted>2017-11-15</field_date_posted>
  <field_date_reviewed>2017-11-14</field_date_reviewed>
  <field_pretty_url>ovarian-cancer-fallopian-tube-origins</field_pretty_url>
  <para_id>1100206</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>581612</id>
  <title>NCI-supported research at ASCO highlights advances in cervical cancer screening and treatment</title>
  <langcode>en</langcode>
  <field_short_title>NCI-supported research at ASCO </field_short_title>
  <field_page_description>Three NCI-supported trials were highlighted at the ASCO Annual Meeting in Chicago on June 2, 2013.</field_page_description>
  <field_date_posted>2013-06-02</field_date_posted>
  <field_date_reviewed>2013-05-31</field_date_reviewed>
  <field_pretty_url>ASCO2013NewsNote</field_pretty_url>
  <para_id>581612</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>587031</id>
  <title>NIH scientists find promising biomarker for predicting HPV-related oropharynx cancer</title>
  <langcode>en</langcode>
  <field_short_title>Scientists find promising predictor of HPV-related oropharynx cancer</field_short_title>
  <field_page_description>Researchers have found that antibodies against the human papillomavirus (HPV) may help identify individuals who are at greatly increased risk of HPV-related cancer of the oropharynx, which is a portion of the throat that contains the tonsils.  </field_page_description>
  <field_date_posted>2013-06-17</field_date_posted>
  <field_date_reviewed>2013-06-14</field_date_reviewed>
  <field_pretty_url>HPVOropharynxCancer</field_pretty_url>
  <para_id>587031</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>660484</id>
  <title>NIH study finds low-intensity therapy for Burkitt lymphoma is highly effective</title>
  <langcode>en</langcode>
  <field_short_title>Study finds low-intensity therapy for Burkitt lymphoma highly effective</field_short_title>
  <field_page_description>Adult patients with a type of cancer known as Burkitt lymphoma had excellent long-term survival rates—upwards of 90 percent—following treatment with low-intensity chemotherapy regimens, according to a new clinical trial finding. Burkitt lymphoma is the mo</field_page_description>
  <field_date_posted>2013-11-13</field_date_posted>
  <field_date_reviewed>2013-11-12</field_date_reviewed>
  <field_pretty_url>BurkittEPOCH</field_pretty_url>
  <para_id>660484</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>608323</term_id>
  <id>678485</id>
  <title>Using the Immune System in the Fight Against Cancer: Discovery of Rituximab</title>
  <langcode>en</langcode>
  <field_short_title>Discovery of Rituximab</field_short_title>
  <field_date_posted>2014-03-07</field_date_posted>
  <field_date_reviewed>2013-12-11</field_date_reviewed>
  <field_pretty_url>blood-cancer</field_pretty_url>
  <para_id>678485</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>918930</term_id>
  <id>684821</id>
  <title>Off-Label Drug Use in Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Off-Label Drug Use in Cancer Treatment</field_short_title>
  <field_date_posted>2014-01-01</field_date_posted>
  <field_date_reviewed>2013-12-23</field_date_reviewed>
  <para_id>684821</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>695703</term_id>
  <id>695704</id>
  <title>Research Advocacy at NCI</title>
  <langcode>en</langcode>
  <field_short_title>Research Advocacy at NCI</field_short_title>
  <field_page_description>Research advocates bring the patient perspective to NCI's work, informing research focus and supporting timely, relevant, and effective advances in cancer research.</field_page_description>
  <field_date_posted>2014-01-23</field_date_posted>
  <field_date_reviewed>2014-01-23</field_date_reviewed>
  <para_id>695704</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911116</term_id>
  <id>13912</id>
  <title>Chemicals in Meat Cooked at High Temperatures and Cancer Risk</title>
  <langcode>en</langcode>
  <field_short_title>Chemicals in Meat Cooked at High Temperatures and Cancer Risk</field_short_title>
  <field_page_description>A fact sheet that explains how certain chemicals form in meat cooked using high-temperature methods. Includes results of research on consumption of these chemicals and cancer risk.</field_page_description>
  <field_date_posted>2018-04-02</field_date_posted>
  <field_date_reviewed>2017-07-11</field_date_reviewed>
  <field_pretty_url>cooked-meats-fact-sheet</field_pretty_url>
  <para_id>13912</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciLandingPage</CONTENTTYPENAME>
  <term_id>12664</term_id>
  <id>13963</id>
  <title>News &amp; Events</title>
  <langcode>en</langcode>
  <field_short_title>News &amp; Events</field_short_title>
  <field_page_description>The latest cancer news from the U.S. government's principal agency for cancer research, plus resources designed for science writers and reporters.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13963</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938142</term_id>
  <id>225392</id>
  <title>Exploring the Anticancer Potential of Valproic Acid in Advanced Thyroid Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Exploring the Anticancer Potential of Valproic Acid in Advanced Thyroid Cancer</field_short_title>
  <field_page_description>In this trial, patients with advanced thyroid cancers of follicular cell origin whose tumors are not sensitive to radioactive iodine therapy will take valproic acid for 10 weeks.</field_page_description>
  <field_date_posted>2012-03-07</field_date_posted>
  <field_date_reviewed>2012-03-07</field_date_reviewed>
  <field_pretty_url>valproic-acid</field_pretty_url>
  <para_id>225392</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922399</term_id>
  <id>253797</id>
  <title>Colonoscopy Reduces Risk of Death from Colorectal Cancer in High-Risk Patients</title>
  <langcode>en</langcode>
  <field_short_title>Colonoscopy Reduces Risk of Death from Colorectal Cancer in High-Risk Patients</field_short_title>
  <field_page_description>Long-term results from the National Polyp Study confirm that removing precancerous adenomas not only reduces the risk of colorectal cancer but also reduces the number of deaths from the disease by more than half.</field_page_description>
  <field_date_posted>2012-03-19</field_date_posted>
  <field_date_reviewed>2012-03-19</field_date_reviewed>
  <field_pretty_url>colonoscopy-reduces-deaths</field_pretty_url>
  <para_id>253797</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1092140</term_id>
  <id>281222</id>
  <title>History of the NCI Cancer Centers Program</title>
  <langcode>en</langcode>
  <field_short_title>History of the NCI Cancer Centers Program</field_short_title>
  <field_date_posted>2012-08-13</field_date_posted>
  <field_date_reviewed>2012-04-20</field_date_reviewed>
  <para_id>281222</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>301280</id>
  <title>NIH study finds that coffee drinkers have lower risk of death  </title>
  <langcode>en</langcode>
  <field_short_title>NIH study finds that coffee drinkers have lower risk of death </field_short_title>
  <field_page_description>Older adults who drank coffee -- caffeinated or decaffeinated -- had a lower risk of death overall than others who did not drink coffee, according a study by researchers from the National Cancer Institute (NCI), part of the National Institutes of Health, </field_page_description>
  <field_date_posted>2012-05-16</field_date_posted>
  <field_date_reviewed>2012-05-16</field_date_reviewed>
  <field_pretty_url>CoffeeProtectiveDCEG</field_pretty_url>
  <para_id>301280</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938030</term_id>
  <id>315415</id>
  <title>More Chemotherapy May Help after Initial Treatment for Childhood Leukemia Fails</title>
  <langcode>en</langcode>
  <field_short_title>More Chemotherapy May Help after Initial Treatment for Childhood Leukemia Fails</field_short_title>
  <field_page_description>A study suggests that at least some children diagnosed with acute lymphoblastic leukemia who respond poorly to initial chemotherapy may do better if they receive additional chemotherapy rather than a stem cell transplant.</field_page_description>
  <field_date_posted>2012-06-07</field_date_posted>
  <field_date_reviewed>2012-06-07</field_date_reviewed>
  <field_pretty_url>more-chemo-helps-all</field_pretty_url>
  <para_id>315415</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>417539</term_id>
  <id>321609</id>
  <title>About CCCT</title>
  <langcode>en</langcode>
  <field_short_title>About CCCT</field_short_title>
  <field_page_description>An overview of how the Coordinating Center for Clinical Trials supports NCI's clinical trials and translational research enterprises. Includes CCCT contact information.</field_page_description>
  <field_date_posted>2012-06-21</field_date_posted>
  <field_date_reviewed>2012-06-21</field_date_reviewed>
  <para_id>321609</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1101053</term_id>
  <id>1101067</id>
  <title>An Organotypic Model Recapitulating Colon Cancer Microenvironment and Metastasis</title>
  <langcode>en</langcode>
  <field_short_title>An Organotypic Model Recapitulating Colon Cancer Microenvironment and Metastasis</field_short_title>
  <field_page_description>In this study, researchers will engineer three models to examine the microenvironment in both the primary site and metastatic sites of colon cancer.</field_page_description>
  <field_date_posted>2017-12-19</field_date_posted>
  <field_date_reviewed>2017-12-01</field_date_reviewed>
  <para_id>1101067</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1066360</term_id>
  <id>1101983</id>
  <title>NCI Center for Global Health’s Scientific Alliance with Kazakhstan on Women’s Cancer Research </title>
  <langcode>en</langcode>
  <field_short_title>NCI Center for Global Health’s Scientific Alliance with Kazakhstan on Women’s Cancer Research </field_short_title>
  <field_page_description>NCI Center for Global Health’s Scientific Alliance with Kazakhstan on Women’s Cancer Research</field_page_description>
  <field_date_posted>2017-12-13</field_date_posted>
  <field_date_reviewed>2017-12-12</field_date_reviewed>
  <field_pretty_url>kazakhstan-womens-cancer</field_pretty_url>
  <para_id>1101983</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1026757</id>
  <title>Low Income Is a Barrier to Clinical Trial Enrollment, Study Suggests </title>
  <langcode>en</langcode>
  <field_short_title>Low Income Is a Barrier to Clinical Trial Enrollment, Study Suggests</field_short_title>
  <field_date_posted>2015-11-16</field_date_posted>
  <field_date_reviewed>2015-11-16</field_date_reviewed>
  <field_pretty_url>income-trials</field_pretty_url>
  <para_id>1026757</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1026053</term_id>
  <id>1026805</id>
  <title>Current Congress </title>
  <langcode>en</langcode>
  <field_short_title>Current Congress </field_short_title>
  <field_page_description>Find legislation introduced in the 116th Congress that is relevant to the NCI.</field_page_description>
  <field_date_posted>2016-02-16</field_date_posted>
  <field_date_reviewed>2015-11-16</field_date_reviewed>
  <para_id>1026805</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1026804</term_id>
  <id>1026837</id>
  <title>Recent Public Laws</title>
  <langcode>en</langcode>
  <field_short_title>Recent Public Laws</field_short_title>
  <field_page_description>Read about legislation related to the mission of NCI that has been signed into law in recent years.</field_page_description>
  <field_date_posted>2017-04-11</field_date_posted>
  <field_date_reviewed>2015-11-17</field_date_reviewed>
  <para_id>1026837</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1026857</term_id>
  <id>1026859</id>
  <title>OGCR Staff</title>
  <langcode>en</langcode>
  <field_short_title>OGCR Staff</field_short_title>
  <field_page_description>Find OGCR staff contact information for questions on current or past legislative activities that relate to the mission of NCI. </field_page_description>
  <field_date_posted>2016-09-01</field_date_posted>
  <field_date_reviewed>2015-11-18</field_date_reviewed>
  <para_id>1026859</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1027924</id>
  <title>Lung Cancer Precision Medicine Trials: Adapting to Progress</title>
  <langcode>en</langcode>
  <field_short_title>Lung Cancer Precision Medicine Trials</field_short_title>
  <field_date_posted>2015-11-30</field_date_posted>
  <field_date_reviewed>2015-11-30</field_date_reviewed>
  <field_pretty_url>lung-cancer-landscape</field_pretty_url>
  <para_id>1027924</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>930502</term_id>
  <id>1032039</id>
  <title>NCI Scientists Identify New Gene Mutation that Predisposes Families to Melanoma</title>
  <langcode>en</langcode>
  <field_short_title>NCI Scientists Identify New Gene Mutation that Predisposes Families to Melanoma</field_short_title>
  <field_date_posted>2014-03-31</field_date_posted>
  <field_date_reviewed>2015-12-18</field_date_reviewed>
  <field_pretty_url>gene-mutation-predisposes-melanoma</field_pretty_url>
  <para_id>1032039</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>1032054</id>
  <title>Modeling Different Breast Cancer Screening Strategies</title>
  <langcode>en</langcode>
  <field_short_title>Modeling Different Breast Cancer Screening Strategies</field_short_title>
  <field_page_description>A modeling study for breast cancer screening found that regular mammography screening for women ages 50 to 74 reduces the risk of dying due to breast cancer, with a smaller benefit for women 40 to 49.</field_page_description>
  <field_date_posted>2009-11-18</field_date_posted>
  <field_date_reviewed>2015-12-18</field_date_reviewed>
  <field_pretty_url>modeling-breast-cancer-screening</field_pretty_url>
  <para_id>1032054</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1033570</id>
  <title>Three New Therapies Approved for Multiple Myeloma</title>
  <langcode>en</langcode>
  <field_short_title>Three New Therapies Approved for Multiple Myeloma</field_short_title>
  <field_date_posted>2016-01-06</field_date_posted>
  <field_date_reviewed>2016-01-05</field_date_reviewed>
  <field_pretty_url>fda-threedrugs-myeloma</field_pretty_url>
  <para_id>1033570</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1032046</term_id>
  <id>1033860</id>
  <title>Mutation-Specific Approaches to KRAS Cancers: What We Can Learn from G12C-Directed Inhibitors</title>
  <langcode>en</langcode>
  <field_short_title>Mutation-specific Approaches to KRAS Cancers</field_short_title>
  <field_page_description>Dr. Sharon Campbell discusses recent advances in targeting specific mutant forms of KRAS proteins in cancers.</field_page_description>
  <field_date_posted>2016-01-12</field_date_posted>
  <field_date_reviewed>2016-01-12</field_date_reviewed>
  <field_pretty_url>kras-g12c-inhibitors</field_pretty_url>
  <para_id>1033860</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1035790</id>
  <title>CGH Supports World Cancer Day Every Day</title>
  <langcode>en</langcode>
  <field_short_title>CGH Supports World Cancer Day Every Day</field_short_title>
  <field_date_posted>2016-02-04</field_date_posted>
  <field_date_reviewed>2016-02-04</field_date_reviewed>
  <field_pretty_url>wcd-every-day</field_pretty_url>
  <para_id>1035790</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1032046</term_id>
  <id>1035900</id>
  <title>Faint Light at the End of the Tunnel</title>
  <langcode>en</langcode>
  <field_short_title>Faint Light at the End of the Tunnel</field_short_title>
  <field_page_description>Gideon Bollag describes progress and some of the challenges in inhibiting RAF, the primary effector of RAS in the MAPK pathway.</field_page_description>
  <field_date_posted>2016-02-08</field_date_posted>
  <field_date_reviewed>2016-02-05</field_date_reviewed>
  <field_pretty_url>bollag-raf-inhibitors</field_pretty_url>
  <para_id>1035900</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1036653</id>
  <title>FDA Approves Eribulin Mesylate for Advanced Liposarcoma</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Eribulin Mesylate for Advanced Liposarcoma</field_short_title>
  <field_page_description>The FDA has approved eribulin mesylate for patients with liposarcoma whose cancers are advanced or cannot be removed by surgery and are no longer responding to anthracycline-based chemotherapy.</field_page_description>
  <field_date_posted>2016-02-11</field_date_posted>
  <field_date_reviewed>2016-02-09</field_date_reviewed>
  <field_pretty_url>fda-eribulin-mesylate</field_pretty_url>
  <para_id>1036653</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1037153</term_id>
  <id>1037684</id>
  <title>Learning to Relax</title>
  <langcode>en</langcode>
  <field_short_title>Learning to Relax</field_short_title>
  <field_page_description>Relaxation and imagery exercises to help reduce pain and stress from cancer and its treatment.</field_page_description>
  <field_date_posted>2016-02-29</field_date_posted>
  <field_date_reviewed>2016-02-17</field_date_reviewed>
  <para_id>1037684</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1038005</term_id>
  <id>1038006</id>
  <title>Cancer Moonshot&amp;#8480; Blue Ribbon Panel</title>
  <langcode>en</langcode>
  <field_short_title>Blue Ribbon Panel</field_short_title>
  <field_page_description>The Blue Ribbon Panel Report outlines 10 recommendations to accelerate progress against cancer. The panel was established to ensure that the Cancer Moonshot's approaches are grounded in the best science.</field_page_description>
  <field_date_posted>2016-04-04</field_date_posted>
  <field_date_reviewed>2016-02-18</field_date_reviewed>
  <para_id>1038006</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102630</term_id>
  <id>1103539</id>
  <title>Planning a Genomic Characterization Study? Tips for Collecting and Processing Biospecimens</title>
  <langcode>en</langcode>
  <field_short_title>Tips for Biospecimen Processing</field_short_title>
  <field_page_description>Guidance and tips for the biospecimen processing aspect of your genomic characterization study</field_page_description>
  <field_date_posted>2018-01-16</field_date_posted>
  <field_date_reviewed>2018-01-16</field_date_reviewed>
  <field_pretty_url>bcr-tips</field_pretty_url>
  <para_id>1103539</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1103047</term_id>
  <id>1104013</id>
  <title>Treatment of Head and Neck Cancer in Children and Adolescents—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Head and Neck Cancer Treatment in Children and Adolescents</field_short_title>
  <field_page_description>Find information about prognosis, staging, and treatment for the following head and neck cancer sites in children: esthesioneuroblastoma, larynx and papillomatosis, nasopharynx, oral cavity, and salivary gland.</field_page_description>
  <field_date_posted>2018-01-15</field_date_posted>
  <field_date_reviewed>2018-01-15</field_date_reviewed>
  <para_id>1104013</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1104873</id>
  <title>Study Finds Biological Differences in Lung Tumors of African Americans and Whites</title>
  <langcode>en</langcode>
  <field_short_title>In Black and White Patients, Biological Differences in Lung Tumors</field_short_title>
  <field_page_description>In patients with lung cancer, a new study shows different patterns of gene expression in the tumors of African American and white patients may contribute to racial disparities.</field_page_description>
  <field_date_posted>2018-01-23</field_date_posted>
  <field_date_reviewed>2018-01-23</field_date_reviewed>
  <field_pretty_url>lung-cancer-biologic-differences-race</field_pretty_url>
  <para_id>1104873</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1102622</term_id>
  <id>1107069</id>
  <title>Szent-Gy&amp;ouml;rgyi Prize to honor NCI’s Douglas R. Lowy and John T. Schiller</title>
  <langcode>en</langcode>
  <field_short_title>Lowy, Schiller win 2018 Szent-Gy&amp;ouml;rgyi Prize</field_short_title>
  <field_page_description>A press release announcing that NCI scientists Douglas R. Lowy and John T. Schiller will receive the 2018 Szent-Györgyi Prize for Progress in Cancer Research from the National Foundation for Cancer Research for their work on HPV vaccines.</field_page_description>
  <field_date_posted>2018-02-15</field_date_posted>
  <field_date_reviewed>2018-02-13</field_date_reviewed>
  <field_pretty_url>lowy-schiller-szent-gyorgyi-prize</field_pretty_url>
  <para_id>1107069</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>941577</term_id>
  <id>1107096</id>
  <title>Clinical Trials to Treat Kidney (Renal Cell) Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trials to Treat Kidney (Renal Cell) Cancer</field_short_title>
  <field_date_posted>2018-02-14</field_date_posted>
  <field_date_reviewed>2018-02-14</field_date_reviewed>
  <field_pretty_url>kidney-cancer</field_pretty_url>
  <para_id>1107096</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1107156</id>
  <title>Retooling NCI MERIT Awards to Support Budding Cancer Researchers</title>
  <langcode>en</langcode>
  <field_short_title>Retooled Award Supports Budding Cancer Researchers</field_short_title>
  <field_page_description>In this Cancer Currents post, NCI Director Dr. Norman Sharpless discusses how NCI is retooling a grant mechanism, called the MERIT R37 Award, to help early-stage investigators by extending the length of time they can receive funding under their first independent NIH grant.</field_page_description>
  <field_date_posted>2018-02-16</field_date_posted>
  <field_date_reviewed>2018-02-15</field_date_reviewed>
  <field_pretty_url>sharpless-merit-awards</field_pretty_url>
  <para_id>1107156</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102626</term_id>
  <id>1108328</id>
  <title>Recognizing HPV Awareness Day</title>
  <langcode>en</langcode>
  <field_short_title>HPV Awareness Day</field_short_title>
  <field_date_posted>2018-02-27</field_date_posted>
  <field_date_reviewed>2018-02-27</field_date_reviewed>
  <field_pretty_url>int-hpv</field_pretty_url>
  <para_id>1108328</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1109255</id>
  <title>FDA Approves Apalutamide for Some Men with Prostate Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Apalutamide for Prostate Cancer</field_short_title>
  <field_page_description>Apalutamide (Erleada) is a hormone therapy that counteracts resistance to androgen deprivation therapy. Learn more about the FDA approval of apalutamide for men with castration-resistant nonmetastatic prostate cancer in this Cancer Currents blog post.</field_page_description>
  <field_date_posted>2018-03-08</field_date_posted>
  <field_date_reviewed>2018-03-07</field_date_reviewed>
  <field_pretty_url>apalutamide-fda-nonmetastatic-prostate</field_pretty_url>
  <para_id>1109255</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1109389</id>
  <title>Targeted Therapy Larotrectinib Shows Promise in Early Trials, Regardless of Cancer Type</title>
  <langcode>en</langcode>
  <field_short_title>Larotrectinib Shows Promise, Regardless of Cancer Type</field_short_title>
  <field_page_description>Larotrectinib shrank tumors in patients with 13 different cancer types, clinical trials show. The drug, which targets tumors with TRK fusions, was effective in children and adults. Update reflects FDA approval.</field_page_description>
  <field_date_posted>2018-03-09</field_date_posted>
  <field_date_reviewed>2018-03-08</field_date_reviewed>
  <field_pretty_url>larotrectinib-effective-across-cancer-types</field_pretty_url>
  <para_id>1109389</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1102947</term_id>
  <id>1111025</id>
  <title>Scientists in the Community Staff and Contact Information</title>
  <langcode>en</langcode>
  <field_short_title>Contact Scientists in the Community</field_short_title>
  <field_date_posted>2018-03-23</field_date_posted>
  <field_date_reviewed>2018-03-23</field_date_reviewed>
  <para_id>1111025</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1038331</id>
  <title>A Milestone in Cancer Research and Treatment in India</title>
  <langcode>en</langcode>
  <field_short_title>A Milestone in Cancer Research and Treatment in India</field_short_title>
  <field_date_posted>2016-02-19</field_date_posted>
  <field_date_reviewed>2016-02-19</field_date_reviewed>
  <field_pretty_url>tmc_jubilee</field_pretty_url>
  <para_id>1038331</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1038908</id>
  <title>BRCA Testing Rates High in Young Women with Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>BRCA Testing Increasing in Young Breast Cancer Patients</field_short_title>
  <field_page_description>Testing for genetic mutations strongly associated with an increased breast cancer risk has risen dramatically among women younger than age 40 who are diagnosed with the disease, according to a new study.</field_page_description>
  <field_date_posted>2016-03-01</field_date_posted>
  <field_date_reviewed>2016-03-01</field_date_reviewed>
  <field_pretty_url>brca-testing-breast-cancer</field_pretty_url>
  <para_id>1038908</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1038904</term_id>
  <id>1038929</id>
  <title>Center for Research Strategy (CRS)</title>
  <langcode>en</langcode>
  <field_short_title>Center for Research Strategy (CRS)</field_short_title>
  <field_page_description>CRS develops recommendations on scientific opportunity, funding gaps and mechanisms, while monitoring the direction and application of knowledge and resources.</field_page_description>
  <field_date_posted>2016-03-29</field_date_posted>
  <field_date_reviewed>2016-03-02</field_date_reviewed>
  <para_id>1038929</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1040909</id>
  <title>HPV Infections Targeted by Vaccine Decrease in U.S.</title>
  <langcode>en</langcode>
  <field_short_title>HPV Infections Drop in the U.S.</field_short_title>
  <field_page_description>Infection with human papillomavirus (HPV) types targeted by the quadrivalent HPV vaccine has declined by nearly two-thirds among teenage girls since HPV vaccination was recommended in the United States.</field_page_description>
  <field_date_posted>2016-03-09</field_date_posted>
  <field_date_reviewed>2016-03-08</field_date_reviewed>
  <field_pretty_url>hpv-infections-decreased</field_pretty_url>
  <para_id>1040909</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1042230</id>
  <title>New Strategy for Treating Advanced Ovarian Cancer Shows Promise in Mice </title>
  <langcode>en</langcode>
  <field_short_title>New Strategy for Treating Advanced Ovarian Cancer Shows Promise in Mice </field_short_title>
  <field_page_description>The use of a protein fragment to stimulate cells in the tumor microenvironment against cancer shows promise in animal models of metastatic ovarian cancer. </field_page_description>
  <field_date_posted>2016-03-28</field_date_posted>
  <field_date_reviewed>2016-03-28</field_date_reviewed>
  <field_pretty_url>ovarian-cancer-prosaposin</field_pretty_url>
  <para_id>1042230</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1032046</term_id>
  <id>1042262</id>
  <title>Nutritional Requirements of Pancreatic Cancers - A Conversation with Dafna Bar-Sagi</title>
  <langcode>en</langcode>
  <field_short_title>A Conversation with Dafna Bar-Sagi</field_short_title>
  <field_page_description>In a new RAS Dialogue blog post, Dr. Dafna Bar-Sagi discusses the new interest in her 1986 discovery of the unexpected dietary preference of pancreatic cancer cells.</field_page_description>
  <field_date_posted>2016-03-30</field_date_posted>
  <field_date_reviewed>2016-03-29</field_date_reviewed>
  <field_pretty_url>dafna-bar-sagi-interview</field_pretty_url>
  <para_id>1042262</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1043594</term_id>
  <id>1043595</id>
  <title>Understanding Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Understanding Cancer</field_short_title>
  <field_page_description>This page is a gateway to basic information about how cancer develops, trends in cancer cases and deaths, and how cancer affects different populations.</field_page_description>
  <field_date_posted>2016-04-07</field_date_posted>
  <field_date_reviewed>2016-04-07</field_date_reviewed>
  <para_id>1043595</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1045533</id>
  <title>A Shared Commitment for Accelerating Progress with the Cancer Moonshot</title>
  <langcode>en</langcode>
  <field_short_title>A Shared Commitment to the Cancer Moonshot</field_short_title>
  <field_page_description>At the AACR annual meeting, Vice President Biden spoke about the National Cancer Moonshot Initiative and the critical role the entire research community will play in accelerating progress against cancer.</field_page_description>
  <field_date_posted>2016-04-20</field_date_posted>
  <field_date_reviewed>2016-04-20</field_date_reviewed>
  <field_pretty_url>moonshot-biden-aacr</field_pretty_url>
  <para_id>1045533</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1048220</id>
  <title>Healthy Kids; Healthy World - Take Your Child to Work Day 2016</title>
  <langcode>en</langcode>
  <field_short_title>Healthy Kids; Healthy World - Take Your Child to Work Day 2016</field_short_title>
  <field_date_posted>2016-05-10</field_date_posted>
  <field_date_reviewed>2016-05-10</field_date_reviewed>
  <field_pretty_url>tyctwd2016</field_pretty_url>
  <para_id>1048220</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1049936</id>
  <title>Crosstalk between Cancer Cells and Neighboring Cells May Contribute to Tumor Growth</title>
  <langcode>en</langcode>
  <field_short_title>Molecular Crosstalk Promotes Pancreatic Tumor Growth</field_short_title>
  <field_page_description>Pancreatic cancer cells and neighboring normal cells engage in a two-way molecular conversation that helps drive malignant behavior in the cancer cells, according to new study results.</field_page_description>
  <field_date_posted>2016-05-16</field_date_posted>
  <field_date_reviewed>2016-05-16</field_date_reviewed>
  <field_pretty_url>crosstalk-pancreatic</field_pretty_url>
  <para_id>1049936</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>940315</term_id>
  <id>1050504</id>
  <title>PET-CT–Guided Surveillance May Reduce Need for Surgery in Some Patients with Advanced Head and Neck Cancer</title>
  <langcode>en</langcode>
  <field_short_title>PET-CT–Guided Surveillance May Reduce Need for Surgery in Some Patients with Advanced Head and Neck </field_short_title>
  <field_page_description>Patients with advanced squamous cell carcinoma of the head and neck who underwent PET-CT–guided surveillance had fewer operations but similar overall survival rates to those of patients who underwent planned neck dissection.</field_page_description>
  <field_date_posted>2016-05-20</field_date_posted>
  <field_date_reviewed>2016-05-20</field_date_reviewed>
  <field_pretty_url>pet-ct-surveillance</field_pretty_url>
  <para_id>1050504</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1026798</term_id>
  <id>1026806</id>
  <title>Biomedical Research Legislation</title>
  <langcode>en</langcode>
  <field_short_title>Biomedical Research Legislation</field_short_title>
  <field_page_description>Legislation from the current Congress dealing with biomedical research related to NCI.</field_page_description>
  <field_date_posted>2016-02-16</field_date_posted>
  <field_date_reviewed>2015-11-16</field_date_reviewed>
  <para_id>1026806</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>1026828</id>
  <title>NIH-IEEE 2015 Strategic Conference on Healthcare Innovations and Point-of-Care Technologies for Precision Medicine</title>
  <langcode>en</langcode>
  <field_short_title>NIH-IEEE 2015 Strategic Conference on Healthcare Innovations and Point-of-Care Technologies for Prec</field_short_title>
  <field_date_posted>2015-11-16</field_date_posted>
  <field_date_reviewed>2015-11-16</field_date_reviewed>
  <field_pretty_url>precision</field_pretty_url>
  <para_id>1026828</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1027009</term_id>
  <id>1027010</id>
  <title>Glossary of Legislative Terms</title>
  <langcode>en</langcode>
  <field_short_title>Glossary of Legislative Terms</field_short_title>
  <field_page_description>The Glossary of Legislative Terms provides brief explanations of terms and procedures used within the United States Congress.</field_page_description>
  <field_date_posted>2016-02-16</field_date_posted>
  <field_date_reviewed>2015-11-19</field_date_reviewed>
  <para_id>1027010</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1026794</term_id>
  <id>1027677</id>
  <title>Legislative Updates</title>
  <langcode>en</langcode>
  <field_short_title>Legislative Updates</field_short_title>
  <field_page_description>Recent developments on legislation involving cancer research, appropriations, congressional testimony and other related topics. </field_page_description>
  <field_date_posted>2016-02-16</field_date_posted>
  <field_date_reviewed>2015-11-24</field_date_reviewed>
  <para_id>1027677</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1027726</id>
  <title>FDA Approves Talimogene Laherparepvec to Treat Metastatic Melanoma</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves T-VEC to Treat Metastatic Melanoma</field_short_title>
  <field_date_posted>2015-11-25</field_date_posted>
  <field_date_reviewed>2015-11-25</field_date_reviewed>
  <field_pretty_url>t-vec-melanoma</field_pretty_url>
  <para_id>1027726</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1030591</term_id>
  <id>1030592</id>
  <title>Public Health Service Act</title>
  <langcode>en</langcode>
  <field_short_title>Public Health Service Act</field_short_title>
  <field_page_description>Information on the Public Health Service Act and related legislation that directly impacted the mission of NCI.</field_page_description>
  <field_date_posted>2016-02-16</field_date_posted>
  <field_date_reviewed>2015-12-10</field_date_reviewed>
  <para_id>1030592</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1031690</id>
  <title>Two Small RNAs, Often Missing from Cancer Cells, May Suppress Tumors</title>
  <langcode>en</langcode>
  <field_short_title>Two Small RNAs, Often Missing from Cancer Cells, May Suppress Tumors</field_short_title>
  <field_date_posted>2015-12-14</field_date_posted>
  <field_date_reviewed>2015-12-14</field_date_reviewed>
  <field_pretty_url>rna-tumor-suppressors</field_pretty_url>
  <para_id>1031690</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1033153</id>
  <title>What's New on NCI’s Websites?</title>
  <langcode>en</langcode>
  <field_short_title>What's New on NCI’s Websites?</field_short_title>
  <field_page_description>NCI periodically provides updates on new websites and other online content of interest to the cancer community.</field_page_description>
  <field_date_posted>2015-12-22</field_date_posted>
  <field_date_reviewed>2015-12-21</field_date_reviewed>
  <field_pretty_url>new-online-december-2015</field_pretty_url>
  <para_id>1033153</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1011702</term_id>
  <id>1033574</id>
  <title>DNA and Chromosome Aberrations Research</title>
  <langcode>en</langcode>
  <field_short_title>DNA and Chromosome Aberrations Research</field_short_title>
  <field_page_description>Part of NCI's Division of Cancer Biology's research portfolio, this research area is focused on making clear the genetic and epigenetic mechanisms of tumorigenesis and mechanisms of chemical and physical carcinogenesis.</field_page_description>
  <field_date_posted>2016-08-08</field_date_posted>
  <field_date_reviewed>2016-01-06</field_date_reviewed>
  <para_id>1033574</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1033862</id>
  <title>Genome Study Links Misfolded DNA to Brain Tumors </title>
  <langcode>en</langcode>
  <field_short_title>Genome Study Links Misfolded DNA to Brain Tumors </field_short_title>
  <field_page_description>Changes in the packaging of DNA in the cell nucleus may activate growth-promoting genes that cause cancer. </field_page_description>
  <field_date_posted>2016-01-12</field_date_posted>
  <field_date_reviewed>2016-01-12</field_date_reviewed>
  <field_pretty_url>misfolded-dna</field_pretty_url>
  <para_id>1033862</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1052108</term_id>
  <id>1052115</id>
  <title>Budget and Appropriations Status</title>
  <langcode>en</langcode>
  <field_short_title>Budget and Appropriations Status</field_short_title>
  <field_page_description>Information on the status of budget and appropriations legislation in the current Congress, including a recap of the previous year’s appropriations request.</field_page_description>
  <field_date_posted>2016-06-08</field_date_posted>
  <field_date_reviewed>2016-06-08</field_date_reviewed>
  <para_id>1052115</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1052849</id>
  <title>Extended Adjuvant Therapy Beneficial for Some Women with Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Extended Adjuvant Therapy Beneficial for Some Women with Breast Cancer</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on findings from a recent clinical trial which showed that extending adjuvant therapy with an aromatase inhibitor can have important benefits for some women with early-stage cancer.</field_page_description>
  <field_date_posted>2016-06-22</field_date_posted>
  <field_date_reviewed>2016-06-22</field_date_reviewed>
  <field_pretty_url>adjuvant-aromatase-breast</field_pretty_url>
  <para_id>1052849</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1056370</id>
  <title>Olanzapine Helps Prevent Nausea and Vomiting Caused by Chemotherapy</title>
  <langcode>en</langcode>
  <field_short_title>Olanzapine Helps Prevent Nausea and Vomiting Caused by Chemotherapy</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on a large clinical trial that showed an anti-psychotic drug can help prevent nausea and vomiting in patients receiving chemotherapy.</field_page_description>
  <field_date_posted>2016-07-21</field_date_posted>
  <field_date_reviewed>2016-07-21</field_date_reviewed>
  <field_pretty_url>olanzapine-chemotherapy-nausea</field_pretty_url>
  <para_id>1056370</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1032046</term_id>
  <id>1060839</id>
  <title>Pancreatic Organoids - A Conversation with Senthil Muthuswamy</title>
  <langcode>en</langcode>
  <field_short_title>Pancreatic Organoids Mimic Patient Tumors</field_short_title>
  <field_page_description>Pancreatic organoids can be established quickly, cheaply, and reliably. They mimic patient histopathology and can be frozen and revived for large studies.</field_page_description>
  <field_date_posted>2016-08-25</field_date_posted>
  <field_date_reviewed>2016-08-25</field_date_reviewed>
  <field_pretty_url>senthil-uthuswamy-interview</field_pretty_url>
  <para_id>1060839</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1062133</id>
  <title>Forging Collaborations to Spur Global Progress against Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Spurring Global Progress against Cancer </field_short_title>
  <field_page_description>An NCI Cancer Currents blog about international collaborations announced by NCI and NIH to accelerate progress in reducing the global cancer burden.</field_page_description>
  <field_date_posted>2016-09-22</field_date_posted>
  <field_date_reviewed>2016-09-19</field_date_reviewed>
  <field_pretty_url>global-cancer-collaboration</field_pretty_url>
  <para_id>1062133</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1133416</id>
  <title>The HPV Vaccine: Increasing the Use of an Important Cancer Prevention Tool</title>
  <langcode>en</langcode>
  <field_short_title>President’s Cancer Panel Report: Increasing HPV Vaccine Use</field_short_title>
  <field_page_description>A new report on the HPV vaccine from the President’s Cancer Panel identifies priorities and strategies for improving uptake of this cancer prevention tool.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2018-12-19</field_date_reviewed>
  <field_pretty_url>hpv-vaccine-presidents-cancer-panel-improving-uptake</field_pretty_url>
  <para_id>1133416</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1114846</term_id>
  <id>1134384</id>
  <title>Scientific Management Training </title>
  <langcode>en</langcode>
  <field_short_title>Scientific Management Training </field_short_title>
  <field_page_description>The Scientific Management Training (SMT) course provides management skills to NCI Principal Investigators and NCI Fellows focusing on personnel and project management to assist in succesfully leading scientific research laboratories.</field_page_description>
  <field_date_posted>2019-01-03</field_date_posted>
  <field_date_reviewed>2019-01-03</field_date_reviewed>
  <field_pretty_url>scientific-management-training</field_pretty_url>
  <para_id>1134384</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1114846</term_id>
  <id>1134386</id>
  <title>Statistical Tutorial </title>
  <langcode>en</langcode>
  <field_short_title>Statistical Tutorial </field_short_title>
  <field_page_description>The Statistical Tutorial (ST) course is designed as a follow up to the Statistical Analysis of Research Data (SARD). This tutorial will apply real-time general principles of statistical analysis of research data.</field_page_description>
  <field_date_posted>2019-01-03</field_date_posted>
  <field_date_reviewed>2019-01-03</field_date_reviewed>
  <field_pretty_url>statistical-tutorial</field_pretty_url>
  <para_id>1134386</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133178</term_id>
  <id>1134552</id>
  <title>What are rare soft tissue tumors?</title>
  <langcode>en</langcode>
  <field_short_title>Rare Soft Tissue Tumors</field_short_title>
  <field_date_posted>2019-01-07</field_date_posted>
  <field_date_reviewed>2019-01-07</field_date_reviewed>
  <para_id>1134552</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1134558</term_id>
  <id>1134554</id>
  <title>What are rare endocrine tumors?</title>
  <langcode>en</langcode>
  <field_short_title>Rare Endocrine Tumors</field_short_title>
  <field_page_description>Rare tumors can develop in the endocrine glands and other cells that produce horomones,like thyroid, adrenal, and pituitary glands, and cells in your pancreas. There are a few specific tumors that affect children, teens, and young adults.</field_page_description>
  <field_date_posted>2019-01-07</field_date_posted>
  <field_date_reviewed>2019-01-07</field_date_reviewed>
  <para_id>1134554</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1134584</term_id>
  <id>1134603</id>
  <title>Brain Tumors Through the Single-Cell RNA Sequencing Lens: Researcher Interview with Mario Suvà</title>
  <langcode>en</langcode>
  <field_short_title>Mario Suvà on Single-cell RNA Sequencing</field_short_title>
  <field_page_description>A neuropathologist talks about single-cell RNA sequencing technology and the brain cancer research it enables.</field_page_description>
  <field_date_posted>2019-01-15</field_date_posted>
  <field_date_reviewed>2019-01-08</field_date_reviewed>
  <field_pretty_url>interview-scRNA-seq</field_pretty_url>
  <para_id>1134603</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1134352</term_id>
  <id>1135220</id>
  <title>Managing Cancer Pain: Are Better Approaches on the Horizon?</title>
  <langcode>en</langcode>
  <field_short_title>Developing Better Approaches for Managing Cancer Pain</field_short_title>
  <field_page_description>Pain is common in cancer patients and long-term survivors, so researchers are studying potential new pain medications and nondrug approaches for cancer pain.</field_page_description>
  <field_date_posted>2019-01-23</field_date_posted>
  <field_date_reviewed>2019-01-15</field_date_reviewed>
  <field_pretty_url>cancer-pain-new-approaches</field_pretty_url>
  <para_id>1135220</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1134352</term_id>
  <id>1135722</id>
  <title>African American Men More Likely to Die from Low-Grade Prostate Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Study Shows Disparities in Death from Low-Grade Prostate Cancer</field_short_title>
  <field_page_description>African American men with low-grade prostate cancer are more likely to die from the disease than men of other races, a new study shows.</field_page_description>
  <field_date_posted>2019-01-28</field_date_posted>
  <field_date_reviewed>2019-01-24</field_date_reviewed>
  <field_pretty_url>prostate-cancer-death-disparities-black-men</field_pretty_url>
  <para_id>1135722</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1134352</term_id>
  <id>1136288</id>
  <title>Pembrolizumab Now Second Immunotherapy Approved to Treat Merkel Cell Carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Pembrolizumab to Treat Merkel Cell Carcinoma</field_short_title>
  <field_page_description>FDA has approved pembrolizumab (Keytruda) to treat people with locally advanced or metastatic Merkel cell carcinoma, a rare and deadly form of skin cancer.</field_page_description>
  <field_date_posted>2019-02-04</field_date_posted>
  <field_date_reviewed>2019-01-30</field_date_reviewed>
  <field_pretty_url>pembrolizumab-merkel-cell-carcinoma-fda-approval</field_pretty_url>
  <para_id>1136288</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1136868</term_id>
  <id>1136877</id>
  <title>FNLCR Acquisitions Reference Library</title>
  <langcode>en</langcode>
  <field_short_title>Reference Library</field_short_title>
  <field_date_posted>2019-02-05</field_date_posted>
  <field_date_reviewed>2019-02-05</field_date_reviewed>
  <para_id>1136877</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1116320</id>
  <title>Dabrafenib–Trametinib Combination Approved for Melanoma, Anaplastic Thyroid Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Dabrafenib Plus Trametinib Approved for Melanoma, Thyroid Cancer</field_short_title>
  <field_page_description>FDA recently approved the combination of dabrafenib (Taflinar) and trametinib (Mekinist) to treat some patients with melanoma and anaplastic thyroid cancer whose tumors have a mutation in the BRAF gene. As this Cancer Currents blog post explains, this is the first treatment approved specifically for anaplastic thyroid </field_page_description>
  <field_date_posted>2018-05-25</field_date_posted>
  <field_date_reviewed>2018-05-24</field_date_reviewed>
  <field_pretty_url>fda-dabrafenib-trametinib-melanoma-thyroid</field_pretty_url>
  <para_id>1116320</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1116396</id>
  <title>Experimental Cancer Drug Metarrestin Targets Metastatic Tumors</title>
  <langcode>en</langcode>
  <field_short_title>Experimental Drug Metarrestin Targets Metastatic Tumors</field_short_title>
  <field_page_description>An experimental drug called metarrestin appears to selectively target tumors that have spread to other parts of the body. As this Cancer Currents blog post reports, the drug shrank metastatic tumors and extended survival in in mouse models of pancreatic cancer.</field_page_description>
  <field_date_posted>2018-05-29</field_date_posted>
  <field_date_reviewed>2018-05-25</field_date_reviewed>
  <field_pretty_url>metaresstin-metastatic-tumors</field_pretty_url>
  <para_id>1116396</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1116537</id>
  <title>New Treatment Approach Could Help Prevent Recurrences of Some Bladder Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Treatment May Help Prevent Bladder Cancer Recurrences</field_short_title>
  <field_page_description>Flushing the bladder with the chemotherapy drug gemcitabine after tumors have been removed surgically may reduce the risk of the cancer returning, according to the results of a large clinical trial. As this Cancer Currents blog post explains, the treatment approach is for patients with low-grade bladder cancer.</field_page_description>
  <field_date_posted>2018-05-31</field_date_posted>
  <field_date_reviewed>2018-05-30</field_date_reviewed>
  <field_pretty_url>gemcitabine-bladder-cancer-recurrence</field_pretty_url>
  <para_id>1116537</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1102622</term_id>
  <id>1116586</id>
  <title>NCI-MATCH precision medicine clinical trial releases new findings, strengthens path forward for targeted cancer therapies</title>
  <langcode>en</langcode>
  <field_short_title>NCI-MATCH trial releases new findings</field_short_title>
  <field_page_description>The NCI-MATCH precision medicine clinical trial has reached a milestone with the release of results from several study treatment arms. Findings from three arms were released at the 2018 ASCO annual meeting, adding to findings from one arm released in 2017.</field_page_description>
  <field_date_posted>2018-06-04</field_date_posted>
  <field_date_reviewed>2018-05-31</field_date_reviewed>
  <field_pretty_url>nci-match-first-results</field_pretty_url>
  <para_id>1116586</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1126555</term_id>
  <id>1117590</id>
  <title>The Cancer Genome Atlas Program</title>
  <langcode>en</langcode>
  <field_short_title>The Cancer Genome Atlas</field_short_title>
  <field_date_posted>2018-06-13</field_date_posted>
  <field_date_reviewed>2018-06-13</field_date_reviewed>
  <para_id>1117590</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102626</term_id>
  <id>1117639</id>
  <title>Successful Outreach for Collaboration on Cancer Research in Eurasia</title>
  <langcode>en</langcode>
  <field_short_title>Successful Outreach for Collaboration on Cancer Research in Eurasia</field_short_title>
  <field_page_description>The National Cancer Institute Center for Global Health and N. N. Alexandrov National Cancer Centre of Belarus convened the first Eurasian Cancer Screening Conference on May 17-18th, 2018. Read CGH's Spotlight Blog to learn more about the conference objectives and outcomes.</field_page_description>
  <field_date_posted>2018-06-14</field_date_posted>
  <field_date_reviewed>2018-06-14</field_date_reviewed>
  <field_pretty_url>ecsc</field_pretty_url>
  <para_id>1117639</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102630</term_id>
  <id>1120535</id>
  <title>From Ignoring Features to Machine Learning Features: Computational Biology Then and Now</title>
  <langcode>en</langcode>
  <field_short_title>Computational Biology Then and Now</field_short_title>
  <field_page_description>How various aspects of the computational biology field has changed over the years</field_page_description>
  <field_date_posted>2018-07-30</field_date_posted>
  <field_date_reviewed>2018-07-23</field_date_reviewed>
  <field_pretty_url>compbio-then-now</field_pretty_url>
  <para_id>1120535</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1121497</term_id>
  <id>1121498</id>
  <title>Develop New Cancer Technologies</title>
  <langcode>en</langcode>
  <field_short_title>Develop New Cancer Technologies</field_short_title>
  <field_page_description>The development of cancer technologies to characterize tumors and test therapies can transform cancer research and clinical care.</field_page_description>
  <field_date_posted>2018-10-22</field_date_posted>
  <field_date_reviewed>2018-08-06</field_date_reviewed>
  <para_id>1121498</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1121657</term_id>
  <id>1121658</id>
  <title>Expand Use of Proven Cancer Prevention and Early Detection Strategies</title>
  <langcode>en</langcode>
  <field_short_title>Expand Use of Prevention and Early Detection Strategies</field_short_title>
  <field_page_description>This initiative aims to develop, test, and adopt proven cancer prevention and early detection approaches to reduce cancer risk and cancer health disparities in all populations. </field_page_description>
  <field_date_posted>2018-10-22</field_date_posted>
  <field_date_reviewed>2018-08-08</field_date_reviewed>
  <para_id>1121658</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1104023</term_id>
  <id>1104026</id>
  <title>Cancer Moonshot℠ - Funding by Research Category</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Moonshot Funding by Category</field_short_title>
  <field_page_description>The Cancer Moonshot Blue Ribbon Panel (BRP) provided research recommendations to accelerate progress against cancer. See the NCI obligations for Cancer Moonshot activities by research category.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2018-01-15</field_date_reviewed>
  <para_id>1104026</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102626</term_id>
  <id>1104097</id>
  <title>CGH Recognizes World Cancer Day 2018</title>
  <langcode>en</langcode>
  <field_short_title>CGH Recognizes World Cancer Day 2018</field_short_title>
  <field_date_posted>2018-01-18</field_date_posted>
  <field_date_reviewed>2018-01-18</field_date_reviewed>
  <field_pretty_url>wcd-2018</field_pretty_url>
  <para_id>1104097</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1106060</term_id>
  <id>1106068</id>
  <title>Dense Breasts: Answers to Commonly Asked Questions</title>
  <langcode>en</langcode>
  <field_short_title>Dense Breasts: Answers to Commonly Asked Questions</field_short_title>
  <field_page_description>Mammograms detect breast density, breast cancer, and breast changes that are not cancer (benign breast changes). Breast density describes the amount of glandular and fibrous tissue, as compared to fatty tissue. Learn what factors are associated with breast density and about other risk factors for breast cancer.</field_page_description>
  <field_date_posted>2018-02-16</field_date_posted>
  <field_date_reviewed>2018-02-06</field_date_reviewed>
  <para_id>1106068</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1109910</id>
  <title>The Imperative of Addressing Cancer Drug Costs and Value  </title>
  <langcode>en</langcode>
  <field_short_title>Addressing Cancer Drug Costs and Value  </field_short_title>
  <field_page_description>The President’s Cancer Panel has released its latest report, Promoting Value, Affordability, and Innovation in Cancer Drug Treatment. The report recommends six actions to maximize the value and affordability of cancer drug treatment.</field_page_description>
  <field_date_posted>2018-03-15</field_date_posted>
  <field_date_reviewed>2018-03-13</field_date_reviewed>
  <field_pretty_url>presidents-cancer-panel-drug-prices</field_pretty_url>
  <para_id>1109910</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1110912</id>
  <title>Higher Risk of Heart Failure Seen in Some Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Higher Risk of Heart Failure Seen in Some Cancers</field_short_title>
  <field_page_description>Some people treated for breast cancer or lymphoma have a higher risk of developing congestive heart failure than people who haven’t had cancer, a new study shows. As this Cancer Currents blog post reports, the risk persisted for at least 20 years.</field_page_description>
  <field_date_posted>2018-03-26</field_date_posted>
  <field_date_reviewed>2018-03-23</field_date_reviewed>
  <field_pretty_url>increased-heart-failure-risk</field_pretty_url>
  <para_id>1110912</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1114556</term_id>
  <id>1114559</id>
  <title>External Beam Radiation Therapy for Cancer</title>
  <langcode>en</langcode>
  <field_short_title>External Beam Radiation</field_short_title>
  <field_page_description>External beam radiation therapy is used to treat many types of cancer. it is a local treatment, where a machine aims radiation at your cancer. Learn more about different types of external beam radiation therapy, and what to expect if you're receiving treatment.</field_page_description>
  <field_date_posted>2018-05-01</field_date_posted>
  <field_date_reviewed>2018-05-01</field_date_reviewed>
  <para_id>1114559</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1115077</term_id>
  <id>1115078</id>
  <title>Mentoring for Trainees and Fellows</title>
  <langcode>en</langcode>
  <field_short_title>Mentoring</field_short_title>
  <field_page_description>Mentorship is an important part of the trainee experience at NCI and NIH. Learn how to choose and find mentors and how to get involved in mentoring others.</field_page_description>
  <field_date_posted>2018-05-25</field_date_posted>
  <field_date_reviewed>2018-05-09</field_date_reviewed>
  <para_id>1115078</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1115090</id>
  <title>FDA Approves Nivolumab and Ipilimumab Combination for Advanced Kidney Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Immunotherapy Combination Approved for Advanced Kidney Cancer</field_short_title>
  <field_page_description>FDA has approved the combination of the immunotherapy drugs nivolumab (Opdivo) and ipilimumab (Yervoy) as an initial treatment for some patients with advanced kidney cancer. The approval is expected to immediately affect patient care, as this Cancer Currents post explains.</field_page_description>
  <field_date_posted>2018-05-10</field_date_posted>
  <field_date_reviewed>2018-05-09</field_date_reviewed>
  <field_pretty_url>kidney-cancer-fda-nivolumab-ipilimumab-first-line</field_pretty_url>
  <para_id>1115090</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1116639</id>
  <title>Easing Concerns about Giving Research Study Participants Their Genetic Test Results </title>
  <langcode>en</langcode>
  <field_short_title>Easing Concerns About Returning Genetic Test Results </field_short_title>
  <field_page_description>Women with breast cancer participating in a research study were given the opportunity to learn their genetic research results. This Cancer Currents blog details the impact these results had on women who opted to review their results with a genetic counselor. </field_page_description>
  <field_date_posted>2018-06-01</field_date_posted>
  <field_date_reviewed>2018-05-31</field_date_reviewed>
  <field_pretty_url>breast-cancer-returning-genetic-testing-results</field_pretty_url>
  <para_id>1116639</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1121660</term_id>
  <id>1121661</id>
  <title>Build a National Cancer Data Ecosystem</title>
  <langcode>en</langcode>
  <field_short_title>Build a National Cancer Data Ecosystem</field_short_title>
  <field_page_description>Researchers, clinicians, and patients across the country will need to share their collective data and knowledge to enable the development of new technologies and reduce the burden of cancer. This Cancer Moonshot initiative empowers and encourages such collaboration.</field_page_description>
  <field_date_posted>2018-10-22</field_date_posted>
  <field_date_reviewed>2018-08-08</field_date_reviewed>
  <para_id>1121661</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1122219</id>
  <title>Liquid Biopsy May Predict Risk of Breast Cancer Returning Years Later</title>
  <langcode>en</langcode>
  <field_short_title>Liquid Biopsy May Help Predict Breast Cancer Relapse</field_short_title>
  <field_page_description>The presence of circulating tumor cells found with a liquid biopsy may identify women treated for breast cancer who may be at higher risk of their disease returning years later. The findings may have implications for treatment, as this Cancer Currents post explains.</field_page_description>
  <field_date_posted>2018-08-15</field_date_posted>
  <field_date_reviewed>2018-08-15</field_date_reviewed>
  <field_pretty_url>liquid-biopsy-breast-cancer-late-recurrence</field_pretty_url>
  <para_id>1122219</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1122694</id>
  <title>Ribociclib Approval Expanded for Some Women with Advanced Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Ribociclib Approval Expanded for Breast Cancer</field_short_title>
  <field_page_description>FDA has expanded the approval of ribociclib (Kisqali) for advanced breast cancer, including new uses in pre- and postmenopausal women. As this Cancer Currents post explains, it’s the first approval under a new FDA program to speed cancer drug reviews.</field_page_description>
  <field_date_posted>2018-08-20</field_date_posted>
  <field_date_reviewed>2018-08-17</field_date_reviewed>
  <field_pretty_url>ribociclib-fda-expanded-approval-breast-cancer</field_pretty_url>
  <para_id>1122694</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102630</term_id>
  <id>1123840</id>
  <title>Finding Pediatric Cancer Genomic Data through PGDI</title>
  <langcode>en</langcode>
  <field_short_title>The Pediatric Genomic Data Inventory</field_short_title>
  <field_page_description>The Pediatric Genomic Data Inventory (PGDI) connects researchers with valuable pediatric cancer data.</field_page_description>
  <field_date_posted>2018-09-05</field_date_posted>
  <field_date_reviewed>2018-08-31</field_date_reviewed>
  <field_pretty_url>PGDI</field_pretty_url>
  <para_id>1123840</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1123940</id>
  <title>TCGA's Study of Ovarian Serous Adenocarcinoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Ovarian Serous Adenocarcinoma</field_short_title>
  <field_page_description>TCGA's Study of Ovarian Serous Adenocarcinoma</field_page_description>
  <field_date_posted>2018-09-05</field_date_posted>
  <field_date_reviewed>2018-09-05</field_date_reviewed>
  <field_pretty_url>ovarian</field_pretty_url>
  <para_id>1123940</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>917216</term_id>
  <id>1126631</id>
  <title>Using Tandem Transplants to Treat Neuroblastoma</title>
  <langcode>en</langcode>
  <field_short_title>Using Tandem Transplants to Treat Neuroblastoma-Julie Park, M.D.</field_short_title>
  <field_page_description>Learn how an NCI-supported trial led by Julie Park established a new standard of care for children with high-risk neuroblastoma. </field_page_description>
  <field_date_posted>2017-09-21</field_date_posted>
  <field_date_reviewed>2018-10-16</field_date_reviewed>
  <field_pretty_url>julie-park-tandem-transplants-treat-neuroblastoma</field_pretty_url>
  <para_id>1126631</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1129127</id>
  <title>Reflections on My First Year as NCI Director</title>
  <langcode>en</langcode>
  <field_short_title>Reflections on My First Year as NCI Director</field_short_title>
  <field_page_description>October 2018 marked Dr. Norman Sharpless’s one-year anniversary as NCI director. He reflects on noteworthy events from the past 12 months.</field_page_description>
  <field_date_posted>2018-11-01</field_date_posted>
  <field_date_reviewed>2018-11-01</field_date_reviewed>
  <field_pretty_url>sharpless-first-year-nci-director</field_pretty_url>
  <para_id>1129127</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1130390</id>
  <title>Eight Factors May Link Disparities in Cancer Death Rates and Income</title>
  <langcode>en</langcode>
  <field_short_title>Factors May Link Disparities in Cancer Death Rates, Income</field_short_title>
  <field_page_description>Eight factors may explain more than 80% of the relationship between poverty and disparities in cancer death rates, according to a new study.</field_page_description>
  <field_date_posted>2018-11-08</field_date_posted>
  <field_date_reviewed>2018-11-08</field_date_reviewed>
  <field_pretty_url>factors-linking-cancer-death-income-disparities</field_pretty_url>
  <para_id>1130390</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1131543</id>
  <title>Study Improves the Quality of Biopsy Specimens for Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Improving the Quality of Cancer Research Biopsy Specimens </field_short_title>
  <field_page_description>NCI researchers have developed and tested recommendations for improving the quality of biopsy specimens collected from patients in cancer clinical trials.</field_page_description>
  <field_date_posted>2018-10-23</field_date_posted>
  <field_date_reviewed>2018-11-27</field_date_reviewed>
  <field_pretty_url>improving-cancer-research-biopsies</field_pretty_url>
  <para_id>1131543</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1132090</term_id>
  <id>1132069</id>
  <title>National CryoEM Facility Acknowledged User Publications</title>
  <langcode>en</langcode>
  <field_short_title>Acknowledged Publications from National CryoEM Facility’s Users</field_short_title>
  <field_page_description> The National CryoEM Facility provides cancer researchers access to the latest technology for high resolution imaging. View a list of acknowledged publications from National CryoEM Facility’s users.</field_page_description>
  <field_date_posted>2018-12-03</field_date_posted>
  <field_date_reviewed>2018-12-03</field_date_reviewed>
  <field_pretty_url>ncef-publications</field_pretty_url>
  <para_id>1132069</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1117583</term_id>
  <id>1117584</id>
  <title>Carryover Unobligated Funds</title>
  <langcode>en</langcode>
  <field_short_title>Carryover Unobligated Funds</field_short_title>
  <field_page_description>Carryover is the process by which unobligated funds remaining at the end of a budget period may be carried forward to cover allowable costs in the next budget period. Learn more about how to carryover NCI grants.</field_page_description>
  <field_date_posted>2018-06-13</field_date_posted>
  <field_date_reviewed>2018-06-13</field_date_reviewed>
  <para_id>1117584</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1117621</term_id>
  <id>1117628</id>
  <title>NAVIGATE: NCI and VA Interagency Group to Accelerate Trials Enrollment</title>
  <langcode>en</langcode>
  <field_short_title>NAVIGATE</field_short_title>
  <field_page_description>The NAVIGATE program will make it easier for veterans to access promising new cancer treatments via clinical trials. This partnership between NCI and the VHA will increase the number of VA Medical Centers participating in and conducting NCI-supported cancer clinical trials.</field_page_description>
  <field_date_posted>2019-01-14</field_date_posted>
  <field_date_reviewed>2018-06-14</field_date_reviewed>
  <para_id>1117628</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1118079</id>
  <title>Do Frequent Follow-Up Tests Benefit Colorectal Cancer Survivors?</title>
  <langcode>en</langcode>
  <field_short_title>Do Frequent Follow-Up Tests Help Colorectal Cancer Survivors?</field_short_title>
  <field_page_description>Two studies of colorectal cancer survivors examined whether more frequent follow-up testing for recurrence improved how long people lived. Read this Cancer Currents blog post to learn whether testing frequency affects survival.</field_page_description>
  <field_date_posted>2018-06-20</field_date_posted>
  <field_date_reviewed>2018-06-20</field_date_reviewed>
  <field_pretty_url>colorectal-cancer-follow-up-testing</field_pretty_url>
  <para_id>1118079</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1129036</term_id>
  <id>1119356</id>
  <title>Outcomes &amp; Impact of The Cancer Genome Atlas</title>
  <langcode>en</langcode>
  <field_short_title>TCGA Outcomes &amp; Impact</field_short_title>
  <field_page_description>TCGA has changed our understanding of cancer, how research is conducted, how the disease is treated in the clinic, and more. Learn about the impact of the TCGA program.</field_page_description>
  <field_date_posted>2018-10-30</field_date_posted>
  <field_date_reviewed>2018-07-05</field_date_reviewed>
  <para_id>1119356</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1119768</id>
  <title>The Opioid Epidemic and Cancer Pain Management: A Conversation with Dr. Judith Paice</title>
  <langcode>en</langcode>
  <field_short_title>The Opioid Epidemic and Cancer Pain Management</field_short_title>
  <field_page_description>The opioid epidemic is having a significant impact on cancer patients, says Dr. Judith Paice of Northwestern University. In this Cancer Currents post, she explains how oncologists can address concerns about opioid misuse when managing cancer pain.</field_page_description>
  <field_date_posted>2018-07-16</field_date_posted>
  <field_date_reviewed>2018-07-13</field_date_reviewed>
  <field_pretty_url>opioid-crisis-cancer-pain-paice</field_pretty_url>
  <para_id>1119768</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1129051</term_id>
  <id>1119790</id>
  <title>Citing TCGA in Publications and Presentations</title>
  <langcode>en</langcode>
  <field_short_title>Citing TCGA</field_short_title>
  <field_date_posted>2018-10-30</field_date_posted>
  <field_date_reviewed>2018-07-13</field_date_reviewed>
  <para_id>1119790</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1119945</term_id>
  <id>1119946</id>
  <title>Intensify Research on the Major Drivers of Childhood Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Drivers of Childhood Cancers</field_short_title>
  <field_page_description>Fusion oncoproteins can lead to the development of childhood cancers. This Cancer Moonshot initiative aims to improve our understanding of these proteins and develop inhibitors that target them.</field_page_description>
  <field_date_posted>2018-10-22</field_date_posted>
  <field_date_reviewed>2018-07-13</field_date_reviewed>
  <para_id>1119946</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1119948</term_id>
  <id>1119949</id>
  <title>Analyze Patient Data and Biospecimens from Past Clinical Trials to Predict Future Patient Outcomes</title>
  <langcode>en</langcode>
  <field_short_title>Mine Past Patient Data to Predict Future Patient Outcomes</field_short_title>
  <field_page_description>Tumor samples and other biospecimens can be analyzed retrospectively to develop hypotheses about which tumor features can help predict clinical benefit. Ideally, this information can be used to improve treatment and outcomes for cancer patients. </field_page_description>
  <field_date_posted>2018-10-22</field_date_posted>
  <field_date_reviewed>2018-07-13</field_date_reviewed>
  <para_id>1119949</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102626</term_id>
  <id>1120185</id>
  <title>Message from the Center for Global Health's Interim Director</title>
  <langcode>en</langcode>
  <field_short_title>Message from the Center for Global Health's Interim Director</field_short_title>
  <field_page_description>Center for Global Health Interim Director, Dr. Robert Croyle, discusses CGH accomplishments and plans for the new leadership.</field_page_description>
  <field_date_posted>2018-07-23</field_date_posted>
  <field_date_reviewed>2018-07-20</field_date_reviewed>
  <field_pretty_url>interim-director-message</field_pretty_url>
  <para_id>1120185</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1120685</id>
  <title>TCGA's Study of Cervical Cancer</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Cervical Cancer</field_short_title>
  <field_page_description>TCGA's Study of Cervical Cancer</field_page_description>
  <field_date_posted>2018-07-26</field_date_posted>
  <field_date_reviewed>2018-07-26</field_date_reviewed>
  <field_pretty_url>cervical</field_pretty_url>
  <para_id>1120685</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1120758</id>
  <title>TCGA's Study of Cholangiocarcinoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Cholangiocarcinoma</field_short_title>
  <field_page_description>TCGA's Study of Cholangiocarcinoma</field_page_description>
  <field_date_posted>2018-07-27</field_date_posted>
  <field_date_reviewed>2018-07-27</field_date_reviewed>
  <field_pretty_url>cholangiocarcinoma</field_pretty_url>
  <para_id>1120758</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>941577</term_id>
  <id>1107103</id>
  <title>Clinical Trials to Treat Childhood Embryonal Tumors</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trials to Treat Childhood Embryonal Tumors</field_short_title>
  <field_date_posted>2018-02-14</field_date_posted>
  <field_date_reviewed>2018-02-14</field_date_reviewed>
  <field_pretty_url>childhood-embryonal-tumors</field_pretty_url>
  <para_id>1107103</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938135</term_id>
  <id>1110729</id>
  <title>TEST - What's New in Pancreatic Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>TEST - What's New in Pancreatic Cancer Research</field_short_title>
  <field_date_posted>2018-03-21</field_date_posted>
  <field_date_reviewed>2018-03-21</field_date_reviewed>
  <field_pretty_url>draft</field_pretty_url>
  <para_id>1110729</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102628</term_id>
  <id>1111029</id>
  <title>Don't Miss the Connection: The Role of RAF1 and ROKα in RAS-Driven Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Caused by Mutant KRAS Requires RAF1 and ROKα</field_short_title>
  <field_page_description>Cancer caused by a mutant KRAS gene is dependent on the presence RAF1. Kinase-independent interaction of RAF1 with ROKα accounts for this dependence.</field_page_description>
  <field_date_posted>2018-03-26</field_date_posted>
  <field_date_reviewed>2018-03-26</field_date_reviewed>
  <field_pretty_url>baccarini-rok</field_pretty_url>
  <para_id>1111029</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1112440</id>
  <title>OncoArray Links Dozens of DNA Variants to Risk for Common Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Linking DNA Variants and Cancer Risk</field_short_title>
  <field_page_description>Researchers with the NCI-supported GAME-ON initiative and OncoArray Network are publishing studies identifying dozens of new genetic variants associated with the risk for developing some of the most common cancers, as this Cancer Currents blog post reports.</field_page_description>
  <field_date_posted>2018-06-12</field_date_posted>
  <field_date_reviewed>2018-04-06</field_date_reviewed>
  <field_pretty_url>oncoarray-genetic-variants-cancer-risk</field_pretty_url>
  <para_id>1112440</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1113235</term_id>
  <id>1113237</id>
  <title>Access to Experimental Cancer Drugs</title>
  <langcode>en</langcode>
  <field_short_title>Access to Experimental Cancer Drugs</field_short_title>
  <field_page_description> An experimental drug has been tested in the lab and with animals and approved for testing in people by the FDA, but can’t yet be advertised, sold, or prescribed. Experimental drugs may be available through clinical trials or expanded access programs - learn more about these programs and how to talk to your doctor.</field_page_description>
  <field_date_posted>2018-04-17</field_date_posted>
  <field_date_reviewed>2018-04-17</field_date_reviewed>
  <para_id>1113237</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894086</term_id>
  <id>1113308</id>
  <title>April Spotlight: National Minority Health Month</title>
  <langcode>en</langcode>
  <field_short_title>April Spotlight: National Minority Health Month</field_short_title>
  <field_date_posted>2018-04-17</field_date_posted>
  <field_date_reviewed>2018-04-17</field_date_reviewed>
  <field_pretty_url>nmhm18</field_pretty_url>
  <para_id>1113308</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102628</term_id>
  <id>1113457</id>
  <title>A Conversation About RAS Dimers</title>
  <langcode>en</langcode>
  <field_short_title>A Conversation About RAS Dimers</field_short_title>
  <field_page_description>RAS proteins seem to be dimeric in living cells, but monomeric in vitro. Understanding RAS dimers may be important for finding treatments for RAS cancers.</field_page_description>
  <field_date_posted>2018-04-20</field_date_posted>
  <field_date_reviewed>2018-04-19</field_date_reviewed>
  <field_pretty_url>ras-dimers</field_pretty_url>
  <para_id>1113457</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1113696</id>
  <title>Cancer Control in American Indian and Alaska Native Populations: A Conversation with Dr. Shobha Srinivasan</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Control in American Indian and Alaska Native Populations</field_short_title>
  <field_page_description>American Indian and Alaska Native (AI/AN) populations are disproportionately affected by certain cancers. In this interview, Dr. Shobha Srinivasan discusses some of these disparities and programs funded by NCI that are helping to address them.</field_page_description>
  <field_date_posted>2018-04-25</field_date_posted>
  <field_date_reviewed>2018-04-25</field_date_reviewed>
  <field_pretty_url>american-indian-alaska-native-cancer-control</field_pretty_url>
  <para_id>1113696</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1113875</id>
  <title>Moving Beyond BMI: Low Muscle Mass May Affect Cancer Survival</title>
  <langcode>en</langcode>
  <field_short_title>Low Muscle Mass Linked with Worse Cancer Survival</field_short_title>
  <field_page_description>In a new study, researchers compared the risk of death for women with breast cancer who had low skeletal muscle mass, or sarcopenia, at diagnosis and women who had adequate muscle mass. Learn what they found and what it might mean for patients in this Cancer Currents blog post.</field_page_description>
  <field_date_posted>2018-04-30</field_date_posted>
  <field_date_reviewed>2018-04-26</field_date_reviewed>
  <field_pretty_url>sarcopenia-breast-cancer-prognosis</field_pretty_url>
  <para_id>1113875</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1113970</id>
  <title>Immunotherapy Drugs Expand Treatment Options for Advanced Lung Cancer </title>
  <langcode>en</langcode>
  <field_short_title>Immunotherapy Expands Lung Cancer Treatment Options</field_short_title>
  <field_page_description>Results from a large clinical trial show combining the immune checkpoint inhibitor pembrolizumab (Keytruda) with chemotherapy helped some patients with advanced cancer live longer. As this Cancer Currents post explains, the results will immediately affect patient care.</field_page_description>
  <field_date_posted>2018-04-27</field_date_posted>
  <field_date_reviewed>2018-04-27</field_date_reviewed>
  <field_pretty_url>pembrolizumab-lung-cancer-first-line</field_pretty_url>
  <para_id>1113970</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1102622</term_id>
  <id>1133166</id>
  <title>Study finds elevated risk of certain rare blood cancers after chemotherapy for most solid tumors</title>
  <langcode>en</langcode>
  <field_short_title>Study finds higher risk of rare blood cancer after chemo</field_short_title>
  <field_page_description>An NIH study finds patients treated with chemotherapy for most solid tumors had an increased risk of tMDS/AML, a rare but often fatal type of leukemia.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>tMDS-AML-risk-chemo</field_pretty_url>
  <para_id>1133166</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133180</term_id>
  <id>1133232</id>
  <title>SDH-deficient Gastrointestinal stromal tumor (GIST)</title>
  <langcode>en</langcode>
  <field_short_title>SDH-deficient Gastrointestinal stromal tumor (GIST)</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>sdh-deficient-gastrointestinal-stromal-tumor-gist</field_pretty_url>
  <para_id>1133232</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1134576</term_id>
  <id>1133249</id>
  <title>Rare Tumor Workshops</title>
  <langcode>en</langcode>
  <field_short_title>Rare Tumor Workshops</field_short_title>
  <field_page_description>MyPART holds workshops in the Center for Cancer Research to help scientists learn what to study about rare cancer and  share research, advocates discuss issues important to patients, clinicians share their experience treating the rare cancer, and FDA representatives help design experiments and clinical trials</field_page_description>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <para_id>1133249</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciLandingPage</CONTENTTYPENAME>
  <term_id>1133172</term_id>
  <id>1133417</id>
  <title>Pediatric and Adult Rare Tumor Network</title>
  <langcode>en</langcode>
  <field_short_title>Pediatric and Adult Rare Tumor Network</field_short_title>
  <field_date_posted>2016-05-25</field_date_posted>
  <field_date_reviewed>2016-05-25</field_date_reviewed>
  <para_id>1133417</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1133200</term_id>
  <id>1133447</id>
  <title>About MyPART</title>
  <langcode>en</langcode>
  <field_short_title>About</field_short_title>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2018-12-20</field_date_reviewed>
  <para_id>1133447</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133753</term_id>
  <id>1133758</id>
  <title>By-Laws for the NIH Fellows Editorial Board</title>
  <langcode>en</langcode>
  <field_short_title>NIH Fellows Editorial Board By-Laws</field_short_title>
  <field_date_posted>2018-12-21</field_date_posted>
  <field_date_reviewed>2018-12-21</field_date_reviewed>
  <field_pretty_url>by-laws</field_pretty_url>
  <para_id>1133758</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133783</term_id>
  <id>1133798</id>
  <title>Manuscript Preparation Guidelines</title>
  <langcode>en</langcode>
  <field_short_title>Manuscript Preparation Guidelines</field_short_title>
  <field_date_posted>2018-12-21</field_date_posted>
  <field_date_reviewed>2018-12-21</field_date_reviewed>
  <field_pretty_url>manuscript-preparation-guidelines</field_pretty_url>
  <para_id>1133798</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1134352</term_id>
  <id>1134353</id>
  <title>For Early-Stage Lung Cancer, Study Identifies Potential New Biomarker, Treatment Target</title>
  <langcode>en</langcode>
  <field_short_title>New Biomarker, Treatment Target for Early-Stage Lung Cancer?</field_short_title>
  <field_page_description>A potential biomarker and treatment target for early-stage non-small cell lung cancer may have been found, results from a new study suggest.</field_page_description>
  <field_date_posted>2019-01-03</field_date_posted>
  <field_date_reviewed>2019-01-02</field_date_reviewed>
  <field_pretty_url>early-stage-lung-cancer-biomarker</field_pretty_url>
  <para_id>1134353</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1114846</term_id>
  <id>1134383</id>
  <title>Redox Biology </title>
  <langcode>en</langcode>
  <field_short_title>Redox Biology Course</field_short_title>
  <field_page_description>The Redox Biology course provides NIH postdoctoral and clinical fellows with an overview of how redox-active species and radicals are generated, their effects on the cellular and physiological level, and how they alter carcinogenesis, angiogenesis and proliferation in animal models of cancer.</field_page_description>
  <field_date_posted>2019-01-03</field_date_posted>
  <field_date_reviewed>2019-01-03</field_date_reviewed>
  <field_pretty_url>redox-biology</field_pretty_url>
  <para_id>1134383</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133180</term_id>
  <id>1134553</id>
  <title>What are rare digestive system tumors?</title>
  <langcode>en</langcode>
  <field_short_title>Rare Digestive System Tumors</field_short_title>
  <field_date_posted>2019-01-07</field_date_posted>
  <field_date_reviewed>2019-01-07</field_date_reviewed>
  <para_id>1134553</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1135273</term_id>
  <id>1135289</id>
  <title>References and Resources</title>
  <langcode>en</langcode>
  <field_short_title>References and Resources</field_short_title>
  <field_page_description>There are many different systems for acquiring grants or contracts from the National Cancer Institute, and regulations that manage their execution. </field_page_description>
  <field_date_posted>2019-01-16</field_date_posted>
  <field_date_reviewed>2019-01-16</field_date_reviewed>
  <para_id>1135289</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1134584</term_id>
  <id>1137544</id>
  <title>Beat AML 1.0: A Collaborative Program for Functional Genomic Data Integration</title>
  <langcode>en</langcode>
  <field_short_title>Beat AML Functional Genomic Study</field_short_title>
  <field_page_description>The Beat AML program publishes an extensive genomic, drug response, and clinical dataset on acute myeloid leukemia. A lead author describes the collaborative effort and future steps.</field_page_description>
  <field_date_posted>2019-02-11</field_date_posted>
  <field_date_reviewed>2019-02-11</field_date_reviewed>
  <field_pretty_url>beataml</field_pretty_url>
  <para_id>1137544</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1137761</id>
  <title>TCGA's Study of Mesothelioma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Mesothelioma</field_short_title>
  <field_date_posted>2019-02-14</field_date_posted>
  <field_date_reviewed>2019-02-14</field_date_reviewed>
  <field_pretty_url>mesothelioma</field_pretty_url>
  <para_id>1137761</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1137929</id>
  <title>TCGA's Study of Uveal Melanoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Uveal Melanoma</field_short_title>
  <field_date_posted>2019-02-15</field_date_posted>
  <field_date_reviewed>2019-02-15</field_date_reviewed>
  <field_pretty_url>melanoma-uvea</field_pretty_url>
  <para_id>1137929</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>903750</term_id>
  <id>13674</id>
  <title>Understanding Laboratory Tests</title>
  <langcode>en</langcode>
  <field_short_title>Understanding Laboratory Tests</field_short_title>
  <field_page_description>A fact sheet that describes the role of screening and diagnostic laboratory tests. Lists the common tests used in cancer medicine and discusses how to interpret test results.</field_page_description>
  <field_date_posted>2013-12-30</field_date_posted>
  <field_date_reviewed>2013-12-11</field_date_reviewed>
  <field_pretty_url>understanding-lab-tests-fact-sheet</field_pretty_url>
  <para_id>13674</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11928</term_id>
  <id>13712</id>
  <title>Malignant Mesothelioma—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Malignant Mesothelioma</field_short_title>
  <field_page_description>Malignant mesothelioma is a cancer of the thin tissue (mesothelium) that lines the lung, chest wall, and abdomen. The major risk factor for mesothelioma is asbestos exposure. Start here to find information on malignant mesothelioma treatment.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13712</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>915878</term_id>
  <id>13762</id>
  <title>Statins and Cancer Prevention</title>
  <langcode>en</langcode>
  <field_short_title>Statins and Cancer Prevention</field_short_title>
  <field_page_description>A fact sheet about results from animal research and ongoing observational studies of people taking statins that suggest that these drugs may lower the risk of certain cancers.</field_page_description>
  <field_date_posted>2005-06-02</field_date_posted>
  <field_date_reviewed>2005-06-02</field_date_reviewed>
  <field_pretty_url>statins-fact-sheet</field_pretty_url>
  <para_id>13762</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911286</term_id>
  <id>13779</id>
  <title>Hyperthermia in Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Hyperthermia in Cancer Treatment</field_short_title>
  <field_page_description>A fact sheet that defines hyperthermia (treating tumors with heat) and its side effects.</field_page_description>
  <field_date_posted>2011-09-09</field_date_posted>
  <field_date_reviewed>2011-08-31</field_date_reviewed>
  <field_pretty_url>hyperthermia-fact-sheet</field_pretty_url>
  <para_id>13779</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11898</term_id>
  <id>13890</id>
  <title>Uterine Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Uterine Cancer</field_short_title>
  <field_page_description>Uterine cancers can be of two types: endometrial cancer (common) and uterine sarcoma (rare). Endometrial cancer can often be cured. Uterine sarcoma is often more aggressive and harder to treat. Start here to find information on uterine cancer treatment, causes and prevention, screening, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13890</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11934</term_id>
  <id>13892</id>
  <title>Myeloproliferative Neoplasms—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Myeloproliferative Neoplasms</field_short_title>
  <field_page_description>Myeloproliferative neoplasms and myelodysplastic syndromes are diseases in which the bone marrow makes too many red blood cells, white blood cells, or platelets. Sometimes both conditions are present. Start here to find information on myeloproliferative neoplasms treatment.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13892</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11944</term_id>
  <id>13896</id>
  <title>Pancreatic Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Pancreatic Cancer</field_short_title>
  <field_page_description>Pancreatic cancer can form in exocrine cells and neuroendocrine cells. The exocrine type is more common and is usually found at an advanced stage. Pancreatic neuroendocrine tumors are less common but have a better prognosis. Start here to find information on pancreatic cancer treatment, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13896</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911184</term_id>
  <id>13960</id>
  <title>Antiperspirants/Deodorants and Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Antiperspirants/Deodorants and Breast Cancer</field_short_title>
  <field_page_description>A fact sheet describing studies on whether there is a link between underarm antiperspirants or deodorants and breast cancer. </field_page_description>
  <field_date_posted>2005-08-18</field_date_posted>
  <field_date_reviewed>2016-08-09</field_date_reviewed>
  <field_pretty_url>antiperspirants-fact-sheet</field_pretty_url>
  <para_id>13960</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911142</term_id>
  <id>13986</id>
  <title>Oral Contraceptives and Cancer Risk</title>
  <langcode>en</langcode>
  <field_short_title>Oral Contraceptives and Cancer Risk</field_short_title>
  <field_page_description>A fact sheet about research on the association of oral contraceptive use (birth control pills) with risk of various cancers.</field_page_description>
  <field_date_posted>2018-03-01</field_date_posted>
  <field_date_reviewed>2018-02-22</field_date_reviewed>
  <field_pretty_url>oral-contraceptives-fact-sheet</field_pretty_url>
  <para_id>13986</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11924</term_id>
  <id>14121</id>
  <title>Liver and Bile Duct Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Liver and Bile Duct Cancer</field_short_title>
  <field_page_description>Liver cancer includes hepatocellular carcinoma and bile duct cancer (cholangiocarcinoma). Risk factors for HCC include chronic infection with hepatitis B or C and cirrhosis of the liver. Start here to find information on liver and bile duct cancer treatment, causes and prevention, screening, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14121</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1120760</id>
  <title>TCGA's Study of Clear Cell Renal Cell Carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Clear Cell Renal Cell Carcinoma</field_short_title>
  <field_page_description>TCGA's Study of Clear Cell Renal Cell Carcinoma</field_page_description>
  <field_date_posted>2018-07-27</field_date_posted>
  <field_date_reviewed>2018-07-27</field_date_reviewed>
  <field_pretty_url>renal-cell-clear-cell</field_pretty_url>
  <para_id>1120760</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1121294</id>
  <title>TCGA's Study of Colorectal Carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Colorectal Carcinoma</field_short_title>
  <field_page_description>TCGA's Study of Colorectal Carcinoma</field_page_description>
  <field_date_posted>2018-08-03</field_date_posted>
  <field_date_reviewed>2018-08-03</field_date_reviewed>
  <field_pretty_url>colorectal</field_pretty_url>
  <para_id>1121294</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1121521</id>
  <title>TCGA's Study of Glioblastoma Multiforme</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Glioblastoma Multiforme</field_short_title>
  <field_page_description>TCGA's Study of Glioblastoma Multiforme</field_page_description>
  <field_date_posted>2018-08-07</field_date_posted>
  <field_date_reviewed>2018-08-07</field_date_reviewed>
  <field_pretty_url>glioblastoma</field_pretty_url>
  <para_id>1121521</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>941577</term_id>
  <id>1121562</id>
  <title>Clinical Trials to Treat Thymoma and Thymic Carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trials to Treat Thymoma and Thymic Carcinoma</field_short_title>
  <field_date_posted>2018-08-07</field_date_posted>
  <field_date_reviewed>2018-08-07</field_date_reviewed>
  <field_pretty_url>thymoma-thymic-carcinoma</field_pretty_url>
  <para_id>1121562</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1102622</term_id>
  <id>1122147</id>
  <title>Cetuximab with radiation found to be inferior to standard treatment in HPV-positive oropharyngeal cancer</title>
  <langcode>en</langcode>
  <field_short_title>Cetuximab inferior to standard treatment for HPV+ oropharyngeal cancer</field_short_title>
  <field_page_description>Results from a randomized clinical trial show patients with HPV-positive oropharyngeal cancer treated with radiation and cetuximab had inferior survival compared to the current standard treatment with radiation and cisplatin. The trial’s goal was to find a less toxic treatment approach without compromising survival.</field_page_description>
  <field_date_posted>2018-08-14</field_date_posted>
  <field_date_reviewed>2018-08-13</field_date_reviewed>
  <field_pretty_url>oropharyngeal-hpv-cisplatin</field_pretty_url>
  <para_id>1122147</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919353</term_id>
  <id>1122430</id>
  <title>The International Rare Cancer Initiative</title>
  <langcode>en</langcode>
  <field_short_title>The International Rare Cancer Initiative</field_short_title>
  <field_page_description>The International Rare cancer Initiative focuses on rare cancers because they are a pressing public health priority. Read more to learn about how CGH pushes for practice-changing clinical trials in rare cancers.</field_page_description>
  <field_date_posted>2018-08-15</field_date_posted>
  <field_date_reviewed>2018-08-15</field_date_reviewed>
  <field_pretty_url>irci</field_pretty_url>
  <para_id>1122430</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1124101</term_id>
  <id>1124102</id>
  <title>Create a Pediatric Immunotherapy Discovery and Development Network (PI-DDN)</title>
  <langcode>en</langcode>
  <field_short_title>Pediatric Immunotherapy Network</field_short_title>
  <field_page_description>This Cancer Moonshot initiative aims to establish a pediatric cancer immunotherapy network to discover and characterize new targets for immunotherapies and ultimately develop new, effective immunotherapy treatments for children and adolescents with cancer.</field_page_description>
  <field_date_posted>2018-10-22</field_date_posted>
  <field_date_reviewed>2017-10-30</field_date_reviewed>
  <para_id>1124102</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1124129</id>
  <title>Appendix Cancers Are Genetically Distinct from Other Gastrointestinal Cancers, Study Shows</title>
  <langcode>en</langcode>
  <field_short_title>Appendix Cancers Genetically Distinct from Other GI Cancers</field_short_title>
  <field_page_description>Appendix cancers are distinct from colorectal and other gastrointestinal cancers, the largest-ever genomic study of its kind has shown. As this Cancer Currents post explains, specific mutations may help identify aggressive appendix tumors.</field_page_description>
  <field_date_posted>2018-09-12</field_date_posted>
  <field_date_reviewed>2018-09-11</field_date_reviewed>
  <field_pretty_url>appendix-cancer-genetic-distinct</field_pretty_url>
  <para_id>1124129</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1124216</id>
  <title>Moxetumomab Approved by FDA for Hairy Cell Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Moxetumomab Approved for Hairy Cell Leukemia</field_short_title>
  <field_page_description>FDA has approved moxetumomab pasudotox (Lumoxiti), a bacterial toxin–based drug, for the treatment of hairy cell leukemia (HCL). The approval covers the use of moxetumomab in patients with HCL who have already undergone standard treatments.</field_page_description>
  <field_date_posted>2018-09-14</field_date_posted>
  <field_date_reviewed>2018-09-13</field_date_reviewed>
  <field_pretty_url>moxetumomab-fda-hairy-cell-leukemia</field_pretty_url>
  <para_id>1124216</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102630</term_id>
  <id>1124602</id>
  <title>Getting to Know the Complexities of Cancer: A 2018 TCGA Symposium Preview</title>
  <langcode>en</langcode>
  <field_short_title>2018 TCGA Symposium Preview</field_short_title>
  <field_page_description>A preview of some of the research to be presented at the 2018 Cell Symposium, TCGA Legacy: Multi-Omic Studies in Cancer.</field_page_description>
  <field_date_posted>2018-09-24</field_date_posted>
  <field_date_reviewed>2018-09-20</field_date_reviewed>
  <field_pretty_url>2018-tcga-symposium</field_pretty_url>
  <para_id>1124602</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1124931</id>
  <title>Hope and Challenge: The NCI Annual Plan and Budget Proposal for Fiscal Year 2020</title>
  <langcode>en</langcode>
  <field_short_title>NCI FY 2020 Annual Plan and Budget Proposal Released</field_short_title>
  <field_page_description>NCI Director Dr. Ned Sharpless announces the release of the institute’s Fiscal Year 2020 Annual Plan and Budget Proposal. The plan represents NCI’s best professional judgement on the optimum funding needed to make the most rapid progress against cancer.</field_page_description>
  <field_date_posted>2018-09-24</field_date_posted>
  <field_date_reviewed>2018-09-24</field_date_reviewed>
  <field_pretty_url>sharpless-nci-annual-plan-2020</field_pretty_url>
  <para_id>1124931</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>762611</term_id>
  <id>1124223</id>
  <title>2018 World Cancer Congress</title>
  <langcode>en</langcode>
  <field_short_title>2018 World Cancer Congress</field_short_title>
  <field_page_description>The 2018 World Cancer Congress features the latest successful interventions in cancer prevention, diagnosis, treatment and care. View a schedule of NCI activities at this year's Congress.  </field_page_description>
  <field_date_posted>2018-09-14</field_date_posted>
  <field_date_reviewed>2018-09-14</field_date_reviewed>
  <field_pretty_url>wcc2018</field_pretty_url>
  <para_id>1124223</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1124596</term_id>
  <id>1124649</id>
  <title>Three-dimensional Organoid Models to Study Breast Cancer Progression</title>
  <langcode>en</langcode>
  <field_short_title>3D Organoid Models to Study Breast Cancer Progression </field_short_title>
  <field_date_posted>2018-10-31</field_date_posted>
  <field_date_reviewed>2018-09-20</field_date_reviewed>
  <para_id>1124649</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1052682</id>
  <title>Early-Stage Cancer Trials Support Promise of Precision Medicine, Immunotherapy</title>
  <langcode>en</langcode>
  <field_short_title>Early-Stage Trials ASCO 2016</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on promising findings from several early-stage clinical trials featured at the 2016 American Society of Clinical Oncology annual meeting in Chicago.</field_page_description>
  <field_date_posted>2016-06-17</field_date_posted>
  <field_date_reviewed>2016-06-17</field_date_reviewed>
  <field_pretty_url>asco-2016-early-trials</field_pretty_url>
  <para_id>1052682</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1053904</id>
  <title>Setting the Stage for the Next Decade of Tobacco Control Research</title>
  <langcode>en</langcode>
  <field_short_title>Setting the Stage for the Next Decade of Tobacco Control Research</field_short_title>
  <field_page_description>An NCI Cancer Currents blog by Dr. Robert Croyle on a new report that lays out recommended priorities to help shape NCI’s future tobacco control research portfolio.</field_page_description>
  <field_date_posted>2016-07-05</field_date_posted>
  <field_date_reviewed>2016-07-01</field_date_reviewed>
  <field_pretty_url>tobacco-control-plan</field_pretty_url>
  <para_id>1053904</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1054553</id>
  <title>International collaboration to create new cancer models to accelerate research</title>
  <langcode>en</langcode>
  <field_short_title>New cancer models to accelerate research</field_short_title>
  <field_date_posted>2016-07-11</field_date_posted>
  <field_date_reviewed>2016-07-06</field_date_reviewed>
  <field_pretty_url>hcmi-cancer-models</field_pretty_url>
  <para_id>1054553</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1056082</id>
  <title>Uncovering a new principle in chemotherapy resistance in breast cancer</title>
  <langcode>en</langcode>
  <field_short_title>New principle of chemotherapy resistance</field_short_title>
  <field_date_posted>2016-07-20</field_date_posted>
  <field_date_reviewed>2016-07-18</field_date_reviewed>
  <field_pretty_url>new-principle-chemo-resistance-breast-cancer</field_pretty_url>
  <para_id>1056082</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1056234</term_id>
  <id>1056236</id>
  <title>National Cancer Reporting Fellowships</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Reporting Fellowships</field_short_title>
  <field_page_description>A four-day seminar to help U.S.-based journalists increase their understanding of scientific research and ability to report accurately on complex scientific findings.</field_page_description>
  <field_date_posted>2016-09-27</field_date_posted>
  <field_date_reviewed>2016-09-27</field_date_reviewed>
  <para_id>1056236</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>822143</term_id>
  <id>1057079</id>
  <title>RAS Spokes/Funding</title>
  <langcode>en</langcode>
  <field_short_title>Spokes/Funding</field_short_title>
  <field_date_posted>2016-07-27</field_date_posted>
  <field_date_reviewed>2016-07-27</field_date_reviewed>
  <para_id>1057079</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1061095</id>
  <title>New on NCI’s Websites for August 2016</title>
  <langcode>en</langcode>
  <field_short_title>New on NCI’s Websites for August 2016</field_short_title>
  <field_page_description>NCI periodically provides updates on new websites and other online content of interest to the cancer community.</field_page_description>
  <field_date_posted>2016-08-29</field_date_posted>
  <field_date_reviewed>2016-08-29</field_date_reviewed>
  <field_pretty_url>new-online-august-2016</field_pretty_url>
  <para_id>1061095</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1061536</id>
  <title>Pancreatic Cancer Cells May Obtain Nutrients from Neighboring Cells</title>
  <langcode>en</langcode>
  <field_short_title>Pancreatic Cancer Cells Rely on Neighbors for Nutrients</field_short_title>
  <field_page_description>An NCI Cancer Currents blog about a study which showed that pancreatic cancer cells instruct healthy cells around them to provide nutrients they need to survive and grow.</field_page_description>
  <field_date_posted>2016-09-12</field_date_posted>
  <field_date_reviewed>2016-09-08</field_date_reviewed>
  <field_pretty_url>pancreatic-metabolism</field_pretty_url>
  <para_id>1061536</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>13193</id>
  <title>The ALTTO Breast Cancer Trial</title>
  <langcode>en</langcode>
  <field_short_title>The ALTTO Breast Cancer Trial</field_short_title>
  <field_page_description>A collection of material about the Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation, or ALTTO, study that will compare the targeted agents lapatinib and trastuzumab alone, in sequence, or in combination as adjuvant therapy for HER2-positive br</field_page_description>
  <field_date_posted>2008-03-14</field_date_posted>
  <field_date_reviewed>2015-07-24</field_date_reviewed>
  <field_pretty_url>altto</field_pretty_url>
  <para_id>13193</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938026</term_id>
  <id>13750</id>
  <title>Second HPV Vaccine Shows Early Positive Results</title>
  <langcode>en</langcode>
  <field_short_title>Second HPV Vaccine Shows Early Results</field_short_title>
  <field_page_description>The vaccine Cervarix® was 90 percent effective against two types of human papillomavirus (HPV) that can cause cervical cancer, according to the June 30, 2007, Lancet.</field_page_description>
  <field_date_posted>2007-07-17</field_date_posted>
  <field_date_reviewed>2007-07-17</field_date_reviewed>
  <field_pretty_url>cervarix-prevents-hpv</field_pretty_url>
  <para_id>13750</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>929824</term_id>
  <id>13790</id>
  <title>Subscribe to Cancer.gov RSS Feeds</title>
  <langcode>en</langcode>
  <field_short_title>Subscribe to Cancer.gov RSS Feeds</field_short_title>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2009-09-08</field_date_reviewed>
  <para_id>13790</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>915538</term_id>
  <id>13918</id>
  <title>Blood-Forming Stem Cell Transplants</title>
  <langcode>en</langcode>
  <field_short_title>Blood-Forming Stem Cell Transplants</field_short_title>
  <field_page_description>A fact sheet that explains the step-by-step procedures of two types of transplantations used with high-dose chemotherapy, including their risks and benefits.  </field_page_description>
  <field_date_posted>2005-09-09</field_date_posted>
  <field_date_reviewed>2013-08-12</field_date_reviewed>
  <field_pretty_url>stem-cell-fact-sheet</field_pretty_url>
  <para_id>13918</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911288</term_id>
  <id>14059</id>
  <title>Targeted Cancer Therapies</title>
  <langcode>en</langcode>
  <field_short_title>Targeted Cancer Therapies</field_short_title>
  <field_page_description>A fact sheet that describes targeted cancer therapies, which are drugs that interfere with specific molecules involved in cancer cell growth and survival.</field_page_description>
  <field_date_posted>2018-05-14</field_date_posted>
  <field_date_reviewed>2018-07-26</field_date_reviewed>
  <field_pretty_url>targeted-therapies-fact-sheet</field_pretty_url>
  <para_id>14059</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911116</term_id>
  <id>14115</id>
  <title>Acrylamide and Cancer Risk</title>
  <langcode>en</langcode>
  <field_short_title>Acrylamide and Cancer Risk</field_short_title>
  <field_page_description>A fact sheet about acrylamide and cancer risk. </field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2017-12-05</field_date_reviewed>
  <field_pretty_url>acrylamide-fact-sheet</field_pretty_url>
  <para_id>14115</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11956</term_id>
  <id>14208</id>
  <title>Retinoblastoma—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Retinoblastoma</field_short_title>
  <field_page_description>Retinoblastoma is a very rare childhood cancer that forms in the tissues of the retina. Most cases of retinoblastoma are not inherited, but some are, and children with a family history of the disease should have their eyes checked beginning at an early age. Start here to find information on retinoblastoma treatment.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14208</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>11886</term_id>
  <id>14237</id>
  <title>Mammograms</title>
  <langcode>en</langcode>
  <field_short_title>Mammograms</field_short_title>
  <field_page_description>A fact sheet that defines screening and diagnostic mammograms; discusses the benefits and potential harms of screening mammography; and summarizes how findings, including breast density, are reported.</field_page_description>
  <field_date_posted>2017-01-06</field_date_posted>
  <field_date_reviewed>2016-12-07</field_date_reviewed>
  <field_pretty_url>mammograms-fact-sheet</field_pretty_url>
  <para_id>14237</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>12774</term_id>
  <id>14257</id>
  <title>Key Initiatives</title>
  <langcode>en</langcode>
  <field_short_title>Key Initiatives</field_short_title>
  <field_page_description>Learn about major research initiatives NCI has developed to address specific issues of high priority for the cancer research community.</field_page_description>
  <field_date_posted>2015-03-09</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14257</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>225408</id>
  <title>U.S. population data show no increase in brain cancer rates during period of expanding cell phone use </title>
  <langcode>en</langcode>
  <field_short_title>No increase in brain cancer rates during period of expanding cell phone use </field_short_title>
  <field_page_description>In a new examination of United States cancer incidence data, investigators at the National Cancer Institute (NCI) reported that incidence trends have remained roughly constant for glioma, the main type of brain cancer hypothesized to be related to cell ph</field_page_description>
  <field_date_posted>2012-03-08</field_date_posted>
  <field_date_reviewed>2012-03-07</field_date_reviewed>
  <field_pretty_url>GliomaCellPhoneUse</field_pretty_url>
  <para_id>225408</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>304596</id>
  <title>The Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial: Questions and Answers</title>
  <langcode>en</langcode>
  <field_short_title>The PLCO Cancer Screening Trial: Q and A</field_short_title>
  <field_page_description>The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial is a large, randomized study to determine whether the use of certain screening tests will reduce the risk of dying of those four cancers. In addition to answering questions about the</field_page_description>
  <field_date_posted>2012-05-21</field_date_posted>
  <field_date_reviewed>2012-05-17</field_date_reviewed>
  <field_pretty_url>PLCOQandA</field_pretty_url>
  <para_id>304596</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938242</term_id>
  <id>312165</id>
  <title>Combining Angiogenesis-Targeted Treatments for Liver Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Combining Angiogenesis-Targeted Treatments for Liver Cancer</field_short_title>
  <field_page_description>In this trial, patients with unresectable hepatocellular carcinoma who are ineligible for a liver transplant or other local therapies will be given oral sorafenib at the standard approved dose and intravenous TRC105. </field_page_description>
  <field_date_posted>2012-05-29</field_date_posted>
  <field_date_reviewed>2012-05-30</field_date_reviewed>
  <field_pretty_url>trc105-sorafenib</field_pretty_url>
  <para_id>312165</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922399</term_id>
  <id>315512</id>
  <title>Sigmoidoscopy Proves to Be Effective Screening Tool for Colorectal Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Sigmoidoscopy Proves to Be Effective Screening Tool for Colorectal Cancer</field_short_title>
  <field_page_description>In a large randomized trial involving healthy men and women aged 55 to 74, sigmoidoscopy substantially reduced the incidence of and mortality from colorectal cancer.</field_page_description>
  <field_date_posted>2012-06-07</field_date_posted>
  <field_date_reviewed>2012-06-07</field_date_reviewed>
  <field_pretty_url>screening-sigmoidoscopy</field_pretty_url>
  <para_id>315512</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>937976</term_id>
  <id>317040</id>
  <title>Study Shows Drug Is Effective for Cancer Patients with Peripheral Neuropathy</title>
  <langcode>en</langcode>
  <field_short_title>Study Shows Drug Is Effective for Cancer Patients with Peripheral Neuropathy</field_short_title>
  <field_page_description>Results of a phase III trial (CALGB-170601) show that duloxetine (Cymbalta) effectively treats painful peripheral neuropathy caused by certain types of chemotherapy.</field_page_description>
  <field_date_posted>2012-06-13</field_date_posted>
  <field_date_reviewed>2012-06-13</field_date_reviewed>
  <field_pretty_url>neuropathy</field_pretty_url>
  <para_id>317040</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>317507</id>
  <title>Cancer survivorship conference highlights research for survivor care: Biennial conference aims to improve quality and length of life for cancer survivors</title>
  <langcode>en</langcode>
  <field_short_title>Survivorship conference highlights research for survivor care</field_short_title>
  <field_page_description>More than 400 leading experts in cancer survivorship convened today for a conference, Cancer Survivorship Research: Translating Science to Care, to focus on such current concerns as how obesity might not have the same effects on all cancer survivors, and </field_page_description>
  <field_date_posted>2012-06-14</field_date_posted>
  <field_date_reviewed>2012-06-14</field_date_reviewed>
  <field_pretty_url>survivorship2012</field_pretty_url>
  <para_id>317507</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>903752</term_id>
  <id>323202</id>
  <title>Tumor Markers</title>
  <langcode>en</langcode>
  <field_short_title>Tumor Markers</field_short_title>
  <field_page_description>A fact sheet that defines tumor markers and describes how they can be used to aid diagnosis and treatment.</field_page_description>
  <field_date_posted>2015-11-09</field_date_posted>
  <field_date_reviewed>2015-11-04</field_date_reviewed>
  <field_pretty_url>tumor-markers-fact-sheet</field_pretty_url>
  <para_id>323202</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1100977</id>
  <title>Expanding Cancer Clinical Trial Access for Patients with HIV</title>
  <langcode>en</langcode>
  <field_short_title>Expanding Clinical Trial Access for Patients with HIV</field_short_title>
  <field_page_description>The immunotherapy drug pembrolizumab (Keytruda) is being tested in people with cancer who are HIV positive, as this Cancer Currents blog post explains.</field_page_description>
  <field_date_posted>2017-12-01</field_date_posted>
  <field_date_reviewed>2017-11-30</field_date_reviewed>
  <field_pretty_url>immunotherapy-cancer-HIV</field_pretty_url>
  <para_id>1100977</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1101156</id>
  <title>Fat Cells May Hinder Effectiveness of Chemotherapy </title>
  <langcode>en</langcode>
  <field_short_title>Fat Cells May Hinder Effectiveness of Chemotherapy</field_short_title>
  <field_page_description>Study shows fat cells can absorb and break down two chemotherapy drugs commonly used to treat leukemia, potentially reducing their effectiveness.</field_page_description>
  <field_date_posted>2017-12-04</field_date_posted>
  <field_date_reviewed>2017-12-01</field_date_reviewed>
  <field_pretty_url>fat-cells-absorb-chemotherapy</field_pretty_url>
  <para_id>1101156</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1102037</id>
  <title>Prior Cancers Common in Patients Newly Diagnosed with Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Prior Cancers Common in Patients Newly Diagnosed with Cancer</field_short_title>
  <field_page_description>Many patients diagnosed with a new cancer have had one or more cancers in the past, which has potential implications for clinical trial enrollment.</field_page_description>
  <field_date_posted>2017-12-14</field_date_posted>
  <field_date_reviewed>2017-12-14</field_date_reviewed>
  <field_pretty_url>prior-cancer-common-newly-diagnosed</field_pretty_url>
  <para_id>1102037</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1102945</term_id>
  <id>1102954</id>
  <title>What We Do</title>
  <langcode>en</langcode>
  <field_short_title>What We Do</field_short_title>
  <field_page_description>NCI fellows and trainees volunteer for science outreach and teaching activities in the greater Washington, D.C. area. Learn more about our seminars, teaching opportunities, and other ways we assist in the classroom.</field_page_description>
  <field_date_posted>2018-01-05</field_date_posted>
  <field_date_reviewed>2018-01-05</field_date_reviewed>
  <para_id>1102954</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102626</term_id>
  <id>1103372</id>
  <title>CGH at APEC: HPV Workshop</title>
  <langcode>en</langcode>
  <field_short_title>APEC 2017</field_short_title>
  <field_page_description>CGH at APEC 2017: HPV Workshop</field_page_description>
  <field_date_posted>2018-01-10</field_date_posted>
  <field_date_reviewed>2018-01-10</field_date_reviewed>
  <field_pretty_url>apec-2017</field_pretty_url>
  <para_id>1103372</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894086</term_id>
  <id>1103386</id>
  <title>Grantee Spotlight: Luis G. Carvajal-Carmona, PhD</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Luis G. Carvajal-Carmona, PhD</field_short_title>
  <field_page_description>CRCHD R21 grantee, Dr. Luis G. Carvajal-Carmona, is an Associate Professor specializing in cancer genetics, epidemiology, and cancer disparities.</field_page_description>
  <field_date_posted>2018-01-19</field_date_posted>
  <field_date_reviewed>2018-01-10</field_date_reviewed>
  <field_pretty_url>carvajal-carmona-spotlight</field_pretty_url>
  <para_id>1103386</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1105355</id>
  <title>TARGET Study Finds Major Differences between Childhood and Adult AML</title>
  <langcode>en</langcode>
  <field_short_title>Study Finds Differences between Childhood and Adult Leukemia</field_short_title>
  <field_page_description>Researchers with TARGET, an NCI-funded program, completed a comprehensive genomic analysis of pediatric acute myeloid leukemia. Learn what they found in this Cancer Currents blog post.</field_page_description>
  <field_date_posted>2018-01-30</field_date_posted>
  <field_date_reviewed>2018-01-30</field_date_reviewed>
  <field_pretty_url>genetic-differences-childhood-adult-aml</field_pretty_url>
  <para_id>1105355</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1102622</term_id>
  <id>1106668</id>
  <title>2018 Press Releases</title>
  <langcode>en</langcode>
  <field_short_title>2018 Press Releases</field_short_title>
  <field_page_description>Press releases from NCI for the year 2018.</field_page_description>
  <field_date_posted>2018-02-09</field_date_posted>
  <field_date_reviewed>2018-02-09</field_date_reviewed>
  <para_id>1106668</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1106698</id>
  <title>Oncolytic Virus Therapy: Using Tumor-Targeting Viruses to Treat Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Using Oncolytic Viruses to Treat Cancer</field_short_title>
  <field_page_description>Cancer treatments known as oncolytic viruses are being tested in clinical trials, and one, T-VEC or Imlygic®, has been approved by the FDA. Research now suggests that these treatments work not only by infecting and killing tumor cells, but that they may also be a form of cancer immunotherapy.</field_page_description>
  <field_date_posted>2018-02-09</field_date_posted>
  <field_date_reviewed>2018-02-09</field_date_reviewed>
  <field_pretty_url>oncolytic-viruses-to-treat-cancer</field_pretty_url>
  <para_id>1106698</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>941577</term_id>
  <id>1107098</id>
  <title>Clinical Trials to Treat Adult Brain Tumors</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trials to Treat Adult Brain Tumors</field_short_title>
  <field_date_posted>2018-02-14</field_date_posted>
  <field_date_reviewed>2018-02-14</field_date_reviewed>
  <field_pretty_url>adult-brain-tumors</field_pretty_url>
  <para_id>1107098</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1108384</id>
  <title>New on NCI Websites, March 2018</title>
  <langcode>en</langcode>
  <field_short_title>New on NCI Websites, March 2018</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post that provides an update on new content of interest to the cancer community recently added to NCI’s websites.</field_page_description>
  <field_date_posted>2018-03-02</field_date_posted>
  <field_date_reviewed>2018-02-27</field_date_reviewed>
  <field_pretty_url>new-online-march-2018</field_pretty_url>
  <para_id>1108384</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1109183</id>
  <title>Testing an Interactive Approach to Promote Exercise in Young Cancer Survivors</title>
  <langcode>en</langcode>
  <field_short_title>Promoting Exercise in Young Cancer Survivors</field_short_title>
  <field_page_description>In children and adolescent cancer survivors, an online game helped them get regular exercise, as this NCI Cancer Currents post explains. A NCI-funded trial is testing the approach for acute lymphoblastic leukemia (ALL) survivors.</field_page_description>
  <field_date_posted>2018-03-06</field_date_posted>
  <field_date_reviewed>2018-03-05</field_date_reviewed>
  <field_pretty_url>childhood-cancer-survivors-increasing-activity</field_pretty_url>
  <para_id>1109183</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1110774</id>
  <title>Many Men with Penile Cancer Do Not Get Recommended Treatments, Study Finds</title>
  <langcode>en</langcode>
  <field_short_title>Are Men with Penile Cancer Getting Recommended Treatments?</field_short_title>
  <field_page_description>Professional guidelines recommend that men with penile cancer that has not spread beyond nearby lymph nodes undergo lymph node dissection and receive chemotherapy. As this Cancer Currents blog post reports, that’s not happening for many men. 	</field_page_description>
  <field_date_posted>2018-03-22</field_date_posted>
  <field_date_reviewed>2018-03-22</field_date_reviewed>
  <field_pretty_url>penile-cancer-recommended-treatment</field_pretty_url>
  <para_id>1110774</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1111556</term_id>
  <id>1111557</id>
  <title>The Finding Cancer Trials Collaborative</title>
  <langcode>en</langcode>
  <field_short_title>Finding Cancer Trials Collaborative </field_short_title>
  <field_date_posted>2018-04-13</field_date_posted>
  <field_date_reviewed>2018-03-29</field_date_reviewed>
  <para_id>1111557</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1113120</id>
  <title>Advancing Patient Care Through Focused Innovation</title>
  <langcode>en</langcode>
  <field_short_title>Advancing Patient Care Through Focused Innovation</field_short_title>
  <field_page_description>In this Cancer Currents post, NCI Director Dr. Norman Sharpless describes the key areas of opportunity he has identified that, with enhanced attention from NCI, he believes can accelerate progress in cancer research and care.</field_page_description>
  <field_date_posted>2018-04-16</field_date_posted>
  <field_date_reviewed>2018-04-13</field_date_reviewed>
  <field_pretty_url>sharpless-nci-focus-areas</field_pretty_url>
  <para_id>1113120</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894086</term_id>
  <id>1113383</id>
  <title>PACHE Spotlight: Yamilé Molina, Ph.D.</title>
  <langcode>en</langcode>
  <field_short_title>PACHE Spotlight: Yamilé Molina, Ph.D.</field_short_title>
  <field_page_description>Dr. Yamilé Molina, an Assistant Professor at the University of Illinois-Chicago, discusses her work comparing intervention approaches’ effects on cancer disparities.  Dr. Molina also describes what CRCHD diversity training programs, including PACHE, have meant to her career.</field_page_description>
  <field_date_posted>2018-04-23</field_date_posted>
  <field_date_reviewed>2018-04-23</field_date_reviewed>
  <field_pretty_url>pache-spotlight-molina</field_pretty_url>
  <para_id>1113383</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1113389</id>
  <title>Take with Food: Study Tests Lowering Dose of Prostate Cancer Drug</title>
  <langcode>en</langcode>
  <field_short_title>Study Tests Way to Lower Dose of Prostate Cancer Drug</field_short_title>
  <field_page_description>In a small clinical trial, researchers compared the efficacy of a low dose of the cancer drug abiraterone (Zytiga) taken with a low-fat breakfast with a full dose taken on an empty stomach, as directed on the drug’s label. Learn what they found in this Cancer Currents blog post.</field_page_description>
  <field_date_posted>2018-04-23</field_date_posted>
  <field_date_reviewed>2018-04-18</field_date_reviewed>
  <field_pretty_url>prostate-cancer-abiraterone-food-low-dose</field_pretty_url>
  <para_id>1113389</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1114848</term_id>
  <id>1114853</id>
  <title>Career Planning for Trainees and Fellows</title>
  <langcode>en</langcode>
  <field_short_title>Career Planning</field_short_title>
  <field_page_description>Cancer research fellows and trainees at NCI can gain technical experience and professional skills while planning for academic, government, or industry careers. Learn more about career development at NCI. </field_page_description>
  <field_date_posted>2018-05-25</field_date_posted>
  <field_date_reviewed>2018-05-04</field_date_reviewed>
  <para_id>1114853</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1102622</term_id>
  <id>1115786</id>
  <title>Annual Report to the Nation: overall cancer mortality continues to decline, prostate cancer mortality has stabilized</title>
  <langcode>en</langcode>
  <field_short_title>Annual Report to the Nation: Overall cancer mortality declines</field_short_title>
  <field_page_description>The 2018 Annual Report to the Nation on the Status of Cancer finds overall cancer death rates continue to decline and cancer incidence dropped in men and remained stable in women. A companion study reports on recent changes in prostate cancer trends.</field_page_description>
  <field_date_posted>2018-05-22</field_date_posted>
  <field_date_reviewed>2018-05-17</field_date_reviewed>
  <field_pretty_url>annual-report-nation-2018</field_pretty_url>
  <para_id>1115786</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102626</term_id>
  <id>1116072</id>
  <title>Building Partnerships to Promote Global Health Equity: Takeaways from the 6th Annual Symposium on Global Cancer Research </title>
  <langcode>en</langcode>
  <field_short_title>Building Partnerships to Promote Global Health Equity: Takeaways from the 6th Annual Symposium</field_short_title>
  <field_page_description>CGH celebrated yet another successful and inspiring Annual Symposium on Global Cancer Research (ASGCR) held in conjunction with the 9th Annual CUGH (Consortium of University on Global Health) Conference on March 15, 2018 in New York, NY. Read more about ASGCR and new global collaborations in cancer research.  </field_page_description>
  <field_date_posted>2018-05-21</field_date_posted>
  <field_date_reviewed>2018-05-21</field_date_reviewed>
  <field_pretty_url>asgcr</field_pretty_url>
  <para_id>1116072</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1117512</id>
  <title>Maximizing the Prospects for Progress Against Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Maximizing the Prospects for Progress Against Cancer</field_short_title>
  <field_page_description>The 2018 American Society of Clinical Oncology annual meeting featured numerous, potentially practice changing research findings, according to NCI Director Dr. Norman Sharpless. In this Cancer Currents post, Dr. Sharpless discusses the rapid pace of progress in cancer research. </field_page_description>
  <field_date_posted>2018-06-11</field_date_posted>
  <field_date_reviewed>2018-06-11</field_date_reviewed>
  <field_pretty_url>asco-sharpless-maximizing-progress</field_pretty_url>
  <para_id>1117512</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1117737</id>
  <title>TCGA's Study of Breast Lobular Carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Breast Lobular Carcinoma</field_short_title>
  <field_page_description>TCGA's Study of Breast Lobular Carcinoma</field_page_description>
  <field_date_posted>2018-06-15</field_date_posted>
  <field_date_reviewed>2018-06-15</field_date_reviewed>
  <field_pretty_url>breast-lobular</field_pretty_url>
  <para_id>1117737</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1129043</term_id>
  <id>1118194</id>
  <title>The Cancer Genome Atlas Computational Tools</title>
  <langcode>en</langcode>
  <field_short_title>Computational Tools</field_short_title>
  <field_date_posted>2018-10-30</field_date_posted>
  <field_date_reviewed>2018-06-22</field_date_reviewed>
  <para_id>1118194</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1102622</term_id>
  <id>1119455</id>
  <title>NCI and VA collaborate to boost veterans’ access to cancer clinical trials</title>
  <langcode>en</langcode>
  <field_short_title>NCI and VA collaborate to boost veterans’ access to cancer clinical trials</field_short_title>
  <field_page_description>NCI and VA are launching the NAVIGATE program at 12 VA facilities across the country to enhance the ability of veterans to participate in NCI-sponsored clinical trials.</field_page_description>
  <field_date_posted>2018-07-10</field_date_posted>
  <field_date_reviewed>2018-07-06</field_date_reviewed>
  <field_pretty_url>navigate-va-clinical-trials</field_pretty_url>
  <para_id>1119455</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102628</term_id>
  <id>1119977</id>
  <title>Combination Screens for Cancer Vulnerabilities: A Conversation with Kris Wood</title>
  <langcode>en</langcode>
  <field_short_title>Combination Screens for Cancer Vulnerabilities: A Conversation with Kris Wood</field_short_title>
  <field_page_description>Combining genetic screens with drugs that work downstream of mutant KRAS reveals cellular adaptations to uncontrolled growth that may be targeted.</field_page_description>
  <field_date_posted>2018-07-19</field_date_posted>
  <field_date_reviewed>2018-07-17</field_date_reviewed>
  <field_pretty_url>kris-wood</field_pretty_url>
  <para_id>1119977</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1120620</id>
  <title>TCGA's Study of Acute Myeloid Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Acute Myeloid Leukemia</field_short_title>
  <field_page_description>TCGA's Study of Acute Myeloid Leukemia</field_page_description>
  <field_date_posted>2018-07-26</field_date_posted>
  <field_date_reviewed>2018-07-26</field_date_reviewed>
  <field_pretty_url>acute-myeloid-leukemia</field_pretty_url>
  <para_id>1120620</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1120759</id>
  <title>TCGA's Study of Chromophobe Renal Cell Carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Chromophobe Renal Cell Carcinoma</field_short_title>
  <field_page_description>TCGA's Study of Chromophobe Renal Cell Carcinoma</field_page_description>
  <field_date_posted>2018-07-27</field_date_posted>
  <field_date_reviewed>2018-07-27</field_date_reviewed>
  <field_pretty_url>chromophobe-renal-cell</field_pretty_url>
  <para_id>1120759</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1121520</id>
  <title>High-Fat Diet or Diabetes Drug May Enhance Response to Targeted Cancer Drug</title>
  <langcode>en</langcode>
  <field_short_title>Enhancing PI3K Inhibitor Response with Diet, Diabetes Drug</field_short_title>
  <field_page_description>Combining targeted cancer drugs known as PI3K inhibitors with a high-fat (ketogenic) diet or a diabetes drug may overcome P13K inhibitor resistance, a new study in mice suggests.</field_page_description>
  <field_date_posted>2018-08-08</field_date_posted>
  <field_date_reviewed>2018-08-07</field_date_reviewed>
  <field_pretty_url>pi3k-resistance-ketogenic-diet-diabetes-drug</field_pretty_url>
  <para_id>1121520</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1123942</id>
  <title>TCGA's Study of Pancreatic Ductal Adenocarcinoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Pancreatic Ductal Adenocarcinoma</field_short_title>
  <field_page_description>TCGA's Study of Pancreatic Ductal Adenocarcinoma</field_page_description>
  <field_date_posted>2018-09-05</field_date_posted>
  <field_date_reviewed>2018-09-05</field_date_reviewed>
  <field_pretty_url>pancreatic</field_pretty_url>
  <para_id>1123942</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1124128</id>
  <title>Integrating Geriatric Assessment into Cancer Care: A Conversation with Dr. Supriya Mohile</title>
  <langcode>en</langcode>
  <field_short_title>Integrating Geriatric Assessment into Cancer Care</field_short_title>
  <field_page_description>Dr. Supriya Mohile discusses efforts to incorporate geriatric assessment into the cancer care of older patients, including the recent publication of ASCO clinical guidelines on geriatric cancer care. </field_page_description>
  <field_date_posted>2018-09-11</field_date_posted>
  <field_date_reviewed>2018-09-11</field_date_reviewed>
  <field_pretty_url>geriatric-assessment-cancer-care-mohile</field_pretty_url>
  <para_id>1124128</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1124184</term_id>
  <id>1124201</id>
  <title>Publications from the RAS Initiative</title>
  <langcode>en</langcode>
  <field_short_title>RAS Initiative Publications</field_short_title>
  <field_page_description>This list of publications from the RAS Initiative reflects the balance between the public responsibilities of the National Cancer Institute and the requirements of our external partners.</field_page_description>
  <field_date_posted>2018-10-16</field_date_posted>
  <field_date_reviewed>2018-09-12</field_date_reviewed>
  <para_id>1124201</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894086</term_id>
  <id>1124678</id>
  <title>Dr. Chanita Hughes-Halbert to Deliver NCI CURE Distinguished Scholars Seminar</title>
  <langcode>en</langcode>
  <field_short_title>Dr. Chanita Hughes-Halbert to Deliver NCI CURE Distinguished Scholars Seminar</field_short_title>
  <field_page_description>On October 17, 2018, Dr. Chanita Hughes-Halbert will deliver the next CURE Distinguished Scholars Seminar. Dr. Hughes-Halbert will present on Translational Issues in Cancer Health Disparities.</field_page_description>
  <field_date_posted>2018-09-20</field_date_posted>
  <field_date_reviewed>2018-09-20</field_date_reviewed>
  <field_pretty_url>Hughes-Halbert-Seminar</field_pretty_url>
  <para_id>1124678</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915605</term_id>
  <id>1124701</id>
  <title>Brushing the Airway to Detect Lung Cancer Earlier</title>
  <langcode>en</langcode>
  <field_short_title>Brushing the Airway to Detect Lung Cancer Earlier</field_short_title>
  <field_page_description>Learn how NCI support enabled pulmonologist Avrum Spira to develop a minimally invasive test to tell whether smokers with suspicious lung lesions have cancer.</field_page_description>
  <field_date_posted>2017-09-21</field_date_posted>
  <field_date_reviewed>2018-09-21</field_date_reviewed>
  <field_pretty_url>avrum-spira-early-detection-lung-cancer</field_pretty_url>
  <para_id>1124701</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>917216</term_id>
  <id>1124707</id>
  <title>Improving Outcomes for Patients with NF1</title>
  <langcode>en</langcode>
  <field_short_title>Improving Outcomes for Patients with NF1</field_short_title>
  <field_page_description>Read about Philip Moss who participated in an NCI clinical trial led by Brigitte Widemann that is showing promise in treating children with NF1.</field_page_description>
  <field_date_posted>2017-09-21</field_date_posted>
  <field_date_reviewed>2018-09-21</field_date_reviewed>
  <field_pretty_url>philip-moss-improving-outcomes-nf1-neurofibromas</field_pretty_url>
  <para_id>1124707</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915609</term_id>
  <id>1126636</id>
  <title>Bringing Research to the Community to Reduce Cancer Disparities</title>
  <langcode>en</langcode>
  <field_short_title>Bringing Research to the Community to Reduce Cancer Disparities-Chanita Hughes-Halbert, Ph.D.</field_short_title>
  <field_page_description>Read about how NCI is working to reduce cancer disparities by bringing clinical trials to minority and underserved communities.</field_page_description>
  <field_date_posted>2017-09-21</field_date_posted>
  <field_date_reviewed>2018-10-16</field_date_reviewed>
  <field_pretty_url>chanita-hughes-halbert-clinical-trials-community-access</field_pretty_url>
  <para_id>1126636</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102626</term_id>
  <id>1126643</id>
  <title>APACT &amp; WCC 2018: Tobacco Control, Oral Cancer and the Sustainable Development Goals in the Asia-Pacific </title>
  <langcode>en</langcode>
  <field_short_title>APACT &amp; WCC 2018: Tobacco Control, Oral Cancer and Sustainable Development in the Asia-Pacific </field_short_title>
  <field_page_description>Want to learn more about tobacco control, oral cancer and sustainable development in the Asia-Pacific? Read CGH's Spotlight Blog: Tobacco Control, Oral Cancer and Sustainable Development in the Asia-Pacific. </field_page_description>
  <field_date_posted>2018-10-16</field_date_posted>
  <field_date_reviewed>2018-10-16</field_date_reviewed>
  <field_pretty_url>tobacco</field_pretty_url>
  <para_id>1126643</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102626</term_id>
  <id>1126837</id>
  <title>Using World RePORT to Measure How Much HPV-related Research is Being Funded Throughout the World</title>
  <langcode>en</langcode>
  <field_short_title>Using World Report to Measure How Much HPV-related Research is Being Funded Throughout the World</field_short_title>
  <field_page_description>Interested in learning in more about HPV-related research? Read: Using World RePORT to Measure How Much HPV-related Research is Being Funded Throughout the World to find out more.</field_page_description>
  <field_date_posted>2018-10-19</field_date_posted>
  <field_date_reviewed>2018-10-19</field_date_reviewed>
  <field_pretty_url>world-report</field_pretty_url>
  <para_id>1126837</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1128965</id>
  <title>New on NCI Websites for October 2018</title>
  <langcode>en</langcode>
  <field_short_title>New on NCI Websites for October 2018</field_short_title>
  <field_page_description>See selected content that has been added to NCI’s websites as of October 2018, in this Cancer Currents blog post.</field_page_description>
  <field_date_posted>2018-10-30</field_date_posted>
  <field_date_reviewed>2018-10-29</field_date_reviewed>
  <field_pretty_url>new-online-Oct-2018</field_pretty_url>
  <para_id>1128965</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1131335</id>
  <title>Tailored Radiation to Treat Brain Metastases Reduces Impact on Cognitive Function</title>
  <langcode>en</langcode>
  <field_short_title>Tailored Radiation for Brain Metastases Reduces Cognitive Impact</field_short_title>
  <field_page_description>For treating brain metastases, a radiation therapy technique called hippocampal avoidance limits the radiation’s cognitive impact, a clinical trial shows.</field_page_description>
  <field_date_posted>2018-11-26</field_date_posted>
  <field_date_reviewed>2018-11-20</field_date_reviewed>
  <field_pretty_url>brain-metastases-radiation-therapy-hippocampal-avoidance</field_pretty_url>
  <para_id>1131335</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894086</term_id>
  <id>1132884</id>
  <title>iCURE Welcomes First Scholars to the NCI</title>
  <langcode>en</langcode>
  <field_short_title>iCURE Welcomes First Scholars to the NCI</field_short_title>
  <field_date_posted>2018-12-14</field_date_posted>
  <field_date_reviewed>2018-12-14</field_date_reviewed>
  <field_pretty_url>icure-welcomes-scholars</field_pretty_url>
  <para_id>1132884</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>1133170</id>
  <title>Drugs Approved for Solid Tumors Anywhere in the Body</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Solid Tumors Anywhere in the Body</field_short_title>
  <field_page_description>A list of cancer drugs approved by the FDA for the treatment of solid tumors.</field_page_description>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>solid-tumors</field_pretty_url>
  <para_id>1133170</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133176</term_id>
  <id>1133220</id>
  <title>Chordoma</title>
  <langcode>en</langcode>
  <field_short_title>Chordoma</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>chordoma</field_pretty_url>
  <para_id>1133220</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133178</term_id>
  <id>1133227</id>
  <title>Synovial sarcoma</title>
  <langcode>en</langcode>
  <field_short_title>Synovial sarcoma</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>synovial-sarcoma</field_pretty_url>
  <para_id>1133227</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1134558</term_id>
  <id>1133234</id>
  <title>Adrenocortical carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>Adrenocortical carcinoma</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>adrenocortical-carcinoma</field_pretty_url>
  <para_id>1133234</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciLandingPage</CONTENTTYPENAME>
  <term_id>1133190</term_id>
  <id>1133245</id>
  <title>Other Rare Tumors</title>
  <langcode>en</langcode>
  <field_short_title>Other Rare Tumors</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <para_id>1133245</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1133439</id>
  <title>FDA Approvals Bring New Options for Older Patients with AML</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approvals Bring New Options for Older Patients with AML</field_short_title>
  <field_page_description>FDA has approved venetoclax (Venclexta) and glasdegib (Daurismo) for older patients with AML and those who can’t tolerate the standard chemotherapy treatment.</field_page_description>
  <field_date_posted>2018-12-27</field_date_posted>
  <field_date_reviewed>2018-12-20</field_date_reviewed>
  <field_pretty_url>fda-approval-glasdegib-venetoclax-aml-older</field_pretty_url>
  <para_id>1133439</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1133194</term_id>
  <id>1133502</id>
  <title>Participate</title>
  <langcode>en</langcode>
  <field_short_title>Participate</field_short_title>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2018-12-20</field_date_reviewed>
  <para_id>1133502</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133753</term_id>
  <id>1133756</id>
  <title>Join the NIH Fellows Editorial Board</title>
  <langcode>en</langcode>
  <field_short_title>Join the NIH Fellows Editorial Board</field_short_title>
  <field_page_description>The NIH Fellows Editorial Board offers fellows a free, confidential scientific document-editing service and gives fellows who join the Board editorial training and experience. The Fellows Editoral Board is by volunteer only of fellows and other professionals  to edit scientific documents and grant applications. </field_page_description>
  <field_date_posted>2018-12-21</field_date_posted>
  <field_date_reviewed>2018-12-21</field_date_reviewed>
  <para_id>1133756</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133783</term_id>
  <id>1133781</id>
  <title>Submissions to the NIH Fellows Editorial Board</title>
  <langcode>en</langcode>
  <field_short_title>Submissions to the NIH Fellows Editorial Board</field_short_title>
  <field_date_posted>2018-12-21</field_date_posted>
  <field_date_reviewed>2018-12-21</field_date_reviewed>
  <para_id>1133781</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1114846</term_id>
  <id>1134381</id>
  <title>Cancer Biotechnology </title>
  <langcode>en</langcode>
  <field_short_title>Cancer Biotechnology Course</field_short_title>
  <field_page_description>The Cancer Biotechnology course educates NCI fellows on new methodologies focusing on the latest advances in DNA, protein and image analysis. This course is targeted to clinical and postdoctoral fellows who want to learn about new biotechnology advances in science.</field_page_description>
  <field_date_posted>2019-01-03</field_date_posted>
  <field_date_reviewed>2019-01-03</field_date_reviewed>
  <field_pretty_url>cancer-biotechnology</field_pretty_url>
  <para_id>1134381</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1114846</term_id>
  <id>1134418</id>
  <title>Writing Cancer Grant Applications</title>
  <langcode>en</langcode>
  <field_short_title>Writing Cancer Grant Applications Course</field_short_title>
  <field_page_description>The Writing Cancer Grant Applications course focuses on how to write clear and persuasive grant applications. This course aims to increase the quality of grant applications by successfully communicating scientific data and ideas.</field_page_description>
  <field_date_posted>2019-01-04</field_date_posted>
  <field_date_reviewed>2019-01-04</field_date_reviewed>
  <field_pretty_url>writing-cancer-grant-applications</field_pretty_url>
  <para_id>1134418</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1114846</term_id>
  <id>1134424</id>
  <title>Translational Research in Clinical Oncology</title>
  <langcode>en</langcode>
  <field_short_title>Translational Research in Clinical Oncology</field_short_title>
  <field_page_description>This course is designed to provide NIH postdoctoral and clinical fellows an overview of general principles of cancer biology and treatment, epidemiology, genomics, precision medicine, mechanisms of resistance, use of preclinical models, and identification of novel molecular targets. </field_page_description>
  <field_date_posted>2019-01-04</field_date_posted>
  <field_date_reviewed>2019-01-04</field_date_reviewed>
  <field_pretty_url>translational-research-clinical-oncology</field_pretty_url>
  <para_id>1134424</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133186</term_id>
  <id>1134556</id>
  <title>What are rare kidney tumors?</title>
  <langcode>en</langcode>
  <field_short_title>Rare Kidney Tumors</field_short_title>
  <field_date_posted>2019-01-07</field_date_posted>
  <field_date_reviewed>2019-01-07</field_date_reviewed>
  <para_id>1134556</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1134630</term_id>
  <id>1134631</id>
  <title>Modeling and Druggable-Genome Screening of Glioblastoma Invasion Using Regional Biopsy-Guided Biomaterials Systems</title>
  <langcode>en</langcode>
  <field_short_title>Modeling and Druggable-Genome Screening of Glioblastoma Invasion</field_short_title>
  <field_page_description>TEC funded grant which will uncover mechanisms by which glioblastoma tumor cells and their microenvironment are altered to drive increased invasiveness as cells migrate away from the tumor core.</field_page_description>
  <field_date_posted>2019-01-08</field_date_posted>
  <field_date_reviewed>2017-06-28</field_date_reviewed>
  <para_id>1134631</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1135266</term_id>
  <id>1135267</id>
  <title>Office of Acquisitions (OA)</title>
  <langcode>en</langcode>
  <field_short_title>Office of Acquisitions (OA)</field_short_title>
  <field_page_description>The National Cancer Institute Office of Acquisitions negotiates, awards, and administers contracts and simplified acquisitions, while ensuring that customer service is paramount, communications are open and continuous, positive relationships are fostered, sound business judgment is employed, and acquisition strategies </field_page_description>
  <field_date_posted>2019-01-15</field_date_posted>
  <field_date_reviewed>2019-01-15</field_date_reviewed>
  <para_id>1135267</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1134352</term_id>
  <id>1137221</id>
  <title>HTAN: Mapping Tumors across Space and Time Using Cutting-Edge Technologies</title>
  <langcode>en</langcode>
  <field_short_title>HTAN: Mapping Tumors across Space and Time</field_short_title>
  <field_page_description>The Human Tumor Atlas Network is using the latest technologies to create detailed maps that capture cancer’s physical features and how tumors evolve over time. </field_page_description>
  <field_date_posted>2019-02-12</field_date_posted>
  <field_pretty_url>human-tumor-atlas-network-cancer-maps</field_pretty_url>
  <para_id>1137221</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1137581</term_id>
  <id>1137582</id>
  <title>Subcontracting Opportunities</title>
  <langcode>en</langcode>
  <field_short_title>Subcontracting Opportunities</field_short_title>
  <field_date_posted>2019-02-11</field_date_posted>
  <field_date_reviewed>2019-02-11</field_date_reviewed>
  <para_id>1137582</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1137978</term_id>
  <id>1137914</id>
  <title>Activities at NCI Exhibit Booth #2111</title>
  <langcode>en</langcode>
  <field_short_title>Activities at NCI Exhibit Booth #2111</field_short_title>
  <field_page_description>Stop by NCI’s Exhibit Booth at AACR 2019 to connect with NCI experts, order free publications, and learn about NCI programs and initiatives.</field_page_description>
  <field_date_posted>2019-02-22</field_date_posted>
  <field_date_reviewed>2018-03-26</field_date_reviewed>
  <para_id>1137914</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>420527</term_id>
  <id>420528</id>
  <title>Scientific Review</title>
  <langcode>en</langcode>
  <field_short_title>Scientific Review</field_short_title>
  <field_page_description>Scientific review ensures that studies are based on sound science, which contributes to the safety of clinical trial participants. Learn about the role of Institutional Review Boards (IRBs), Data and Safety Monitoring Boards (DSMBs), and government agenci</field_page_description>
  <field_date_posted>2012-09-11</field_date_posted>
  <field_date_reviewed>2016-06-22</field_date_reviewed>
  <para_id>420528</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>425264</term_id>
  <id>425591</id>
  <title>Special Funding</title>
  <langcode>en</langcode>
  <field_short_title>Special Funding</field_short_title>
  <field_page_description>Funding opportunities for biomarker, imaging, quality of life and cost effectiveness studies (BIQSFP) and mid-career clinical investigators (CCITLA)</field_page_description>
  <field_date_posted>2012-09-14</field_date_posted>
  <field_date_reviewed>2012-09-14</field_date_reviewed>
  <para_id>425591</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>430358</id>
  <title>What Impedes Cancer Research?: NCI Director Harold Varmus to address National Press Club</title>
  <langcode>en</langcode>
  <field_short_title>NCI Director Harold Varmus to address National Press Club</field_short_title>
  <field_page_description>The barriers that impede greater and faster progress against cancer include the inherent biological properties of tumors; the difficulties of developing new ways to prevent, diagnose and treat cancers; and economic and social factors that slow the nation’</field_page_description>
  <field_date_posted>2012-09-21</field_date_posted>
  <field_date_reviewed>2012-09-20</field_date_reviewed>
  <field_pretty_url>VarmusNationalPressClubSept25</field_pretty_url>
  <para_id>430358</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>11958</term_id>
  <id>109373</id>
  <title>What Does a Mole Look Like?</title>
  <langcode>en</langcode>
  <field_short_title>What Does a Mole Look Like?</field_short_title>
  <field_date_posted>2011-10-13</field_date_posted>
  <field_pretty_url>mole-photos</field_pretty_url>
  <para_id>109373</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>487755</term_id>
  <id>777775</id>
  <title>Steps to Find a Clinical Trial</title>
  <langcode>en</langcode>
  <field_short_title>Steps to Find a Clinical Trial</field_short_title>
  <field_page_description>Learn how to gather details about your cancer, places to search for clinical trials, how to narrow your search, and questions to ask to help you find a trial that is appropriate for you. </field_page_description>
  <field_date_posted>2014-05-30</field_date_posted>
  <field_date_reviewed>2014-05-30</field_date_reviewed>
  <para_id>777775</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>778109</id>
  <title>NCI at ASCO: A brief overview on research in women's cancers</title>
  <langcode>en</langcode>
  <field_short_title>NCI at ASCO: A brief overview on women's cancers</field_short_title>
  <field_page_description>The 2014 annual American Society of Clinical Oncology (ASCO) meeting in Chicago in June highlighted results from a number of NCI-supported and -sponsored clinical trial results in women’s cancers. Taken together, these results represent important advances</field_page_description>
  <field_date_posted>2014-06-02</field_date_posted>
  <field_date_reviewed>2014-05-30</field_date_reviewed>
  <field_pretty_url>ASCOWomensCancerPerspective</field_pretty_url>
  <para_id>778109</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922410</term_id>
  <id>789639</id>
  <title>Lung-MAP: Master Protocol for Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Lung-MAP: Master Protocol for Lung Cancer</field_short_title>
  <field_page_description>The Lung Cancer Master Protocol, or Lung-MAP, is a precision medicine research study for people with advanced non-small cell lung cancer that has continued to grow after treatment. Patients are assigned to different study drug combinations based on the results of genomic profiling of their tumors.</field_page_description>
  <field_date_posted>2014-06-16</field_date_posted>
  <field_date_reviewed>2014-06-10</field_date_reviewed>
  <field_pretty_url>lung-map</field_pretty_url>
  <para_id>789639</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>792942</id>
  <title>NIH and NSF collaborate to accelerate biomedical research innovations into the marketplace</title>
  <langcode>en</langcode>
  <field_short_title>NIH/NSF accelerate biomedical research innovations</field_short_title>
  <field_page_description>A collaboration between the National Science Foundation and the National Institutes of Health will give NIH-funded researchers training to help them evaluate their scientific discoveries for commercial potential, with the aim of accelerating biomedical in</field_page_description>
  <field_date_posted>2014-06-18</field_date_posted>
  <field_date_reviewed>2014-06-18</field_date_reviewed>
  <field_pretty_url>ICORPsNIHNSF</field_pretty_url>
  <para_id>792942</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>797656</id>
  <title>Where HIV genetic information is inserted into host DNA is linked to clonal growth and persistence of infected cells</title>
  <langcode>en</langcode>
  <field_short_title>HIV genetic information and clonal growth </field_short_title>
  <field_page_description>Based on an analysis of blood cells from five HIV-infected individuals, NCI researchers have identified more than 2,400 HIV DNA insertion sites. Analysis of these sites showed that there is extensive clonal expansion (growth) of HIV infected cells. </field_page_description>
  <field_date_posted>2014-06-26</field_date_posted>
  <field_date_reviewed>2014-06-25</field_date_reviewed>
  <field_pretty_url>HIVDNAinsertionSites</field_pretty_url>
  <para_id>797656</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>810173</id>
  <title>NCI Community Oncology Research Program (NCORP) Gets Underway</title>
  <langcode>en</langcode>
  <field_short_title>NCORP Gets Underway</field_short_title>
  <field_page_description>NCI has awarded 53 new 5-year grants to researchers across the country to conduct multi-site cancer clinical trials and cancer care delivery research studies in their communities. The grants are being awarded under the NCI Community Oncology Research Prog</field_page_description>
  <field_date_posted>2014-08-01</field_date_posted>
  <field_date_reviewed>2014-08-01</field_date_reviewed>
  <field_pretty_url>NCORP01Aug2014</field_pretty_url>
  <para_id>810173</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>816951</term_id>
  <id>816969</id>
  <title>RAS Image-Based Screens</title>
  <langcode>en</langcode>
  <field_short_title>Image-Based Screens</field_short_title>
  <field_date_posted>2014-09-22</field_date_posted>
  <field_date_reviewed>2014-08-19</field_date_reviewed>
  <para_id>816969</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>816958</term_id>
  <id>817097</id>
  <title>RAS Informatics</title>
  <langcode>en</langcode>
  <field_short_title>RAS Informatics</field_short_title>
  <field_page_description>The RAS Informatics lab group develops tools to track and analyze “big data” from the RAS Initiative, as well as analyzes data from external projects. By integrating internal and external data, this group helps improve understanding of RAS-driven cancers.</field_page_description>
  <field_date_posted>2014-09-22</field_date_posted>
  <field_date_reviewed>2014-08-20</field_date_reviewed>
  <para_id>817097</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915376</term_id>
  <id>819947</id>
  <title>Questions to Ask Your Doctor about Cancer Screening</title>
  <langcode>en</langcode>
  <field_short_title>Questions to Ask Your Doctor about Cancer Screening</field_short_title>
  <field_date_posted>2012-11-27</field_date_posted>
  <field_date_reviewed>2014-08-27</field_date_reviewed>
  <field_pretty_url>questions-screening-audio</field_pretty_url>
  <para_id>819947</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>937976</term_id>
  <id>822289</id>
  <title>Tackling the Conundrum of Cachexia in Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Tackling the Conundrum of Cachexia in Cancer</field_short_title>
  <field_date_posted>2011-11-01</field_date_posted>
  <field_date_reviewed>2014-09-04</field_date_reviewed>
  <field_pretty_url>cachexia</field_pretty_url>
  <para_id>822289</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>920152</id>
  <title>Annual Report to the Nation on the Status of Cancer, 1975 -2011: Questions and Answers</title>
  <langcode>en</langcode>
  <field_short_title>Annual Report to the Nation on the Status of Cancer, 1975 -2011: Questions and Answers</field_short_title>
  <field_page_description>This report provides a yearly update of cancer incidence (new cases) and mortality (death) rates, and trends in these rates in the United States. The special feature section of this year’s report highlights the incidence of breast cancer subtypes by race,</field_page_description>
  <field_date_posted>2015-03-30</field_date_posted>
  <field_date_reviewed>2015-03-26</field_date_reviewed>
  <field_pretty_url>report-nation-march-2015-qanda</field_pretty_url>
  <para_id>920152</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciLandingPage</CONTENTTYPENAME>
  <term_id>12732</term_id>
  <id>15273</id>
  <title>Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Research</field_short_title>
  <field_page_description>NCI is the nation's leader in cancer research. Learn more about NCI's cancer research areas, key initiatives, progress made in cancer research, and resources for researchers like research tools, specimens and data. </field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>15273</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciLandingPage</CONTENTTYPENAME>
  <term_id>11868</term_id>
  <id>15288</id>
  <title>Cancer Types</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Types</field_short_title>
  <field_page_description>Alphabetical list of all cancers, with links to disease-specific and general information about treatment, coping, screening, prevention, clinical trials, and other topics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2010-07-23</field_date_reviewed>
  <para_id>15288</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>882603</term_id>
  <id>15428</id>
  <title>Asbestos Exposure and Cancer Risk</title>
  <langcode>en</langcode>
  <field_short_title>Asbestos Exposure and Cancer Risk</field_short_title>
  <field_page_description>A fact sheet about asbestos, asbestos-related diseases, and who to contact for more information. </field_page_description>
  <field_date_posted>2017-06-15</field_date_posted>
  <field_date_reviewed>2017-06-07</field_date_reviewed>
  <field_pretty_url>asbestos-fact-sheet</field_pretty_url>
  <para_id>15428</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>11890</term_id>
  <id>15596</id>
  <title>Pap and HPV Testing</title>
  <langcode>en</langcode>
  <field_short_title>Pap and HPV Testing</field_short_title>
  <field_page_description>Pap tests detect abnormal cervical cells, including precancerous cervical lesions, as well as early cervical cancers. HPV tests detect HPV infections that can cause cervical cell abnormalities. Learn how Pap and HPV tests are done, how often testing should be done, and how are HPV test results are reported.</field_page_description>
  <field_date_posted>2014-09-15</field_date_posted>
  <field_date_reviewed>2014-09-09</field_date_reviewed>
  <field_pretty_url>pap-hpv-testing-fact-sheet</field_pretty_url>
  <para_id>15596</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>12742</term_id>
  <id>16143</id>
  <title>Funding for Extramural Cancer Training by the Cancer Training Branch</title>
  <langcode>en</langcode>
  <field_short_title>Funding for Cancer Training</field_short_title>
  <field_page_description>Find funding for training grants, fellowships, research career development awards, and education research grants for students and scientists at universities and institutions across the country. </field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2008-11-14</field_date_reviewed>
  <para_id>16143</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>11738</term_id>
  <id>16392</id>
  <title>NCI Cancer Genetics Services Directory</title>
  <langcode>en</langcode>
  <field_short_title>NCI Cancer Genetics Services Directory</field_short_title>
  <field_date_posted>2011-02-02</field_date_posted>
  <field_date_reviewed>2011-02-02</field_date_reviewed>
  <para_id>16392</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>396055</term_id>
  <id>396077</id>
  <title>Use of Placebos</title>
  <langcode>en</langcode>
  <field_short_title>Use of Placebos</field_short_title>
  <field_date_posted>2012-08-10</field_date_posted>
  <field_date_reviewed>2016-06-22</field_date_reviewed>
  <para_id>396077</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919012</term_id>
  <id>445962</id>
  <title>Spanish-Language Social Media at NCI</title>
  <langcode>en</langcode>
  <field_short_title>Spanish-Language Social Media at NCI</field_short_title>
  <field_date_posted>2012-10-09</field_date_posted>
  <field_date_reviewed>2012-10-09</field_date_reviewed>
  <para_id>445962</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>445983</id>
  <title>Patient Education Publications</title>
  <langcode>en</langcode>
  <field_short_title>Patient Education Publications</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2014-10-17</field_date_reviewed>
  <para_id>445983</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938139</term_id>
  <id>476523</id>
  <title>New Targeted Treatment May Slow Disease in Patients with Advanced GIST</title>
  <langcode>en</langcode>
  <field_short_title>New Targeted Treatment May Slow Disease in Patients with Advanced GIST</field_short_title>
  <field_page_description>A new oral drug, regorafenib (Stivarga®), may delay the progression of advanced gastrointestinal stromal tumors (GIST) that are resistant to treatment, according to results from an international clinical trial published November 22, 2012, in The Lancet. </field_page_description>
  <field_date_posted>2012-12-11</field_date_posted>
  <field_date_reviewed>2012-12-11</field_date_reviewed>
  <field_pretty_url>regorafenib-gist</field_pretty_url>
  <para_id>476523</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917237</term_id>
  <id>478613</id>
  <title>Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)</title>
  <langcode>en</langcode>
  <field_short_title>Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)</field_short_title>
  <field_page_description>Funding for NCTN and NCORP Research Bases to support biomarker, imaging, quality of life and cost-effectiveness studies (BIQSFP) associated with network trials.</field_page_description>
  <field_date_posted>2012-12-17</field_date_posted>
  <field_date_reviewed>2012-12-17</field_date_reviewed>
  <para_id>478613</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>11886</term_id>
  <id>112306</id>
  <title>Moving Beyond Breast Cancer Videos</title>
  <langcode>en</langcode>
  <field_short_title>Moving Beyond Breast Cancer Videos</field_short_title>
  <field_date_posted>2011-11-14</field_date_posted>
  <field_date_reviewed>2011-10-05</field_date_reviewed>
  <field_pretty_url>beyond-cancer-video</field_pretty_url>
  <para_id>112306</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>776849</id>
  <title>Clinical trial analysis suggests drug combination may be highly effective in recurrent ovarian cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drug combination may be highly effective in recurrent ovarian cancer</field_short_title>
  <field_page_description>Significant improvement with the use of a combination drug therapy for recurrent ovarian cancer was reported at the annual meeting of the American Society of Clinical Oncology meeting in Chicago. The trial compared the activity of a combination of the dru</field_page_description>
  <field_date_posted>2014-05-31</field_date_posted>
  <field_date_reviewed>2014-05-28</field_date_reviewed>
  <field_pretty_url>OvarianNCT01116648ASCO</field_pretty_url>
  <para_id>776849</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>776903</term_id>
  <id>776914</id>
  <title>Office of Grants Administration (OGA)</title>
  <langcode>en</langcode>
  <field_short_title>Office of Grants Administration (OGA)</field_short_title>
  <field_date_posted>2014-05-28</field_date_posted>
  <field_date_reviewed>2014-05-28</field_date_reviewed>
  <para_id>776914</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917235</term_id>
  <id>777714</id>
  <title>Cancer Clinical Investigator Team Leadership Award (CCITLA)</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Clinical Investigator Team Leadership Award (CCITLA)</field_short_title>
  <field_page_description>NCI’s Cancer Clinical Investigator Team Leadership Awards (CCITLAs) recognize mid-career clinical investigators at NCI Cancer Centers.</field_page_description>
  <field_date_posted>2014-05-30</field_date_posted>
  <field_date_reviewed>2014-05-30</field_date_reviewed>
  <para_id>777714</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919514</term_id>
  <id>807054</id>
  <title>Contact OGA</title>
  <langcode>en</langcode>
  <field_short_title>Contact OGA</field_short_title>
  <field_date_posted>2016-04-04</field_date_posted>
  <field_date_reviewed>2014-07-22</field_date_reviewed>
  <para_id>807054</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922410</term_id>
  <id>814247</id>
  <title>The ALCHEMIST Lung Cancer Trials</title>
  <langcode>en</langcode>
  <field_short_title>The ALCHEMIST Lung Cancer Trials</field_short_title>
  <field_date_posted>2014-08-18</field_date_posted>
  <field_date_reviewed>2014-08-12</field_date_reviewed>
  <field_pretty_url>alchemist</field_pretty_url>
  <para_id>814247</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1075067</term_id>
  <id>817904</id>
  <title>NCI Social Media Events</title>
  <langcode>en</langcode>
  <field_short_title>Social Media Events</field_short_title>
  <field_page_description>Learn about NCI's upcoming and recent social media events.</field_page_description>
  <field_date_posted>2014-08-22</field_date_posted>
  <field_date_reviewed>2018-10-15</field_date_reviewed>
  <para_id>817904</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>916996</term_id>
  <id>819746</id>
  <title>Careers at NCI</title>
  <langcode>en</langcode>
  <field_short_title>Careers at NCI</field_short_title>
  <field_date_posted>2014-08-27</field_date_posted>
  <field_date_reviewed>2014-08-27</field_date_reviewed>
  <para_id>819746</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915376</term_id>
  <id>819945</id>
  <title>Crunching Numbers: What Cancer Screening Statistics Really Tell Us</title>
  <langcode>en</langcode>
  <field_short_title>Crunching Numbers: What Cancer Screening Statistics Really Tell Us</field_short_title>
  <field_page_description>Cancer screening studies have shown that more screening does not necessarily translate into fewer cancer deaths. This article explains how to interpret the statistics used to describe the results of screening studies.</field_page_description>
  <field_date_posted>2012-05-01</field_date_posted>
  <field_date_reviewed>2014-08-27</field_date_reviewed>
  <field_pretty_url>what-screening-statistics-mean</field_pretty_url>
  <para_id>819945</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>821434</id>
  <title>Risk factors identified for certain lymphoma subtypes</title>
  <langcode>en</langcode>
  <field_short_title>Risk factors identified for certain lymphoma subtypes</field_short_title>
  <field_page_description>In a large international collaborative analysis of risk factors for non-Hodgkin lymphoma (NHL), scientists were able to quantify risk associated with medical history, lifestyle factors, family history of blood or lymph-borne cancers, and occupation for 11</field_page_description>
  <field_date_posted>2014-09-02</field_date_posted>
  <field_date_reviewed>2014-09-02</field_date_reviewed>
  <field_pretty_url>NHLinterlymphMonograph</field_pretty_url>
  <para_id>821434</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>904109</term_id>
  <id>828587</id>
  <title>Contact &amp; Staff Bios</title>
  <langcode>en</langcode>
  <field_short_title>Contact &amp; Staff Bios</field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-09-17</field_date_reviewed>
  <para_id>828587</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069528</term_id>
  <id>835077</id>
  <title>The RAS Initiative - Welcome</title>
  <langcode>en</langcode>
  <field_short_title>The RAS Initiative - Welcome</field_short_title>
  <field_page_description>Blog post from Dr. Harold Varmus, introducing the collaborative initiative to study RAS and provide better treatment for the many cancers driven by RAS mutations around the world.</field_page_description>
  <field_date_posted>2014-10-20</field_date_posted>
  <field_date_reviewed>2014-10-20</field_date_reviewed>
  <field_pretty_url>welcome</field_pretty_url>
  <para_id>835077</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>836586</id>
  <title>Trial results show high remission rate in leukemia following immune cell therapy</title>
  <langcode>en</langcode>
  <field_short_title>Trial results show high remission rate in leukemia following immune cell therapy</field_short_title>
  <field_page_description>Children and young adults (age 1 to age 30) with chemotherapy-resistant B-cell acute lymphoblastic leukemia (ALL) experienced high remission rates following treatment with an experimental immunotherapy. Results demonstrated that the immunotherapy treatmen</field_page_description>
  <field_date_posted>2014-10-12</field_date_posted>
  <field_date_reviewed>2014-10-03</field_date_reviewed>
  <field_pretty_url>car-tleukemia</field_pretty_url>
  <para_id>836586</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>836659</id>
  <title>When Someone You Love Has Advanced Cancer: Support for Caregivers</title>
  <langcode>en</langcode>
  <field_short_title>When Someone You Love Has Advanced Cancer</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2014-10-03</field_date_reviewed>
  <field_pretty_url>when-someone-you-love-has-advanced-cancer</field_pretty_url>
  <para_id>836659</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>449472</id>
  <title>Comparing Relaxation Programs for Breast Cancer Patients Receiving Radiotherapy</title>
  <langcode>en</langcode>
  <field_short_title>Comparing Relaxation Programs for Breast Cancer Patients Receiving Radiotherapy</field_short_title>
  <field_page_description>In this study, women with breast cancer who have had surgery and are scheduled to undergo radiation therapy will be randomly assigned to one of two different stretching and relaxation programs or to a control group that will receive usual care. </field_page_description>
  <field_date_posted>2012-10-16</field_date_posted>
  <field_date_reviewed>2012-10-16</field_date_reviewed>
  <field_pretty_url>relaxation-radiotherapy</field_pretty_url>
  <para_id>449472</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>463785</id>
  <title>Chemotherapy and You: Support for People With Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Chemotherapy and You: Support for People With Cancer</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2012-11-20</field_date_reviewed>
  <field_pretty_url>chemo-and-you</field_pretty_url>
  <para_id>463785</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>464419</id>
  <title>Cancer Pain Control: Support for People With Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Pain Control: Support for People With Cancer</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2012-11-23</field_date_reviewed>
  <field_pretty_url>pain-control</field_pretty_url>
  <para_id>464419</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938030</term_id>
  <id>476945</id>
  <title>New Drug Shows Promise against Drug-Resistant Leukemias</title>
  <langcode>en</langcode>
  <field_short_title>New Drug Shows Promise against Drug-Resistant Leukemias</field_short_title>
  <field_page_description>A new drug called ponatinib may be a new treatment option for patients with chronic myeloid leukemia (CML) that is resistant to other therapies, according to results of two early clinical trials.</field_page_description>
  <field_date_posted>2012-12-17</field_date_posted>
  <field_date_reviewed>2012-12-12</field_date_reviewed>
  <field_pretty_url>ponatinib-cml</field_pretty_url>
  <para_id>476945</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917237</term_id>
  <id>478618</id>
  <title>Funded Studies</title>
  <langcode>en</langcode>
  <field_short_title>Funded Studies</field_short_title>
  <field_date_posted>2012-12-17</field_date_posted>
  <field_date_reviewed>2012-12-17</field_date_reviewed>
  <field_pretty_url>funded-studies</field_pretty_url>
  <para_id>478618</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917237</term_id>
  <id>478620</id>
  <title>Glossary</title>
  <langcode>en</langcode>
  <field_short_title>Glossary</field_short_title>
  <field_date_posted>2012-12-17</field_date_posted>
  <field_date_reviewed>2012-12-17</field_date_reviewed>
  <field_pretty_url>glossary</field_pretty_url>
  <para_id>478620</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>920814</id>
  <title>Dr. Dinah Singer: Increasing Diversity in Cancer Research: One Lab at a Time</title>
  <langcode>en</langcode>
  <field_short_title>Dr. Dinah Singer: Increasing Diversity in Cancer Research: One Lab at a Time</field_short_title>
  <field_date_posted>2015-03-27</field_date_posted>
  <field_date_reviewed>2015-03-27</field_date_reviewed>
  <field_pretty_url>singer-spotlight</field_pretty_url>
  <para_id>920814</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>922313</id>
  <title>The Importance of Cancer Prevention Research and its Challenges</title>
  <langcode>en</langcode>
  <field_short_title>The Importance of Cancer Prevention Research and its Challenges</field_short_title>
  <field_date_posted>2015-04-01</field_date_posted>
  <field_date_reviewed>2015-03-31</field_date_reviewed>
  <field_pretty_url>cancer-prevention-research-importance</field_pretty_url>
  <para_id>922313</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>922408</id>
  <title>The Study of Tamoxifen and Raloxifene (STAR): Questions and Answers</title>
  <langcode>en</langcode>
  <field_short_title>The Study of Tamoxifen and Raloxifene (STAR): Questions and Answers</field_short_title>
  <field_page_description>Learn about the Study of Tamoxifen and Raloxifene (STAR) clinical trial, which is comparing the drug raloxifene (Evista®) with the drug tamoxifen (Nolvadex®) in reducing the incidence of breast cancer in at-risk postmenopausal women.</field_page_description>
  <field_date_posted>2006-04-17</field_date_posted>
  <field_date_reviewed>2015-04-01</field_date_reviewed>
  <field_pretty_url>star-trial-results-qa</field_pretty_url>
  <para_id>922408</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>844114</term_id>
  <id>922513</id>
  <title>Publications</title>
  <langcode>en</langcode>
  <field_short_title>Publications</field_short_title>
  <field_page_description>Information about NCI publications including PDQ cancer information for patients and health professionals, patient-education publications, fact sheets, dictionaries, NCI blogs and newsletters and major reports.</field_page_description>
  <field_date_posted>2015-04-01</field_date_posted>
  <field_date_reviewed>2015-04-01</field_date_reviewed>
  <para_id>922513</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>922515</id>
  <title>A Message to the Cancer Research Community</title>
  <langcode>en</langcode>
  <field_short_title>A Message to the Cancer Research Community</field_short_title>
  <field_date_posted>2015-04-01</field_date_posted>
  <field_date_reviewed>2015-04-01</field_date_reviewed>
  <field_pretty_url>lowy-message</field_pretty_url>
  <para_id>922515</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922597</term_id>
  <id>922598</id>
  <title>Immunosuppression</title>
  <langcode>en</langcode>
  <field_short_title>Immunosuppression</field_short_title>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-04-02</field_date_reviewed>
  <para_id>922598</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069530</term_id>
  <id>935795</id>
  <title>RAS Insight</title>
  <langcode>en</langcode>
  <field_short_title>RAS Insight</field_short_title>
  <field_date_posted>2015-04-13</field_date_posted>
  <field_date_reviewed>2015-04-13</field_date_reviewed>
  <field_pretty_url>ras-insight</field_pretty_url>
  <para_id>935795</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>936157</id>
  <title>Researchers report initial feasibility of identifying patients who are exceptional responders to cancer therapy</title>
  <langcode>en</langcode>
  <field_short_title>Identifying patients who are exceptional responders to cancer therapy</field_short_title>
  <field_page_description>A pilot study evaluating identification of cancer patients who respond to treatment that is ineffective in at least 90 percent of patients found that it was indeed able to confirm a majority of proposed patients as exceptional responders based on clinical</field_page_description>
  <field_date_posted>2015-04-19</field_date_posted>
  <field_date_reviewed>2015-04-14</field_date_reviewed>
  <field_pretty_url>exceptional-responders-initial-feasibility-results</field_pretty_url>
  <para_id>936157</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>105034</id>
  <title>Drugs Approved for Penile Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Penile Cancer</field_short_title>
  <field_date_posted>2011-10-04</field_date_posted>
  <field_date_reviewed>2011-08-16</field_date_reviewed>
  <field_pretty_url>penile</field_pretty_url>
  <para_id>105034</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>11958</term_id>
  <id>109372</id>
  <title>What Does Melanoma Look Like?</title>
  <langcode>en</langcode>
  <field_short_title>What Does Melanoma Look Like?</field_short_title>
  <field_date_posted>2011-10-13</field_date_posted>
  <field_pretty_url>melanoma-photos</field_pretty_url>
  <para_id>109372</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>11958</term_id>
  <id>119953</id>
  <title>Common Moles, Dysplastic Nevi, and Risk of Melanoma</title>
  <langcode>en</langcode>
  <field_short_title>Common Moles, Dysplastic Nevi, and Risk of Melanoma</field_short_title>
  <field_page_description>A fact sheet about moles and how some moles may be related to melanoma, the most serious type of skin cancer. Includes photos of differences between moles and cancer.</field_page_description>
  <field_date_posted>2018-05-02</field_date_posted>
  <field_date_reviewed>2018-04-27</field_date_reviewed>
  <field_pretty_url>moles-fact-sheet</field_pretty_url>
  <para_id>119953</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>777515</id>
  <title>New treatment option for young women with hormone-sensitive breast cancer</title>
  <langcode>en</langcode>
  <field_short_title>New treatment option for women with hormone-sensitive breast cancer</field_short_title>
  <field_page_description>A drug used for treating breast cancer, known as exemestane, is more effective than a common breast cancer prevention drug, tamoxifen, in preventing breast cancer recurrence in young women who also receive post-surgical treatment to suppress ovarian funct</field_page_description>
  <field_date_posted>2014-06-01</field_date_posted>
  <field_date_reviewed>2014-05-29</field_date_reviewed>
  <field_pretty_url>ASCOSOFTandTEXT</field_pretty_url>
  <para_id>777515</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>792909</id>
  <title>CGH’s Third Year with NCI: Progress, Partnerships, &amp; Possibilities</title>
  <langcode>en</langcode>
  <field_short_title>CGH’s Third Year with NCI: Progress, Partnerships, &amp; Possibilities</field_short_title>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-06-17</field_date_reviewed>
  <field_pretty_url>welcome</field_pretty_url>
  <para_id>792909</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>792910</id>
  <title>2013 Awardees: Request for Proposals for Pilot Collaborations with Low- and Mid-Income Countries (LMICs) in Global Cancer Research or Global Health Research at NCI-Designated Cancer Centers</title>
  <langcode>en</langcode>
  <field_short_title>2013 CGH Awardees</field_short_title>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-06-17</field_date_reviewed>
  <field_pretty_url>2013-cgh-awardees</field_pretty_url>
  <para_id>792910</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922399</term_id>
  <id>799624</id>
  <title>Redefining Adjuvant Therapy for Stage III Resected Colon Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Redefining Adjuvant Therapy for Stage III Resected Colon Cancer</field_short_title>
  <field_page_description>In this trial, patients with resected stage III colon cancer are being randomly assigned to receive FOLFOX chemotherapy for either 3 or 6 months and to take either a pill called celecoxib or a matching placebo pill for 3 years. </field_page_description>
  <field_date_posted>2014-07-03</field_date_posted>
  <field_date_reviewed>2014-06-30</field_date_reviewed>
  <field_pretty_url>folfox-celecoxib</field_pretty_url>
  <para_id>799624</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>800243</id>
  <title>NCI study finds extreme obesity may shorten life expectancy up to 14 years</title>
  <langcode>en</langcode>
  <field_short_title>NCI study finds extreme obesity may shorten life expectancy up to 14 years</field_short_title>
  <field_page_description>Extremely obese people have increased risks of dying from cancer and many other causes including heart disease, stroke, diabetes, and kidney and liver diseases, according to results of an analysis of data pooled from 20 large studies of people from three </field_page_description>
  <field_date_posted>2014-07-08</field_date_posted>
  <field_date_reviewed>2014-07-03</field_date_reviewed>
  <field_pretty_url>ClassObesity</field_pretty_url>
  <para_id>800243</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>801686</id>
  <title>Study identifies novel genomic changes in the most common type of lung cancer; &lt;span style="font-weight:normal"&gt;&lt;i&gt;TCGA finds mutations in a key cancer-causing pathway, expanding targets for existing drugs&lt;/i&gt;&lt;/span&gt;</title>
  <langcode>en</langcode>
  <field_short_title>Novel genomic changes in most common type of lung cancer</field_short_title>
  <field_page_description>Researchers from The Cancer Genome Atlas (TCGA) Research Network have identified novel mutations in a well-known cancer-causing pathway in lung adenocarcinoma, the most common subtype of lung cancer.</field_page_description>
  <field_date_posted>2014-07-09</field_date_posted>
  <field_date_reviewed>2014-07-07</field_date_reviewed>
  <field_pretty_url>TCGAlungAdeno</field_pretty_url>
  <para_id>801686</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>809150</id>
  <title>Molecular mechanism identified for activation and desensitization of prominent neurotransmitter receptor in the brain</title>
  <langcode>en</langcode>
  <field_short_title>Mechanism for the activation of glutamate receptors</field_short_title>
  <field_page_description>Scientists at the NIH have used a technique called cryo-electron microscopy to determine a molecular mechanism for the activation and desensitization of ionotropic glutamate receptors, a prominent class of neurotransmitter receptors in the brain and spina</field_page_description>
  <field_date_posted>2014-08-04</field_date_posted>
  <field_date_reviewed>2014-07-29</field_date_reviewed>
  <field_pretty_url>GlutamateReceptors</field_pretty_url>
  <para_id>809150</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>921705</id>
  <title>CGH and OCC Announce a New, Two-Year Funding Opportunity for NCI-designated Cancer Centers </title>
  <langcode>en</langcode>
  <field_short_title>CGH and OCC Announce a New, Two-Year Funding Opportunity for NCI-designated Cancer Centers </field_short_title>
  <field_date_posted>2015-03-30</field_date_posted>
  <field_date_reviewed>2015-03-30</field_date_reviewed>
  <field_pretty_url>funding-opportunity-cancercenters</field_pretty_url>
  <para_id>921705</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>922332</term_id>
  <id>922330</id>
  <title>Metastatic Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Metastatic Cancer</field_short_title>
  <field_page_description>Metastatic cancer is cancer that spreads from its site of origin to another part of the body. Learn how cancer spreads, possible symptoms, common sites where cancer spreads, and how to find out about treatment options.</field_page_description>
  <field_date_posted>2015-05-12</field_date_posted>
  <field_date_reviewed>2015-03-31</field_date_reviewed>
  <para_id>922330</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922403</term_id>
  <id>922404</id>
  <title>Prostate Cancer Screening Results from the Prostate, Lung, Colorectal, and Ovarian Cancer Randomized Screening Trial: Questions and Answers</title>
  <langcode>en</langcode>
  <field_short_title>Prostate Cancer Screening Results from PLCO</field_short_title>
  <field_page_description>Learn the results of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, a large-scale clinical trial to determine whether certain cancer screening tests can help reduce deaths from prostate, lung, colorectal, and ovarian cancer.</field_page_description>
  <field_date_posted>2009-03-19</field_date_posted>
  <field_date_reviewed>2015-04-01</field_date_reviewed>
  <field_pretty_url>plco-screening-results-qa</field_pretty_url>
  <para_id>922404</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>608323</term_id>
  <id>929956</id>
  <title>A Story of Discovery: Natural Compound Helps Treat Breast and Ovarian Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Science and Nature Team Up Against Breast and Ovarian Cancers</field_short_title>
  <field_page_description>NCI Story of Discovery describes how researchers discover the lifesaving compound Taxol, a drug now commonly used to treat breast and ovarian cancers.</field_page_description>
  <field_date_posted>2015-03-31</field_date_posted>
  <field_date_reviewed>2015-04-08</field_date_reviewed>
  <field_pretty_url>taxol</field_pretty_url>
  <para_id>929956</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>930347</id>
  <title>Facilitating Research, Fueling Collaboration: Dr. Frank McCormick on the RAS Initiative</title>
  <langcode>en</langcode>
  <field_short_title>Facilitating Research, Fueling Collaboration: Dr. Frank McCormick on the RAS Initiative</field_short_title>
  <field_date_posted>2015-04-09</field_date_posted>
  <field_date_reviewed>2015-04-09</field_date_reviewed>
  <field_pretty_url>mccormick-qa</field_pretty_url>
  <para_id>930347</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>930560</id>
  <title>Grantee Spotlight: Jennie Williams, Ph.D. - Investigating Genetic Biomarkers for Colon Cancer in African Americans</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Jennie Williams, Ph.D.</field_short_title>
  <field_date_posted>2015-04-09</field_date_posted>
  <field_date_reviewed>2015-04-09</field_date_reviewed>
  <field_pretty_url>williams-spotlight</field_pretty_url>
  <para_id>930560</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>936147</id>
  <title>Grantee Spotlight: Rafael E. Guerrero-Preston, Dr.P.H., M.P.H. - Exploring Genetic and Epigenetic Factors Underlying Head and Neck Cancer Disparities</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Rafael E. Guerrero-Preston, Dr.P.H., M.P.H.  </field_short_title>
  <field_date_posted>2014-08-11</field_date_posted>
  <field_date_reviewed>2014-08-11</field_date_reviewed>
  <field_pretty_url>preston-spotlight-blog</field_pretty_url>
  <para_id>936147</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>937762</id>
  <title>Special Spotlight: Levi A. Garraway, M.D., Ph.D., Receives Prestigious Jane Cooke Wright Award from American Association for Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Special Spotlight: Levi A. Garraway, M.D., Ph.D.</field_short_title>
  <field_date_posted>2014-04-17</field_date_posted>
  <field_date_reviewed>2014-04-17</field_date_reviewed>
  <field_pretty_url>garraway-spotlight</field_pretty_url>
  <para_id>937762</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>939329</id>
  <title>Scientific Cooperation Between the U.S. and the Republic of South Africa Funds 7 Cancer-Specific Projects</title>
  <langcode>en</langcode>
  <field_short_title>Scientific Cooperation Between the U.S. and the Republic of South Africa Funds 7 Cancer-Specific Pro</field_short_title>
  <field_date_posted>2015-04-27</field_date_posted>
  <field_date_reviewed>2015-04-27</field_date_reviewed>
  <field_pretty_url>southafrica-collaboration</field_pretty_url>
  <para_id>939329</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>939440</id>
  <title>Advancing Global Cancer Research @ AACR 2015</title>
  <langcode>en</langcode>
  <field_short_title>Advancing Global Cancer Research @ AACR 2015</field_short_title>
  <field_date_posted>2015-04-27</field_date_posted>
  <field_date_reviewed>2015-04-27</field_date_reviewed>
  <field_pretty_url>AACR</field_pretty_url>
  <para_id>939440</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>939851</term_id>
  <id>939858</id>
  <title>Bladder Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Bladder Cancer </field_short_title>
  <field_page_description>Transitional cell carcinoma of the bladder can be low-grade or high-grade. Bladder cancer is also divided into muscle-invasive and nonmuscle-invasive disease. Find evidence-based information on bladder cancer including treatment, screening, research, and statistics.</field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-04-30</field_date_reviewed>
  <para_id>939858</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938032</term_id>
  <id>939929</id>
  <title>Brain Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on brain cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-04-30</field_date_reviewed>
  <para_id>939929</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>828586</id>
  <title>Cancer Detection, Diagnosis, and Treatment Technologies for Global Health: Supporting the development of low-cost technologies for LMICs </title>
  <langcode>en</langcode>
  <field_short_title>Cancer Detection, Diagnosis, and Treatment Technologies for Global Health</field_short_title>
  <field_date_posted>2014-09-17</field_date_posted>
  <field_date_reviewed>2014-09-17</field_date_reviewed>
  <field_pretty_url>low-cost-technologies</field_pretty_url>
  <para_id>828586</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>904111</term_id>
  <id>828593</id>
  <title>CRCHD Offices and Branches</title>
  <langcode>en</langcode>
  <field_short_title>Offices and Branches</field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-09-17</field_date_reviewed>
  <para_id>828593</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>919383</term_id>
  <id>833192</id>
  <title>CRCHD Integrated Networks</title>
  <langcode>en</langcode>
  <field_short_title>CRCHD Integrated Networks</field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-09-24</field_date_reviewed>
  <para_id>833192</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>836256</id>
  <title>If You Want to Find Ways to Prevent Cancer...Learn About Prevention Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>If You Want to Find Ways to Prevent Cancer...Learn About Prevention Clinical Trials</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2014-10-02</field_date_reviewed>
  <field_pretty_url>about-prevention-trials</field_pretty_url>
  <para_id>836256</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>836317</id>
  <title>Taking Part in Cancer Treatment Research Studies</title>
  <langcode>en</langcode>
  <field_short_title>Taking Part in Cancer Treatment Research Studies</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2014-10-02</field_date_reviewed>
  <field_pretty_url>cancer-treatment-research-studies</field_pretty_url>
  <para_id>836317</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>150013</id>
  <title>Combination Therapy Shows Promise for Treating Advanced Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Combination Therapy Shows Promise for Treating Advanced Breast Cancer</field_short_title>
  <field_page_description>Adding the drug everolimus (Afinitor®) to exemestane helped postmenopausal women whose advanced breast cancer had stopped responding to hormonal therapy live about 4 months longer without the disease progressing than women who received exemestane alone.</field_page_description>
  <field_date_posted>2011-12-21</field_date_posted>
  <field_date_reviewed>2011-12-21</field_date_reviewed>
  <field_pretty_url>everolimus-plus-exemestane</field_pretty_url>
  <para_id>150013</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>904030</term_id>
  <id>840882</id>
  <title>Center for Cancer Training (CCT)</title>
  <langcode>en</langcode>
  <field_short_title>About Center for Cancer Training (CCT)</field_short_title>
  <field_date_posted>2015-04-06</field_date_posted>
  <field_date_reviewed>2014-10-16</field_date_reviewed>
  <para_id>840882</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919680</term_id>
  <id>847655</id>
  <title>About the NCI Cancer Bulletin</title>
  <langcode>en</langcode>
  <field_short_title>About the NCI Cancer Bulletin</field_short_title>
  <field_date_posted>2014-10-28</field_date_posted>
  <field_date_reviewed>2014-10-28</field_date_reviewed>
  <field_pretty_url>cancer-bulletin</field_pretty_url>
  <para_id>847655</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>848991</term_id>
  <id>849014</id>
  <title>Partnerships to Advance Cancer Health Equity (PACHE)</title>
  <langcode>en</langcode>
  <field_short_title>Partnerships to Advance Cancer Health Equity (PACHE)</field_short_title>
  <field_page_description>PACHE fosters collaboration among institutions serving underserved health disparity populations and NCI-Designated Cancer Centers.</field_page_description>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-10-29</field_date_reviewed>
  <para_id>849014</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>852822</id>
  <title>Building Partnerships Begins at Home  </title>
  <langcode>en</langcode>
  <field_short_title>Building Partnerships Begins at Home  </field_short_title>
  <field_date_posted>2014-11-03</field_date_posted>
  <field_date_reviewed>2014-11-03</field_date_reviewed>
  <field_pretty_url>partnerships</field_pretty_url>
  <para_id>852822</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>856983</id>
  <title>Recipients of Cancer Clinical Investigator Team Leadership Awards Announced</title>
  <langcode>en</langcode>
  <field_short_title>Recipients of CCITLA Announced</field_short_title>
  <field_page_description>NCI’s Cancer Clinical Investigator Team Leadership Awards recognize and support outstanding mid-career clinical investigators at NCI-Designated Cancer Centers who participate extensively in NCI-funded collaborative clinical trials and whose leadership, pa</field_page_description>
  <field_date_posted>2014-11-12</field_date_posted>
  <field_date_reviewed>2014-11-10</field_date_reviewed>
  <field_pretty_url>CCITLA</field_pretty_url>
  <para_id>856983</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>857649</term_id>
  <id>857634</id>
  <title>Children's Assent</title>
  <langcode>en</langcode>
  <field_short_title>Children's Assent</field_short_title>
  <field_date_posted>2014-11-13</field_date_posted>
  <field_date_reviewed>2016-06-22</field_date_reviewed>
  <para_id>857634</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>858170</term_id>
  <id>859589</id>
  <title>Keep Up with Your Daily Routine</title>
  <langcode>en</langcode>
  <field_short_title>Daily Routine</field_short_title>
  <field_page_description>Tips on managing your daily life, incorporating fun, humor, and physical activities.</field_page_description>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-17</field_date_reviewed>
  <para_id>859589</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>858172</term_id>
  <id>859593</id>
  <title>Your Faith and Spirituality</title>
  <langcode>en</langcode>
  <field_short_title>Faith &amp; Spirituality</field_short_title>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-17</field_date_reviewed>
  <para_id>859593</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>916478</term_id>
  <id>882397</id>
  <title>Strong Inorganic Acid Mists Containing Sulfuric Acid</title>
  <langcode>en</langcode>
  <field_short_title>Strong Inorganic Acid Mists Containing Sulfuric Acid</field_short_title>
  <field_page_description>Copper smelting and other manufacturing processes generate strong inorganic acid mists that can increase your risk of laryngeal and lung cancers. </field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2014-12-15</field_date_reviewed>
  <para_id>882397</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>916472</term_id>
  <id>882446</id>
  <title>Hexavalent Chromium Compounds</title>
  <langcode>en</langcode>
  <field_short_title>Hexavalent Chromium Compounds</field_short_title>
  <field_page_description>Learn about chromium, exposure to which can increase your risk of lung cancer and cancer of the paranasal sinuses and nasal cavity. Hexavalent chromium compounds have been used as corrosion inhibitors in a wide variety of products and processes.</field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2019-02-15</field_date_reviewed>
  <para_id>882446</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>11738</term_id>
  <id>109060</id>
  <title>Application Form for NCI Cancer Genetics Services Directory</title>
  <langcode>en</langcode>
  <field_short_title>Application Form for NCI Cancer Genetics Services Directory</field_short_title>
  <field_page_description>Professionals who provide services related to cancer genetics (cancer risk assessment, genetic counseling, genetic susceptibility testing, and others) may fill out this application form to be listed in the National Cancer Institute's Cancer Genetics Services Directory. </field_page_description>
  <field_date_posted>2011-09-12</field_date_posted>
  <field_date_reviewed>2011-09-12</field_date_reviewed>
  <field_pretty_url>application-form</field_pretty_url>
  <para_id>109060</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>777000</id>
  <title>Treatment helps young women preserve their fertility during breast cancer chemotherapy</title>
  <langcode>en</langcode>
  <field_short_title>Treatment helps young women preserve fertility during breast cancer chemo</field_short_title>
  <field_page_description>Researchers have found that young women with breast cancer were able to better preserve their fertility during cancer treatments by using hormone-blocking drug injections that put them into temporary menopause. The results announced today at the annual me</field_page_description>
  <field_date_posted>2014-05-30</field_date_posted>
  <field_date_reviewed>2014-05-28</field_date_reviewed>
  <field_pretty_url>ASCOPOEMS</field_pretty_url>
  <para_id>777000</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938030</term_id>
  <id>797387</id>
  <title>Ibrutinib Improves Survival Compared with Ofatumumab in Patients with Previously Treated Chronic Lymphocytic Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Ibrutinib Improves Survival in Patients with Previously Treated Chronic Lymphocytic Leukemia</field_short_title>
  <field_page_description>A summary of results from an international phase III trial that compared ibrutinib (Imbruvica®) and ofatumumab (Arzerra®) for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).</field_page_description>
  <field_date_posted>2014-06-27</field_date_posted>
  <field_date_reviewed>2014-06-27</field_date_reviewed>
  <field_pretty_url>ibrutinib-cll</field_pretty_url>
  <para_id>797387</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922403</term_id>
  <id>797388</id>
  <title>Enzalutamide Improves Survival in Patients with Metastatic Prostate Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Enzalutamide Improves Survival in Patients with Metastatic Prostate Cancer</field_short_title>
  <field_page_description>A summary of results from an international phase III trial that compared enzalutamide (Xtandi®) and placebo for the treatment of metastatic prostate cancer that had progressed during treatment with androgen deprivation therapy. </field_page_description>
  <field_date_posted>2014-06-27</field_date_posted>
  <field_date_reviewed>2014-06-27</field_date_reviewed>
  <field_pretty_url>enzalutamide-metastatic</field_pretty_url>
  <para_id>797388</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069528</term_id>
  <id>799465</id>
  <title>Are All RAS Proteins Created Equal in Cancer?</title>
  <langcode>en</langcode>
  <field_short_title>Are All RAS Proteins Created Equal in Cancer?</field_short_title>
  <field_date_posted>2014-09-22</field_date_posted>
  <field_date_reviewed>2014-06-30</field_date_reviewed>
  <field_pretty_url>ras-proteins-created-equal</field_pretty_url>
  <para_id>799465</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>804882</id>
  <title>NIH study finds negative HPV screening test result is a better predictor of low cervical cancer risk than a negative Pap test</title>
  <langcode>en</langcode>
  <field_short_title>Negative HPV screening test predicts low cervical cancer risk better than negative Pap test</field_short_title>
  <field_page_description>Based on a study that included more than 1 million women, investigators at NCI have determined that a negative test for HPV infection compared to a negative Pap test provides greater safety, or assurance, against future risk of cervical cancer.</field_page_description>
  <field_date_posted>2014-07-18</field_date_posted>
  <field_date_reviewed>2014-07-15</field_date_reviewed>
  <field_pretty_url>HPVscreeningPredictor</field_pretty_url>
  <para_id>804882</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>937976</term_id>
  <id>819880</id>
  <title>Understanding “Chemobrain” and Cognitive Impairment after Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Understanding Post-Treatment “Chemobrain”</field_short_title>
  <field_page_description>An NCI research update about research to investigate what factors play a role in “chemobrain” or cognitive impairment after cancer treatment.</field_page_description>
  <field_date_posted>2009-03-24</field_date_posted>
  <field_date_reviewed>2014-08-27</field_date_reviewed>
  <field_pretty_url>understanding-chemobrain</field_pretty_url>
  <para_id>819880</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>904176</term_id>
  <id>828658</id>
  <title>Cancer Health Disparities Definitions</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Health Disparities Definitions</field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-09-17</field_date_reviewed>
  <para_id>828658</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>833183</term_id>
  <id>833186</id>
  <title>Patient Navigation Research Program (PNRP)</title>
  <langcode>en</langcode>
  <field_short_title>PNRP </field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-09-24</field_date_reviewed>
  <para_id>833186</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>833194</term_id>
  <id>833197</id>
  <title>Geographic Management of Cancer Health Disparities Program (GMaP)</title>
  <langcode>en</langcode>
  <field_short_title>GMaP</field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-09-24</field_date_reviewed>
  <para_id>833197</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>836252</id>
  <title>NCI scientists find protective mechanism against cancer in the cells of progeria patients</title>
  <langcode>en</langcode>
  <field_short_title>Protective mechanism against cancer found in progeria patient cells</field_short_title>
  <field_page_description>NCI scientists have studied cells of patients with an extremely rare genetic disease that is characterized by drastic premature aging and discovered a new protective cellular mechanism against cancer. They found that cells from patients with Hutchinson Gi</field_page_description>
  <field_date_posted>2014-10-02</field_date_posted>
  <field_date_reviewed>2014-10-02</field_date_reviewed>
  <field_pretty_url>ProgeriaBRDR</field_pretty_url>
  <para_id>836252</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>936257</id>
  <title>2012 Press Releases</title>
  <langcode>en</langcode>
  <field_short_title>2012 Press Releases</field_short_title>
  <field_page_description>Press releases from the National Cancer Institute for the year 2012.</field_page_description>
  <field_date_posted>2015-04-15</field_date_posted>
  <field_date_reviewed>2015-04-15</field_date_reviewed>
  <para_id>936257</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>936261</id>
  <title>2013 Press Releases</title>
  <langcode>en</langcode>
  <field_short_title>2013 Press Releases</field_short_title>
  <field_page_description>Press releases from the National Cancer Institute for the year 2013.</field_page_description>
  <field_date_posted>2015-04-15</field_date_posted>
  <field_date_reviewed>2015-04-15</field_date_reviewed>
  <para_id>936261</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>936775</id>
  <title>Future Directions for NCI’s Surveillance Research Program</title>
  <langcode>en</langcode>
  <field_short_title>Future Directions for NCI’s Surveillance Research Program</field_short_title>
  <field_page_description>Since the early 1970s, NCI’s SEER program has been an invaluable resource for statistics on cancer in the United States. For the past several years, SEER researchers have been working toward a much broader and comprehensive goal for providing cancer stati</field_page_description>
  <field_date_posted>2015-04-17</field_date_posted>
  <field_date_reviewed>2015-04-17</field_date_reviewed>
  <field_pretty_url>seer-future</field_pretty_url>
  <para_id>936775</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>937767</id>
  <title>Program Spotlight: Dana Farber/Harvard Cancer Center Partnership Receives $8 Million Grant to Start Center for Personalized Cancer Therapy </title>
  <langcode>en</langcode>
  <field_short_title>Program Spotlight: Dana Farber/Harvard Cancer Center Partnership Receives $8 Million Grant </field_short_title>
  <field_date_posted>2014-04-10</field_date_posted>
  <field_date_reviewed>2014-04-10</field_date_reviewed>
  <field_pretty_url>DF-HCC-spotlight</field_pretty_url>
  <para_id>937767</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>953206</term_id>
  <id>937872</id>
  <title>Common Cancer Types</title>
  <langcode>en</langcode>
  <field_short_title>Common Cancer Types</field_short_title>
  <field_page_description>List of common cancer types, or cancers that are diagnosed with the greatest frequency in the United States; provides most recent incidence and mortality statistics for these cancers. </field_page_description>
  <field_date_posted>2015-04-21</field_date_posted>
  <field_date_reviewed>2015-04-21</field_date_reviewed>
  <para_id>937872</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>939712</id>
  <title>Near-atomic resolution of protein structure by electron microscopy holds promise for drug discovery</title>
  <langcode>en</langcode>
  <field_short_title>Near-atomic resolution of protein structure by electron microscopy</field_short_title>
  <field_page_description>An imaging technique, cryo-electron microscopy, can view in near-atomic detail the architecture of an enzyme bound to a drug that blocks its activity</field_page_description>
  <field_date_posted>2015-05-07</field_date_posted>
  <field_date_reviewed>2015-04-30</field_date_reviewed>
  <field_pretty_url>cryo-electron-microscopy</field_pretty_url>
  <para_id>939712</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>939921</term_id>
  <id>939928</id>
  <title>Brain Tumors—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Brain Tumors </field_short_title>
  <field_page_description>Brain and spinal cord tumors include anaplastic astrocytomas and glioblastomas, meningiomas, pituitary tumors, schwannomas, ependymomas, and sarcomas. Find evidence-based information on brain tumor treatment, research, genetics, and statistics.</field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-04-30</field_date_reviewed>
  <para_id>939928</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940027</term_id>
  <id>940034</id>
  <title>Cervical Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Cervical Cancer </field_short_title>
  <field_page_description>The primary risk factor for cervical cancer is human papillomavirus (HPV) infection. Most cases of cervical cancer are preventable by routine screening and by treatment of precancerous lesions. Find evidence-based information on cervical cancer treatment, causes and prevention, screening, research, and statistics.</field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-04-30</field_date_reviewed>
  <para_id>940034</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940173</term_id>
  <id>940178</id>
  <title>Extragonadal Germ Cell Tumors—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Extragonadal Germ Cell Tumors</field_short_title>
  <field_page_description>Extragonadal germ cell tumors are rare and account for only a small percentage of all germ cell tumors. However, the true incidence of these tumors may be higher than originally thought because of failure to diagnose them properly. Find evidence-based information on extragonadal germ cell tumors treatment.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940178</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938030</term_id>
  <id>940446</id>
  <title>Leukemia Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on leukemia, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940446</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940502</term_id>
  <id>940507</id>
  <title>Lung Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Lung Cancer </field_short_title>
  <field_page_description>Lung cancer appears in two main types. Non-small cell (squamous cell carcinoma, large cell carcinoma, and adenocarcinoma), and small cell lung cancer (oat cell cancer and combined small cell carcinoma). Find evidence-based information on lung cancer treatment, causes and prevention, research, screening, and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940507</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>930502</term_id>
  <id>139015</id>
  <title>Study Suggests Smaller Melanoma Excision Margins May Be Option for Some Patients</title>
  <langcode>en</langcode>
  <field_short_title>Study Suggests Smaller Melanoma Excision Margins May Be Option for Some Patients</field_short_title>
  <field_page_description>A randomized controlled trial of patients with stage IIA–C cutaneous melanoma thicker than 2-mm found that a 2-cm surgical resection margin is sufficient and is as safe for patients as a 4-cm margin.</field_page_description>
  <field_date_posted>2011-12-02</field_date_posted>
  <field_date_reviewed>2011-12-02</field_date_reviewed>
  <field_pretty_url>smaller-margins</field_pretty_url>
  <para_id>139015</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938142</term_id>
  <id>139034</id>
  <title>Targeted Therapy Shows Benefit in Rare Type of Thyroid Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Targeted Therapy Shows Benefit in Rare Type of Thyroid Cancer</field_short_title>
  <field_page_description>Treatment with the multitargeted agent vandetanib (Caprelsa) improved progression-free survival in patients with medullary thyroid cancer (MTC), according to findings from a randomized clinical trial.</field_page_description>
  <field_date_posted>2011-12-02</field_date_posted>
  <field_date_reviewed>2011-12-02</field_date_reviewed>
  <field_pretty_url>vandetanib</field_pretty_url>
  <para_id>139034</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>837258</id>
  <title>Treatment Choices for Men With Early-Stage Prostate Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Treatment Choices for Men With Early-Stage Prostate Cancer</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2014-10-04</field_date_reviewed>
  <field_pretty_url>understanding-prostate-cancer-treatment</field_pretty_url>
  <para_id>837258</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>858160</term_id>
  <id>858277</id>
  <title>Talking with Your Health Care Team</title>
  <langcode>en</langcode>
  <field_short_title>Talking with Your Health Care Team</field_short_title>
  <field_page_description>talking to your doctor, ask questions, take notes, ask about costs</field_page_description>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-14</field_date_reviewed>
  <para_id>858277</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>857991</term_id>
  <id>859577</id>
  <title>Self-Image and Sexuality</title>
  <langcode>en</langcode>
  <field_short_title>Self-Image &amp; Sexuality</field_short_title>
  <field_page_description>Cancer and its treatment can change how you look and feel about yourself. Learn to cope with body changes and issues related to sexuality and intimacy.</field_page_description>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-17</field_date_reviewed>
  <para_id>859577</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911145</term_id>
  <id>14469</id>
  <title>Physical Activity and Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Physical Activity and Cancer</field_short_title>
  <field_page_description>A fact sheet that summarizes evidence linking exercise and other physical activity, including work and household chores, to reduced cancer risks.</field_page_description>
  <field_date_posted>2017-02-03</field_date_posted>
  <field_date_reviewed>2017-01-27</field_date_reviewed>
  <field_pretty_url>physical-activity-fact-sheet</field_pretty_url>
  <para_id>14469</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911184</term_id>
  <id>14648</id>
  <title>Hair Dyes and Cancer Risk</title>
  <langcode>en</langcode>
  <field_short_title>Hair Dyes and Cancer Risk</field_short_title>
  <field_page_description>A fact sheet that reviews research about the possibility of a connection between personal hair dye use and cancer.</field_page_description>
  <field_date_posted>2017-01-13</field_date_posted>
  <field_date_reviewed>2016-08-18</field_date_reviewed>
  <field_pretty_url>hair-dyes-fact-sheet</field_pretty_url>
  <para_id>14648</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>892789</id>
  <title>Grantee Spotlight: Dr. Kolawole Okuyemi - Improving Cervical Cancer Screening Attitudes of African Immigrants and Refugees</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Dr. Kolawole Okuyemi - Improving Cervical Cancer Screening Attitudes</field_short_title>
  <field_date_posted>2015-01-05</field_date_posted>
  <field_date_reviewed>2015-01-09</field_date_reviewed>
  <field_pretty_url>okuyemi-spotlight</field_pretty_url>
  <para_id>892789</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>897081</id>
  <title>Bacterial Biofilms Provide Clues into Colorectal Cancer Risk</title>
  <langcode>en</langcode>
  <field_short_title>Bacterial Biofilms Provide Clues into Colorectal Cancer Risk</field_short_title>
  <field_page_description>New data suggest that dense bacterial communities called biofilms may contribute to some colon cancers.</field_page_description>
  <field_date_posted>2015-01-16</field_date_posted>
  <field_date_reviewed>2015-01-16</field_date_reviewed>
  <field_pretty_url>bacterial-biofilms-provide-clues</field_pretty_url>
  <para_id>897081</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>279438</term_id>
  <id>898412</id>
  <title>Surgery Choices for Women with DCIS or Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Surgery Choices for Women with DCIS or Breast Cancer</field_short_title>
  <field_date_posted>2015-01-19</field_date_posted>
  <field_date_reviewed>2015-01-19</field_date_reviewed>
  <para_id>898412</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>901853</term_id>
  <id>901854</id>
  <title>Appetite Loss and Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Appetite Loss</field_short_title>
  <field_page_description>Cancer treatments may lower your appetite. Side effects such as nausea, fatigue, or mouth sores can also making eating difficult. Learn how to eat well to avoid losing weight or becoming dehydrated, so you stay strong during treatment.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2018-09-14</field_date_reviewed>
  <para_id>901854</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>903707</term_id>
  <id>903708</id>
  <title>Constipation and Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Constipation</field_short_title>
  <field_page_description>Cancer treatment can cause constipation. Symptoms include hard stools, stomach cramps, bloating, and nausea. Causes also include pain medicine, diet changes, dehydration, and being less active. Prevention and treatment of constipation is explained. </field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2018-08-09</field_date_reviewed>
  <para_id>903708</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>914566</term_id>
  <id>903713</id>
  <title>Nerve Problems (Peripheral Neuropathy) and Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Nerve Problems (Peripheral Neuropathy)</field_short_title>
  <field_page_description>Nerve problems, such as peripheral neuropathy, can be caused by cancer treatment. Learn about signs and symptoms of nerve changes. Find out how to prevent or manage nerve problems during cancer treatment.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2017-12-04</field_date_reviewed>
  <para_id>903713</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>899928</term_id>
  <id>903737</id>
  <title>Hair Loss (Alopecia) and Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Hair Loss (Alopecia) </field_short_title>
  <field_page_description>Hair loss, also called alopecia, is a side effect of cancer treatments, such as chemotherapy and radiation therapy. Learn how to cope with and manage hair loss. Listen to tips from others who have experienced hair loss.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2017-12-04</field_date_reviewed>
  <para_id>903737</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922403</term_id>
  <id>211442</id>
  <title>Long-Term Trial Results Show No Mortality Benefit from Annual Prostate Cancer Screening</title>
  <langcode>en</langcode>
  <field_short_title>Long-Term Trial Results Show No Mortality Benefit from Annual Prostate Cancer Screening</field_short_title>
  <field_page_description>Thirteen year follow-up data from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial show higher incidence but similar mortality among men screened annually with the prostate-specific antigen (PSA) test and digital rectal examination</field_page_description>
  <field_date_posted>2012-02-17</field_date_posted>
  <field_date_reviewed>2012-02-17</field_date_reviewed>
  <field_pretty_url>screening-psa-dre</field_pretty_url>
  <para_id>211442</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>217874</id>
  <title>Heavy exposure to diesel exhaust linked to lung cancer death in miners</title>
  <langcode>en</langcode>
  <field_short_title>Exposure to diesel exhaust linked to lung cancer in miners</field_short_title>
  <field_page_description>In a study of non-metal miners in the United States, federal government scientists reported that heavy exposure to diesel exhaust increased risk of death from lung cancer. The research, all part of the Diesel Exhaust in Miners Study, was designed to evalu</field_page_description>
  <field_date_posted>2012-03-02</field_date_posted>
  <field_date_reviewed>2012-03-01</field_date_reviewed>
  <field_pretty_url>DieselMinersPressRelease</field_pretty_url>
  <para_id>217874</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>898464</term_id>
  <id>905730</id>
  <title>Side Effects of Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Side Effects of Cancer Treatment</field_short_title>
  <field_page_description>Side effects are problems that occur when cancer treatment affects healthy tissues or organs. Learn about side effects caused by cancer treatment. Know what signs and symptoms to call your doctor about. Learn about treatments for side effects.      </field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2017-09-22</field_date_reviewed>
  <para_id>905730</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>915370</term_id>
  <id>941396</id>
  <title>Research on Coping with Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941396</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>917295</term_id>
  <id>941591</id>
  <title>Resources for Caregivers</title>
  <langcode>en</langcode>
  <field_short_title>Resources for Caregivers</field_short_title>
  <field_page_description>Information to help you care for the cancer patient in your life and take care of yourself, as well as general information about cancer and the latest cancer research.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941591</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>917301</term_id>
  <id>941619</id>
  <title>Resources for Industry</title>
  <langcode>en</langcode>
  <field_short_title>Resources for Industry</field_short_title>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941619</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>951268</term_id>
  <id>951269</id>
  <title>Scientific Meetings and Lectures</title>
  <langcode>en</langcode>
  <field_short_title>Scientific Meetings and Lectures</field_short_title>
  <field_page_description>Scientific meetings and lectures hosted at NCI.</field_page_description>
  <field_date_posted>2015-05-06</field_date_posted>
  <field_date_reviewed>2015-05-06</field_date_reviewed>
  <para_id>951269</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11908</term_id>
  <id>14581</id>
  <title>Gallbladder Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Gallbladder Cancer </field_short_title>
  <field_page_description>Gallbladder cancer is a rare cancer that is usually diagnosed late due a to lack of early signs and symptoms. It is sometimes found when the gallbladder is checked for gallstones or removed. Start here to find information on gallbladder cancer treatment.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14581</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>11888</term_id>
  <id>14587</id>
  <title>Cancers by Body Location/System</title>
  <langcode>en</langcode>
  <field_short_title>Cancers by Body Location/System</field_short_title>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2010-07-09</field_date_reviewed>
  <para_id>14587</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11958</term_id>
  <id>14938</id>
  <title>Skin Cancer (Including Melanoma)—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Skin Cancer </field_short_title>
  <field_page_description>Skin cancer is the most common type of cancer. The main types of skin cancer are squamous cell carcinoma, basal cell carcinoma, and melanoma. Most deaths from skin cancer are caused by melanoma. Start here to find information on skin cancer treatment, causes and prevention, screening, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14938</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938410</term_id>
  <id>15059</id>
  <title>PDQ&amp;reg; Editorial Boards</title>
  <langcode>en</langcode>
  <field_short_title>Editorial Boards</field_short_title>
  <field_page_description>Description About the PDQ Editorial Boards</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>15059</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911116</term_id>
  <id>15185</id>
  <title>Calcium and Cancer Prevention</title>
  <langcode>en</langcode>
  <field_short_title>Calcium and Cancer Prevention</field_short_title>
  <field_page_description>A fact sheet that summarizes the results of studies on calcium and cancer prevention.  It includes information about dietary recommendations for calcium.</field_page_description>
  <field_date_posted>2009-05-04</field_date_posted>
  <field_date_reviewed>2009-05-04</field_date_reviewed>
  <field_pretty_url>calcium-fact-sheet</field_pretty_url>
  <para_id>15185</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>488281</id>
  <title>When Your Parent Has Cancer: A Guide for Teens</title>
  <langcode>en</langcode>
  <field_short_title>When Your Parent Has Cancer: A Guide for Teens</field_short_title>
  <field_page_description>Help for teens whose mom or dad has cancer. Learn how families cope and find support when a parent has cancer. Tips to help you talk with your friends, deal with stress, and take care of your mind and body are also shared.</field_page_description>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2013-01-10</field_date_reviewed>
  <field_pretty_url>when-your-parent-has-cancer</field_pretty_url>
  <para_id>488281</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>12612</term_id>
  <id>505627</id>
  <title>Policies</title>
  <langcode>en</langcode>
  <field_short_title>Policies</field_short_title>
  <field_page_description>Learn about the policies governing the National Cancer Institute’s website, including accessibility, comments, privacy and security, reuse of graphics and text, and more.</field_page_description>
  <field_date_posted>2013-02-05</field_date_posted>
  <field_date_reviewed>2013-02-05</field_date_reviewed>
  <para_id>505627</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>505619</term_id>
  <id>505754</id>
  <title>Reuse of NCI Information</title>
  <langcode>en</langcode>
  <field_short_title>Reuse of NCI Information</field_short_title>
  <field_page_description>Find information about use of NCI information, registered trademarks, and copyrighted material.</field_page_description>
  <field_date_posted>2013-02-05</field_date_posted>
  <field_date_reviewed>2018-05-08</field_date_reviewed>
  <para_id>505754</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>505621</term_id>
  <id>505756</id>
  <title>Freedom of Information Act</title>
  <langcode>en</langcode>
  <field_short_title>Freedom of Information Act</field_short_title>
  <field_page_description>Learn about the Freedom of Information Act (FOIA) and how it provides  individuals with a right to access information in the possession of the U.S. federal government. </field_page_description>
  <field_date_posted>2013-02-05</field_date_posted>
  <field_date_reviewed>2018-04-05</field_date_reviewed>
  <para_id>505756</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>506205</id>
  <title>Bevacizumab significantly improves survival for patients with recurrent and metastatic cervical cancer </title>
  <langcode>en</langcode>
  <field_short_title>Bevacizumab improves survival for patients with advanced cervical cancer </field_short_title>
  <field_page_description>Patients with advanced, recurrent, or persistent cervical cancer that was not curable with standard treatment who received the drug bevacizumab (Avastin) lived 3.7 months longer than patients who did not receive the drug, according to an interim analysis </field_page_description>
  <field_date_posted>2013-02-07</field_date_posted>
  <field_date_reviewed>2013-02-07</field_date_reviewed>
  <field_pretty_url>GOG240</field_pretty_url>
  <para_id>506205</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>929892</term_id>
  <id>929896</id>
  <title>PDQ&amp;reg; Levels of Evidence</title>
  <langcode>en</langcode>
  <field_short_title>Levels of Evidence</field_short_title>
  <field_date_posted>2015-04-16</field_date_posted>
  <field_date_reviewed>2015-04-07</field_date_reviewed>
  <para_id>929896</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>930032</id>
  <title>Turning Evidence into Practice</title>
  <langcode>en</langcode>
  <field_short_title>Turning Evidence into Practice</field_short_title>
  <field_date_posted>2015-04-08</field_date_posted>
  <field_date_reviewed>2015-04-08</field_date_reviewed>
  <field_pretty_url>symposium-global-research</field_pretty_url>
  <para_id>930032</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>936162</id>
  <title>Advancing Cancer Care Delivery Research in the Next Decade</title>
  <langcode>en</langcode>
  <field_short_title>Advancing Cancer Care Delivery Research in the Next Decade</field_short_title>
  <field_page_description>NCI’s new Healthcare Delivery Research Program (HDRP) will focus on advancing the science of cancer care delivery in ways that improve survival and enhance patient care experiences.</field_page_description>
  <field_date_posted>2015-04-14</field_date_posted>
  <field_date_reviewed>2015-04-14</field_date_reviewed>
  <field_pretty_url>advancing-care-delivery</field_pretty_url>
  <para_id>936162</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>936262</id>
  <title>2014 Press Releases</title>
  <langcode>en</langcode>
  <field_short_title>2014 Press Releases</field_short_title>
  <field_page_description>Press releases from the National Cancer Institute for the year 2014.</field_page_description>
  <field_date_posted>2015-04-15</field_date_posted>
  <field_date_reviewed>2015-04-15</field_date_reviewed>
  <para_id>936262</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>936441</id>
  <title>Grantee Spotlight: Julie Dang, M.P.H. - Personalizing Outreach to Address Asian Cancer Health Disparities </title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Julie Dang, M.P.H.</field_short_title>
  <field_date_posted>2014-05-15</field_date_posted>
  <field_date_reviewed>2014-05-15</field_date_reviewed>
  <field_pretty_url>dang-spotlight</field_pretty_url>
  <para_id>936441</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>936592</id>
  <title>A higher than expected fraction of adolescent osteosarcoma patients carry a gene mutation that is often inherited </title>
  <langcode>en</langcode>
  <field_short_title>A higher than expected fraction of adolescent osteosarcoma patients carry a gene mutation</field_short_title>
  <field_page_description>A new study shows that inherited variations in a known tumor suppressor gene among children and adolescents with osteosarcoma, a cancer of the bone, are more common than previously thought.</field_page_description>
  <field_date_posted>2015-04-20</field_date_posted>
  <field_date_reviewed>2015-04-16</field_date_reviewed>
  <field_pretty_url>osteosarcoma-tp53-inherited-gene-mutation-adolescents</field_pretty_url>
  <para_id>936592</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>937991</id>
  <title>Grantee Spotlight: Nathan Ellis, Ph.D. Seeks Molecular Basis of Colorectal Cancer Disparities in African Americans </title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Nathan Ellis, Ph.D.</field_short_title>
  <field_date_posted>2014-03-28</field_date_posted>
  <field_date_reviewed>2014-03-28</field_date_reviewed>
  <field_pretty_url>ellis-spotlight</field_pretty_url>
  <para_id>937991</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>939817</term_id>
  <id>939824</id>
  <title>Anal Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Anal Cancer</field_short_title>
  <field_page_description>Anal cancer is a rare malignancy and accounts for a small percentage of cancers of the lower alimentary tract. The most common type of anal cancer is squamous cell carcinoma in the anal canal. Find evidence-based information on anal cancer treatment, causes and prevention, research, and statistics.</field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-04-30</field_date_reviewed>
  <para_id>939824</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938026</term_id>
  <id>940035</id>
  <title>Cervical Cancer  Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on cervical cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-04-30</field_date_reviewed>
  <para_id>940035</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940199</term_id>
  <id>940204</id>
  <title>Gallbladder Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Gallbladder Cancer </field_short_title>
  <field_page_description>Cancer that arises in the gallbladder is uncommon. Almost all gallbladder cancers are adenocarcinomas. The most common symptoms caused by gallbladder cancer are jaundice, pain, and fever. Find evidence-based information on gallbladder cancer treatment.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940204</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>940315</term_id>
  <id>940323</id>
  <title>Head and Neck Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on head and neck cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940323</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940375</term_id>
  <id>940382</id>
  <title>Kidney (Renal Cell) Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Kidney Cancer </field_short_title>
  <field_page_description>Kidney cancer has three main types. Renal cell cancer, or renal cell adenocarcinoma, forms in the tubules of the kidney. Transitional cell carcinoma forms in the renal pelvis and ureter. Wilms tumors are common in children. Find evidence-based information on kidney cancer treatment, research, genetics, and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940382</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911142</term_id>
  <id>14676</id>
  <title>Menopausal Hormone Therapy and Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Menopausal Hormone Therapy and Cancer</field_short_title>
  <field_page_description>A fact sheet about the results of research on menopausal hormone therapy (MHT). Includes information about the effect of MHT on the body and benefits and risks of using menopausal hormones.</field_page_description>
  <field_date_posted>2011-12-05</field_date_posted>
  <field_date_reviewed>2018-07-17</field_date_reviewed>
  <field_pretty_url>mht-fact-sheet</field_pretty_url>
  <para_id>14676</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>939391</term_id>
  <id>14798</id>
  <title>PDQ&amp;reg; - NCI's Comprehensive Database</title>
  <langcode>en</langcode>
  <field_short_title>PDQ&amp;reg; </field_short_title>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14798</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>952681</term_id>
  <id>15008</id>
  <title>PDQ&amp;reg; Screening and Prevention Editorial Board</title>
  <langcode>en</langcode>
  <field_short_title>Screening &amp;amp; Prevention Editorial Board</field_short_title>
  <field_date_posted>2002-05-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>15008</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>505617</term_id>
  <id>505759</id>
  <title>Website Linking Policy</title>
  <langcode>en</langcode>
  <field_short_title>Website Linking</field_short_title>
  <field_page_description>Learn about linking to the website of the National Cancer Institute (NCI) and about NCI's policy for links on its site.</field_page_description>
  <field_date_posted>2013-02-05</field_date_posted>
  <field_date_reviewed>2018-04-05</field_date_reviewed>
  <para_id>505759</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>530168</id>
  <title>Drugs Approved for Soft Tissue Sarcoma</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Soft Tissue Sarcoma</field_short_title>
  <field_date_posted>2013-03-13</field_date_posted>
  <field_date_reviewed>2013-03-08</field_date_reviewed>
  <field_pretty_url>soft-tissue-sarcoma</field_pretty_url>
  <para_id>530168</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>538205</id>
  <title>Ten Years of Tamoxifen Reduces Breast Cancer Recurrences, Improves Survival</title>
  <langcode>en</langcode>
  <field_short_title>Ten Years of Tamoxifen Reduces Breast Cancer Recurrences, Improves Survival</field_short_title>
  <field_page_description>Taking adjuvant tamoxifen for 10 years after primary treatment leads to a greater reduction in breast cancer recurrences and deaths than taking the drug for only 5 years, according to the results of a large international clinical trial.</field_page_description>
  <field_date_posted>2013-03-20</field_date_posted>
  <field_date_reviewed>2013-03-20</field_date_reviewed>
  <field_pretty_url>10-years-tamoxifen</field_pretty_url>
  <para_id>538205</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>546310</id>
  <title>Cancer immunotherapy in children: How does it differ from approaches in adults?</title>
  <langcode>en</langcode>
  <field_short_title>Cancer immunotherapy in children</field_short_title>
  <field_page_description>More often than not, cancer immunotherapies that work in adults are used in modified ways in children.  Seldom are new therapies developed just for children, primarily because of the small number of pediatric patients relative to the adult cancer patient </field_page_description>
  <field_date_posted>2013-04-08</field_date_posted>
  <field_date_reviewed>2013-04-04</field_date_reviewed>
  <field_pretty_url>PediatricImmunotherapy</field_pretty_url>
  <para_id>546310</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938231</term_id>
  <id>953384</id>
  <title>Research on Childhood Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Research on Childhood Cancers</field_short_title>
  <field_page_description>Find research articles on childhood cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-13</field_date_posted>
  <field_date_reviewed>2015-05-13</field_date_reviewed>
  <para_id>953384</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>954351</id>
  <title>Grantee Spotlight: Monica Baskin, Ph.D. - Studying Weight Loss for Cancer Prevention in African-American Women</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Monica Baskin, Ph.D. - Studying Weight Loss for Cancer Prevention</field_short_title>
  <field_date_posted>2015-05-15</field_date_posted>
  <field_date_reviewed>2015-05-15</field_date_reviewed>
  <field_pretty_url>baskin-spotlight</field_pretty_url>
  <para_id>954351</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>961751</id>
  <title>Most American Adults Do Not Use Sunscreen Regularly </title>
  <langcode>en</langcode>
  <field_short_title>American Adults Not Using Sunscreen</field_short_title>
  <field_date_posted>2015-06-01</field_date_posted>
  <field_date_reviewed>2015-05-29</field_date_reviewed>
  <field_pretty_url>no-sunscreen</field_pretty_url>
  <para_id>961751</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>962799</id>
  <title>Benefit of fewer than three doses of HPV vaccine reported</title>
  <langcode>en</langcode>
  <field_short_title>Fewer than 3 doses of HPV vaccine found beneficial</field_short_title>
  <field_date_posted>2015-06-10</field_date_posted>
  <field_date_reviewed>2015-06-02</field_date_reviewed>
  <field_pretty_url>fewer-doses-hpv-vaccine</field_pretty_url>
  <para_id>962799</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>962982</id>
  <title>International Partnerships for Clinical Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>International Partnerships for Clinical Cancer Research</field_short_title>
  <field_date_posted>2015-06-03</field_date_posted>
  <field_date_reviewed>2015-06-03</field_date_reviewed>
  <field_pretty_url>clinicalcancerresearch</field_pretty_url>
  <para_id>962982</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>963867</id>
  <title>Study Finds Storytelling Helps Overcome Cervical Cancer Screening Disparities</title>
  <langcode>en</langcode>
  <field_short_title>Storytelling Helps Overcome Cervical Cancer Screening Disparities</field_short_title>
  <field_date_posted>2015-06-10</field_date_posted>
  <field_date_reviewed>2015-06-10</field_date_reviewed>
  <field_pretty_url>cervical-screening-narrative-video</field_pretty_url>
  <para_id>963867</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>768744</term_id>
  <id>966541</id>
  <title>Teleconference Summary: NCI Clinical Trials Systems</title>
  <langcode>en</langcode>
  <field_short_title>Teleconference Summary: NCI Clinical Trials Systems</field_short_title>
  <field_date_posted>2015-06-12</field_date_posted>
  <field_date_reviewed>2015-06-12</field_date_reviewed>
  <field_pretty_url>clinical-trials-teleconference</field_pretty_url>
  <para_id>966541</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>969704</term_id>
  <id>969705</id>
  <title>Most Recent Reported Fiscal Year Budget</title>
  <langcode>en</langcode>
  <field_short_title>Recent Fiscal Year Budget</field_short_title>
  <field_page_description>See NCI obligations resulting from appropriated and reimbursable funding for the recently reported fiscal year.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-06-24</field_date_reviewed>
  <para_id>969705</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940546</term_id>
  <id>940553</id>
  <title>Lymphoma—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Lymphoma </field_short_title>
  <field_page_description>Lymphoma refers to cancers that form in the lymphatic system, including Hodgkin lymphoma, non-Hodgkin lymphoma, AIDS-related lymphoma, and primary CNS lymphoma. Find evidence-based information on lymphoma treatment, research, genomics, and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940553</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938103</term_id>
  <id>940554</id>
  <title>Lymphoma Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on lymphoma, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940554</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938135</term_id>
  <id>940746</id>
  <title>Pancreatic Cancer Research Results and Study Updates</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on pancreatic cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940746</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>915376</term_id>
  <id>941393</id>
  <title>Screening Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941393</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>11884</term_id>
  <id>941586</id>
  <title>Clinical Trials to Treat Brain Tumors</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trials to Treat Brain Tumors</field_short_title>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <field_pretty_url>clinical-trials</field_pretty_url>
  <para_id>941586</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>903752</term_id>
  <id>14293</id>
  <title>Pathology Reports</title>
  <langcode>en</langcode>
  <field_short_title>Pathology Reports</field_short_title>
  <field_page_description>A fact sheet describing the information found in a pathology report, the document that contains results of the examination of tissue removed during biopsy or surgery.</field_page_description>
  <field_date_posted>2007-12-06</field_date_posted>
  <field_date_reviewed>2010-09-23</field_date_reviewed>
  <field_pretty_url>pathology-reports-fact-sheet</field_pretty_url>
  <para_id>14293</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911291</term_id>
  <id>14564</id>
  <title>Secondhand Smoke and Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Secondhand Smoke and Cancer</field_short_title>
  <field_page_description>A fact sheet that summarizes the studies on the health effects of exposure to environmental (secondhand) tobacco smoke.</field_page_description>
  <field_date_posted>2018-12-10</field_date_posted>
  <field_date_reviewed>2018-12-04</field_date_reviewed>
  <field_pretty_url>second-hand-smoke-fact-sheet</field_pretty_url>
  <para_id>14564</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>914480</term_id>
  <id>14778</id>
  <title>Lymphoma—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Lymphoma</field_short_title>
  <field_page_description>Lymphoma is cancer that begins in cells of the lymph system. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). Hodgkin lymphoma can often be cured. The prognosis of NHL depends on the specific type. Start here to find information about lymphoma treatment, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14778</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>916790</term_id>
  <id>14824</id>
  <title>Research Funding Opportunities</title>
  <langcode>en</langcode>
  <field_short_title>Research Funding Opportunities</field_short_title>
  <field_page_description>Find a wide range of funding announcements to support cancer research and training, organized by topic and by funding mechanism.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14824</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>929549</term_id>
  <id>14890</id>
  <title>The Genetics of Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Genetics</field_short_title>
  <field_page_description>Information about genetic changes, how they may be inherited or acquired during a person's life, how they can increase cancer risk, and genetic testing for mutations.</field_page_description>
  <field_date_posted>2015-04-22</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14890</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11976</term_id>
  <id>15005</id>
  <title>Carcinoma of Unknown Primary—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Carcinoma of Unknown Primary</field_short_title>
  <field_page_description>Carcinoma of unknown primary (CUP) occurs when cancer cells have spread in the body and formed metastatic tumors but the site of the primary cancer is not known. There are a number of reasons why the primary cancer may not be found. Start here to find treatment information for carcinoma of unknown primary.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>15005</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>911145</term_id>
  <id>15113</id>
  <title>Obesity</title>
  <langcode>en</langcode>
  <field_short_title>Obesity</field_short_title>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>15113</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>917500</term_id>
  <id>15132</id>
  <title>Complementary and Alternative Medicine</title>
  <langcode>en</langcode>
  <field_short_title>Complementary and Alternative Medicine</field_short_title>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>15132</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>505751</id>
  <title>Refining Post-Surgical Therapy for Women with Lymph Node-Positive Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Refining Post-Surgical Therapy for Women with Lymph Node-Positive Breast Cancer</field_short_title>
  <field_page_description>In this trial, women with HER2-negative, HR-positive breast cancer and 1-3 positive lymph nodes with recurrence scores of 25 or lower will be randomized to undergo adjuvant chemotherapy before starting endocrine therapy or to begin endocrine therapy.</field_page_description>
  <field_date_posted>2013-02-05</field_date_posted>
  <field_date_reviewed>2013-02-05</field_date_reviewed>
  <field_pretty_url>post-surgical-therapy</field_pretty_url>
  <para_id>505751</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>505623</term_id>
  <id>505757</id>
  <title>Comment Policy</title>
  <langcode>en</langcode>
  <field_short_title>Comment Policy</field_short_title>
  <field_page_description>Learn the policy about how comments are managed on National Cancer Institute websites.</field_page_description>
  <field_date_posted>2013-02-05</field_date_posted>
  <field_date_reviewed>2018-04-05</field_date_reviewed>
  <para_id>505757</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>506116</id>
  <title>NCI study finds that sunitinib benefits patients with renal cell carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>Sunitinib benefits patients with renal cell carcinoma</field_short_title>
  <field_page_description>Findings from clinical trial patients with metastatic renal cell carcinoma, a common kidney cancer, show they did not have accelerated tumor growth after treatment with sunitinib, in contrast to some study results in animals. </field_page_description>
  <field_date_posted>2013-02-07</field_date_posted>
  <field_date_reviewed>2013-02-06</field_date_reviewed>
  <field_pretty_url>sunitinib</field_pretty_url>
  <para_id>506116</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>530170</id>
  <title>Drugs Approved for Gastrointestinal Stromal Tumors</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Gastrointestinal Stromal Tumors</field_short_title>
  <field_date_posted>2013-03-08</field_date_posted>
  <field_date_reviewed>2013-03-08</field_date_reviewed>
  <field_pretty_url>gist</field_pretty_url>
  <para_id>530170</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>547099</id>
  <title>A tumor suppressor is identified as an inhibitor of inflammatory pathways</title>
  <langcode>en</langcode>
  <field_short_title>Tumor suppressor identified as inhibitor of inflammation </field_short_title>
  <field_page_description>Scientists at NCI have found that a protein, FBXW7, which acts as a tumor suppressor, is also important for the reduction in strength of inflammatory pathways. It has long been recognized that a complex interaction exists between cancer causing mechanisms</field_page_description>
  <field_date_posted>2013-04-09</field_date_posted>
  <field_date_reviewed>2013-04-05</field_date_reviewed>
  <field_pretty_url>FBXW7</field_pretty_url>
  <para_id>547099</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>904030</term_id>
  <id>962800</id>
  <title>Jonathan S. Wiest, Ph.D.</title>
  <langcode>en</langcode>
  <field_short_title>Jonathan S. Wiest, Ph.D.</field_short_title>
  <field_date_posted>2015-06-02</field_date_posted>
  <field_date_reviewed>2015-06-02</field_date_reviewed>
  <field_pretty_url>wiest-bio</field_pretty_url>
  <para_id>962800</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>963862</id>
  <title>Better Care for Children with Cancer Linked to Longer Lifespans</title>
  <langcode>en</langcode>
  <field_short_title>Childhood Cancer Survivors Are Living Longer</field_short_title>
  <field_date_posted>2015-06-11</field_date_posted>
  <field_date_reviewed>2015-06-11</field_date_reviewed>
  <field_pretty_url>longer-childhood-survivor-lifespans</field_pretty_url>
  <para_id>963862</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>969907</term_id>
  <id>969908</id>
  <title>Special Sources of Funds</title>
  <langcode>en</langcode>
  <field_short_title>Special Sources of Funds</field_short_title>
  <field_page_description>Find details about Cooperative Research and Development Agreements (CRADAs) and other special funding sources, including the Stamp Out Breast Cancer Act. </field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-06-24</field_date_reviewed>
  <para_id>969908</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>974642</id>
  <title>Next Round of Grant Solicitations for Provocative Questions Announced</title>
  <langcode>en</langcode>
  <field_short_title>Next Round of Grant Solicitations for Provocative Questions Announced</field_short_title>
  <field_date_posted>2015-07-10</field_date_posted>
  <field_date_reviewed>2015-07-09</field_date_reviewed>
  <field_pretty_url>provocative-questions-new</field_pretty_url>
  <para_id>974642</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>976521</id>
  <title>Pancreatic Cancer Study Finds Possible Diagnostic Marker in Blood</title>
  <langcode>en</langcode>
  <field_short_title>Possible Diagnostic Marker for Pancreatic Cancer</field_short_title>
  <field_date_posted>2015-07-15</field_date_posted>
  <field_date_reviewed>2015-07-14</field_date_reviewed>
  <field_pretty_url>pancreatic-exosomes</field_pretty_url>
  <para_id>976521</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>976983</id>
  <title>Oncolytic Virus Therapy Shows Benefit in Patients with Melanoma</title>
  <langcode>en</langcode>
  <field_short_title>Oncolytic Virus Therapy Shows Benefit in Patients with Melanoma</field_short_title>
  <field_date_posted>2015-07-21</field_date_posted>
  <field_date_reviewed>2015-07-16</field_date_reviewed>
  <field_pretty_url>oncolyticvirus-melanoma</field_pretty_url>
  <para_id>976983</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>978894</term_id>
  <id>978895</id>
  <title>RAS Lab Discussion Forum</title>
  <langcode>en</langcode>
  <field_short_title>RAS Lab Discussion Forum</field_short_title>
  <field_date_posted>2015-07-21</field_date_posted>
  <field_date_reviewed>2015-07-21</field_date_reviewed>
  <para_id>978895</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>981114</term_id>
  <id>980954</id>
  <title>Cancer Research in the Media: International Workshop for Scientific Journalism</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Research in the Media</field_short_title>
  <field_date_posted>2015-07-27</field_date_posted>
  <field_date_reviewed>2015-07-27</field_date_reviewed>
  <para_id>980954</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>987523</id>
  <title>U.S. and Peru Formalize Alliance in Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>U.S. and Peru Formalize Alliance in Cancer Research</field_short_title>
  <field_date_posted>2015-08-20</field_date_posted>
  <field_date_reviewed>2015-08-20</field_date_reviewed>
  <field_pretty_url>peru-signing</field_pretty_url>
  <para_id>987523</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069530</term_id>
  <id>988292</id>
  <title>Taking Food Away: Targeting Nutrient Scavenging by RAS-driven Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Taking Food Away: Targeting Nutrient Scavenging by RAS-driven Cancers</field_short_title>
  <field_date_posted>2015-08-25</field_date_posted>
  <field_date_reviewed>2015-08-25</field_date_reviewed>
  <field_pretty_url>targeting-nutrient-scavenging</field_pretty_url>
  <para_id>988292</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>988377</term_id>
  <id>988378</id>
  <title>Division of Cancer Biology</title>
  <langcode>en</langcode>
  <field_short_title>Division of Cancer Biology</field_short_title>
  <field_page_description>DCB supports a broad range of investigator-initiated research in its mission to facilitate existing and emerging research areas in basic cancer biology.</field_page_description>
  <field_date_posted>2016-08-08</field_date_posted>
  <field_date_reviewed>2015-08-26</field_date_reviewed>
  <para_id>988378</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>989416</id>
  <title>Anyone Can Get Skin Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Anyone Can Get Skin Cancer</field_short_title>
  <field_date_posted>2015-09-01</field_date_posted>
  <field_date_reviewed>2015-09-01</field_date_reviewed>
  <field_pretty_url>anyone-can-get-skin-cancer</field_pretty_url>
  <para_id>989416</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>912173</id>
  <title>FDA Approves Lenvatinib for Radioactive Iodine-Refractory Thyroid Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Lenvatinib for Radioactive Iodine-Refractory Thyroid Cancer</field_short_title>
  <field_page_description>The FDA has approved lenvatinib (Lenvima) to treat some patients with the most common type of thyroid cancer.</field_page_description>
  <field_date_posted>2015-03-02</field_date_posted>
  <field_date_reviewed>2015-03-02</field_date_reviewed>
  <field_pretty_url>fda-approves-lenvima</field_pretty_url>
  <para_id>912173</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>914470</id>
  <title>Conference Report: Pursuing Progress Against HIV-Related Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Conference Report: Pursuing Progress Against HIV-Related Cancers</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post on the recent annual Conference on Retroviruses and Opportunistic Infections, where investigators presented important new findings on HIV-related cancers.</field_page_description>
  <field_date_posted>2015-03-09</field_date_posted>
  <field_date_reviewed>2015-03-09</field_date_reviewed>
  <field_pretty_url>conference-report-hiv</field_pretty_url>
  <para_id>914470</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>914806</term_id>
  <id>915261</id>
  <title>Introduction to the Grants Process</title>
  <langcode>en</langcode>
  <field_short_title>Introduction to Grants Process</field_short_title>
  <field_page_description>Information about the NCI grants process, including recipient eligibility, the different people involved, and information about funding.</field_page_description>
  <field_date_posted>2015-04-02</field_date_posted>
  <field_date_reviewed>2015-03-12</field_date_reviewed>
  <para_id>915261</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915355</term_id>
  <id>915356</id>
  <title>Age and Cancer Risk</title>
  <langcode>en</langcode>
  <field_short_title>Age</field_short_title>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915356</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>911172</term_id>
  <id>915359</id>
  <title>Infectious Agents</title>
  <langcode>en</langcode>
  <field_short_title>Infectious Agents</field_short_title>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915359</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915634</term_id>
  <id>915680</id>
  <title>Cancer Treatment Research</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Treatment Research</field_short_title>
  <field_date_posted>2015-05-07</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915680</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069530</term_id>
  <id>916489</id>
  <title>More Evidence That a Wild-Type KRAS Allele Plays a Role in Cancer</title>
  <langcode>en</langcode>
  <field_short_title>More Evidence That a Wild-Type KRAS Allele Plays a Role in Cancer</field_short_title>
  <field_date_posted>2015-03-16</field_date_posted>
  <field_date_reviewed>2015-03-16</field_date_reviewed>
  <field_pretty_url>kras-allele</field_pretty_url>
  <para_id>916489</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>916659</id>
  <title>Grantee Spotlight: Katherine Briant, MPH, CHES - Bridging Community Cancer Education Efforts with Health Disparities Research</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Katherine Briant, MPH, CHES</field_short_title>
  <field_date_posted>2014-08-22</field_date_posted>
  <field_date_reviewed>2014-08-22</field_date_reviewed>
  <field_pretty_url>briant-spotlight-blog</field_pretty_url>
  <para_id>916659</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917006</term_id>
  <id>917210</id>
  <title>CTRP System Access and Training</title>
  <langcode>en</langcode>
  <field_short_title>CTRP System Access and Training</field_short_title>
  <field_page_description>Find Clinical Trials Reporting Program (CTRP) user guides, resources, and contact information.</field_page_description>
  <field_date_posted>2015-03-17</field_date_posted>
  <field_date_reviewed>2015-03-17</field_date_reviewed>
  <para_id>917210</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>882432</term_id>
  <id>15302</id>
  <title>Radon and Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Radon and Cancer</field_short_title>
  <field_page_description>A fact sheet about radon, an odorless radioactive gas, and its possible association with cancer, and how to test for radon in the home.</field_page_description>
  <field_date_posted>2011-12-06</field_date_posted>
  <field_date_reviewed>2011-12-06</field_date_reviewed>
  <field_pretty_url>radon-fact-sheet</field_pretty_url>
  <para_id>15302</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11882</term_id>
  <id>15577</id>
  <title>Bone Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Bone Cancer</field_short_title>
  <field_page_description>Bone cancer is rare and includes several types. Some bone cancers, including osteosarcoma and Ewing sarcoma, are seen most often in children and young adults. Start here to find information on bone cancer treatment, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>15577</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>906093</term_id>
  <id>15646</id>
  <title>Sentinel Lymph Node Biopsy</title>
  <langcode>en</langcode>
  <field_short_title>Sentinel Lymph Node Biopsy</field_short_title>
  <field_page_description>A fact sheet that describes the sentinel lymph node biopsy procedure and details two clinical trials evaluating the effectiveness of this procedure.</field_page_description>
  <field_date_posted>2011-08-11</field_date_posted>
  <field_date_reviewed>2011-08-11</field_date_reviewed>
  <field_pretty_url>sentinel-node-biopsy-fact-sheet</field_pretty_url>
  <para_id>15646</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>929549</term_id>
  <id>15684</id>
  <title>BRCA Mutations: Cancer Risk and Genetic Testing</title>
  <langcode>en</langcode>
  <field_short_title>BRCA Mutations: Cancer Risk &amp; Genetic Testing</field_short_title>
  <field_page_description>A fact sheet about the BRCA1 and BRCA2 genes, what to do if a person tests positive for alterations in one of these genes, and consequences of genetic testing.</field_page_description>
  <field_date_posted>2018-02-05</field_date_posted>
  <field_date_reviewed>2018-01-30</field_date_reviewed>
  <field_pretty_url>brca-fact-sheet</field_pretty_url>
  <para_id>15684</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11904</term_id>
  <id>15711</id>
  <title>Extracranial Germ Cell Tumors—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Extracranial Germ Cell Tumors</field_short_title>
  <field_page_description>Extracranial germ cell tumors are tumors that develop from germ cells (fetal cells that give rise to sperm and eggs) and can form in many parts of the body. They are most common in teenagers and can often be cured. Start here to find information on extracranial germ cell tumors treatment.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>15711</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>994198</id>
  <title>Intraperitoneal Chemotherapy in Advanced Ovarian Cancer Improves Survival, But Is Underused</title>
  <langcode>en</langcode>
  <field_short_title>IP Chemo for Ovarian Cancer is Underused</field_short_title>
  <field_date_posted>2015-09-04</field_date_posted>
  <field_date_reviewed>2015-09-03</field_date_reviewed>
  <field_pretty_url>IP-Chemo</field_pretty_url>
  <para_id>994198</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>608323</term_id>
  <id>1001477</id>
  <title>The Biology of Cancer Health Disparities</title>
  <langcode>en</langcode>
  <field_short_title>The Biology of Cancer Health Disparities</field_short_title>
  <field_page_description>These examples show how biology contributes to health disparities (differences in disease incidence and outcomes among distinct racial and ethnic groups, ), and how biological factors interact with other relevant factors, such as diet and the environment.</field_page_description>
  <field_date_posted>2015-09-11</field_date_posted>
  <field_date_reviewed>2015-09-11</field_date_reviewed>
  <field_pretty_url>biology-cancer-health-disparities</field_pretty_url>
  <para_id>1001477</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1052661</term_id>
  <id>1002084</id>
  <title>About the Genomic Data Sharing (GDS) Policy</title>
  <langcode>en</langcode>
  <field_short_title>About the GDS Policy</field_short_title>
  <field_page_description>Find helpful information about the GDS Policy, including when the policy applies, example projects, and providing informed consent.</field_page_description>
  <field_date_posted>2015-10-22</field_date_posted>
  <field_date_reviewed>2015-09-15</field_date_reviewed>
  <para_id>1002084</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1004619</id>
  <title>"Fine Tuning" Engineered T Cells May Extend Immunotherapy Approach to More Cancer Types</title>
  <langcode>en</langcode>
  <field_short_title>Expanding Immunotherapy to More Cancer Types</field_short_title>
  <field_date_posted>2015-09-28</field_date_posted>
  <field_date_reviewed>2015-09-23</field_date_reviewed>
  <field_pretty_url>finetuned-tcells</field_pretty_url>
  <para_id>1004619</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1126285</term_id>
  <id>1004649</id>
  <title>NCI at APHA 2018</title>
  <langcode>en</langcode>
  <field_short_title>APHA 2018</field_short_title>
  <field_date_posted>2018-10-11</field_date_posted>
  <field_date_reviewed>2018-10-11</field_date_reviewed>
  <para_id>1004649</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1015773</id>
  <title>In Triple-Negative Breast Cancer, Targeting an Addiction</title>
  <langcode>en</langcode>
  <field_short_title>In Triple-Negative Breast Cancer, Targeting an Addiction</field_short_title>
  <field_date_posted>2015-10-26</field_date_posted>
  <field_date_reviewed>2015-10-22</field_date_reviewed>
  <field_pretty_url>targeting-transcription</field_pretty_url>
  <para_id>1015773</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1016887</id>
  <title>Study Identifies New Opportunities for Targeted Immunotherapy</title>
  <langcode>en</langcode>
  <field_short_title>Study Identifies New Opportunities for Targeted Immunotherapy</field_short_title>
  <field_page_description>A team of NCI researchers has reported that several types of gastrointestinal cancer have tumor-specific mutations that can be recognized by the immune system, thereby offering a new therapeutic opportunity for patients with these tumors.</field_page_description>
  <field_date_posted>2015-10-29</field_date_posted>
  <field_date_reviewed>2015-10-29</field_date_reviewed>
  <field_pretty_url>tumor-specific-mutations-immunotherapy</field_pretty_url>
  <para_id>1016887</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1023566</term_id>
  <id>1023569</id>
  <title>Precision Medicine in Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Precision Medicine</field_short_title>
  <field_page_description>Precision medicine helps doctors select cancer treatments that are most likely to help patients based on a genetic understanding of their disease. Learn about the promise of precision medicine and the role it plays in cancer treatment.</field_page_description>
  <field_date_posted>2015-11-16</field_date_posted>
  <field_date_reviewed>2015-11-06</field_date_reviewed>
  <para_id>1023569</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>65324</id>
  <title>Drugs Approved for Thyroid Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Thyroid Cancer</field_short_title>
  <field_date_posted>2011-05-04</field_date_posted>
  <field_date_reviewed>2011-03-11</field_date_reviewed>
  <field_pretty_url>thyroid</field_pretty_url>
  <para_id>65324</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>11596</term_id>
  <id>65861</id>
  <title>Education and Training for Health Professionals </title>
  <langcode>en</langcode>
  <field_short_title>Education and Training for Health Professionals </field_short_title>
  <field_page_description>A collection of cancer education and training tools from NCI and NIH for health care providers, public health program planners, and cancer registrars. Courses are available in a variety of formats.</field_page_description>
  <field_date_posted>2011-03-15</field_date_posted>
  <field_date_reviewed>2011-03-15</field_date_reviewed>
  <para_id>65861</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>65902</term_id>
  <id>65947</id>
  <title>Cancer Research Education Grants Program (R25)</title>
  <langcode>en</langcode>
  <field_short_title>NCI R25 Award</field_short_title>
  <field_date_posted>2011-03-18</field_date_posted>
  <field_date_reviewed>2011-03-18</field_date_reviewed>
  <para_id>65947</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>65904</term_id>
  <id>65952</id>
  <title>Cancer Education and Career Development Program (R25T)</title>
  <langcode>en</langcode>
  <field_short_title>NCI R25T Award</field_short_title>
  <field_date_posted>2011-03-18</field_date_posted>
  <field_date_reviewed>2011-03-18</field_date_reviewed>
  <para_id>65952</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1047605</term_id>
  <id>68415</id>
  <title>Mentored Quantitative Research Career Award (K25)</title>
  <langcode>en</langcode>
  <field_short_title>NCI K25 Award</field_short_title>
  <field_date_posted>2011-03-22</field_date_posted>
  <field_date_reviewed>2011-03-22</field_date_reviewed>
  <para_id>68415</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>68506</term_id>
  <id>68514</id>
  <title>Ruth L. Kirschstein NRSA for Senior Fellows (F33)</title>
  <langcode>en</langcode>
  <field_short_title>NCI F33 Award</field_short_title>
  <field_date_posted>2011-03-22</field_date_posted>
  <field_date_reviewed>2011-03-22</field_date_reviewed>
  <para_id>68514</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>68510</term_id>
  <id>68595</id>
  <title>Established  Investigator Award in Cancer Prevention and Control (K05)</title>
  <langcode>en</langcode>
  <field_short_title>NCI K05 Award</field_short_title>
  <field_date_posted>2011-03-22</field_date_posted>
  <field_date_reviewed>2011-03-22</field_date_reviewed>
  <para_id>68595</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>744907</id>
  <title>Statement on Forthcoming Changes in NCI's Clinical Trials Programs</title>
  <langcode>en</langcode>
  <field_short_title>Statement on Forthcoming Changes in NCI's Clinical Trials Programs</field_short_title>
  <field_page_description>Clinical trials are pivotal elements in the conversion of scientific discoveries into practical means to prevent and treat cancers.</field_page_description>
  <field_date_posted>2014-04-04</field_date_posted>
  <field_date_reviewed>2014-04-04</field_date_reviewed>
  <field_pretty_url>NCTNstatement</field_pretty_url>
  <para_id>744907</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>974316</term_id>
  <id>974320</id>
  <title>Grants to NCI-Designated Cancer Centers</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Centers</field_short_title>
  <field_page_description>NCI Cancer Centers develop more effective approaches to prevent, diagnose, and treat cancer. See the number and dollar amount of Cancer Center awards by state.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-07-07</field_date_reviewed>
  <para_id>974320</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>974495</term_id>
  <id>974496</id>
  <title>Research Career Awards “K” Program</title>
  <langcode>en</langcode>
  <field_short_title>Research Career “K” Awards</field_short_title>
  <field_page_description>Career development "K" awards are a significant component of NCI’s training effort. See funding amounts and the percentage of total research career award funding.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-07-07</field_date_reviewed>
  <para_id>974496</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>979441</id>
  <title>Program Spotlight: CURE Scholars Participate in Annual Mock Grant Review to Prepare for Independent Research Careers</title>
  <langcode>en</langcode>
  <field_short_title>Program Spotlight: CURE Scholars Participate in Annual Mock Grant Review</field_short_title>
  <field_date_posted>2015-07-23</field_date_posted>
  <field_date_reviewed>2015-07-23</field_date_reviewed>
  <field_pretty_url>MockReview-2015</field_pretty_url>
  <para_id>979441</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>979474</id>
  <title>Program Spotlight: 2015 Scientific Poster Winners at CRCHD Professional Development Workshop</title>
  <langcode>en</langcode>
  <field_short_title>Program Spotlight: 2015 Scientific Poster Winners</field_short_title>
  <field_date_posted>2015-07-23</field_date_posted>
  <field_date_reviewed>2015-07-23</field_date_reviewed>
  <field_pretty_url>Poster-Winners-2015</field_pretty_url>
  <para_id>979474</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>979827</id>
  <title>U.S. Indoor Tanning Rates Are Dropping, But Still High</title>
  <langcode>en</langcode>
  <field_short_title>U.S. Indoor Tanning Rates Are Dropping, But Still High</field_short_title>
  <field_date_posted>2015-07-24</field_date_posted>
  <field_date_reviewed>2015-07-24</field_date_reviewed>
  <field_pretty_url>indoor-tanning</field_pretty_url>
  <para_id>979827</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>983684</id>
  <title>NCI-Designated Cancer Centers Expand, Four Awarded Comprehensive Designation </title>
  <langcode>en</langcode>
  <field_short_title>NCI-Designated Cancer Centers Expand, Four Awarded Comprehensive Designation </field_short_title>
  <field_page_description>NCI’s cancer centers program added a new institution and awarded the comprehensive designation to four existing NCI-designated centers.</field_page_description>
  <field_date_posted>2015-08-06</field_date_posted>
  <field_date_reviewed>2015-08-06</field_date_reviewed>
  <field_pretty_url>new-cancer-centers</field_pretty_url>
  <para_id>983684</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>983859</id>
  <title>Cellular factors that shape the 3D landscape of the genome identified</title>
  <langcode>en</langcode>
  <field_short_title>Cellular Factors Shape 3D Genome Landscape</field_short_title>
  <field_date_posted>2015-08-13</field_date_posted>
  <field_date_reviewed>2015-08-06</field_date_reviewed>
  <field_pretty_url>cellular-factors-shape-3d-landscape-genome</field_pretty_url>
  <para_id>983859</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>989278</id>
  <title>FDA Approves Sonidegib for Some Patients with Advanced Basal Cell Carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>Sonidegib Approved for Advanced Basal Cell Carcinoma</field_short_title>
  <field_date_posted>2015-09-02</field_date_posted>
  <field_date_reviewed>2015-09-02</field_date_reviewed>
  <field_pretty_url>sonidegib-BCC</field_pretty_url>
  <para_id>989278</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>1002050</id>
  <title>Improving Chronic Disease in the Caribbean through Evidence-based Behavioral and Social Interventions</title>
  <langcode>en</langcode>
  <field_short_title>Improving Chronic Disease in the Caribbean through Evidence-based Behavioral and Social In</field_short_title>
  <field_date_posted>2015-09-15</field_date_posted>
  <field_date_reviewed>2015-09-15</field_date_reviewed>
  <field_pretty_url>chronic_disease</field_pretty_url>
  <para_id>1002050</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1002112</id>
  <title>For Some Children with Cancer, Genomic Information May Help Guide Treatment Decisions</title>
  <langcode>en</langcode>
  <field_short_title>Using Genomic Tools to Analyze Tumors in Children</field_short_title>
  <field_date_posted>2015-09-18</field_date_posted>
  <field_date_reviewed>2015-09-15</field_date_reviewed>
  <field_pretty_url>sequencing-pediatric</field_pretty_url>
  <para_id>1002112</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915352</term_id>
  <id>1004582</id>
  <title>CRISPR: Genome Editing Comes of Age</title>
  <langcode>en</langcode>
  <field_short_title>CRISPR: Genome Editing Comes of Age</field_short_title>
  <field_page_description>A research article about a technique for gene editing known as CRISPR-Cas9. The technique has made it much easier and faster for cancer researchers to study mutations and test new therapeutic targets.</field_page_description>
  <field_date_posted>2015-09-23</field_date_posted>
  <field_date_reviewed>2015-09-23</field_date_reviewed>
  <field_pretty_url>crispr</field_pretty_url>
  <para_id>1004582</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1007348</id>
  <title>Persistence of Genetic Mutations after Chemotherapy Linked to Poor Outcomes in Some Patients with AML</title>
  <langcode>en</langcode>
  <field_short_title>Mutation Persistence after Chemotherapy Linked to Poor Outcomes in AML</field_short_title>
  <field_date_posted>2015-10-02</field_date_posted>
  <field_date_reviewed>2015-09-30</field_date_reviewed>
  <field_pretty_url>aml-mutations</field_pretty_url>
  <para_id>1007348</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>1010970</id>
  <title>TCGA study identifies genomic features of invasive lobular breast carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>Genomic Features of Invasive Lobular Carcinoma</field_short_title>
  <field_date_posted>2015-10-08</field_date_posted>
  <field_date_reviewed>2015-10-06</field_date_reviewed>
  <field_pretty_url>ilc-2015</field_pretty_url>
  <para_id>1010970</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1014606</id>
  <title>New on NCI’s Websites</title>
  <langcode>en</langcode>
  <field_short_title>New on NCI’s Websites</field_short_title>
  <field_page_description>An update about new websites and online content from NCI </field_page_description>
  <field_date_posted>2015-10-16</field_date_posted>
  <field_date_reviewed>2015-10-16</field_date_reviewed>
  <field_pretty_url>new-online-Oct2015</field_pretty_url>
  <para_id>1014606</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1015931</id>
  <title>Bringing Cancer Research to the Public: NCI’s Networks and Programs</title>
  <langcode>en</langcode>
  <field_short_title>Bringing Cancer Research to the Public: NCI’s Networks and Programs</field_short_title>
  <field_date_posted>2015-10-22</field_date_posted>
  <field_date_reviewed>2015-10-22</field_date_reviewed>
  <field_pretty_url>research-to-public</field_pretty_url>
  <para_id>1015931</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127288</term_id>
  <id>57469</id>
  <title>Terminology Resources</title>
  <langcode>en</langcode>
  <field_short_title>Terminology Resources</field_short_title>
  <field_page_description>NCI's reference terminology and related vocabulary resources to help researchers, clinicians, and administrators identify types of cancer, treatments, and other cancer-related topics.</field_page_description>
  <field_date_posted>2011-02-07</field_date_posted>
  <field_date_reviewed>2015-06-12</field_date_reviewed>
  <para_id>57469</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>327700</id>
  <title>NCI scientists image proteins displayed on HIV surface </title>
  <langcode>en</langcode>
  <field_short_title>NCI scientists image proteins displayed on HIV surface </field_short_title>
  <field_page_description>Using a technique called cryo-electron microscopy, researchers NCI have been able to detect shape changes in a protein called Env that is part of HIV</field_page_description>
  <field_date_posted>2012-07-12</field_date_posted>
  <field_date_reviewed>2012-07-12</field_date_reviewed>
  <field_pretty_url>HIVimagingSpikeSubrmaniam</field_pretty_url>
  <para_id>327700</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>420514</term_id>
  <id>420515</id>
  <title>Federal Government Programs</title>
  <langcode>en</langcode>
  <field_short_title>Federal Government Programs</field_short_title>
  <field_date_posted>2012-09-11</field_date_posted>
  <field_date_reviewed>2016-06-22</field_date_reviewed>
  <para_id>420515</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>937976</term_id>
  <id>430360</id>
  <title>Treating KSHV-Associated Multicentric Castleman Disease</title>
  <langcode>en</langcode>
  <field_short_title>Treating KSHV-Associated Multicentric Castleman Disease</field_short_title>
  <field_page_description>In this study, patients with KSHV-associated multicentric Castleman disease will receive IV tocilizumab every other week for up to 12 weeks. Patients who do not benefit may go on to receive high-dose AZT and valganciclovir as well.</field_page_description>
  <field_date_posted>2012-09-18</field_date_posted>
  <field_date_reviewed>2012-09-20</field_date_reviewed>
  <field_pretty_url>kshv-multicentric-castleman-disease</field_pretty_url>
  <para_id>430360</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>463788</id>
  <title>Facing Forward: Life After Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Facing Forward: Life After Cancer Treatment</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2012-11-20</field_date_reviewed>
  <field_pretty_url>facing-forward</field_pretty_url>
  <para_id>463788</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>480964</id>
  <title>Investigators discover new gene that affects clearance of hepatitis C virus</title>
  <langcode>en</langcode>
  <field_short_title>IFNL4 affects clearance of hepatitis C virus</field_short_title>
  <field_page_description>Scientists have discovered a new human interferon gene, Interferon Lambda 4  (IFNL4), that affects clearance of the hepatitis C virus. They also identified an inherited genetic variant within IFNL4 that predicts how people respond to treatment for hepatit</field_page_description>
  <field_date_posted>2013-01-07</field_date_posted>
  <field_date_reviewed>2012-12-26</field_date_reviewed>
  <field_pretty_url>IFNL4affectsclearanceofhepatitisCvirus</field_pretty_url>
  <para_id>480964</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>920598</id>
  <title>FDA Approves First Therapy for High-Risk Neuroblastoma</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves First Therapy for High-Risk Neuroblastoma</field_short_title>
  <field_date_posted>2015-03-27</field_date_posted>
  <field_date_reviewed>2015-03-27</field_date_reviewed>
  <field_pretty_url>dinutuximab-neuroblastoma</field_pretty_url>
  <para_id>920598</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>921989</term_id>
  <id>921990</id>
  <title>Childhood Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Childhood Cancers</field_short_title>
  <field_date_posted>2015-05-13</field_date_posted>
  <field_date_reviewed>2015-03-30</field_date_reviewed>
  <para_id>921990</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>917289</term_id>
  <id>922315</id>
  <title>Resources for Health Professionals</title>
  <langcode>en</langcode>
  <field_short_title>Resources for Health Professionals</field_short_title>
  <field_date_posted>2015-03-31</field_date_posted>
  <field_date_reviewed>2015-03-31</field_date_reviewed>
  <para_id>922315</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>541748</id>
  <title>Mitochondrial chaperones may represent novel targets for developing anti-cancer drugs</title>
  <langcode>en</langcode>
  <field_short_title>Mitochondrial chaperones may be targets for anti-cancer drugs</field_short_title>
  <field_page_description>Scientists at NCI have found that a mitochondrial chaperone protein, TRAP1, may act indirectly as a tumor suppressor as well as a novel target for developing anti-cancer drugs. Chaperone proteins, such as TRAP1, help other proteins adapt to stress, but sc</field_page_description>
  <field_date_posted>2013-04-01</field_date_posted>
  <field_date_reviewed>2013-03-28</field_date_reviewed>
  <field_pretty_url>TRAP1</field_pretty_url>
  <para_id>541748</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>280109</term_id>
  <id>953974</id>
  <title>Digital Standards for NCI Websites and Social Media</title>
  <langcode>en</langcode>
  <field_short_title>NCI Digital Standards</field_short_title>
  <field_page_description>NCI digital standards provide content managers and developers guidance on content standards, visual design and branding, and policies and procedures in effect for NCI digital media. </field_page_description>
  <field_date_posted>2015-05-14</field_date_posted>
  <field_date_reviewed>2015-05-14</field_date_reviewed>
  <para_id>953974</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>770439</term_id>
  <id>770467</id>
  <title>Gynecologic Cancer Steering Committee Roster</title>
  <langcode>en</langcode>
  <field_short_title>Gynecologic Cancer Steering Committee Roster</field_short_title>
  <field_date_posted>2014-05-21</field_date_posted>
  <field_date_reviewed>2014-05-21</field_date_reviewed>
  <field_pretty_url>roster</field_pretty_url>
  <para_id>770467</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>770500</term_id>
  <id>770502</id>
  <title>Leukemia Steering Committee Roster</title>
  <langcode>en</langcode>
  <field_short_title>Leukemia Steering Committee Roster</field_short_title>
  <field_date_posted>2014-05-21</field_date_posted>
  <field_date_reviewed>2014-05-21</field_date_reviewed>
  <field_pretty_url>roster</field_pretty_url>
  <para_id>770502</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>771995</term_id>
  <id>772111</id>
  <title>Myeloma Steering Committee Roster</title>
  <langcode>en</langcode>
  <field_short_title>Myeloma Steering Committee Roster</field_short_title>
  <field_date_posted>2014-05-23</field_date_posted>
  <field_date_reviewed>2014-05-23</field_date_reviewed>
  <field_pretty_url>roster</field_pretty_url>
  <para_id>772111</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>772128</term_id>
  <id>772129</id>
  <title>Patient Advocate Steering Committee</title>
  <langcode>en</langcode>
  <field_short_title>Patient Advocate Steering Committee</field_short_title>
  <field_page_description>The Patient Advocate Steering Committee (PASC) works to ensure advocates involved with the Scientific Steering Committees (SSCs) are completely integrated in the development, implementation, and monitoring of clinical trials within those groups.</field_page_description>
  <field_date_posted>2015-05-23</field_date_posted>
  <field_date_reviewed>2018-04-04</field_date_reviewed>
  <para_id>772129</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894082</term_id>
  <id>1062753</id>
  <title>Program Spotlight: 2016 NCI/CRCHD Professional Development Workshop Scientific Poster Winners</title>
  <langcode>en</langcode>
  <field_short_title>2016 PDW Scientific Poster Winners</field_short_title>
  <field_page_description>Professional Development and Mock Review Workshop 2016, 2016 PDW, Poster Session, Winners </field_page_description>
  <field_date_posted>2016-09-26</field_date_posted>
  <field_date_reviewed>2016-09-26</field_date_reviewed>
  <field_pretty_url>Poster-Winners-2016</field_pretty_url>
  <para_id>1062753</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1062765</id>
  <title>IEEE-NIH 2016 Special Topics Conference on Healthcare Innovations and Point-of-Care Technologies</title>
  <langcode>en</langcode>
  <field_short_title>IEEE-NIH 2016 Special Topics Conference</field_short_title>
  <field_page_description>Institute of Electrical and Electronics Engineers, Incorporated (IEEE)-NIH 2016 Special Topics Conference on Healthcare Innovations and Point-of-Care Technologies</field_page_description>
  <field_date_posted>2016-09-26</field_date_posted>
  <field_date_reviewed>2016-09-26</field_date_reviewed>
  <field_pretty_url>ieee-special-topics-conference</field_pretty_url>
  <para_id>1062765</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1062777</id>
  <title>Many Cancer Caregivers Report Feeling Unprepared for Caregiving Challenges</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Caregivers Feel Unprepared for Some Challenges</field_short_title>
  <field_page_description>An NCI Cancer Currents blog about a new study that showed cancer caregivers play multiple roles and need more information to help their loved ones.  </field_page_description>
  <field_date_posted>2016-09-27</field_date_posted>
  <field_date_reviewed>2016-09-27</field_date_reviewed>
  <field_pretty_url>caregivers-needs-challenges</field_pretty_url>
  <para_id>1062777</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1035160</term_id>
  <id>1065450</id>
  <title>CCG Welcomes a New Genomic Data Analysis Network</title>
  <langcode>en</langcode>
  <field_short_title>CCG's New Genomic Data Analysis Network</field_short_title>
  <field_date_posted>2016-10-20</field_date_posted>
  <field_date_reviewed>2016-10-20</field_date_reviewed>
  <field_pretty_url>new-genomic-data-analysis-network</field_pretty_url>
  <para_id>1065450</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1065961</id>
  <title>DINO RNA Molecule Triggers Anticancer Response in Damaged Cells</title>
  <langcode>en</langcode>
  <field_short_title>DINO RNA Molecule Triggers Anticancer Response in Damaged Cells</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post about a noncoding RNA called DINO, which helps accelerate the cellular self-destruct process that prevents tumor development.</field_page_description>
  <field_date_posted>2016-10-24</field_date_posted>
  <field_date_reviewed>2016-10-24</field_date_reviewed>
  <field_pretty_url>dino-p53</field_pretty_url>
  <para_id>1065961</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1032046</term_id>
  <id>1066212</id>
  <title>Structure of KRAS4b-PDE&amp;delta; Complex</title>
  <langcode>en</langcode>
  <field_short_title>Structure of the KRAS4b-PDEδ complex</field_short_title>
  <field_page_description>The structure of farnesylated, carboxymethylated KRAS4b protein complexed with its chaperone PDEδ has been solved.</field_page_description>
  <field_date_posted>2016-11-02</field_date_posted>
  <field_date_reviewed>2016-11-01</field_date_reviewed>
  <field_pretty_url>kras4b-pded-complex</field_pretty_url>
  <para_id>1066212</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1066609</id>
  <title>CDC Updates Recommendations on HPV Vaccine</title>
  <langcode>en</langcode>
  <field_short_title>CDC Updates Recommendations on HPV Vaccine</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post about an updated CDC recommendation that those younger than age 15 need only two doses of the HPV vaccine instead of three.</field_page_description>
  <field_date_posted>2016-11-14</field_date_posted>
  <field_date_reviewed>2016-11-10</field_date_reviewed>
  <field_pretty_url>hpv-vaccine-doses</field_pretty_url>
  <para_id>1066609</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1067183</id>
  <title>Device Uses Cancer Cells' Mass to Predict Response to Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Device May Predict Cancer Treatment Response</field_short_title>
  <field_page_description>A blog post on a study demonstrating the ability of a device, called a suspended microchannel resonator, to predict cancer cell death or growth following cancer treatment.</field_page_description>
  <field_date_posted>2016-11-22</field_date_posted>
  <field_date_reviewed>2016-11-22</field_date_reviewed>
  <field_pretty_url>cell-mass-treatment-response</field_pretty_url>
  <para_id>1067183</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1032046</term_id>
  <id>1069132</id>
  <title>Targeting the KRAS G12D Neoantigen to Treat Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Targeting the KRAS G12D Neoantigen to Treat Cancer</field_short_title>
  <field_page_description>Steven A. Rosenberg and colleagues at the National Cancer Institute have treated a patient with metastatic colon cancer by using the patient's own cells to target the G12D mutation in KRAS.</field_page_description>
  <field_date_posted>2016-12-15</field_date_posted>
  <field_date_reviewed>2016-12-15</field_date_reviewed>
  <field_pretty_url>immunotherapy-kras-g12d-rosenberg</field_pretty_url>
  <para_id>1069132</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1070068</term_id>
  <id>1074213</id>
  <title>NCI launches study of African-American cancer survivors</title>
  <langcode>en</langcode>
  <field_short_title>NCI launches study of African-American cancer survivors</field_short_title>
  <field_page_description>An NCI press release about the launch of the Detroit Research on Cancer Survivors (ROCS) study, which will look at factors affecting cancer progression, recurrence, mortality, and quality of life among African-American cancer survivors.</field_page_description>
  <field_date_posted>2017-02-27</field_date_posted>
  <field_date_reviewed>2017-02-27</field_date_reviewed>
  <field_pretty_url>detroit-cancer-survivors-study</field_pretty_url>
  <para_id>1074213</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1066360</term_id>
  <id>1074434</id>
  <title>CGH Hosts the Regional Centers of Research Excellence Program Launch Meeting for Cohort 1 Investigators</title>
  <langcode>en</langcode>
  <field_short_title>CGH Hosts the Regional Centers of Research Excellence Program Launch Meeting for Cohort 1 Investigat</field_short_title>
  <field_date_posted>2017-03-01</field_date_posted>
  <field_date_reviewed>2017-03-01</field_date_reviewed>
  <field_pretty_url>rcre-launch</field_pretty_url>
  <para_id>1074434</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1078424</term_id>
  <id>1078666</id>
  <title>About the Office of HIV and AIDS Malignancy</title>
  <langcode>en</langcode>
  <field_short_title>About the Office of HIV and AIDS Malignancy</field_short_title>
  <field_page_description>The Office of HIV and AIDS Malignancy (OHAM) enhances NCI’s research in the field of HIV/AIDS and facilitates coordination of this effort. Learn more about the clinical and programmatic initiatives that OHAM oversees.</field_page_description>
  <field_date_posted>2017-07-10</field_date_posted>
  <field_date_reviewed>2017-03-31</field_date_reviewed>
  <para_id>1078666</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070072</term_id>
  <id>1080448</id>
  <title>A Panel of Isogenic RAS-Dependent Cell Lines Developed at the Frederick National Laboratory</title>
  <langcode>en</langcode>
  <field_short_title>A Panel of Isogenic RAS-Dependent Cell Lines Developed at the Frederick National Laboratory</field_short_title>
  <field_page_description>Cells lacking all RAS genes but those that have been modified and introduced by viral transduction are highly useful for drug screens.</field_page_description>
  <field_date_posted>2017-04-06</field_date_posted>
  <field_date_reviewed>2017-04-06</field_date_reviewed>
  <field_pretty_url>rasless-mefs-drug-screens</field_pretty_url>
  <para_id>1080448</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1080960</id>
  <title>FDA Approves Niraparib as Maintenance Therapy for Recurrent Ovarian Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Niraparib as Maintenance Therapy for Recurrent Ovarian Cancer</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on the FDA’s approval of niraparib as maintenance therapy for some women with recurrent ovarian cancer.</field_page_description>
  <field_date_posted>2017-04-12</field_date_posted>
  <field_date_reviewed>2017-04-11</field_date_reviewed>
  <field_pretty_url>fda-niraparib-ovarian</field_pretty_url>
  <para_id>1080960</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894084</term_id>
  <id>1081004</id>
  <title>Multiple Myeloma Awareness and African American Disparities</title>
  <langcode>en</langcode>
  <field_short_title>Multiple Myeloma Awareness and African American Disparities</field_short_title>
  <field_date_posted>2017-04-13</field_date_posted>
  <field_date_reviewed>2017-04-13</field_date_reviewed>
  <field_pretty_url>multiple-myeloma-disparities</field_pretty_url>
  <para_id>1081004</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1074837</term_id>
  <id>1081662</id>
  <title>Cancer Driver Discovery Program</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Driver Discovery</field_short_title>
  <field_page_description>The Cancer Driver Discovery Program aims to sequence a large number of cancer cases in order to increase statistical power for identifying recurrent driver mutations.</field_page_description>
  <field_date_posted>2017-08-04</field_date_posted>
  <field_date_reviewed>2017-04-17</field_date_reviewed>
  <field_pretty_url>driver-discovery</field_pretty_url>
  <para_id>1081662</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1084121</id>
  <title>FDA Approves Immunotherapy Drugs for Patients with Bladder Cancer </title>
  <langcode>en</langcode>
  <field_short_title>Immunotherapy Drugs Approved for Bladder Cancer</field_short_title>
  <field_page_description>A Cancer Currents blog on the FDA’s approval of four immunotherapy drugs for patients with bladder cancer. </field_page_description>
  <field_date_posted>2017-05-30</field_date_posted>
  <field_date_reviewed>2017-05-09</field_date_reviewed>
  <field_pretty_url>approvals-fda-checkpoint-bladder</field_pretty_url>
  <para_id>1084121</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>860258</term_id>
  <id>1084772</id>
  <title>Screening and Early Detection - Cancer Currents Blog</title>
  <langcode>en</langcode>
  <field_short_title>Screening &amp; Early Detection</field_short_title>
  <field_page_description>Blog posts on cancer screening and early detection research—including diagnostic biomarkers and advances or trends in screening practices—from NCI Cancer Currents. </field_page_description>
  <field_date_posted>2017-05-12</field_date_posted>
  <field_date_reviewed>2017-05-12</field_date_reviewed>
  <field_pretty_url>screening-early-detection</field_pretty_url>
  <para_id>1084772</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>860258</term_id>
  <id>1084774</id>
  <title>Survivorship and Supportive Care - Cancer Currents Blog</title>
  <langcode>en</langcode>
  <field_short_title>Survivorship &amp; Supportive Care</field_short_title>
  <field_page_description>Blog posts on survivorship and supportive care research—including the physical, psychosocial, and economic issues faced by cancer survivors and their caregivers—from NCI Cancer Currents.</field_page_description>
  <field_date_posted>2017-05-12</field_date_posted>
  <field_date_reviewed>2017-05-12</field_date_reviewed>
  <field_pretty_url>survivorship-supportive-care</field_pretty_url>
  <para_id>1084774</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1086212</id>
  <title>Study Identifies Genetic Mutations in Tumors From 10,000 Patients with Metastatic Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Mutations in 10,000 Patients with Metastatic Cancer</field_short_title>
  <field_page_description>Researchers have reported the results of an initiative to characterize the genetic mutations in tumors from more than 10,000 patients with advanced cancer treated at the center.</field_page_description>
  <field_date_posted>2017-05-31</field_date_posted>
  <field_date_reviewed>2017-05-25</field_date_reviewed>
  <field_pretty_url>mutations-metastatic-cancer</field_pretty_url>
  <para_id>1086212</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>930502</term_id>
  <id>959693</id>
  <title>Pembrolizumab Improves Overall Survival in Patients with Advanced Melanoma </title>
  <langcode>en</langcode>
  <field_short_title>Pembrolizumab for Advanced Melanoma</field_short_title>
  <field_page_description>A summary of results from a randomized phase III study that showed pembrolizumab (Keytruda®) improved survival in patients with advanced melanoma compared with Ipilimumab (Yervoy®).</field_page_description>
  <field_date_posted>2015-05-26</field_date_posted>
  <field_date_reviewed>2015-05-26</field_date_reviewed>
  <field_pretty_url>pembrolizumab</field_pretty_url>
  <para_id>959693</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>916844</term_id>
  <id>966144</id>
  <title>Download the NCI FYI Mobile App</title>
  <langcode>en</langcode>
  <field_short_title>Download the NCI FYI Mobile App</field_short_title>
  <field_page_description>The NCI FYI mobile application offers a centralized source of available resources to fellows and trainees working at NCI in Maryland.</field_page_description>
  <field_date_posted>2015-06-10</field_date_posted>
  <field_date_reviewed>2015-06-10</field_date_reviewed>
  <field_pretty_url>fyi-app</field_pretty_url>
  <para_id>966144</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>966169</id>
  <title>CURE Spotlight: Cesar Castro, M.D. Develops Smartphone Technology for Cancer Detection in Underserved Communities</title>
  <langcode>en</langcode>
  <field_short_title>CURE Spotlight: Cesar Castro, M.D. </field_short_title>
  <field_date_posted>2015-06-10</field_date_posted>
  <field_date_reviewed>2015-06-10</field_date_reviewed>
  <field_pretty_url>castro-spotlight</field_pretty_url>
  <para_id>966169</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>969476</id>
  <title>Many Women with Dense Breasts May Not Need Additional Screening</title>
  <langcode>en</langcode>
  <field_short_title>Many Women with Dense Breasts May Not Need Additional Screening</field_short_title>
  <field_date_posted>2015-06-22</field_date_posted>
  <field_date_reviewed>2015-06-22</field_date_reviewed>
  <field_pretty_url>dense-breasts-screening</field_pretty_url>
  <para_id>969476</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>969701</term_id>
  <id>969702</id>
  <title>NCI Budget Summary Data</title>
  <langcode>en</langcode>
  <field_short_title>Budget Summary Data</field_short_title>
  <field_page_description>Find detailed data about funds available to NCI and information about how NCI obligated its funding this fiscal year.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-06-24</field_date_reviewed>
  <para_id>969702</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>970159</term_id>
  <id>970160</id>
  <title>NCI Extramural Programs</title>
  <langcode>en</langcode>
  <field_short_title>Extramural Programs</field_short_title>
  <field_page_description>The majority of NCI's budget funds extramural grants and contracts.  Find information about extramural funding by grant activity, institution, state, and country.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-06-26</field_date_reviewed>
  <para_id>970160</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>974639</term_id>
  <id>974641</id>
  <title>NCI and NIH AIDS Funding History</title>
  <langcode>en</langcode>
  <field_short_title>AIDS Funding History</field_short_title>
  <field_page_description>NCI scientists have made a number of key discoveries in HIV/AIDS research. Find information about the history of funding levels for HIV/AIDS research year over year. </field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-07-08</field_date_reviewed>
  <para_id>974641</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>979458</id>
  <title>Director's Corner: Professional Development Workshop Helps Early Stage Investigators Build Independent Careers in Scientific Research</title>
  <langcode>en</langcode>
  <field_short_title>Director's Corner: Professional Development Workshop Helps Early Stage Investigators</field_short_title>
  <field_date_posted>2015-07-23</field_date_posted>
  <field_date_reviewed>2015-07-23</field_date_reviewed>
  <field_pretty_url>PDW-2015</field_pretty_url>
  <para_id>979458</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>981175</id>
  <title>New Research: Using Lung Cancer Screening As An Opportunity to Help Smokers Quit</title>
  <langcode>en</langcode>
  <field_short_title>New Research: Using Lung Cancer Screening As An Opportunity to Help Smokers Quit</field_short_title>
  <field_date_posted>2015-07-29</field_date_posted>
  <field_date_reviewed>2015-07-29</field_date_reviewed>
  <field_pretty_url>cessation-rfa</field_pretty_url>
  <para_id>981175</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>982345</term_id>
  <id>982944</id>
  <title>Vulvar Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on vulvar cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-08-03</field_date_posted>
  <field_date_reviewed>2015-08-03</field_date_reviewed>
  <para_id>982944</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>985598</id>
  <title>Too Few Patients with Cancer Communicate Preferences for End-of-Life Care</title>
  <langcode>en</langcode>
  <field_short_title>Study Shows Need for End-of-Life Care Preferences</field_short_title>
  <field_date_posted>2015-08-10</field_date_posted>
  <field_date_reviewed>2015-08-10</field_date_reviewed>
  <field_pretty_url>end-of-life-communication</field_pretty_url>
  <para_id>985598</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>915112</term_id>
  <id>988770</id>
  <title>Study Identifies Biomarker that Detects Early Pancreatic Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Biomarker Detects Pancreatic Cancer</field_short_title>
  <field_page_description>Exosome Biomarker Detects Pancreatic Cancer</field_page_description>
  <field_date_posted>2015-09-15</field_date_posted>
  <field_date_reviewed>2015-08-28</field_date_reviewed>
  <field_pretty_url>pancreatic-biomarker</field_pretty_url>
  <para_id>988770</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1001474</id>
  <title>FDA Approves Rolapitant to Prevent Nausea and Vomiting from Chemotherapy</title>
  <langcode>en</langcode>
  <field_short_title>Preventing Nausea and Vomiting from Chemotherapy</field_short_title>
  <field_date_posted>2015-09-11</field_date_posted>
  <field_date_reviewed>2015-09-10</field_date_reviewed>
  <field_pretty_url>rolapitant-approved</field_pretty_url>
  <para_id>1001474</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1004902</term_id>
  <id>1004971</id>
  <title>Contact the Division of Cancer Biology</title>
  <langcode>en</langcode>
  <field_short_title>DCB Contact and Staff</field_short_title>
  <field_page_description>Find staff and contact information for DCB's offices and branches.</field_page_description>
  <field_date_posted>2016-08-08</field_date_posted>
  <field_date_reviewed>2015-09-25</field_date_reviewed>
  <para_id>1004971</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1012388</id>
  <title>Progress against Cancer: The Role of Basic Science</title>
  <langcode>en</langcode>
  <field_short_title>Progress against Cancer: The Role of Basic Science</field_short_title>
  <field_date_posted>2015-10-08</field_date_posted>
  <field_date_reviewed>2015-10-08</field_date_reviewed>
  <field_pretty_url>bypass-basic-science</field_pretty_url>
  <para_id>1012388</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>937976</term_id>
  <id>1069449</id>
  <title>Identifying Novel Drug Combinations to Overcome Treatment Resistance</title>
  <langcode>en</langcode>
  <field_short_title>Drug Combinations to Overcome Treatment Resistance</field_short_title>
  <field_page_description>A review of current research identifying and testing drug combination approaches that have the potential to overcome or delay resistance to cancer treatment.</field_page_description>
  <field_date_posted>2016-12-21</field_date_posted>
  <field_date_reviewed>2016-12-20</field_date_reviewed>
  <field_pretty_url>drug-combo-resistance</field_pretty_url>
  <para_id>1069449</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1069570</id>
  <title>CGH Director strengthens research and control partnerships in Kenya</title>
  <langcode>en</langcode>
  <field_short_title>CGH Director strengthens research and control partnerships in Kenya</field_short_title>
  <field_page_description>NCI’s Center for Global Health director Edward Trimble met with Kenyan partners in December 2016 to increase engagement in cancer control strategy.</field_page_description>
  <field_date_posted>2016-12-21</field_date_posted>
  <field_date_reviewed>2016-12-21</field_date_reviewed>
  <field_pretty_url>trimble-partnerships-kenya</field_pretty_url>
  <para_id>1069570</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1070648</id>
  <title>For Some Breast Cancer Survivors, Drug May Reduce Treatment-Related Joint Pain</title>
  <langcode>en</langcode>
  <field_short_title>Drug Reduces Cancer Treatment-Related Joint Pain </field_short_title>
  <field_page_description>A Cancer Currents blog post about a clinical trial demonstrating that duloxetine (Cymbalta®) may reduce joint pain caused by aromatase inhibitors in women being treated for early-stage breast cancer. </field_page_description>
  <field_date_posted>2017-01-04</field_date_posted>
  <field_date_reviewed>2017-01-03</field_date_reviewed>
  <field_pretty_url>duloxetine-breast-joint-pain</field_pretty_url>
  <para_id>1070648</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1071546</id>
  <title>Shifts Seen in Tobacco Product Types Purchased in US</title>
  <langcode>en</langcode>
  <field_short_title>Shifts Seen in Tobacco Product Types Purchased in US</field_short_title>
  <field_page_description>A Cancer Currents blog post on a new study showing shifts in the types of tobacco products purchased in the United States, including increased purchases of snuff and large cigars.</field_page_description>
  <field_date_posted>2017-01-23</field_date_posted>
  <field_date_reviewed>2017-01-23</field_date_reviewed>
  <field_pretty_url>tobacco-consumption-shifting</field_pretty_url>
  <para_id>1071546</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1099301</term_id>
  <id>1073391</id>
  <title>Selected Publications by Dr. Doug Lowy</title>
  <langcode>en</langcode>
  <field_short_title>Selected Publications by Doug Lowy</field_short_title>
  <field_page_description>In these selected published articles, Douglas R. Lowy, M.D., Deputy Director of the National Cancer Institute (NCI), presents some of his work in cancer research.</field_page_description>
  <field_date_posted>2017-02-28</field_date_posted>
  <field_date_reviewed>2017-02-15</field_date_reviewed>
  <para_id>1073391</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1073661</id>
  <title>Conditional Reprogramming: An Interview with Dr. Richard Schlegel on Growing Cancer Cells</title>
  <langcode>en</langcode>
  <field_short_title>Conditional Reprogramming to Grow Cancer Cells</field_short_title>
  <field_page_description>An NCI Cancer Currents blog featuring Dr. Richard Schlegel discussing conditional reprogramming, a new cell culture technique for rapidly growing normal and tumor cells.</field_page_description>
  <field_date_posted>2017-02-22</field_date_posted>
  <field_date_reviewed>2017-02-21</field_date_reviewed>
  <field_pretty_url>schlegel-conditional-reprogramming</field_pretty_url>
  <para_id>1073661</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1074403</id>
  <title>FDA Approves Nivolumab for Bladder Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Nivolumab for Bladder Cancer</field_short_title>
  <field_page_description>A Cancer Currents blog on the clinical trial that led the FDA to approve nivolumab for bladder cancer and what the approval means for patients.</field_page_description>
  <field_date_posted>2017-03-01</field_date_posted>
  <field_date_reviewed>2017-02-28</field_date_reviewed>
  <field_pretty_url>fda-nivolumab-bladder</field_pretty_url>
  <para_id>1074403</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1074833</term_id>
  <id>1074842</id>
  <title>Center for Cancer Genomics Research</title>
  <langcode>en</langcode>
  <field_short_title>CCG Research</field_short_title>
  <field_page_description>NCI’s Center for Cancer Genomics aims to transform the diagnosis and treatment of cancer through structural, functional, and computational genomics research, and the promotion of data sharing. </field_page_description>
  <field_date_posted>2017-03-06</field_date_posted>
  <field_date_reviewed>2017-03-06</field_date_reviewed>
  <para_id>1074842</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1075757</id>
  <title>Researchers Use CRISPR Gene-Editing Tool to Help Turn Immune Cells against Tumors</title>
  <langcode>en</langcode>
  <field_short_title>CRISPR Gene-Editing Tool May Help Improve Cancer Immunotherapy</field_short_title>
  <field_page_description>A Cancer Currents blog about using the CRISPR gene-editing technology to genetically engineered immune cells and improve the ability of these cells to kill cancer cells in mice.</field_page_description>
  <field_date_posted>2017-03-20</field_date_posted>
  <field_date_reviewed>2017-03-17</field_date_reviewed>
  <field_pretty_url>crispr-immunotherapy</field_pretty_url>
  <para_id>1075757</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1077979</id>
  <title>Targeted Cancer Drug May Also Help Protect Fertility, Study Suggests</title>
  <langcode>en</langcode>
  <field_short_title>Targeted Cancer Drug May Also Help Protect Fertility</field_short_title>
  <field_page_description>A Cancer Currents blog on a new study in mice suggesting that a class of targeted cancer drugs may help some women undergoing cancer treatments preserve their fertility.</field_page_description>
  <field_date_posted>2017-03-27</field_date_posted>
  <field_date_reviewed>2017-03-24</field_date_reviewed>
  <field_pretty_url>mtor-cancer-fertility-preservation</field_pretty_url>
  <para_id>1077979</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1086924</id>
  <title>Less Chemotherapy May Be Best Choice for Some Patients with Colon Cancer, Study Shows</title>
  <langcode>en</langcode>
  <field_short_title>Less Adjuvant Chemotherapy for Colon Cancer</field_short_title>
  <field_page_description>A Cancer Currents blog on a study which showed a shorter chemotherapy course following surgery may be preferred for some patients with colon cancer.</field_page_description>
  <field_date_posted>2017-06-07</field_date_posted>
  <field_date_reviewed>2017-06-07</field_date_reviewed>
  <field_pretty_url>adjuvant-chemo-colorectal</field_pretty_url>
  <para_id>1086924</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070072</term_id>
  <id>1087027</id>
  <title>Powering Off Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Powering Off Cancer</field_short_title>
  <field_page_description>Many cancers are more dependent on metabolic reactions that occur in mitochondria than normal cells. New therapies that target these reactions are being tested.</field_page_description>
  <field_date_posted>2017-06-09</field_date_posted>
  <field_date_reviewed>2017-06-08</field_date_reviewed>
  <field_pretty_url>targeting-mitochondria</field_pretty_url>
  <para_id>1087027</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1080236</term_id>
  <id>1087222</id>
  <title>Geraldina Dominguez, Ph.D.</title>
  <langcode>en</langcode>
  <field_short_title>Geraldina Dominguez, Ph.D.</field_short_title>
  <field_date_posted>2017-06-09</field_date_posted>
  <field_date_reviewed>2017-06-09</field_date_reviewed>
  <field_pretty_url>geraldina-dominguez</field_pretty_url>
  <para_id>1087222</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1088594</id>
  <title>Extensive Lymph Node Surgery Does Not Increase Survival in Melanoma</title>
  <langcode>en</langcode>
  <field_short_title>Trial Provides Guidance on Lymph Node Surgery in Melanoma</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post on results from a clinical trial which show that a conservative approach to lymph node removal surgery may be best for some patients with melanoma.</field_page_description>
  <field_date_posted>2017-06-30</field_date_posted>
  <field_date_reviewed>2017-06-29</field_date_reviewed>
  <field_pretty_url>lymph-node-surgery-melanoma</field_pretty_url>
  <para_id>1088594</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1088987</id>
  <title>Cancer Researchers Report Progress in Studying Exceptional Responders</title>
  <langcode>en</langcode>
  <field_short_title>Exceptional Responders Initiative Moving Forward</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post about a recent NCI-sponsored meeting to discuss research on exceptional responders—patients with cancer who have dramatic and long-lasting treatment responses.</field_page_description>
  <field_date_posted>2017-07-06</field_date_posted>
  <field_date_reviewed>2017-07-06</field_date_reviewed>
  <field_pretty_url>exceptional-responders-progress</field_pretty_url>
  <para_id>1088987</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1090915</id>
  <title>Glioblastoma—Unraveling the Threads: A Q&amp;A with Drs. Mark Gilbert and Terri Armstrong of the NIH Neuro-Oncology Branch</title>
  <langcode>en</langcode>
  <field_short_title>Unraveling the Threads: Making Progress against Glioblastoma</field_short_title>
  <field_page_description>Progress against the brain cancer glioblastoma has been slow. In this Cancer Currents post, Drs. Mark Gilbert and Terri Armstrong of NCI’s Neuro-Oncology Branch discuss what’s being done to change that.</field_page_description>
  <field_date_posted>2017-08-03</field_date_posted>
  <field_date_reviewed>2017-08-02</field_date_reviewed>
  <field_pretty_url>glioblastoma-research-making-progress</field_pretty_url>
  <para_id>1090915</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1093691</id>
  <title>Two New Therapies Approved for Acute Myeloid Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Two New Therapies Approved for Acute Myeloid Leukemia</field_short_title>
  <field_page_description>Two new treatments for adults with acute myeloid leukemia (AML) have been approved by FDA: enasidenib (Idhifa®) and cytarabine-daunorubicin CPX-351 (Vyxeos®), as this Cancer Currents post explains</field_page_description>
  <field_date_posted>2017-08-28</field_date_posted>
  <field_date_reviewed>2017-08-28</field_date_reviewed>
  <field_pretty_url>fda-enasidenib-vyxeos-aml</field_pretty_url>
  <para_id>1093691</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1093741</term_id>
  <id>1093742</id>
  <title>Sexual Health Issues in Women with Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Sexual Health Issues in Women</field_short_title>
  <field_page_description>Cancer treatments such as chemotherapy, hormone therapy, and radiation may cause sexual problems in women. Conditions may include vaginal dryness, vaginal stenosis, and vaginal atrophy. Learn how to manage and treat these sexual problems.</field_page_description>
  <field_date_posted>2017-09-22</field_date_posted>
  <field_date_reviewed>2017-08-28</field_date_reviewed>
  <para_id>1093742</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894084</term_id>
  <id>1093825</id>
  <title>CRCHD Hosts Career Development and Scientific Workshop</title>
  <langcode>en</langcode>
  <field_short_title>CRCHD Hosts Career Development and Scientific Workshop</field_short_title>
  <field_page_description>CRCHD recently hosted a Career Development and Scientific Workshop to support investigators interested in applying for NIH funding opportunities.</field_page_description>
  <field_date_posted>2017-08-30</field_date_posted>
  <field_date_reviewed>2017-08-29</field_date_reviewed>
  <field_pretty_url>crchd-workshop-philadelphia</field_pretty_url>
  <para_id>1093825</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1066360</term_id>
  <id>1093957</id>
  <title>NCI supports 10 New Bilateral Collaborative Research Partnerships on Cancer</title>
  <langcode>en</langcode>
  <field_short_title>NCI supports 10 New Bilateral Collaborative Research Partnerships on Cancer</field_short_title>
  <field_date_posted>2017-08-30</field_date_posted>
  <field_date_reviewed>2017-08-30</field_date_reviewed>
  <field_pretty_url>bilateral-partnerships</field_pretty_url>
  <para_id>1093957</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1090265</term_id>
  <id>1094047</id>
  <title>Cancer Prevention Steering Committee Roster</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Prevention Steering Committee Roster</field_short_title>
  <field_page_description>Roster of members on the Cancer Prevention Steering Committee.</field_page_description>
  <field_date_posted>2017-09-28</field_date_posted>
  <field_date_reviewed>2017-09-28</field_date_reviewed>
  <field_pretty_url>roster</field_pretty_url>
  <para_id>1094047</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1095446</id>
  <title>CAR T-Cell Therapy Approved for Some Children and Young Adults with Leukemia </title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves CAR T-Cell Therapy for Children with Leukemia</field_short_title>
  <field_page_description>Tisagenlecleucel (Kymriah™), a form of CAR T-cell therapy, has been approved by FDA for some children and young adults with advanced acute lymphoblastic leukemia (ALL).</field_page_description>
  <field_date_posted>2017-09-11</field_date_posted>
  <field_date_reviewed>2017-09-08</field_date_reviewed>
  <field_pretty_url>tisagenlecleucel-fda-childhood-leukemia</field_pretty_url>
  <para_id>1095446</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1095763</id>
  <title>FDA Approves Olaparib as Maintenance Therapy for Recurrent Ovarian Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Expands Approval of Olaparib for Ovarian Cancer</field_short_title>
  <field_page_description>Olaparib tablets (Lynparza®) have been approved by FDA for some women with ovarian cancer to use as a maintenance treatment, this Cancer Currents post explains.</field_page_description>
  <field_date_posted>2017-09-14</field_date_posted>
  <field_date_reviewed>2017-09-12</field_date_reviewed>
  <field_pretty_url>fda-olaparib-ovarian-cancer-maintenance</field_pretty_url>
  <para_id>1095763</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1066360</term_id>
  <id>1096315</id>
  <title>Why I Do Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Why I Do Cancer Research</field_short_title>
  <field_date_posted>2017-09-18</field_date_posted>
  <field_date_reviewed>2017-09-18</field_date_reviewed>
  <field_pretty_url>cancer-research-day</field_pretty_url>
  <para_id>1096315</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1097879</term_id>
  <id>1097880</id>
  <title>National Cryo-Electron Microscopy Facility Team Members</title>
  <langcode>en</langcode>
  <field_short_title>NCEF Team Members</field_short_title>
  <field_page_description>The National Cryo-Electron Microscopy Facility team is responsible for the operational activities of NCEF. Find team member bios and a list of NCEF working group members.</field_page_description>
  <field_date_posted>2017-10-13</field_date_posted>
  <field_date_reviewed>2017-10-09</field_date_reviewed>
  <para_id>1097880</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1098487</term_id>
  <id>1098488</id>
  <title>Supporting Informed Decision Making</title>
  <langcode>en</langcode>
  <field_short_title>Supporting Informed Decision Making</field_short_title>
  <field_page_description>CRS conducts portfolio analyses and collects data on scientific topics, funding mechanisms, and investigator characteristics to help NCI leadership make data-driven decisions about the scientific research enterprise.</field_page_description>
  <field_date_posted>2018-04-13</field_date_posted>
  <field_date_reviewed>2017-10-17</field_date_reviewed>
  <para_id>1098488</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1100186</term_id>
  <id>1100187</id>
  <title>Contact the Office of Communications and Public Liaison</title>
  <langcode>en</langcode>
  <field_short_title>Contact &amp; Staff</field_short_title>
  <field_page_description>Find contact and staff information for NCI's Office of Communications and Public Liaison (OCPL). OCPL is staffed by experts in science writing, digital communications, and media and public affairs.</field_page_description>
  <field_date_posted>2017-11-17</field_date_posted>
  <field_date_reviewed>2017-11-14</field_date_reviewed>
  <para_id>1100187</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1100186</term_id>
  <id>1100355</id>
  <title>Peter Garrett</title>
  <langcode>en</langcode>
  <field_short_title>Peter Garrett, Director, OCPL</field_short_title>
  <field_page_description>Bio for Peter Garrett, director of NCI's Office of Communications and Public Liaison (OCPL). As OCPL Director, Peter oversees digital communications and social media, science writing, clearance, stakeholder outreach, media relations, and internal communications.</field_page_description>
  <field_date_posted>2017-11-21</field_date_posted>
  <field_date_reviewed>2017-11-16</field_date_reviewed>
  <field_pretty_url>peter-garrett-bio</field_pretty_url>
  <para_id>1100355</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1100545</id>
  <title>Endometrial Cancer Incidence Rising in the US and Worldwide</title>
  <langcode>en</langcode>
  <field_short_title>Endometrial Cancer Incidence Rising Worldwide</field_short_title>
  <field_page_description>Endometrial cancer diagnoses have increased worldwide in recent years, with the highest incidence rates in North America and Europe, as this Cancer Currents post explains.</field_page_description>
  <field_date_posted>2017-11-20</field_date_posted>
  <field_date_reviewed>2017-11-20</field_date_reviewed>
  <field_pretty_url>endometrial-cancer-incidence-rising</field_pretty_url>
  <para_id>1100545</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911152</term_id>
  <id>584571</id>
  <title>Alcohol and Cancer Risk</title>
  <langcode>en</langcode>
  <field_short_title>Alcohol and Cancer Risk</field_short_title>
  <field_page_description>A fact sheet that summarizes the evidence linking alcohol consumption to the risk of various cancers. Includes information about factors that affect the risk of alcohol-associated cancers.</field_page_description>
  <field_date_posted>2018-09-17</field_date_posted>
  <field_date_reviewed>2018-09-13</field_date_reviewed>
  <field_pretty_url>alcohol-fact-sheet</field_pretty_url>
  <para_id>584571</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922399</term_id>
  <id>588480</id>
  <title>Preventing High-Risk Adenomas and Second Cancers in Colon Cancer Survivors</title>
  <langcode>en</langcode>
  <field_short_title>Preventing High-Risk Adenomas and Second Cancers in Colon Cancer Survivors</field_short_title>
  <field_page_description>In this phase III trial, people who have had curative surgery for colon cancer will be randomly assigned to take sulindac and a placebo, eflornithine and a placebo, both sulindac and eflornithine, or two placebo pills for 36 months.</field_page_description>
  <field_date_posted>2013-06-20</field_date_posted>
  <field_date_reviewed>2013-06-20</field_date_reviewed>
  <field_pretty_url>eflornithine-sulindac</field_pretty_url>
  <para_id>588480</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>591260</id>
  <title>New understanding of oral HPV infections in healthy men</title>
  <langcode>en</langcode>
  <field_short_title>New understanding of oral HPV infections in healthy men</field_short_title>
  <field_page_description>Scientists report that newly acquired oral HPV infections in healthy men are uncommon and, when present, tend to go away within one year.</field_page_description>
  <field_date_posted>2013-07-02</field_date_posted>
  <field_date_reviewed>2013-07-01</field_date_reviewed>
  <field_pretty_url>OralHPVmen</field_pretty_url>
  <para_id>591260</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>608323</term_id>
  <id>679331</id>
  <title>Relieving Mouth Sores from Cancer Treatment: The Discovery of Palifermin</title>
  <langcode>en</langcode>
  <field_short_title>Relieving Mouth Sores of Cancer Treatment</field_short_title>
  <field_page_description>Painful mouth and throat sores can be a side effect of intensive cancer treatments for many patients. Learn how NCI scientists developed the drug, Palifermin, which vastly improves the quality of life for cancer patients.</field_page_description>
  <field_date_posted>2018-02-23</field_date_posted>
  <field_date_reviewed>2013-12-12</field_date_reviewed>
  <field_pretty_url>oral-mucositis</field_pretty_url>
  <para_id>679331</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>11954</term_id>
  <id>682307</id>
  <title>Hormone Therapy for Prostate Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Hormone Therapy for Prostate Cancer</field_short_title>
  <field_page_description>A fact sheet that describes hormone therapy and its role in treating prostate cancer. Includes information about the types of hormone therapy, how they are used, and possible side effects.</field_page_description>
  <field_date_posted>2014-01-17</field_date_posted>
  <field_date_reviewed>2014-06-23</field_date_reviewed>
  <field_pretty_url>prostate-hormone-therapy-fact-sheet</field_pretty_url>
  <para_id>682307</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>608323</term_id>
  <id>684837</id>
  <title>Enhancing Breast and Ovarian Cancer Care: The Discovery of BRCA1 and BRCA2</title>
  <langcode>en</langcode>
  <field_short_title>Enhancing Breast and Ovarian Cancer Care: BRCA1 and BRCA2</field_short_title>
  <field_date_posted>2014-03-07</field_date_posted>
  <field_date_reviewed>2013-12-23</field_date_reviewed>
  <field_pretty_url>brca</field_pretty_url>
  <para_id>684837</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>697682</id>
  <title>TCGA bladder cancer study reveals potential drug targets, similarities to several cancers</title>
  <langcode>en</langcode>
  <field_short_title>TCGA bladder cancer study reveals potential drug targets</field_short_title>
  <field_page_description>Investigators with TCGA have identified new potential therapeutic targets for a major form of bladder cancer, including important genes and pathways that are disrupted in the disease. They also discovered that, at the molecular level, some subtypes of bla</field_page_description>
  <field_date_posted>2014-01-29</field_date_posted>
  <field_date_reviewed>2014-01-28</field_date_reviewed>
  <field_pretty_url>TCGAbladder</field_pretty_url>
  <para_id>697682</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1026057</term_id>
  <id>1026866</id>
  <title>Committees of Interest</title>
  <langcode>en</langcode>
  <field_short_title>Committees of Interest</field_short_title>
  <field_page_description>Learn more about the specific committees which appropriate funds, authorize programs, or oversee activities of the National Cancer Institute.</field_page_description>
  <field_date_posted>2016-02-16</field_date_posted>
  <field_date_reviewed>2015-11-18</field_date_reviewed>
  <para_id>1026866</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1028622</term_id>
  <id>1028623</id>
  <title>National Cancer Act of 1937</title>
  <langcode>en</langcode>
  <field_short_title>National Cancer Act of 1937</field_short_title>
  <field_page_description>National Cancer Act of 1937, signed into law by President Franklin D. Roosevelt, created the National Cancer Institute. </field_page_description>
  <field_date_posted>2016-02-16</field_date_posted>
  <field_date_reviewed>2015-12-04</field_date_reviewed>
  <para_id>1028623</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1031954</id>
  <title>Checking In on Cancer Checkpoint Inhibitors</title>
  <langcode>en</langcode>
  <field_short_title>Checking In on Cancer Checkpoint Inhibitors</field_short_title>
  <field_date_posted>2015-12-18</field_date_posted>
  <field_date_reviewed>2015-12-18</field_date_reviewed>
  <field_pretty_url>gulley-checkpoint</field_pretty_url>
  <para_id>1031954</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1033176</id>
  <title>Cancer Can Lead to Financial Hardship, Study Confirms</title>
  <langcode>en</langcode>
  <field_short_title>Study of Cancer and Financial Hardship</field_short_title>
  <field_page_description>A substantial number of working-age cancer survivors report material or psychological financial hardship associated with their cancer.</field_page_description>
  <field_date_posted>2015-12-23</field_date_posted>
  <field_date_reviewed>2015-12-22</field_date_reviewed>
  <field_pretty_url>cancer-financial-hardship</field_pretty_url>
  <para_id>1033176</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1035160</term_id>
  <id>1034108</id>
  <title>DNA Misfolding Revealed as Novel Oncogenic Mechanism</title>
  <langcode>en</langcode>
  <field_short_title>DNA Misfolding Revealed as Novel Oncogenic Mechanism</field_short_title>
  <field_date_posted>2016-02-01</field_date_posted>
  <field_date_reviewed>2016-01-19</field_date_reviewed>
  <field_pretty_url>gliomas-reveal-dna-misfolding</field_pretty_url>
  <para_id>1034108</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>1034200</term_id>
  <id>1034201</id>
  <title>Penile Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Penile Cancer Research</field_short_title>
  <field_page_description>Find research articles on penile cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2016-01-20</field_date_posted>
  <field_date_reviewed>2016-01-20</field_date_reviewed>
  <para_id>1034201</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1035818</term_id>
  <id>1034875</id>
  <title>Genomic Data Commons</title>
  <langcode>en</langcode>
  <field_short_title>Genomic Data Commons</field_short_title>
  <field_page_description>The NCI Genomic Data Commons (GDC) is a unified cancer genomics knowledge base that promotes data sharing and facilitates precision medicine in oncology.</field_page_description>
  <field_date_posted>2016-02-01</field_date_posted>
  <field_date_reviewed>2016-01-28</field_date_reviewed>
  <para_id>1034875</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1034962</id>
  <title>Opportunities in Cancer Nanotechnology: A Conversation with NCI’s Dr. Piotr Grodzinski </title>
  <langcode>en</langcode>
  <field_short_title>Opportunities in Cancer Nanotechnology: A Conversation with NCI’s Dr. Piotr Grodzinski</field_short_title>
  <field_date_posted>2016-01-29</field_date_posted>
  <field_date_reviewed>2016-01-29</field_date_reviewed>
  <field_pretty_url>grodzinski-nanotechnology</field_pretty_url>
  <para_id>1034962</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127298</term_id>
  <id>633818</id>
  <title>Pediatric Terminology</title>
  <langcode>en</langcode>
  <field_short_title>Pediatric Terminology</field_short_title>
  <field_date_posted>2013-09-05</field_date_posted>
  <field_date_reviewed>2017-03-31</field_date_reviewed>
  <para_id>633818</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>641736</id>
  <title>The benefits of looking across many cancer genomes: A perspective</title>
  <langcode>en</langcode>
  <field_short_title>The benefits of looking across many cancer genomes</field_short_title>
  <field_page_description>Cancer is not a single entity, but rather, it is more than one hundred complex and distinct diseases, with most cancer types demanding a unique treatment strategy. TCGA researchers have developed a formal project for a cross tumor analysis, called Pan-Can</field_page_description>
  <field_date_posted>2013-09-27</field_date_posted>
  <field_date_reviewed>2013-09-25</field_date_reviewed>
  <field_pretty_url>PanCanPerspective2013</field_pretty_url>
  <para_id>641736</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>656279</id>
  <title>Genomic understanding of glioblastoma expanded</title>
  <langcode>en</langcode>
  <field_short_title>Genomic understanding of glioblastoma expanded</field_short_title>
  <field_page_description>Glioblastoma multiforme (GBM) was the first cancer type to be systematically studied by TCGA in 2008. In a new, complementary report, TCGA experts examined more than 590 GBM samples--the largest to date utilizing genomic characterization techniques and ne</field_page_description>
  <field_date_posted>2013-10-10</field_date_posted>
  <field_date_reviewed>2013-10-10</field_date_reviewed>
  <field_pretty_url>GBM500</field_pretty_url>
  <para_id>656279</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>679657</id>
  <title>Annual Report to the Nation on the Status of Cancer, 1975–2010, Featuring Prevalence of Comorbidity and Impact on Survival Among Persons with Lung, Colorectal, Breast or Prostate Cancer: Questions and Answers</title>
  <langcode>en</langcode>
  <field_short_title>Annual Report to the Nation on the Status of Cancer, 1975–2010 </field_short_title>
  <field_page_description>The Annual Report to the Nation on the Status of Cancer, covering the period 1975–2010, showed death rates for lung cancer, which accounts for more than one in four cancer deaths, dropping at a faster pace than in previous years. </field_page_description>
  <field_date_posted>2013-12-16</field_date_posted>
  <field_date_reviewed>2013-12-13</field_date_reviewed>
  <field_pretty_url>ReportNationDec2013QandA</field_pretty_url>
  <para_id>679657</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>685623</id>
  <title>When Your Brother or Sister Has Cancer: A Guide for Teens</title>
  <langcode>en</langcode>
  <field_short_title>When Your Brother or Sister Has Cancer</field_short_title>
  <field_page_description>Help when a brother or sister has cancer. Learn how families cope and find support when a sibling has cancer. Tips to help you talk with your friends, deal with stress, and take care of your mind and body are also shared.</field_page_description>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2013-12-26</field_date_reviewed>
  <field_pretty_url>sibling-has-cancer</field_pretty_url>
  <para_id>685623</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>911184</term_id>
  <id>695232</id>
  <title>Common Cancer Myths and Misconceptions</title>
  <langcode>en</langcode>
  <field_short_title>Common Cancer Myths and Misconceptions</field_short_title>
  <field_date_posted>2014-02-03</field_date_posted>
  <field_date_reviewed>2014-01-23</field_date_reviewed>
  <para_id>695232</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>915112</term_id>
  <id>1026924</id>
  <title>Cancer Informatics: Expanding Access to Cancer Genomics Data</title>
  <langcode>en</langcode>
  <field_short_title>Expanding Data Access</field_short_title>
  <field_page_description>The NCI Genomic Data Commons and Cloud Pilots expand access to cancer genomics data by compiling and harmonzed data into a central data repository.</field_page_description>
  <field_date_posted>2015-12-02</field_date_posted>
  <field_date_reviewed>2015-11-19</field_date_reviewed>
  <field_pretty_url>cancer-informatics-hangout</field_pretty_url>
  <para_id>1026924</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>1027131</id>
  <title>What an Indian Proverb Can Teach Us About Communication</title>
  <langcode>en</langcode>
  <field_short_title>What an Indian Proverb Can Teach Us About Communication</field_short_title>
  <field_date_posted>2015-11-20</field_date_posted>
  <field_date_reviewed>2015-11-20</field_date_reviewed>
  <field_pretty_url>crim_india</field_pretty_url>
  <para_id>1027131</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069530</term_id>
  <id>1030529</id>
  <title>A Conversation with Allan Balmain</title>
  <langcode>en</langcode>
  <field_short_title>A Conversation with Allan Balmain</field_short_title>
  <field_date_posted>2015-12-10</field_date_posted>
  <field_date_reviewed>2015-12-10</field_date_reviewed>
  <field_pretty_url>allan-balmain-interview</field_pretty_url>
  <para_id>1030529</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1031741</term_id>
  <id>1031742</id>
  <title>Managing Costs and Medical Information </title>
  <langcode>en</langcode>
  <field_short_title>Managing Medical Care and Costs</field_short_title>
  <field_page_description>People with cancer may face major financial challenges and need help dealing with the high costs of care. Cancer treatment can be very expensive, even when you have insurance. Learn ways to manage medical information, paperwork, bills, and other records.</field_page_description>
  <field_date_posted>2016-10-19</field_date_posted>
  <field_date_reviewed>2016-10-18</field_date_reviewed>
  <para_id>1031742</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>911291</term_id>
  <id>1032053</id>
  <title>A Harmful Trend: Increased Waterpipe Smoking</title>
  <langcode>en</langcode>
  <field_short_title>A Harmful Trend: Increased Waterpipe Smoking</field_short_title>
  <field_date_posted>2010-05-18</field_date_posted>
  <field_date_reviewed>2015-12-18</field_date_reviewed>
  <field_pretty_url>waterpipe-smoking</field_pretty_url>
  <para_id>1032053</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1007397</term_id>
  <id>1033175</id>
  <title>Profiles in Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Profiles in Cancer Research</field_short_title>
  <field_date_posted>2015-12-22</field_date_posted>
  <field_date_reviewed>2015-12-22</field_date_reviewed>
  <para_id>1033175</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1011698</term_id>
  <id>1033573</id>
  <title>Cancer Immunology, Hematology, and Etiology Research</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Immunology, Hematology, and Etiology Research</field_short_title>
  <field_page_description>Part of NCI’s Division of Cancer Biology’s research portfolio, studies supported include the characterization of basic mechanisms relevant to anti-tumor immune responses and hematologic malignancies. </field_page_description>
  <field_date_posted>2016-08-08</field_date_posted>
  <field_date_reviewed>2016-01-06</field_date_reviewed>
  <para_id>1033573</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1068137</term_id>
  <id>1068980</id>
  <title>Track 4: Cancer Prevention Product Research and Review for Postdoctoral Research Fellows</title>
  <langcode>en</langcode>
  <field_short_title>IOTF: Cancer Prevention Product Review</field_short_title>
  <field_page_description>NCI and FDA collaborate to train individuals in the medical product development and application process. Learn more about this cancer training program.</field_page_description>
  <field_date_posted>2016-12-12</field_date_posted>
  <field_date_reviewed>2016-12-12</field_date_reviewed>
  <para_id>1068980</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1068124</term_id>
  <id>1068988</id>
  <title>IOTF Mentors: Track 1 and Track 2</title>
  <langcode>en</langcode>
  <field_short_title>IOTF Mentors: Tracks 1 and 2</field_short_title>
  <field_page_description>While at FDA, fellows are assigned a mentor who is a senior member of FDA scientific review staff. Learn more about mentors for Tracks 1 and 2. </field_page_description>
  <field_date_posted>2016-12-12</field_date_posted>
  <field_date_reviewed>2016-12-12</field_date_reviewed>
  <field_pretty_url>mentors-track-1-2</field_pretty_url>
  <para_id>1068988</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1069392</id>
  <title>GICR Partners Task Force for Cancer Registration in Vietnam</title>
  <langcode>en</langcode>
  <field_short_title>GICR Partners Task Force for Cancer Registration in Vietnam</field_short_title>
  <field_page_description>Global taskforce aims strengthen population-based cancer registries with improved operations, access to case reports, and cancer surveillance.</field_page_description>
  <field_date_posted>2016-12-20</field_date_posted>
  <field_date_reviewed>2016-12-19</field_date_reviewed>
  <field_pretty_url>cancer-registration-vietnam</field_pretty_url>
  <para_id>1069392</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>940315</term_id>
  <id>1070677</id>
  <title>Nivolumab Improves Survival for Patients with Recurrent Head and Neck Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Nivolumab for Recurrent Head and Neck Cancer Improves Survival</field_short_title>
  <field_page_description>A summary of clinical trial results showing that nivolumab (Opdivo®) improved overall survival compared with standard chemotherapy in patients with head and neck squamous cell carcinoma.</field_page_description>
  <field_date_posted>2017-01-04</field_date_posted>
  <field_date_reviewed>2017-01-04</field_date_reviewed>
  <field_pretty_url>nivolumab-hnscc</field_pretty_url>
  <para_id>1070677</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1071062</id>
  <title>The Global Economic Burden of Tobacco: An Interview with Dr. Mark Parascandola</title>
  <langcode>en</langcode>
  <field_short_title>Economic Study of Global Tobacco Burden</field_short_title>
  <field_page_description>In an interview on Cancer Currents, Dr. Mark Parascandola discusses findings from an economics study showing that, globally, tobacco use burdens economies with more than US $1 trillion annually in health care costs and lost productivity.</field_page_description>
  <field_date_posted>2017-01-18</field_date_posted>
  <field_date_reviewed>2017-01-17</field_date_reviewed>
  <field_pretty_url>tobacco-global-economic-burden</field_pretty_url>
  <para_id>1071062</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1070068</term_id>
  <id>1071155</id>
  <title>Study finds premature death rates diverge in the United States by race and ethnicity</title>
  <langcode>en</langcode>
  <field_short_title>Premature death rates diverge in the United States</field_short_title>
  <field_page_description>An NCI press release on a study that shows premature death rates have declined in the United States among Hispanics, blacks, and Asian/Pacific Islanders but increased among whites and American Indian/Alaska Natives.</field_page_description>
  <field_date_posted>2017-01-25</field_date_posted>
  <field_date_reviewed>2017-01-20</field_date_reviewed>
  <field_pretty_url>premature-death-rates-diverge</field_pretty_url>
  <para_id>1071155</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070074</term_id>
  <id>1074765</id>
  <title>Democratizing Access to CCG Data: Cancer Genomics Cloud Pilots</title>
  <langcode>en</langcode>
  <field_short_title>Clouds Democratize CCG Data</field_short_title>
  <field_page_description>The cloud pilots provide access to NCI data and computational resources in the cloud, enabling diverse researchers to advance precision oncology.</field_page_description>
  <field_date_posted>2017-03-07</field_date_posted>
  <field_date_reviewed>2017-03-06</field_date_reviewed>
  <field_pretty_url>cloud-pilots-democratize-data</field_pretty_url>
  <para_id>1074765</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1078432</term_id>
  <id>1078687</id>
  <title>HIV and AIDS Research News &amp; Events</title>
  <langcode>en</langcode>
  <field_short_title>News &amp; Events</field_short_title>
  <field_page_description>OHAM monitors HIV/AIDS research and events. Keep up-to-date with news about HIV/AIDS-related cancer research and learn about relevant meetings and conferences.</field_page_description>
  <field_date_posted>2017-07-10</field_date_posted>
  <field_date_reviewed>2017-03-31</field_date_reviewed>
  <para_id>1078687</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1080186</id>
  <title>Avelumab Becomes First Approved Treatment for Patients with Merkel Cell Carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>Avelumab First Approved Drug for Rare Skin Cancer </field_short_title>
  <field_page_description>A Cancer Currents blog on the FDA’s first-ever approval of a drug for the rare skin cancer Merkel cell carcinoma and updated data on patients’ tumor responses.</field_page_description>
  <field_date_posted>2017-04-03</field_date_posted>
  <field_date_reviewed>2017-04-02</field_date_reviewed>
  <field_pretty_url>avelumab-fda-merkel-cell</field_pretty_url>
  <para_id>1080186</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1080368</term_id>
  <id>1080369</id>
  <title>Cancer Moonshot&amp;#8480; Blue Ribbon Panel Members</title>
  <langcode>en</langcode>
  <field_short_title>Blue Ribbon Panel Members</field_short_title>
  <field_page_description>Information about the Cancer Moonshot Blue Ribbon Panel of experts. The panel was established to ensure the Cancer Moonshot's goals and approaches are grounded in the best science.</field_page_description>
  <field_date_posted>2016-09-07</field_date_posted>
  <field_date_reviewed>2016-08-18</field_date_reviewed>
  <para_id>1080369</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>915112</term_id>
  <id>1033671</id>
  <title>Researcher Interview: Jinghui Zhang</title>
  <langcode>en</langcode>
  <field_short_title>Researcher Interview: Jinghui Zhang</field_short_title>
  <field_page_description>Center for Cancer Genomics Interview with Jinghui Zhang, Ph.D.</field_page_description>
  <field_date_posted>2016-01-12</field_date_posted>
  <field_date_reviewed>2016-01-08</field_date_reviewed>
  <field_pretty_url>jinghui-zhang-interview</field_pretty_url>
  <para_id>1033671</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1034077</term_id>
  <id>1034078</id>
  <title>Recurrent Cancer: When Cancer Comes Back</title>
  <langcode>en</langcode>
  <field_short_title>When Cancer Comes Back</field_short_title>
  <field_page_description>Cancer can recur when treatment doesn’t fully remove or destroy all the cancer cells. Learn about the different types of recurrence and how recurrent cancer is restaged and treated.</field_page_description>
  <field_date_posted>2016-01-18</field_date_posted>
  <field_date_reviewed>2016-01-18</field_date_reviewed>
  <para_id>1034078</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1034142</term_id>
  <id>1034143</id>
  <title>Support for Families When a Child Has Cancer                                                                                   </title>
  <langcode>en</langcode>
  <field_short_title>Support for Families When a Child Has Cancer</field_short_title>
  <field_page_description>When a child has been diagnosed with cancer, parents need practical advice and information. Learn how to talk with your child and their siblings about cancer. Get answers to commonly asked questions from parents and children. Tips to help you talk with your child’s doctor, during treatment, are included.</field_page_description>
  <field_date_posted>2016-01-20</field_date_posted>
  <field_date_reviewed>2018-03-22</field_date_reviewed>
  <para_id>1034143</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1035119</id>
  <title>NCI-MATCH: A Status Report and Future Directions</title>
  <langcode>en</langcode>
  <field_short_title>NCI-MATCH: A Status Report and Future Directions</field_short_title>
  <field_page_description>Leaders of the NCI-MATCH trial provide an update to the cancer community on the trial’s status and plans for it moving forward.</field_page_description>
  <field_date_posted>2016-02-01</field_date_posted>
  <field_date_reviewed>2016-02-01</field_date_reviewed>
  <field_pretty_url>nci-match-update</field_pretty_url>
  <para_id>1035119</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1035160</term_id>
  <id>1038560</id>
  <title>The CTD&lt;sup&gt;2&lt;/sup&gt; Dashboard: A Platform to Explore Evidence-based Observations</title>
  <langcode>en</langcode>
  <field_short_title>The CTD2 Dashboard</field_short_title>
  <field_page_description>Findings from CTD2 centers are displayed on the Dashboard for the community to explore. </field_page_description>
  <field_date_posted>2016-03-02</field_date_posted>
  <field_date_reviewed>2016-03-02</field_date_reviewed>
  <field_pretty_url>dashboard</field_pretty_url>
  <para_id>1038560</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1114581</id>
  <title>Study Shows Experimental Screening Test Can Detect Endometrial and Ovarian Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Experimental Test Detects Endometrial and Ovarian Cancers</field_short_title>
  <field_page_description>Finding a way to detect endometrial and ovarian cancers early, when they are most likely to respond to treatment, has been a challenge for cancer researchers. An experimental liquid biopsy test called PapSEEK may help to change that, this Cancer Currents post explains.</field_page_description>
  <field_date_posted>2018-05-02</field_date_posted>
  <field_date_reviewed>2018-05-02</field_date_reviewed>
  <field_pretty_url>liquid-biopsy-screening-test-endometrial-ovarian</field_pretty_url>
  <para_id>1114581</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1114846</term_id>
  <id>1114851</id>
  <title>Courses and Fellowships for Trainees and Fellows</title>
  <langcode>en</langcode>
  <field_short_title>Courses and Fellowships</field_short_title>
  <field_page_description>Cancer research fellows and trainees at NCI can take advantage of scientific and professional development courses. Current and prospective trainees will also find a listing of fellowships opportunities. Learn more about courses and fellowships. </field_page_description>
  <field_date_posted>2018-05-25</field_date_posted>
  <field_date_reviewed>2018-05-04</field_date_reviewed>
  <para_id>1114851</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1115758</term_id>
  <id>1115765</id>
  <title>Collaboration and Team Science: A Field Guide</title>
  <langcode>en</langcode>
  <field_short_title>Collaboration and Team Science</field_short_title>
  <field_page_description>Collaboration and Team Science: A Field Guide provides insight into the practices of conducting collaborative work. Since its 2010 publication, the authors have worked and learned from teams and organizations all over the world. Learn from these experiences in the second edition of the Team Science Field Guide.</field_page_description>
  <field_date_posted>2018-05-18</field_date_posted>
  <field_date_reviewed>2018-05-17</field_date_reviewed>
  <para_id>1115765</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>922517</term_id>
  <id>1117070</id>
  <title>Paulette Gray, Ph.D.</title>
  <langcode>en</langcode>
  <field_short_title>Paulette Gray, Ph.D.</field_short_title>
  <field_page_description>Paulette S. Gray, Ph.D. is the Director for the Division of Extramural Activities (DEA). As the director of the division, she is responsible for the overall scientific, fiscal, and administrative management of the division, including broad strategic planning, development, implementation, and evaluation.</field_page_description>
  <field_date_posted>2018-06-05</field_date_posted>
  <field_date_reviewed>2018-06-05</field_date_reviewed>
  <field_pretty_url>paulette-gray-bio</field_pretty_url>
  <para_id>1117070</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1134297</term_id>
  <id>1117589</id>
  <title>TCGA Timeline &amp; Milestones</title>
  <langcode>en</langcode>
  <field_short_title>Timeline &amp; Milestones</field_short_title>
  <field_date_posted>2018-06-13</field_date_posted>
  <field_date_reviewed>2018-06-13</field_date_reviewed>
  <para_id>1117589</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1118607</id>
  <title>Altering Chemotherapy Improves Outcomes in Early-Stage Pancreatic Cancer </title>
  <langcode>en</langcode>
  <field_short_title>Chemotherapy Change Improves Pancreatic Cancer Outcomes</field_short_title>
  <field_page_description>For people with early-stage pancreatic cancer, results from two clinical trials suggest that altering the type and timing of chemotherapy improves survival. The findings will likely change the standard of care, as this Cancer Currents post explains.</field_page_description>
  <field_date_posted>2018-06-28</field_date_posted>
  <field_date_reviewed>2018-06-27</field_date_reviewed>
  <field_pretty_url>pancreatic-cancer-chemotherapy-regimen-change</field_pretty_url>
  <para_id>1118607</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1118652</id>
  <title>NExT: Advancing Promising Cancer Therapies from the Lab to Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>NExT: Advancing Promising Cancer Therapies</field_short_title>
  <field_page_description>The NCI Experimental Therapeutics (NExT) program works with researchers and top scientific experts to advance promising or novel cancer therapies from the earliest stages of research to clinical trials. Learn about recent successes from NExT in this Cancer Currents blog post.</field_page_description>
  <field_date_posted>2018-06-29</field_date_posted>
  <field_date_reviewed>2018-06-28</field_date_reviewed>
  <field_pretty_url>next-developing-cancer-therapies</field_pretty_url>
  <para_id>1118652</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1119325</id>
  <title>Can Age Affect Response to Immune Checkpoint Inhibitors?</title>
  <langcode>en</langcode>
  <field_short_title>Patient Age and Response to Immune Checkpoint Inhibitors</field_short_title>
  <field_page_description>The age of patients with melanoma may influence how well their cancer responds to immune checkpoint inhibitors. As this Cancer Currents post explains, researchers who led the study believe the findings may point to a strategy to improve responses to these immunotherapy drugs.</field_page_description>
  <field_date_posted>2018-07-06</field_date_posted>
  <field_date_reviewed>2018-07-03</field_date_reviewed>
  <field_pretty_url>age-checkpoint-inhibitor-response</field_pretty_url>
  <para_id>1119325</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1102622</term_id>
  <id>1119629</id>
  <title>NIH and Prostate Cancer Foundation launch large study on aggressive prostate cancer in African-American men</title>
  <langcode>en</langcode>
  <field_short_title>NIH, PCF launch study on prostate cancer in black men</field_short_title>
  <field_page_description>RESPOND is the largest coordinated study on biological and non-biological factors associated with aggressive prostate cancer in African-American men. The study is an effort to learn why these men disproportionally experience aggressive disease.</field_page_description>
  <field_date_posted>2018-07-17</field_date_posted>
  <field_date_reviewed>2018-07-10</field_date_reviewed>
  <field_pretty_url>respond-prostate-black-men</field_pretty_url>
  <para_id>1119629</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1111088</id>
  <title>Cancer Immunotherapy Drug Simultaneously Targets Two Proteins that Block Immune Response</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Immunotherapy Drug Targets Two Proteins</field_short_title>
  <field_page_description>Two groups of researchers, working independently, have fused a TGF-beta receptor to a monoclonal antibody that targets a checkpoint protein. The result, this Cancer Currents blog describes, is a single hybrid molecule called a Y-trap that blocks two pathways used by tumors to evade the immune system.</field_page_description>
  <field_date_posted>2018-04-04</field_date_posted>
  <field_date_reviewed>2018-03-27</field_date_reviewed>
  <field_pretty_url>y-trap-immunotherapy-drug</field_pretty_url>
  <para_id>1111088</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1102622</term_id>
  <id>1112136</id>
  <title>NIH completes in-depth genomic analysis of 33 cancer types</title>
  <langcode>en</langcode>
  <field_short_title>NIH completes PanCancer Atlas</field_short_title>
  <field_page_description>The NIH’s TCGA program concludes with the PanCancer Atlas, an in-depth genomic analysis of 33 cancer types. Findings are being published as a collection of 27 papers across multiple Cell journals.</field_page_description>
  <field_date_posted>2018-04-05</field_date_posted>
  <field_date_reviewed>2018-04-04</field_date_reviewed>
  <field_pretty_url>tcga-pancancer-atlas</field_pretty_url>
  <para_id>1112136</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1114603</id>
  <title>Rucaparib Approved as Maintenance Treatment for Some Recurrent Ovarian Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Rucaparib Approved as Maintenance Therapy for Ovarian Cancer</field_short_title>
  <field_page_description>FDA has expanded its approval of rucaparib for women with ovarian, fallopian tube, or primary peritoneal cancer. As this Cancer Currents blog post explains, it can now be used to treat women with recurrent disease whose tumors shrank after subsequent treatment with a platinum-based chemotherapy.</field_page_description>
  <field_date_posted>2018-05-04</field_date_posted>
  <field_date_reviewed>2018-05-03</field_date_reviewed>
  <field_pretty_url>rucaparib-fda-ovarian-cancer-maintenance-therapy</field_pretty_url>
  <para_id>1114603</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1114840</term_id>
  <id>1114852</id>
  <title>Resources for Trainees</title>
  <langcode>en</langcode>
  <field_short_title>Resources for Trainees</field_short_title>
  <field_page_description>Fellows and cancer research trainees can find orientation, community involvement, and career development information. Learn more about resources for trainees. </field_page_description>
  <field_date_posted>2018-05-25</field_date_posted>
  <field_date_reviewed>2018-05-04</field_date_reviewed>
  <para_id>1114852</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102630</term_id>
  <id>1115383</id>
  <title>After TCGA: Building Clinical Genomic Resources</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Genomic Resources</field_short_title>
  <field_page_description>Clinical focus on upcoming cancer characterization projects after TCGA</field_page_description>
  <field_date_posted>2018-05-16</field_date_posted>
  <field_date_reviewed>2018-05-15</field_date_reviewed>
  <field_pretty_url>After-TCGA</field_pretty_url>
  <para_id>1115383</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102626</term_id>
  <id>1116317</id>
  <title>Tobacco Breaks Hearts: World No Tobacco Day 2018</title>
  <langcode>en</langcode>
  <field_short_title>Tobacco Breaks Hearts: World No Tobacco Day 2018</field_short_title>
  <field_page_description>This year World No Tobacco Day highlights the impact of tobacco use on heart disease under the banner “Tobacco Breaks Hearts.” Read more about the effects of tobacco use on your health.</field_page_description>
  <field_date_posted>2018-05-24</field_date_posted>
  <field_date_reviewed>2018-05-24</field_date_reviewed>
  <field_pretty_url>wntd</field_pretty_url>
  <para_id>1116317</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1102622</term_id>
  <id>1116592</id>
  <title>TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy </title>
  <langcode>en</langcode>
  <field_short_title>TAILORx finds no chemotherapy benefit for most early breast cancers</field_short_title>
  <field_page_description>Findings from the TAILORx clinical trial show chemotherapy does not benefit most women with early breast cancer. The new data, released at the 2018 ASCO annual meeting, will help inform treatment decisions for many women with early-stage breast cancer.</field_page_description>
  <field_date_posted>2018-06-03</field_date_posted>
  <field_date_reviewed>2018-05-31</field_date_reviewed>
  <field_pretty_url>tailorx-breast-cancer-chemotherapy</field_pretty_url>
  <para_id>1116592</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1117036</id>
  <title>Toxin-Based Drug Moxetumomab Pasudotox May Be New Option for Rare Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Toxin-Based Drug May Be New Option for Rare Leukemia</field_short_title>
  <field_page_description>In patients with hairy cell leukemia, the toxin-based treatment moxetumomab pasudotox may be an effective new treatment option. As this Cancer Currents post explains, the drug looked to be highly effective in a large clinical trial.</field_page_description>
  <field_date_posted>2018-06-05</field_date_posted>
  <field_date_reviewed>2018-06-04</field_date_reviewed>
  <field_pretty_url>hairy-cell-leukemia-moxetumomab</field_pretty_url>
  <para_id>1117036</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>922517</term_id>
  <id>1117067</id>
  <title>Donna Siegle</title>
  <langcode>en</langcode>
  <field_short_title>Donna Siegle</field_short_title>
  <field_page_description>Donna Siegle serves as the NCI Acting Executive Officer, responsible for leading the NCI Office of Management (OM). </field_page_description>
  <field_date_posted>2018-06-05</field_date_posted>
  <field_date_reviewed>2018-06-05</field_date_reviewed>
  <field_pretty_url>donna-siegle-bio</field_pretty_url>
  <para_id>1117067</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1119642</term_id>
  <id>1119646</id>
  <title>Cancer Research Training Award (CRTA)</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Research Training Award (CRTA)</field_short_title>
  <field_page_description>The Cancer Research Training Award (CRTA) is an NCI fellowship award with an “umbrella” appointment mechanism for fellowship programs within NCI divisions, offices, and centers. Learn more about CRTA at NCI. </field_page_description>
  <field_date_posted>2018-07-11</field_date_posted>
  <field_date_reviewed>2018-07-11</field_date_reviewed>
  <para_id>1119646</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1102622</term_id>
  <id>1121214</id>
  <title>NCI-led research team develops predictor for immunotherapy response in melanoma</title>
  <langcode>en</langcode>
  <field_short_title>IMPRES predicts which melanomas will respond to immunotherapy </field_short_title>
  <field_page_description>In a new study, NCI-led researchers developed a gene expression predictor that can indicate whether melanoma in a specific patient is likely to respond to treatment with immune checkpoint inhibitors, a type of immunotherapy.</field_page_description>
  <field_date_posted>2018-08-20</field_date_posted>
  <field_date_reviewed>2018-07-31</field_date_reviewed>
  <field_pretty_url>melanoma-immunotherapy-predictor</field_pretty_url>
  <para_id>1121214</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1121282</id>
  <title>Combination of Immunotherapy Drugs Approved for Metastatic Colorectal Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Immunotherapy Combination Approved for Colorectal Cancer</field_short_title>
  <field_page_description>The combination of the immune checkpoint inhibitors ipilimumab (Yervoy) and nivolumab (Opdivo) has been approved by FDA for the treatment of patients with metastatic colorectal cancer whose tumor cells have DNA repair defects.</field_page_description>
  <field_date_posted>2018-08-03</field_date_posted>
  <field_date_reviewed>2018-08-03</field_date_reviewed>
  <field_pretty_url>fda-ipilimumab-nivolumab-colorectal-dna-repair</field_pretty_url>
  <para_id>1121282</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1121484</id>
  <title>TCGA's Study of Cutaneous Melanoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Cutaneous Melanoma</field_short_title>
  <field_page_description>TCGA's Study of Cutaneous Melanoma</field_page_description>
  <field_date_posted>2018-08-06</field_date_posted>
  <field_date_reviewed>2018-08-06</field_date_reviewed>
  <field_pretty_url>melanoma-skin</field_pretty_url>
  <para_id>1121484</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1121667</id>
  <title>TCGA's Study of Lower Grade Glioma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Lower Grade Glioma</field_short_title>
  <field_page_description>TCGA's Study of Lower Grade Glioma</field_page_description>
  <field_date_posted>2018-08-08</field_date_posted>
  <field_date_reviewed>2018-08-08</field_date_reviewed>
  <field_pretty_url>glioma</field_pretty_url>
  <para_id>1121667</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1121733</id>
  <title>Targeted Drug Approved for Acute Myeloid Leukemia with IDH1 Gene Mutations</title>
  <langcode>en</langcode>
  <field_short_title>Ivosidenib Approved for Acute Myeloid Leukemia</field_short_title>
  <field_page_description>FDA has approved ivosidenib (Tibsovo) for the treatment of adults with acute myeloid leukemia (AML) that has a specific mutation in a gene called IDH1. Ivosidenib becomes the first FDA-approved treatment that targets IDH1. </field_page_description>
  <field_date_posted>2018-08-13</field_date_posted>
  <field_date_reviewed>2018-08-10</field_date_reviewed>
  <field_pretty_url>ivosidenib-aml-fda-approval</field_pretty_url>
  <para_id>1121733</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>1123473</id>
  <title>Drugs Approved for Pheochromocytoma and Paraganglioma </title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Pheochromocytoma and Paraganglioma </field_short_title>
  <field_page_description>Find information about drugs for Pheochromocytoma and Paraganglioma. The drugs listed have been approved by the Food and Drug Administration (FDA) and include both generic and brand names.</field_page_description>
  <field_date_posted>2018-08-24</field_date_posted>
  <field_date_reviewed>2018-08-24</field_date_reviewed>
  <field_pretty_url>pheochromocytoma-paraganglioma</field_pretty_url>
  <para_id>1123473</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1123732</id>
  <title>Study Provides Closer Look at Postmenopausal Bleeding and Endometrial Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Closer Look at Postmenopausal Bleeding and Endometrial Cancer</field_short_title>
  <field_page_description>A new study shows that 90% of postmenopausal women diagnosed with endometrial cancer reported vaginal bleeding before their diagnosis. Approximately 9% of women who saw a doctor for bleeding, the study showed, later received an endometrial cancer diagnosis.</field_page_description>
  <field_date_posted>2018-08-29</field_date_posted>
  <field_date_reviewed>2018-08-28</field_date_reviewed>
  <field_pretty_url>endometrial-cancer-bleeding-common-symptom</field_pretty_url>
  <para_id>1123732</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1123971</id>
  <title>Exosomes May Help Tumors Evade Immune System</title>
  <langcode>en</langcode>
  <field_short_title>Exosomes May Help Tumors Evade Immune System</field_short_title>
  <field_page_description>Exosomes studded with the PD-L1 protein may help cancers evade the immune system, findings from a new study suggest. The presence of exosomes bearing the immune checkpoint protein could be a treatment biomarker, as this Cancer Currents post explains.</field_page_description>
  <field_date_posted>2018-09-07</field_date_posted>
  <field_date_reviewed>2018-09-06</field_date_reviewed>
  <field_pretty_url>exosomes-tumors-evade-immune-system</field_pretty_url>
  <para_id>1123971</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1124104</term_id>
  <id>1124105</id>
  <title>Prevention and Early Detection of Hereditary Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Hereditary Cancer Prevention &amp; Detection </field_short_title>
  <field_page_description>This Moonshot initiative aims to develop effective cancer prevention and early detection approaches for those at high risk for inherited cancer syndromes and implement appropriate clinical management.</field_page_description>
  <field_date_posted>2018-10-22</field_date_posted>
  <field_date_reviewed>2018-08-08</field_date_reviewed>
  <para_id>1124105</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1129049</term_id>
  <id>1119757</id>
  <title>TCGA Research Network Publications</title>
  <langcode>en</langcode>
  <field_short_title>TCGA Publications</field_short_title>
  <field_date_posted>2018-10-30</field_date_posted>
  <field_date_reviewed>2018-07-12</field_date_reviewed>
  <para_id>1119757</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1120625</id>
  <title>TCGA's Study of Breast Ductal Carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Breast Ductal Carcinoma</field_short_title>
  <field_page_description>TCGA's Study of Breast Ductal Carcinoma</field_page_description>
  <field_date_posted>2018-07-26</field_date_posted>
  <field_date_reviewed>2018-07-26</field_date_reviewed>
  <field_pretty_url>breast-ductal</field_pretty_url>
  <para_id>1120625</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1121522</id>
  <title>TCGA's Study of Head and Neck Squamous Cell Carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Head and Neck Squamous Cell Carcinoma</field_short_title>
  <field_page_description>TCGA's Study of Head and Neck Squamous Cell Carcinoma</field_page_description>
  <field_date_posted>2018-08-07</field_date_posted>
  <field_date_reviewed>2018-08-07</field_date_reviewed>
  <field_pretty_url>head-and-neck</field_pretty_url>
  <para_id>1121522</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1121561</id>
  <title>Tailored Psychotherapy Eases Depression in People with Advanced Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Easing Depression in People with Advanced Cancer</field_short_title>
  <field_page_description>In people recently diagnosed with advanced cancer, a tailored psychotherapy approach called CALM lessened symptoms of depression, results from a clinical trial show. The approach also may help prevent depression, this Cancer Currents post explains.</field_page_description>
  <field_date_posted>2018-08-09</field_date_posted>
  <field_date_reviewed>2018-08-07</field_date_reviewed>
  <field_pretty_url>advanced-cancer-calm-therapy-reduces-depression</field_pretty_url>
  <para_id>1121561</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1123401</id>
  <title>Enhancements to NCI’s SEER Program Creating New Research Opportunities</title>
  <langcode>en</langcode>
  <field_short_title>SEER Creating New Research Opportunities</field_short_title>
  <field_page_description>NCI’s SEER program is expanding and operating a series of pilot studies that, as Dr. Lynne Penberthy explains, are focused on the routine collection of more clinical and genomic data to help researchers better understand cancer and its impact.</field_page_description>
  <field_date_posted>2018-08-23</field_date_posted>
  <field_date_reviewed>2018-08-23</field_date_reviewed>
  <field_pretty_url>nci-seer-enhancements-creating-opportunities</field_pretty_url>
  <para_id>1123401</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1123783</id>
  <title>Two Drugs Work Together to Block ‘Master Regulator’ of Breast, Other Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Drug Combination Blocks Driver of Breast and Other Cancers</field_short_title>
  <field_page_description>Arsenic trioxide and retinoic acid work together to target Pin1, a master regulator protein that drives breast and other cancers. The findings could spur clinical trials, as this Cancer Currents blog explains.</field_page_description>
  <field_date_posted>2018-09-04</field_date_posted>
  <field_date_reviewed>2018-09-04</field_date_reviewed>
  <field_pretty_url>arsenic-retinoic-acid-cancer-master-regulator</field_pretty_url>
  <para_id>1123783</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1123937</id>
  <title>TCGA's Study of Lung Squamous Cell Carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Lung Squamous Cell Carcinoma</field_short_title>
  <field_page_description>TCGA's Study of Lung Squamous Cell Carcinoma</field_page_description>
  <field_date_posted>2018-09-05</field_date_posted>
  <field_date_reviewed>2018-09-05</field_date_reviewed>
  <field_pretty_url>lung-squamous</field_pretty_url>
  <para_id>1123937</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1124474</id>
  <title>Nivolumab and Ipilimumab Effective against Melanoma That Has Spread to the Brain</title>
  <langcode>en</langcode>
  <field_short_title>Immunotherapy Drugs Shrink Brain Metastases from Melanoma</field_short_title>
  <field_page_description>In patients with melanoma that has spread to the brain, the combination of the immune checkpoint inhibitors nivolumab (Opdivo) and ipilimumab (Yervoy) halted the growth of or shrank metastatic brain tumors, an early phase clinical trial shows. </field_page_description>
  <field_date_posted>2018-09-20</field_date_posted>
  <field_date_reviewed>2018-09-18</field_date_reviewed>
  <field_pretty_url>melanoma-brain-metastases-nivolumab-ipilimumab</field_pretty_url>
  <para_id>1124474</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1090878</term_id>
  <id>1124679</id>
  <title>Annual Plan and Budget Proposal FY 2020 Coming Soon</title>
  <langcode>en</langcode>
  <field_short_title>Annual Plan and Budget Proposal FY 2020 Coming Soon</field_short_title>
  <field_page_description>Annual Plan and Budget Proposal FY 2020 Coming Soon</field_page_description>
  <field_date_posted>2018-09-20</field_date_posted>
  <field_date_reviewed>2018-09-20</field_date_reviewed>
  <field_pretty_url>placeholder</field_pretty_url>
  <para_id>1124679</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1125012</id>
  <title>The R50 Research Specialist Award: Ensuring a Stable Cancer Research Workforce</title>
  <langcode>en</langcode>
  <field_short_title>Ensuring a Stable Cancer Research Workforce</field_short_title>
  <field_page_description>NCI’s R50 Research Specialist Award was launched in 2016 to help sustain a stable workforce of experienced scientists who can take fullest advantage of advanced technologies and the era of big data.</field_page_description>
  <field_date_posted>2018-09-27</field_date_posted>
  <field_date_reviewed>2018-09-27</field_date_reviewed>
  <field_pretty_url>nci-r50-research-specialist-award</field_pretty_url>
  <para_id>1125012</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>916700</term_id>
  <id>1126528</id>
  <title>Resources for Researchers</title>
  <langcode>en</langcode>
  <field_short_title>Resources for Researchers</field_short_title>
  <field_page_description>Resources for Researchers is a directory of NCI-supported tools and services for cancer researchers. </field_page_description>
  <field_date_posted>2018-10-15</field_date_posted>
  <field_date_reviewed>2018-10-15</field_date_reviewed>
  <para_id>1126528</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1040844</id>
  <title>Annual Report to the Nation: Cancer Death Rates Continue to Decline; &lt;i&gt;Increase in Liver Cancer Deaths Cause For Concern&lt;/i&gt;</title>
  <langcode>en</langcode>
  <field_short_title>Annual Report to the Nation: Cancer Death Rates Continue to Decline</field_short_title>
  <field_page_description>The Report to the Nation on the Status of Cancer (1975-2012) shows that death rates continued to decline for all cancers combined, as well as for most cancer sites for men and women, as well as for most cancer sites for men and women.</field_page_description>
  <field_date_posted>2016-03-09</field_date_posted>
  <field_date_reviewed>2016-03-07</field_date_reviewed>
  <field_pretty_url>annual-report-nation-1975-2012</field_pretty_url>
  <para_id>1040844</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1041012</id>
  <title>Novel Strategy Isolates Immune Cells in the Blood that Recognize Melanoma</title>
  <langcode>en</langcode>
  <field_short_title>Identifying Immune Cells in Blood that Recognize Tumors</field_short_title>
  <field_page_description>NCI scientists have developed a novel strategy for identifying immune cells circulating in the blood that recognize specific proteins on tumor cells, a finding they believe may have potential implications for immune-based therapies.</field_page_description>
  <field_date_posted>2016-03-11</field_date_posted>
  <field_date_reviewed>2016-03-10</field_date_reviewed>
  <field_pretty_url>reactive-immune-cells-blood</field_pretty_url>
  <para_id>1041012</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1042060</id>
  <title>Blue Ribbon Panel announced to help guide Vice President Biden’s National Cancer Moonshot Initiative</title>
  <langcode>en</langcode>
  <field_short_title>Blue Ribbon Panel announced to help guide Vice President Biden’s National Cancer Moonshot Initiative</field_short_title>
  <field_page_description>The Blue Ribbon Panel, a working group of the National Cancer Advisory Board, will recommend how best to advance the themes of the National Cancer Moonshot Initiative. </field_page_description>
  <field_date_posted>2016-04-04</field_date_posted>
  <field_date_reviewed>2016-03-24</field_date_reviewed>
  <field_pretty_url>blue-ribbon-panel-announced</field_pretty_url>
  <para_id>1042060</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1044319</id>
  <title>Toward Precision Therapy for Children with Cancer: An Interview with Dr. Javed Khan</title>
  <langcode>en</langcode>
  <field_short_title>Toward Precision Therapy for Children with Cancer: An Interview with Dr. Javed Khan</field_short_title>
  <field_page_description>NCI’s Dr. Javed Khan discusses a new NCI clinical program and the promise and challenges of genome-guided therapy for children with cancer.</field_page_description>
  <field_date_posted>2016-04-13</field_date_posted>
  <field_date_reviewed>2016-04-12</field_date_reviewed>
  <field_pretty_url>nci-clinomics-pediatric</field_pretty_url>
  <para_id>1044319</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1047145</id>
  <title>Strengthening relations with Latin American countries through health diplomacy</title>
  <langcode>en</langcode>
  <field_short_title>Strengthening relations with Latin American countries through health diplomacy</field_short_title>
  <field_date_posted>2016-04-22</field_date_posted>
  <field_date_reviewed>2016-04-22</field_date_reviewed>
  <field_pretty_url>diplomacy</field_pretty_url>
  <para_id>1047145</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1047410</id>
  <title>Venetoclax Approved for Some Patients with Chronic Lymphocytic Leukemia </title>
  <langcode>en</langcode>
  <field_short_title>Venetoclax for Chronic Lymphocytic Leukemia</field_short_title>
  <field_page_description>The FDA has approved venetoclax for patients with chronic lymphocytic leukemia (CLL) whose tumors have a specific genetic alteration.</field_page_description>
  <field_date_posted>2016-05-04</field_date_posted>
  <field_date_reviewed>2016-04-27</field_date_reviewed>
  <field_pretty_url>venetoclax-cll</field_pretty_url>
  <para_id>1047410</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1002055</term_id>
  <id>1047991</id>
  <title>Genomic Data Sharing (GDS) Policy</title>
  <langcode>en</langcode>
  <field_short_title>Genomic Data Sharing Policy</field_short_title>
  <field_page_description>The NIH Genomic Data Sharing (GDS) Policy was issued to promote broad sharing of genomic research data and ensure oversight and protections for research involving human data. </field_page_description>
  <field_date_posted>2016-05-06</field_date_posted>
  <field_date_reviewed>2016-05-06</field_date_reviewed>
  <para_id>1047991</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1050939</id>
  <title>Online Tool Helps Users Distinguish Moles from Melanoma</title>
  <langcode>en</langcode>
  <field_short_title>Online Tool Helps Users Distinguish Moles from Melanoma</field_short_title>
  <field_page_description>“Moles to Melanoma: Recognizing the ABCDE Features” presents photos that show changes in individual pigmented lesions over time, and describes the different appearances of moles, dysplastic nevi, and melanomas.</field_page_description>
  <field_date_posted>2016-05-23</field_date_posted>
  <field_date_reviewed>2016-05-23</field_date_reviewed>
  <field_pretty_url>moles-to-melanoma</field_pretty_url>
  <para_id>1050939</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>916998</term_id>
  <id>1051328</id>
  <title>Clinical Trial Registration, Amendments, and Updates</title>
  <langcode>en</langcode>
  <field_short_title>Trial Registration, Amendments, and Updates</field_short_title>
  <field_page_description>Policies on clinical trial registration, amendments and updates related to CTRP.</field_page_description>
  <field_date_posted>2016-05-25</field_date_posted>
  <field_date_reviewed>2016-05-25</field_date_reviewed>
  <para_id>1051328</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1035160</term_id>
  <id>1051445</id>
  <title>The Genomic Data Commons Launches</title>
  <langcode>en</langcode>
  <field_short_title>NCI Genomic Data Commons Launches</field_short_title>
  <field_date_posted>2016-06-06</field_date_posted>
  <field_date_reviewed>2016-05-26</field_date_reviewed>
  <field_pretty_url>gdc-launches</field_pretty_url>
  <para_id>1051445</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1048567</term_id>
  <id>1048568</id>
  <title>Intramural Investigators Submitting Data</title>
  <langcode>en</langcode>
  <field_short_title>Intramural Investigators Submitting Data</field_short_title>
  <field_page_description>Find general requirements for intramural investigators submitting genomic data. Different processes may exist based on operational differences in NCI intramural research programs. </field_page_description>
  <field_date_posted>2016-05-13</field_date_posted>
  <field_date_reviewed>2016-05-13</field_date_reviewed>
  <para_id>1048568</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1050046</id>
  <title>A short narrative - Challenges and opportunities in expanding research in the Middle East, North Africa Region</title>
  <langcode>en</langcode>
  <field_short_title>A short narrative - Challenges and opportunities in expanding research in the Middle East, North Afr</field_short_title>
  <field_date_posted>2016-05-18</field_date_posted>
  <field_date_reviewed>2016-05-18</field_date_reviewed>
  <field_pretty_url>mena</field_pretty_url>
  <para_id>1050046</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1052074</id>
  <title>Patient-Derived Antibody Appears to Selectively Target Tumor Cells, Spur Immune Attack</title>
  <langcode>en</langcode>
  <field_short_title>Antibody Targets Tumor Cells, Spurs Immune Attack</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on an antibody derived from patients that killed tumor cells in cell lines of several cancer types and slowed tumor growth in mouse models of brain and lung cancer without evidence of side effects.</field_page_description>
  <field_date_posted>2016-06-06</field_date_posted>
  <field_date_reviewed>2016-06-06</field_date_reviewed>
  <field_pretty_url>cfh-antibody</field_pretty_url>
  <para_id>1052074</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1052543</id>
  <title>Blood Test for Genetic Changes in Tumors Shows Promise as Alternative to Tumor Biopsy</title>
  <langcode>en</langcode>
  <field_short_title>Blood Test Shows Promise as Alternative to Tumor Biopsy</field_short_title>
  <field_page_description>An NCI Cancer Currents blog about a study which showed that a so-called liquid biopsy produced results highly similar to those of traditional tumor biopsies.</field_page_description>
  <field_date_posted>2016-06-14</field_date_posted>
  <field_date_reviewed>2016-06-14</field_date_reviewed>
  <field_pretty_url>asco-liquid-biopsy</field_pretty_url>
  <para_id>1052543</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1052784</id>
  <title>Addressing a silent killer - The International Conference on Betel Quid and Areca Nut</title>
  <langcode>en</langcode>
  <field_short_title>Addressing a silent killer - The International Conference on Betel Quid and Areca Nut</field_short_title>
  <field_date_posted>2016-06-20</field_date_posted>
  <field_date_reviewed>2016-06-20</field_date_reviewed>
  <field_pretty_url>betel_quid</field_pretty_url>
  <para_id>1052784</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1054392</id>
  <title>NCI launches largest-ever study of breast cancer genetics in black women</title>
  <langcode>en</langcode>
  <field_short_title>NCI launches largest-ever study of breast cancer genetics in black women</field_short_title>
  <field_page_description>The Breast Cancer Genetic Study in African-Ancestry Populations initiative is a collaborative research project that will identify genetic factors that may underlie breast cancer disparities.</field_page_description>
  <field_date_posted>2016-07-06</field_date_posted>
  <field_date_reviewed>2016-07-05</field_date_reviewed>
  <field_pretty_url>breast-cancer-genetics-black-women</field_pretty_url>
  <para_id>1054392</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915373</term_id>
  <id>1055261</id>
  <title>Seeking Cancer Clues in Blood, Researchers Explore Exosomes </title>
  <langcode>en</langcode>
  <field_short_title>Seeking Cancer Clues in Blood, Researchers Explore Exosomes</field_short_title>
  <field_page_description>A feature-length Research Update article about exploring ways to use vesicles known as exosomes to develop new clinical tests and tools for patients with cancer. </field_page_description>
  <field_date_posted>2016-07-12</field_date_posted>
  <field_date_reviewed>2016-07-12</field_date_reviewed>
  <field_pretty_url>exosomes</field_pretty_url>
  <para_id>1055261</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1055682</id>
  <title>New on NCI's Websites for July 2016</title>
  <langcode>en</langcode>
  <field_short_title>New on NCI’s Websites for July 2016</field_short_title>
  <field_page_description>NCI periodically provides updates on new websites and other online content of interest to the cancer community.</field_page_description>
  <field_date_posted>2016-07-15</field_date_posted>
  <field_date_reviewed>2016-07-15</field_date_reviewed>
  <field_pretty_url>new-online-july-2016</field_pretty_url>
  <para_id>1055682</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>417547</term_id>
  <id>1057088</id>
  <title>Scientific Steering Committees</title>
  <langcode>en</langcode>
  <field_short_title>Scientific Steering Committees</field_short_title>
  <field_page_description>A functional overview of NCI's Scientific Steering Committees (SSCs). SSCs are tasked with evaluating and prioritizing clinical trials based on scientific merit in a transparent process.</field_page_description>
  <field_date_posted>2016-07-27</field_date_posted>
  <field_date_reviewed>2016-07-27</field_date_reviewed>
  <para_id>1057088</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1057845</id>
  <title>Mutations Linked to Immunotherapy Resistance</title>
  <langcode>en</langcode>
  <field_short_title>Mutations Linked to Immunotherapy Resistance</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on a study that identified acquired mutations in relapsed melanoma tumors that led to resistance to the checkpoint inhibitor pembrolizumab.</field_page_description>
  <field_date_posted>2016-08-05</field_date_posted>
  <field_date_reviewed>2016-08-02</field_date_reviewed>
  <field_pretty_url>immunotherapy-resistance-melanoma</field_pretty_url>
  <para_id>1057845</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1061101</id>
  <title>Tumor DNA in Blood May Signal Response to T-Cell Transfer Immunotherapy </title>
  <langcode>en</langcode>
  <field_short_title>Tumor DNA in Blood May Signal Immunotherapy Response</field_short_title>
  <field_page_description>An NCI Cancer Currents blog about using tumor DNA in blood as a marker of response for a form of immunotherapy.</field_page_description>
  <field_date_posted>2016-08-31</field_date_posted>
  <field_date_reviewed>2016-08-30</field_date_reviewed>
  <field_pretty_url>ctdna-immunotherapy-response</field_pretty_url>
  <para_id>1061101</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1084982</id>
  <title>Counseling Improves Survivorship Plan Implementation for Low-Income Breast Cancer Survivors</title>
  <langcode>en</langcode>
  <field_short_title>Counseling Improves Survivorship Care Plan Implementation</field_short_title>
  <field_page_description>A Cancer Currents blog post on a randomized trial that showed that low-income women who received counseling and a survivorship care plan got improved follow-up care</field_page_description>
  <field_date_posted>2017-05-16</field_date_posted>
  <field_date_reviewed>2017-05-15</field_date_reviewed>
  <field_pretty_url>counseling-survivorship-care</field_pretty_url>
  <para_id>1084982</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>937976</term_id>
  <id>1085271</id>
  <title>Exceptional Responders Initiative: Questions and Answers</title>
  <langcode>en</langcode>
  <field_short_title>Exceptional Responders Initiative: Questions and Answers</field_short_title>
  <field_page_description>NCI has embarked on the Exceptional Responders Initiative to understand the molecular underpinnings of exceptional responses to treatment, primarily via chemotherapy, in cancer patients.</field_page_description>
  <field_date_posted>2017-05-17</field_date_posted>
  <field_date_reviewed>2017-05-17</field_date_reviewed>
  <field_pretty_url>exceptional-responders-initiative-qa</field_pretty_url>
  <para_id>1085271</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1087111</id>
  <title>CAR T Cells: Expanding into Multiple Myeloma</title>
  <langcode>en</langcode>
  <field_short_title>CAR T Cells Expanding into Multiple Myeloma</field_short_title>
  <field_page_description>CAR T-cell therapy is showing promise in multiple myeloma, according to recently presented data from two early-phase clinical trials. </field_page_description>
  <field_date_posted>2017-06-12</field_date_posted>
  <field_date_reviewed>2017-06-09</field_date_reviewed>
  <field_pretty_url>car-t-cell-multiple-myeloma</field_pretty_url>
  <para_id>1087111</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>848639</term_id>
  <id>1087287</id>
  <title>CURE Honors</title>
  <langcode>en</langcode>
  <field_short_title>CURE Honors</field_short_title>
  <field_page_description>In celebration of 21 years of the CURE program, CRCHD honors outstanding CURE scholars, mentors, and champions.</field_page_description>
  <field_date_posted>2017-06-13</field_date_posted>
  <field_date_reviewed>2017-06-13</field_date_reviewed>
  <field_pretty_url>honors</field_pretty_url>
  <para_id>1087287</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1088503</id>
  <title>FDA Expands Approval of Ceritinib for ALK-Positive Non-Small Cell Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Expands Ceritinib Approval for Lung Cancer</field_short_title>
  <field_page_description>A Cancer Currents blog on the FDA approval of ceritinib for patients with untreated ALK-positive non-small cell lung cancer and a clinical trial of alectinib as a first-line lung cancer treatment.</field_page_description>
  <field_date_posted>2017-06-27</field_date_posted>
  <field_date_reviewed>2017-06-27</field_date_reviewed>
  <field_pretty_url>fda-ceritinib-nsclc</field_pretty_url>
  <para_id>1088503</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070072</term_id>
  <id>1088703</id>
  <title>RAS and MYC: Co-conspirators in Cancer</title>
  <langcode>en</langcode>
  <field_short_title>RAS and MYC: Co-conspirators in Cancer</field_short_title>
  <field_page_description>Inhibiting post-translational modifications of MYC to decrease its transcriptional activity is a new strategy for treating RAS-driven cancers.</field_page_description>
  <field_date_posted>2017-07-13</field_date_posted>
  <field_date_reviewed>2017-06-29</field_date_reviewed>
  <field_pretty_url>myc-ras</field_pretty_url>
  <para_id>1088703</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1089961</id>
  <title>Two-Drug Combination Approved for Lung Cancers with BRAF Mutations</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Drugs for Lung Cancers with BRAF Mutations</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on FDA’s approval of dabrafenib (Tafinlar®) plus trametinib (Mekinist®) for the treatment of metastatic non-small cell lung cancer with the BRAF V600E mutation.</field_page_description>
  <field_date_posted>2017-07-18</field_date_posted>
  <field_date_reviewed>2017-07-17</field_date_reviewed>
  <field_pretty_url>fda-trametinib-dabrafenib-lung-cancer</field_pretty_url>
  <para_id>1089961</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>911277</term_id>
  <id>1090830</id>
  <title>Types of Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Types of Cancer Treatment</field_short_title>
  <field_page_description>This page lists the different cancer treatments, including chemotherapy, radiation therapy, immunotherapy, and targeted therapy and takes you to more information about each type.</field_page_description>
  <field_date_posted>2017-07-31</field_date_posted>
  <field_date_reviewed>2017-07-31</field_date_reviewed>
  <para_id>1090830</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1091320</id>
  <title>Dual-Biomarker Blood Test Shows Promise for Pancreatic Cancer Early Detection</title>
  <langcode>en</langcode>
  <field_short_title>Test Shows Promise for Pancreatic Cancer Early Detection</field_short_title>
  <field_page_description>A new blood test may accurately detect pancreatic cancer at its earliest stages, when it is most likely to respond to treatment, findings from a new study suggest.</field_page_description>
  <field_date_posted>2017-08-09</field_date_posted>
  <field_date_reviewed>2017-08-08</field_date_reviewed>
  <field_pretty_url>blood-test-pancreatic-cancer</field_pretty_url>
  <para_id>1091320</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1092506</term_id>
  <id>1092524</id>
  <title>Annual Reporting and Auditing </title>
  <langcode>en</langcode>
  <field_short_title>Annual Reporting and Auditing </field_short_title>
  <field_page_description>Reporting helps ensure desired results are achieved throughout the grants lifecycle. Learn more about reporting and auditing requirements for cancer research grants. </field_page_description>
  <field_date_posted>2017-08-17</field_date_posted>
  <field_date_reviewed>2017-08-17</field_date_reviewed>
  <para_id>1092524</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1093795</id>
  <title>Bringing the Investigational Breast Cancer Drug Endoxifen from Bench to Bedside with NCI Support</title>
  <langcode>en</langcode>
  <field_short_title>Bringing Endoxifen from Bench to Bedside</field_short_title>
  <field_page_description>Endoxifen, a breast cancer drug being tested in clinical trials, had critical support from NCI, the Mayo Clinic’s Dr. Matthew Goetz writes in this Cancer Currents blog post.</field_page_description>
  <field_date_posted>2017-08-31</field_date_posted>
  <field_date_reviewed>2017-08-29</field_date_reviewed>
  <field_pretty_url>endoxifen-breast-cancer-NCI-support</field_pretty_url>
  <para_id>1093795</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>937976</term_id>
  <id>675725</id>
  <title>CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers</title>
  <langcode>en</langcode>
  <field_short_title>CAR T Cells: Engineering Immune Cells to Treat Cancer</field_short_title>
  <field_page_description>Research on CAR T-cell therapy—a rapidly emerging form of cancer treatment, primarily for blood cancers like leukemia and lymphoma—is moving at a swift pace.</field_page_description>
  <field_date_posted>2013-12-06</field_date_posted>
  <field_date_reviewed>2013-12-04</field_date_reviewed>
  <field_pretty_url>car-t-cells</field_pretty_url>
  <para_id>675725</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>675784</id>
  <title>NIH-funded study shows increased survival in men with metastatic prostate cancer who receive chemotherapy when starting hormone therapy</title>
  <langcode>en</langcode>
  <field_short_title>Increased survival in men with metastatic prostate cancer receiving chemo and hormone therapy</field_short_title>
  <field_page_description>Men with hormone-sensitive metastatic prostate cancer who received the chemotherapy drug docetaxel given at the start of standard hormone therapy lived longer than patients who received hormone therapy alone, according to early results from a NIH-supporte</field_page_description>
  <field_date_posted>2013-12-05</field_date_posted>
  <field_date_reviewed>2013-12-05</field_date_reviewed>
  <field_pretty_url>E3805</field_pretty_url>
  <para_id>675784</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1026063</term_id>
  <id>1026249</id>
  <title>Office of Government and Congressional Relations (OGCR)</title>
  <langcode>en</langcode>
  <field_short_title>Office of Government and Congressional Relations (OGCR)</field_short_title>
  <field_page_description>The Office of Government and Congressional Relations (OGCR) advises the NCI Director, staff, and advisory boards on legislative and Congressional activities as they relate to the NCI mission.</field_page_description>
  <field_date_posted>2016-02-16</field_date_posted>
  <field_date_reviewed>2015-11-13</field_date_reviewed>
  <para_id>1026249</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1026836</id>
  <title>FDA Approves Pembrolizumab for Patients with Non-Small Cell Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Pembrolizumab to Treat Non-Small Cell Lung Cancer</field_short_title>
  <field_date_posted>2015-11-18</field_date_posted>
  <field_date_reviewed>2015-11-17</field_date_reviewed>
  <field_pretty_url>pembrolizumab-nsclc</field_pretty_url>
  <para_id>1026836</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915352</term_id>
  <id>1032044</id>
  <title>Microbes within Our Bodies May Cause or Contribute to Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Microbes within Our Bodies May Cause or Contribute to Cancer</field_short_title>
  <field_date_posted>2012-06-12</field_date_posted>
  <field_date_reviewed>2015-12-18</field_date_reviewed>
  <field_pretty_url>microbes-cancer-link</field_pretty_url>
  <para_id>1032044</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1007397</term_id>
  <id>1033164</id>
  <title>Christal Sohl, Ph.D.</title>
  <langcode>en</langcode>
  <field_short_title>Christal Sohl, Ph.D.</field_short_title>
  <field_date_posted>2015-12-22</field_date_posted>
  <field_date_reviewed>2015-12-21</field_date_reviewed>
  <field_pretty_url>christal-sohl</field_pretty_url>
  <para_id>1033164</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1033306</term_id>
  <id>1033307</id>
  <title>The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)</title>
  <langcode>en</langcode>
  <field_short_title>The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)</field_short_title>
  <field_page_description>Apply for the NCI F99/K00 Award that helps late-stage doctoral candidates finish their training and then transition into cancer-focused research positions.</field_page_description>
  <field_date_posted>2015-12-29</field_date_posted>
  <field_date_reviewed>2016-01-26</field_date_reviewed>
  <para_id>1033307</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919353</term_id>
  <id>1033564</id>
  <title>Asia-Pacific Economic Cooperation (APEC)</title>
  <langcode>en</langcode>
  <field_short_title>Asia-Pacific Economic Cooperation (APEC)</field_short_title>
  <field_page_description>As the leading economic forum in the Asia-Pacific region, APEC facilitates economic growth and prosperity in the Asia-Pacific region through trade and investment liberalization, business facilitation, and economic and technical cooperation.</field_page_description>
  <field_date_posted>2016-01-05</field_date_posted>
  <field_date_reviewed>2016-01-05</field_date_reviewed>
  <field_pretty_url>apec</field_pretty_url>
  <para_id>1033564</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1011704</term_id>
  <id>1033575</id>
  <title>Structural Biology and Molecular Applications Research</title>
  <langcode>en</langcode>
  <field_short_title>Structural Biology and Molecular Applications Research</field_short_title>
  <field_page_description>Part of NCI's Division of Cancer Biology's research portfolio, research and development in this area focuses on enabling technologies, models, and methodologies to support basic and applied cancer research. </field_page_description>
  <field_date_posted>2016-08-08</field_date_posted>
  <field_date_reviewed>2016-01-06</field_date_reviewed>
  <para_id>1033575</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1011706</term_id>
  <id>1033576</id>
  <title>Tumor Biology and Microenvironment Research</title>
  <langcode>en</langcode>
  <field_short_title>Tumor Biology and Microenvironment Research</field_short_title>
  <field_page_description>Part of NCI's Division of Cancer Biology's research portfolio, research in this area seeks to understand the role of tumor cells and the tumor microenvironment (TME) in driving cancer initiation, progression, maintenance and recurrence.</field_page_description>
  <field_date_posted>2016-08-08</field_date_posted>
  <field_date_reviewed>2016-01-06</field_date_reviewed>
  <para_id>1033576</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1034081</id>
  <title>FDA Approves Alectinib for ALK-Positive Non-Small Cell Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Alectinib Approved for ALK-Positive NSCLC</field_short_title>
  <field_date_posted>2016-01-19</field_date_posted>
  <field_date_reviewed>2016-01-19</field_date_reviewed>
  <field_pretty_url>fda-alectinib-nsclc</field_pretty_url>
  <para_id>1034081</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915603</term_id>
  <id>1126609</id>
  <title>Shining a Spotlight on Tumor Exosomes</title>
  <langcode>en</langcode>
  <field_short_title>Shining a Spotlight on Tumor Exosomes-David Lyden M.D., Ph.D.</field_short_title>
  <field_page_description>Learn how NCI support is helping researcher David Lyden understand how cancer cell exosomes create a nurturing environment for the growth of metastatic tumors.</field_page_description>
  <field_date_posted>2017-09-21</field_date_posted>
  <field_date_reviewed>2018-10-16</field_date_reviewed>
  <field_pretty_url>david-lyden-exosomes-metastasis</field_pretty_url>
  <para_id>1126609</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915624</term_id>
  <id>1126634</id>
  <title>Working to Reduce the Cancer Burden Caused by Tobacco</title>
  <langcode>en</langcode>
  <field_short_title>Working to Reduce the Cancer Burden Caused by Tobacco-Michael Fiore, M.D., M.P.H., M.B.A.</field_short_title>
  <field_page_description>Tobacco use in the US continues to cause great harm. Learn about Dr. Michael Fiore and his NCI working group’s recommendations on Tobacco Control Research Priorities for the Next Decade.</field_page_description>
  <field_date_posted>2017-09-21</field_date_posted>
  <field_date_reviewed>2018-10-16</field_date_reviewed>
  <field_pretty_url>michael-fiore-reducing-tobacco-cancer-burden</field_pretty_url>
  <para_id>1126634</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1127246</id>
  <title>Studying “Total Diet” and Its Impact on Health, Including Cancer Risk</title>
  <langcode>en</langcode>
  <field_short_title>Studying the Impact of Total Diet on Cancer Risk</field_short_title>
  <field_page_description>Dr. Jill Reedy explains a shift in diet and cancer risk studies, with researchers using a holistic approach that analyzes dietary patterns across the lifespan.</field_page_description>
  <field_date_posted>2018-10-25</field_date_posted>
  <field_date_reviewed>2018-10-24</field_date_reviewed>
  <field_pretty_url>cancer-risk-total-diet</field_pretty_url>
  <para_id>1127246</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127269</term_id>
  <id>1127270</id>
  <title>Engineered ECM Platforms to Analyze Progression in High Grade Serous Ovarian Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Engineered ECM Platforms Analyze Progression in High Grade Serous Ovarian Cancer</field_short_title>
  <field_date_posted>2018-10-31</field_date_posted>
  <field_date_reviewed>2018-09-20</field_date_reviewed>
  <para_id>1127270</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1131832</id>
  <title>Genomic Test Helps Identify Thyroid Nodules That Don’t Require Surgery</title>
  <langcode>en</langcode>
  <field_short_title>Test Identifies Thyroid Nodules That Don’t Require Surgery </field_short_title>
  <field_page_description>A new test measures genomic changes in thyroid biopsy samples and generates a score based on how strongly each change is associated with thyroid cancer.</field_page_description>
  <field_date_posted>2018-11-30</field_date_posted>
  <field_date_reviewed>2018-11-29</field_date_reviewed>
  <field_pretty_url>thyroid-cancer-diagnostic-genomic-test</field_pretty_url>
  <para_id>1131832</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1132343</id>
  <title>Targeted Treatment for Rare Digestive Tract Cancers May Extend Survival</title>
  <langcode>en</langcode>
  <field_short_title>Targeted Treatment for Rare GI Cancers May Extend Survival</field_short_title>
  <field_page_description>In patients with biliary tract cancer with a BRAF mutation, treatment with dabrafenib plus trametinib shrank tumors, results from a phase 2 trial show.</field_page_description>
  <field_date_posted>2018-12-07</field_date_posted>
  <field_date_reviewed>2018-12-07</field_date_reviewed>
  <field_pretty_url>biliary-tract-cancer-dabrafenib-trametinib</field_pretty_url>
  <para_id>1132343</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133176</term_id>
  <id>1133218</id>
  <title>Adamantinoma</title>
  <langcode>en</langcode>
  <field_short_title>Adamantinoma</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>adamantinoma</field_pretty_url>
  <para_id>1133218</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciLandingPage</CONTENTTYPENAME>
  <term_id>1133172</term_id>
  <id>1133229</id>
  <title>Pediatric and Adult Rare Tumor Network - Backup</title>
  <langcode>en</langcode>
  <field_short_title>Pediatric and Adult Rare Tumor Network - Backup</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>backup</field_pretty_url>
  <para_id>1133229</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1134558</term_id>
  <id>1133236</id>
  <title>Medullary thyroid carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>Medullary thyroid carcinoma</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>medullary-thyroid-carcinoma</field_pretty_url>
  <para_id>1133236</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133465</term_id>
  <id>1133261</id>
  <title>MyPART Team</title>
  <langcode>en</langcode>
  <field_short_title>MyPART Team</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <para_id>1133261</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1134343</term_id>
  <id>1134347</id>
  <title>2019 Speakers for the Preparing for Science-Based Non-Traditional Careers Course</title>
  <langcode>en</langcode>
  <field_short_title>2019 Preparing for Science-Based Non-Traditional Careers Course Speakers</field_short_title>
  <field_date_posted>2019-01-02</field_date_posted>
  <field_date_reviewed>2019-01-02</field_date_reviewed>
  <field_pretty_url>2019-speakers</field_pretty_url>
  <para_id>1134347</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1134378</term_id>
  <id>1134379</id>
  <title>Johns Hopkins/NCI Molecular Target and Drug Discovery Fellowship</title>
  <langcode>en</langcode>
  <field_short_title>JHU and NCI Molecular Target and Drug Discovery Fellowship</field_short_title>
  <field_page_description>Training fellows in bioassay development, chemical libraries, molecular targets and cancer, and high-throughput screening laboratory automation.</field_page_description>
  <field_date_posted>2019-01-03</field_date_posted>
  <field_date_reviewed>2019-01-03</field_date_reviewed>
  <para_id>1134379</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1114848</term_id>
  <id>1134483</id>
  <title>Director’s Innovation Award Program</title>
  <langcode>en</langcode>
  <field_short_title>NCI Director’s Innovation Award Program</field_short_title>
  <field_page_description>The NCI Director’s Intramural Innovation Award Program is designed to support development of highly innovative approaches and technology aimed at significant problems from across the CCR portfolio.</field_page_description>
  <field_date_posted>2019-01-04</field_date_posted>
  <field_date_reviewed>2019-01-04</field_date_reviewed>
  <field_pretty_url>directors-innovation-awards</field_pretty_url>
  <para_id>1134483</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1034470</id>
  <title>New study using cryo-electron microscopy shows how potential drugs could inhibit cancer</title>
  <langcode>en</langcode>
  <field_short_title>Cryo-electron microscopy shows how potential drugs could inhibit cancer</field_short_title>
  <field_page_description>New study shows an imaging technique called cryo-electron microscopy that views, in atomic detail, the binding of a potential drug to a protein in cancer cells.</field_page_description>
  <field_date_posted>2016-01-28</field_date_posted>
  <field_date_reviewed>2016-01-26</field_date_reviewed>
  <field_pretty_url>cryo-electron-microscopy</field_pretty_url>
  <para_id>1034470</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919157</term_id>
  <id>1127125</id>
  <title>Stopping Multiple Myeloma in Its Tracks</title>
  <langcode>en</langcode>
  <field_short_title>Stopping Multiple Myeloma in Its Tracks-Valerie Winston</field_short_title>
  <field_page_description>The results of standard tests indicated that Valerie Winston was at risk for multiple myeloma. Read how an NCI combination therapy clinical trial helped her avoid the full impact of multiple myeloma.</field_page_description>
  <field_date_posted>2017-09-21</field_date_posted>
  <field_date_reviewed>2018-10-22</field_date_reviewed>
  <field_pretty_url>valerie-winston-clinical-trial-multiple-myeloma</field_pretty_url>
  <para_id>1127125</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1107074</term_id>
  <id>1127139</id>
  <title>Developing the First Precision Immunotherapy</title>
  <langcode>en</langcode>
  <field_short_title>Developing the First Precision Immunotherapy</field_short_title>
  <field_page_description>Learn about the NCI-funded research that enabled the first FDA approved precision medicine- the immune checkpoint inhibitor pembrolizumab.</field_page_description>
  <field_date_posted>2017-09-21</field_date_posted>
  <field_date_reviewed>2018-10-22</field_date_reviewed>
  <field_pretty_url>pembrolizumab-first-precision-immunotherapy</field_pretty_url>
  <para_id>1127139</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1130551</id>
  <title>Gene Tied to Alzheimer’s May Be Associated with Cancer-Related Cognitive Problems</title>
  <langcode>en</langcode>
  <field_short_title>Alzheimer’s Gene May Play Role in Chemobrain </field_short_title>
  <field_date_posted>2018-11-09</field_date_posted>
  <field_date_reviewed>2018-11-09</field_date_reviewed>
  <field_pretty_url>chemobrain-cancer-survivors-alzheimers-gene</field_pretty_url>
  <para_id>1130551</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922410</term_id>
  <id>1130633</id>
  <title>TEST - What's New in Lung Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>TEST - What's New in Lung Cancer Research</field_short_title>
  <field_date_posted>2018-11-29</field_date_posted>
  <field_date_reviewed>2018-11-09</field_date_reviewed>
  <field_pretty_url>draft</field_pretty_url>
  <para_id>1130633</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1130666</id>
  <title>The Cancer Moonshot: Moving from Planning to Research</title>
  <langcode>en</langcode>
  <field_short_title>The Cancer Moonshot: Moving from Planning to Research</field_short_title>
  <field_page_description>The Cancer Moonshot is supporting innovative science, as it moves from the planning phase to the research phase, explains NCI’s Dr. Dinah Singer. </field_page_description>
  <field_date_posted>2018-11-19</field_date_posted>
  <field_date_reviewed>2018-11-09</field_date_reviewed>
  <field_pretty_url>cancer-moonshot-planning-to-research</field_pretty_url>
  <para_id>1130666</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133178</term_id>
  <id>1133223</id>
  <title>Desmoid tumor</title>
  <langcode>en</langcode>
  <field_short_title>Desmoid tumor</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>desmoid-tumor</field_pretty_url>
  <para_id>1133223</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133178</term_id>
  <id>1133224</id>
  <title>Desmoplastic small round cell tumor</title>
  <langcode>en</langcode>
  <field_short_title>Desmoplastic small round cell tumor</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>desmoplastic-small-round-cell-tumor</field_pretty_url>
  <para_id>1133224</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133184</term_id>
  <id>1133238</id>
  <title>Angiosarcoma</title>
  <langcode>en</langcode>
  <field_short_title>Angiosarcoma</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>angiosarcoma</field_pretty_url>
  <para_id>1133238</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133186</term_id>
  <id>1133241</id>
  <title>Clear cell renal carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>Clear cell renal carcinoma</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>clear-cell-renal-carcinoma</field_pretty_url>
  <para_id>1133241</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133186</term_id>
  <id>1133242</id>
  <title>Papillary renal cell carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>Papillary renal cell carcinoma</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>papillary-renal-cell-carcinoma</field_pretty_url>
  <para_id>1133242</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133196</term_id>
  <id>1133255</id>
  <title>The Role of Families and Caregivers of People with Rare Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Family and Caregivers</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <para_id>1133255</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1134352</term_id>
  <id>1134545</id>
  <title>Atezolizumab Approved for Initial Treatment of Metastatic Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Atezolizumab Approved for Lung Cancer Initial Treatment</field_short_title>
  <field_page_description>FDA recently approved the immunotherapy drug atezolizumab (Tecentriq) for advanced nonsmall cell lung cancer (NSCLC) that lacks EGFR or ALK mutations.</field_page_description>
  <field_date_posted>2019-01-07</field_date_posted>
  <field_date_reviewed>2019-01-07</field_date_reviewed>
  <field_pretty_url>atezolizumab-lung-cancer-first-line</field_pretty_url>
  <para_id>1134545</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133470</term_id>
  <id>1134559</id>
  <title>Participating in a Clinical Trial for Rare Cancer</title>
  <langcode>en</langcode>
  <field_short_title> Participating in a Clinical Trial for Rare Cancer</field_short_title>
  <field_page_description>When you are diagnosed with a rare cancer, you and your family may think about joining a clinical trial or study.You may get access to a new drug, or a chance to see world-renowned doctors. You are also helping future rare cancer patients by helping researchers today.</field_page_description>
  <field_date_posted>2019-01-07</field_date_posted>
  <field_date_reviewed>2019-01-07</field_date_reviewed>
  <para_id>1134559</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>12598</term_id>
  <id>14165</id>
  <title>E-mail Us</title>
  <langcode>en</langcode>
  <field_short_title>E-mail Us</field_short_title>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-03-29</field_date_reviewed>
  <field_pretty_url>email-us</field_pretty_url>
  <para_id>14165</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>226145</id>
  <title>Nearly 800,000 deaths prevented due to declines in smoking; NIH study examines the impact of tobacco control policies and programs, and the potential for further reduction in lung cancer deaths</title>
  <langcode>en</langcode>
  <field_short_title>Nearly 800,000 deaths prevented due to declines in smoking</field_short_title>
  <field_page_description>Twentieth-century tobacco control programs and policies were responsible for preventing more than 795,000 lung cancer deaths in the United States from 1975 through 2000. If all cigarette smoking in this country had ceased following the release of the firs</field_page_description>
  <field_date_posted>2012-03-14</field_date_posted>
  <field_date_reviewed>2012-03-09</field_date_reviewed>
  <field_pretty_url>TobaccoControlCISNET</field_pretty_url>
  <para_id>226145</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>254763</id>
  <title>Report to the nation finds continuing declines in cancer death rates since the early 1990s; &lt;span style="font-weight:normal;"&gt;&lt;i&gt;Feature highlights cancers associated with excess weight and lack of sufficient physical activity&lt;/i&gt;&lt;/span&gt;</title>
  <langcode>en</langcode>
  <field_short_title>Report to the nation finds continuing declines in cancer death rates </field_short_title>
  <field_page_description>Death rates from all cancers combined for men, women, and children continued to decline in the United States between 2004 and 2008, according to the Annual Report to the Nation on the Status of Cancer, 1975-2008. The overall rate of new cancer diagnoses, </field_page_description>
  <field_date_posted>2012-03-28</field_date_posted>
  <field_date_reviewed>2012-03-30</field_date_reviewed>
  <field_pretty_url>ReportNationRelease2012</field_pretty_url>
  <para_id>254763</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>286359</id>
  <title>Scientists find that chromosomal abnormalities are associated with aging and cancer </title>
  <langcode>en</langcode>
  <field_short_title>Chromosomal abnormalities are associated with aging and cancer </field_short_title>
  <field_page_description>Two new studies have found that large structural abnormalities in chromosomes, some of which have been associated with increased risk of cancer, can be detected in a small fraction of people without a prior history of cancer. The studies found that these </field_page_description>
  <field_date_posted>2012-05-07</field_date_posted>
  <field_date_reviewed>2012-05-03</field_date_reviewed>
  <field_pretty_url>mosaicismNCINHGRI</field_pretty_url>
  <para_id>286359</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938103</term_id>
  <id>317032</id>
  <title>Study Suggests New Treatment Option for Some Lymphomas</title>
  <langcode>en</langcode>
  <field_short_title>Study Suggests New Treatment Option for Some Lymphomas</field_short_title>
  <field_page_description>Updated findings from a large European clinical trial indicate that patients with some types of lymphoma could initially be treated with the chemotherapy drug bendamustine (Treanda) and the targeted agent rituximab (Rituxan).</field_page_description>
  <field_date_posted>2012-06-13</field_date_posted>
  <field_date_reviewed>2012-06-13</field_date_reviewed>
  <field_pretty_url>bendamustine-rituximab</field_pretty_url>
  <para_id>317032</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938195</term_id>
  <id>317771</id>
  <title>Preoperative Chemotherapy, Radiation Improve Survival in Esophageal Cancer (Updated)</title>
  <langcode>en</langcode>
  <field_short_title>Preoperative Chemotherapy, Radiation Improve Survival in Esophageal Cancer (Updated)</field_short_title>
  <field_page_description>Patients with esophageal cancer who received chemotherapy and radiation before surgery survived, on average, nearly twice as long as patients treated with surgery alone, according to results of a randomized clinical trial published May 31, 2012, in NEJM.</field_page_description>
  <field_date_posted>2012-06-14</field_date_posted>
  <field_date_reviewed>2012-06-14</field_date_reviewed>
  <field_pretty_url>preop-treatment-improves-survival</field_pretty_url>
  <para_id>317771</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1101055</term_id>
  <id>1101059</id>
  <title>Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade</title>
  <langcode>en</langcode>
  <field_short_title>Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Block</field_short_title>
  <field_page_description>This study seeks to better predict patient-derived tumor responsiveness to immune checkpoint blockade.</field_page_description>
  <field_date_posted>2017-12-19</field_date_posted>
  <field_date_reviewed>2017-12-01</field_date_reviewed>
  <para_id>1101059</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1101415</id>
  <title>FDA Approves Alectinib For Initial Treatment of ALK-Positive Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Alectinib for Untreated ALK-Positive Lung Cancer</field_short_title>
  <field_page_description>Alectinib (Alcensa) has been approved by the FDA for untreated ALK-positive non-small cell lung cancer (NSCLC), based on results from the ALEX trial. </field_page_description>
  <field_date_posted>2017-12-06</field_date_posted>
  <field_date_reviewed>2017-12-05</field_date_reviewed>
  <field_pretty_url>alectinib-fda-untreated-lung-cancer</field_pretty_url>
  <para_id>1101415</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894086</term_id>
  <id>1117063</id>
  <title>Dr. Levi Garraway to Deliver NCI CURE Distinguished Scholars Seminar</title>
  <langcode>en</langcode>
  <field_short_title>Dr. Levi Garraway to Deliver NCI CURE Distinguished Scholars Seminar</field_short_title>
  <field_page_description>On July 24, 2018, Dr. Levi Garraway will deliver the next CURE Distinguished Scholars Seminar. Dr. Garraway will present on the Molecular and Genomic Characterization of Human Solid Tumors.</field_page_description>
  <field_date_posted>2018-06-05</field_date_posted>
  <field_date_reviewed>2018-06-05</field_date_reviewed>
  <field_pretty_url>garraway-seminar</field_pretty_url>
  <para_id>1117063</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1117120</id>
  <title>Selumetinib Continues to Show Promise in Children with NF1</title>
  <langcode>en</langcode>
  <field_short_title>Selumetinib Shrinks Tumors in Children with NF1</field_short_title>
  <field_page_description>The investigational drug selumetinib shrank tumors in some children with a genetic syndrome called neurofibromatosis type 1 (NF1). As this Cancer Currents post explains, the drug also improved symptoms related to tumors known as neurofibromas, which can cause pain, difficulty breathing or walking, and disfigurement. </field_page_description>
  <field_date_posted>2018-06-08</field_date_posted>
  <field_date_reviewed>2018-06-07</field_date_reviewed>
  <field_pretty_url>selumetinib-nf1-neurofibromas</field_pretty_url>
  <para_id>1117120</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1104028</term_id>
  <id>1117581</id>
  <title>Respondent Burden</title>
  <langcode>en</langcode>
  <field_short_title>Respondent Burden</field_short_title>
  <field_date_posted>2018-06-13</field_date_posted>
  <field_date_reviewed>2018-06-13</field_date_reviewed>
  <field_pretty_url>respondent-burden</field_pretty_url>
  <para_id>1117581</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1118100</id>
  <title>Approval Expanded for Venetoclax in Chronic Lymphocytic Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Approval Expanded for Venetoclax in Chronic Lymphocytic Leukemia</field_short_title>
  <field_page_description>FDA expanded the approval of venetoclax (Venclexta) for people with chronic lymphocytic leukemia (CLL) to include those whose cancer has progressed after previous treatment, regardless of whether their cancer cells have the deletion 17p gene alteration.</field_page_description>
  <field_date_posted>2018-06-22</field_date_posted>
  <field_date_reviewed>2018-06-20</field_date_reviewed>
  <field_pretty_url>venetoclax-fda-cll-expanded-approval</field_pretty_url>
  <para_id>1118100</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1119354</id>
  <title>Dr. Alan S. Rabson, Long-Time NCI Deputy Director and Cancer Research Stalwart, Dies</title>
  <langcode>en</langcode>
  <field_short_title>Long-Time NCI Deputy Director Dr. Alan Rabson Dies</field_short_title>
  <field_page_description>Long-time NCI senior leader Alan Rabson, M.D., passed away on July 4, at the age of 92. His career spanned 6 decades, including research on tumor virology and cancer pathology and senior NCI leadership roles.</field_page_description>
  <field_date_posted>2018-07-05</field_date_posted>
  <field_date_reviewed>2018-07-05</field_date_reviewed>
  <field_pretty_url>alan-rabson-passes-away</field_pretty_url>
  <para_id>1119354</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1129038</term_id>
  <id>1119635</id>
  <title>TCGA Ethics &amp; Policies</title>
  <langcode>en</langcode>
  <field_short_title>Ethics &amp; Policies</field_short_title>
  <field_date_posted>2018-10-30</field_date_posted>
  <field_date_reviewed>2018-07-10</field_date_reviewed>
  <para_id>1119635</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1120621</id>
  <title>TCGA's Study of Adrenocortical Carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Adrenocortical Carcinoma</field_short_title>
  <field_page_description>TCGA's Study of Adrenocortical Carcinoma</field_page_description>
  <field_date_posted>2018-07-26</field_date_posted>
  <field_date_reviewed>2018-07-26</field_date_reviewed>
  <field_pretty_url>adrenocortical</field_pretty_url>
  <para_id>1120621</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1121095</id>
  <title>Aggressive Prostate Cancer Subtype More Common Than Expected</title>
  <langcode>en</langcode>
  <field_short_title>Aggressive Prostate Cancer Subtype More Common Than Expected</field_short_title>
  <field_page_description>Some men with advanced prostate cancer may be more likely than previously thought to develop a more aggressive form of the disease, a new study shows. As this Cancer Currents post reports, the subtype, called t-SCNC, was linked with shorter survival.</field_page_description>
  <field_date_posted>2018-07-31</field_date_posted>
  <field_date_reviewed>2018-07-30</field_date_reviewed>
  <field_pretty_url>prostate-cancer-neuroendocrine-more-common</field_pretty_url>
  <para_id>1121095</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1121643</id>
  <title>TCGA's Study of Hepatocellular Carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Hepatocellular Carcinoma</field_short_title>
  <field_page_description>TCGA's Study of Hepatocellular Carcinoma</field_page_description>
  <field_date_posted>2018-08-08</field_date_posted>
  <field_date_reviewed>2018-08-08</field_date_reviewed>
  <field_pretty_url>liver</field_pretty_url>
  <para_id>1121643</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1102622</term_id>
  <id>1123642</id>
  <title>Statement from NCI Director Dr. Norman E. Sharpless on the Death of Senator John McCain</title>
  <langcode>en</langcode>
  <field_short_title>Statement from NCI Director on the Death of Senator McCain</field_short_title>
  <field_page_description>Statement from NCI Director on the death of Senator John McCain. McCain, a long-time supporter of cancer research, passed away on August 25. </field_page_description>
  <field_date_posted>2018-08-27</field_date_posted>
  <field_date_reviewed>2018-08-27</field_date_reviewed>
  <field_pretty_url>statement-senator-mccain-passing</field_pretty_url>
  <para_id>1123642</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1123797</id>
  <title>TCGA's Study of Lung Adenocarcinoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Lung Adenocarcinoma</field_short_title>
  <field_page_description>TCGA's Study of Lung Adenocarcinoma</field_page_description>
  <field_date_posted>2018-08-30</field_date_posted>
  <field_date_reviewed>2018-08-30</field_date_reviewed>
  <field_pretty_url>lung-adenocarcinoma</field_pretty_url>
  <para_id>1123797</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102628</term_id>
  <id>1125053</id>
  <title>Conversation with Scott Kopetz: RAS in Colorectal Cancer, Initiation and Resistance</title>
  <langcode>en</langcode>
  <field_short_title>Conversation with Scott Kopetz: RAS in Colorectal Cancer, Initiation and Resistance</field_short_title>
  <field_page_description>Mutated RAS genes are an important cause of colorectal cancers, and play a role in resistance to current drug therapies.</field_page_description>
  <field_date_posted>2018-09-28</field_date_posted>
  <field_date_reviewed>2018-09-27</field_date_reviewed>
  <field_pretty_url>scott-kopetz</field_pretty_url>
  <para_id>1125053</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1125675</id>
  <title>Vaping Pods Produce High Nicotine Levels in Young Users</title>
  <langcode>en</langcode>
  <field_short_title>Vaping Pods Produce High Nicotine Levels in Young Users</field_short_title>
  <field_page_description>Pod-style e-cigarettes produce higher levels of nicotine in the body than conventional cigarettes. Learn why this finding in young users is so concerning.</field_page_description>
  <field_date_posted>2018-10-05</field_date_posted>
  <field_date_reviewed>2018-10-04</field_date_reviewed>
  <field_pretty_url>youth-vaping-high-nicotine-levels</field_pretty_url>
  <para_id>1125675</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1126201</id>
  <title>For HPV-Positive Women, Test Can Guide Cervical Cancer Screening Follow-Up</title>
  <langcode>en</langcode>
  <field_short_title>For HPV-Positive Women, Test Can Guide Screening Follow-Up</field_short_title>
  <field_page_description>For women who test HPV-positive during cervical cancer screening, the dual stain test is better than the Pap test at identifying those at increased risk of developing precancers over the next 5 years and can better guide follow-up care. </field_page_description>
  <field_date_posted>2018-10-11</field_date_posted>
  <field_date_reviewed>2018-10-11</field_date_reviewed>
  <field_pretty_url>dual-stain-test-cervical-hpv-positive</field_pretty_url>
  <para_id>1126201</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915634</term_id>
  <id>1126608</id>
  <title>Thinking Chemically to Discover New Targeted Cancer Drugs</title>
  <langcode>en</langcode>
  <field_short_title>Thinking Chemically to Discover New Targeted Cancer Drugs-Kevan Shokat, Ph.D.</field_short_title>
  <field_page_description>About a third of all cancers are driven by mutations in RAS genes. Learn how NCI funding is helping Dr. Kevan Shokat develop drugs that inactivate molecular drivers of cancer such as RAS.</field_page_description>
  <field_date_posted>2017-09-21</field_date_posted>
  <field_date_reviewed>2018-10-16</field_date_reviewed>
  <field_pretty_url>kevan-shokat-targeted-drug-discovery</field_pretty_url>
  <para_id>1126608</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>914506</term_id>
  <id>1126610</id>
  <title>Pursuing a Cancer Prevention Vaccine</title>
  <langcode>en</langcode>
  <field_short_title>Pursuing a Cancer Prevention Vaccine-Olivera Finn, Ph.D.</field_short_title>
  <field_page_description>Read the story of NCI-funded scientist Olivera Finn whose research led to the first clinical trial of a prevention vaccine for people at high risk for cancer.</field_page_description>
  <field_date_posted>2017-09-21</field_date_posted>
  <field_date_reviewed>2018-10-16</field_date_reviewed>
  <field_pretty_url>olivera-finn-prevention-vaccine</field_pretty_url>
  <para_id>1126610</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915624</term_id>
  <id>1126633</id>
  <title>Running (and Eating) Away from Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Running (and Eating) Away from Cancer-Sue Wharfe</field_short_title>
  <field_page_description>Learn how Sue Wharfe benefitted from taking part in a clinical trial of exercise and nutrition for breast cancer survivors that was supported by NCI funding.</field_page_description>
  <field_date_posted>2017-09-21</field_date_posted>
  <field_date_reviewed>2018-10-16</field_date_reviewed>
  <field_pretty_url>sue-wharfe-lifestyle-exercise-nutrition-study</field_pretty_url>
  <para_id>1126633</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915609</term_id>
  <id>1126635</id>
  <title>Addressing Cancer Disparities in Appalachia</title>
  <langcode>en</langcode>
  <field_short_title>Addressing Cancer Disparities in Appalachia-Electra Paskett, Ph.D.</field_short_title>
  <field_page_description>Dr. Electra Paskett addresses cancer disparities through science and community partnerships. With NCI’s support, her efforts have made improvements in underserved communities.</field_page_description>
  <field_date_posted>2017-09-21</field_date_posted>
  <field_date_reviewed>2018-10-16</field_date_reviewed>
  <field_pretty_url>electra-paskett-addressing-cancer-disparities-appalachia</field_pretty_url>
  <para_id>1126635</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919157</term_id>
  <id>1127101</id>
  <title>Combining Drugs to Treat Ovarian Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Combining Drugs to Treat Ovarian Cancer-Betsy Brauser</field_short_title>
  <field_page_description>Approximately 70 percent of women diagnosed with ovarian cancer will die from the disease. Read about the NCI-funded combination drug trial that has successfully treated Betsy Brauser's recurrent cancer.</field_page_description>
  <field_date_posted>2017-09-21</field_date_posted>
  <field_date_reviewed>2018-10-22</field_date_reviewed>
  <field_pretty_url>betsy-brauser-combining-drugs-treat-ovarian-cancer</field_pretty_url>
  <para_id>1127101</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1129040</term_id>
  <id>1129041</id>
  <title>Using TCGA Data, Resources, and Materials</title>
  <langcode>en</langcode>
  <field_short_title>Using TCGA Data, Resources, and Materials</field_short_title>
  <field_page_description>Using TCGA in your research? Learn about the data and other resources available.</field_page_description>
  <field_date_posted>2018-10-30</field_date_posted>
  <field_date_reviewed>2018-10-30</field_date_reviewed>
  <para_id>1129041</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1129516</id>
  <title>Blood Test Shows Promise for Detecting Genetic Changes in Brain Tumors</title>
  <langcode>en</langcode>
  <field_short_title>Blood Test May Detect Genetic Changes in Brain Tumors</field_short_title>
  <field_page_description>The minimally invasive test could be used to identify and follow molecular changes in children with highly lethal brain tumors called diffuse midline gliomas.</field_page_description>
  <field_date_posted>2018-11-05</field_date_posted>
  <field_date_reviewed>2018-11-02</field_date_reviewed>
  <field_pretty_url>liquid-biopsy-childhood-brain-tumors</field_pretty_url>
  <para_id>1129516</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1101493</id>
  <title>With Advances in Cancer Immunotherapy, Scientists Discuss Need to Develop New Mouse Models</title>
  <langcode>en</langcode>
  <field_short_title>Researchers Discuss Developing Better Cancer Immunotherapy Models</field_short_title>
  <field_page_description>Developing better cancer immunotherapy mouse models was the focus of a recent NCI-sponsored meeting, including current challenges and future opportunities. </field_page_description>
  <field_date_posted>2017-12-08</field_date_posted>
  <field_date_reviewed>2017-12-07</field_date_reviewed>
  <field_pretty_url>immunotherapy-mouse-models-meeting</field_pretty_url>
  <para_id>1101493</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1102509</id>
  <title>Genomic Profiling Tests Cleared by FDA Can Help Guide Cancer Treatment, Clinical Trial Enrollment</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Two Genomic Profiling Tests for Cancer</field_short_title>
  <field_page_description>FDA has approved two genomic profiling tests for tumors. One of the tests, FoundationOne CDx (F1CDx), can be used as a companion diagnostic for some cancer therapies.</field_page_description>
  <field_date_posted>2017-12-21</field_date_posted>
  <field_date_reviewed>2017-12-21</field_date_reviewed>
  <field_pretty_url>genomic-profiling-tests-cancer</field_pretty_url>
  <para_id>1102509</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1102692</id>
  <title>Fusobacterium May Help Colorectal Cancer Grow and Spread</title>
  <langcode>en</langcode>
  <field_short_title>Bacteria May Aid Growth of Colorectal Cancer</field_short_title>
  <field_page_description>The bacteria Fusobacterium may help fuel the growth of colorectal cancer, and antibiotics may help to treat it, a new study suggests.</field_page_description>
  <field_date_posted>2017-12-29</field_date_posted>
  <field_date_reviewed>2017-12-26</field_date_reviewed>
  <field_pretty_url>bacteria-colorectal-cancer</field_pretty_url>
  <para_id>1102692</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1102943</term_id>
  <id>1102955</id>
  <title>NCI Scientists in the Community</title>
  <langcode>en</langcode>
  <field_short_title>NCI Scientists in the Community</field_short_title>
  <field_date_posted>2018-01-05</field_date_posted>
  <field_date_reviewed>2018-01-05</field_date_reviewed>
  <para_id>1102955</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1103889</term_id>
  <id>1104010</id>
  <title>Treatment of Head and Neck Cancer in Adults—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Head and Neck Cancer Treatment in Adults</field_short_title>
  <field_page_description>Find diagnosis, staging, and treatment information for these head and neck cancers: hypopharynx, larynx, lip and oral cavity, neck cancer with occult primary, nasopharynx, oropharynx, paranasal sinus and nasal cavity, and salivary gland cancer.</field_page_description>
  <field_date_posted>2018-01-15</field_date_posted>
  <field_date_reviewed>2018-01-15</field_date_reviewed>
  <para_id>1104010</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1104021</term_id>
  <id>1104025</id>
  <title>Cancer Moonshot℠ - Obligations by Budget Mechanism</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Moonshot Obligations</field_short_title>
  <field_page_description>NCI reports Cancer Moonshot obligations by funding mechanism. See obligations for Moonshot grants, intramural research, and contracts, including the number of grant awards, funding amounts, and percentages by mechanism of the total Cancer Moonshot budget.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2018-01-15</field_date_reviewed>
  <para_id>1104025</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>922410</term_id>
  <id>1104089</id>
  <title>TEST - Lung Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>TEST - Lung Cancer Research</field_short_title>
  <field_date_posted>2018-01-18</field_date_posted>
  <field_date_reviewed>2018-01-18</field_date_reviewed>
  <field_pretty_url>2</field_pretty_url>
  <para_id>1104089</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1105037</id>
  <title>Study Identifies Potential Cause of Hearing Loss from Cisplatin</title>
  <langcode>en</langcode>
  <field_short_title>Potential Cause of Cisplatin-Linked Hearing Loss Identified</field_short_title>
  <field_page_description>The chemotherapy drug cisplatin is retained in the inner ear for long periods, possibly explaining the hearing loss linked to treatment with the drug.</field_page_description>
  <field_date_posted>2018-01-26</field_date_posted>
  <field_date_reviewed>2018-01-25</field_date_reviewed>
  <field_pretty_url>cisplatin-hearing-loss</field_pretty_url>
  <para_id>1105037</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1105714</id>
  <title>Gut Bacteria Influence Effectiveness of a Type of Immunotherapy</title>
  <langcode>en</langcode>
  <field_short_title>Gut Bacteria Affect Response to Immunotherapy</field_short_title>
  <field_page_description>Three new studies have identified intestinal bacteria that appear to influence the response to checkpoint inhibitors. This Cancer Currents blog post explains how the researchers think their findings could be used to improve patients’ responses to these immunotherapy drugs.</field_page_description>
  <field_date_posted>2018-02-05</field_date_posted>
  <field_date_reviewed>2018-02-02</field_date_reviewed>
  <field_pretty_url>gut-bacteria-checkpoint-inhibitors</field_pretty_url>
  <para_id>1105714</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102626</term_id>
  <id>1106258</id>
  <title>2017 Embassy Science Fellowship: Bangkok, Thailand</title>
  <langcode>en</langcode>
  <field_short_title>2017 ESF in Thailand</field_short_title>
  <field_date_posted>2018-02-08</field_date_posted>
  <field_date_reviewed>2018-02-08</field_date_reviewed>
  <field_pretty_url>2017-esf-thailand</field_pretty_url>
  <para_id>1106258</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1106282</id>
  <title>FDA Approves New Treatment for Certain Neuroendocrine Tumors</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves New Treatment for Neuroendocrine Tumors</field_short_title>
  <field_page_description>FDA has approved Lutathera® for some people with neuroendocrine tumors (NETs) that affect the digestive tract. On January 29, FDA approved Lutathera® for adult patients with advanced NETs that affect the pancreas or gastrointestinal tract, known as GEP-NETs.</field_page_description>
  <field_date_posted>2018-02-08</field_date_posted>
  <field_date_reviewed>2018-02-08</field_date_reviewed>
  <field_pretty_url>lutathera-fda-gastrointestinal-nets</field_pretty_url>
  <para_id>1106282</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1130979</id>
  <title>NCI-MATCH Update: More Labs, New Arms, and Initial Findings</title>
  <langcode>en</langcode>
  <field_short_title>NCI-MATCH: More Labs, New Arms, and Initial Findings</field_short_title>
  <field_page_description>The NCI-MATCH cancer precision medicine trial is adding new treatment arms and testing labs, and reporting initial findings, NCI’s Dr. Lyndsay Harris explains.</field_page_description>
  <field_date_posted>2018-11-15</field_date_posted>
  <field_date_reviewed>2018-11-14</field_date_reviewed>
  <field_pretty_url>nci-match-update-new-arms-more-labs</field_pretty_url>
  <para_id>1130979</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1132182</term_id>
  <id>1132183</id>
  <title>TCGA Contact Information</title>
  <langcode>en</langcode>
  <field_short_title>Contact TCGA</field_short_title>
  <field_page_description>Find contact information for The Cancer Genome Atlas Program.</field_page_description>
  <field_date_posted>2018-12-05</field_date_posted>
  <field_date_reviewed>2018-12-05</field_date_reviewed>
  <para_id>1132183</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133176</term_id>
  <id>1133219</id>
  <title>Chondromyxoid fibroma</title>
  <langcode>en</langcode>
  <field_short_title>Chondromyxoid fibroma</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>chondromyxoid-fibroma</field_pretty_url>
  <para_id>1133219</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133178</term_id>
  <id>1133226</id>
  <title>Rhabdoid Tumor</title>
  <langcode>en</langcode>
  <field_short_title>Rhabdoid Tumor</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>rhabdoid-tumor</field_pretty_url>
  <para_id>1133226</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133468</term_id>
  <id>1133251</id>
  <title>Natural History Study of Rare Solid Tumors</title>
  <langcode>en</langcode>
  <field_short_title>Natural History Study of Rare Solid Tumors</field_short_title>
  <field_page_description>By taking part in a natural history study, you can speed up the development of new treatments by giving researchers the tools they need to understand how cancer forms and grows and to find new treatments. </field_page_description>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <para_id>1133251</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133472</term_id>
  <id>1133253</id>
  <title>The Role of Advocacy in MyPART</title>
  <langcode>en</langcode>
  <field_short_title>The Role of Advocacy in MyPART</field_short_title>
  <field_page_description>Our mission is to engage patients as partners in rare tumor research. Non-profit organizations dedicated to improving the experiences and outcomes of people with rare solid tumors are important members of the MyPART network.</field_page_description>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <para_id>1133253</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133463</term_id>
  <id>1133260</id>
  <title>What Is MyPART?</title>
  <langcode>en</langcode>
  <field_short_title>What Is MyPART?</field_short_title>
  <field_page_description>MyPART is a group of scientists, patients, family members, advocates, and healthcare providers who want to help find treatments for rare cancers. We are working on childhood, teen, and young adult solid rare tumors that have no cures. </field_page_description>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <para_id>1133260</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133449</term_id>
  <id>1133262</id>
  <title>Contact MyPART</title>
  <langcode>en</langcode>
  <field_short_title>Contact MyPART</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <para_id>1133262</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1114846</term_id>
  <id>1133377</id>
  <title>Statistical Analysis of Research Data</title>
  <langcode>en</langcode>
  <field_short_title>Statistical Analysis of Research Data</field_short_title>
  <field_date_posted>2018-12-19</field_date_posted>
  <field_date_reviewed>2018-12-19</field_date_reviewed>
  <field_pretty_url>statistical-analysis-research-data</field_pretty_url>
  <para_id>1133377</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1133421</id>
  <title>New on NCI Websites for December 2018</title>
  <langcode>en</langcode>
  <field_short_title>New on NCI Websites for December 2018</field_short_title>
  <field_page_description>See selected content that has been added to NCI’s websites as of December 2018, in this Cancer Currents blog post.</field_page_description>
  <field_date_posted>2018-12-28</field_date_posted>
  <field_date_reviewed>2018-12-19</field_date_reviewed>
  <field_pretty_url>new-online-december-2018</field_pretty_url>
  <para_id>1133421</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1133198</term_id>
  <id>1133528</id>
  <title>News</title>
  <langcode>en</langcode>
  <field_short_title>News</field_short_title>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2018-12-20</field_date_reviewed>
  <para_id>1133528</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1114844</term_id>
  <id>1134421</id>
  <title>CCR Fellows and Young Investigators Association</title>
  <langcode>en</langcode>
  <field_short_title>CCR Fellows &amp; Young Investigators Association</field_short_title>
  <field_page_description>The Fellows and Young Investigators Association enhances the intramural training program by organizing, promoting and informing the NCI fellows of career development and training opportunities at the NIH. This association fosters communcation among fellows, NCI research community and senior management. </field_page_description>
  <field_date_posted>2019-01-04</field_date_posted>
  <field_date_reviewed>2019-01-04</field_date_reviewed>
  <field_pretty_url>fellows-young-investigators-association</field_pretty_url>
  <para_id>1134421</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133184</term_id>
  <id>1134555</id>
  <title>What are rare vascular tumors?</title>
  <langcode>en</langcode>
  <field_short_title>Rare Vascular Tumors</field_short_title>
  <field_page_description>Rare vascular tumors form in cells that make blood or lymph vessels, and can occur anywhere in the body, such as the skin, in the tissues below the skin, or in an organ. There are specific tumors that affect children, teens, and young adults.</field_page_description>
  <field_date_posted>2019-01-07</field_date_posted>
  <field_date_reviewed>2019-01-07</field_date_reviewed>
  <para_id>1134555</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1134352</term_id>
  <id>1136950</id>
  <title>Curbing Production of Immune Checkpoint Protein Slows Liver Cancer in Mice</title>
  <langcode>en</langcode>
  <field_short_title>Blocking Cancer’s Production of an Immune Checkpoint Protein</field_short_title>
  <field_page_description>Production of PD-L1, an immune checkpoint protein, can be blocked in mice with liver cancer by an investigational drug called eFT508, a new study shows.</field_page_description>
  <field_date_posted>2019-02-06</field_date_posted>
  <field_date_reviewed>2019-02-05</field_date_reviewed>
  <field_pretty_url>translation-inhibitor-immune-checkpoint-protein</field_pretty_url>
  <para_id>1136950</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1133188</term_id>
  <id>1134560</id>
  <title>What are rare nerve tumors?</title>
  <langcode>en</langcode>
  <field_short_title>Rare Nerve Tumors</field_short_title>
  <field_page_description>Rare nerve tumors can form in the nervous system anywhere in the body. They can form in nerve cells or in cells around the nerve cells, like Schwann or perineurial cells.</field_page_description>
  <field_date_posted>2019-01-07</field_date_posted>
  <field_date_reviewed>2019-01-07</field_date_reviewed>
  <para_id>1134560</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1135271</term_id>
  <id>1135277</id>
  <title>Frederick National Laboratory for Cancer Research Acquisitions</title>
  <langcode>en</langcode>
  <field_short_title>FNLCR Acquisitions </field_short_title>
  <field_page_description>The NCI Office of Acquisition administers contracts for the Frederick National Laboratory for Cancer Research. Browse opportunities for subcontracting and learn more about the prime contract competition.</field_page_description>
  <field_date_posted>2019-01-15</field_date_posted>
  <field_date_reviewed>2019-01-15</field_date_reviewed>
  <para_id>1135277</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciLandingPage</CONTENTTYPENAME>
  <term_id>1135495</term_id>
  <id>1135496</id>
  <title>test rare tumor1</title>
  <langcode>en</langcode>
  <field_short_title>test rare tumor2</field_short_title>
  <field_date_posted>2019-01-18</field_date_posted>
  <field_date_reviewed>2019-01-18</field_date_reviewed>
  <para_id>1135496</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1134352</term_id>
  <id>1137212</id>
  <title>After Lung Cancer Screening, Follow-Up Procedures May Be Riskier than Thought</title>
  <langcode>en</langcode>
  <field_short_title>Risks of Follow-Up Procedures after Lung Cancer Screening</field_short_title>
  <field_page_description>After lung cancer screening, complication rates from diagnostic procedures may be higher than indicated by results of the NLST trial, a new study suggests.</field_page_description>
  <field_date_posted>2019-02-08</field_date_posted>
  <field_date_reviewed>2019-02-08</field_date_reviewed>
  <field_pretty_url>lung-cancer-screening-complications-diagnostic-follow-up</field_pretty_url>
  <para_id>1137212</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1134388</term_id>
  <id>1137579</id>
  <title>Szent-Györgyi Prize to honor NCI’s Steven A. Rosenberg</title>
  <langcode>en</langcode>
  <field_short_title>NCI’s Rosenberg Wins Szent-Györgyi Prize</field_short_title>
  <field_page_description>The 2019 Szent-Györgyi Prize for Progress in Cancer Research will be awarded to NCI’s Steven A. Rosenberg, M.D., Ph.D., for his pioneering role in the development of immunotherapy.</field_page_description>
  <field_date_posted>2019-02-12</field_date_posted>
  <field_date_reviewed>2019-02-11</field_date_reviewed>
  <field_pretty_url>szent-gyorgyi-prize-rosenberg</field_pretty_url>
  <para_id>1137579</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1137868</id>
  <title>TCGA's Study of Thymoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Thymoma</field_short_title>
  <field_date_posted>2019-02-15</field_date_posted>
  <field_date_reviewed>2019-02-15</field_date_reviewed>
  <field_pretty_url>thymoma</field_pretty_url>
  <para_id>1137868</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1137885</id>
  <title>TCGA's Study of Uterine Carcinosarcoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Uterine Carcinosarcoma</field_short_title>
  <field_page_description>TCGA's Study of Uterine Carcinosarcoma</field_page_description>
  <field_date_posted>2019-02-15</field_date_posted>
  <field_date_reviewed>2019-02-15</field_date_reviewed>
  <field_pretty_url>uterine-carcinosarcoma</field_pretty_url>
  <para_id>1137885</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1138011</term_id>
  <id>1137918</id>
  <title>NCI Meeting Room</title>
  <langcode>en</langcode>
  <field_short_title>NCI Meeting Room</field_short_title>
  <field_page_description>Researchers can arrange a meeting with their Program Directors ahead of AACR to discuss individual grants and learn about new research initiatives at NCI. See the NCI Resource Room hours.</field_page_description>
  <field_date_posted>2019-02-22</field_date_posted>
  <field_date_reviewed>2018-03-26</field_date_reviewed>
  <para_id>1137918</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1123947</id>
  <title>TCGA's Study of Paraganglioma &amp; Pheochromocytoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Paraganglioma &amp; Pheochromocytoma</field_short_title>
  <field_page_description>TCGA's Study of Paraganglioma &amp; Pheochromocytoma</field_page_description>
  <field_date_posted>2018-09-05</field_date_posted>
  <field_date_reviewed>2018-09-05</field_date_reviewed>
  <field_pretty_url>paraganglioma</field_pretty_url>
  <para_id>1123947</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102626</term_id>
  <id>1124937</id>
  <title>Working with NCI Divisions, Offices and Centers to Advance Global Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Working with NCI Divisions, Offices and Centers to Advance Global Cancer Research</field_short_title>
  <field_page_description>According to recently released global cancer burden statistics, an estimated 18.1 new cancer cases and 9.6 million deaths from cancer were expected in 2018.  Read CGH's newest Spotlight Blog to see how we are Working with NCI Divisions, Offices, and Centers to Advance Global Cancer Research.</field_page_description>
  <field_date_posted>2018-09-24</field_date_posted>
  <field_date_reviewed>2018-09-24</field_date_reviewed>
  <field_pretty_url>cancer-research-day</field_pretty_url>
  <para_id>1124937</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1125001</id>
  <title>Stimulating the Immune System Shrinks Some Slow-Growing Lymphomas</title>
  <langcode>en</langcode>
  <field_short_title>Stimulating Immune System Shrinks Some Lymphomas</field_short_title>
  <field_page_description>Injecting SD-101 into a single tumor, plus radiation, in patients with indolent B-cell lymphoma shrank tumors elsewhere in the body, trial results show.</field_page_description>
  <field_date_posted>2018-09-26</field_date_posted>
  <field_date_reviewed>2018-09-26</field_date_reviewed>
  <field_pretty_url>lymphoma-sd-101-in-situ-vaccine</field_pretty_url>
  <para_id>1125001</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1126138</id>
  <title>Using Artificial Intelligence to Classify Lung Cancer Types, Predict Mutations</title>
  <langcode>en</langcode>
  <field_short_title>Using Artificial Intelligence to Classify Lung Cancer Types</field_short_title>
  <field_page_description>Using artificial intelligence, cancer researchers have trained a computer program to read slides of tissue samples and accurately identify the two most common forms of lung cancer.</field_page_description>
  <field_date_posted>2018-10-10</field_date_posted>
  <field_date_reviewed>2018-10-09</field_date_reviewed>
  <field_pretty_url>artificial-intelligence-lung-cancer-classification</field_pretty_url>
  <para_id>1126138</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1126329</id>
  <title>Trial Results Highlight Changing Lung Cancer Treatment Landscape</title>
  <langcode>en</langcode>
  <field_short_title>Trials Highlight Changing Lung Cancer Treatment Landscape</field_short_title>
  <field_page_description>The ALK inhibitor brigatinib (Alunbrig) and checkpoint inhibitor durvalumab (Imfinzi) can improve outcomes in patients with advanced non-small cell lung cancer, results from two large clinical trials have affirmed.</field_page_description>
  <field_date_posted>2018-10-15</field_date_posted>
  <field_date_reviewed>2018-10-12</field_date_reviewed>
  <field_pretty_url>durvalumab-brigatinib-lung-cancer-trials</field_pretty_url>
  <para_id>1126329</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1126791</id>
  <title>Immunotherapy Drug Cemiplimab Approved for Advanced Squamous Cell Skin Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Cemiplimab Approved for Advanced Squamous Cell Skin Cancer</field_short_title>
  <field_page_description>The immunotherapy drug cemiplimab (Libtayo) has been approved by FDA for advanced cutaneous squamous cell carcinoma, a common type of skin cancer. </field_page_description>
  <field_date_posted>2018-10-19</field_date_posted>
  <field_date_reviewed>2018-10-19</field_date_reviewed>
  <field_pretty_url>cemiplimab-fda-squamous-cell-carcinoma</field_pretty_url>
  <para_id>1126791</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1107074</term_id>
  <id>1127224</id>
  <title>Making the Case for Biomarkers in Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Making the Case for Biomarkers in Cancer Treatment-T.J. Sharpe</field_short_title>
  <field_page_description>Read how melanoma survivor T.J. Sharpe’s experience on two clinical trials highlights the need for biomarkers to predict benefit from immunotherapy.</field_page_description>
  <field_date_posted>2017-09-21</field_date_posted>
  <field_date_reviewed>2018-10-24</field_date_reviewed>
  <field_pretty_url>tj-sharpe-biomarkers-immunotherapy-melanoma</field_pretty_url>
  <para_id>1127224</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102630</term_id>
  <id>1127271</id>
  <title>ATAC-seq on TCGA: Insights Into the Noncoding Region in Primary Cancers</title>
  <langcode>en</langcode>
  <field_short_title>ATAC-seq on TCGA</field_short_title>
  <field_page_description>Using a chromatin accessibility assay to examine the noncoding genome in TCGA.</field_page_description>
  <field_date_posted>2018-10-25</field_date_posted>
  <field_date_reviewed>2018-10-25</field_date_reviewed>
  <field_pretty_url>atac-seq</field_pretty_url>
  <para_id>1127271</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102630</term_id>
  <id>1130980</id>
  <title>Meticulous Reconstructions of Tumor Origins With Single-Cell DNA Sequencing: Researcher Interview with Nicholas Navin</title>
  <langcode>en</langcode>
  <field_short_title>Nicholas Navin on Single-Cell DNA Sequencing</field_short_title>
  <field_page_description>A pioneer in single-cell DNA sequencing talks about the technology and the research it enables.</field_page_description>
  <field_date_posted>2018-11-27</field_date_posted>
  <field_date_reviewed>2018-11-14</field_date_reviewed>
  <field_pretty_url>interview-scDNA-seq</field_pretty_url>
  <para_id>1130980</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1131168</id>
  <title>Olaparib after Initial Treatment Delays Ovarian Cancer Progression</title>
  <langcode>en</langcode>
  <field_short_title>Olaparib Maintenance Therapy Delays Ovarian Cancer Progression</field_short_title>
  <field_page_description>Could results from the SOLO-1 trial change the standard of care for women with newly diagnosed ovarian cancer that harbors a BRCA mutation?</field_page_description>
  <field_date_posted>2018-11-20</field_date_posted>
  <field_date_reviewed>2018-11-16</field_date_reviewed>
  <field_pretty_url>ovarian-cancer-olaparib-maintenance-therapy</field_pretty_url>
  <para_id>1131168</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>941577</term_id>
  <id>1107097</id>
  <title>Clinical Trials to Treat Testicular Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trials to Treat Testicular Cancer</field_short_title>
  <field_date_posted>2018-02-14</field_date_posted>
  <field_date_reviewed>2018-02-14</field_date_reviewed>
  <field_pretty_url>testicular-cancer</field_pretty_url>
  <para_id>1107097</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>941577</term_id>
  <id>1107099</id>
  <title>Clinical Trials to Treat Adult Glioblastoma</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trials to Treat Adult Glioblastoma</field_short_title>
  <field_date_posted>2018-02-14</field_date_posted>
  <field_date_reviewed>2018-02-14</field_date_reviewed>
  <field_pretty_url>adult-glioblastoma</field_pretty_url>
  <para_id>1107099</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1107845</id>
  <title>Molecular Switch Links High-Fat Diet to Prostate Cancer Metastasis</title>
  <langcode>en</langcode>
  <field_short_title>High-Fat Diet Linked to Prostate Cancer Metastasis</field_short_title>
  <field_page_description>A new study in mice has revealed a molecular link between a high-fat diet and the growth and spread of prostate cancer. As this Cancer Currents post explains, researchers also showed that an anti-obesity drug that targets a protein that controls fat synthesis could potentially be used to treat metastatic prostate cance</field_page_description>
  <field_date_posted>2018-02-22</field_date_posted>
  <field_date_reviewed>2018-02-22</field_date_reviewed>
  <field_pretty_url>high-fat-diet-prostate-metastasis</field_pretty_url>
  <para_id>1107845</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1108310</id>
  <title>Lung Cancer Screening Most Beneficial for Those at Highest Risk, Analysis Suggests</title>
  <langcode>en</langcode>
  <field_short_title>Lung Cancer Screening May Benefit Those at Highest Risk</field_short_title>
  <field_page_description>People at the highest risk for lung cancer, based on a risk model, may be more likely to benefit from screening with low-dose CT, a new analysis suggests. The study authors believe the findings may better define who should undergo lung cancer screening, as this Cancer Currents blog post explains.</field_page_description>
  <field_date_posted>2018-02-28</field_date_posted>
  <field_date_reviewed>2018-02-27</field_date_reviewed>
  <field_pretty_url>lung-cancer-screening-identifying-who-benefits</field_pretty_url>
  <para_id>1108310</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>1110239</id>
  <title>TEST - What's New in Breast Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>TEST - What's New in Breast Cancer Research</field_short_title>
  <field_date_posted>2018-03-21</field_date_posted>
  <field_date_reviewed>2018-03-15</field_date_reviewed>
  <field_pretty_url>draft</field_pretty_url>
  <para_id>1110239</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1112845</id>
  <title>Brentuximab Approved for Initial Treatment of Advanced Hodgkin Lymphoma</title>
  <langcode>en</langcode>
  <field_short_title>FDA Expands Approval of Brentuximab for Hodgkin Lymphoma</field_short_title>
  <field_page_description>The FDA has expanded the approved uses of brentuximab (Adcetris) in people with Hodgkin lymphoma. As this Cancer Currents post explains, it can now be used in combination with three chemotherapy drugs as an initial treatment in patients with advanced disease.</field_page_description>
  <field_date_posted>2018-04-17</field_date_posted>
  <field_date_reviewed>2018-04-10</field_date_reviewed>
  <field_pretty_url>brentuximab-fda-expanded-indication-hodgkin-lymphoma</field_pretty_url>
  <para_id>1112845</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1113481</id>
  <title>NCI Expands Repository of Cancer Research Models: A Conversation with Drs. Doroshow and Evrard</title>
  <langcode>en</langcode>
  <field_short_title>NCI Expands Repository of Cancer Research Models</field_short_title>
  <field_page_description>NCI is expanding its Patient-Derived Models Repository (PDMR), which generates and distributes models like patient-derived xenografts and organoids. In this Cancer Currents Q&amp;A with Drs. Yvonne Evrard and James Doroshow,  learn how the expansion can help cancer researchers make more rapid progress.</field_page_description>
  <field_date_posted>2018-04-20</field_date_posted>
  <field_date_reviewed>2018-04-20</field_date_reviewed>
  <field_pretty_url>nci-pdmr-cancer-research-models</field_pretty_url>
  <para_id>1113481</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919353</term_id>
  <id>1114552</id>
  <title> International Cancer Screening Network</title>
  <langcode>en</langcode>
  <field_short_title> International Cancer Screening Network</field_short_title>
  <field_page_description>The International Cancer Screening Network promotes evidence-based cancer screening implementation and evaluation with cooperation from multilateral organizations around the globe. Learn more about how ICSN aims to reduce the global burden of cancer by supporting research and international collaboration.</field_page_description>
  <field_date_posted>2018-05-01</field_date_posted>
  <field_date_reviewed>2018-05-01</field_date_reviewed>
  <field_pretty_url>icsn</field_pretty_url>
  <para_id>1114552</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1114548</term_id>
  <id>1114561</id>
  <title>Radiation Therapy Side Effects</title>
  <langcode>en</langcode>
  <field_short_title>Radiation Therapy Side Effects</field_short_title>
  <field_page_description>Radiation therapy has side effects because it not only kills or slows the growth of cancer cells, it can also affect nearby healthy cells. Many people who get radiation therapy experience fatigue. Other side effects depend on the part of the body that is being treated. Learn more about possible side effects.</field_page_description>
  <field_date_posted>2018-05-01</field_date_posted>
  <field_date_reviewed>2018-05-01</field_date_reviewed>
  <para_id>1114561</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1137532</term_id>
  <id>1137533</id>
  <title>NCI Awardee Skills Development Consortium: Program Logistics and Evaluation Coordinating Center (U24)</title>
  <langcode>en</langcode>
  <field_short_title>NCI U24 Award</field_short_title>
  <field_date_posted>2019-02-15</field_date_posted>
  <field_date_reviewed>2019-02-12</field_date_reviewed>
  <para_id>1137533</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1135698</term_id>
  <id>1137608</id>
  <title>An NCI Affordable Cancer Technologies project selected as one of Physics World’s Top Ten Breakthroughs of 2018</title>
  <langcode>en</langcode>
  <field_short_title>An NCI Affordable Cancer Technologies project selected as one of Physics World’s Top Ten</field_short_title>
  <field_page_description>Interested in technology devices for LMICs? Read how Eric Ford from the University of Washington and his team have recently been recognized by Physics World for his NCI-funded work to bring intensity-modulate radiotherapy (IMRT) to low- and middle-income settings.</field_page_description>
  <field_date_posted>2019-02-12</field_date_posted>
  <field_date_reviewed>2019-02-12</field_date_reviewed>
  <field_pretty_url>eric-ford</field_pretty_url>
  <para_id>1137608</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1137767</id>
  <title>TCGA's Study of Prostate Cancer</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Prostate Cancer</field_short_title>
  <field_page_description>TCGA's Study of Prostate Cancer</field_page_description>
  <field_date_posted>2019-02-14</field_date_posted>
  <field_date_reviewed>2019-02-14</field_date_reviewed>
  <field_pretty_url>prostate</field_pretty_url>
  <para_id>1137767</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1137840</id>
  <title>TCGA's Study of Adult Soft Tissue Sarcoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Sarcoma</field_short_title>
  <field_date_posted>2019-02-15</field_date_posted>
  <field_date_reviewed>2019-02-15</field_date_reviewed>
  <field_pretty_url>sarcoma</field_pretty_url>
  <para_id>1137840</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1137874</id>
  <title>TCGA'S Study of Papillary Thyroid Carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA'S Study of Papillary Thyroid Carcinoma</field_short_title>
  <field_page_description>TCGA'S Study of Papillary Thyroid Carcinoma</field_page_description>
  <field_date_posted>2019-02-15</field_date_posted>
  <field_date_reviewed>2019-02-15</field_date_reviewed>
  <field_pretty_url>thyroid</field_pretty_url>
  <para_id>1137874</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1115344</term_id>
  <id>1115345</id>
  <title>Blog Posts by the NCI Director Dr. Norman Sharpless</title>
  <langcode>en</langcode>
  <field_short_title>Blog Posts by the NCI Director</field_short_title>
  <field_page_description>NCI Director Dr. Norman Sharpless writes posts regularly for NCI's Cancer Currents Blog that highlight his vision for NCI, meetings with and partnerships in the cancer community, and strategic and scientific initiatives to advance cancer research and care.</field_page_description>
  <field_date_posted>2018-05-25</field_date_posted>
  <field_date_reviewed>2018-05-12</field_date_reviewed>
  <para_id>1115345</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1102622</term_id>
  <id>1115930</id>
  <title>NCI study finds gut microbiome can control antitumor immune function in liver</title>
  <langcode>en</langcode>
  <field_short_title>Gut microbiome can control antitumor immune function in liver</field_short_title>
  <field_page_description>An NCI study in mice that found a connection between gut bacteria and antitumor immune responses in the liver has implications for understanding mechanisms that lead to liver cancer and for potential treatments. The study was published in Science.</field_page_description>
  <field_date_posted>2018-05-24</field_date_posted>
  <field_date_reviewed>2018-05-18</field_date_reviewed>
  <field_pretty_url>gut-microbiome-liver-cancer</field_pretty_url>
  <para_id>1115930</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1116069</id>
  <title>FDA Approves Second CAR T-Cell Therapy for Lymphoma</title>
  <langcode>en</langcode>
  <field_short_title>Tisagenlecleucel Approved to Treat Some Lymphomas</field_short_title>
  <field_page_description>FDA has approved the CAR T-cell therapy tisagenlecleucel for adults with diffuse large B-cell lymphoma that is relapsed or refractory. Learn more about this new approval and how it may affect patients in this NCI Cancer Currents blog post.</field_page_description>
  <field_date_posted>2018-05-22</field_date_posted>
  <field_date_reviewed>2018-05-22</field_date_reviewed>
  <field_pretty_url>tisagenlecleucel-fda-lymphoma</field_pretty_url>
  <para_id>1116069</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1116081</id>
  <title>Can Immunotherapy Succeed in Glioblastoma?</title>
  <langcode>en</langcode>
  <field_short_title>Can Immunotherapy Succeed in Glioblastoma?</field_short_title>
  <field_page_description>Researchers are hopeful that, for the deadly brain cancer glioblastoma, immunotherapy might succeed where other therapies have not. As this Cancer Currents post reports, different immunotherapy approaches are being tested in clinical trials.</field_page_description>
  <field_date_posted>2018-05-24</field_date_posted>
  <field_date_reviewed>2018-05-22</field_date_reviewed>
  <field_pretty_url>immunotherapy-glioblastoma</field_pretty_url>
  <para_id>1116081</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1116105</term_id>
  <id>1116106</id>
  <title>Meet the Expert Sessions</title>
  <langcode>en</langcode>
  <field_short_title>Meet the Expert Sessions</field_short_title>
  <field_page_description>Meet the Expert Sessions at American Public Health Association (APHA) Annual Meeting and Expo from Saturday, November 10 to Wednesday, November 14 in San Diego, CA.</field_page_description>
  <field_date_posted>2018-05-22</field_date_posted>
  <field_date_reviewed>2018-05-22</field_date_reviewed>
  <para_id>1116106</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102630</term_id>
  <id>1116535</id>
  <title>The Genomic Data Commons Turns 2: Progress in Clinical Tool Development</title>
  <langcode>en</langcode>
  <field_short_title>Genomic Data Commons Turns 2</field_short_title>
  <field_page_description>Milestones and challenges ahead in building an interactive, open-access precision medicine tool</field_page_description>
  <field_date_posted>2018-05-31</field_date_posted>
  <field_date_reviewed>2018-05-30</field_date_reviewed>
  <field_pretty_url>GDC-2-years</field_pretty_url>
  <para_id>1116535</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1117603</id>
  <title>Trial Produces Practice-Changing Findings for Some Children, Young Adults with Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Nelarabine Improves Survival in Young Patients with T-Cell ALL</field_short_title>
  <field_page_description>For some children and young adults with T-cell ALL, adding nelarabine (Arranon) to chemotherapy should be the standard of care, new clinical trial results suggest.</field_page_description>
  <field_date_posted>2018-06-14</field_date_posted>
  <field_date_reviewed>2018-06-14</field_date_reviewed>
  <field_pretty_url>leukemia-nelarabine-improves-survival</field_pretty_url>
  <para_id>1117603</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1117904</id>
  <title>Biosimilars for Cancer Emerge as Patents on Widely Used Biological Drugs Expire </title>
  <langcode>en</langcode>
  <field_short_title>Biosimilar Drugs for Cancer Emerge </field_short_title>
  <field_page_description>As the patents on widely used biological drugs to treat cancer expire, biosimilar drugs are being developed for the treatment of patients with cancer. You can learn how biosimilars may expand treatment options in this Cancer Currents blog post.  </field_page_description>
  <field_date_posted>2018-06-18</field_date_posted>
  <field_date_reviewed>2018-06-18</field_date_reviewed>
  <field_pretty_url>biosimilars-cancer-treatment</field_pretty_url>
  <para_id>1117904</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1129045</term_id>
  <id>1119406</id>
  <title>TCGA Molecular Characterization Platforms</title>
  <langcode>en</langcode>
  <field_short_title>Molecular Characterization Platforms</field_short_title>
  <field_date_posted>2019-01-23</field_date_posted>
  <field_date_reviewed>2018-07-05</field_date_reviewed>
  <para_id>1119406</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>858174</term_id>
  <id>859630</id>
  <title>Going Back to Work</title>
  <langcode>en</langcode>
  <field_short_title>Going Back to Work</field_short_title>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-17</field_date_reviewed>
  <para_id>859630</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>858179</term_id>
  <id>859637</id>
  <title>A New Normal</title>
  <langcode>en</langcode>
  <field_short_title>A New Normal</field_short_title>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-17</field_date_reviewed>
  <para_id>859637</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogSeries</CONTENTTYPENAME>
  <term_id>860258</term_id>
  <id>860259</id>
  <title>Cancer Currents: An NCI Cancer Research Blog</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Currents Blog</field_short_title>
  <field_page_description>Cancer Currents blog providing news and research updates from the National Cancer Institute</field_page_description>
  <field_date_posted>2014-11-20</field_date_posted>
  <field_date_reviewed>2014-11-20</field_date_reviewed>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>861460</term_id>
  <id>860833</id>
  <title>Get the Facts about Exposure to I-131 Radiation</title>
  <langcode>en</langcode>
  <field_short_title>I-131 Radiation Exposure from Fallout</field_short_title>
  <field_date_posted>2014-12-05</field_date_posted>
  <field_date_reviewed>2014-11-24</field_date_reviewed>
  <field_pretty_url>i-131</field_pretty_url>
  <para_id>860833</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>866278</term_id>
  <id>866280</id>
  <title>Center for Cancer Genomics (CCG)</title>
  <langcode>en</langcode>
  <field_short_title>Center for Cancer Genomics (CCG)</field_short_title>
  <field_date_posted>2015-04-13</field_date_posted>
  <field_date_reviewed>2015-04-13</field_date_reviewed>
  <para_id>866280</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>881866</id>
  <title>More than 300 million people in at least 70 countries use smokeless tobacco</title>
  <langcode>en</langcode>
  <field_short_title>More than 300 million people in at least 70 countries use smokeless tobacco</field_short_title>
  <field_page_description>The first-ever report on the global use and public health impact of smokeless tobacco finds that more than 300 million people in at least 70 countries use these harmful products.</field_page_description>
  <field_date_posted>2014-12-15</field_date_posted>
  <field_date_reviewed>2014-12-15</field_date_reviewed>
  <field_pretty_url>NCIandCDCSmokelessTobaccoReport</field_pretty_url>
  <para_id>881866</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>904487</term_id>
  <id>882415</id>
  <title>Secondhand Tobacco Smoke (Environmental Tobacco Smoke) </title>
  <langcode>en</langcode>
  <field_short_title>Secondhand Tobacco Smoke (Environmental Tobacco Smoke) </field_short_title>
  <field_page_description>Learn about secondhand tobacco smoke, which can raise your risk of lung cancer. Secondhand tobacco smoke is the combination of the smoke given off by a burning tobacco product and the smoke exhaled by a smoker. Also called environmental tobacco smoke, involuntary smoke, and passive smoke.  </field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2014-12-15</field_date_reviewed>
  <para_id>882415</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>882603</term_id>
  <id>882604</id>
  <title>Asbestos</title>
  <langcode>en</langcode>
  <field_short_title>Asbestos</field_short_title>
  <field_page_description>Asbestos are a group of naturally occurring fibrous minerals used in fire-resistant and insulating material. Breathing high levels of asbestos can cause several diseases, including lung cancer and malignant mesothelioma. The use of asbestos is now highly regulated in the United States.</field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2019-02-13</field_date_reviewed>
  <para_id>882604</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>930502</term_id>
  <id>890792</id>
  <title>Nivolumab Improves Overall Survival in Patients with Metastatic Melanoma without a BRAF Mutation</title>
  <langcode>en</langcode>
  <field_short_title>Nivolumab for Metastatic Melanoma without a BRAF Mutation</field_short_title>
  <field_page_description>A summary of results from an international phase III trial show that nivolumab (Opdivo®) improves overall survival compared with the chemotherapy drug dacarbazine in patients with metastatic melanoma whose tumors do not have a mutation in the BRAF gene.</field_page_description>
  <field_date_posted>2015-01-06</field_date_posted>
  <field_date_reviewed>2015-01-06</field_date_reviewed>
  <field_pretty_url>nivolumab</field_pretty_url>
  <para_id>890792</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>882606</term_id>
  <id>882607</id>
  <title>Benzene</title>
  <langcode>en</langcode>
  <field_short_title>Benzene</field_short_title>
  <field_page_description>Learn about benzene, a component of crude oil and other substances. Exposure to benzene may increase the risk of leukemia and other blood disorders.  Among smokers, 90 percent of benzene exposure comes from smoking. Benzene may also be found in glues, adhesives, and paint or cleaning products.</field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2019-01-14</field_date_reviewed>
  <para_id>882607</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>882613</term_id>
  <id>882624</id>
  <title>Beryllium</title>
  <langcode>en</langcode>
  <field_short_title>Beryllium</field_short_title>
  <field_page_description>Learn about beryllium, exposure to which can increase your risk of lung cancer. Beryllium is a naturally occurring, light-weight metal used in products such as aerospace components, transistors, nuclear reactors, and golf clubs. Most exposures occur to workers who produce such products.</field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2019-01-31</field_date_reviewed>
  <para_id>882624</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>882651</term_id>
  <id>882656</id>
  <title>Coal Tar and Coal-Tar Pitch</title>
  <langcode>en</langcode>
  <field_short_title>Coal Tar and Coal-Tar Pitch</field_short_title>
  <field_page_description>Learn about coal-tar products, which can raise your risk of skin cancer, lung cancer, and other types of cancer. Examples of coal-tar products include creosote, coal-tar pitch, and certain preparations used to treat skin conditions such as eczema, psoriasis, and dandruff.</field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2018-12-28</field_date_reviewed>
  <para_id>882656</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>882655</term_id>
  <id>882658</id>
  <title>Crystalline Silica</title>
  <langcode>en</langcode>
  <field_short_title>Crystalline Silica</field_short_title>
  <field_page_description>Learn about crystalline silica (quartz dust), which can raise your risk of lung cancer. Crystalline silica is present in certain construction materials such as concrete, masonry, and brick and also in commercial products such as some cleansers, cosmetics, pet litter, talcum powder, caulk, and paint.</field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2019-02-01</field_date_reviewed>
  <para_id>882658</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>884837</id>
  <title>Global Prostate Cancer Disparities in Black Men</title>
  <langcode>en</langcode>
  <field_short_title>Global Prostate Cancer Disparities in Black Men</field_short_title>
  <field_date_posted>2014-12-18</field_date_posted>
  <field_date_reviewed>2014-12-18</field_date_reviewed>
  <field_pretty_url>global-prostate-cancer-disparities-in-black-men</field_pretty_url>
  <para_id>884837</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>930502</term_id>
  <id>890811</id>
  <title>Combining Two Types of Targeted Therapy Improves Survival in Some Patients with Advanced Melanoma (Updated)</title>
  <langcode>en</langcode>
  <field_short_title>Dabrafenib Plus Trametinib for Advanced Melanoma</field_short_title>
  <field_page_description>A summary of results from two phase III trials show that patients with metastatic melanoma whose tumors have specific mutations in the BRAF gene lived longer following treatment with dabrafenib (Tafinlar®), a BRAF inhibitor, plus trametinib (Mekinist®), a</field_page_description>
  <field_date_posted>2015-01-06</field_date_posted>
  <field_date_reviewed>2015-01-06</field_date_reviewed>
  <field_pretty_url>dabrafenib-trametinib</field_pretty_url>
  <para_id>890811</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069530</term_id>
  <id>892450</id>
  <title>Targeting Ras Membrane Association:  Still an Achilles Heel</title>
  <langcode>en</langcode>
  <field_short_title>Targeting Ras Membrane Association:  Still an Achilles Heel</field_short_title>
  <field_page_description>Mark Philips describes how post-translational modifications of KRAS protein influence trafficking</field_page_description>
  <field_date_posted>2015-01-20</field_date_posted>
  <field_date_reviewed>2015-01-09</field_date_reviewed>
  <field_pretty_url>targeting-ras-membrane-association-still-an-achilles-heel</field_pretty_url>
  <para_id>892450</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>895441</id>
  <title>Program Spotlight: 2014 Professional Development Workshop Scientific Poster Winners</title>
  <langcode>en</langcode>
  <field_short_title>Program Spotlight: 2014 Professional Development Workshop Scientific Poster Winners</field_short_title>
  <field_date_posted>2014-07-17</field_date_posted>
  <field_date_reviewed>2014-07-17</field_date_reviewed>
  <field_pretty_url>pwd-spotlight</field_pretty_url>
  <para_id>895441</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>895443</id>
  <title>Program Spotlight: CRCHD Mock Grant Review </title>
  <langcode>en</langcode>
  <field_short_title>Program Spotlight: CRCHD Mock Grant Review </field_short_title>
  <field_date_posted>2014-07-17</field_date_posted>
  <field_date_reviewed>2014-07-17</field_date_reviewed>
  <field_pretty_url>mock-review</field_pretty_url>
  <para_id>895443</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>896515</id>
  <title>Drugs Approved for Esophageal Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Esophageal Cancer</field_short_title>
  <field_date_posted>2015-01-15</field_date_posted>
  <field_date_reviewed>2015-01-15</field_date_reviewed>
  <field_pretty_url>esophageal</field_pretty_url>
  <para_id>896515</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>899446</id>
  <title>Program Spotlight: Partnership for the Advancement of Cancer Research Project Brings Cancer Research Training to Underrepresented Students at New Mexico State University</title>
  <langcode>en</langcode>
  <field_short_title>Program Spotlight: Partnership for the Advancement of Cancer Research Project</field_short_title>
  <field_date_posted>2014-03-28</field_date_posted>
  <field_date_reviewed>2014-03-28</field_date_reviewed>
  <field_pretty_url>nmsu-spotlight-blog</field_pretty_url>
  <para_id>899446</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>816561</id>
  <title>Rare kidney tumor provides insights on role of metabolic changes in cancer</title>
  <langcode>en</langcode>
  <field_short_title>Rare kidney tumor provides insight on metabolic changes </field_short_title>
  <field_page_description>Researchers in The Cancer Genome Atlas (TCGA) Network have uncovered a number of new  findings about the biology and development of a rare form of kidney cancer. They found that the disease – chromophobe renal cell carcinoma – stems in part from alteratio</field_page_description>
  <field_date_posted>2014-08-21</field_date_posted>
  <field_date_reviewed>2014-08-18</field_date_reviewed>
  <field_pretty_url>TCGAkidneyChromophobe</field_pretty_url>
  <para_id>816561</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>816956</term_id>
  <id>817098</id>
  <title>RAS Reagents</title>
  <langcode>en</langcode>
  <field_short_title>RAS Reagents</field_short_title>
  <field_page_description>The RAS Reagents group prepares proteins, DNAs, and cell lines, all of which are required to attack cancers caused by mutant RAS.</field_page_description>
  <field_date_posted>2014-09-22</field_date_posted>
  <field_date_reviewed>2014-08-20</field_date_reviewed>
  <para_id>817098</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922410</term_id>
  <id>821432</id>
  <title>National Lung Screening Trial</title>
  <langcode>en</langcode>
  <field_short_title>National Lung Screening Trial</field_short_title>
  <field_page_description>The National Lung Screening Trial (NLST), a research study sponsored by the National Cancer Institute that used low-dose helical CT scans or chest X-ray to screen men and women at risk for lung cancer. </field_page_description>
  <field_date_posted>2014-09-08</field_date_posted>
  <field_date_reviewed>2014-09-08</field_date_reviewed>
  <field_pretty_url>nlst</field_pretty_url>
  <para_id>821432</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>822011</id>
  <title>NCI study examines outcomes from surgery to prevent ovarian cancer</title>
  <langcode>en</langcode>
  <field_short_title>Study examines outcomes from surgery to prevent ovarian cancer</field_short_title>
  <field_page_description>A new study looked at women at high risk of ovarian cancer who had no clinical signs of the disease and who underwent risk-reducing salpingo-oophorectomy (RRSO).  The study results showed cancer in the removed tissues of 2.6 percent (25 of 966) of the par</field_page_description>
  <field_date_posted>2014-09-08</field_date_posted>
  <field_date_reviewed>2014-09-03</field_date_reviewed>
  <field_pretty_url>RRSOovarian</field_pretty_url>
  <para_id>822011</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>836725</id>
  <title>Understanding Cervical Changes: A Health Guide for Women</title>
  <langcode>en</langcode>
  <field_short_title>Understanding Cervical Changes: A Health Guide for Women</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2014-10-03</field_date_reviewed>
  <field_pretty_url>understanding-cervical-changes</field_pretty_url>
  <para_id>836725</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>836829</id>
  <title>Facing Forward: Making a Difference in Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Facing Forward: Making a Difference in Cancer</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2014-10-03</field_date_reviewed>
  <field_pretty_url>make-a-difference</field_pretty_url>
  <para_id>836829</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>836921</id>
  <title>Thinking About Complementary and Alternative Medicine</title>
  <langcode>en</langcode>
  <field_short_title>Thinking About Complementary and Alternative Medicine</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2014-10-03</field_date_reviewed>
  <field_pretty_url>thinking-about-cam</field_pretty_url>
  <para_id>836921</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>847971</term_id>
  <id>847972</id>
  <title>CRCHD Diversity Training</title>
  <langcode>en</langcode>
  <field_short_title>CRCHD Diversity Training</field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-10-29</field_date_reviewed>
  <para_id>847972</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>11826</term_id>
  <id>849987</id>
  <title>Breast Changes and Conditions</title>
  <langcode>en</langcode>
  <field_short_title>Breast Changes and Conditions</field_short_title>
  <field_page_description>Breast changes include benign conditions and those that increase the risk of breast cancer. Symptoms and treatment of breast conditions such as ADH, ALH, cysts, DCIS, and LCIS are explained to women who may have received an abnormal mammogram finding.</field_page_description>
  <field_date_posted>2014-10-30</field_date_posted>
  <field_date_reviewed>2014-10-30</field_date_reviewed>
  <para_id>849987</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>857987</term_id>
  <id>858130</id>
  <title>Feelings and Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Feelings and Cancer</field_short_title>
  <field_page_description>Ways to cope with your emotions and manage the emotional effects of cancer, including anger, fear, stress, and depression.</field_page_description>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-14</field_date_reviewed>
  <para_id>858130</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>692708</term_id>
  <id>866188</id>
  <title>The RAS Initiative</title>
  <langcode>en</langcode>
  <field_short_title>The RAS Initiative</field_short_title>
  <field_page_description>NCI established the RAS Initiative to explore innovative approaches for attacking the proteins encoded by mutant forms of RAS genes and to ultimately create effective, new therapies for RAS-related cancers.</field_page_description>
  <field_date_posted>2014-12-01</field_date_posted>
  <field_date_reviewed>2014-12-01</field_date_reviewed>
  <para_id>866188</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>860262</term_id>
  <id>873808</id>
  <title>Method for Identifying Combination Therapies to Combat Treatment Resistance Shows Promise</title>
  <langcode>en</langcode>
  <field_short_title>Method for Studying Treatment Resistance Shows Promise</field_short_title>
  <field_page_description>A blog post about a method for studying treatment resistance</field_page_description>
  <field_date_posted>2014-12-12</field_date_posted>
  <field_date_reviewed>2014-12-12</field_date_reviewed>
  <field_pretty_url>treatment-resistance</field_pretty_url>
  <para_id>873808</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>881839</term_id>
  <id>881840</id>
  <title>CRCHD Mission</title>
  <langcode>en</langcode>
  <field_short_title>Mission</field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-12-15</field_date_reviewed>
  <para_id>881840</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>882332</term_id>
  <id>882333</id>
  <title>Vinyl Chloride</title>
  <langcode>en</langcode>
  <field_short_title>Vinyl Chloride</field_short_title>
  <field_page_description>Learn about vinyl chloride, which can raise the  risk of a rare form of liver cancer, as well as brain and lung cancers, and leukemia and lymphoma. Vinyl chloride is used primarily to make PVC, a substance used in products such as pipes.</field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2018-12-28</field_date_reviewed>
  <para_id>882333</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940066</term_id>
  <id>940071</id>
  <title>Colorectal Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Colorectal Cancer</field_short_title>
  <field_page_description>Colorectal cancer studies often consider colon and rectal cancer together. Worldwide, colorectal cancer is the third most common form of cancer. Find evidence-based information on colon and rectal cancer treatment, causes and prevention, screening, research, genetics, and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940071</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938028</term_id>
  <id>940233</id>
  <title>Stomach Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on stomach cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940233</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940438</term_id>
  <id>940445</id>
  <title>Leukemia—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Leukemia</field_short_title>
  <field_page_description>There are different types of leukemia, including acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, and hairy cell leukemia. Find evidence-based information on leukemia treatment, research, genomics, and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940445</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>937976</term_id>
  <id>941398</id>
  <title>Treatment Research</title>
  <langcode>en</langcode>
  <field_short_title>Treatment Research</field_short_title>
  <field_page_description>Find research articles on cancer treatment, including news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941398</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciLandingPage</CONTENTTYPENAME>
  <term_id>914792</term_id>
  <id>941573</id>
  <title>Grants &amp; Training</title>
  <langcode>en</langcode>
  <field_short_title>Grants &amp; Training</field_short_title>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941573</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>922824</term_id>
  <id>951178</id>
  <title>Scientific Conferences Where NCI Exhibits</title>
  <langcode>en</langcode>
  <field_short_title>Conferences</field_short_title>
  <field_page_description>Scientific conferences where NCI will be exhibiting, including ASCO, AACR, BIO, and APHA.</field_page_description>
  <field_date_posted>2015-05-06</field_date_posted>
  <field_date_reviewed>2015-05-06</field_date_reviewed>
  <para_id>951178</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>11482</term_id>
  <id>14304</id>
  <title>NCI Organization</title>
  <langcode>en</langcode>
  <field_short_title>NCI Organization</field_short_title>
  <field_page_description>Links to NCI's 30 divisions, offices, and centers who work together to build, maintain, and enhance a cohesive and comprehensive cancer research agenda.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14304</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>11886</term_id>
  <id>14381</id>
  <title>Surgery to Reduce the Risk of Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Surgery to Reduce the Risk of Breast Cancer</field_short_title>
  <field_page_description>A fact sheet that describes mastectomy and salpingo-oophorectomy, two surgeries that may be used to reduce breast cancer risk in women at very high risk, and nonsurgical options.</field_page_description>
  <field_date_posted>2013-10-18</field_date_posted>
  <field_date_reviewed>2013-08-12</field_date_reviewed>
  <field_pretty_url>risk-reducing-surgery-fact-sheet</field_pretty_url>
  <para_id>14381</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>12598</term_id>
  <id>14539</id>
  <title>Contact Us for Help</title>
  <langcode>en</langcode>
  <field_short_title>Contact Us for Help</field_short_title>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14539</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>903754</term_id>
  <id>14586</id>
  <title>Tumor Grade</title>
  <langcode>en</langcode>
  <field_short_title>Tumor Grade</field_short_title>
  <field_page_description>A fact sheet that discusses tumor grade and its role in prognosis. Explains concepts like normal cell biology and cell differentiation.</field_page_description>
  <field_date_posted>2013-05-09</field_date_posted>
  <field_date_reviewed>2013-05-03</field_date_reviewed>
  <field_pretty_url>tumor-grade-fact-sheet</field_pretty_url>
  <para_id>14586</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>903750</term_id>
  <id>14686</id>
  <title>Computed Tomography (CT) Scans and Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Computed Tomography (CT) Scans and Cancer</field_short_title>
  <field_page_description>A fact sheet that describes the CT scan procedure and technology and its uses in screening, diagnosis, and treatment. </field_page_description>
  <field_date_posted>2013-07-26</field_date_posted>
  <field_date_reviewed>2013-07-16</field_date_reviewed>
  <field_pretty_url>ct-scans-fact-sheet</field_pretty_url>
  <para_id>14686</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1105271</term_id>
  <id>14815</id>
  <title>MERIT Award</title>
  <langcode>en</langcode>
  <field_short_title>MERIT Award</field_short_title>
  <field_page_description>Early Stage Investigators who have submitted R01 applications may be eligible for the Method to Extend Research in Time (MERIT) (R37) Award.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14815</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911145</term_id>
  <id>14822</id>
  <title>Obesity and Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Obesity and Cancer </field_short_title>
  <field_page_description>A fact sheet that summarizes the evidence linking overweight and obesity to the risk of various cancers and to cancer survivorship.</field_page_description>
  <field_date_posted>2017-02-03</field_date_posted>
  <field_date_reviewed>2017-01-17</field_date_reviewed>
  <field_pretty_url>obesity-fact-sheet</field_pretty_url>
  <para_id>14822</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>12770</term_id>
  <id>14868</id>
  <title>Partners and Collaborators</title>
  <langcode>en</langcode>
  <field_short_title>Partners &amp; Collaborators</field_short_title>
  <field_date_posted>2015-05-09</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14868</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>921989</term_id>
  <id>15181</id>
  <title>Childhood Cancer Survivor Study: An Overview</title>
  <langcode>en</langcode>
  <field_short_title>Childhood Cancer Survivor Study: An Overview</field_short_title>
  <field_page_description>Health problems that develop years later as a result of a cancer treatment are known as late effects. The Childhood Cancer Survivor Study (CCSS) was started in 1994 to better understand these late effects.</field_page_description>
  <field_date_posted>2007-01-10</field_date_posted>
  <field_date_reviewed>2017-08-14</field_date_reviewed>
  <field_pretty_url>ccss</field_pretty_url>
  <para_id>15181</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>105036</id>
  <title>Drugs Approved for Retinoblastoma</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Retinoblastoma</field_short_title>
  <field_date_posted>2011-10-04</field_date_posted>
  <field_date_reviewed>2011-08-16</field_date_reviewed>
  <field_pretty_url>retinoblastoma</field_pretty_url>
  <para_id>105036</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922399</term_id>
  <id>107272</id>
  <title>Cetuximab Combined with Oxaliplatin-Based Chemotherapy May Not Be Effective First-Line Treatment for Metastatic Colorectal Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Cetuximab Plus Oxaliplatin May Not Be Effective Primary Treatment for Metastatic Colorectal Cancer</field_short_title>
  <field_page_description>In a randomized phase III trial, the addition of the targeted therapy cetuximab to oxaliplatin and fluoropyrimidine chemotherapy did not prolong survival or time to disease progression of patients with advanced colorectal cancer.</field_page_description>
  <field_date_posted>2011-08-30</field_date_posted>
  <field_date_reviewed>2011-08-30</field_date_reviewed>
  <field_pretty_url>cetuximab-chemo-no-benefit</field_pretty_url>
  <para_id>107272</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>11740</term_id>
  <id>109064</id>
  <title>Inclusion Criteria for NCI Cancer Genetics Services Directory</title>
  <langcode>en</langcode>
  <field_short_title>Inclusion Criteria for NCI Cancer Genetics Services Directory</field_short_title>
  <field_page_description>Professionals who provide services related to cancer genetics (cancer risk assessment, genetic counseling, genetic susceptibility testing, and others) must meet these criteria before applying to be listed in the National Cancer Institute's Cancer Genetics Services Directory. </field_page_description>
  <field_date_posted>2011-09-12</field_date_posted>
  <field_date_reviewed>2011-09-12</field_date_reviewed>
  <para_id>109064</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>789793</id>
  <title>Lung-MAP Launches: First Precision Medicine Trial From National Clinical Trials Network</title>
  <langcode>en</langcode>
  <field_short_title>Lung-MAP Launches: First Precision Medicine Trial From National Clinical Trials Network</field_short_title>
  <field_page_description>A unique public-private collaboration today announced the initiation of the Lung Cancer Master Protocol (Lung-MAP) trial, a multi-drug, multi-arm, biomarker-driven clinical trial for patients with advanced squamous cell lung cancer. Squamous cell carcinom</field_page_description>
  <field_date_posted>2014-06-16</field_date_posted>
  <field_date_reviewed>2014-06-11</field_date_reviewed>
  <field_pretty_url>LungMAPlaunch</field_pretty_url>
  <para_id>789793</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogSeries</CONTENTTYPENAME>
  <term_id>919769</term_id>
  <id>792905</id>
  <title>CGH Spotlight Blog</title>
  <langcode>en</langcode>
  <field_short_title>CGH Spotlight Blog</field_short_title>
  <field_page_description>Stay up-to-date with the latest information and news from CGH and the global health communities.</field_page_description>
  <field_date_posted>2014-06-17</field_date_posted>
  <field_date_reviewed>2014-06-17</field_date_reviewed>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>919529</term_id>
  <id>799546</id>
  <title>RAS Central</title>
  <langcode>en</langcode>
  <field_short_title>RAS Central</field_short_title>
  <field_page_description>RAS Central is NCI's online forum for RAS researchers, featuring blog posts, an online discussion forum, events and videos, and other useful tools and resources.</field_page_description>
  <field_date_posted>2014-09-22</field_date_posted>
  <field_date_reviewed>2014-06-30</field_date_reviewed>
  <para_id>799546</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>801793</term_id>
  <id>801796</id>
  <title>RAS Reference Reagents</title>
  <langcode>en</langcode>
  <field_short_title>Reference Reagents</field_short_title>
  <field_page_description>NCI researchers have developed unique and powerful reagents at the NCI labs. Learn about and purchase the latest RAS pathways and reagents.</field_page_description>
  <field_date_posted>2014-09-22</field_date_posted>
  <field_date_reviewed>2014-07-07</field_date_reviewed>
  <para_id>801796</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>801793</term_id>
  <id>802095</id>
  <title>RAS Cell Lines</title>
  <langcode>en</langcode>
  <field_short_title>Mutant KRAS Cell Lines</field_short_title>
  <field_page_description>Cell lines expressing mutant RAS genes are essential tools for finding ways to intervene in RAS cancers. Learn about the work of NCI RAS Initiative scientists to engineer and characterize these cell lines, creating a reliable resource.</field_page_description>
  <field_date_posted>2016-09-28</field_date_posted>
  <field_date_reviewed>2014-07-10</field_date_reviewed>
  <field_pretty_url>cell-lines</field_pretty_url>
  <para_id>802095</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919492</term_id>
  <id>805062</id>
  <title>About the Office of Budget and Finance </title>
  <langcode>en</langcode>
  <field_short_title>About OBF</field_short_title>
  <field_page_description>The Office of Budget and Finance (OBF) advises the NCI Office of the Director and senior NCI staff on the effective management of financial and other resources to ensure that NCI operates in an efficient and fiscally responsible manner.</field_page_description>
  <field_date_posted>2014-12-21</field_date_posted>
  <field_date_reviewed>2014-07-17</field_date_reviewed>
  <para_id>805062</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>806040</id>
  <title>TCGA researchers identify four subtypes of stomach cancer</title>
  <langcode>en</langcode>
  <field_short_title>TCGA researchers identify 4 subtypes of stomach cancer</field_short_title>
  <field_page_description>Stomach cancers fall into four distinct molecular subtypes, researchers with The Cancer Genome Atlas (TCGA) Network have found. Scientists report that this discovery could change how researchers think about developing treatments for stomach cancer, also c</field_page_description>
  <field_date_posted>2014-07-23</field_date_posted>
  <field_date_reviewed>2014-07-18</field_date_reviewed>
  <field_pretty_url>TCGAgastric</field_pretty_url>
  <para_id>806040</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>922410</term_id>
  <id>940508</id>
  <title>Lung Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on lung cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940508</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940578</term_id>
  <id>940587</id>
  <title>Malignant Mesothelioma—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Malignant Mesothelioma </field_short_title>
  <field_page_description>Epithelial mesothelioma is the most common type of malignant mesothelioma, which forms in the cells that line organs. The other types begin in spindle-shaped cells called sarcomatoid cells or are a mixture of both cell types. Find evidence-based information on malignant mesothelioma treatment.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940587</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940610</term_id>
  <id>940617</id>
  <title>Plasma Cell Neoplasms (Including Multiple Myeloma)—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Plasma Cell Neoplasms (Including Multiple Myeloma)</field_short_title>
  <field_page_description>There are several types of plasma cell neoplasms, including monoclonal gammopathy of undetermined significance (MGUS), isolated plasmacytoma of the bone, extramedullary plasmacytoma, and multiple myeloma. Find evidence-based information on plasma cell neoplasms treatment, research, and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940617</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940674</term_id>
  <id>940681</id>
  <title>Neuroblastoma—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Neuroblastoma</field_short_title>
  <field_page_description>Neuroblastoma is a disease in which malignant cells form in the neuroblasts of the adrenal glands and paraspinal nerve tissue from the neck to the pelvis. Find evidence-based information on neuroblastoma treatment, screening, research, and genetics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940681</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938350</term_id>
  <id>940682</id>
  <title>Neuroblastoma Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on neuroblastoma, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940682</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>941018</term_id>
  <id>941025</id>
  <title>Soft Tissue Sarcoma—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Soft Tissue Sarcoma </field_short_title>
  <field_page_description>Soft tissue sarcomas are malignant tumors that arise in any of the mesodermal tissues of the extremities, trunk and retroperitoneum, or head and neck. Soft tissue sarcomas may be heterogeneous. Find evidence-based information on soft tissue sarcoma treatment and research.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941025</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>941050</term_id>
  <id>941055</id>
  <title>Testicular Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Testicular Cancer </field_short_title>
  <field_page_description>Most testicular cancers are germ cell tumors. Germ cell tumors are divided into seminomas and nonseminomas. Nonseminomas tend to grow and spread more quickly than seminomas. Find evidence-based information on testicular cancer treatment, screening, and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941055</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>937897</term_id>
  <id>941394</id>
  <title>Advanced Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941394</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>917299</term_id>
  <id>941622</id>
  <title>Resources for International Partners</title>
  <langcode>en</langcode>
  <field_short_title>Resources for International Partners</field_short_title>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941622</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911160</term_id>
  <id>14336</id>
  <title>Palliative Care in Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Palliative Care in Cancer</field_short_title>
  <field_page_description>A fact sheet that describes the role of palliative care, which is comfort care given to patients from the time of cancer diagnosis and throughout the course of illness. </field_page_description>
  <field_date_posted>2018-01-12</field_date_posted>
  <field_date_reviewed>2017-10-20</field_date_reviewed>
  <field_pretty_url>palliative-care-fact-sheet</field_pretty_url>
  <para_id>14336</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11886</term_id>
  <id>14376</id>
  <title>Breast Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Breast Cancer</field_short_title>
  <field_page_description>Breast cancer is the second most common cancer in women after skin cancer. Mammograms can detect breast cancer early, possibly before it has spread. Start here to find information on breast cancer treatment, causes and prevention, screening, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14376</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>899448</id>
  <title>Program Spotlight: Ground Broken for NCI-supported Cancer Treatment Center in Puerto Rico</title>
  <langcode>en</langcode>
  <field_short_title>Program Spotlight: Ground Broken for NCI-supported Cancer Treatment Center in Puerto Rico</field_short_title>
  <field_date_posted>2014-03-14</field_date_posted>
  <field_date_reviewed>2014-03-14</field_date_reviewed>
  <field_pretty_url>uprccc-spotlight</field_pretty_url>
  <para_id>899448</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>900750</id>
  <title>NIH-funded study uncovers range of molecular alterations in head and neck cancers, new potential drug targets; &lt;span style="font-weight:normal"&gt;&lt;i&gt;TCGA tumor genome sequencing analyses offer new insights into the effects of HPV and smoking&lt;/i&gt;&lt;/span&gt; </title>
  <langcode>en</langcode>
  <field_short_title>Study uncovers range of molecular alterations in head/neck cancers</field_short_title>
  <field_page_description>Investigators with The Cancer Genome Atlas (TCGA) Research Network have discovered genomic differences – with potentially important clinical implications – in head and neck cancers caused by infection with the human papillomavirus (HPV).</field_page_description>
  <field_date_posted>2015-01-28</field_date_posted>
  <field_date_reviewed>2015-01-27</field_date_reviewed>
  <field_pretty_url>TCGAheadNeck</field_pretty_url>
  <para_id>900750</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>903744</term_id>
  <id>903745</id>
  <title>Infection and Neutropenia during Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Infection and Neutropenia</field_short_title>
  <field_page_description>Infection and neutropenia can be serious side effects during cancer treatment. Chemotherapy can increase your risk. Learn how to prevent infection during treatment. Find out what signs and symptoms to call the doctor about. </field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2018-09-14</field_date_reviewed>
  <para_id>903745</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11966</term_id>
  <id>12880</id>
  <title>Testicular Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Testicular Cancer</field_short_title>
  <field_page_description>Testicular cancer most often begins in germ cells (cells that make sperm). It is rare and is most frequently diagnosed in men 20-34 years old. Most testicular cancers can be cured, even if diagnosed at an advanced stage. Start here to find information on testicular cancer treatment, screening, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>12880</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciHome</CONTENTTYPENAME>
  <term_id>12614</term_id>
  <id>13019</id>
  <title>Cancer.gov Home Page</title>
  <langcode>en</langcode>
  <field_short_title>Comprehensive Cancer Information</field_short_title>
  <field_page_description>Accurate, up-to-date, comprehensive cancer information from the U.S. government's principal agency for cancer research.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13019</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>160933</id>
  <title>NIH partners with industry to create new ‘Living Lab’ for research into molecular structures that can affect disease</title>
  <langcode>en</langcode>
  <field_short_title>Living Lab created</field_short_title>
  <field_page_description>A new type of lab has been created to utilize near-atomic resolution microscopy and other structural biology technologies </field_page_description>
  <field_date_posted>2012-01-12</field_date_posted>
  <field_date_reviewed>2012-01-12</field_date_reviewed>
  <field_pretty_url>LivingLab</field_pretty_url>
  <para_id>160933</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911116</term_id>
  <id>200019</id>
  <title>Vitamin D and Cancer Prevention</title>
  <langcode>en</langcode>
  <field_short_title>Vitamin D and Cancer Prevention</field_short_title>
  <field_page_description>A fact sheet that summarizes the results of studies on vitamin D and cancer prevention.  It includes information about dietary recommendations for vitamin D.</field_page_description>
  <field_date_posted>2013-10-28</field_date_posted>
  <field_date_reviewed>2013-10-21</field_date_reviewed>
  <field_pretty_url>vitamin-d-fact-sheet</field_pretty_url>
  <para_id>200019</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>909539</id>
  <title>"Flipping the Switch": An Interview with Dr. Mark Gilbert, Chief of NIH’s Neuro-Oncology Branch</title>
  <langcode>en</langcode>
  <field_short_title>"Flipping the Switch": Dr. Mark Gilbert Interview</field_short_title>
  <field_date_posted>2015-02-18</field_date_posted>
  <field_date_reviewed>2015-02-18</field_date_reviewed>
  <field_pretty_url>gilbert-interview</field_pretty_url>
  <para_id>909539</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>911286</term_id>
  <id>912891</id>
  <title>Surgery to Treat Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Surgery</field_short_title>
  <field_page_description>Surgery, when used to treat cancer, is a procedure in which a surgeon removes cancer from your body. Learn how surgery is performed and different types of surgery.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-03-17</field_date_reviewed>
  <para_id>912891</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>913173</term_id>
  <id>913176</id>
  <title>NCI CCT K Awards Evaluation</title>
  <langcode>en</langcode>
  <field_short_title>Evaluation of the Career Development (K) Awards Program</field_short_title>
  <field_date_posted>2015-03-05</field_date_posted>
  <field_date_reviewed>2015-03-05</field_date_reviewed>
  <para_id>913176</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>914506</term_id>
  <id>914512</id>
  <title>Cancer Prevention Research </title>
  <langcode>en</langcode>
  <field_short_title>Cancer Prevention Research </field_short_title>
  <field_date_posted>2015-05-10</field_date_posted>
  <field_date_reviewed>2015-03-10</field_date_reviewed>
  <para_id>914512</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>915112</term_id>
  <id>915129</id>
  <title>Researcher Interview: Elaine Mardis</title>
  <langcode>en</langcode>
  <field_short_title>Researcher Interview: Elaine Mardis</field_short_title>
  <field_date_posted>2015-04-13</field_date_posted>
  <field_date_reviewed>2015-03-12</field_date_reviewed>
  <field_pretty_url>elaine-mardis-interview</field_pretty_url>
  <para_id>915129</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>882441</term_id>
  <id>882442</id>
  <title>Mineral Oils: Untreated and Mildly Treated</title>
  <langcode>en</langcode>
  <field_short_title>Mineral Oils: Untreated and Mildly Treated</field_short_title>
  <field_page_description>Learn about mineral oils, which can raise the risk of nonmelanoma skin cancer, particularly of the scrotum. Workers in a variety of manufacturing industries are most commonly exposed to mineral oils, as are workers in engine repair, copper mining, and commercial printing.  </field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2019-02-15</field_date_reviewed>
  <para_id>882442</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>882519</term_id>
  <id>882520</id>
  <title>Ethylene Oxide</title>
  <langcode>en</langcode>
  <field_short_title>Ethylene Oxide</field_short_title>
  <field_page_description>Learn about ethylene oxide, which can raise your risk of lymphoma and leukemia. Exposure may occur through industrial emissions, tobacco smoke, and the use of products sterilized with ethylene oxide, such as certain medical products or cosmetics. </field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2014-12-28</field_date_reviewed>
  <para_id>882520</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>882600</term_id>
  <id>882601</id>
  <title>Arsenic</title>
  <langcode>en</langcode>
  <field_short_title>Arsenic</field_short_title>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2018-12-31</field_date_reviewed>
  <para_id>882601</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069530</term_id>
  <id>890810</id>
  <title>RAS Pathway v2.0</title>
  <langcode>en</langcode>
  <field_short_title>RAS Pathway v2.0</field_short_title>
  <field_date_posted>2015-01-13</field_date_posted>
  <field_date_reviewed>2015-01-06</field_date_reviewed>
  <field_pretty_url>ras-pathway-v2</field_pretty_url>
  <para_id>890810</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>898733</id>
  <title>October Spotlight: Breast Cancer Disparity Highlights</title>
  <langcode>en</langcode>
  <field_short_title>October Spotlight: Breast Cancer Disparity Highlights</field_short_title>
  <field_date_posted>2014-10-01</field_date_posted>
  <field_date_reviewed>2014-10-01</field_date_reviewed>
  <field_pretty_url>october-spotlight</field_pretty_url>
  <para_id>898733</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>608323</term_id>
  <id>898807</id>
  <title>How Imatinib Transformed Leukemia Treatment and Cancer Research </title>
  <langcode>en</langcode>
  <field_short_title>How Gleevec Transformed Leukemia Treatment</field_short_title>
  <field_page_description>This story outlines the discovery of imatinib (Gleevec), a ground-breaking drug that transformed the treatment of chronic myelogenous leukemia and sparked the beginnings of precision medicine.</field_page_description>
  <field_date_posted>2015-02-02</field_date_posted>
  <field_date_reviewed>2015-01-21</field_date_reviewed>
  <field_pretty_url>gleevec</field_pretty_url>
  <para_id>898807</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>899255</id>
  <title>Image-guided biopsy for diagnosis of prostate cancer can increase detection of high-risk tumors</title>
  <langcode>en</langcode>
  <field_short_title>Image-guided diagnosis of prostate cancer can increase detection of tumors</field_short_title>
  <field_page_description>In the largest prospective study to date of image-guided technology for identifying suspicious regions of the prostate to biopsy, researchers compared the ability of this technology to detect high-risk prostate cancer with that of the current standard of </field_page_description>
  <field_date_posted>2015-01-27</field_date_posted>
  <field_date_reviewed>2015-01-22</field_date_reviewed>
  <field_pretty_url>ProstateFusionTargetedBiopsyJAMA</field_pretty_url>
  <para_id>899255</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>899532</id>
  <title>Grantee Spotlight: Kimberly Payne, Ph.D. - Investigating Leukemia Health Disparities in Hispanic and Native American Children</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Kimberly Payne, Ph.D. - Investigating Leukemia Health Disparities in Children</field_short_title>
  <field_date_posted>2014-09-19</field_date_posted>
  <field_date_reviewed>2014-09-19</field_date_reviewed>
  <field_pretty_url>payne-spotlight</field_pretty_url>
  <para_id>899532</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919023</term_id>
  <id>900519</id>
  <title>Media Contacts</title>
  <langcode>en</langcode>
  <field_short_title>Media Contacts</field_short_title>
  <field_date_posted>2015-01-27</field_date_posted>
  <field_date_reviewed>2015-01-27</field_date_reviewed>
  <para_id>900519</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>903590</term_id>
  <id>903603</id>
  <title>Advance Directives</title>
  <langcode>en</langcode>
  <field_short_title>Advance Directives</field_short_title>
  <field_page_description>Advance directives are legal documents that allow you to decide ahead of time what kind of medical care you want or who you want to make decisions for you if you're too ill to speak for yourself.</field_page_description>
  <field_date_posted>2015-03-10</field_date_posted>
  <field_date_reviewed>2015-02-02</field_date_reviewed>
  <para_id>903603</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>901011</term_id>
  <id>903727</id>
  <title>Pain in People with Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Pain</field_short_title>
  <field_page_description>Controlling pain is an important part of your cancer treatment plan. Learn how to track levels of pain. Find out how pain, a side effect of cancer treatment, is treated using acupuncture, biofeedback, and physical therapy. </field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2017-12-04</field_date_reviewed>
  <para_id>903727</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>899924</term_id>
  <id>903729</id>
  <title>Urinary and Bladder Problems</title>
  <langcode>en</langcode>
  <field_short_title>Urinary and Bladder Problems</field_short_title>
  <field_page_description>Problems such as radiation cystitis and urinary tract infections, which are sometimes caused by cancer treatments, are discussed along with ways to prevent or manage them.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-02-04</field_date_reviewed>
  <para_id>903729</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>903735</term_id>
  <id>903736</id>
  <title>Edema (Swelling) and Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Edema (Swelling)</field_short_title>
  <field_page_description>Edema is a condition in which fluid builds up in your body’s tissues. The swelling may be caused by chemotherapy, cancer, and conditions not related to cancer. Learn about signs of edema, including swelling in your feet, ankles, and legs.  </field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2017-03-14</field_date_reviewed>
  <para_id>903736</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>497641</id>
  <title>DNA breaks early in replication process associated with B cell cancers</title>
  <langcode>en</langcode>
  <field_short_title>DNA breaks early in replication in B cell cancers </field_short_title>
  <field_page_description>Research by scientists at the NCI has identified a new class of DNA sites in cells that break early in the replication process. They found that these break sites correlate with damage often seen in B cell cancers, such as diffuse large B cell lymphoma. </field_page_description>
  <field_date_posted>2013-01-24</field_date_posted>
  <field_date_reviewed>2013-01-24</field_date_reviewed>
  <field_pretty_url>DNAbreaksearlyinreplicationinBcellcancers</field_pretty_url>
  <para_id>497641</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>279438</term_id>
  <id>505608</id>
  <title>Lymphedema and Breast Cancer Surgery</title>
  <langcode>en</langcode>
  <field_short_title>Lymphedema and Breast Cancer Surgery</field_short_title>
  <field_date_posted>2013-03-01</field_date_posted>
  <field_date_reviewed>2013-02-05</field_date_reviewed>
  <field_pretty_url>lymphedema</field_pretty_url>
  <para_id>505608</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>505611</term_id>
  <id>505752</id>
  <title>Disclaimer of Endorsement and Liability</title>
  <langcode>en</langcode>
  <field_short_title>Disclaimer</field_short_title>
  <field_page_description>As detailed in this disclaimer policy, the National Cancer Institute does not endorse or recommend any commercial product or activity on its websites.</field_page_description>
  <field_date_posted>2013-02-05</field_date_posted>
  <field_date_reviewed>2018-04-05</field_date_reviewed>
  <para_id>505752</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>525098</id>
  <title>The potential of large studies for building genetic risk prediction models</title>
  <langcode>en</langcode>
  <field_short_title>The potential of large studies for building genetic risk prediction models</field_short_title>
  <field_page_description>NCI scientists have developed a new paradigm to assess hereditary risk prediction in common diseases, such as prostate cancer. This genetic risk prediction concept is based on polygenic analysis—the study of a group of common DNA sequences, known as singl</field_page_description>
  <field_date_posted>2013-03-04</field_date_posted>
  <field_date_reviewed>2013-02-28</field_date_reviewed>
  <field_pretty_url>PolygenicGWAS</field_pretty_url>
  <para_id>525098</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>530171</id>
  <title>Drugs Approved for Rhabdomyosarcoma </title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Rhabdomyosarcoma </field_short_title>
  <field_date_posted>2013-03-13</field_date_posted>
  <field_date_reviewed>2013-03-08</field_date_reviewed>
  <field_pretty_url>rhabdomyosarcoma</field_pretty_url>
  <para_id>530171</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>532546</id>
  <title>Surgery Choices for Women with DCIS or Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Surgery Choices for Women with DCIS or Breast Cancer</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2013-03-11</field_date_reviewed>
  <field_pretty_url>surgery-choices</field_pretty_url>
  <para_id>532546</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>564063</id>
  <title>Study establishes basis for genomic classification of endometrial cancers; &lt;span style="font-weight:normal;"&gt;&lt;i&gt;proper categorization is important for choosing the best treatment&lt;/i&gt;&lt;/span&gt;</title>
  <langcode>en</langcode>
  <field_short_title>Study establishes basis for genomic classification of endometrial cancers</field_short_title>
  <field_page_description>A comprehensive genomic analysis of nearly 400 endometrial tumors suggests that certain molecular characteristics – such as the frequency of mutations – could complement current pathology methods and help distinguish between principal types of endometrial</field_page_description>
  <field_date_posted>2013-05-01</field_date_posted>
  <field_date_reviewed>2013-04-29</field_date_reviewed>
  <field_pretty_url>TCGAendometrial</field_pretty_url>
  <para_id>564063</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>952731</id>
  <title>Insights into a signaling process that enhances the effectiveness of cancer immunotherapy</title>
  <langcode>en</langcode>
  <field_short_title>Signaling Enhances the Effectiveness of Cancer Immunotherapy</field_short_title>
  <field_date_posted>2015-05-04</field_date_posted>
  <field_date_reviewed>2015-05-04</field_date_reviewed>
  <field_pretty_url>signaling-and-cancer-immunotherapy</field_pretty_url>
  <para_id>952731</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>953136</id>
  <title>Collateral Damage: Missing Tumor Suppressor Gene Creates Opening for Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Missing Tumor Suppressor Gene Creates Treatment Opportunity</field_short_title>
  <field_page_description>Tumor cells that are missing one copy of the tumor suppressor gene TP53 often harbor another genetic alteration that may make them susceptible to a targeted attack, according to a new study.</field_page_description>
  <field_date_posted>2015-05-15</field_date_posted>
  <field_date_reviewed>2015-05-12</field_date_reviewed>
  <field_pretty_url>collateral-vulnerability</field_pretty_url>
  <para_id>953136</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069530</term_id>
  <id>960046</id>
  <title>Ras: Do We Know Its Structure Well Enough?</title>
  <langcode>en</langcode>
  <field_short_title>Ras: Do We Know Its Structure Well Enough?</field_short_title>
  <field_date_posted>2015-05-27</field_date_posted>
  <field_date_reviewed>2015-05-27</field_date_reviewed>
  <field_pretty_url>mattos-ras-structure</field_pretty_url>
  <para_id>960046</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>962854</id>
  <title>Dr. Stefan Ambs: Increasing Diversity in Cancer Research: One Lab at a Time</title>
  <langcode>en</langcode>
  <field_short_title>Dr. Stefan Ambs: Increasing Diversity in Cancer Research: One Lab at a Time</field_short_title>
  <field_date_posted>2015-06-02</field_date_posted>
  <field_date_reviewed>2015-06-02</field_date_reviewed>
  <field_pretty_url>ambs-spotlight</field_pretty_url>
  <para_id>962854</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>963159</id>
  <title>Adjuvant Chemotherapy Modestly Improves Survival in Some Men with Prostate Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Adjuvant Chemotherapy Improves Prostate Cancer Survival</field_short_title>
  <field_date_posted>2015-06-08</field_date_posted>
  <field_date_reviewed>2015-06-05</field_date_reviewed>
  <field_pretty_url>adjuvant-chemo-prostate</field_pretty_url>
  <para_id>963159</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911291</term_id>
  <id>14388</id>
  <title>Smokeless Tobacco and Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Smokeless Tobacco and Cancer</field_short_title>
  <field_page_description>A fact sheet about the health risks associated with the use of smokeless tobacco.</field_page_description>
  <field_date_posted>2005-08-18</field_date_posted>
  <field_date_reviewed>2010-10-25</field_date_reviewed>
  <field_pretty_url>smokeless-fact-sheet</field_pretty_url>
  <para_id>14388</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciLandingPage</CONTENTTYPENAME>
  <term_id>10952</term_id>
  <id>14423</id>
  <title>About NCI</title>
  <langcode>en</langcode>
  <field_short_title>About NCI</field_short_title>
  <field_page_description>Information about the National Cancer Institute, including information about NCI's organization, budget, advisory boards, and employment opportunities.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14423</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11950</term_id>
  <id>14435</id>
  <title>Pheochromocytoma and Paraganglioma—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Pheochromocytoma and Paraganglioma</field_short_title>
  <field_page_description>Pheochromocytoma and paraganglioma are rare tumors that can be benign (not cancer) or malignant. Pheochromocytomas form in the adrenal glands, and paragangliomas usually along nerve pathways in the head, neck, and spine. Start here to find information on pheochromocytoma and paraganglioma treatment, and research.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14435</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>952654</term_id>
  <id>14490</id>
  <title>PDQ&amp;reg; Cancer Information Summaries: Pediatric Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Pediatric Treatment</field_short_title>
  <field_page_description>Find treatment information for different types of cancer in children. Includes information about diagnosis, staging, and prognosis.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14490</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>952670</term_id>
  <id>14510</id>
  <title>PDQ&amp;reg; Adult Treatment Editorial Board</title>
  <langcode>en</langcode>
  <field_short_title>Adult Treatment Editorial Board</field_short_title>
  <field_date_posted>2002-03-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14510</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>14626</id>
  <title>The TAILORx Breast Cancer Trial</title>
  <langcode>en</langcode>
  <field_short_title>The TAILORx Breast Cancer Trial</field_short_title>
  <field_page_description>A collection of material about the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx.</field_page_description>
  <field_date_posted>2006-05-23</field_date_posted>
  <field_date_reviewed>2018-06-04</field_date_reviewed>
  <field_pretty_url>tailorx</field_pretty_url>
  <para_id>14626</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11906</term_id>
  <id>14885</id>
  <title>Extragonadal Germ Cell Tumors—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Extragonadal Germ Cell Tumors</field_short_title>
  <field_page_description>Extragonadal germ cell tumors form in parts of the body outside the gonads. They may begin to grow anywhere in the body, but usually form in the pineal gland in the brain, the chest, the lower part of the spine, or the abdomen. Start here to find information on extragonadal germ cell tumors treatment.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14885</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>10960</term_id>
  <id>14930</id>
  <title>NCI Budget and Appropriations</title>
  <langcode>en</langcode>
  <field_short_title>Budget and Appropriations</field_short_title>
  <field_page_description>Information about NCI's current and previous annual budgets, strategic plans for the institute, and Congressional Justification documents.</field_page_description>
  <field_date_posted>2015-04-24</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14930</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>929549</term_id>
  <id>14987</id>
  <title>Ataxia Telangiectasia</title>
  <langcode>en</langcode>
  <field_short_title>Ataxia Telangiectasia</field_short_title>
  <field_page_description>A fact sheet about ataxia telangiectasia (A-T), a rare, recessive genetic disorder of childhood that occurs in between one out of 40,000 and one out of 100,000 persons worldwide.</field_page_description>
  <field_date_posted>2002-02-26</field_date_posted>
  <field_date_reviewed>2006-01-26</field_date_reviewed>
  <field_pretty_url>ataxia-fact-sheet</field_pretty_url>
  <para_id>14987</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>915528</term_id>
  <id>14999</id>
  <title>Biological Therapies for Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Biological Therapies for Cancer</field_short_title>
  <field_page_description>A fact sheet that provides an overview of how the immune system functions and describes the actions of biological therapies.</field_page_description>
  <field_date_posted>2018-05-21</field_date_posted>
  <field_date_reviewed>2018-04-26</field_date_reviewed>
  <field_pretty_url>bio-therapies-fact-sheet</field_pretty_url>
  <para_id>14999</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11978</term_id>
  <id>15048</id>
  <title>Urethral Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Urethral Cancer</field_short_title>
  <field_page_description>Urethral cancer is rare and is more common in men than in women. Urethral cancer can metastasize (spread) quickly to tissues around the urethra and has often spread to nearby lymph nodes by the time it is diagnosed. Start here to find information on urethral cancer treatment.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>15048</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>952662</term_id>
  <id>15076</id>
  <title>PDQ&amp;reg; Cancer Information Summaries: Genetics</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Genetics</field_short_title>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>15076</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>922590</id>
  <title>Study reports peak longevity benefit with an hour of daily exercise</title>
  <langcode>en</langcode>
  <field_short_title>Peak longevity with an hour of exercise</field_short_title>
  <field_page_description>People who engage in three to five times the recommended minimum level of leisure-time physical activity derive the greatest benefit in terms of mortality reduction when compared with people who do not engage in leisure-time physical activity.</field_page_description>
  <field_date_posted>2015-04-06</field_date_posted>
  <field_date_reviewed>2015-04-02</field_date_reviewed>
  <field_pretty_url>peak-longevity-physical-activity</field_pretty_url>
  <para_id>922590</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922403</term_id>
  <id>923421</id>
  <title>Selenium and Vitamin E Cancer Prevention Trial (SELECT): Questions and Answers</title>
  <langcode>en</langcode>
  <field_short_title>Selenium and Vitamin E Cancer Prevention Trial (SELECT): Questions and Answers</field_short_title>
  <field_page_description>Learn the results of the Selenium and Vitamin E Cancer Prevention Trial. SELECT was a clinical trial to see if one or both of these substances could help prevent prostate cancer when taken as dietary supplements. </field_page_description>
  <field_date_posted>2008-10-31</field_date_posted>
  <field_date_reviewed>2015-04-03</field_date_reviewed>
  <field_pretty_url>select-trial-results-qa</field_pretty_url>
  <para_id>923421</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>930720</id>
  <title>Common Myths about Cancer and Cancer Health Disparities</title>
  <langcode>en</langcode>
  <field_short_title>Common Myths about Cancer and Cancer Health Disparities</field_short_title>
  <field_date_posted>2015-04-09</field_date_posted>
  <field_date_reviewed>2015-04-09</field_date_reviewed>
  <field_pretty_url>chdmyths-spotlight</field_pretty_url>
  <para_id>930720</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>936430</id>
  <title>Grantee Spotlight: Manuel L. Penichet, M.D., Ph.D. - Reprogramming the Immune System to Kill Cancer </title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Manuel L. Penichet, M.D., Ph.D. - Reprogramming the Immune System to Kill Cancer </field_short_title>
  <field_date_posted>2014-06-20</field_date_posted>
  <field_date_reviewed>2014-06-20</field_date_reviewed>
  <field_pretty_url>penichet-spotlight-blog</field_pretty_url>
  <para_id>936430</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>511136</id>
  <title>NIH study finds increases in risk of certain leukemias related to treatment</title>
  <langcode>en</langcode>
  <field_short_title>Study finds increases in risk of leukemias related to treatment</field_short_title>
  <field_page_description>A new study describes the pattern of risk for chemotherapy-related acute myeloid leukemia among adult cancer survivors over the past three decades who have previously been treated with chemotherapy for other cancers. These patterns coincide with major shi</field_page_description>
  <field_date_posted>2013-02-14</field_date_posted>
  <field_date_reviewed>2013-02-12</field_date_reviewed>
  <field_pretty_url>AMLtreatmentSecondCancers</field_pretty_url>
  <para_id>511136</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938137</term_id>
  <id>545408</id>
  <title>Electrocautery Superior to Topical Treatments for Precancerous Anal Lesions</title>
  <langcode>en</langcode>
  <field_short_title>Electrocautery for Precancerous Anal Lesions</field_short_title>
  <field_page_description>Results from a randomized clinical trial conducted in Amsterdam suggest that electrocautery is better than topical imiquimod or fluorouracil at treating potentially precancerous anal lesions in HIV-positive men who have sex with men.</field_page_description>
  <field_date_posted>2013-04-04</field_date_posted>
  <field_date_reviewed>2013-04-02</field_date_reviewed>
  <field_pretty_url>electrocautery</field_pretty_url>
  <para_id>545408</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>546311</id>
  <title>NIH trial shows promising results in treating a lymphoma in young people</title>
  <langcode>en</langcode>
  <field_short_title>Promising results in treating lymphoma in young people</field_short_title>
  <field_page_description>Patients with a type of cancer known as primary mediastinal B-cell lymphoma who received infusions of chemotherapy, but who did not have radiation therapy to an area of the thorax known as the mediastinum, had excellent outcomes, according to clinical tri</field_page_description>
  <field_date_posted>2013-04-10</field_date_posted>
  <field_date_reviewed>2013-04-04</field_date_reviewed>
  <field_pretty_url>DA-EPOCHlymphoma</field_pretty_url>
  <para_id>546311</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>549597</id>
  <title>Testing lung cancer drugs and therapies in mice</title>
  <langcode>en</langcode>
  <field_short_title>Testing lung cancer drugs and therapies in mice</field_short_title>
  <field_page_description>National Cancer Institute (NCI) investigators have designed a genetically engineered mouse for use in the study of human lung squamous cell carcinoma (SCC). SCC is a type of non-small cell lung carcinoma, one of the most common types of lung cancer, with </field_page_description>
  <field_date_posted>2013-04-15</field_date_posted>
  <field_date_reviewed>2013-04-12</field_date_reviewed>
  <field_pretty_url>SCCmouse</field_pretty_url>
  <para_id>549597</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>953644</id>
  <title>Welcome to the New Cancer.gov</title>
  <langcode>en</langcode>
  <field_short_title>Welcome to the New Cancer.gov</field_short_title>
  <field_page_description>NCI has launched a new, dynamic, and easier-to-use version of NCI’s main websites, Cancer.gov and its counterpart in Spanish, Cancer.gov/espanol.</field_page_description>
  <field_date_posted>2015-05-15</field_date_posted>
  <field_date_reviewed>2015-05-14</field_date_reviewed>
  <field_pretty_url>new-website</field_pretty_url>
  <para_id>953644</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>962601</term_id>
  <id>962602</id>
  <title>Building a Diverse Workforce</title>
  <langcode>en</langcode>
  <field_short_title>Building a Diverse Workforce</field_short_title>
  <field_page_description>Find information about cancer research training for those from backgrounds underrepresented in cancer biomedical and behavioral sciences.</field_page_description>
  <field_date_posted>2015-06-01</field_date_posted>
  <field_date_reviewed>2015-06-01</field_date_reviewed>
  <para_id>962602</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>962855</id>
  <title>Whole Brain Radiation for Some Patients with Brain Metastases Worsens Cognitive Decline </title>
  <langcode>en</langcode>
  <field_short_title>Brain Metastases Treatment Worsens Cognitive Decline </field_short_title>
  <field_date_posted>2015-06-02</field_date_posted>
  <field_date_reviewed>2015-06-02</field_date_reviewed>
  <field_pretty_url>brainmets-radiation</field_pretty_url>
  <para_id>962855</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>966675</id>
  <title>Enhancing the Clinical Trials Search Function on Cancer.gov</title>
  <langcode>en</langcode>
  <field_short_title>Enhancing the Clinical Trials Search Function on Cancer.gov</field_short_title>
  <field_date_posted>2015-06-16</field_date_posted>
  <field_date_reviewed>2015-06-16</field_date_reviewed>
  <field_pretty_url>trials-search</field_pretty_url>
  <para_id>966675</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>968013</id>
  <title>Linking International Cancer Screening Efforts</title>
  <langcode>en</langcode>
  <field_short_title>Linking International Cancer Screening Efforts</field_short_title>
  <field_date_posted>2015-06-18</field_date_posted>
  <field_date_reviewed>2015-06-18</field_date_reviewed>
  <field_pretty_url>ICSN</field_pretty_url>
  <para_id>968013</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>930502</term_id>
  <id>969383</id>
  <title>Nivolumab Improves Survival for Some Patients with Advanced Melanoma</title>
  <langcode>en</langcode>
  <field_short_title>Nivolumab Improves Survival for Some Patients with Advanced Melanoma</field_short_title>
  <field_page_description>A summary of results from an international, double-blind, randomized phase III trial testing the combination of  nivolumab (Opdivo®) and ipilimumab (Yervoy®) against nivolumab alone and ipilimumab alone in patients with advanced melanoma.</field_page_description>
  <field_date_posted>2015-06-26</field_date_posted>
  <field_date_reviewed>2015-06-22</field_date_reviewed>
  <field_pretty_url>nivolumab-checkmate067</field_pretty_url>
  <para_id>969383</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>969710</term_id>
  <id>969896</id>
  <title>Funding Allocated to Major NCI Program Areas</title>
  <langcode>en</langcode>
  <field_short_title>Program Structure</field_short_title>
  <field_page_description>See obligations to major NCI program areas, including research; resource development; cancer prevention and control; and program management and support.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-06-24</field_date_reviewed>
  <para_id>969896</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>1004820</id>
  <title>TAILORx Trial Shows Women at Low Risk for Breast Cancer Recurrence May Forgo Chemotherapy</title>
  <langcode>en</langcode>
  <field_short_title>TAILORx Trial Shows Women at Low Risk for Breast Cancer Recurring May Forgo Chemo</field_short_title>
  <field_page_description>A summary of results from the Trial Assigning Individualized Options for Treatment, or TAILORx, finds that women with early-stage hormone receptor-positive breast cancer have a low risk of recurrence based on a test for the expression of 21 genes.</field_page_description>
  <field_date_posted>2015-09-28</field_date_posted>
  <field_date_reviewed>2015-09-25</field_date_reviewed>
  <field_pretty_url>tailorx-low-risk</field_pretty_url>
  <para_id>1004820</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069530</term_id>
  <id>1007342</id>
  <title>Targeting RAL-GEF signaling and cytokines in KRAS driven lung cancer</title>
  <langcode>en</langcode>
  <field_short_title>Targeting RAL-GEF signaling and cytokines in KRAS driven lung cancer</field_short_title>
  <field_date_posted>2015-10-09</field_date_posted>
  <field_date_reviewed>2015-09-30</field_date_reviewed>
  <field_pretty_url>targeting-ral-gef</field_pretty_url>
  <para_id>1007342</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938042</term_id>
  <id>1014731</id>
  <title>Hormone Replacement Therapy May Improve Survival for Women with Ovarian Cancer </title>
  <langcode>en</langcode>
  <field_short_title>Hormone Replacement Therapy May Improve Survival for Women with Ovarian Cancer </field_short_title>
  <field_page_description>The randomized, controlled Adjuvant Hormone Therapy trial was launched in 1990 to assess the effects of estrogen-alone hormone replacement therapy in women treated for epithelial ovarian cancer.</field_page_description>
  <field_date_posted>2015-10-21</field_date_posted>
  <field_date_reviewed>2015-10-16</field_date_reviewed>
  <field_pretty_url>hrt-survival</field_pretty_url>
  <para_id>1014731</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>915112</term_id>
  <id>1016185</id>
  <title>Funding Opportunity: Genomic Data Analysis Network Centers</title>
  <langcode>en</langcode>
  <field_short_title>Funding Opportunity: Genomic Data Centers</field_short_title>
  <field_page_description>Funding Opportunity CCG, Funding Opportunity Center for Cancer Genomics, CCG, Center for Cancer Genomics, CCG RFA, Center for cancer genomics rfa, genomic data analysis network, genomic data analysis network centers,</field_page_description>
  <field_date_posted>2015-10-29</field_date_posted>
  <field_date_reviewed>2015-10-23</field_date_reviewed>
  <field_pretty_url>fundinggdan</field_pretty_url>
  <para_id>1016185</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>915112</term_id>
  <id>1022100</id>
  <title>Researcher Interview: Matthew Meyerson</title>
  <langcode>en</langcode>
  <field_short_title>Researcher Interview: Matthew Meyerson</field_short_title>
  <field_page_description>CCG Interview with Matthew Meyerson</field_page_description>
  <field_date_posted>2015-11-06</field_date_posted>
  <field_date_reviewed>2015-11-05</field_date_reviewed>
  <field_pretty_url>matthew-meyerson-interview</field_pretty_url>
  <para_id>1022100</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>65189</id>
  <title>Drugs Approved for Bladder Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Bladder Cancer</field_short_title>
  <field_date_posted>2011-05-04</field_date_posted>
  <field_date_reviewed>2011-03-09</field_date_reviewed>
  <field_pretty_url>bladder</field_pretty_url>
  <para_id>65189</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>65316</id>
  <title>Drugs Approved for Colon and Rectal Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Colon and Rectal Cancer</field_short_title>
  <field_date_posted>2011-05-04</field_date_posted>
  <field_date_reviewed>2011-03-10</field_date_reviewed>
  <field_pretty_url>colorectal</field_pretty_url>
  <para_id>65316</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>12738</term_id>
  <id>65884</id>
  <title>Ruth L. Kirschstein National Research Service Award (NRSA) for Individual Postdoctoral Fellows (F32)</title>
  <langcode>en</langcode>
  <field_short_title>NCI F32 Award</field_short_title>
  <field_date_posted>2011-03-17</field_date_posted>
  <field_date_reviewed>2011-03-17</field_date_reviewed>
  <para_id>65884</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>937976</term_id>
  <id>70473</id>
  <title>Certain Physicians Are More Likely to Refer Patients to Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>Certain Physicians Are More Likely to Refer Patients to Clinical Trials</field_short_title>
  <field_page_description>According to a survey-based study of more than 1,500 physicians treating patients with lung or colorectal cancer, medical oncologists were the most likely and surgeons the least likely to refer patients to, or enroll them in, clinical trials.</field_page_description>
  <field_date_posted>2011-04-08</field_date_posted>
  <field_date_reviewed>2011-04-08</field_date_reviewed>
  <field_pretty_url>clinical-trial-referral</field_pretty_url>
  <para_id>70473</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>937976</term_id>
  <id>84135</id>
  <title>Denosumab Effective for Multiple Myeloma and Solid Tumors</title>
  <langcode>en</langcode>
  <field_short_title>Denosumab Effective for Multiple Myeloma and Solid Tumors</field_short_title>
  <field_page_description>Results from a randomized phase III trial of denosumab to prevent skeletal related events in several types of cancer were published online February 22, 2011, in the Journal of Clinical Oncology (JCO).</field_page_description>
  <field_date_posted>2011-06-08</field_date_posted>
  <field_date_reviewed>2011-06-08</field_date_reviewed>
  <field_pretty_url>denosumab-prevent-bone-problems</field_pretty_url>
  <para_id>84135</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>731273</id>
  <title>NCI intramural research highlighted at 2014 AACR meeting</title>
  <langcode>en</langcode>
  <field_short_title>NCI intramural research highlighted at 2014 AACR meeting</field_short_title>
  <field_page_description>This year’s American Association for Cancer Research meeting featured plenary talks by two NCI scientists, Steven Rosenberg, M.D., and Louis Staudt, M.D., Ph.D., that highlighted the challenges in developing varied and potentially synergistic treatments f</field_page_description>
  <field_date_posted>2014-04-07</field_date_posted>
  <field_date_reviewed>2014-04-07</field_date_reviewed>
  <field_pretty_url>AACR2014annualmeetingPerspective</field_pretty_url>
  <para_id>731273</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>938033</id>
  <title>Grantee Spotlight: Marcia Cruz-Correa, M.D., Ph.D., Finds Link between Human Papillomavirus and Colorectal Cancer </title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Marcia Cruz-Correa, M.D., Ph.D.</field_short_title>
  <field_date_posted>2014-03-14</field_date_posted>
  <field_date_reviewed>2014-03-14</field_date_reviewed>
  <field_pretty_url>cruz-correa-spotlight</field_pretty_url>
  <para_id>938033</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>938034</id>
  <title>Grantee Spotlight: Community Health Educator Antoinette Ayers, Helps VA Residents Become More Proactive about Managing Their Health</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Antoinette Ayers</field_short_title>
  <field_date_posted>2014-01-10</field_date_posted>
  <field_date_reviewed>2014-01-10</field_date_reviewed>
  <field_pretty_url>ayers-spotlight</field_pretty_url>
  <para_id>938034</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>939549</id>
  <title>CGH Celebrates Take Your Child To Work Day 2015</title>
  <langcode>en</langcode>
  <field_short_title>CGH Celebrates Take Your Child To Work Day 2015</field_short_title>
  <field_date_posted>2015-04-28</field_date_posted>
  <field_date_reviewed>2015-04-28</field_date_reviewed>
  <field_pretty_url>tyctwd</field_pretty_url>
  <para_id>939549</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>939581</id>
  <title>Hands-on Workshops Aim to Strengthen Tobacco Control Efforts in Indonesia</title>
  <langcode>en</langcode>
  <field_short_title>Hands-on Workshops Aim to Strengthen Tobacco Control Efforts in Indonesia</field_short_title>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-04-29</field_date_reviewed>
  <field_pretty_url>indonesia-workshop2015</field_pretty_url>
  <para_id>939581</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>922399</term_id>
  <id>940072</id>
  <title>Colorectal Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on colorectal cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940072</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938269</term_id>
  <id>940383</id>
  <title>Kidney Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on kidney cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940383</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938242</term_id>
  <id>940478</id>
  <title>Liver and Bile Duct Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on liver cancer and bile duct cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies. </field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940478</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940738</term_id>
  <id>940745</id>
  <title>Pancreatic Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Pancreatic Cancer </field_short_title>
  <field_page_description>Exocrine pancreatic cancer is cancer of the exocrine gland of the pancreas, whereas cancer of the endocrine gland usually forms as a collection of tumor cell types referred to as pancreatic neuroendocrine tumors. Find evidence-based information on pancreatic cancer treatment, research, and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940745</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940775</term_id>
  <id>940780</id>
  <title>Parathyroid Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Parathyroid Cancer</field_short_title>
  <field_page_description>Parathyroid cancer often presents as a benign adenoma, though malignant carcinomas are possible. Parathyroid adenomas represent a common endocrine problem, whereas parathyroid carcinomas are very rare tumors. Find evidence-based information on parathyroid cancer treatment.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940780</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940922</term_id>
  <id>940927</id>
  <title>Retinoblastoma—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Retinoblastoma</field_short_title>
  <field_page_description>Retinoblastoma is a pediatric cancer. For patients with extraocular retinoblastoma, intensive chemotherapy is required, including high-dose chemotherapy and autologous hematopoietic stem cell rescue. Find evidence-based information on retinoblastoma treatment.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940927</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940946</term_id>
  <id>940953</id>
  <title>Skin Cancer (Including Melanoma)—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Skin Cancer</field_short_title>
  <field_page_description>Basal cell carcinoma and squamous cell carcinoma are referred to as nonmelanoma skin cancers. Melanoma is a malignant tumor of melanocytes, which make the melanin. Find evidence-based information on skin cancer treatment, causes and prevention, screening, research, genetics, and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940953</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>930502</term_id>
  <id>940954</id>
  <title>Skin Cancer (Including Melanoma) Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on skin cancer, including melanoma, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940954</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>974455</term_id>
  <id>974489</id>
  <title>Specialized Programs of Research Excellence (SPOREs)</title>
  <langcode>en</langcode>
  <field_short_title>Specialized Programs of Research Excellence</field_short_title>
  <field_page_description>SPOREs enable the rapid movement of basic findings into clinical settings and help determine the biological basis for research observations. See funding for SPORE programs by mechanism and cancer site. </field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-07-07</field_date_reviewed>
  <para_id>974489</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>974530</term_id>
  <id>974533</id>
  <title>NCI Funding Trends</title>
  <langcode>en</langcode>
  <field_short_title>Funding Trends</field_short_title>
  <field_page_description>Find information about NCI funding in past fiscal years, including percent growth by mechanism and percent share by mechanism.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-07-07</field_date_reviewed>
  <para_id>974533</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>976766</id>
  <title>Study shows promise of precision medicine for most common type of lymphoma</title>
  <langcode>en</langcode>
  <field_short_title>Promise of Precision Medicine for Common Type of Lymphoma</field_short_title>
  <field_date_posted>2015-07-20</field_date_posted>
  <field_date_reviewed>2015-07-14</field_date_reviewed>
  <field_pretty_url>ibrutinib-lymphoma-subtype</field_pretty_url>
  <para_id>976766</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>981038</id>
  <title>What’s New Online from NCI?</title>
  <langcode>en</langcode>
  <field_short_title>What’s New Online from NCI?</field_short_title>
  <field_date_posted>2015-08-06</field_date_posted>
  <field_date_reviewed>2015-08-06</field_date_reviewed>
  <field_pretty_url>new-online-july-2015</field_pretty_url>
  <para_id>981038</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>986218</id>
  <title>With FDA Approval, Gefitinib Returns to U.S. Market for Some Patients with Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Gefitinib Approved for Some Lung Cancer Patients</field_short_title>
  <field_date_posted>2015-08-18</field_date_posted>
  <field_date_reviewed>2015-08-13</field_date_reviewed>
  <field_pretty_url>fda-gefitinib</field_pretty_url>
  <para_id>986218</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>988387</term_id>
  <id>988388</id>
  <title>About the Division of Cancer Biology</title>
  <langcode>en</langcode>
  <field_short_title>About DCB</field_short_title>
  <field_page_description>Learn about DCB’s offices and branches as well as how it prioritizes programs, facilitates research, and communicates with scientists.</field_page_description>
  <field_date_posted>2016-08-08</field_date_posted>
  <field_date_reviewed>2015-08-26</field_date_reviewed>
  <para_id>988388</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915634</term_id>
  <id>1001483</id>
  <title>Enhancing Drug Discovery and Development</title>
  <langcode>en</langcode>
  <field_short_title>Enhancing Drug Discovery and Development</field_short_title>
  <field_page_description>Cancer drug discovery and development has long been a priority for the National Cancer Institute, most importantly in areas of need  that are not being adequately addressed by the private sector.</field_page_description>
  <field_date_posted>2015-09-11</field_date_posted>
  <field_date_reviewed>2015-09-11</field_date_reviewed>
  <field_pretty_url>enhancing-drug-discovery</field_pretty_url>
  <para_id>1001483</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1002421</id>
  <title>NCI Releases Budget Proposal for Fiscal Year 2017</title>
  <langcode>en</langcode>
  <field_short_title>NCI Releases FY2017 Annual Plan &amp; Budget Proposal</field_short_title>
  <field_date_posted>2015-09-17</field_date_posted>
  <field_date_reviewed>2015-09-16</field_date_reviewed>
  <field_pretty_url>lowy-annual-plan-2017</field_pretty_url>
  <para_id>1002421</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919351</term_id>
  <id>1004456</id>
  <title>Regional Centers of Research Excellence in Non-communicable Diseases in LMICs FAQs</title>
  <langcode>en</langcode>
  <field_short_title>Regional Centers of Research Excellence in Non-communicable Diseases in LMICs FAQs</field_short_title>
  <field_date_posted>2015-09-22</field_date_posted>
  <field_date_reviewed>2015-09-22</field_date_reviewed>
  <field_pretty_url>rcre-faq</field_pretty_url>
  <para_id>1004456</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1007397</term_id>
  <id>1007710</id>
  <title>David Q. Matus, Ph.D.</title>
  <langcode>en</langcode>
  <field_short_title>David Q. Matus, Ph.D.</field_short_title>
  <field_page_description>David Matus studies cellular invasion--a characteristic behavior of metastatic cancer cells--in an evolutionary context. </field_page_description>
  <field_date_posted>2015-10-01</field_date_posted>
  <field_date_reviewed>2015-10-01</field_date_reviewed>
  <field_pretty_url>david-matus</field_pretty_url>
  <para_id>1007710</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1016859</id>
  <title>Patients with Advanced Cancer May Benefit from Discussing Prognosis with Physicians</title>
  <langcode>en</langcode>
  <field_short_title>Patients with Advanced Cancer May Benefit from Discussing Prognosis with Physicians</field_short_title>
  <field_date_posted>2015-10-30</field_date_posted>
  <field_date_reviewed>2015-10-28</field_date_reviewed>
  <field_pretty_url>prognosis-discussion</field_pretty_url>
  <para_id>1016859</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1025858</id>
  <title>Antioxidants Accelerate the Growth and Invasiveness of Tumors in Mice </title>
  <langcode>en</langcode>
  <field_short_title>Antioxidants Accelerate the Growth and Invasiveness of Tumors in Mice </field_short_title>
  <field_date_posted>2015-11-12</field_date_posted>
  <field_date_reviewed>2015-11-10</field_date_reviewed>
  <field_pretty_url>antioxidants-metastasis</field_pretty_url>
  <para_id>1025858</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918927</term_id>
  <id>65156</id>
  <title>Drugs Approved for Conditions Related to Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Conditions Related to Cancer</field_short_title>
  <field_page_description>People with cancer may have other conditions caused by the cancer or its treatment. Drugs approved by the FDA for some of these cancer-related conditions are listed on this page, and link to NCI's Cancer Drug Information Summaries. </field_page_description>
  <field_date_posted>2011-08-18</field_date_posted>
  <field_date_reviewed>2011-03-08</field_date_reviewed>
  <para_id>65156</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>65327</id>
  <title>Drugs Approved for Melanoma</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Melanoma</field_short_title>
  <field_date_posted>2011-05-16</field_date_posted>
  <field_date_reviewed>2011-03-11</field_date_reviewed>
  <field_pretty_url>melanoma</field_pretty_url>
  <para_id>65327</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>65207</term_id>
  <id>65887</id>
  <title>Ruth L.  Kirschstein NRSA for Individual Predoctoral MD/PhD Degree Fellows (F30)</title>
  <langcode>en</langcode>
  <field_short_title>NCI F30 Award</field_short_title>
  <field_date_posted>2011-03-17</field_date_posted>
  <field_date_reviewed>2011-03-17</field_date_reviewed>
  <para_id>65887</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>941142</term_id>
  <id>941147</id>
  <title>Urethral Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Urethral Cancer </field_short_title>
  <field_page_description>Urethral cancer is a rare cancer. There are three types of urethral cancer. Squamous cell carcinoma is the most common type. Transitional cell carcinoma of the urethra, and adenocarcinoma in the glands around the urethra are less common. Find evidence-based information on urethral cancer treatment.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941147</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>915352</term_id>
  <id>941395</id>
  <title>Causes and Prevention Research</title>
  <langcode>en</langcode>
  <field_short_title>Causes and Prevention Research</field_short_title>
  <field_page_description>Find the latest research articles on cancer causes and risk factors for cancers and how some cancers may be prevented.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941395</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>11922</term_id>
  <id>941596</id>
  <title>Clinical Trials to Treat Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trials to Treat Leukemia</field_short_title>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <field_pretty_url>clinical-trials</field_pretty_url>
  <para_id>941596</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919678</term_id>
  <id>14404</id>
  <title>Site Map</title>
  <langcode>en</langcode>
  <field_short_title>Site Map</field_short_title>
  <field_page_description>Site map for the National Cancer Institute website.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14404</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11880</term_id>
  <id>14454</id>
  <title>Bladder Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Bladder Cancer</field_short_title>
  <field_page_description>The most common type of bladder cancer is transitional cell carcinoma, also called urothelial carcinoma. Smoking is a major risk factor for bladder cancer. Bladder cancer is often diagnosed at an early stage. Start here to find information on bladder cancer treatment, screening, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14454</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11952</term_id>
  <id>14519</id>
  <title>Pituitary Tumors—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Pituitary Tumors</field_short_title>
  <field_page_description>Pituitary tumors are usually not cancer and are called pituitary adenomas. They grow slowly and do not spread. Rarely, pituitary tumors are cancer and they can spread to distant parts of the body. Start here to find information on pituitary tumors treatment.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14519</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>921989</term_id>
  <id>14652</id>
  <title>Cancer in Children and Adolescents</title>
  <langcode>en</langcode>
  <field_short_title>Cancer in Children and Adolescents</field_short_title>
  <field_page_description>A fact sheet about statistics, types, causes, and treatment of childhood cancers in the United States.</field_page_description>
  <field_date_posted>2017-09-01</field_date_posted>
  <field_date_reviewed>2018-10-08</field_date_reviewed>
  <field_pretty_url>child-adolescent-cancers-fact-sheet</field_pretty_url>
  <para_id>14652</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>11596</term_id>
  <id>14703</id>
  <title>Professional Resources for Cancer Patient Education</title>
  <langcode>en</langcode>
  <field_short_title>Resources for Cancer Patient Education</field_short_title>
  <field_date_posted>2005-07-01</field_date_posted>
  <field_date_reviewed>2009-11-16</field_date_reviewed>
  <field_pretty_url>cancer-patient-education-resource</field_pretty_url>
  <para_id>14703</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>11896</term_id>
  <id>14718</id>
  <title>Tests to Detect Colorectal Cancer and Polyps</title>
  <langcode>en</langcode>
  <field_short_title>Tests to Detect Colorectal Cancer and Polyps</field_short_title>
  <field_page_description>A fact sheet that discusses the advantages and disadvantages of several colorectal cancer screening tests.</field_page_description>
  <field_date_posted>2016-07-13</field_date_posted>
  <field_date_reviewed>2016-07-07</field_date_reviewed>
  <field_pretty_url>screening-fact-sheet</field_pretty_url>
  <para_id>14718</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11922</term_id>
  <id>14790</id>
  <title>Leukemia—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Leukemia</field_short_title>
  <field_page_description>Leukemia is a broad term for cancers of the blood cells. The type of leukemia depends on the type of blood cell that becomes cancer and whether it grows quickly or slowly. Start here to find information on leukemia treatment, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14790</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911116</term_id>
  <id>14942</id>
  <title>Garlic and Cancer Prevention</title>
  <langcode>en</langcode>
  <field_short_title>Garlic and Cancer Prevention</field_short_title>
  <field_page_description>A fact sheet that summarizes the results of studies on the consumption of garlic for cancer prevention.</field_page_description>
  <field_date_posted>2008-01-22</field_date_posted>
  <field_date_reviewed>2008-01-22</field_date_reviewed>
  <field_pretty_url>garlic-fact-sheet</field_pretty_url>
  <para_id>14942</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>505605</id>
  <title>NIH scientists identify molecular link between metabolism and breast cancer</title>
  <langcode>en</langcode>
  <field_short_title>NIH scientists identify molecular link between metabolism and breast cancer</field_short_title>
  <field_page_description>A protein associated with conditions of metabolic imbalance, such as diabetes and obesity, may play a role in the development of aggressive forms of breast cancer, according to new findings by researchers at the National Cancer Institute (NCI), part of th</field_page_description>
  <field_date_posted>2013-02-05</field_date_posted>
  <field_date_reviewed>2013-02-05</field_date_reviewed>
  <field_pretty_url>CtBPbreastcancer</field_pretty_url>
  <para_id>505605</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>608323</term_id>
  <id>759773</id>
  <title>Velcade®: A New Tool in the Fight against Multiple Myeloma</title>
  <langcode>en</langcode>
  <field_short_title>Velcade® and the Fight against Multiple Myeloma</field_short_title>
  <field_date_posted>2014-06-30</field_date_posted>
  <field_date_reviewed>2014-04-21</field_date_reviewed>
  <field_pretty_url>velcade</field_pretty_url>
  <para_id>759773</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919353</term_id>
  <id>762657</id>
  <title>Cancer Control Leadership Forums</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Control Leadership Forums</field_short_title>
  <field_page_description>The Cancer Control Leadership Forums help increase the capacity of participating countries to initiate or enhance cancer control planning and implementation in their respective countries.</field_page_description>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-04-30</field_date_reviewed>
  <field_pretty_url>cancer-control-leadership-forums</field_pretty_url>
  <para_id>762657</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919353</term_id>
  <id>762663</id>
  <title>Women's Cancers Program (WCP)</title>
  <langcode>en</langcode>
  <field_short_title>Women's Cancers Program (WCP)</field_short_title>
  <field_page_description>CGH is committed to build capacity for prevention, screening, detection, diagnosis and treatment of women’s cancers in LMICs.</field_page_description>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-04-30</field_date_reviewed>
  <field_pretty_url>womens-cancers-program</field_pretty_url>
  <para_id>762663</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>770439</term_id>
  <id>770440</id>
  <title>Gynecologic Cancers Steering Committee</title>
  <langcode>en</langcode>
  <field_short_title>Gynecologic Cancers Steering Committee</field_short_title>
  <field_page_description>The Gynecologic Cancers Steering Committee evaluates and prioritizes concepts for phase 2 and 3 clinical trials in adult gynecologic cancers. The GCSC is also intent on fostering collaboration with international groups and institutions conducting trials.</field_page_description>
  <field_date_posted>2014-05-21</field_date_posted>
  <field_date_reviewed>2014-05-21</field_date_reviewed>
  <para_id>770440</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>778027</term_id>
  <id>772091</id>
  <title>Clinical Trial Concept Submission Guidelines</title>
  <langcode>en</langcode>
  <field_short_title>Concept Submission Guidelines</field_short_title>
  <field_page_description>A guide to current NCI procedures for submitting phase 3 or large phase 2 clinical trial concepts to be evaluated by Scientific Steering Committees.</field_page_description>
  <field_date_posted>2014-05-23</field_date_posted>
  <field_date_reviewed>2014-05-23</field_date_reviewed>
  <para_id>772091</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>772008</term_id>
  <id>772126</id>
  <title>Clinical Imaging Steering Committee Roster</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Imaging Steering Committee Roster</field_short_title>
  <field_date_posted>2014-05-23</field_date_posted>
  <field_date_reviewed>2014-05-23</field_date_reviewed>
  <field_pretty_url>roster</field_pretty_url>
  <para_id>772126</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1066544</id>
  <title>Symposium Brings Rising Global Cancer Burden into Focus</title>
  <langcode>en</langcode>
  <field_short_title>Symposium Focuses on Global Cancer Burden </field_short_title>
  <field_page_description>The NCI Global Cancer Research Symposium examined ways of increasing research collaboration, particularly in cancer prevention and screening, to reduce the global cancer burden.</field_page_description>
  <field_date_posted>2016-11-09</field_date_posted>
  <field_date_reviewed>2016-11-09</field_date_reviewed>
  <field_pretty_url>global-cancer-symposium</field_pretty_url>
  <para_id>1066544</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894082</term_id>
  <id>1066826</id>
  <title>NCI’s CRCHD Launches National Colorectal Cancer Outreach and Screening Initiative</title>
  <langcode>en</langcode>
  <field_short_title>CRCHD Launches National Colorectal Cancer Outreach and Screening Initiative</field_short_title>
  <field_page_description>The NCI CRCHD launches National Screen to Save Colorectal Cancer Outreach and Screening Initiative which aims to increase colorectal cancer screening rates among racially and ethnically diverse and rural communities.</field_page_description>
  <field_date_posted>2016-11-22</field_date_posted>
  <field_date_reviewed>2016-11-16</field_date_reviewed>
  <field_pretty_url>screentosave-launch</field_pretty_url>
  <para_id>1066826</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1068117</id>
  <title>CGH Continues Building Partnership with the Commonwealth of Independent States at World Cancer Congress</title>
  <langcode>en</langcode>
  <field_short_title>Recent Activities with partners in the Commonwealth of Independent States</field_short_title>
  <field_page_description>NCI's Center for Global Health and Commonwealth of Independent States partners collaborate on cancer control in Uzbekistan, Kazakhstan, Kyrgyzstan, Tajikistan, and Turkmenistan.</field_page_description>
  <field_date_posted>2016-12-07</field_date_posted>
  <field_date_reviewed>2016-12-06</field_date_reviewed>
  <field_pretty_url>partnership-commonwealth-independent-states</field_pretty_url>
  <para_id>1068117</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1068135</term_id>
  <id>1068977</id>
  <title>Track 3: Oncology Product Research and Review for Postdoctoral Research Fellows</title>
  <langcode>en</langcode>
  <field_short_title>IOTF: Oncology Product Review for Postdoc Fellows</field_short_title>
  <field_page_description>NCI and FDA collaborate to train physicians in aspects of drug, biologic, or device development and standards for assessing medical product safety. Learn more about this cancer training program.</field_page_description>
  <field_date_posted>2016-12-12</field_date_posted>
  <field_date_reviewed>2016-12-12</field_date_reviewed>
  <para_id>1068977</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1068985</id>
  <title>Single Tumor Cells Reveal Clues to Biology of Multiple Myeloma </title>
  <langcode>en</langcode>
  <field_short_title>Myeloma Cells in Blood Provide Disease Insights</field_short_title>
  <field_page_description>A Cancer Currents blog post about research showing that individual tumor cells in patients with multiple myeloma may provide important clues about the genetic drivers of their disease.   </field_page_description>
  <field_date_posted>2016-12-13</field_date_posted>
  <field_date_reviewed>2016-12-12</field_date_reviewed>
  <field_pretty_url>myeloma-ctcs-genomic</field_pretty_url>
  <para_id>1068985</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>969990</id>
  <title>Special Spotlight: The Alabama Project Celebrates Survivors and Their Communities</title>
  <langcode>en</langcode>
  <field_short_title>Special Spotlight: The Alabama Project Celebrates Survivors and Their Communities</field_short_title>
  <field_date_posted>2015-06-25</field_date_posted>
  <field_date_reviewed>2015-06-25</field_date_reviewed>
  <field_pretty_url>alabama-project</field_pretty_url>
  <para_id>969990</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>970222</term_id>
  <id>970255</id>
  <title>Research Project Grants (RPGs)</title>
  <langcode>en</langcode>
  <field_short_title>Research Project Grants</field_short_title>
  <field_page_description>See the number of grants requested and awarded by activity code and funding mechanism.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-06-26</field_date_reviewed>
  <para_id>970255</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>974322</term_id>
  <id>974323</id>
  <title>Bypass Budget Requests and NCI Appropriations</title>
  <langcode>en</langcode>
  <field_short_title>Bypass Requests and Appropriations</field_short_title>
  <field_page_description>NCI receives its budget from the United States Congress as part of the federal budget process. Find information about appropriations for each fiscal year since 1938 and budget requests since 1974.</field_page_description>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2015-07-07</field_date_reviewed>
  <para_id>974323</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>982343</term_id>
  <id>982346</id>
  <title>Vaginal Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on vaginal cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-07-31</field_date_posted>
  <field_date_reviewed>2015-07-31</field_date_reviewed>
  <para_id>982346</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>986192</id>
  <title>Gene Therapy Approach for Ovarian Cancer Shows Encouraging Signs in Animal Model</title>
  <langcode>en</langcode>
  <field_short_title>Gene Therapy in Mouse Model of Ovarian Cancer</field_short_title>
  <field_date_posted>2015-08-14</field_date_posted>
  <field_date_reviewed>2015-08-14</field_date_reviewed>
  <field_pretty_url>genetherapy-ovarian</field_pretty_url>
  <para_id>986192</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>988385</term_id>
  <id>988476</id>
  <title>DCB Funding</title>
  <langcode>en</langcode>
  <field_short_title>DCB Funding</field_short_title>
  <field_page_description>The Division of Cancer Biology (DCB) funds and supports extramural basic research that investigates the fundamental biology behind cancer. Find out more about DCB's grants process and funding opportunities.</field_page_description>
  <field_date_posted>2016-08-08</field_date_posted>
  <field_date_reviewed>2015-08-26</field_date_reviewed>
  <para_id>988476</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1002027</term_id>
  <id>1002028</id>
  <title>Bioinformatics, Big Data, and Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Bioinformatics, Big Data, and Cancer</field_short_title>
  <field_page_description>Researchers take on challenges and opportunities to mine big data for answers to complex biological questions. Learn how bioinformatics uses advanced computing, mathematics, and technological platforms to store, manage, analyze, and understand data.</field_page_description>
  <field_date_posted>2015-09-14</field_date_posted>
  <field_date_reviewed>2015-09-14</field_date_reviewed>
  <para_id>1002028</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>918917</term_id>
  <id>1004257</id>
  <title>New Planning Grant Announced Promotes NCD Research</title>
  <langcode>en</langcode>
  <field_short_title>New Planning Grant Announced Promotes NCD Research</field_short_title>
  <field_date_posted>2015-09-21</field_date_posted>
  <field_date_reviewed>2015-09-21</field_date_reviewed>
  <field_pretty_url>NCD_FOA</field_pretty_url>
  <para_id>1004257</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1004623</id>
  <title>Cancer Trends: Influencing Care and Research Priorities</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Trends: Influencing Care and Research Priorities</field_short_title>
  <field_date_posted>2015-09-24</field_date_posted>
  <field_date_reviewed>2015-09-24</field_date_reviewed>
  <field_pretty_url>cancer-trends</field_pretty_url>
  <para_id>1004623</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>1019389</id>
  <title>TCGA findings on papillary renal cell carcinoma and prostate cancer</title>
  <langcode>en</langcode>
  <field_short_title>TCGA Findings for Kidney and Prostate Cancers</field_short_title>
  <field_date_posted>2015-11-05</field_date_posted>
  <field_date_reviewed>2015-11-02</field_date_reviewed>
  <field_pretty_url>tcga-prcc-prostate-cancer</field_pretty_url>
  <para_id>1019389</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1025849</id>
  <title>Bringing Precision to Screening for Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Bringing Precision to Screening for Cancer</field_short_title>
  <field_date_posted>2015-11-17</field_date_posted>
  <field_date_reviewed>2015-11-10</field_date_reviewed>
  <field_pretty_url>precision-screening</field_pretty_url>
  <para_id>1025849</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>65188</id>
  <title>Drugs Approved for Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Breast Cancer</field_short_title>
  <field_date_posted>2011-05-04</field_date_posted>
  <field_date_reviewed>2011-03-09</field_date_reviewed>
  <field_pretty_url>breast</field_pretty_url>
  <para_id>65188</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>65193</id>
  <title>Drugs Approved for Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Lung Cancer</field_short_title>
  <field_date_posted>2011-05-04</field_date_posted>
  <field_date_reviewed>2011-03-09</field_date_reviewed>
  <field_pretty_url>lung</field_pretty_url>
  <para_id>65193</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>65323</id>
  <title>Drugs Approved for Kidney (Renal Cell) Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Kidney (Renal Cell) Cancer</field_short_title>
  <field_date_posted>2011-05-04</field_date_posted>
  <field_date_reviewed>2011-03-11</field_date_reviewed>
  <field_pretty_url>kidney</field_pretty_url>
  <para_id>65323</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>65325</id>
  <title>Drugs Approved for Pancreatic Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Pancreatic Cancer</field_short_title>
  <field_date_posted>2011-05-04</field_date_posted>
  <field_date_reviewed>2011-03-11</field_date_reviewed>
  <field_pretty_url>pancreatic</field_pretty_url>
  <para_id>65325</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>65908</term_id>
  <id>65964</id>
  <title>Sallie Rosen Kaplan (SRK) Postdoctoral Fellowship for Women Scientists</title>
  <langcode>en</langcode>
  <field_short_title>NCI SRK Award</field_short_title>
  <field_date_posted>2011-03-18</field_date_posted>
  <field_date_reviewed>2011-03-18</field_date_reviewed>
  <para_id>65964</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>68334</term_id>
  <id>68353</id>
  <title>Paul Calabresi Career Development Award for Clinical Oncology (K12)</title>
  <langcode>en</langcode>
  <field_short_title>NCI K12 Award</field_short_title>
  <field_date_posted>2011-03-21</field_date_posted>
  <field_date_reviewed>2011-03-21</field_date_reviewed>
  <para_id>68353</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>68512</term_id>
  <id>68601</id>
  <title>Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07)</title>
  <langcode>en</langcode>
  <field_short_title>NCI K07 Award</field_short_title>
  <field_date_posted>2011-03-22</field_date_posted>
  <field_date_reviewed>2011-03-22</field_date_reviewed>
  <para_id>68601</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>68370</term_id>
  <id>68379</id>
  <title>The NCI Transition Career Development Award (K22)</title>
  <langcode>en</langcode>
  <field_short_title>NCI K22 Award</field_short_title>
  <field_date_posted>2011-03-21</field_date_posted>
  <field_date_reviewed>2012-03-16</field_date_reviewed>
  <para_id>68379</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922403</term_id>
  <id>73714</id>
  <title>Denosumab Reduces Risk of Bone Side Effects in Advanced Prostate Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Denosumab Reduces Risk of Bone Side Effects in Advanced Prostate Cancer</field_short_title>
  <field_page_description>The biological agent denosumab (Xgeva) is more effective than zoledronic acid at decreasing the risk of bone fractures and other skeletal-related events (SRE) in men with castration-resistant metastatic prostate cancer, according to results from a randomi</field_page_description>
  <field_date_posted>2011-04-13</field_date_posted>
  <field_date_reviewed>2011-04-13</field_date_reviewed>
  <field_pretty_url>denosumab-bone-fractures</field_pretty_url>
  <para_id>73714</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>76380</id>
  <title>Sentinel Lymph Node Occult Metastases Have Minimal Survival Effect in Node-Negative Breast Cancer Patients</title>
  <langcode>en</langcode>
  <field_short_title>Sentinel Lymph Node Occult Metastases Have Minimal Survival Effect in Some Breast Cancer Patients</field_short_title>
  <field_page_description>Detailed examination of sentinel lymph node tissue from breast cancer patients revealed previously unidentified metastases in about 16% of the samples, but the difference in 5-year survival between patients with and without these metastases was very small</field_page_description>
  <field_date_posted>2011-04-26</field_date_posted>
  <field_date_reviewed>2011-04-26</field_date_reviewed>
  <field_pretty_url>occult-mets</field_pretty_url>
  <para_id>76380</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>79694</id>
  <title>Drugs Approved for Cervical Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Cervical Cancer</field_short_title>
  <field_date_posted>2011-06-10</field_date_posted>
  <field_date_reviewed>2011-05-20</field_date_reviewed>
  <field_pretty_url>cervical</field_pretty_url>
  <para_id>79694</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>83997</id>
  <title>Drugs Approved for Kaposi Sarcoma</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Kaposi Sarcoma</field_short_title>
  <field_date_posted>2011-07-12</field_date_posted>
  <field_date_reviewed>2011-06-01</field_date_reviewed>
  <field_pretty_url>kaposi-sarcoma</field_pretty_url>
  <para_id>83997</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>720365</id>
  <title>Breast Cancer Startup Challenge announces ten winning teams of entrepreneurs; Promising technologies identified to speed cancer research</title>
  <langcode>en</langcode>
  <field_short_title>Breast Cancer Startup Challenge winners</field_short_title>
  <field_page_description>Ten winners of a world-wide competition to bring emerging breast cancer research technologies to market faster were announced today by the Avon Foundation for Women, in partnership with NCI and the Center for Advancing Innovation (CAI).  Avon is providing</field_page_description>
  <field_date_posted>2014-03-05</field_date_posted>
  <field_date_reviewed>2014-03-04</field_date_reviewed>
  <field_pretty_url>BCSCwinners</field_pretty_url>
  <para_id>720365</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>608323</term_id>
  <id>730874</id>
  <title>Preventing Cervical Cancer: The Development of HPV Vaccines</title>
  <langcode>en</langcode>
  <field_short_title>Preventing Cervical Cancer with HPV Vaccines</field_short_title>
  <field_date_posted>2014-04-03</field_date_posted>
  <field_date_reviewed>2014-03-31</field_date_reviewed>
  <field_pretty_url>hpv-vaccines</field_pretty_url>
  <para_id>730874</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919353</term_id>
  <id>762660</id>
  <title>NCI Affordable Cancer Technologies Program </title>
  <langcode>en</langcode>
  <field_short_title>Affordable Technologies</field_short_title>
  <field_page_description>CGH supports the development and validation of affordable technology to increase access to cancer prevention, screening, detection, diagnosis and treatment in LMICs.</field_page_description>
  <field_date_posted>2016-09-16</field_date_posted>
  <field_date_reviewed>2014-04-30</field_date_reviewed>
  <field_pretty_url>affordable-cancer-technology</field_pretty_url>
  <para_id>762660</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919353</term_id>
  <id>762661</id>
  <title>Trans-NIH Regional Grant Writing &amp; Scientific Peer Review Workshops</title>
  <langcode>en</langcode>
  <field_short_title>Trans-NIH Regional Grant Writing &amp; Scientific Peer Review Workshops</field_short_title>
  <field_page_description>The Trans-NIH Regional Grant Writing &amp; Scientific Peer Review Workshops increase the participation of scientists from LMICs in the research grant process.</field_page_description>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-04-30</field_date_reviewed>
  <field_pretty_url>trans-nih-regional-workshops</field_pretty_url>
  <para_id>762661</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919159</term_id>
  <id>770089</id>
  <title>NCTN: NCI’s National Clinical Trials Network</title>
  <langcode>en</langcode>
  <field_short_title>NCI’s National Clinical Trials Network</field_short_title>
  <field_page_description>Information about the National Clinical Trial Network's infrastructure and a synopsis of how NCTN improves the speed and efficiency of cancer clinical trials.</field_page_description>
  <field_date_posted>2014-05-29</field_date_posted>
  <field_date_reviewed>2014-05-19</field_date_reviewed>
  <para_id>770089</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>770469</term_id>
  <id>770498</id>
  <title>Head and Neck Steering Committee Roster</title>
  <langcode>en</langcode>
  <field_short_title>Head and Neck Steering Committee Roster</field_short_title>
  <field_date_posted>2014-05-21</field_date_posted>
  <field_date_reviewed>2014-05-21</field_date_reviewed>
  <field_pretty_url>roster</field_pretty_url>
  <para_id>770498</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>771997</term_id>
  <id>772112</id>
  <title>Pediatric and Adolescent Solid Tumor Steering Committee</title>
  <langcode>en</langcode>
  <field_short_title>Pediatric and Adolescent Solid Tumor Steering Committee</field_short_title>
  <field_page_description>The Pediatric and Adolescent Solid Tumor Steering Committee addresses the design, prioritization and evaluation of concepts for large phase 2 and phase 3 clinical trials in extracranial solid tumors of children and youth. </field_page_description>
  <field_date_posted>2014-05-23</field_date_posted>
  <field_date_reviewed>2014-05-23</field_date_reviewed>
  <para_id>772112</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1063148</id>
  <title>Study Confirms Benefits of Early Palliative Care for Advanced Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Study Confirms Early Palliative Care Benefits</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post about a clinical trial showing that patients with advanced cancer who receive early palliative care had improved quality of life and mood. </field_page_description>
  <field_date_posted>2016-10-05</field_date_posted>
  <field_date_reviewed>2016-10-03</field_date_reviewed>
  <field_pretty_url>palliative-care-quality</field_pretty_url>
  <para_id>1063148</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1065432</id>
  <title>Metabolomics Study Reveals another Energy Source for Cancer Cells </title>
  <langcode>en</langcode>
  <field_short_title>Study Reveals another Cancer Cell Energy Source</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post on a study showing that, instead of discarding lactate, cancer cells can use it to fuel biochemical reactions, support their growth.</field_page_description>
  <field_date_posted>2016-10-20</field_date_posted>
  <field_date_reviewed>2016-10-20</field_date_reviewed>
  <field_pretty_url>cancer-metabolism-lactate</field_pretty_url>
  <para_id>1065432</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1066057</id>
  <title>‘Unexpected’ Vulnerability Creates Treatment Opportunity in Aggressive Type of Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>New Treatment Opportunity in Aggressive Lung Cancer</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post about a study that identified a way to target a key vulnerability in lung cancers that have mutations in the KRAS gene.</field_page_description>
  <field_date_posted>2016-10-27</field_date_posted>
  <field_date_reviewed>2016-10-27</field_date_reviewed>
  <field_pretty_url>nsclc-kras-xpo1</field_pretty_url>
  <para_id>1066057</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1067305</id>
  <title>Partnership in Cancer Control Planning Saves Lives</title>
  <langcode>en</langcode>
  <field_short_title>Partnership in Cancer Control Planning Saves Lives</field_short_title>
  <field_page_description>NCI’s Center for Global Health and partner Pink Ribbon Red Ribbon collaborate to reduce cervical and breast cancer in Zambia, Botswana, Ethiopia, and Tanzania.</field_page_description>
  <field_date_posted>2016-11-28</field_date_posted>
  <field_date_reviewed>2016-11-28</field_date_reviewed>
  <field_pretty_url>partnership-cancer-control-africa</field_pretty_url>
  <para_id>1067305</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1068124</term_id>
  <id>1068129</id>
  <title>Interagency Oncology Task Force Fellowship</title>
  <langcode>en</langcode>
  <field_short_title>Interagency Oncology Task Force Fellowship</field_short_title>
  <field_date_posted>2016-12-06</field_date_posted>
  <field_date_reviewed>2016-12-06</field_date_reviewed>
  <para_id>1068129</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1068124</term_id>
  <id>1068994</id>
  <title>Current and Alumni Fellows</title>
  <langcode>en</langcode>
  <field_short_title>IOTF Current Fellows</field_short_title>
  <field_page_description>NCI and FDA collaborate to train scientists in research and research-related regulatory review. Meet the current IOTF fellows. </field_page_description>
  <field_date_posted>2016-12-12</field_date_posted>
  <field_date_reviewed>2016-12-12</field_date_reviewed>
  <field_pretty_url>iotf-current-fellows</field_pretty_url>
  <para_id>1068994</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1069230</id>
  <title>Brain Cancer’s Cholesterol Addiction May Offer New Treatment Strategy</title>
  <langcode>en</langcode>
  <field_short_title>Targeting Cholesterol in Brain Cancer</field_short_title>
  <field_page_description>A Cancer Currents blog post on a study showing that treating mice with brain tumors with a cholesterol-depleting drug slowed tumor growth and improved survival.</field_page_description>
  <field_date_posted>2016-12-16</field_date_posted>
  <field_date_reviewed>2016-12-16</field_date_reviewed>
  <field_pretty_url>brain-cancer-cholesterol</field_pretty_url>
  <para_id>1069230</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1069455</id>
  <title>New Mouse Model Closely Mimics Most Common Leukemia in Infants</title>
  <langcode>en</langcode>
  <field_short_title>Improved Research Model for Childhood Leukemia</field_short_title>
  <field_page_description>A Cancer Currents blog post on a study describing the development of a long-sought-after mouse model for an aggressive form of acute lymphoblastic leukemia that occurs commonly in infants.</field_page_description>
  <field_date_posted>2016-12-30</field_date_posted>
  <field_date_reviewed>2016-12-20</field_date_reviewed>
  <field_pretty_url>leukemia-infant-research-model</field_pretty_url>
  <para_id>1069455</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1068124</term_id>
  <id>1069568</id>
  <title>IOTF Mentors: Track 3 and Track 4</title>
  <langcode>en</langcode>
  <field_short_title>IOTF Mentors: Tracks 3 and 4</field_short_title>
  <field_page_description>While at FDA, fellows are assigned a mentor who is a senior member of FDA scientific review staff. Learn more about mentors for Tracks 3 and 4. </field_page_description>
  <field_date_posted>2016-12-21</field_date_posted>
  <field_date_reviewed>2016-12-21</field_date_reviewed>
  <field_pretty_url>mentors-tracks-3-4</field_pretty_url>
  <para_id>1069568</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1069576</id>
  <title>New Targeted Therapies Show Promise for Treating Advanced GIST</title>
  <langcode>en</langcode>
  <field_short_title>Therapies Target Treatment-Resistant GIST</field_short_title>
  <field_page_description>A &lt;i&gt;Cancer Currents&lt;/i&gt; blog post on early-stage clinical trials of two new therapies that target genetic mutations in gastrointestinal stromal tumors that fuel resistance to standard therapies.</field_page_description>
  <field_date_posted>2016-12-21</field_date_posted>
  <field_date_reviewed>2016-12-21</field_date_reviewed>
  <field_pretty_url>targeting-gist-resistance</field_pretty_url>
  <para_id>1069576</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1070068</term_id>
  <id>1070069</id>
  <title>2017 Press Releases</title>
  <langcode>en</langcode>
  <field_short_title>2017 Press Releases</field_short_title>
  <field_page_description>Press releases from the National Cancer Institute for the year 2017.</field_page_description>
  <field_date_posted>2016-12-30</field_date_posted>
  <field_date_reviewed>2016-12-30</field_date_reviewed>
  <para_id>1070069</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922399</term_id>
  <id>70026</id>
  <title>When Combined with Chemotherapy, Bevacizumab Is Associated with Increased Risk of Death</title>
  <langcode>en</langcode>
  <field_short_title>When Combined with Chemotherapy, Bevacizumab Is Associated with Increased Risk of Death</field_short_title>
  <field_page_description>Cancer patients who receive the targeted therapy bevacizumab (Avastin) in combination with chemotherapy are at increased risk of serious side effects that may lead to death, according to a meta-analysis of 16 clinical trials that was published February 2,</field_page_description>
  <field_date_posted>2011-03-30</field_date_posted>
  <field_date_reviewed>2011-03-30</field_date_reviewed>
  <field_pretty_url>bevacizumab-severe-side-effects</field_pretty_url>
  <para_id>70026</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922403</term_id>
  <id>73712</id>
  <title>PSA Velocity Does Not Improve Prostate Cancer Detection</title>
  <langcode>en</langcode>
  <field_short_title>PSA Velocity Does Not Improve Prostate Cancer Detection</field_short_title>
  <field_page_description>A rapid increase in prostate-specific antigen (PSA) levels is not grounds for automatically recommending a prostate biopsy, according to a study published online February 24, 2011, in the Journal of the National Cancer Institute.</field_page_description>
  <field_date_posted>2011-04-13</field_date_posted>
  <field_date_reviewed>2011-04-13</field_date_reviewed>
  <field_pretty_url>psa-velocity-detection</field_pretty_url>
  <para_id>73712</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>74351</id>
  <title>Drugs Approved for Non-Hodgkin Lymphoma</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Non-Hodgkin Lymphoma</field_short_title>
  <field_date_posted>2011-05-04</field_date_posted>
  <field_date_reviewed>2013-06-10</field_date_reviewed>
  <field_pretty_url>non-hodgkin</field_pretty_url>
  <para_id>74351</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938195</term_id>
  <id>87572</id>
  <title>Adding Targeted Therapy to Treatment for Esophageal Cancer </title>
  <langcode>en</langcode>
  <field_short_title>Adding Targeted Therapy to Treatment for Esophageal Cancer </field_short_title>
  <field_page_description>In this phase III clinical trial, people with confirmed HER2-positive locally advanced esophageal cancer will be randomly assigned to receive preoperative radiation therapy and chemotherapy, with or without trastuzumab. </field_page_description>
  <field_date_posted>2011-06-28</field_date_posted>
  <field_date_reviewed>2011-06-29</field_date_reviewed>
  <field_pretty_url>trastuzumab</field_pretty_url>
  <para_id>87572</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1034464</term_id>
  <id>1034951</id>
  <title>Cancer Moonshot&amp;#8480;</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Moonshot&amp;#8480;</field_short_title>
  <field_page_description>The Cancer Moonshot is marshalling resources across the federal government to speed progress in cancer research and lead to improved cancer prevention, detection, and treatment.</field_page_description>
  <field_date_posted>2016-02-01</field_date_posted>
  <field_date_reviewed>2016-01-29</field_date_reviewed>
  <para_id>1034951</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1035196</id>
  <title>The ‘Crisis’ of Low HPV Vaccination Rates: A Conversation with Dr. Noel Brewer</title>
  <langcode>en</langcode>
  <field_short_title>A Conversation about the HPV Vaccination Crisis</field_short_title>
  <field_page_description>Following the release of a consensus statement from the NCI-Designated Cancer Centers urging HPV vaccination in the United States, Dr. Noel Brewer discusses the country’s low vaccination rates and how clinicians can help to improve them.</field_page_description>
  <field_date_posted>2016-02-02</field_date_posted>
  <field_date_reviewed>2016-02-02</field_date_reviewed>
  <field_pretty_url>hpv-vaccination-rates</field_pretty_url>
  <para_id>1035196</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1035894</id>
  <title>Mouse Study Points to Mechanism Linking Obesity and Colorectal Cancer Risk</title>
  <langcode>en</langcode>
  <field_short_title>Mouse Study Points to Mechanism Linking Obesity and Colorectal Cancer Risk</field_short_title>
  <field_page_description>A missing hormone in obese mice may help explain a longstanding association between obesity and an increased risk of colorectal cancer in humans.</field_page_description>
  <field_date_posted>2016-02-08</field_date_posted>
  <field_date_reviewed>2016-02-05</field_date_reviewed>
  <field_pretty_url>obesity-mechanism-colorectal</field_pretty_url>
  <para_id>1035894</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1032046</term_id>
  <id>1040879</id>
  <title>A Conversation with Elizabeth Jaffee</title>
  <langcode>en</langcode>
  <field_short_title>A Conversation with Elizabeth Jaffee</field_short_title>
  <field_page_description>In this RAS Dialogue blost post, Dr. Elizabeth Jaffee talks about her career developing immunotherapies for cancer.</field_page_description>
  <field_date_posted>2016-03-07</field_date_posted>
  <field_date_reviewed>2016-03-07</field_date_reviewed>
  <field_pretty_url>elizabeth-jaffee-interview</field_pretty_url>
  <para_id>1040879</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1040907</term_id>
  <id>1040908</id>
  <title>Reports</title>
  <langcode>en</langcode>
  <field_short_title>Reports</field_short_title>
  <field_page_description>Information about major NCI reports as well as other reports released by government health agencies and nonprofit groups that provide information about cancer.</field_page_description>
  <field_date_posted>2016-03-08</field_date_posted>
  <field_date_reviewed>2016-03-08</field_date_reviewed>
  <para_id>1040908</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1041747</id>
  <title>What’s New on NCI’s Websites?</title>
  <langcode>en</langcode>
  <field_short_title>What’s New on NCI’s Websites?</field_short_title>
  <field_page_description>NCI periodically provides updates on new websites and other online content of interest to the cancer community.</field_page_description>
  <field_date_posted>2016-03-18</field_date_posted>
  <field_date_reviewed>2016-03-17</field_date_reviewed>
  <field_pretty_url>new-online-march-2016</field_pretty_url>
  <para_id>1041747</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1041998</id>
  <title>Crizotinib Approval Expanded for Advanced Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Crizotinib Approval Expanded for Lung Cancer </field_short_title>
  <field_date_posted>2016-03-22</field_date_posted>
  <field_date_reviewed>2016-03-22</field_date_reviewed>
  <field_pretty_url>fda-crizotinib-ros1</field_pretty_url>
  <para_id>1041998</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1043475</id>
  <title>Drug Combination Shrinks Duodenal Polyps in People with Familial Adenomatous Polyposis</title>
  <langcode>en</langcode>
  <field_short_title>Drug Combo Shrinks Duodenal Polyps in FAP</field_short_title>
  <field_page_description>In a small clinical trial of people with an inherited condition that greatly increases gastrointestinal cancer risk, a two-drug combination shrank precancerous lesions in the duodenum.</field_page_description>
  <field_date_posted>2016-04-07</field_date_posted>
  <field_date_reviewed>2016-04-06</field_date_reviewed>
  <field_pretty_url>erlotinib-sulindac-fap</field_pretty_url>
  <para_id>1043475</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1043875</id>
  <title>Nanoparticle Generator Slips Chemotherapy Past Tumor Cells’ Protective Barriers</title>
  <langcode>en</langcode>
  <field_short_title>Nanoparticle Generator Targets Metastatic Breast Cancer</field_short_title>
  <field_page_description>Researchers have developed a new injectable nanoparticle-generating technology that can deliver a cancer drug to the nucleus of metastatic breast cancer cells.</field_page_description>
  <field_date_posted>2016-04-11</field_date_posted>
  <field_date_reviewed>2016-04-08</field_date_reviewed>
  <field_pretty_url>nanoparticle-generator-metastases</field_pretty_url>
  <para_id>1043875</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1044411</id>
  <title>Vitamin D Deficiency May Promote Spread of Some Breast Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Vitamin D Deficiency May Promote Spread of Some Breast Cancers</field_short_title>
  <field_page_description>Low vitamin D levels are associated with metastasis in women with breast cancer, suggests a new study.</field_page_description>
  <field_date_posted>2016-04-14</field_date_posted>
  <field_date_reviewed>2016-04-13</field_date_reviewed>
  <field_pretty_url>vitamin-d-metastasis</field_pretty_url>
  <para_id>1044411</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1036622</id>
  <title>President Obama’s Budget Request Affirms Commitment to Progress against Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Budget Request Includes Funds for Cancer Initiative</field_short_title>
  <field_page_description>President Obama’s FY 2017 Budget Request includes $680 million to support Vice President Biden’s cancer research initiative.</field_page_description>
  <field_date_posted>2016-02-10</field_date_posted>
  <field_date_reviewed>2016-02-09</field_date_reviewed>
  <field_pretty_url>moonshot-budget-request</field_pretty_url>
  <para_id>1036622</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1038482</id>
  <title>Gene Fusion May Drive Rare Childhood Brain Tumor</title>
  <langcode>en</langcode>
  <field_short_title>Genomic Study Identifies Gene Fusion in Rare Childhood Brain Tumor</field_short_title>
  <field_page_description>Researchers have identified a genetic rearrangement that may drive the development of a rare benign brain tumor in children through three distinct biological mechanisms simultaneously.</field_page_description>
  <field_date_posted>2016-02-22</field_date_posted>
  <field_date_reviewed>2016-02-22</field_date_reviewed>
  <field_pretty_url>gene-fusion-pediatric-glioma</field_pretty_url>
  <para_id>1038482</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1044802</id>
  <title>NCI opens online platform to submit ideas about research for Cancer Moonshot </title>
  <langcode>en</langcode>
  <field_short_title>NCI opens online platform to submit ideas about research for Cancer Moonshot </field_short_title>
  <field_page_description>NCI has launched an online platform to enable the research community and the public to submit ideas on the National Cancer Moonshot efforts. </field_page_description>
  <field_date_posted>2016-04-18</field_date_posted>
  <field_date_reviewed>2016-04-14</field_date_reviewed>
  <field_pretty_url>moonshot-get-involved</field_pretty_url>
  <para_id>1044802</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1047031</term_id>
  <id>1047038</id>
  <title>DCB Research Resources</title>
  <langcode>en</langcode>
  <field_short_title>DCB Research Resources</field_short_title>
  <field_page_description>A collection of researcher resources specific to cancer biology research.</field_page_description>
  <field_date_posted>2016-08-08</field_date_posted>
  <field_date_reviewed>2016-04-22</field_date_reviewed>
  <para_id>1047038</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1047286</id>
  <title>Targeted Photoimmunotherapy Approach for Cancer Moves Forward</title>
  <langcode>en</langcode>
  <field_short_title>Targeted Photoimmunotherapy for Cancer Moves Forward</field_short_title>
  <field_page_description>Two new studies from NCI researchers add to growing evidence of the promise of a novel type of cancer immunotherapy that uses infrared light to activate rapid and selective killing of cancer cells.</field_page_description>
  <field_date_posted>2016-04-25</field_date_posted>
  <field_date_reviewed>2016-04-25</field_date_reviewed>
  <field_pretty_url>photoimmunotherapy-cancer</field_pretty_url>
  <para_id>1047286</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1047414</term_id>
  <id>1047418</id>
  <title>NCI Graduate Student Recruiting Program</title>
  <langcode>en</langcode>
  <field_short_title>NCI Graduate Student Recruiting Program</field_short_title>
  <field_date_posted>2016-05-19</field_date_posted>
  <field_date_reviewed>2016-04-27</field_date_reviewed>
  <para_id>1047418</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1048310</id>
  <title>Increased Physical Activity Associated with Lower Risk of 13 Types of Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Physical activity can lower risk of 13 types of cancer</field_short_title>
  <field_date_posted>2016-05-16</field_date_posted>
  <field_date_reviewed>2016-05-11</field_date_reviewed>
  <field_pretty_url>physical-activity-lowers-cancer-risk</field_pretty_url>
  <para_id>1048310</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938227</term_id>
  <id>1050232</id>
  <title>Trial of Pembrolizumab for HIV-Positive Patients with Recurrent or Refractory Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Pembrolizumab for HIV-Positive Patients with Recurrent or Refractory Cancer</field_short_title>
  <field_page_description>In this phase I clinical trial, HIV-positive patients receiving combination antiretroviral therapy who have cancer that has recurred after or has not responded to previous treatment will receive the immune checkpoint inhibitor pembrolizumab.</field_page_description>
  <field_date_posted>2016-05-19</field_date_posted>
  <field_date_reviewed>2016-05-19</field_date_reviewed>
  <field_pretty_url>hiv-pembrolizumab-trial</field_pretty_url>
  <para_id>1050232</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1051873</id>
  <title>Enhanced Risk-Based Lung Cancer Screening May Prevent More Deaths than Current Approaches</title>
  <langcode>en</langcode>
  <field_short_title>Risk Profiling May Improve Lung Cancer Screening </field_short_title>
  <field_page_description>A new modeling study suggests that individualized, risk-based selection of ever-smokers for lung cancer screening may prevent more lung cancer deaths and improve the effectiveness and efficiency of screening compared with current screening recommendations</field_page_description>
  <field_date_posted>2016-06-02</field_date_posted>
  <field_date_reviewed>2016-06-01</field_date_reviewed>
  <field_pretty_url>risk-profile-lung-screening</field_pretty_url>
  <para_id>1051873</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1052092</id>
  <title>Russian delegation visits NIH and NCI to discuss research collaboration</title>
  <langcode>en</langcode>
  <field_short_title>Russian delegation visits NIH and NCI to discuss research collaboration</field_short_title>
  <field_date_posted>2016-06-07</field_date_posted>
  <field_date_reviewed>2016-06-07</field_date_reviewed>
  <field_pretty_url>russia</field_pretty_url>
  <para_id>1052092</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>16374</term_id>
  <id>1052944</id>
  <title>Find NCI-Supported Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>Find NCI-Supported Clinical Trials</field_short_title>
  <field_date_posted>2016-06-23</field_date_posted>
  <field_date_reviewed>2016-06-23</field_date_reviewed>
  <para_id>1052944</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1055469</id>
  <title>3-D View of Mutations May Identify Potential Targets for Cancer Drugs</title>
  <langcode>en</langcode>
  <field_short_title>3-D View of Mutations May Identify Potential Targets for Cancer Drugs</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on a new 3-D modeling tool that may help identify effective treatments for some cancers.</field_page_description>
  <field_date_posted>2016-07-14</field_date_posted>
  <field_date_reviewed>2016-07-14</field_date_reviewed>
  <field_pretty_url>protein-structure-drug-targets</field_pretty_url>
  <para_id>1055469</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1081005</id>
  <title>Studies Identify Potential Treatment Strategies for Pediatric DIPG Brain Tumors</title>
  <langcode>en</langcode>
  <field_short_title>Studies Identify Potential Treatments for DIPG Brain Tumors</field_short_title>
  <field_page_description>A Cancer Currents blog on research from two studies which found that drugs known as PRC2 and BET inhibitors shrank tumors in mouse models of the childhood brain cancer DIPG. </field_page_description>
  <field_date_posted>2017-04-13</field_date_posted>
  <field_date_reviewed>2017-04-13</field_date_reviewed>
  <field_pretty_url>dipg-treatment-strategies</field_pretty_url>
  <para_id>1081005</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894084</term_id>
  <id>1084389</id>
  <title>Mentor Spotlight: Elisa V. Bandera, MD, PhD</title>
  <langcode>en</langcode>
  <field_short_title>Mentor Spotlight: Elisa V. Bandera, MD, PhD</field_short_title>
  <field_page_description>Dr. Brian D. Gonzalez, a K01 awardee, shares how his mentor, Dr. Elisa V. Bandera, has supported his career development.</field_page_description>
  <field_date_posted>2017-05-11</field_date_posted>
  <field_date_reviewed>2017-05-11</field_date_reviewed>
  <field_pretty_url>mentor-spotlight-bandera</field_pretty_url>
  <para_id>1084389</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>860258</term_id>
  <id>1084764</id>
  <title>Global Health - Cancer Currents Blog</title>
  <langcode>en</langcode>
  <field_short_title>Global Health</field_short_title>
  <field_page_description>Blog posts on global cancer research—including factors that influence global cancer incidence and mortality and new research initiatives—from NCI Cancer Currents.</field_page_description>
  <field_date_posted>2017-05-12</field_date_posted>
  <field_date_reviewed>2017-05-12</field_date_reviewed>
  <field_pretty_url>global-health</field_pretty_url>
  <para_id>1084764</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>860258</term_id>
  <id>1084781</id>
  <title>Technology - Cancer Currents Blog</title>
  <langcode>en</langcode>
  <field_short_title>Technology</field_short_title>
  <field_page_description>Blog posts on technologies that affect cancer research and care—including new technologies for detecting cancer, testing treatments, storing/analyzing data, and improving patient care—from NCI Cancer Currents.</field_page_description>
  <field_date_posted>2017-05-12</field_date_posted>
  <field_date_reviewed>2017-05-12</field_date_reviewed>
  <field_pretty_url>technology</field_pretty_url>
  <para_id>1084781</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1085505</id>
  <title>Intensive Pre-Stem Cell Transplant Regimen May be Best for Younger Patients with AML, MDS</title>
  <langcode>en</langcode>
  <field_short_title>Pre-Stem Cell Transplant Treatment Regimen for AML, MDS</field_short_title>
  <field_page_description>A Cancer Currents blog on a study suggesting that an intensive preparatory regimen should be used for younger patients with AML undergoing a stem cell transplant.</field_page_description>
  <field_date_posted>2017-05-26</field_date_posted>
  <field_date_reviewed>2017-05-18</field_date_reviewed>
  <field_pretty_url>aml-stem-cell-transplant</field_pretty_url>
  <para_id>1085505</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1085520</id>
  <title>FDA Grants Brigatinib Accelerated Approval for Metastatic Non-Small Cell Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Brigatinib Approved by FDA for Lung Cancer</field_short_title>
  <field_page_description>A Cancer Currents blog on the FDA’s approval of brigatinib (Alunbrig™) for patients with metastatic non-small cell lung cancer (NSCLC) that has alterations in the ALK gene.</field_page_description>
  <field_date_posted>2017-05-19</field_date_posted>
  <field_date_reviewed>2017-05-19</field_date_reviewed>
  <field_pretty_url>brigatinib-fda-lung-cancer</field_pretty_url>
  <para_id>1085520</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894084</term_id>
  <id>1085525</id>
  <title>Mentor Spotlight: Monica L. Baskin, PhD</title>
  <langcode>en</langcode>
  <field_short_title>Mentor Spotlight: Monica L. Baskin, PhD</field_short_title>
  <field_date_posted>2017-05-19</field_date_posted>
  <field_date_reviewed>2017-05-19</field_date_reviewed>
  <field_pretty_url>mentor-spotlight-baskin</field_pretty_url>
  <para_id>1085525</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922410</term_id>
  <id>1085893</id>
  <title>ALCHEMIST &lt;span style="font-weight:normal"&gt;&lt;i&gt;(The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)&lt;/i&gt;&lt;/span&gt;:  Questions and Answers</title>
  <langcode>en</langcode>
  <field_short_title>ALCHEMIST: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials</field_short_title>
  <field_page_description>ALCHEMIST represents three integrated, precision medicine trials that are designed to identify people with early-stage lung cancer who have tumors that harbor certain uncommon genetic changes and evaluate whether drug treatments targeted against those mol</field_page_description>
  <field_date_posted>2014-08-18</field_date_posted>
  <field_date_reviewed>2014-08-18</field_date_reviewed>
  <field_pretty_url>alechmist-launch-qa</field_pretty_url>
  <para_id>1085893</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1066360</term_id>
  <id>1086595</id>
  <title>May 31st is World No Tobacco Day</title>
  <langcode>en</langcode>
  <field_short_title>May 31st is World No Tobacco Day</field_short_title>
  <field_date_posted>2017-05-31</field_date_posted>
  <field_date_reviewed>2017-05-31</field_date_reviewed>
  <field_pretty_url>wntd2017</field_pretty_url>
  <para_id>1086595</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922410</term_id>
  <id>1086824</id>
  <title>Combining Targeted Therapies for Newly Diagnosed Metastatic Lung Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Combining Targeted Therapies for Newly Diagnosed Metastatic Lung Cancer</field_short_title>
  <field_page_description>Combining Targeted Therapies for Newly Diagnosed Metastatic Lung Cancer</field_page_description>
  <field_date_posted>2017-06-06</field_date_posted>
  <field_date_reviewed>2017-06-05</field_date_reviewed>
  <field_pretty_url>combined-targeted-therapies-nsclc</field_pretty_url>
  <para_id>1086824</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1074837</term_id>
  <id>1086929</id>
  <title>Early Onset Malignancies Initiative</title>
  <langcode>en</langcode>
  <field_short_title>Early Onset Malignancies Initiative</field_short_title>
  <field_page_description>The Early Onset Malignancies Initiative studies the genomic basis of six cancers that develop at an earlier age, occur in higher rates, and are typically more aggressive in certain minority populations.</field_page_description>
  <field_date_posted>2017-08-04</field_date_posted>
  <field_date_reviewed>2017-06-07</field_date_reviewed>
  <field_pretty_url>early-onset-disparities</field_pretty_url>
  <para_id>1086929</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1056297</id>
  <title>Anthrax Toxin-Based Cancer Therapy Targets Tumor Blood Vessels</title>
  <langcode>en</langcode>
  <field_short_title>Anthrax Toxin-Based Cancer Therapy Targets Tumor Blood Vessels</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on a study which shows that an anthrax toxin-based cancer therapy may attack tumors by selectively targeting blood vessels that feed them.</field_page_description>
  <field_date_posted>2016-07-20</field_date_posted>
  <field_date_reviewed>2016-07-20</field_date_reviewed>
  <field_pretty_url>toxin-targets-tumor-vessels</field_pretty_url>
  <para_id>1056297</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1060186</id>
  <title>CA-125 Testing, CT Scans Still Used for Ovarian Cancer Surveillance Despite Lack of Proven Benefit</title>
  <langcode>en</langcode>
  <field_short_title>Tests without Proven Benefit Still Used for Ovarian Cancer Surveillance</field_short_title>
  <field_page_description>An NCI Cancer Currents blog about a study that shows clinicians continue to use routine CA-125 testing and CT scans to monitor for recurrences although the benefit of these tests has not been proven</field_page_description>
  <field_date_posted>2016-08-16</field_date_posted>
  <field_date_reviewed>2016-08-15</field_date_reviewed>
  <field_pretty_url>surveillance-tests-ovarian</field_pretty_url>
  <para_id>1060186</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>1060214</id>
  <title>Clearing The Air: Quit Smoking Today</title>
  <langcode>en</langcode>
  <field_short_title>Clearing The Air: Quit Smoking Today</field_short_title>
  <field_page_description>This booklet outlines successful strategies that can help people quit smoking and stay smoke-free.</field_page_description>
  <field_date_posted>2016-08-16</field_date_posted>
  <field_date_reviewed>2016-08-16</field_date_reviewed>
  <field_pretty_url>clearing-the-air</field_pretty_url>
  <para_id>1060214</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1061150</term_id>
  <id>1061151</id>
  <title>Research Directions for Childhood Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Research Directions for Childhood Cancer</field_short_title>
  <field_page_description>NCI has identified areas for which more research is needed on childhood cancers, including investments in basic research, immunotherapies, and moleculary targeted therapies.</field_page_description>
  <field_date_posted>2016-08-31</field_date_posted>
  <field_date_reviewed>2016-08-31</field_date_reviewed>
  <para_id>1061151</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1061647</term_id>
  <id>1061651</id>
  <title>RAS Collaborations</title>
  <langcode>en</langcode>
  <field_short_title>Collaborations</field_short_title>
  <field_page_description>RAS Initiative collaborations with both organizations and individual scientists have expanded research capabilities and maximized the impact of RAS Initiative discoveries. </field_page_description>
  <field_date_posted>2016-09-12</field_date_posted>
  <field_date_reviewed>2016-09-12</field_date_reviewed>
  <para_id>1061651</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1061720</term_id>
  <id>1061722</id>
  <title>Learn About the RAS Initiative</title>
  <langcode>en</langcode>
  <field_short_title>About the RAS Initiative </field_short_title>
  <field_page_description>The RAS Initiative, a "hub and spoke" model, connects researchers to better understand and target the more than 30% of cancers driven by mutations in RAS genes. Includes oversight and contact information.</field_page_description>
  <field_date_posted>2016-09-14</field_date_posted>
  <field_date_reviewed>2016-09-14</field_date_reviewed>
  <para_id>1061722</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>916666</term_id>
  <id>13184</id>
  <title>Extramural Research</title>
  <langcode>en</langcode>
  <field_short_title>Extramural Research</field_short_title>
  <field_page_description>Five extramural research divisions and several offices and centers monitor and administer NCI’s extramural grant and contract research activities.</field_page_description>
  <field_date_posted>2015-05-08</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13184</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>952672</term_id>
  <id>13270</id>
  <title>PDQ&amp;reg; Pediatric Treatment Editorial Board</title>
  <langcode>en</langcode>
  <field_short_title>Pediatric Treatment Editorial Board</field_short_title>
  <field_date_posted>2002-05-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13270</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>861460</term_id>
  <id>13362</id>
  <title>Radiation Risks and Pediatric Computed Tomography (CT): A Guide for Health Care Providers</title>
  <langcode>en</langcode>
  <field_short_title>Radiation Risks and Pediatric Computed Tomography</field_short_title>
  <field_date_posted>2002-08-20</field_date_posted>
  <field_date_reviewed>2018-09-04</field_date_reviewed>
  <field_pretty_url>pediatric-ct-scans</field_pretty_url>
  <para_id>13362</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11936</term_id>
  <id>13495</id>
  <title>Neuroblastoma—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Neuroblastoma</field_short_title>
  <field_page_description>Neuroblastoma is a cancer of immature nerve cells that most often occurs in young children. It usually begins in the adrenal glands but can form in the neck, chest, abdomen, and spine. Start here to find information on neuroblastoma treatment, screening, and research.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13495</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938028</term_id>
  <id>13591</id>
  <title>Chemotherapy Before Surgery May Increase Survival in Stomach Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Chemo Before Surgery May Help Stomach Cancer</field_short_title>
  <field_page_description>Chemotherapy given before surgery for cancer of the lower esophagus and stomach increased the number of patients surviving for five years compared to surgery alone, according to findings presented at the 2007 ASCO meeting in Chicago.</field_page_description>
  <field_date_posted>2007-07-09</field_date_posted>
  <field_date_reviewed>2011-10-19</field_date_reviewed>
  <field_pretty_url>preop-chemo</field_pretty_url>
  <para_id>13591</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11914</term_id>
  <id>13813</id>
  <title>Head and Neck Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Head and Neck Cancer</field_short_title>
  <field_page_description>Head and neck cancers include cancers in the larynx (voice box), throat, lips, mouth, nose, and salivary glands. Start here to find information on head and neck cancer treatment in adults and children, causes and prevention, screening, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13813</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1014294</term_id>
  <id>1014309</id>
  <title>NCI Outstanding Investigator Award Recipients</title>
  <langcode>en</langcode>
  <field_short_title>NCI Outstanding Investigator Award Recipients</field_short_title>
  <field_page_description>Learn how these investigators' projects aim to break new ground in biomedical, behavioral, and clinical cancer research.</field_page_description>
  <field_date_posted>2015-10-14</field_date_posted>
  <field_date_reviewed>2015-10-14</field_date_reviewed>
  <para_id>1014309</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1015446</id>
  <title>Long-Term Study Finds No Increased Risk of Miscarriage after HPV Vaccination</title>
  <langcode>en</langcode>
  <field_short_title>Long-Term Study Finds No Increased Risk of Miscarriage after HPV Vaccination</field_short_title>
  <field_date_posted>2015-10-20</field_date_posted>
  <field_date_reviewed>2015-10-20</field_date_reviewed>
  <field_pretty_url>hpv-vaccine-risk-miscarriage</field_pretty_url>
  <para_id>1015446</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915376</term_id>
  <id>1019525</id>
  <title>Shared Decision Making to Improve Cancer Screening Choices</title>
  <langcode>en</langcode>
  <field_short_title>Shared Decision Making in Cancer Screening </field_short_title>
  <field_page_description>A research update article about helping patients make informed decisions about cancer screening that reflect their own values and preferences.</field_page_description>
  <field_date_posted>2015-11-03</field_date_posted>
  <field_date_reviewed>2015-11-03</field_date_reviewed>
  <field_pretty_url>shared-decision-making</field_pretty_url>
  <para_id>1019525</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1023341</term_id>
  <id>1023342</id>
  <title>NCI Research Specialist Award (R50)</title>
  <langcode>en</langcode>
  <field_short_title>NCI Research Specialist Award (R50)</field_short_title>
  <field_date_posted>2015-11-06</field_date_posted>
  <field_date_reviewed>2015-11-06</field_date_reviewed>
  <para_id>1023342</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>1025854</id>
  <title>FDA Approves Nivolumab for Some Melanomas and Lung Cancers</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Nivolumab for Some Melanomas and Lung Cancers</field_short_title>
  <field_date_posted>2015-11-10</field_date_posted>
  <field_date_reviewed>2015-11-10</field_date_reviewed>
  <field_pretty_url>nivolumab-expanded</field_pretty_url>
  <para_id>1025854</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>65906</term_id>
  <id>65958</id>
  <title>The Ruth L. Kirschstein NRSA Institutional Research Training Grant (T32)</title>
  <langcode>en</langcode>
  <field_short_title>NCI T32 Award</field_short_title>
  <field_date_posted>2016-02-02</field_date_posted>
  <field_date_reviewed>2016-02-02</field_date_reviewed>
  <para_id>65958</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>65252</term_id>
  <id>65973</id>
  <title>Ruth L. Kirschstein National Research Service Award (NRSA) for Individual Predoctoral Fellows (F31) </title>
  <langcode>en</langcode>
  <field_short_title>NCI F31 Award</field_short_title>
  <field_date_posted>2011-03-18</field_date_posted>
  <field_date_reviewed>2011-03-18</field_date_reviewed>
  <para_id>65973</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>68311</term_id>
  <id>68382</id>
  <title>Mentored Patient-Oriented Research Career Development Award (K23)</title>
  <langcode>en</langcode>
  <field_short_title>NCI K23 Award</field_short_title>
  <field_date_posted>2011-03-21</field_date_posted>
  <field_date_reviewed>2015-12-14</field_date_reviewed>
  <para_id>68382</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938137</term_id>
  <id>69986</id>
  <title>Vaccine Reduces HPV Infections in Young Men</title>
  <langcode>en</langcode>
  <field_short_title>Vaccine Reduces HPV Infections in Young Men</field_short_title>
  <field_page_description>An international randomized clinical trial has shown that the vaccine Gardasil can reduce the incidence of anogenital human papillomavirus (HPV) infections in young men 16 to 26 years of age at the time of vaccination.</field_page_description>
  <field_date_posted>2011-03-29</field_date_posted>
  <field_date_reviewed>2011-03-29</field_date_reviewed>
  <field_pretty_url>quad-hpv-vaccine-men</field_pretty_url>
  <para_id>69986</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938135</term_id>
  <id>70472</id>
  <title>Targeted Therapies Sunitinib and Everolimus Improve Survival for Patients with Rare Type of Pancreatic Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Targeted Therapies Improve Survival for Patients with Rare Pancreatic Cancers</field_short_title>
  <field_page_description>In 2011, based on initial findings from two clinical trials, the Food and Drug Administration approved sunitinib and everolimus for patients with pancreatic neuroendocrine tumors. Updated results from the everolimus trial were published in September 2016.</field_page_description>
  <field_date_posted>2011-04-08</field_date_posted>
  <field_date_reviewed>2011-04-08</field_date_reviewed>
  <field_pretty_url>neuroendocrine-sunitinib-everolimus</field_pretty_url>
  <para_id>70472</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>11958</term_id>
  <id>73729</id>
  <title>Anyone Can Get Skin Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Anyone Can Get Skin Cancer</field_short_title>
  <field_date_posted>2011-04-26</field_date_posted>
  <field_date_reviewed>2016-04-19</field_date_reviewed>
  <field_pretty_url>anyone-can-get-skin-cancer</field_pretty_url>
  <para_id>73729</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>78414</id>
  <title>Trastuzumab after Chemotherapy Is Effective in HER2-Positive Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Trastuzumab after Chemotherapy Is Effective in HER2-Positive Breast Cancer</field_short_title>
  <field_page_description>Treatment with trastuzumab for 1 year following standard chemotherapy improved disease-free survival in women with HER2-positive early breast cancer, according to 4-year follow-up results of the Herceptin Adjuvant (HERA) trial reported February 25, 2011, </field_page_description>
  <field_date_posted>2011-05-06</field_date_posted>
  <field_date_reviewed>2011-05-06</field_date_reviewed>
  <field_pretty_url>trastuzumab-after-chemo</field_pretty_url>
  <para_id>78414</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>79028</id>
  <title>Drugs Approved for Leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Leukemia</field_short_title>
  <field_date_posted>2011-05-20</field_date_posted>
  <field_date_reviewed>2011-05-12</field_date_reviewed>
  <field_pretty_url>leukemia</field_pretty_url>
  <para_id>79028</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938032</term_id>
  <id>79346</id>
  <title>Lenalidomide and Radiation for Children with Brain Cancers </title>
  <langcode>en</langcode>
  <field_short_title>Lenalidomide and Radiation for Children with Brain Cancers </field_short_title>
  <field_page_description>n this trial, patients up to age 18 who are newly diagnosed with diffuse intrinsic pontine gliomas (DIPG) or who have other incompletely resected high-grade gliomas will undergo radiation therapy and receive oral lenalidomide, followed by lenalidomide. </field_page_description>
  <field_date_posted>2011-05-17</field_date_posted>
  <field_date_reviewed>2011-05-17</field_date_reviewed>
  <field_pretty_url>children-lenalidomide-radiation</field_pretty_url>
  <para_id>79346</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1048172</id>
  <title>Improving Public Health through Increased Tobacco Regulation</title>
  <langcode>en</langcode>
  <field_short_title>Improving Public Health with Increased Tobacco Regulation</field_short_title>
  <field_page_description>NCI’s Dr. Robert Croyle discusses the Food and Drug Administration’s release of a rule that extends its regulatory authority over tobacco products to include cigars, e-cigarettes, hookah tobacco, and others.</field_page_description>
  <field_date_posted>2016-05-10</field_date_posted>
  <field_date_reviewed>2016-05-09</field_date_reviewed>
  <field_pretty_url>fda-rule-tobacco</field_pretty_url>
  <para_id>1048172</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>1048366</term_id>
  <id>1048367</id>
  <title>Adrenocortical Carcinoma Research</title>
  <langcode>en</langcode>
  <field_short_title>Adrenocortical Carcinoma Research</field_short_title>
  <field_date_posted>2016-05-12</field_date_posted>
  <field_date_reviewed>2016-05-12</field_date_reviewed>
  <para_id>1048367</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1050286</id>
  <title>NIH study visualizes proteins involved in cancer cell metabolism</title>
  <langcode>en</langcode>
  <field_short_title>Visualizing proteins involved in cancer cell metabolism</field_short_title>
  <field_page_description>Scientists using cryo-electron microscopy have broken through a technological barrier in visualizing proteins.</field_page_description>
  <field_date_posted>2016-05-26</field_date_posted>
  <field_date_reviewed>2016-05-20</field_date_reviewed>
  <field_pretty_url>cryo-em-visualize-proteins</field_pretty_url>
  <para_id>1050286</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1051624</id>
  <title>Colorectal Cancer Survival Linked to Primary Tumor Location</title>
  <langcode>en</langcode>
  <field_short_title>Colorectal Cancer Survival Linked to Primary Tumor Location</field_short_title>
  <field_page_description> In patients with metastatic colorectal cancer, the location in the colon where the tumor originated appears to strongly influence how long patients live, according to a new study.</field_page_description>
  <field_date_posted>2016-05-27</field_date_posted>
  <field_date_reviewed>2016-05-27</field_date_reviewed>
  <field_pretty_url>colorectal-survival-location</field_pretty_url>
  <para_id>1051624</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1051984</id>
  <title>Two New Therapies Approved by FDA for Advanced Kidney Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Two New Therapies Approved for Advanced Kidney Cancer</field_short_title>
  <field_page_description>An NCI’s Cancer Currents blog on the FDA’s recent approval of cabozantinib (Cometriq®) and lenvatinib (Lenvima®) for the treatment of patients whose advanced kidney cancers have progressed after prior treatment with antiangiogenic therapies. </field_page_description>
  <field_date_posted>2016-06-03</field_date_posted>
  <field_date_reviewed>2016-06-03</field_date_reviewed>
  <field_pretty_url>fda-cabozantinib-lenvatinib-kidney</field_pretty_url>
  <para_id>1051984</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1052062</id>
  <title>NCI and the Chinese National Cancer Center pursue new collaborations in cancer research</title>
  <langcode>en</langcode>
  <field_short_title>NCI and the Chinese National Cancer Center pursue new collaborations in cancer research</field_short_title>
  <field_date_posted>2016-06-06</field_date_posted>
  <field_date_reviewed>2016-06-06</field_date_reviewed>
  <field_pretty_url>ncc_collaboration</field_pretty_url>
  <para_id>1052062</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1035160</term_id>
  <id>1052813</id>
  <title>The Genomic Data Commons Expands with New Data Sharing Agreement</title>
  <langcode>en</langcode>
  <field_short_title>GDC grows with new data</field_short_title>
  <field_page_description>The Genomic Data Commons (GDC) will gain data from 18,000 patients through an agreement signed today with Foundation Medicine, Inc.</field_page_description>
  <field_date_posted>2016-06-29</field_date_posted>
  <field_date_reviewed>2016-06-22</field_date_reviewed>
  <field_pretty_url>genomic-data-commons-foundation-medicine</field_pretty_url>
  <para_id>1052813</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1052954</id>
  <title>The Moonshot Blue Ribbon Panel: Moving Toward a Final Report</title>
  <langcode>en</langcode>
  <field_short_title>Moonshot Blue Ribbon Panel Moving Toward Final Report</field_short_title>
  <field_page_description>An NCI Cancer Currents blog from acting NCI Director Dr. Doug Lowy providing an update on the activities of the National Cancer Moonshot Initiative’s Blue Ribbon Panel and its work to develop a final report.</field_page_description>
  <field_date_posted>2016-06-23</field_date_posted>
  <field_date_reviewed>2016-06-23</field_date_reviewed>
  <field_pretty_url>moonshot-blue-ribbon-update</field_pretty_url>
  <para_id>1052954</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1054541</id>
  <title>Mouse Study Illuminates the Spread of Breast Cancer to Bone</title>
  <langcode>en</langcode>
  <field_short_title>Mouse Study Illuminates the Spread of Breast Cancer to Bone</field_short_title>
  <field_page_description>An NCI Cancer Currents blog about research into the mechanisms that allow breast cancer cells to invade bone and remain there for years before emerging to cause cancer.</field_page_description>
  <field_date_posted>2016-07-07</field_date_posted>
  <field_date_reviewed>2016-07-06</field_date_reviewed>
  <field_pretty_url>breast-cancer-bone-metastasis</field_pretty_url>
  <para_id>1054541</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1059229</id>
  <title>Adolescents Who Wouldn’t Have Smoked May Be Drawn to E-Cigarettes</title>
  <langcode>en</langcode>
  <field_short_title>Adolescents Who Wouldn’t Have Smoked May Be Drawn to E-Cigarettes</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post on a recent study that suggest adolescents are not just using e-cigarettes as a substitute for conventional cigarettes but that e-cigarettes are attracting new users to tobacco products.</field_page_description>
  <field_date_posted>2016-08-11</field_date_posted>
  <field_date_reviewed>2016-08-10</field_date_reviewed>
  <field_pretty_url>adolescents-e-cigarettes</field_pretty_url>
  <para_id>1059229</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>81827</id>
  <title>Drugs Approved for Gestational Trophoblastic Disease</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Gestational Trophoblastic Disease</field_short_title>
  <field_date_posted>2011-06-10</field_date_posted>
  <field_date_reviewed>2011-05-23</field_date_reviewed>
  <field_pretty_url>gestationaldisease</field_pretty_url>
  <para_id>81827</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938135</term_id>
  <id>84128</id>
  <title>Chemotherapy Regimen Extends Survival in Advanced Pancreatic Cancer Patients</title>
  <langcode>en</langcode>
  <field_short_title>Chemotherapy Regimen Extends Survival in Advanced Pancreatic Cancer Patients</field_short_title>
  <field_page_description>A four-drug chemotherapy regimen has produced the longest improvement in survival ever seen in a phase III clinical trial of patients with metastatic pancreatic cancer, one of the deadliest types of cancer. </field_page_description>
  <field_date_posted>2011-06-07</field_date_posted>
  <field_date_reviewed>2011-06-07</field_date_reviewed>
  <field_pretty_url>folfirinox</field_pretty_url>
  <para_id>84128</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>84738</id>
  <title>Drugs Approved for Hodgkin Lymphoma</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Hodgkin Lymphoma</field_short_title>
  <field_date_posted>2011-07-12</field_date_posted>
  <field_date_reviewed>2011-06-13</field_date_reviewed>
  <field_pretty_url>hodgkin-lymphoma</field_pretty_url>
  <para_id>84738</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>919351</term_id>
  <id>748892</id>
  <title>Health Economics Fellowships in Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Health Economics Fellowships in Cancer</field_short_title>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-04-10</field_date_reviewed>
  <field_pretty_url>health-economics-fellowships</field_pretty_url>
  <para_id>748892</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919353</term_id>
  <id>762633</id>
  <title>The International Cancer Control Partnership (ICCP)</title>
  <langcode>en</langcode>
  <field_short_title>The International Cancer Control Partnership (ICCP)</field_short_title>
  <field_page_description>The ICCP is a collaboration of governments, United Nations agencies, and Non-government organizations (NGOs) that work together to reduce the global burden of cancer.</field_page_description>
  <field_date_posted>2014-06-23</field_date_posted>
  <field_date_reviewed>2014-04-30</field_date_reviewed>
  <field_pretty_url>ICCP</field_pretty_url>
  <para_id>762633</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>763025</id>
  <title>Drugs Approved for Multicentric Castleman Disease</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Multicentric Castleman Disease</field_short_title>
  <field_page_description>This page lists cancer drugs approved by the Food and Drug Administration (FDA) for mutlicentric Castleman disease.</field_page_description>
  <field_date_posted>2014-05-01</field_date_posted>
  <field_date_reviewed>2014-05-01</field_date_reviewed>
  <field_pretty_url>multicentric-castleman-disease</field_pretty_url>
  <para_id>763025</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>764905</id>
  <title>NIH study demonstrates that a new cancer immunotherapy method could be effective against a wide range of cancers</title>
  <langcode>en</langcode>
  <field_short_title>New immunotherapy could be effective against a wide range of cancers</field_short_title>
  <field_page_description>A new method for using immunotherapy to specifically attack tumor cells that have mutations unique to a patient's cancer has been developed by NCI scientists.</field_page_description>
  <field_date_posted>2014-05-08</field_date_posted>
  <field_date_reviewed>2014-05-05</field_date_reviewed>
  <field_pretty_url>ACTepithelial</field_pretty_url>
  <para_id>764905</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>695683</term_id>
  <id>768882</id>
  <title>Office of Advocacy Relations</title>
  <langcode>en</langcode>
  <field_short_title>Office of Advocacy Relations</field_short_title>
  <field_date_posted>2014-05-15</field_date_posted>
  <field_date_reviewed>2014-05-15</field_date_reviewed>
  <para_id>768882</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>770425</term_id>
  <id>770404</id>
  <title>Brain Malignancies Steering Committee</title>
  <langcode>en</langcode>
  <field_short_title>Brain Malignancies Steering Committee</field_short_title>
  <field_page_description>The Brain Malignancies Steering Committee addresses the design, prioritization, and evaluation of concepts for large phase 2 and phase 3 clinical trials in both adult and pediatric brain cancers.</field_page_description>
  <field_date_posted>2014-05-21</field_date_posted>
  <field_date_reviewed>2014-05-21</field_date_reviewed>
  <para_id>770404</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>770427</term_id>
  <id>770428</id>
  <title>Breast Cancer Steering Committee</title>
  <langcode>en</langcode>
  <field_short_title>Breast Cancer Steering Committee</field_short_title>
  <field_page_description>The Breast Cancer Steering Committee addresses the design, prioritization, and evaluation of concepts for phase 2 and phase 3 treatment trials in adult breast cancer.</field_page_description>
  <field_date_posted>2014-05-21</field_date_posted>
  <field_date_reviewed>2014-05-21</field_date_reviewed>
  <para_id>770428</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>770435</term_id>
  <id>770436</id>
  <title>Genitourinary Cancers Steering Committee</title>
  <langcode>en</langcode>
  <field_short_title>Genitourinary Cancers Steering Committee</field_short_title>
  <field_page_description>The Genitourinary Cancers Steering Committee evaluates and prioritizes concepts for phase 3 and large phase 2 therapeutic clinical trials in genitourinary cancers.</field_page_description>
  <field_date_posted>2014-05-21</field_date_posted>
  <field_date_reviewed>2014-05-21</field_date_reviewed>
  <para_id>770436</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>770500</term_id>
  <id>770501</id>
  <title>Leukemia Steering Committee</title>
  <langcode>en</langcode>
  <field_short_title>Leukemia Steering Committee</field_short_title>
  <field_page_description>The Leukemia Steering Committee addresses the design, prioritization, and evaluation of concepts for phase 2 and phase 3 clinical trials in adult leukemia cancer.</field_page_description>
  <field_date_posted>2014-05-21</field_date_posted>
  <field_date_reviewed>2014-05-21</field_date_reviewed>
  <para_id>770501</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>771995</term_id>
  <id>772095</id>
  <title>Myeloma Steering Committee</title>
  <langcode>en</langcode>
  <field_short_title>Myeloma Steering Committee</field_short_title>
  <field_page_description>The Myeloma Steering Committee evaluates and prioritizes concepts for phase 3 and large phase 2 therapeutic clinical trials.</field_page_description>
  <field_date_posted>2014-05-23</field_date_posted>
  <field_date_reviewed>2014-05-23</field_date_reviewed>
  <para_id>772095</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922410</term_id>
  <id>586922</id>
  <title>Crizotinib Improves Progression-Free Survival in Some Patients with Advanced Lung Cancer (Updated)</title>
  <langcode>en</langcode>
  <field_short_title>Crizotinib Improves Progression-Free Survival in Some Patients with Advanced Lung Cancer</field_short_title>
  <field_page_description>A summary of results from an international phase III clinical trial that compared crizotinib versus chemotherapy in previously treated patients with advanced lung cancer whose tumors have an EML4-ALK fusion gene.</field_page_description>
  <field_date_posted>2013-06-17</field_date_posted>
  <field_date_reviewed>2013-06-17</field_date_reviewed>
  <field_pretty_url>crizotinib</field_pretty_url>
  <para_id>586922</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>636603</id>
  <title>Seven potential immunotherapy targets for treatment of melanoma identified</title>
  <langcode>en</langcode>
  <field_short_title>Seven potential immunotherapy targets for treatment of melanoma identified</field_short_title>
  <field_page_description>NCI scientists, using a unique digital technology that counts RNA molecules in small amounts of tumor tissue, identified seven potential immunotherapy targets for treatment of melanoma.</field_page_description>
  <field_date_posted>2013-09-10</field_date_posted>
  <field_date_reviewed>2013-09-09</field_date_reviewed>
  <field_pretty_url>GeneTargetsMelanoma</field_pretty_url>
  <para_id>636603</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>646038</id>
  <title>Checklist for clinical readiness of lab tests derived from complex molecular assays published </title>
  <langcode>en</langcode>
  <field_short_title>Checklist for clinical readiness published </field_short_title>
  <field_page_description>Scientists from NCI, together with collaborators from outside academic centers, have developed a checklist of criteria to evaluate the readiness of complex molecular tests that will guide decisions made during clinical trials. The checklist focuses on tes</field_page_description>
  <field_date_posted>2013-10-17</field_date_posted>
  <field_date_reviewed>2013-10-17</field_date_reviewed>
  <field_pretty_url>OmicsChecklist</field_pretty_url>
  <para_id>646038</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>649782</id>
  <title>HIV and influenza share a similar structural blueprint</title>
  <langcode>en</langcode>
  <field_short_title>HIV and influenza share a similar structural blueprint</field_short_title>
  <field_page_description>HIV uses a protein called the envelope glycoprotein spike to attach itself and fuse with the cell membrane; NCI scientists have now defined the structure of this spike in its pre-fusion state using cryo-electron microscopy</field_page_description>
  <field_date_posted>2013-10-23</field_date_posted>
  <field_date_reviewed>2013-10-23</field_date_reviewed>
  <field_pretty_url>HIVspike</field_pretty_url>
  <para_id>649782</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>655586</id>
  <title>Fewer doses of HPV vaccine result in immune response similar to three-dose regimen</title>
  <langcode>en</langcode>
  <field_short_title>Fewer doses of HPV vaccine result in immune response similar to three-dose regimen</field_short_title>
  <field_page_description>NCI scientists report that two doses of a human papillomavirus (HPV) vaccine, trademarked as Cervarix, resulted in similar serum antibody levels against two of the most carcinogenic types of HPV (16 and 18), compared to a standard three dose regimen.</field_page_description>
  <field_date_posted>2013-11-04</field_date_posted>
  <field_date_reviewed>2013-10-30</field_date_reviewed>
  <field_pretty_url>HPVdose</field_pretty_url>
  <para_id>655586</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938135</term_id>
  <id>661405</id>
  <title>Combination of Nab-Paclitaxel and Gemcitabine Improves Survival in Patients with Metastatic Pancreatic Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer</field_short_title>
  <field_page_description>A summary of results from a phase III trial that compared the combination of albumin-bound paclitaxel (nab-paclitaxel [Abraxane®]) and gemcitabine (Gemzar®) versus gemcitabine alone in patients with metastatic pancreatic cancer. </field_page_description>
  <field_date_posted>2013-11-15</field_date_posted>
  <field_date_reviewed>2013-11-15</field_date_reviewed>
  <field_pretty_url>nab-paclitaxel-gemcitabine</field_pretty_url>
  <para_id>661405</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>662171</id>
  <title>NIH mouse study finds gut microorganisms may determine cancer treatment outcome</title>
  <langcode>en</langcode>
  <field_short_title>NIH mouse study finds gut microorganisms may determine cancer treatment outcome</field_short_title>
  <field_page_description>An intact gut commensal microbiota, which is a population of microorganisms living in the intestine, is required for optimal response to cancer therapy, according to a mouse study by scientists at the National Cancer Institute (NCI)</field_page_description>
  <field_date_posted>2013-11-21</field_date_posted>
  <field_date_reviewed>2013-11-20</field_date_reviewed>
  <field_pretty_url>CommensalMicrobiotaCancerTreatments</field_pretty_url>
  <para_id>662171</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>898585</term_id>
  <id>675557</id>
  <title>NCI Portfolio Analyses</title>
  <langcode>en</langcode>
  <field_short_title>NCI Portfolio Analyses</field_short_title>
  <field_date_posted>2013-12-04</field_date_posted>
  <field_date_reviewed>2013-12-04</field_date_reviewed>
  <field_pretty_url>portfolio-analyses</field_pretty_url>
  <para_id>675557</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>678411</id>
  <title>Lung cancer death rates continue to fall, helping drive decrease in overall cancer death rates; Annual Report to the Nation includes special feature highlighting the contribution of other diseases on survival of patients</title>
  <langcode>en</langcode>
  <field_short_title>Lung cancer death rates fall, helping drive decrease in overall cancer death rates</field_short_title>
  <field_page_description>The Annual Report to the Nation on the Status of Cancer, covering the period 1975–2010, showed death rates for lung cancer, which accounts for more than one in four cancer deaths, dropping at a faster pace than in previous years.</field_page_description>
  <field_date_posted>2013-12-16</field_date_posted>
  <field_date_reviewed>2013-12-11</field_date_reviewed>
  <field_pretty_url>ReportNationDec2013Release</field_pretty_url>
  <para_id>678411</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1082116</id>
  <title>PARP Inhibitors May Be Effective in Brain, Other Cancers with IDH Mutations</title>
  <langcode>en</langcode>
  <field_short_title>PARP Inhibitors May Treat Cancers with IDH Mutations</field_short_title>
  <field_page_description>A Cancer Currents blog on studies that suggest brain and other cancers with an IDH mutation are susceptible to treatment with PARP inhibitors, such as olaparib.</field_page_description>
  <field_date_posted>2017-04-24</field_date_posted>
  <field_date_reviewed>2017-04-21</field_date_reviewed>
  <field_pretty_url>idh-mutation-parp</field_pretty_url>
  <para_id>1082116</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1082165</id>
  <title>Making Greater Progress Against Cancer—Not Just a Hope but a Reality</title>
  <langcode>en</langcode>
  <field_short_title>Making Greater Progress Against Cancer a Reality</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post from Acting NCI Director Dr. Doug Lowy on the recent Annual Report to the Nation and how NCI is promoting further progress against cancer.</field_page_description>
  <field_date_posted>2017-04-21</field_date_posted>
  <field_date_reviewed>2017-04-21</field_date_reviewed>
  <field_pretty_url>lowy-report-to-nation</field_pretty_url>
  <para_id>1082165</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>860258</term_id>
  <id>1084756</id>
  <title>Childhood Cancer - Cancer Currents Blog</title>
  <langcode>en</langcode>
  <field_short_title>Childhood Cancer</field_short_title>
  <field_page_description>Blog posts on childhood cancer research—including new treatments, the biology of pediatric cancers, and special research initiatives—from NCI Cancer Currents.</field_page_description>
  <field_date_posted>2017-05-12</field_date_posted>
  <field_date_reviewed>2017-05-12</field_date_reviewed>
  <field_pretty_url>childhood-cancer</field_pretty_url>
  <para_id>1084756</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>860258</term_id>
  <id>1084758</id>
  <title>Clinical Trial Results - Cancer Currents Blog</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trial Results</field_short_title>
  <field_page_description>Blog posts on practice-changing cancer clinical trials—including trials of targeted therapies, immunotherapies, and prevention drugs—from NCI Cancer Currents.</field_page_description>
  <field_date_posted>2017-05-12</field_date_posted>
  <field_date_reviewed>2017-05-12</field_date_reviewed>
  <field_pretty_url>clinical-trial-results</field_pretty_url>
  <para_id>1084758</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070074</term_id>
  <id>1085441</id>
  <title>ROS1+ Cancer Patients Partner to Increase Research</title>
  <langcode>en</langcode>
  <field_short_title>ROS1 Patient-Driven Research</field_short_title>
  <field_page_description>ROS1ders, a group of lung cancer patients who share a rare genetic abnormality, united to promote research by foundations, academics, and industry.</field_page_description>
  <field_date_posted>2017-05-23</field_date_posted>
  <field_date_reviewed>2017-05-18</field_date_reviewed>
  <field_pretty_url>ros1-patient-driven-research</field_pretty_url>
  <para_id>1085441</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>919353</term_id>
  <id>1086097</id>
  <title>Pathology and Laboratory Medicine Programs</title>
  <langcode>en</langcode>
  <field_short_title>Pathology and Laboratory Medicine Programs</field_short_title>
  <field_date_posted>2017-05-24</field_date_posted>
  <field_date_reviewed>2017-05-24</field_date_reviewed>
  <field_pretty_url>pathology</field_pretty_url>
  <para_id>1086097</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1087084</id>
  <title>Biomarker Test Could Reduce Unnecessary Biopsies to Detect Prostate Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Test Could Reduce Unnecessary Prostate Biopsies</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on a study showing that two biomarkers in urine may help identify who does and doesn’t need a biopsy to detect a suspected prostate cancer.</field_page_description>
  <field_date_posted>2017-06-09</field_date_posted>
  <field_date_reviewed>2017-06-08</field_date_reviewed>
  <field_pretty_url>biomarkers-urine-prostate-biopsy</field_pretty_url>
  <para_id>1087084</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1087294</id>
  <title>Trastuzumab Emtansine Improves Survival in Previously Treated Metastatic HER2-Positive Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Trastuzumab Emtansine for HER2-Positive Breast Cancer</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on results from the TH3RESA and EMILIA clinical trials showing trastuzumab emtansine (T-DM1) improved overall survival in patients with previously treated metastatic HER2-positive breast cancer.</field_page_description>
  <field_date_posted>2017-06-14</field_date_posted>
  <field_date_reviewed>2017-06-13</field_date_reviewed>
  <field_pretty_url>trastuzumab-emtansine-breast-cancer</field_pretty_url>
  <para_id>1087294</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>941577</term_id>
  <id>1087306</id>
  <title>Disease Dynamic Trial Listing Page</title>
  <langcode>en</langcode>
  <field_short_title>Disease Dynamic Trial Listing Page</field_short_title>
  <field_date_posted>2017-06-13</field_date_posted>
  <field_date_reviewed>2017-06-13</field_date_reviewed>
  <field_pretty_url>disease</field_pretty_url>
  <para_id>1087306</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1087879</id>
  <title>FDA Approves Pembrolizumab for Tumors with Specific Genetic Features</title>
  <langcode>en</langcode>
  <field_short_title>Pembrolizumab Approved for Tumors with Specific Genetic Features</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on FDA’s approval of pembrolizumab for patients with mismatch repair deficient and microsatellite instability high tumors.</field_page_description>
  <field_date_posted>2017-06-20</field_date_posted>
  <field_date_reviewed>2017-06-19</field_date_reviewed>
  <field_pretty_url>fda-pembrolizumab-genetic-features</field_pretty_url>
  <para_id>1087879</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1088669</id>
  <title>Introducing DAVE: Online Analysis Tools for the Genomic Data Commons</title>
  <langcode>en</langcode>
  <field_short_title>DAVE Provides New Tools for Genomic Data Commons</field_short_title>
  <field_page_description>An NCI Cancer Currents blog post from NCI’s Dr. Louis Staudt about the release of an online, open-access cancer research resource for the Genomic Data Commons called DAVE.</field_page_description>
  <field_date_posted>2017-06-29</field_date_posted>
  <field_date_reviewed>2017-06-29</field_date_reviewed>
  <field_pretty_url>gdc-dave-tools</field_pretty_url>
  <para_id>1088669</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>771999</term_id>
  <id>772116</id>
  <title>Pediatric Leukemia and Lymphoma Steering Committee</title>
  <langcode>en</langcode>
  <field_short_title>Pediatric Leukemia and Lymphoma Steering Committee</field_short_title>
  <field_page_description>The Pediatric Leukemia and Lymphoma Steering Committee addresses the design, prioritization, and evaluation of concepts for phase II and phase III clinical trials in pediatric hematologic cancers.</field_page_description>
  <field_date_posted>2014-05-23</field_date_posted>
  <field_date_reviewed>2014-05-23</field_date_reviewed>
  <para_id>772116</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>772002</term_id>
  <id>772118</id>
  <title>Thoracic Malignancy Steering Committee</title>
  <langcode>en</langcode>
  <field_short_title>Thoracic Malignancy Steering Committee</field_short_title>
  <field_page_description>The Thoracic Malignancy Steering Committee addresses the design, prioritization, and evaluation of concepts for phase II and phase III clinical trials in chest malignancies.</field_page_description>
  <field_date_posted>2014-05-23</field_date_posted>
  <field_date_reviewed>2014-05-23</field_date_reviewed>
  <para_id>772118</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>772004</term_id>
  <id>772120</id>
  <title>Investigational Drug Steering Committee</title>
  <langcode>en</langcode>
  <field_short_title>Investigational Drug Steering Committee</field_short_title>
  <field_page_description>The Investigational Drug Steering Committee (IDSC) collaborates with NCI in the design and prioritization of early phase drug development trials conducted by the Experimental Therapeutics Clinical Trials Network (ETCTN).</field_page_description>
  <field_date_posted>2014-05-23</field_date_posted>
  <field_date_reviewed>2014-05-23</field_date_reviewed>
  <para_id>772120</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>772004</term_id>
  <id>772121</id>
  <title>Investigational Drug Steering Committee Roster</title>
  <langcode>en</langcode>
  <field_short_title>Investigational Drug Steering Committee Roster</field_short_title>
  <field_page_description>The Investigational Drug Steering Committee collaborates with NCI in the design and prioritization of early phase drug development clinical trials. View the committee member roster.</field_page_description>
  <field_date_posted>2014-05-23</field_date_posted>
  <field_date_reviewed>2018-04-04</field_date_reviewed>
  <field_pretty_url>roster</field_pretty_url>
  <para_id>772121</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1035160</term_id>
  <id>1062708</id>
  <title>Using Genomics to Better Treat Children with Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Genomics and Childhood Cancer</field_short_title>
  <field_page_description>NCI's Center for Cancer Genomics seeks to use genomics to find better treatments for childhood cancer</field_page_description>
  <field_date_posted>2016-09-26</field_date_posted>
  <field_date_reviewed>2016-09-26</field_date_reviewed>
  <field_pretty_url>childhood-cancer-month</field_pretty_url>
  <para_id>1062708</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>762611</term_id>
  <id>1035658</id>
  <title>CGH Celebrates World Cancer Day 2017</title>
  <langcode>en</langcode>
  <field_short_title>CGH Celebrates World Cancer Day 2017</field_short_title>
  <field_date_posted>2017-01-31</field_date_posted>
  <field_date_reviewed>2016-02-03</field_date_reviewed>
  <field_pretty_url>WCD2017</field_pretty_url>
  <para_id>1035658</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1035659</id>
  <title>Persistent Peripheral Neuropathy Increases Fall Risk among Cancer Survivors</title>
  <langcode>en</langcode>
  <field_short_title>Persistent Peripheral Neuropathy Increases Fall Risk among Cancer Survivors</field_short_title>
  <field_page_description>Many female cancer survivors have problems with mobility and other physical functioning as a result of persistent peripheral neuropathy caused by chemotherapy treatment, according to a new study. </field_page_description>
  <field_date_posted>2016-02-05</field_date_posted>
  <field_date_reviewed>2016-02-03</field_date_reviewed>
  <field_pretty_url>peripheral-neuropathy-falls</field_pretty_url>
  <para_id>1035659</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1041142</term_id>
  <id>1041143</id>
  <title>National Cryo-Electron Microscopy Facility</title>
  <langcode>en</langcode>
  <field_short_title>National Program for Cryo-Em</field_short_title>
  <field_page_description>Information about the National Cryo-EM Facility at NCI, created to provide researchers access to the latest cryo-EM technology for high resolution imaging. Includes timeline for installation and how to access the facility.</field_page_description>
  <field_date_posted>2016-03-22</field_date_posted>
  <field_date_reviewed>2016-03-11</field_date_reviewed>
  <para_id>1041143</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>1043885</term_id>
  <id>1043891</id>
  <title>Small Intestine Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on small intestine cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2016-04-08</field_date_posted>
  <field_date_reviewed>2016-04-08</field_date_reviewed>
  <para_id>1043891</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1035160</term_id>
  <id>1044285</id>
  <title>Single-Cell Analysis Zooms in on Melanoma</title>
  <langcode>en</langcode>
  <field_short_title>Melanoma Single-Cell RNA Sequencing</field_short_title>
  <field_page_description>Single-Cell RNA Sequencing Study of Melanoma</field_page_description>
  <field_date_posted>2016-04-26</field_date_posted>
  <field_date_reviewed>2016-04-11</field_date_reviewed>
  <field_pretty_url>melanoma-single-cell</field_pretty_url>
  <para_id>1044285</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1047008</id>
  <title>New Treatment Target Identified for Key Prostate Cancer Driver</title>
  <langcode>en</langcode>
  <field_short_title>Study Identifies New Treatment Target for Prostate Cancer</field_short_title>
  <field_page_description>Researchers have identified a potential alternative approach to blocking a key molecular driver of an advanced form of prostate cancer, called androgen-independent or castration-resistant prostate cancer.</field_page_description>
  <field_date_posted>2016-04-22</field_date_posted>
  <field_date_reviewed>2016-04-21</field_date_reviewed>
  <field_pretty_url>prostate-ror-gamma-inhibitor</field_pretty_url>
  <para_id>1047008</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1047400</id>
  <title>Elevated bladder cancer risk in New England and arsenic in drinking water from private wells</title>
  <langcode>en</langcode>
  <field_short_title>Elevated Bladder Cancer Risk in New England</field_short_title>
  <field_date_posted>2016-05-02</field_date_posted>
  <field_date_reviewed>2016-05-02</field_date_reviewed>
  <field_pretty_url>bladder-cancer-risk-arsenic-private-wells</field_pretty_url>
  <para_id>1047400</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1048347</id>
  <title>CGH observes National Women’s Health Week </title>
  <langcode>en</langcode>
  <field_short_title>CGH observes National Women’s Health Week </field_short_title>
  <field_date_posted>2016-05-12</field_date_posted>
  <field_date_reviewed>2016-05-12</field_date_reviewed>
  <field_pretty_url>womens-health</field_pretty_url>
  <para_id>1048347</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1048571</term_id>
  <id>1048572</id>
  <title>Grantees or Grant Applicants Submitting Data</title>
  <langcode>en</langcode>
  <field_short_title>Grantees or Grant Applicants Submitting Data</field_short_title>
  <field_page_description>In order to be compliant with the Genomic Data Sharing (GDS) Policy, extramural investigators should use the following to guide their steps through the grant life-cycle process.</field_page_description>
  <field_date_posted>2016-05-13</field_date_posted>
  <field_date_reviewed>2016-05-13</field_date_reviewed>
  <para_id>1048572</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1048574</term_id>
  <id>1048575</id>
  <title>Non-NIH Funded Investigators Submitting Data</title>
  <langcode>en</langcode>
  <field_short_title>Non-NIH Funded Investigators Submitting Data</field_short_title>
  <field_page_description>Learn how non-NIH funded investigators may submit genomic data to the database of Genotypes and Phenotypes (dbGaP) or the Genomic Data Commons (GDC), under the NIH Genomic Data Sharing policy.</field_page_description>
  <field_date_posted>2016-05-13</field_date_posted>
  <field_date_reviewed>2016-05-13</field_date_reviewed>
  <para_id>1048575</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1052662</id>
  <title>New on NCI’s Websites for June 2016</title>
  <langcode>en</langcode>
  <field_short_title>New on NCI’s Websites for June 2016</field_short_title>
  <field_page_description>NCI periodically provides updates on new websites and other online content of interest to the cancer community.</field_page_description>
  <field_date_posted>2016-06-16</field_date_posted>
  <field_date_reviewed>2016-06-16</field_date_reviewed>
  <field_pretty_url>new-online-june-2016</field_pretty_url>
  <para_id>1052662</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1135269</term_id>
  <id>1135276</id>
  <title>Contracting Opportunities</title>
  <langcode>en</langcode>
  <field_short_title>Contracting Opportunities</field_short_title>
  <field_page_description>Contracting opportunities with the National Cancer Institute can be found in several different ways. The NCI Office of Acquisitions also works to connect small and disadvantaged buisnesses with subcontracting opportunities. </field_page_description>
  <field_date_posted>2019-01-15</field_date_posted>
  <field_date_reviewed>2019-01-15</field_date_reviewed>
  <para_id>1135276</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1135275</term_id>
  <id>1135290</id>
  <title>About OA</title>
  <langcode>en</langcode>
  <field_short_title>About OA</field_short_title>
  <field_page_description>NCI’s Office of Office of Acquisitions (OA) has several divisions that handle contracting and acquisitions for different parts of the National Cancer Institute.</field_page_description>
  <field_date_posted>2019-01-16</field_date_posted>
  <field_date_reviewed>2019-01-16</field_date_reviewed>
  <para_id>1135290</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1134352</term_id>
  <id>1135988</id>
  <title>Glioblastoma Study Highlights Sex Differences in Brain Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Study Reveals Sex Differences in Glioblastoma</field_short_title>
  <field_page_description>Men and women with glioblastoma appear to respond differently to treatment. A new study identifies biological factors that might contribute to this sex difference.</field_page_description>
  <field_date_posted>2019-01-30</field_date_posted>
  <field_date_reviewed>2019-01-28</field_date_reviewed>
  <field_pretty_url>glioblastoma-treatment-response-differs-by-sex</field_pretty_url>
  <para_id>1135988</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1137047</term_id>
  <id>1137048</id>
  <title>FNLCR Acquisitions FedBIzOpps Notices</title>
  <langcode>en</langcode>
  <field_short_title>FedBizOpps Notices</field_short_title>
  <field_page_description>Browse the list of FedBizOpps Notices regarding the FNLCR prime contractor competitive acquisition process.</field_page_description>
  <field_date_posted>2019-02-07</field_date_posted>
  <field_date_reviewed>2019-02-07</field_date_reviewed>
  <para_id>1137048</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1137529</term_id>
  <id>1137530</id>
  <title>NCI Awardee Skills Development Consortium: Research Education Short Courses (UE5)</title>
  <langcode>en</langcode>
  <field_short_title>NCI UE5 Award</field_short_title>
  <field_date_posted>2019-02-15</field_date_posted>
  <field_date_reviewed>2011-03-18</field_date_reviewed>
  <para_id>1137530</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1137841</id>
  <title>TCGA's Study of Gastric Adenocarcinoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Gastric Adenocarcinoma</field_short_title>
  <field_date_posted>2019-02-15</field_date_posted>
  <field_date_reviewed>2019-02-15</field_date_reviewed>
  <field_pretty_url>stomach</field_pretty_url>
  <para_id>1137841</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1137972</term_id>
  <id>1137909</id>
  <title>NCI at AACR 2019</title>
  <langcode>en</langcode>
  <field_short_title>NCI at AACR 2019</field_short_title>
  <field_page_description>NCI is participating at the American Association for Cancer Research (AACR) Annual Meeting, March 29-April 3, 2019 at the Georgia World Congress Center in Atlanta, GA. See the schedule of NCI-sponsored sessions and NCI expert booth presentations</field_page_description>
  <field_date_posted>2019-02-22</field_date_posted>
  <field_date_reviewed>2018-02-26</field_date_reviewed>
  <para_id>1137909</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1138001</term_id>
  <id>1137916</id>
  <title>Sessions Featuring NCI Staff</title>
  <langcode>en</langcode>
  <field_short_title>Sessions Featuring NCI Staff</field_short_title>
  <field_page_description>The NCI-sponsored sessions at AACR are dedicated to discussing programs held throughout NCI, while the poster sessions and presentations offer a platform for NCI scientists to relay study findings. Find the sessions led by NCI staff at AACR 2019.</field_page_description>
  <field_date_posted>2019-02-22</field_date_posted>
  <field_date_reviewed>2018-03-26</field_date_reviewed>
  <para_id>1137916</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1032046</term_id>
  <id>1052064</id>
  <title>Tumor Microenvironment Influences Metabolism of Cancer Cells</title>
  <langcode>en</langcode>
  <field_short_title>Tumor Microenvironment Influences Metabolism of Cancer Cells</field_short_title>
  <field_page_description>In a new blog post in RAS Dialogue, Dr. Cosimo Commisso discusses how the metabolism of cancer cells might be different in different parts of solid tumors.</field_page_description>
  <field_date_posted>2016-06-06</field_date_posted>
  <field_date_reviewed>2016-06-06</field_date_reviewed>
  <field_pretty_url>metabolic-heterogeneity-solid-tumors</field_pretty_url>
  <para_id>1052064</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1052864</id>
  <title>Significant expansion of data available in the Genomic Data Commons</title>
  <langcode>en</langcode>
  <field_short_title>Expansion of data available in the Genomic Data Commons</field_short_title>
  <field_page_description>The recently launched Genomic Data Commons will get a dramatic increase in the power and utility of its resources with the signing today of a data sharing agreement between the NCI and Foundation Medicine, Inc. (FMI), a molecular information company. </field_page_description>
  <field_date_posted>2016-06-29</field_date_posted>
  <field_date_reviewed>2016-06-23</field_date_reviewed>
  <field_pretty_url>gdc-data-expansion-fmi</field_pretty_url>
  <para_id>1052864</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1053529</id>
  <title>The Cancer Moonshot Summit: Reaching New Heights</title>
  <langcode>en</langcode>
  <field_short_title>The Cancer Moonshot Summit: Reaching New Heights</field_short_title>
  <field_page_description>An NCI Cancer Currents blog from acting NCI Director Dr. Doug Lowy on the Cancer Moonshot national summit hosted by Vice President Joe Biden in Washington, D.C., including a summary of the NCI-related activities stimulated by the Cancer Moonshot.</field_page_description>
  <field_date_posted>2016-06-30</field_date_posted>
  <field_date_reviewed>2016-06-30</field_date_reviewed>
  <field_pretty_url>moonshot-summit</field_pretty_url>
  <para_id>1053529</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1056793</id>
  <title>Inherited Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers</title>
  <langcode>en</langcode>
  <field_short_title>Inherited Mutations Identified in Advanced Prostate Cancers</field_short_title>
  <field_page_description>An NCI Cancer Currents blog about the discovery in men with advanced prostate cancer of inherited mutations in genes that play a role in repairing damaged DNA. </field_page_description>
  <field_date_posted>2016-07-25</field_date_posted>
  <field_date_reviewed>2016-07-25</field_date_reviewed>
  <field_pretty_url>dna-repair-mutations-prostate</field_pretty_url>
  <para_id>1056793</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1056870</id>
  <title>Partner-Aided Skin Exams Increase Early Detection of New Melanomas</title>
  <langcode>en</langcode>
  <field_short_title>Partner-Aided Skin Exams Increase Early Detection of New Melanomas</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on a study which showed that people previously treated for melanoma can team up with a partner and be trained to find new melanomas.</field_page_description>
  <field_date_posted>2016-07-27</field_date_posted>
  <field_date_reviewed>2016-07-26</field_date_reviewed>
  <field_pretty_url>partner-skin-exams-melanoma</field_pretty_url>
  <para_id>1056870</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1057582</id>
  <title>Nanoparticle Delivers Cancer Drugs to Tumor Blood Vessels</title>
  <langcode>en</langcode>
  <field_short_title>Nanoparticle Delivers Cancer Drugs to Tumor Blood Vessels</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on a study showing that, in cancer mouse models, nanoparticles that target P-selectin on tumor blood vessels shrank tumors and extended survival.</field_page_description>
  <field_date_posted>2016-08-01</field_date_posted>
  <field_date_reviewed>2016-07-29</field_date_reviewed>
  <field_pretty_url>nanoparticle-tumor-vessels</field_pretty_url>
  <para_id>1057582</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1060283</id>
  <title>Oxygen can impair cancer immunotherapy in mice</title>
  <langcode>en</langcode>
  <field_short_title>Oxygen can impair immune response in mice</field_short_title>
  <field_page_description>Researchers have identified a mechanism in mice by which anticancer immune responses are inhibited within the lungs, a common site of metastasis for many cancers.</field_page_description>
  <field_date_posted>2016-08-25</field_date_posted>
  <field_date_reviewed>2016-08-17</field_date_reviewed>
  <field_pretty_url>oxygen-impair-cancer-immune-response-in-mice</field_pretty_url>
  <para_id>1060283</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1061367</id>
  <title>Approach May Allow for Stem Cell Transplant without Radiation, Chemotherapy</title>
  <langcode>en</langcode>
  <field_short_title>Study Tests Safer Stem Cell Transplant</field_short_title>
  <field_page_description>An NCI Cancer Currents blog about a study testing a potentially safer way to perform stem cell transplants for treating cancer and other diseases.</field_page_description>
  <field_date_posted>2016-09-07</field_date_posted>
  <field_date_reviewed>2016-09-06</field_date_reviewed>
  <field_pretty_url>safer-stem-cell-transplant</field_pretty_url>
  <para_id>1061367</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1061552</term_id>
  <id>1061553</id>
  <title>RAS Biochemistry and Biophysics</title>
  <langcode>en</langcode>
  <field_short_title>Biochemistry and Biophysics</field_short_title>
  <field_page_description>This RAS Biochemistry and Biophysics lab investigates signaling by RAS proteins, which is regulated by the interactions with substrates, protein partners, and membranes.</field_page_description>
  <field_date_posted>2016-09-08</field_date_posted>
  <field_date_reviewed>2016-09-08</field_date_reviewed>
  <para_id>1061553</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1124207</id>
  <title>NCI and FDA Address Common Concerns: A Win–Win for Making Progress against Cancer</title>
  <langcode>en</langcode>
  <field_short_title>NCI and FDA Collaborating on Common Concerns</field_short_title>
  <field_page_description>NCI Director Dr. Norman Sharpless discusses efforts between NCI and FDA to advance progress against cancer, including initiatives to improve labeling of patient tumor and tissue samples and address challenges presented by new tobacco products.</field_page_description>
  <field_date_posted>2018-09-17</field_date_posted>
  <field_date_reviewed>2018-09-13</field_date_reviewed>
  <field_pretty_url>sharpless-nci-fda-collaboration</field_pretty_url>
  <para_id>1124207</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1124536</term_id>
  <id>1124541</id>
  <title>Strategic Planning at NCI</title>
  <langcode>en</langcode>
  <field_short_title>Strategic Planning at NCI</field_short_title>
  <field_page_description>NCI’s strategic goals and priorities aim to direct progress against cancer to meet the needs of all people. Learn how priorities are set and how funding decisions are made at NCI.</field_page_description>
  <field_date_posted>2019-01-15</field_date_posted>
  <field_date_reviewed>2018-09-19</field_date_reviewed>
  <para_id>1124541</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1124643</id>
  <title>Heart Problems: Investigating the Cardiac Side Effects of Cancer Treatments</title>
  <langcode>en</langcode>
  <field_short_title>Investigating the Cardiac Side Effects of Cancer Treatments</field_short_title>
  <field_page_description>Certain cancer treatments can damage the heart and the cardiovascular system, a problem known as cardiotoxicity. Cardiologists and oncologists met recently to discuss strategies and future research directions for addressing these side effects. </field_page_description>
  <field_date_posted>2018-09-21</field_date_posted>
  <field_date_reviewed>2018-09-20</field_date_reviewed>
  <field_pretty_url>cancer-treatment-heart-side-effects</field_pretty_url>
  <para_id>1124643</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1126546</term_id>
  <id>1126547</id>
  <title>2017 Outstanding Investigator Award Recipients</title>
  <langcode>en</langcode>
  <field_short_title>2017 NCI OIA Recipients</field_short_title>
  <field_page_description>Learn how these investigators' projects aim to break new ground in biomedical, behavioral, and clinical cancer research.</field_page_description>
  <field_date_posted>2018-10-15</field_date_posted>
  <field_date_reviewed>2015-10-14</field_date_reviewed>
  <para_id>1126547</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>917216</term_id>
  <id>1126632</id>
  <title>Searching for Less-Toxic Cancer Treatments for Kids</title>
  <langcode>en</langcode>
  <field_short_title>Searching for Less-Toxic Cancer Treatments for Kids-Gregory Aune, M.D., Ph.D.</field_short_title>
  <field_page_description>Frustration with the toxicities of chemotherapy and radiation spurs cancer survivor and investigator Greg Aune to look for less-toxic therapies for children.</field_page_description>
  <field_date_posted>2017-09-21</field_date_posted>
  <field_date_reviewed>2018-10-16</field_date_reviewed>
  <field_pretty_url>gregory-aune-less-toxic-cancer-treatments-kids</field_pretty_url>
  <para_id>1126632</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102628</term_id>
  <id>1132070</id>
  <title>Conversation with Dr. Shiva Malek and Dr. Christiaan Klijn</title>
  <langcode>en</langcode>
  <field_short_title>Conversation with Dr. Shiva Malek and Dr. Christiaan Klijn</field_short_title>
  <field_page_description>Inhibiting MEK re-wires regulation of MAPK signaling so that inhibitors of RAF kinases are more effective against cells driven by mutant KRAS.</field_page_description>
  <field_date_posted>2018-12-06</field_date_posted>
  <field_date_reviewed>2018-12-03</field_date_reviewed>
  <field_pretty_url>shiva-malek</field_pretty_url>
  <para_id>1132070</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1132206</term_id>
  <id>1132207</id>
  <title>Trichloroethylene (TCE)</title>
  <langcode>en</langcode>
  <field_short_title>Trichloroethylene </field_short_title>
  <field_page_description>Trichloroethylene (TCE) is a chemical used to make refrigerants and as a metal degreaser. It may be found in contaminated soil or water near military bases and in some commercial and household cleaning products. TCE exposure may cause kidney cancer and increase the risk of lymphoma and liver cancer.</field_page_description>
  <field_date_posted>2018-12-10</field_date_posted>
  <field_date_reviewed>2018-12-05</field_date_reviewed>
  <para_id>1132207</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1133143</id>
  <title>Plans for NCI’s Fiscal Year 2019 Budget</title>
  <langcode>en</langcode>
  <field_short_title>Plans for NCI’s Fiscal Year 2019 Budget</field_short_title>
  <field_page_description>NCI Director Dr. Ned Sharpless on NCI’s FY2019 budget and important budgetary decisions, including those related to the Cancer Moonshot and young investigators.</field_page_description>
  <field_date_posted>2018-12-18</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>sharpless-nci-fy2019-budget</field_pretty_url>
  <para_id>1133143</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133484</term_id>
  <id>1133216</id>
  <title>About Rare Cancers</title>
  <langcode>en</langcode>
  <field_short_title>About Rare Cancers</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <para_id>1133216</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133180</term_id>
  <id>1133231</id>
  <title>Fibrolamellar hepatocellular carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>Fibrolamellar hepatocellular carcinoma</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>fibrolamellar-hepatocellular-carcinoma</field_pretty_url>
  <para_id>1133231</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1137220</term_id>
  <id>1133248</id>
  <title>Challenges for Rare Tumor Researchers</title>
  <langcode>en</langcode>
  <field_short_title>Challenges for Rare Tumor Researchers</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <para_id>1133248</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1133314</id>
  <title>Whole- and Partial-Breast Radiation Effective at Preventing Breast Cancer from Returning</title>
  <langcode>en</langcode>
  <field_short_title>Two Radiation Therapy Approaches Prevent Breast Cancer Recurrences</field_short_title>
  <field_page_description>In women with early-stage breast cancer, whole- and partial-breast radiation therapy effectively prevent cancer from returning after breast-conserving surgery.</field_page_description>
  <field_date_posted>2018-12-19</field_date_posted>
  <field_date_reviewed>2018-12-18</field_date_reviewed>
  <field_pretty_url>breast-cancer-radiation-therapy-whole-partial-recurrence</field_pretty_url>
  <para_id>1133314</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>417543</term_id>
  <id>1051290</id>
  <title>Clinical Trials Reporting Program</title>
  <langcode>en</langcode>
  <field_short_title>CTRP</field_short_title>
  <field_page_description>The Clinical Trials Reporting Program is a comprehensive database of all NCI-supported clinical trials.</field_page_description>
  <field_date_posted>2016-05-25</field_date_posted>
  <field_date_reviewed>2016-05-25</field_date_reviewed>
  <para_id>1051290</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>16374</term_id>
  <id>1052956</id>
  <title>Clinical Trials Search Results</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trials Search Results</field_short_title>
  <field_date_posted>2011-02-02</field_date_posted>
  <field_date_reviewed>2011-02-02</field_date_reviewed>
  <field_pretty_url>r</field_pretty_url>
  <para_id>1052956</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>16374</term_id>
  <id>1052961</id>
  <title>Clinical Trials (PDQ®)</title>
  <langcode>en</langcode>
  <field_short_title>Clinical Trials (PDQ®)</field_short_title>
  <field_date_posted>2011-02-02</field_date_posted>
  <field_date_reviewed>2011-02-02</field_date_reviewed>
  <field_pretty_url>v</field_pretty_url>
  <para_id>1052961</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1053426</id>
  <title>Reflections from a Year at the Center for Global Health</title>
  <langcode>en</langcode>
  <field_short_title>Reflections from a Year at the Center for Global Health</field_short_title>
  <field_date_posted>2016-06-28</field_date_posted>
  <field_date_reviewed>2016-06-28</field_date_reviewed>
  <field_pretty_url>crta</field_pretty_url>
  <para_id>1053426</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1035160</term_id>
  <id>1054523</id>
  <title>Human Cancer Models Initiative Will Create Next Generation Cancer Models That Have Genomic and Clinical Data</title>
  <langcode>en</langcode>
  <field_short_title>Launch of Human Cancer Models Initiative</field_short_title>
  <field_page_description>The NCI has formed new international collaboration called the Human Cancer Models Initiative to generate better models of human cancers to support cancer research.</field_page_description>
  <field_date_posted>2016-07-11</field_date_posted>
  <field_date_reviewed>2016-07-06</field_date_reviewed>
  <field_pretty_url>human-cancer-models-initiative-launch</field_pretty_url>
  <para_id>1054523</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1035160</term_id>
  <id>1057853</id>
  <title>Researcher Interview: Aviv Regev</title>
  <langcode>en</langcode>
  <field_short_title>Aviv Regev Interview</field_short_title>
  <field_page_description>Amy E. Blum, M.A. spoke with Aviv Regev, Ph.D. in this CCG researcher interview.</field_page_description>
  <field_date_posted>2016-08-15</field_date_posted>
  <field_date_reviewed>2016-08-02</field_date_reviewed>
  <field_pretty_url>aviv-regev-interview</field_pretty_url>
  <para_id>1057853</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1058013</term_id>
  <id>1058014</id>
  <title>Cancer Disparities</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Disparities</field_short_title>
  <field_page_description>Basic information about cancer disparities in the U.S., factors that contribute to the disproportionate burden of cancer in some groups, and examples of disparities in incidence and mortality among certain populations.</field_page_description>
  <field_date_posted>2016-08-04</field_date_posted>
  <field_date_reviewed>2016-08-03</field_date_reviewed>
  <para_id>1058014</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1060461</id>
  <title>Nanoparticle that Mimics Salmonella Counteracts Chemotherapy Resistance</title>
  <langcode>en</langcode>
  <field_short_title>Nanoparticle Counteracts Chemotherapy Resistance</field_short_title>
  <field_page_description>An NCI Cancer Currents blog about a nanoparticle that mimics Salmonella and may help counteract chemotherapy resistance.</field_page_description>
  <field_date_posted>2016-08-22</field_date_posted>
  <field_date_reviewed>2016-08-19</field_date_reviewed>
  <field_pretty_url>chemotherapy-resistance-salmonella</field_pretty_url>
  <para_id>1060461</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1060809</id>
  <title>FDA Approves Pembrolizumab for Head and Neck Cancer</title>
  <langcode>en</langcode>
  <field_short_title>FDA Approves Pembrolizumab for Head and Neck Cancer</field_short_title>
  <field_page_description>FDA granted pembrolizumab accelerated approval for some patients with head and neck cancer.</field_page_description>
  <field_date_posted>2016-08-24</field_date_posted>
  <field_date_reviewed>2016-08-24</field_date_reviewed>
  <field_pretty_url>fda-pembrolizumab-hnscc</field_pretty_url>
  <para_id>1060809</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1034468</term_id>
  <id>1061216</id>
  <title>NCI embraces scientific road map to achieve Cancer Moonshot goals</title>
  <langcode>en</langcode>
  <field_short_title>NCI embraces scientific road map to achieve Cancer Moonshot goals</field_short_title>
  <field_page_description>NCI Acting Director Douglas Lowy, M.D., today accepted, with revisions that reflect NCAB’s discussion, the 10 transformative recommendations of a Blue Ribbon Panel.</field_page_description>
  <field_date_posted>2016-09-07</field_date_posted>
  <field_date_reviewed>2016-09-01</field_date_reviewed>
  <field_pretty_url>ncab-nci-accept-brp-report</field_pretty_url>
  <para_id>1061216</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1044202</term_id>
  <id>1061763</id>
  <title>CGH Roundtable on HPV Screening</title>
  <langcode>en</langcode>
  <field_short_title>CGH Roundtable on HPV Screening</field_short_title>
  <field_date_posted>2016-09-14</field_date_posted>
  <field_date_reviewed>2016-09-14</field_date_reviewed>
  <field_pretty_url>prrr-roundtable</field_pretty_url>
  <para_id>1061763</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11970</term_id>
  <id>13211</id>
  <title>Thymoma and Thymic Carcinoma—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Thymoma and Thymic Carcinoma</field_short_title>
  <field_page_description>Thymomas and thymic carcinomas are rare tumors that form in cells on the thymus. Thymomas grow slowly and rarely spread beyond the thymus. Thymic carcinoma grows faster, often spreads to other parts of the body, and is harder to treat. Start here to find information on thymoma and thymic carcinoma treatment.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13211</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11896</term_id>
  <id>13420</id>
  <title>Colorectal Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Colorectal Cancer</field_short_title>
  <field_page_description>Colorectal cancer often begins as a growth called a polyp inside the colon or rectum. Finding and removing polyps can prevent colorectal cancer. Start here to find information on colon and rectal cancer treatment, causes and prevention, screening, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13420</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1061909</id>
  <title>Meeting Patients Where They Are: Liberating Clinical Trials Data Under the Cancer Moonshot</title>
  <langcode>en</langcode>
  <field_short_title>Liberating NCI Clinical Trials Data</field_short_title>
  <field_page_description>An NCI Cancer Currents blog about a new application programming interface (API) that allows anyone to build online tools that help people find NCI-supported clinical trials.</field_page_description>
  <field_date_posted>2016-09-16</field_date_posted>
  <field_date_reviewed>2016-09-16</field_date_reviewed>
  <field_pretty_url>clinical-trials-api</field_pretty_url>
  <para_id>1061909</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1032046</term_id>
  <id>1062106</id>
  <title>Message from Dr. Lowy</title>
  <langcode>en</langcode>
  <field_short_title>Message from Dr. Lowy</field_short_title>
  <field_page_description>A message from NCI Acting Director, Douglas Lowy, about the progress of the RAS Initiative and its goal to create a virtual network of scientists working collaboratively to solve the RAS problem.</field_page_description>
  <field_date_posted>2016-01-04</field_date_posted>
  <field_date_reviewed>2016-09-19</field_date_reviewed>
  <field_pretty_url>dr-lowy-message</field_pretty_url>
  <para_id>1062106</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11960</term_id>
  <id>13658</id>
  <title>Small Intestine Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Small Intestine Cancer</field_short_title>
  <field_page_description>Small intestine cancer usually begins in an area of the intestine called the duodenum. This cancer is rarer than cancers in other parts of the gastrointestinal system, such as the colon and stomach. Explore the links on this page to learn more about small intestine cancer treatment, statistics, research, and clinical t</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2007-05-14</field_date_reviewed>
  <para_id>13658</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11948</term_id>
  <id>13695</id>
  <title>Penile Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Penile Cancer</field_short_title>
  <field_page_description>Penile cancer usually forms on or under the foreskin. Human papillomavirus (HPV) causes about one-third of penile cancer cases. When found early, penile cancer is usually curable. Start here to find information on penile cancer treatment and research.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13695</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11876</term_id>
  <id>13937</id>
  <title>Anal Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Anal Cancer</field_short_title>
  <field_page_description>Anal cancer cases have been increasing over several decades. Infection with human papillomavirus (HPV) is the major risk factor for anal cancer. Start here to find information on anal cancer treatment, causes and prevention, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13937</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>11844</term_id>
  <id>14034</id>
  <title>Cancer Treatment</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Treatment</field_short_title>
  <field_page_description>Information on cancer treatment methods, specific anticancer drugs, and drug development and approval. Research updates, cancer treatment facilities, and other topics also covered. </field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14034</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>941579</term_id>
  <id>14272</id>
  <title>Selected NCI-Supported Trials</title>
  <langcode>en</langcode>
  <field_short_title>Selected NCI-Supported Trials</field_short_title>
  <field_page_description>Information about selected NCI-supported clinical trials, open or closed to patient enrollment.</field_page_description>
  <field_date_posted>2006-12-19</field_date_posted>
  <field_date_reviewed>2006-12-19</field_date_reviewed>
  <para_id>14272</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>254313</id>
  <title>New report highlights epidemic of tobacco and global health inequalities </title>
  <langcode>en</langcode>
  <field_short_title>New report highlights epidemic of tobacco and global health inequalities </field_short_title>
  <field_page_description>A new set of 11 global health studies calls attention to the burden of tobacco-related inequalities in low- and middle-income countries and finds that socioeconomic inequalities are associated with increased tobacco use, second-hand smoke exposure and tob</field_page_description>
  <field_date_posted>2012-03-21</field_date_posted>
  <field_date_reviewed>2012-03-21</field_date_reviewed>
  <field_pretty_url>GlobalTobaccoSupplementTCRB</field_pretty_url>
  <para_id>254313</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>300957</id>
  <title>NIH study finds sigmoidoscopy reduces colorectal cancer rates</title>
  <langcode>en</langcode>
  <field_short_title>NIH study finds sigmoidoscopy reduces colorectal cancer rates</field_short_title>
  <field_page_description>Study finds that flexible sigmoidoscopy is effective in reducing the rates of new cases and deaths due to colorectal cancer.  Researchers found that overall colorectal cancer mortality was reduced by 26 percent and incidence was reduced by 21 percent as a</field_page_description>
  <field_date_posted>2012-05-21</field_date_posted>
  <field_date_reviewed>2012-05-15</field_date_reviewed>
  <field_pretty_url>PLCOScreening</field_pretty_url>
  <para_id>300957</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>311599</id>
  <title>REMARK checklist elaborated to improve tumor prognostic study reporting</title>
  <langcode>en</langcode>
  <field_short_title>REMARK checklist elaborated to improve tumor prognostician</field_short_title>
  <field_page_description>Experts have elaborated on a previously published checklist of 20 items -- including descriptions of design, methods, and analysis -- that researchers should address when publishing studies of prognostic markers. These markers are indicators that enable d</field_page_description>
  <field_date_posted>2012-05-29</field_date_posted>
  <field_date_reviewed>2012-05-29</field_date_reviewed>
  <field_pretty_url>REMARKchecklist</field_pretty_url>
  <para_id>311599</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1053375</id>
  <title>Prognosis Discussions Improve Understanding of Illness for Patients with Terminal Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Prognosis Discussions Improve Understanding of Illness for Patients with Terminal Cancer</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on patients with advanced, curable cancer and the effect of discussing their prognosis and their understanding of the serious nature of their illness.</field_page_description>
  <field_date_posted>2016-06-27</field_date_posted>
  <field_date_reviewed>2016-06-27</field_date_reviewed>
  <field_pretty_url>cancer-prognosis-discussions</field_pretty_url>
  <para_id>1053375</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1054637</id>
  <title>Study Forecasts ‘Silver Tsunami’ of Cancer Survivors</title>
  <langcode>en</langcode>
  <field_short_title>Study Forecasts ‘Silver Tsunami’ of Cancer Survivors</field_short_title>
  <field_page_description>An NCI Cancer Currents blog on an NCI study that is forecasting a substantial increase in older cancer survivors over the next 25 years.</field_page_description>
  <field_date_posted>2016-07-08</field_date_posted>
  <field_date_reviewed>2016-07-07</field_date_reviewed>
  <field_pretty_url>cancer-silver-tsunami</field_pretty_url>
  <para_id>1054637</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1047564</term_id>
  <id>1061084</id>
  <title>New Awards in NCI’s Cancer Systems Biology Consortium </title>
  <langcode>en</langcode>
  <field_short_title>New Awards in NCI’s Cancer Systems Biology Consortium </field_short_title>
  <field_page_description>Announcement that NCI awarded four new grants in the Cancer Systems Biology Consortium (CSBC).</field_page_description>
  <field_date_posted>2017-06-08</field_date_posted>
  <field_date_reviewed>2016-08-29</field_date_reviewed>
  <field_pretty_url>announcement</field_pretty_url>
  <para_id>1061084</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1061146</term_id>
  <id>1061148</id>
  <title>Cancer Clinical Trials API</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Clinical Trials API</field_short_title>
  <field_date_posted>2016-08-31</field_date_posted>
  <field_date_reviewed>2016-08-31</field_date_reviewed>
  <para_id>1061148</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1033569</term_id>
  <id>1061186</id>
  <title>Engineered Stem Cells Help Identify Potential New Treatment for Medulloblastoma</title>
  <langcode>en</langcode>
  <field_short_title>Improved Lab Model Developed for Studying Medulloblastoma</field_short_title>
  <field_page_description>An NCI Cancer Currents blog about neural stem cells engineered to provide a new laboratory model for studying medulloblastoma.</field_page_description>
  <field_date_posted>2016-09-01</field_date_posted>
  <field_date_reviewed>2016-09-01</field_date_reviewed>
  <field_pretty_url>medulloblastoma-model</field_pretty_url>
  <para_id>1061186</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1061650</term_id>
  <id>1061652</id>
  <title>RAS Initiative Events</title>
  <langcode>en</langcode>
  <field_short_title>RAS Events</field_short_title>
  <field_page_description>The NCI RAS Initiative has organized multiple events with outside experts to discuss how the latest scientific and technological breakthroughs can be applied to discover vulnerabilities in RAS-driven cancers.</field_page_description>
  <field_date_posted>2016-09-12</field_date_posted>
  <field_date_reviewed>2016-09-28</field_date_reviewed>
  <para_id>1061652</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911116</term_id>
  <id>13327</id>
  <title>Tea and Cancer Prevention</title>
  <langcode>en</langcode>
  <field_short_title>Tea and Cancer Prevention</field_short_title>
  <field_page_description>A fact sheet that summarizes the results of studies about tea and cancer prevention. Includes information about the ingredients of tea and safety considerations regarding tea consumption.</field_page_description>
  <field_date_posted>2010-11-17</field_date_posted>
  <field_date_reviewed>2010-11-17</field_date_reviewed>
  <field_pretty_url>tea-fact-sheet</field_pretty_url>
  <para_id>13327</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>910891</term_id>
  <id>13704</id>
  <title>What Is Cancer?</title>
  <langcode>en</langcode>
  <field_short_title>What Is Cancer?</field_short_title>
  <field_page_description>Explanations about what cancer is, how cancer cells differ from normal cells, and genetic changes that cause cancer to grow and spread.</field_page_description>
  <field_date_posted>2007-09-17</field_date_posted>
  <field_date_reviewed>2007-03-28</field_date_reviewed>
  <para_id>13704</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>11886</term_id>
  <id>13782</id>
  <title>Abortion, Miscarriage, and Breast Cancer Risk: 2003 Workshop</title>
  <langcode>en</langcode>
  <field_short_title>Abortion, Miscarriage, and Breast Cancer Risk: 2003 Workshop</field_short_title>
  <field_date_posted>2003-02-20</field_date_posted>
  <field_date_reviewed>2010-01-12</field_date_reviewed>
  <field_pretty_url>abortion-miscarriage-risk</field_pretty_url>
  <para_id>13782</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>861460</term_id>
  <id>14017</id>
  <title>Electromagnetic Fields and Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Electromagnetic Fields and Cancer</field_short_title>
  <field_page_description>A fact sheet about research on electric and magnetic fields and studies examining their potential connection with cancer.</field_page_description>
  <field_date_posted>2019-01-07</field_date_posted>
  <field_date_reviewed>2016-04-04</field_date_reviewed>
  <field_pretty_url>electromagnetic-fields-fact-sheet</field_pretty_url>
  <para_id>14017</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>952656</term_id>
  <id>14106</id>
  <title>PDQ&amp;reg; Cancer Information Summaries: Supportive and Palliative Care</title>
  <langcode>en</langcode>
  <field_short_title>Supportive &amp;amp; Palliative Care</field_short_title>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14106</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911116</term_id>
  <id>14147</id>
  <title>Antioxidants and Cancer Prevention</title>
  <langcode>en</langcode>
  <field_short_title>Antioxidants and Cancer Prevention</field_short_title>
  <field_page_description>A fact sheet about antioxidants, substances that may protect cells from the damage caused by unstable molecules known as free radicals. Free radical damage may lead to cancer.</field_page_description>
  <field_date_posted>2014-01-17</field_date_posted>
  <field_date_reviewed>2017-02-06</field_date_reviewed>
  <field_pretty_url>antioxidants-fact-sheet</field_pretty_url>
  <para_id>14147</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>817860</term_id>
  <id>14175</id>
  <title>Social Media at NCI</title>
  <langcode>en</langcode>
  <field_short_title>Social Media at NCI</field_short_title>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2010-03-29</field_date_reviewed>
  <para_id>14175</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>253980</id>
  <title>Drug that blocks blood vessel growth may be beneficial in treating AIDS-related Kaposi’s sarcoma</title>
  <langcode>en</langcode>
  <field_short_title>Blood vessel growth blocker may treat AIDS-related Kaposi’s sarcoma</field_short_title>
  <field_page_description>Patients with an AIDS-associated cancer, Kaposi's sarcoma (KS), showed improvement after receiving the combination of bevacizumab, a cancer drug that blocks the growth of new blood vessels, and highly active antiretroviral therapy (HAART). </field_page_description>
  <field_date_posted>2012-03-20</field_date_posted>
  <field_date_reviewed>2012-03-20</field_date_reviewed>
  <field_pretty_url>bevacizumabAIDS_KSnewsnote</field_pretty_url>
  <para_id>253980</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>11882</term_id>
  <id>13598</id>
  <title>Primary Bone Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Primary Bone Cancer</field_short_title>
  <field_page_description>A fact sheet about the diagnosis and treatment of cancers that develop in the bones.</field_page_description>
  <field_date_posted>2018-12-06</field_date_posted>
  <field_date_reviewed>2018-11-20</field_date_reviewed>
  <field_pretty_url>bone-fact-sheet</field_pretty_url>
  <para_id>13598</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11964</term_id>
  <id>13641</id>
  <title>Stomach (Gastric) Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Stomach (Gastric) Cancer</field_short_title>
  <field_page_description>Stomach (gastric) cancer occurs when cancer cells form in the lining of the stomach. Risk factors include smoking, infection with H. pylori bacteria, and certain inherited conditions. Start here to find information on stomach (gastric) cancer treatment, causes and prevention, screening, research, and statistics. </field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13641</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>11886</term_id>
  <id>13720</id>
  <title>Early Reproductive Events and Breast Cancer: Workshop Statement</title>
  <langcode>en</langcode>
  <field_short_title>Early Reproductive Events/Breast Cancer Statement</field_short_title>
  <field_page_description>This scientific workshop was convened by the National Cancer Institute in 2003 to present and review the information available on the risk of breast cancer associated with pregnancy. </field_page_description>
  <field_date_posted>2003-02-26</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <field_pretty_url>ere-workshop-statement</field_pretty_url>
  <para_id>13720</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911160</term_id>
  <id>13730</id>
  <title>End-of-Life Care for People Who Have Cancer</title>
  <langcode>en</langcode>
  <field_short_title>End-of-Life Care</field_short_title>
  <field_page_description>A fact sheet that answers some of the questions patients, their family members, and caregivers may have about the end of life.</field_page_description>
  <field_date_posted>2005-09-01</field_date_posted>
  <field_date_reviewed>2012-05-10</field_date_reviewed>
  <field_pretty_url>care-fact-sheet</field_pretty_url>
  <para_id>13730</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11954</term_id>
  <id>13780</id>
  <title>Prostate Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Prostate Cancer</field_short_title>
  <field_page_description>Prostate cancer is the most common cancer among men in the United States. Prostate cancer usually grows very slowly, and finding and treating it before symptoms occur may not improve men’s health. Start here to find information on prostate cancer treatment, research, causes and prevention, screening, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13780</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11962</term_id>
  <id>13832</id>
  <title>Soft Tissue Sarcoma—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Soft Tissue Sarcoma</field_short_title>
  <field_page_description>Soft tissue sarcoma is a cancer that starts in soft tissues like muscle, tendons, fat, lymph vessels, blood vessels, and nerves. These cancers can develop anywhere in the body but are found mostly in the arms, legs, chest, and abdomen. Start here to find information on soft tissue sarcoma treatment and research.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13832</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11942</term_id>
  <id>13916</id>
  <title>Ovarian, Fallopian Tube, and Primary Peritoneal Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Ovarian, Fallopian Tube, and Primary Peritoneal Cancer</field_short_title>
  <field_page_description>Ovarian epithelial cancer is the most common type of ovarian cancer. Cancer can also form at the end of the fallopian tube near the ovary or the peritoneum and spread to the ovary. Start here to find information on ovarian cancer treatment, causes and prevention, screening, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>13916</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>11738</term_id>
  <id>13982</id>
  <title>Description of NCI Cancer Genetics Services Directory</title>
  <langcode>en</langcode>
  <field_short_title>Description of NCI Cancer Genetics Services Directory</field_short_title>
  <field_page_description>Background and Purpose of PDQ Cancer Genetics Services Directory</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <field_pretty_url>description</field_pretty_url>
  <para_id>13982</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911291</term_id>
  <id>14073</id>
  <title>Cigar Smoking and Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Cigar Smoking and Cancer</field_short_title>
  <field_page_description>A fact sheet about the health risks associated with cigar smoking.</field_page_description>
  <field_date_posted>2005-08-18</field_date_posted>
  <field_date_reviewed>2010-10-27</field_date_reviewed>
  <field_pretty_url>cigars-fact-sheet</field_pretty_url>
  <para_id>14073</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917291</term_id>
  <id>14178</id>
  <title>Certificates of Confidentiality</title>
  <langcode>en</langcode>
  <field_short_title>Certificates of Confidentiality</field_short_title>
  <field_page_description>Background information and application procedures for researchers.</field_page_description>
  <field_date_posted>2000-05-04</field_date_posted>
  <field_date_reviewed>2013-01-23</field_date_reviewed>
  <field_pretty_url>certificates-confidentiality</field_pretty_url>
  <para_id>14178</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>255466</id>
  <title>Annual Report to the Nation on the Status of Cancer, 1975-2008, Featuring Cancers Associated with Excess Weight and Lack of Sufficient Physical Activity: Questions and Answers </title>
  <langcode>en</langcode>
  <field_short_title>Annual Report to the Nation on Cancer, 1975-2008: Q&amp;A</field_short_title>
  <field_page_description>Overall cancer death rates have continued to decrease since the early 1990s among men, women, and children. Death rates decreased on average 1.6 percent per year between 2004 and 2008.</field_page_description>
  <field_date_posted>2012-03-28</field_date_posted>
  <field_date_reviewed>2012-03-23</field_date_reviewed>
  <field_pretty_url>ReportNationQA2012</field_pretty_url>
  <para_id>255466</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>11886</term_id>
  <id>283901</id>
  <title>Hormone Therapy for Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Hormone Therapy for Breast Cancer</field_short_title>
  <field_page_description>A fact sheet that describes types of hormone therapy, its role in preventing and treating breast cancer, and possible side effects.</field_page_description>
  <field_date_posted>2017-03-03</field_date_posted>
  <field_date_reviewed>2017-02-14</field_date_reviewed>
  <field_pretty_url>breast-hormone-therapy-fact-sheet</field_pretty_url>
  <para_id>283901</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>937976</term_id>
  <id>298554</id>
  <title>Many Patients with Cancer Need Better Treatments for Pain</title>
  <langcode>en</langcode>
  <field_short_title>Many Patients with Cancer Need Better Treatments for Pain</field_short_title>
  <field_date_posted>2012-05-09</field_date_posted>
  <field_date_reviewed>2012-05-08</field_date_reviewed>
  <field_pretty_url>pain-management</field_pretty_url>
  <para_id>298554</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938161</term_id>
  <id>300494</id>
  <title>Chemoradiation May Help Some Patients with Bladder Cancer Avoid Radical Surgery</title>
  <langcode>en</langcode>
  <field_short_title>Chemoradiation May Help Some Patients with Bladder Cancer Avoid Radical Surgery</field_short_title>
  <field_page_description>Researchers in the United Kingdom have found that adding chemotherapy to radiation therapy as a treatment for bladder cancer may reduce the risk of a recurrence more than radiation alone, without causing a substantial increase in side effects.</field_page_description>
  <field_date_posted>2012-05-14</field_date_posted>
  <field_date_reviewed>2012-05-14</field_date_reviewed>
  <field_pretty_url>chemoradiation</field_pretty_url>
  <para_id>300494</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>317031</id>
  <title>For Some Breast Cancers, New Drug May Be Treatment Option</title>
  <langcode>en</langcode>
  <field_short_title>For Some Breast Cancers, New Drug May Be Treatment Option</field_short_title>
  <field_page_description>Results from an international clinical trial suggest that women with metastatic, HER2-positive breast cancer that is no longer responding to the targeted therapy trastuzumab (Herceptin) may soon have a new treatment option.</field_page_description>
  <field_date_posted>2012-06-13</field_date_posted>
  <field_date_reviewed>2012-06-13</field_date_reviewed>
  <field_pretty_url>t-dm1</field_pretty_url>
  <para_id>317031</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>417551</term_id>
  <id>321610</id>
  <title>CCCT Contact and Staff Information</title>
  <langcode>en</langcode>
  <field_short_title>Contact CCCT</field_short_title>
  <field_page_description>Contact and staff information for NCI's Coordinating Center for Clinical Trials (CCCT).</field_page_description>
  <field_date_posted>2012-06-21</field_date_posted>
  <field_date_reviewed>2012-06-21</field_date_reviewed>
  <para_id>321610</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1100622</id>
  <title>Expanding Smoking Cessation Services at NCI-Designated Cancer Centers: An Interview with Dr. Glen Morgan</title>
  <langcode>en</langcode>
  <field_short_title>Expanding Smoking Cessation at NCI-Designated Cancer Centers</field_short_title>
  <field_page_description>A new smoking cessation initiative will support NCI-Designated Cancer Centers efforts to help more patients quit smoking, as Dr. Glen Morgan explains in this Cancer Currents interview.</field_page_description>
  <field_date_posted>2017-11-22</field_date_posted>
  <field_date_reviewed>2017-11-22</field_date_reviewed>
  <field_pretty_url>smoking-cessation-nci-cancer-centers</field_pretty_url>
  <para_id>1100622</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1101951</id>
  <title>Acalabrutinib Receives FDA Approval for Mantle Cell Lymphoma</title>
  <langcode>en</langcode>
  <field_short_title>Acalabrutinib Approved for Mantle Cell Lymphoma</field_short_title>
  <field_page_description>Acalabrutinib (Calquence®) has been granted accelerated approval by FDA for the treatment of adults with mantle cell lymphoma whose cancer has progressed after receiving at least one prior therapy.</field_page_description>
  <field_date_posted>2017-12-12</field_date_posted>
  <field_date_reviewed>2017-12-11</field_date_reviewed>
  <field_pretty_url>acalabrutinib-fda-mantle-cell-lymphoma</field_pretty_url>
  <para_id>1101951</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1066360</term_id>
  <id>1102407</id>
  <title>Strengthening CGH’s partnerships in cancer research and control in Africa: AORTIC 2017</title>
  <langcode>en</langcode>
  <field_short_title>Strengthening CGH’s partnerships in cancer research and control in Africa: AORTIC 2017</field_short_title>
  <field_date_posted>2017-12-20</field_date_posted>
  <field_date_reviewed>2017-12-20</field_date_reviewed>
  <field_pretty_url>aortic-2017</field_pretty_url>
  <para_id>1102407</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1102706</term_id>
  <id>1102704</id>
  <title>Selected Interviews with the NCI Director</title>
  <langcode>en</langcode>
  <field_short_title>Selected Interviews by the NCI Director</field_short_title>
  <field_page_description>See interviews given by Dr. Norman “Ned” Sharpless during his time as NCI director.</field_page_description>
  <field_date_posted>2017-12-27</field_date_posted>
  <field_date_reviewed>2017-12-27</field_date_reviewed>
  <para_id>1102704</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1102951</term_id>
  <id>1102952</id>
  <title>Volunteer Opportunities and Events</title>
  <langcode>en</langcode>
  <field_short_title>Volunteer Opportunities</field_short_title>
  <field_page_description>Volunteer with Scientists in the Community. NCI Trainees can participate upcoming events or an ongoing opportunity with flexible days and times.</field_page_description>
  <field_date_posted>2018-01-05</field_date_posted>
  <field_date_reviewed>2018-01-05</field_date_reviewed>
  <para_id>1102952</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1103243</term_id>
  <id>1104011</id>
  <title>Treatment of Head and Neck Cancer in Children and Adolescents—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Head and Neck Cancer Treatment in Children and Adolescents</field_short_title>
  <field_page_description>Find diagnosis, staging, and treatment information for these head and neck cancers: hypopharynx, larynx, lip and oral cavity, neck cancer with occult primary, nasopharynx, oropharynx, paranasal sinus and nasal cavity, and salivary gland cancer.</field_page_description>
  <field_date_posted>2018-01-15</field_date_posted>
  <field_date_reviewed>2018-01-15</field_date_reviewed>
  <para_id>1104011</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1070068</term_id>
  <id>1094192</id>
  <title>NCI’s Douglas R. Lowy and John T. Schiller to receive 2017 Lasker Award</title>
  <langcode>en</langcode>
  <field_short_title>NCI’s Lowy and Schiller win 2017 Lasker Award</field_short_title>
  <field_page_description>NCI’s Douglas R. Lowy and John T. Schiller will receive the 2017 Lasker-DeBakey Clinical Medical Research Award. This NCI press release describes their HPV research, which led to the honor.</field_page_description>
  <field_date_posted>2017-09-06</field_date_posted>
  <field_date_reviewed>2017-09-05</field_date_reviewed>
  <field_pretty_url>lowy-schiller-lasker-award</field_pretty_url>
  <para_id>1094192</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1094911</id>
  <title>Forgoing Conventional Cancer Treatments for Alternative Medicine Increases Risk of Death</title>
  <langcode>en</langcode>
  <field_short_title>Alternative Medicine for Cancer Treatment Raises Mortality Risk</field_short_title>
  <field_page_description>Choosing alternative medicine as an initial cancer treatment led to substantially worse survival than patients who received conventional cancer treatments, this Cancer Currents post explains.</field_page_description>
  <field_date_posted>2017-09-12</field_date_posted>
  <field_date_reviewed>2017-09-07</field_date_reviewed>
  <field_pretty_url>alternative-medicine-cancer-survival</field_pretty_url>
  <para_id>1094911</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070074</term_id>
  <id>1095674</id>
  <title>A Brief Tour of DAVE: The Genomic Data Commons Analysis Toolkit</title>
  <langcode>en</langcode>
  <field_short_title>A tour of GDC DAVE</field_short_title>
  <field_page_description>Get a tour of GDC's genomic analysis and visualization tools</field_page_description>
  <field_date_posted>2017-09-12</field_date_posted>
  <field_date_reviewed>2017-09-12</field_date_reviewed>
  <field_pretty_url>gdc-dave-tour</field_pretty_url>
  <para_id>1095674</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1097627</id>
  <title>Study Identifies Crucial Characteristic of High-Risk HPV</title>
  <langcode>en</langcode>
  <field_short_title>Study Identifies Crucial Characteristic of High-Risk HPV</field_short_title>
  <field_page_description>For human papillomavirus type 16 (HPV16) to cause cervical cancer, a precise DNA sequence of the E7 gene may be required, this Cancer Currents post on a new study explains.</field_page_description>
  <field_date_posted>2017-10-05</field_date_posted>
  <field_date_reviewed>2017-10-05</field_date_reviewed>
  <field_pretty_url>hpv-viral-gene</field_pretty_url>
  <para_id>1097627</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1097905</id>
  <title>Pembrolizumab Secures FDA Approval in Stomach Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Pembrolizumab Secures FDA Approval in Stomach Cancer</field_short_title>
  <field_page_description>FDA has approved the immunotherapy drug pembrolizumab (Keytruda®) for use in some patients with advanced gastric (stomach) cancer that is PD-L1 positive.</field_page_description>
  <field_date_posted>2017-10-12</field_date_posted>
  <field_date_reviewed>2017-10-11</field_date_reviewed>
  <field_pretty_url>gastric-cancer-fda-keytruda</field_pretty_url>
  <para_id>1097905</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1070066</term_id>
  <id>1099018</id>
  <title>Abemaciclib Approved by FDA for Advanced or Metastatic Breast Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Abemaciclib Approved for Breast Cancer</field_short_title>
  <field_page_description>Abemaciclib (Verzenio™), a type of CDK4/6 inhibitor, has been approved by FDA for some patients with advanced or metastatic breast cancer.</field_page_description>
  <field_date_posted>2017-10-26</field_date_posted>
  <field_date_reviewed>2017-10-24</field_date_reviewed>
  <field_pretty_url>fda-abemaciclib-breast-cancer</field_pretty_url>
  <para_id>1099018</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>89699</id>
  <title>Drugs Approved for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer</field_short_title>
  <field_date_posted>2011-12-05</field_date_posted>
  <field_date_reviewed>2011-07-14</field_date_reviewed>
  <field_pretty_url>ovarian</field_pretty_url>
  <para_id>89699</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>930502</term_id>
  <id>94636</id>
  <title>New Therapies Offer Valuable Options for Patients with Melanoma</title>
  <langcode>en</langcode>
  <field_short_title>New Therapies Offer Valuable Options for Patients with Melanoma</field_short_title>
  <field_page_description>Two phase III clinical trials of new therapies for patients with metastatic melanoma presented in June at the 2011 ASCO conference confirmed that vemurafenib and ipilimumab (Yervoy™) offer valuable new options for the disease. </field_page_description>
  <field_date_posted>2011-07-19</field_date_posted>
  <field_date_reviewed>2011-07-19</field_date_reviewed>
  <field_pretty_url>vemurafenib-ipilimumab</field_pretty_url>
  <para_id>94636</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>94637</id>
  <title>Exemestane Reduces Breast Cancer Risk in High-Risk Postmenopausal Women</title>
  <langcode>en</langcode>
  <field_short_title>Exemestane Reduces Breast Cancer Risk in High-Risk Postmenopausal Women</field_short_title>
  <field_page_description>Clinical trial results presented at the 2011 ASCO annual meeting showed that the aromatase inhibitor exemestane—used to treat early and advanced breast cancer—substantially reduced the risk of invasive breast cancer in high-risk postmenopausal women.</field_page_description>
  <field_date_posted>2011-07-19</field_date_posted>
  <field_date_reviewed>2011-07-19</field_date_reviewed>
  <field_pretty_url>exemestane-reduces-risk</field_pretty_url>
  <para_id>94637</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>918919</term_id>
  <id>102660</id>
  <title>Drugs Approved for Liver Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Drugs Approved for Liver Cancer</field_short_title>
  <field_date_posted>2011-10-04</field_date_posted>
  <field_date_reviewed>2011-08-05</field_date_reviewed>
  <field_pretty_url>liver</field_pretty_url>
  <para_id>102660</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>916971</term_id>
  <id>587661</id>
  <title>Contributing to Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Contributing to Cancer Research</field_short_title>
  <field_page_description>Information about donating money to cancer research and contributing in other ways, such as volunteering, donating tissue, or participating in a research study.</field_page_description>
  <field_date_posted>2014-12-21</field_date_posted>
  <field_date_reviewed>2013-06-18</field_date_reviewed>
  <para_id>587661</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1119645</id>
  <title>Sodium Thiosulfate Prevents Cisplatin-Induced Hearing Loss in Some Children</title>
  <langcode>en</langcode>
  <field_short_title>Drug Prevents Chemo-Related Hearing Loss in Some Children</field_short_title>
  <field_page_description>Sodium thiosulfate protected cisplatin-related hearing loss in children with a form of liver cancer, results from a clinical trial show. As this Cancer Currents post explains, the findings should affect clinical practice.</field_page_description>
  <field_date_posted>2018-07-13</field_date_posted>
  <field_date_reviewed>2018-07-11</field_date_reviewed>
  <field_pretty_url>cisplatin-hearing-loss-sodium-thiosulfate</field_pretty_url>
  <para_id>1119645</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1102622</term_id>
  <id>1132086</id>
  <title>Ibrutinib plus rituximab superior to standard treatment for some patients with chronic leukemia</title>
  <langcode>en</langcode>
  <field_short_title>Ibrutinib-based therapy superior in CLL trial</field_short_title>
  <field_page_description>An interim analysis of an NCI-supported clinical trial found ibrutinib plus rituximab superior to standard treatment for patients age 70 and younger with untreated chronic lymphocytic leukemia (CLL).</field_page_description>
  <field_date_posted>2018-12-04</field_date_posted>
  <field_date_reviewed>2018-12-03</field_date_reviewed>
  <field_pretty_url>cll-ibrutinib-trial</field_pretty_url>
  <para_id>1132086</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1114846</term_id>
  <id>1132190</id>
  <title>Teaching in Medical Education</title>
  <langcode>en</langcode>
  <field_short_title>Teaching in Medical Education</field_short_title>
  <field_page_description>The Teaching in Medical Education (TIME) course provides NCI postdoctoral fellows with basic knowledge in teaching methods, course planning, writing a syllabus and developing examinations. This course is for postdoctoral fellows interested in pursing an academic career at a medical school.</field_page_description>
  <field_date_posted>2018-12-05</field_date_posted>
  <field_date_reviewed>2018-12-05</field_date_reviewed>
  <field_pretty_url>teaching-medical-education</field_pretty_url>
  <para_id>1132190</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1132734</id>
  <title>Vitamin D Supplements Don’t Reduce Cancer Incidence, Trial Shows</title>
  <langcode>en</langcode>
  <field_short_title>Vitamin D Supplements Don’t Reduce Cancer Incidence</field_short_title>
  <field_page_description>Taking vitamin D supplements doesn’t decrease cancer risk, according to results from VITAL, the largest-ever clinical trial of vitamin D for cancer prevention. </field_page_description>
  <field_date_posted>2018-12-13</field_date_posted>
  <field_date_reviewed>2018-12-12</field_date_reviewed>
  <field_pretty_url>vitamin-d-supplement-cancer-prevention</field_pretty_url>
  <para_id>1132734</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133178</term_id>
  <id>1133222</id>
  <title>Alveolar soft tissue sarcoma</title>
  <langcode>en</langcode>
  <field_short_title>Alveolar soft tissue sarcoma</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>alveolar-soft-tissue-sarcoma</field_pretty_url>
  <para_id>1133222</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133178</term_id>
  <id>1133225</id>
  <title>Inflammatory myofibroblastic tumor</title>
  <langcode>en</langcode>
  <field_short_title>Inflammatory myofibroblastic tumor</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>inflammatory-myofibroblastic-tumor</field_pretty_url>
  <para_id>1133225</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133184</term_id>
  <id>1133239</id>
  <title>Epithelioid hemangioendothelioma</title>
  <langcode>en</langcode>
  <field_short_title>Epithelioid hemangioendothelioma</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>epithelioid-hemangioendothelioma</field_pretty_url>
  <para_id>1133239</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1134568</term_id>
  <id>1133257</id>
  <title>Center for Cancer Research Rare Tumor Clinics</title>
  <langcode>en</langcode>
  <field_short_title>Rare Tumor Clinics</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <para_id>1133257</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133198</term_id>
  <id>1133258</id>
  <title>New Research</title>
  <langcode>en</langcode>
  <field_short_title>New Research</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>new-research</field_pretty_url>
  <para_id>1133258</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1133174</term_id>
  <id>1133525</id>
  <title>Rare Tumors</title>
  <langcode>en</langcode>
  <field_short_title>Rare Tumors</field_short_title>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2018-12-20</field_date_reviewed>
  <para_id>1133525</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1133192</term_id>
  <id>1133526</id>
  <title>Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_date_posted>2018-12-20</field_date_posted>
  <field_date_reviewed>2018-12-20</field_date_reviewed>
  <para_id>1133526</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133724</term_id>
  <id>1133725</id>
  <title>The Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00)</title>
  <langcode>en</langcode>
  <field_short_title>New Early K99/R00 Award</field_short_title>
  <field_page_description>The early K99/R00 will help researchers to complete n needed mentored training and transition in a timely manner to independent, tenure-track or equivalent. </field_page_description>
  <field_date_posted>2018-12-27</field_date_posted>
  <field_date_reviewed>2018-12-21</field_date_reviewed>
  <para_id>1133725</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133753</term_id>
  <id>1133757</id>
  <title>NIH Fellows Editorial Board Editorial Process Guidelines</title>
  <langcode>en</langcode>
  <field_short_title>Editorial Process Guidelines</field_short_title>
  <field_date_posted>2018-12-21</field_date_posted>
  <field_date_reviewed>2018-12-21</field_date_reviewed>
  <field_pretty_url>editorial-process</field_pretty_url>
  <para_id>1133757</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1134343</term_id>
  <id>1134344</id>
  <title>Preparing for Science-Based Non-Traditional Careers</title>
  <langcode>en</langcode>
  <field_short_title>Preparing for Science-Based Non-Traditional Careers</field_short_title>
  <field_date_posted>2019-01-16</field_date_posted>
  <field_date_reviewed>2019-01-02</field_date_reviewed>
  <para_id>1134344</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133176</term_id>
  <id>1134393</id>
  <title>What are rare bone tumors?</title>
  <langcode>en</langcode>
  <field_short_title>Rare Bone Tumors</field_short_title>
  <field_page_description>Rare bone tumors include bone cancer and cartilage cancer. They can be called by different names depending on where they are in the body. Particulare types of rare bone tumors affect children, adolescents, and young adults.</field_page_description>
  <field_date_posted>2019-01-03</field_date_posted>
  <field_date_reviewed>2019-01-03</field_date_reviewed>
  <para_id>1134393</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1134388</term_id>
  <id>1134426</id>
  <title>BRCA Exchange aggregates data on thousands of BRCA variants to inform understanding of cancer risk</title>
  <langcode>en</langcode>
  <field_short_title>BRCA Exchange serves as global data resource on gene variants</field_short_title>
  <field_page_description>The BRCA Exchange, a global resource that includes data on thousands of variants in the BRCA1 and BRCA2 genes, is available to the public through a website and new smartphone app.</field_page_description>
  <field_date_posted>2019-01-09</field_date_posted>
  <field_date_reviewed>2019-01-04</field_date_reviewed>
  <field_pretty_url>BRCA-exchange</field_pretty_url>
  <para_id>1134426</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1120154</id>
  <title>Mouse Study Links Immune Cells to Diarrhea Caused by Chemotherapy </title>
  <langcode>en</langcode>
  <field_short_title>Immune Cells Linked to Diarrhea Caused by Chemotherapy</field_short_title>
  <field_page_description>A study in mice sheds light onto how some chemotherapies cause diarrhea. The findings could be the basis for developing new treatments for patients with cancer who develop gastrointestinal side effects from chemotherapy, explains this Cancer Currents blog post.</field_page_description>
  <field_date_posted>2018-07-20</field_date_posted>
  <field_date_reviewed>2018-07-19</field_date_reviewed>
  <field_pretty_url>macrophages-chemotherapy-induced-diarrhea</field_pretty_url>
  <para_id>1120154</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1120791</id>
  <title>New Immunotherapy Option Approved for Cervical Cancer, Rare Lymphoma</title>
  <langcode>en</langcode>
  <field_short_title>Pembrolizumab Approved for Cervical Cancer, Rare Lymphoma</field_short_title>
  <field_page_description>The FDA has approved pembrolizumab (Keytruda) for some women with advanced cervical cancer and for some patients with primary mediastinal large B-cell lymphoma (PMBCL), a rare type of non-Hodgkin lymphoma.</field_page_description>
  <field_date_posted>2018-08-02</field_date_posted>
  <field_date_reviewed>2018-07-27</field_date_reviewed>
  <field_pretty_url>pembrolizumab-approved-fda-cervical-pmbcl</field_pretty_url>
  <para_id>1120791</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1121514</id>
  <title>TCGA's Study of Esophageal Cancer</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Esophageal Cancer</field_short_title>
  <field_page_description>TCGA's Study of Esophageal Cancer</field_page_description>
  <field_date_posted>2018-08-07</field_date_posted>
  <field_date_reviewed>2018-08-07</field_date_reviewed>
  <field_pretty_url>esophageal</field_pretty_url>
  <para_id>1121514</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1121524</term_id>
  <id>1121525</id>
  <title>OMB Burden Statements for NCI Information Collections</title>
  <langcode>en</langcode>
  <field_short_title>OMB Burden Statements</field_short_title>
  <field_page_description>Under the Paperwork Reduction Act, information collections approved by the Office of Management and Budget (OMB) are linked to OMB Burden Statements that explain more about the specific collection and who to contact for more information. Burden statements for information collection by NCI are kept here. </field_page_description>
  <field_date_posted>2018-09-24</field_date_posted>
  <field_date_reviewed>2018-08-07</field_date_reviewed>
  <para_id>1121525</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1121637</id>
  <title>TCGA's Study of Papillary Renal Cell Carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Papillary Renal Cell Carcinoma</field_short_title>
  <field_date_posted>2018-08-08</field_date_posted>
  <field_date_reviewed>2018-08-08</field_date_reviewed>
  <field_pretty_url>renal-cell-papillary</field_pretty_url>
  <para_id>1121637</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1125566</id>
  <title>For Small Cell Lung Cancer, Immunotherapy Drug Finally Brings Improved Survival</title>
  <langcode>en</langcode>
  <field_short_title>For Small Cell Lung Cancer, Immunotherapy Drug Improves Survival</field_short_title>
  <field_page_description>In a clinical trial of patients with advanced small cell lung cancer (SCLC), atezolizumab (Tecentriq), combined with standard chemotherapy, modestly increased survival—the first trial in more than 20 years to show a survival improvement in this cancer. </field_page_description>
  <field_date_posted>2018-10-03</field_date_posted>
  <field_date_reviewed>2018-10-02</field_date_reviewed>
  <field_pretty_url>small-cell-lung-cancer-atezolizumab-survival</field_pretty_url>
  <para_id>1125566</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1126287</term_id>
  <id>1126299</id>
  <title>Cancer Moonshot&amp;#8480; – FY 2017 and FY 2018 Funding Opportunities</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Moonshot - Closed Funding Opportunities </field_short_title>
  <field_page_description>Find funding opportunities that were available in previous fiscal years to align with the efforts of the Cancer Moonshot. </field_page_description>
  <field_date_posted>2018-10-22</field_date_posted>
  <field_date_reviewed>2018-10-11</field_date_reviewed>
  <para_id>1126299</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>916700</term_id>
  <id>1127109</id>
  <title>About Resources for Researchers </title>
  <langcode>en</langcode>
  <field_short_title>About Resources for Researchers </field_short_title>
  <field_page_description>Find contact information to add or edit a resource in the Resources for Researchers tool. </field_page_description>
  <field_date_posted>2018-10-22</field_date_posted>
  <field_date_reviewed>2018-10-22</field_date_reviewed>
  <field_pretty_url>about</field_pretty_url>
  <para_id>1127109</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1127126</id>
  <title>TCGA Cancers Selected for Study</title>
  <langcode>en</langcode>
  <field_short_title>TCGA Cancers Selected for Study</field_short_title>
  <field_page_description>An overview of the 33 cancers selected for molecular characterization and the criteria TCGA used to select them.</field_page_description>
  <field_date_posted>2018-10-22</field_date_posted>
  <field_date_reviewed>2018-10-22</field_date_reviewed>
  <para_id>1127126</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915634</term_id>
  <id>1127128</id>
  <title>Combining Immunotherapy and Radiation against Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Combining Immunotherapy and Radiation against Cancer</field_short_title>
  <field_page_description>Read how an NCI-funded team led by Robert Vonderheide showed the promise of combining immune checkpoint inhibitors and radiation therapy in melanoma.</field_page_description>
  <field_date_posted>2017-09-21</field_date_posted>
  <field_date_reviewed>2018-10-22</field_date_reviewed>
  <field_pretty_url>vonderheide-minn-twyman-saint-victor-radiation-checkpoint-inhibitors</field_pretty_url>
  <para_id>1127128</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102626</term_id>
  <id>1129034</id>
  <title>NCI Summer Curriculum: Strengthening Global Cancer Research Capacity</title>
  <langcode>en</langcode>
  <field_short_title>NCI Summer Curriculum: Strengthening Global Cancer Research Capacity</field_short_title>
  <field_page_description>Interested in learning about principles and practice of cancer prevention and control and molecular prevention? Read NCI Summer Curriculum: Strengthening Global Cancer Research Capacity and learn details about 2019 courses.</field_page_description>
  <field_date_posted>2018-10-30</field_date_posted>
  <field_date_reviewed>2018-10-30</field_date_reviewed>
  <field_pretty_url>summer-curriculum</field_pretty_url>
  <para_id>1129034</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1134542</term_id>
  <id>1134543</id>
  <title>2018 Social Media Events</title>
  <langcode>en</langcode>
  <field_short_title>2018 Social Media Events</field_short_title>
  <field_page_description>Find past social media events involving NCI and its partners from 2018.</field_page_description>
  <field_date_posted>2018-01-03</field_date_posted>
  <field_date_reviewed>2017-03-28</field_date_reviewed>
  <para_id>1134543</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1135698</term_id>
  <id>1135760</id>
  <title>CGH Recognizes World Cancer Day 2019</title>
  <langcode>en</langcode>
  <field_short_title>CGH Recognizes World Cancer Day 2019</field_short_title>
  <field_page_description>Want to know more about World Cancer Day?  Read how the NCI Center for Global Health promotes knowledge sharing in global cancer research and cancer control. </field_page_description>
  <field_date_posted>2019-01-25</field_date_posted>
  <field_date_reviewed>2019-01-25</field_date_reviewed>
  <field_pretty_url>wcd</field_pretty_url>
  <para_id>1135760</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1134352</term_id>
  <id>1137664</id>
  <title>A CAR T-Cell Therapy for Multiple Childhood Cancers?</title>
  <langcode>en</langcode>
  <field_short_title>CAR T-Cell Study Suggests Promise for Childhood Cancers</field_short_title>
  <field_page_description>A CAR T-cell therapy targeting the B7-H3 protein may have potential as a treatment for several childhood cancers, results from a study in mice suggest.</field_page_description>
  <field_date_posted>2019-02-14</field_date_posted>
  <field_date_reviewed>2019-02-13</field_date_reviewed>
  <field_pretty_url>car-t-cell-childhood-cancers</field_pretty_url>
  <para_id>1137664</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1127122</term_id>
  <id>1137852</id>
  <title>TCGA's Study of Testicular Germ Cell Cancer</title>
  <langcode>en</langcode>
  <field_short_title>TCGA's Study of Testicular Germ Cell Cancer</field_short_title>
  <field_date_posted>2019-02-15</field_date_posted>
  <field_date_reviewed>2019-02-15</field_date_reviewed>
  <field_pretty_url>testicular-germ-cell</field_pretty_url>
  <para_id>1137852</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1132043</id>
  <title>Can Topical Drugs Help Prevent Breast Cancer?</title>
  <langcode>en</langcode>
  <field_short_title>Can Topical Drugs Help Prevent Breast Cancer?</field_short_title>
  <field_page_description>A topical form of tamoxifen, called 4-OHT, is being tested to see if it can prevent breast cancer as effectively as oral tamoxifen but with fewer side effects.</field_page_description>
  <field_date_posted>2018-12-04</field_date_posted>
  <field_date_reviewed>2018-12-03</field_date_reviewed>
  <field_pretty_url>tamoxifen-gel-breast-cancer-prevention</field_pretty_url>
  <para_id>1132043</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1102624</term_id>
  <id>1133022</id>
  <title>Drug Combination May Target the Unique Metabolism of Leukemia Stem Cells</title>
  <langcode>en</langcode>
  <field_short_title>Drug Combination May Target Metabolism of Leukemia Stem Cells</field_short_title>
  <field_page_description>In AML, the drugs venetoclax (Venclexta) and azacitidine (Vidaza) team up to block the unique metabolism of leukemia stem cells, two studies show.</field_page_description>
  <field_date_posted>2018-12-14</field_date_posted>
  <field_date_reviewed>2018-12-14</field_date_reviewed>
  <field_pretty_url>aml-venetoclax-azacitidine-target-leukemia-stem-cells</field_pretty_url>
  <para_id>1133022</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1134558</term_id>
  <id>1133235</id>
  <title>Anaplastic thyroid carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>Anaplastic thyroid carcinoma</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>anaplastic-thyroid-carcinoma</field_pretty_url>
  <para_id>1133235</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133188</term_id>
  <id>1133244</id>
  <title>Neuroblastoma</title>
  <langcode>en</langcode>
  <field_short_title>Neuroblastoma</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>neuroblastoma</field_pretty_url>
  <para_id>1133244</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1133190</term_id>
  <id>1133246</id>
  <title>NUT midline carcinoma</title>
  <langcode>en</langcode>
  <field_short_title>NUT midline carcinoma</field_short_title>
  <field_date_posted>2018-12-17</field_date_posted>
  <field_date_reviewed>2018-12-17</field_date_reviewed>
  <field_pretty_url>nut-midline-carcinoma</field_pretty_url>
  <para_id>1133246</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>929499</term_id>
  <id>1134348</id>
  <title>Cancer Research Interns</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Research Interns</field_short_title>
  <field_page_description>The Cancer Research Interns (CRI) summer program goal is to train a diverse number of students in labs and branches across the Center for Cancer Research.</field_page_description>
  <field_date_posted>2019-01-16</field_date_posted>
  <field_date_reviewed>2019-01-02</field_date_reviewed>
  <field_pretty_url>cancer-research-interns</field_pretty_url>
  <para_id>1134348</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1114846</term_id>
  <id>1134382</id>
  <title>Non-Academic Jobs for Fellows in Law Firms, Patent and Trademark Office and Scientific Intellectual Property </title>
  <langcode>en</langcode>
  <field_short_title>Non-Academic Jobs for Fellows</field_short_title>
  <field_page_description>The Non-Academic Jobs for Fellows in Law Firms, Patent and Trademark Office and Scientific Intellectual Property workshop assists NCI Fellows, Staff Scientists, and Staff Clinicians in positioning themselves for job opportunites.</field_page_description>
  <field_date_posted>2019-01-03</field_date_posted>
  <field_date_reviewed>2019-01-03</field_date_reviewed>
  <field_pretty_url>non-academic-jobs</field_pretty_url>
  <para_id>1134382</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>1134388</term_id>
  <id>1134607</id>
  <title>AI approach outperformed human experts in identifying cervical precancer</title>
  <langcode>en</langcode>
  <field_short_title>Researchers create AI approach for cervical cancer screening</field_short_title>
  <field_page_description>An AI algorithm outperformed other screening methods in identifying cervical precancer. The approach could be especially valuable in low-resource settings.</field_page_description>
  <field_date_posted>2019-01-10</field_date_posted>
  <field_date_reviewed>2019-01-08</field_date_reviewed>
  <field_pretty_url>deep-learning-cervical-cancer-screening</field_pretty_url>
  <para_id>1134607</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1134352</term_id>
  <id>1134650</id>
  <title>Immunotherapy Effective in Alveolar Soft Part Sarcoma</title>
  <langcode>en</langcode>
  <field_short_title>Immunotherapy Effective in Alveolar Soft Part Sarcoma</field_short_title>
  <field_page_description>In some people with alveolar soft part sarcoma (ASPS), atezolizumab (Tecentriq) shrank tumors or stopped them from growing, a small clinical trial has shown.</field_page_description>
  <field_date_posted>2019-01-09</field_date_posted>
  <field_date_reviewed>2019-01-08</field_date_reviewed>
  <field_pretty_url>atezolizumab-alveolar-soft-part-sarcoma-trial</field_pretty_url>
  <para_id>1134650</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>1134388</term_id>
  <id>1134661</id>
  <title>2019 Press Releases</title>
  <langcode>en</langcode>
  <field_short_title>2019 Press Releases</field_short_title>
  <field_page_description>Press releases from NCI for the year 2019.</field_page_description>
  <field_date_posted>2018-02-09</field_date_posted>
  <field_date_reviewed>2018-02-09</field_date_reviewed>
  <para_id>1134661</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1137807</term_id>
  <id>1137813</id>
  <title>MyPART Upcoming Events</title>
  <langcode>en</langcode>
  <field_short_title>Upcoming Events</field_short_title>
  <field_page_description>MyPART team members are participating in meetings to talk about our programs and to answer questions. Find us at events across the country!</field_page_description>
  <field_date_posted>2019-02-15</field_date_posted>
  <field_date_reviewed>2019-02-15</field_date_reviewed>
  <para_id>1137813</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894088</term_id>
  <id>1138083</id>
  <title>CRCHD Supplements Café celebrates Black History Month</title>
  <langcode>en</langcode>
  <field_short_title>CRCHD Supplements Café celebrates Black History Month</field_short_title>
  <field_date_posted>2019-02-15</field_date_posted>
  <field_date_reviewed>2019-02-15</field_date_reviewed>
  <field_pretty_url>BlackHistoryMonth2019</field_pretty_url>
  <para_id>1138083</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>840891</term_id>
  <id>836320</id>
  <title>When Cancer Returns</title>
  <langcode>en</langcode>
  <field_short_title>When Cancer Returns</field_short_title>
  <field_date_posted>2014-10-17</field_date_posted>
  <field_date_reviewed>2014-10-02</field_date_reviewed>
  <field_pretty_url>when-cancer-returns</field_pretty_url>
  <para_id>836320</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>138990</id>
  <title>Study Confirms Letrozole Prevents More Breast Cancer Recurrences than Tamoxifen</title>
  <langcode>en</langcode>
  <field_short_title>Study Confirms Letrozole Prevents More Breast Cancer Recurrences than Tamoxifen</field_short_title>
  <field_page_description>After a median of 8 years of follow-up, women with estrogen-receptor positive breast cancer who received 5 years of letrozole were less likely to have their cancer recur or to die during follow-up than women who received 5 years of tamoxifen.</field_page_description>
  <field_date_posted>2011-12-02</field_date_posted>
  <field_date_reviewed>2011-12-02</field_date_reviewed>
  <field_pretty_url>letrozole-prevents-recurrence</field_pretty_url>
  <para_id>138990</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>837414</id>
  <title>Global Health Diplomacy on Display:  Dr. Varmus and Indian Prime Minister Modi</title>
  <langcode>en</langcode>
  <field_short_title>Global Health Diplomacy on Display:  Dr. Varmus and Indian Prime Minister Modi</field_short_title>
  <field_page_description>Global Health Diplomacy on Display:  Dr. Varmus and Indian Prime Minister Modi</field_page_description>
  <field_date_posted>2014-10-06</field_date_posted>
  <field_date_reviewed>2014-10-06</field_date_reviewed>
  <field_pretty_url>global-health-diplomacy</field_pretty_url>
  <para_id>837414</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>848639</term_id>
  <id>848368</id>
  <title>The Continuing Umbrella of Research Experiences (CURE)</title>
  <langcode>en</langcode>
  <field_short_title>Continuing Umbrella of Research Experiences</field_short_title>
  <field_page_description>The CURE program offers training and career development opportunities to increase diversity in the cancer and cancer health disparities research workforce.</field_page_description>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-10-29</field_date_reviewed>
  <para_id>848368</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>848847</term_id>
  <id>848845</id>
  <title>Tips and Tools for Applying for Grants </title>
  <langcode>en</langcode>
  <field_short_title>Tips &amp; Tools </field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-10-29</field_date_reviewed>
  <para_id>848845</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>855118</id>
  <title>Regional Cancer Registries – 20 Years and Growing</title>
  <langcode>en</langcode>
  <field_short_title>Regional Cancer Registries – 20 Years and Growing</field_short_title>
  <field_date_posted>2014-11-07</field_date_posted>
  <field_date_reviewed>2014-11-07</field_date_reviewed>
  <field_pretty_url>regional-cancer-registries</field_pretty_url>
  <para_id>855118</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>860822</term_id>
  <id>858227</id>
  <title>Adjusting to Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Adjusting to Cancer</field_short_title>
  <field_page_description>Information that helps you and your family face life’s changes from cancer. Includes talking with your doctors, talking to children, changes for the family, and information on cancer support groups.</field_page_description>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-14</field_date_reviewed>
  <para_id>858227</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>858162</term_id>
  <id>858316</id>
  <title>Changes for the Family</title>
  <langcode>en</langcode>
  <field_short_title>Changes for the Family</field_short_title>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-14</field_date_reviewed>
  <para_id>858316</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349495</term_id>
  <id>862420</id>
  <title>NCI establishes Genomic Data Commons to facilitate identification of molecular subtypes of cancer and potential drug targets</title>
  <langcode>en</langcode>
  <field_short_title>NCI establishes GDC to facilitate identification of molecular subtypes of cancer</field_short_title>
  <field_page_description>NCI is establishing the Genomic Data Commons to store, analyze and distribute cancer genomics data generated by NCI and other research organizations. The GDC will provide an interactive system for researchers to access data, with the goal of advancing the</field_page_description>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-11-25</field_date_reviewed>
  <field_pretty_url>GenomicDataCommonsNewsNote</field_pretty_url>
  <para_id>862420</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069528</term_id>
  <id>866187</id>
  <title>Quantitative Assays for RAS Pathway Proteins and Phosphorylation States</title>
  <langcode>en</langcode>
  <field_short_title>Quantitative Assays for RAS Pathway Proteins and Phosphorylation States</field_short_title>
  <field_date_posted>2014-12-01</field_date_posted>
  <field_date_reviewed>2014-12-01</field_date_reviewed>
  <field_pretty_url>ras-quantitative-assays</field_pretty_url>
  <para_id>866187</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>860262</term_id>
  <id>866206</id>
  <title>Building on Opportunities in Cancer Research: NCI’s Annual Plan and Budget Proposal for FY 2016</title>
  <langcode>en</langcode>
  <field_short_title>Building on Opportunities in Cancer Research: NCI’s Annual Plan and Budget Proposal for FY 2016</field_short_title>
  <field_page_description>NCI’s Director, Dr. Harold Varmus, introduces the NCI Annual Plan and Budget Proposal for Fiscal Year 2016.</field_page_description>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2014-12-02</field_date_reviewed>
  <field_pretty_url>NCIresearchfuture</field_pretty_url>
  <para_id>866206</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>912567</term_id>
  <id>867905</id>
  <title>Cancer Genomics Overview</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Genomics Overview</field_short_title>
  <field_page_description>Cancer genomics uses technologies such as sequencing to identify DNA and RNA alterations, define molecular subtypes, and develop precision medicine in oncology.</field_page_description>
  <field_date_posted>2015-04-13</field_date_posted>
  <field_date_reviewed>2014-12-05</field_date_reviewed>
  <para_id>867905</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>904107</term_id>
  <id>870061</id>
  <title>Message from the Director</title>
  <langcode>en</langcode>
  <field_short_title>Message from the Director</field_short_title>
  <field_date_posted>2015-02-17</field_date_posted>
  <field_date_reviewed>2014-12-10</field_date_reviewed>
  <para_id>870061</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>882493</term_id>
  <id>882505</id>
  <title>Formaldehyde</title>
  <langcode>en</langcode>
  <field_short_title>Formaldehyde</field_short_title>
  <field_page_description>Learn about formaldehyde, which can raise your risk of myeloid leukemia and rare cancers of or near the nasal cavity. Formaldehyde is used in pressed-wood building materials, fungicides, germicides, disinfectants, and certain preservatives. Other sources include tobacco smoke and car emissions.</field_page_description>
  <field_date_posted>2015-03-20</field_date_posted>
  <field_date_reviewed>2019-02-14</field_date_reviewed>
  <para_id>882505</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>915875</term_id>
  <id>883453</id>
  <title>Cancer-Causing Substances in the Environment</title>
  <langcode>en</langcode>
  <field_short_title>Cancer-Causing Substances</field_short_title>
  <field_date_posted>2015-03-18</field_date_posted>
  <field_date_reviewed>2014-12-16</field_date_reviewed>
  <para_id>883453</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>11502</term_id>
  <id>889734</id>
  <title>Journal of the National Cancer Institute, Published by Oxford University Press, Is Not Affiliated With NCI</title>
  <langcode>en</langcode>
  <field_short_title>JNCI, Published by Oxford University Press, Is Not Affiliated With NCI</field_short_title>
  <field_date_posted>2015-01-08</field_date_posted>
  <field_date_reviewed>2015-01-05</field_date_reviewed>
  <field_pretty_url>jnci</field_pretty_url>
  <para_id>889734</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>894075</id>
  <title>Analyzing the Gut Microbiome to Help Detect Colorectal Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Analyzing the Gut Microbiome to Help Detect Colorectal Cancer</field_short_title>
  <field_page_description>Two studies suggest that changes in the gut microbiome could help distinguish people with healthy colons from those with colorectal polyps or colorectal cancer.</field_page_description>
  <field_date_posted>2015-01-13</field_date_posted>
  <field_date_reviewed>2015-01-12</field_date_reviewed>
  <field_pretty_url>gut-microbiome</field_pretty_url>
  <para_id>894075</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>899250</id>
  <title>Grantee Spotlight: Veena Rao, Ph.D. - Unraveling the Mysteries of BRCA1 in African American Women</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Veena Rao, Ph.D. - Unraveling the Mysteries of BRCA1 in African American Women</field_short_title>
  <field_date_posted>2014-10-20</field_date_posted>
  <field_date_reviewed>2014-10-20</field_date_reviewed>
  <field_pretty_url>rao-spotlight</field_pretty_url>
  <para_id>899250</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>792907</term_id>
  <id>902306</id>
  <title>CGH Celebrates World Cancer Day 2015</title>
  <langcode>en</langcode>
  <field_short_title>CGH Celebrates World Cancer Day 2015</field_short_title>
  <field_date_posted>2015-01-30</field_date_posted>
  <field_date_reviewed>2015-01-30</field_date_reviewed>
  <field_pretty_url>World-Cancer-Day-2015</field_pretty_url>
  <para_id>902306</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>903594</term_id>
  <id>903599</id>
  <title>People in Health Care</title>
  <langcode>en</langcode>
  <field_short_title>People in Health Care</field_short_title>
  <field_page_description>Information about the treatment team of health care providers who work together to help cancer patients.</field_page_description>
  <field_date_posted>2015-03-10</field_date_posted>
  <field_date_reviewed>2015-02-02</field_date_reviewed>
  <para_id>903599</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>903752</term_id>
  <id>903689</id>
  <title>How Cancer Is Diagnosed</title>
  <langcode>en</langcode>
  <field_short_title>Diagnosis</field_short_title>
  <field_page_description>Learn about tests and procedures that diagnose cancer. Your doctor may ask about personal and family medical history or order lab tests, imaging scans, or a biopsy.</field_page_description>
  <field_date_posted>2015-03-09</field_date_posted>
  <field_date_reviewed>2015-03-09</field_date_reviewed>
  <para_id>903689</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11926</term_id>
  <id>12897</id>
  <title>Lung Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Lung Cancer</field_short_title>
  <field_page_description>The two main types of lung cancer are non-small cell lung cancer and small cell lung cancer. Smoking causes most lung cancers, but nonsmokers can also develop lung cancer. Start here to find information on lung cancer treatment, causes and prevention, screening, research, and statistics on lung cancer.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>12897</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11900</term_id>
  <id>12963</id>
  <title>Esophageal Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Esophageal Cancer</field_short_title>
  <field_page_description>The most common types of esophageal cancer are adenocarcinoma and squamous cell carcinoma. These forms of esophageal cancer develop in some parts of the esophagus and are driven by genetic changes. Start here to find information on esophageal cancer treatment, causes and prevention, screening, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>12963</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>11646</term_id>
  <id>13054</id>
  <title>Coping with Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Coping with Cancer</field_short_title>
  <field_date_posted>2014-12-02</field_date_posted>
  <field_date_reviewed>2009-10-08</field_date_reviewed>
  <para_id>13054</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922407</term_id>
  <id>178191</id>
  <title>Exemestane Following Tamoxifen Reduces Breast Cancer Recurrences and Prolongs Survival</title>
  <langcode>en</langcode>
  <field_short_title>Exemestane Following Tamoxifen Reduces Breast Cancer Recurrences and Prolongs Survival</field_short_title>
  <field_page_description>Postmenopausal women with early-stage hormone receptor-positive breast cancer had delayed disease recurrence and longer survival after taking 2-3 years of tamoxifen followed by exemestane for a total of 5 years compared to taking tamoxifen for 5 years.</field_page_description>
  <field_date_posted>2012-02-01</field_date_posted>
  <field_date_reviewed>2012-02-01</field_date_reviewed>
  <field_pretty_url>exemestane-prolongs-survival</field_pretty_url>
  <para_id>178191</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>11708</term_id>
  <id>909853</id>
  <title>NCI Fact Sheets</title>
  <langcode>en</langcode>
  <field_short_title>Fact Sheets</field_short_title>
  <field_date_posted>2015-02-19</field_date_posted>
  <field_date_reviewed>2015-02-19</field_date_reviewed>
  <para_id>909853</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>894080</term_id>
  <id>910289</id>
  <title>Grantee Spotlight: Dr. David Turner - Investigating the Role of Nutrition in Cancer Growth for African Americans Living with Prostate Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Dr. David Turner - Role of Nutrition in Cancer Growth for African Americans</field_short_title>
  <field_date_posted>2015-02-20</field_date_posted>
  <field_date_reviewed>2015-02-20</field_date_reviewed>
  <field_pretty_url>turner-spotlight-blog</field_pretty_url>
  <para_id>910289</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>1069530</term_id>
  <id>912334</id>
  <title>Ras Mitogenic Signaling: p53 Enters the Stage</title>
  <langcode>en</langcode>
  <field_short_title>Ras Mitogenic Signaling: p53 Enters the Stage</field_short_title>
  <field_date_posted>2015-03-09</field_date_posted>
  <field_date_reviewed>2015-03-02</field_date_reviewed>
  <field_pretty_url>ras-mitogenic-signaling</field_pretty_url>
  <para_id>912334</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>912836</term_id>
  <id>912839</id>
  <title>Chemotherapy to Treat Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Chemotherapy </field_short_title>
  <field_page_description>Chemotherapy is a type of cancer treatment that uses drugs to kill cancer cells. Learn how chemotherapy works against cancer, why it causes side effects, and how it is used with other cancer treatments.</field_page_description>
  <field_date_posted>2015-04-29</field_date_posted>
  <field_date_reviewed>2015-03-17</field_date_reviewed>
  <para_id>912839</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>914818</term_id>
  <id>915049</id>
  <title>Step 4: Award Negotiation &amp; Issuance</title>
  <langcode>en</langcode>
  <field_short_title>Step 4: Award Negotiation &amp; Issuance</field_short_title>
  <field_page_description>Before a grant can be awarded and accepted, several pre-award activities must happen to formalize the partnership. Ensuring compliance with federal laws, a review of costs and a negotiation of the appropriate funding level must all happen in order to receive a grant.</field_page_description>
  <field_date_posted>2015-04-02</field_date_posted>
  <field_date_reviewed>2015-03-12</field_date_reviewed>
  <para_id>915049</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>915112</term_id>
  <id>915113</id>
  <title>Researchers use Modified CRISPR Systems to Modulate Gene Expression on a Genomic Scale</title>
  <langcode>en</langcode>
  <field_short_title>Researchers use Modified CRISPR Systems to Modulate Gene Expression on a Genomic Scale</field_short_title>
  <field_date_posted>2015-04-13</field_date_posted>
  <field_date_reviewed>2015-03-12</field_date_reviewed>
  <field_pretty_url>CRISPRa</field_pretty_url>
  <para_id>915113</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>915269</id>
  <title>Grantee Spotlight: Habtom Ressom, Ph.D. - Multi-Omic Approaches for the Early Detection of Liver Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Habtom Ressom, Ph.D.</field_short_title>
  <field_date_posted>2014-12-18</field_date_posted>
  <field_date_reviewed>2014-12-18</field_date_reviewed>
  <field_pretty_url>ressom-spotlight-blog</field_pretty_url>
  <para_id>915269</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>915266</term_id>
  <id>915271</id>
  <title>Grants Policies and Process</title>
  <langcode>en</langcode>
  <field_short_title>Grants Policies and Process</field_short_title>
  <field_page_description>NIH prior approval is required for the transfer of a grant. Learn more about transferring a cancer research grant from one entity to another.</field_page_description>
  <field_date_posted>2015-03-12</field_date_posted>
  <field_date_reviewed>2015-03-12</field_date_reviewed>
  <para_id>915271</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvTopicPage</CONTENTTYPENAME>
  <term_id>911158</term_id>
  <id>915971</id>
  <title>Advanced Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Advanced Cancer</field_short_title>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>915971</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>915818</term_id>
  <id>916033</id>
  <title>Taking Care of Yourself</title>
  <langcode>en</langcode>
  <field_short_title>Taking Care of Yourself</field_short_title>
  <field_page_description>Caring for someone with advanced cancer brings new challenges and concerns. It's important to take care of yourself and reach out for help. Find tips specific to caregivers of patients with advanced cancer.</field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-03-13</field_date_reviewed>
  <para_id>916033</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>916854</term_id>
  <id>916855</id>
  <title>History of the National Cancer Institute</title>
  <langcode>en</langcode>
  <field_short_title>History</field_short_title>
  <field_page_description>Since its establishment in 1937, the National Cancer Institute has supported and advanced cancer research in many ways.</field_page_description>
  <field_date_posted>2015-03-18</field_date_posted>
  <field_date_reviewed>2015-03-16</field_date_reviewed>
  <para_id>916855</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917279</term_id>
  <id>919802</id>
  <title>Cancer Care Delivery Research Steering Committee Roster</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Care Delivery Research Steering Committee Roster</field_short_title>
  <field_page_description>Roster of members on the Cancer Care Delivery Research Steering Committee.</field_page_description>
  <field_date_posted>2015-03-26</field_date_posted>
  <field_date_reviewed>2015-03-26</field_date_reviewed>
  <field_pretty_url>roster</field_pretty_url>
  <para_id>919802</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>937920</term_id>
  <id>15305</id>
  <title>Multicultural Media Outreach Program</title>
  <langcode>en</langcode>
  <field_short_title>Multicultural Media Outreach Program</field_short_title>
  <field_date_posted>2010-11-05</field_date_posted>
  <field_date_reviewed>2010-08-23</field_date_reviewed>
  <para_id>15305</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>11502</term_id>
  <id>15309</id>
  <title>National Cancer Institute Overview and Mission </title>
  <langcode>en</langcode>
  <field_short_title>NCI Overview</field_short_title>
  <field_page_description>Learn about the National Cancer Institute and what we do, our impact, and our future plans.</field_page_description>
  <field_date_posted>2015-03-18</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>15309</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciAppModulePage</CONTENTTYPENAME>
  <term_id>16384</term_id>
  <id>16385</id>
  <title>NCI Dictionary of Cancer Terms</title>
  <langcode>en</langcode>
  <field_short_title>NCI Dictionary of Cancer Terms</field_short_title>
  <field_page_description>NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine.</field_page_description>
  <field_date_posted>2011-02-02</field_date_posted>
  <field_date_reviewed>2011-02-02</field_date_reviewed>
  <para_id>16385</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>333101</id>
  <title>NIH tools facilitate matching cancer drugs with gene targets</title>
  <langcode>en</langcode>
  <field_short_title>NIH tools facilitate matching cancer drugs with gene targets</field_short_title>
  <field_page_description>A new study details how a suite of web-based tools provides the research community with greatly improved capacity to compare data derived from large collections of genomic information against thousands of drugs.  By comparing drugs and genetic targets, re</field_page_description>
  <field_date_posted>2012-07-16</field_date_posted>
  <field_date_reviewed>2012-07-16</field_date_reviewed>
  <field_pretty_url>CellMiner</field_pretty_url>
  <para_id>333101</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>396053</term_id>
  <id>396065</id>
  <title>Randomization and Bias in Cancer Clinical Trials</title>
  <langcode>en</langcode>
  <field_short_title>Randomization</field_short_title>
  <field_date_posted>2012-08-10</field_date_posted>
  <field_date_reviewed>2016-06-22</field_date_reviewed>
  <para_id>396065</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>420501</term_id>
  <id>420502</id>
  <title>Where Trials Take Place</title>
  <langcode>en</langcode>
  <field_short_title>Where Trials Take Place</field_short_title>
  <field_date_posted>2012-09-11</field_date_posted>
  <field_date_reviewed>2012-09-11</field_date_reviewed>
  <para_id>420502</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>420521</term_id>
  <id>420524</id>
  <title>Informed Consent</title>
  <langcode>en</langcode>
  <field_short_title>Informed Consent</field_short_title>
  <field_date_posted>2012-09-11</field_date_posted>
  <field_date_reviewed>2016-06-22</field_date_reviewed>
  <para_id>420524</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>420530</term_id>
  <id>420531</id>
  <title>Ending Trials Early</title>
  <langcode>en</langcode>
  <field_short_title>Ending Trials Early</field_short_title>
  <field_date_posted>2012-09-11</field_date_posted>
  <field_date_reviewed>2016-06-22</field_date_reviewed>
  <para_id>420531</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349491</term_id>
  <id>434303</id>
  <title>NIH study uncovers likely role of major cancer protein</title>
  <langcode>en</langcode>
  <field_short_title>Major cancer protein amplifies global gene expression</field_short_title>
  <field_page_description>Scientists may have discovered why a protein called MYC can provoke a variety of cancers. Like many proteins associated with cancer, MYC helps regulate cell growth. A new study carried out by researchers at the National Institutes of Health and colleagues</field_page_description>
  <field_date_posted>2012-09-27</field_date_posted>
  <field_date_reviewed>2012-09-26</field_date_reviewed>
  <field_pretty_url>MYCLeven</field_pretty_url>
  <para_id>434303</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938229</term_id>
  <id>476532</id>
  <title>Treating Patients with High-Risk Smoldering Myeloma</title>
  <langcode>en</langcode>
  <field_short_title>Treating Patients with High-Risk Smoldering Myeloma</field_short_title>
  <field_page_description>In this phase III clinical trial, patients with smoldering myeloma classified as high risk for progression will be randomly assigned to undergo standard observation or six 4-week courses of treatment with the drug lenalidomide. </field_page_description>
  <field_date_posted>2012-12-11</field_date_posted>
  <field_date_reviewed>2012-12-11</field_date_reviewed>
  <field_pretty_url>lenalidomide-high-risk-smoldering</field_pretty_url>
  <para_id>476532</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>917237</term_id>
  <id>478619</id>
  <title>Contacts</title>
  <langcode>en</langcode>
  <field_short_title>Contacts</field_short_title>
  <field_date_posted>2012-12-17</field_date_posted>
  <field_date_reviewed>2012-12-17</field_date_reviewed>
  <field_pretty_url>contacts</field_pretty_url>
  <para_id>478619</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>11886</term_id>
  <id>479707</id>
  <title>Breast Reconstruction After Mastectomy</title>
  <langcode>en</langcode>
  <field_short_title>Breast Reconstruction After Mastectomy</field_short_title>
  <field_page_description>A fact sheet that describes breast reconstruction after mastectomy, including surgical options, follow-up care, and breast cancer screening after reconstruction. </field_page_description>
  <field_date_posted>2016-10-17</field_date_posted>
  <field_date_reviewed>2017-02-24</field_date_reviewed>
  <field_pretty_url>reconstruction-fact-sheet</field_pretty_url>
  <para_id>479707</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>349493</term_id>
  <id>480973</id>
  <title>Report to the Nation shows U.S. cancer death rates continue to drop; Special feature highlights trends in HPV-associated cancers and HPV vaccination coverage levels</title>
  <langcode>en</langcode>
  <field_short_title>Report to the Nation shows cancer death rates dropping</field_short_title>
  <field_page_description>The Annual Report to the Nation on the Status of Cancer, 1975–2009, shows that overall cancer death rates continued to decline in the United States among both men and women, among all major racial and ethnic groups, and for all of the most common cancer s</field_page_description>
  <field_date_posted>2013-01-07</field_date_posted>
  <field_date_reviewed>2012-12-26</field_date_reviewed>
  <field_pretty_url>ReportNation</field_pretty_url>
  <para_id>480973</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>922399</term_id>
  <id>922401</id>
  <title>Results of the National CT Colonography Trial: Questions and Answers</title>
  <langcode>en</langcode>
  <field_short_title>Results of the National CT Colonography Trial: Questions and Answers</field_short_title>
  <field_page_description>Learn the results of the National Computerized Tomographic Colonography (CTC) clinical trial, which evaluated how well CTC identifies participants with at least one significantly large polyp using colonoscopy as the gold (or reference) standard.</field_page_description>
  <field_date_posted>2008-09-17</field_date_posted>
  <field_date_reviewed>2015-04-01</field_date_reviewed>
  <field_pretty_url>virtual-colonoscopy-results-qa</field_pretty_url>
  <para_id>922401</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>923365</term_id>
  <id>923366</id>
  <title>Cancer Statistics</title>
  <langcode>en</langcode>
  <field_short_title>Cancer Statistics</field_short_title>
  <field_page_description>Basic information about cancer statistics in the U.S. and how they are used to understand the impact of cancer on society and to develop strategies that address the challenges that cancer poses.</field_page_description>
  <field_date_posted>2015-04-02</field_date_posted>
  <field_date_reviewed>2015-04-02</field_date_reviewed>
  <para_id>923366</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>929807</term_id>
  <id>929808</id>
  <title>About This Website</title>
  <langcode>en</langcode>
  <field_short_title>About This Website</field_short_title>
  <field_page_description>The National Cancer Institute (NCI) website serves to disseminate authoritative, evidence-based, and up-to-date information about cancer and NCI-supported cancer research. Much of the information is available for content reuse and syndication.</field_page_description>
  <field_date_posted>2015-04-10</field_date_posted>
  <field_date_reviewed>2018-04-05</field_date_reviewed>
  <para_id>929808</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>890156</term_id>
  <id>936434</id>
  <title>Immune-Based Treatment Shows Promise against Metastatic Cervical Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Immunotherapy for Cervical Cancer</field_short_title>
  <field_page_description>In an early phase NCI clinical trial, two patients with metastatic cervical cancer had a complete disappearance of their tumors after receiving treatment with a form of immunotherapy called adoptive cell transfer.</field_page_description>
  <field_date_posted>2015-04-16</field_date_posted>
  <field_date_reviewed>2015-04-16</field_date_reviewed>
  <field_pretty_url>immunotherapy-cervical</field_pretty_url>
  <para_id>936434</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>936435</id>
  <title>Grantee Spotlight: Elisa Rodriguez, Ph.D., M.S. - Community-based Education and Outreach Can Increase Biospecimen Donations among Hispanics and African Americans </title>
  <langcode>en</langcode>
  <field_short_title>Grantee Spotlight: Elisa Rodriguez, Ph.D., M.S.</field_short_title>
  <field_date_posted>2014-06-25</field_date_posted>
  <field_date_reviewed>2014-06-25</field_date_reviewed>
  <field_pretty_url>rodriguez-spotlight-blog</field_pretty_url>
  <para_id>936435</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>938053</id>
  <title>Program Spotlight: National Outreach Network's Community Health Educators Provide Much-Needed Support to Cancer Survivors from Racially/Ethnically Diverse Communities</title>
  <langcode>en</langcode>
  <field_short_title>Program Spotlight: National Outreach Network's Community Health Educators </field_short_title>
  <field_date_posted>2014-04-17</field_date_posted>
  <field_date_reviewed>2014-04-17</field_date_reviewed>
  <field_pretty_url>survivorship-spotlight</field_pretty_url>
  <para_id>938053</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>938140</id>
  <title>July Spotlight: Cancer Awareness Highlights</title>
  <langcode>en</langcode>
  <field_short_title>July Spotlight: Cancer Awareness Highlights</field_short_title>
  <field_date_posted>2014-07-01</field_date_posted>
  <field_date_reviewed>2014-07-01</field_date_reviewed>
  <field_pretty_url>july2014-spotlight</field_pretty_url>
  <para_id>938140</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvBlogPost</CONTENTTYPENAME>
  <term_id>828705</term_id>
  <id>938159</id>
  <title>Special Spotlight: Asian American and Pacific Islander Heritage Month </title>
  <langcode>en</langcode>
  <field_short_title>Special Spotlight: Asian American and Pacific Islander Heritage Month </field_short_title>
  <field_date_posted>2014-05-01</field_date_posted>
  <field_date_reviewed>2014-05-01</field_date_reviewed>
  <field_pretty_url>may2014-spotlight</field_pretty_url>
  <para_id>938159</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938223</term_id>
  <id>939893</id>
  <title>Bone Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on bone cancers, such as osteosarcoma and Ewing sarcoma, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-04-30</field_date_reviewed>
  <para_id>939893</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940001</term_id>
  <id>940006</id>
  <title>Carcinoma of Unknown Primary—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Carcinoma of Unknown Primary</field_short_title>
  <field_page_description>Carcinoma of unknown primary (CUP) is a rare disease in which malignant cells are found in the body but the site of the primary cancer is not known. Most CUPs are adenocarcinomas, or undifferentiated tumors. Find evidence-based information on the treatment for carcinoma of unknown primary.</field_page_description>
  <field_date_posted>2015-04-30</field_date_posted>
  <field_date_reviewed>2015-04-30</field_date_reviewed>
  <para_id>940006</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938195</term_id>
  <id>940117</id>
  <title>Esophageal Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on esophageal cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940117</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940287</term_id>
  <id>940292</id>
  <title>Gestational Trophoblastic Disease—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Gestational Trophoblastic Disease</field_short_title>
  <field_page_description>Gestational trophoblastic disease (GTD) is a broad term encompassing both benign and malignant growths arising from products of conception in the uterus. GTDs contain paternal chromosomes and are placental in origin. Find evidence-based information on gestational trophoblastic disease treatment.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940292</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940349</term_id>
  <id>940354</id>
  <title>Intraocular (Eye) Melanoma—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Intraocular (Eye) Melanoma</field_short_title>
  <field_page_description>Intraocular (uveal) melanoma of the uveal tract (iris, ciliary body, and choroid), though rare, is the most common primary intraocular malignancy in adults. Find evidence-based information on intraocular melanoma treatment.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940354</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>914484</term_id>
  <id>940417</id>
  <title>Langerhans Cell Histiocytosis—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Langerhans Cell Histiocytosis</field_short_title>
  <field_page_description>Langerhans cell histiocytosis is a rare blood cancer that forms when a type of white blood cell called Langerhans cells becomes abnormal and grows in different parts of the body. LCH is most common in young children but can occur at any age. Start here to find information on Langerhans cell histiocytosis treatment.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940417</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940412</term_id>
  <id>940418</id>
  <title>Langerhans Cell Histiocytosis—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Langerhans Cell Histiocytosis</field_short_title>
  <field_page_description>Histiocytic diseases, like Langerhans cell histiocytosis (LCH) and myeloid-derived dendritic cell disorder, in children and adults are caused by an abnormal accumulation of cells of the mononuclear phagocytic system. Find evidence-based information on Langerhans cell histiocytosis treatment.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940418</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940827</term_id>
  <id>940836</id>
  <title>Pheochromocytoma and Paraganglioma—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Pheochromocytoma and Paraganglioma</field_short_title>
  <field_page_description>Pheochromocytomas and extra-adrenal paragangliomas are rare tumors arising from neural crest tissue that develops into sympathetic and parasympathetic paraganglia throughout the body. Find evidence-based information on pheochromocytoma and paraganglioma treatment, research, and genetics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940836</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>940885</term_id>
  <id>940890</id>
  <title>Prostate Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Prostate Cancer </field_short_title>
  <field_page_description>Prostate cancers are often adenocarcinomas. Prostatic intraepithelial neoplasia is often present in association with prostatic adenocarcinoma. Find evidence-based information on prostate cancer including treatment, causes and prevention, screening, research, genetics, and statistics.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>940890</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>938142</term_id>
  <id>941115</id>
  <title>Thyroid Cancer Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_page_description>Find research articles on thyroid cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941115</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>941205</term_id>
  <id>941210</id>
  <title>Vaginal Cancer—Health Professional Version</title>
  <langcode>en</langcode>
  <field_short_title>Vaginal Cancer </field_short_title>
  <field_page_description> Vaginal cancer is often squamous cell carcinoma. Other types of vaginal cancer are adenocarcinoma, melanoma, and sarcoma. Infection with certain types of human papillomavirus (HPV) causes most vaginal cancer. Find evidence-based information on vaginal cancer treatment and research.</field_page_description>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941210</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerResearch</CONTENTTYPENAME>
  <term_id>915373</term_id>
  <id>941397</id>
  <title>Diagnosis and Staging Research</title>
  <langcode>en</langcode>
  <field_short_title>Research</field_short_title>
  <field_date_posted>2015-05-01</field_date_posted>
  <field_date_reviewed>2015-05-01</field_date_reviewed>
  <para_id>941397</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>12758</term_id>
  <id>14365</id>
  <title>The NCI Intramural Research Program</title>
  <langcode>en</langcode>
  <field_short_title>Intramural Research</field_short_title>
  <field_date_posted>2015-05-07</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14365</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911142</term_id>
  <id>14370</id>
  <title>Reproductive History and Cancer Risk </title>
  <langcode>en</langcode>
  <field_short_title>Reproductive History and Cancer Risk</field_short_title>
  <field_page_description>A fact sheet that describes what is known about the relationship between pregnancy, miscarriage, abortion, fertility treatment and the risk of cancer. </field_page_description>
  <field_date_posted>2016-11-30</field_date_posted>
  <field_date_reviewed>2016-11-09</field_date_reviewed>
  <field_pretty_url>reproductive-history-fact-sheet</field_pretty_url>
  <para_id>14370</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11870</term_id>
  <id>14506</id>
  <title>Adrenocortical Carcinoma—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Adrenocortical Carcinoma</field_short_title>
  <field_page_description>Adrenocortical carcinoma is a rare cancer which forms in the cortex (outer layer) of an adrenal gland. There are two adrenal glands. One sits on top of each kidney. Start here to find information on adrenocortical carcinoma treatment and research.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14506</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11982</term_id>
  <id>14707</id>
  <title>Vaginal Cancer—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Vaginal Cancer</field_short_title>
  <field_page_description>Two-thirds of vaginal cancer cases are caused by human papillomavirus (HPV). Vaccines that protect against infection with HPV may reduce the risk of vaginal cancer. When found early, vaginal cancer can often be cured. Start here to find information on vaginal cancer treatment and research.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14707</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvFactSheet</CONTENTTYPENAME>
  <term_id>911172</term_id>
  <id>14759</id>
  <title>Human Papillomavirus (HPV) Vaccines</title>
  <langcode>en</langcode>
  <field_short_title>Human Papillomavirus (HPV) Vaccines</field_short_title>
  <field_page_description>A fact sheet about human papillomavirus (HPV) vaccines for the prevention of infection with certain types of HPV, which is the major cause of cervical cancer.</field_page_description>
  <field_date_posted>2018-05-25</field_date_posted>
  <field_date_reviewed>2018-05-16</field_date_reviewed>
  <field_pretty_url>hpv-vaccine-fact-sheet</field_pretty_url>
  <para_id>14759</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvCancerTypeHome</CONTENTTYPENAME>
  <term_id>11932</term_id>
  <id>14831</id>
  <title>Plasma Cell Neoplasms (Including Multiple Myeloma)—Patient Version</title>
  <langcode>en</langcode>
  <field_short_title>Plasma Cell Neoplasms (Including Multiple Myeloma)</field_short_title>
  <field_page_description>Plasma cell neoplasms occur when abnormal plasma cells form cancerous tumors. When there is only one tumor, the disease is called a plasmacytoma. When there are multiple tumors, it is called multiple myeloma. Start here to find information on plasma cell neoplasms treatment, research, and statistics.</field_page_description>
  <field_date_posted>1980-01-01</field_date_posted>
  <field_date_reviewed>2004-12-29</field_date_reviewed>
  <para_id>14831</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938030</term_id>
  <id>14957</id>
  <title>Eliminating Hairy Cell Leukemia Minimal Residual Disease</title>
  <langcode>en</langcode>
  <field_short_title>Eliminating Hairy Cell Leukemia Minimal Residual Disease</field_short_title>
  <field_page_description>In this trial, patients with hairy cell leukemia who have disease-related symptoms that require treatment will be randomly assigned to receive cladribine with either concurrent rituximab or rituximab at least 6 months after completing cladribine therapy.</field_page_description>
  <field_date_posted>2010-10-19</field_date_posted>
  <field_date_reviewed>2010-10-20</field_date_reviewed>
  <field_pretty_url>cladribine-hairy-cell</field_pretty_url>
  <para_id>14957</para_id>
</row>
<row>
  <CONTENTTYPENAME>nciGeneral</CONTENTTYPENAME>
  <term_id>505613</term_id>
  <id>505758</id>
  <title>Privacy and Security Policy</title>
  <langcode>en</langcode>
  <field_short_title>Privacy and Security</field_short_title>
  <field_page_description>Learn about the privacy and security policies for the National Cancer Institute (NCI) website.</field_page_description>
  <field_date_posted>2013-02-05</field_date_posted>
  <field_date_reviewed>2013-02-05</field_date_reviewed>
  <para_id>505758</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>938231</term_id>
  <id>953354</id>
  <title>Treatment Prevents Chemotherapy Side Effects for Children with Cancer</title>
  <langcode>en</langcode>
  <field_short_title>Treatment Prevents Chemotherapy Side Effects for Children with Cancer</field_short_title>
  <field_page_description>Adding aprepitant to the anti-nausea drug ondansetron, with or without dexamethasone, effectively prevents chemotherapy-induced nausea and vomiting in children. </field_page_description>
  <field_date_posted>2015-05-13</field_date_posted>
  <field_date_reviewed>2015-05-13</field_date_reviewed>
  <field_pretty_url>aprepitant-side-effects</field_pretty_url>
  <para_id>953354</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvArticle</CONTENTTYPENAME>
  <term_id>1090852</term_id>
  <id>956477</id>
  <title>NCI and the Precision Medicine Initiative&amp;reg;</title>
  <langcode>en</langcode>
  <field_short_title>NCI and the Precision Medicine Initiative&amp;reg;</field_short_title>
  <field_page_description>NCI's activities related to precision medicine focuses on new and expanded precision medicine clinical trials; mechanisms to overcome drug resistance to cancer treatments; and developing a shared digital repository of precision medicine trials data.</field_page_description>
  <field_date_posted>2015-05-19</field_date_posted>
  <field_date_reviewed>2015-05-19</field_date_reviewed>
  <para_id>956477</para_id>
</row>
<row>
  <CONTENTTYPENAME>cgvPressRelease</CONTENTTYPENAME>
  <term_id>899356</term_id>
  <id>960437</id>
  <title>NCI-MATCH trial will link targeted cancer drugs to gene abnormalities</title>
  <langcode>en</langcode>
  <field_short_title>NCI-MATCH Links Targeted Drugs to Mutations</field_short_title>
  <field_date_posted>2015-06-01</field_date_posted>
  <field_date_reviewed>2015-05-28</field_date_reviewed>
  <field_pretty_url>nci-match</field_pretty_url>
  <para_id>960437</para_id>
</row>
</rows>
